## all.seq (last updated: 981201) : SWISS-PROT version
##      
##  IMPORTANT NOTICE:
##
##	These data consist of excerpts from complete Swiss-prot entries. 
##	The original entries are available from the ExPASY (http://www.
##	expasy.ch/) and EBI (http://www.ebi.ac.uk/) servers.
##	Anyone including commercial users may use the data in this file 
##	freely.
##	
##      Special thanks to Dr. Amos Bairoch for this courtesy.
##
## -----------------------------------------------------------------------
##
## This file contains:
##        4 csk (cytoskeletal)
##      161 cyt (cytoplasmic)
##       58 end (endoplasmic reticulum)
##       21 exc (extracellular, including cell wall)
##       17 gol (Golgi)
##      257 mit (mitochondrial)
##      494 nuc (nuclear)
##        9 pla (plasma membrane)
##       25 pox (peroxisomal)
##       19 vac (vacuolar)
##       15 ves (vesicles of secretory system)
##   S. cerevisiae proteins (1080 in total)
##
##   Unusally small amount of plasma membrane proteins may cause bad effects
##
>P15891 csk ACTIN BINDING PROTEIN.
     MALEPIDYTT HSREIDAEYL KIVRGSDPDT TWLIISPNAK KEYEPESTGS SFHDFLQLFD
     ETKVQYGLAR VSPPGSDVEK IIIIGWCPDS APLKTRASFA ANFAAVANNL FKGYHVQVTA
     RDEDDLDENE LLMKISNAAG ARYSIQTSSK QQGKASTPPV KKSFTPSKSP APVSKKEPVK
     TPSPAPAAKI SSRVNDNNDD DDWNEPELKE RDFDQAPLKP NQSSYKPIGK IDLQKVIAEE
     KAKEDPRLVQ KPTAAGSKID PSSDIANLKN ESKLKRDSEF NSFLGTTKPP SMTESSLKND
     DDKVIKGFRN EKSPAQLWAE RKAKQNSGNA ETKAEAPKPE VPEDEPEGEP DVKDLKSKFE
     GLAASEKEEE EMENKFAPPP KKSEPTIISP KPFSKPQEPV KAEEAEQPKT DYKKIGNPLP
     GMHIEADNEE EPEENDDDWD DDEDEAAQPP LPSRNVASGA PVQKEEPEQE EIAPSLPSRN
     SIPAPKQEEA PEQAPEEEIE EEAEEAAPQL PSRSSAAPPP PPRRATPEKK PKENPWATAE
     YDYDAAEDNE LTFVENDKII NIEFVDDDWW LGELEKDGSK GLFPSNYVSL GN
>P43638 csk MAP-HOMOLOGOUS PROTEIN 1.
     MDSKDTQKLL KEHRIPCIDV GWLVRPSAST SKSSRPGKSE SKANSVAPDI QMDTARPPVF
     ETSVDSSSSI LSSNDKGRRH SVAASLLMDN QRANAGSTSV PTNIPPPRGR SKSVVETNLS
     NVEADSGHHH HHRHHHHTED APAPKKVGFF KSLFGHRKKD QEQQEKERER KERSPSPTHV
     DRGAAIRRER TATISAESPP PLQYNAPPSY NDTVVPLTRS KTESEVYYEN HPQSYYHGRM
     RTYHSPEEGK VDGTSPADDH NYGGSRPDPR LMDFLRYYKS KDYKLAAFKE GNFIKSSASP
     TTKKNRRASF SLHNDKPQPA KSLAHQKFDA KGRPIPPHPD APKLPSAFRK KHPSNASIVD
     TVDSNSDVSS SAQNNNQTPS SHKFGAFLRK VTSYGNNNNN STNASSLSAN VNNPDTSSTS
     LWSSSSMEFD PSKITTVPGL ENIRPLKHVS FATNTYFNDP PQQICSKNPR KGEVEVKPNG
     SVVIHRLTPQ ERKKIMESTS LGVVVGGTGQ LKLLNPEEDD ANAKSKEEMA PQKQNEVEAH
     DEEDNNSQRR NIVMAAAEAA AEARAKEAPN ELKRIVTNNE EEVTVSKTAS HLTIDKPMIS
     RRGASTSSLA SMVSSDTNGT NADDEGEILP PPSLKIPHDI VYTRCCHLRE ILPIPATLKQ
     LKKGSTDPIP ILQLRNPRPS MVEIWSFSDF LSIAPVLCLS LDGVQLTVQM LRIILSSLVY
     KQHFQKLSLR NTPLDEEGWK VLCYFVSKAK SLHSIDLTMV PSIKTNVQKP SKSSLKSKIL
     RMQCNLENRS DMNWDLLTAS IALMGGLEEI VISGAKMNSA QFKNFILVAC IATERLGLAY
     NGLSKSQCDD LAKWMVQSKV TGLDVGFNDL NGKLSSFTDA VLGKIQKANE KNVFKFLSLN
     GTNLRVNEHD TFENNEVLKL ISVLCYLENL KFLDISNNPA IFPHCVPTLI DFLPVFVNLV
     RLHIDYNNLS STSVVMLAEI LPMCSRLNYF SMLGTELDLA SSKALAEAVR KSSSLMTLDV
     DYVYMPENIK EKISLYALRN IQGELKRVNS DDKDIKDSQF SSLQDQLSLL LTEKADNSEH
     YNKMVENFMA KIALARIKIS KVVHDLFDLK LNGQLNLEGK EALIRLCFIE ASLERGCDLL
     KQRHNNTLKS PEAVSKSRKG GNQAQPNSES CQRMLLSSSI LQNSDHIALM PFGSAIVEKS
     SPDAEDAVEF REGDDSNVNH EDVPANDQQF RDEVDIKNKY SIIKRELEHE KLVGGGDLPV
     DKEILNRAAQ SLDSDQIKEF LLKNDVSTIL GVIDELHSQG YHLHHIFKKQ GNQEETAFRT
     KDEQQSSQSN DSSANASPTT DPISTGSNTS RTNDNAHIPP TDAPGFDKFM NNAEENAIDA
     AYDDVLDKIQ DARNSSTK
>P27895 csk KINESIN-LIKE PROTEIN CIN8.
     MVWPESNVEY RYRSKQFKGK SNKKYIKAQK IQQERICLMP AENQNTGQDR SSNSISKNGN
     SQVGCHTVPN EELNITVAVR CRGRNEREIS MKSSVVVNVP DITGSKEISI NTTGDTGITA
     QMNAKRYTVD KVFGPGASQD LIFDEVAGPL FQDFIKGYNC TVLVYGMTST GKTYTMTGDE
     KLYNGELSDA AGIIPRVLLK LFDTLELQQN DYVVKCSFIE LYNEELKDLL DSNSNGSSNT
     GFDGQFMKKL RIFDSSTANN TTSNSASSSR SNSRNSSPRS LNDLTPKAAL LRKRLRTKSL
     PNTIKQQYQQ QQAVNSRNNS SSNSGSTTNN ASSNTNTNNG QRSSMAPNDQ TNGIYIQNLQ
     EFHITNAMEG LNLLQKGLKH RQVASTKMND FSSRSHTIFT ITLYKKHQDE LFRISKMNLV
     DLAGSENINR SGALNQRAKE AGSINQSLLT LGRVINALVD KSGHIPFRES KLTRLLQDSL
     GGNTKTALIA TISPAKVTSE ETCSTLEYAS KAKNIKNKPQ LGSFIMKDIL VKNITMELAK
     IKSDLLSTKS KEGIYMSQDH YKNLNSDLES YKNEVQECKR EIESLTSKNA LLVKDKLKSK
     ETIQSQNCQI ESLKTTIDHL RAQLDKQHKT EIEISDFNNK LQKLTEVMQM ALHDYKKREL
     DLNQKFEMHI TKEIKKLKST LFLQLNTMQQ ESILQETNIQ PNLDMIKNEV LTLMRTMQEK
     AELMYKDCVK KILNESPKFF NVVIEKIDII RVDFQKFYKN IAENLSDISE ENNNMKQYLK
     NHFFKNNHQE LLNRHVDSTY ENIEKRTNEF VENFKKVLND HLDENKKLIM QNLTTATSAV
     IDQEMDLFEP KRVKWENSFD LINDCDSMNN EFYNSMAATL SQIKSTVDTS SNSMNESISV
     MKGQVEESEN AISLLKNNTK FNDQFEQLIN KHNMLKDNIK NSITSTHSHI TNVDDIYNTI
     ENIMKNYGNK ENATKDEMIE NILKEIPNLS KKMPLRLSNI NSNSVQSVIS PKKHAIEDEN
     KSSENVDNEG SRKMLKIE
>P28742 csk KINESIN-LIKE PROTEIN KIP1.
     MARSSLPNRR TAQFEANKRR TIAHAPSPSL SNGMHTLTPP TCNNGAATSD SNIHVYVRCR
     SRNKREIEEK SSVVISTLGP QGKEIILSNG SHQSYSSSKK TYQFDQVFGA ESDQETVFNA
     TAKNYIKEML HGYNCTIFAY GQTGTGKTYT MSGDINILGD VQSTDNLLLG EHAGIIPRVL
     VDLFKELSSL NKEYSVKISF LELYNENLKD LLSDSEDDDP AVNDPKRQIR IFDNNNNNSS
     IMVKGMQEIF INSAHEGLNL LMQGSLKRKV AATKCNDLSS RSHTVFTITT NIVEQDSKDH
     GQNKNFVKIG KLNLVDLAGS ENINRSGAEN KRAQEAGLIN KSLLTLGRVI NALVDHSNHI
     PYRESKLTRL LQDSLGGMTK TCIIATISPA KISMEETAST LEYATRAKSI KNTPQVNQSL
     SKDTCLKDYI QEIEKLRNDL KNSRNKQGIF ITQDQLDLYE SNSILIDEQN LKIHNLREQI
     KKFKENYLNQ LDINNLLQSE KEKLIAIIQN FNVDFSNFYS EIQKIHHTNL ELMNEVIQQR
     DFSLENSQKQ YNTNQNMQLK ISQQVLQTLN TLQGSLNNYN SKCSEVIKGV TEELTRNVNT
     HKAKHDSTLK SLLNITTNLL MNQMNELVRS ISTSLEIFQS DSTSHYRKDL NEIYQSHQQF
     LKNLQNDIKS CLDSIGSSIL TSINEISQNC TTNLNSMNVL IENQQSGSSK LIKEQDLEIK
     KLKNDLINER RISNQFNQQL AEMKRYFQDH VSRTRSEFHD ELNKCIDNLK DKQSKLDQDI
     WQKTASIFNE TDIVVNKIHS DSIASLAHNA ENTLKTVSQN NESFTNDLIS LSRGMNMDIS
     SKLRSLPINE FLNKISQTIC ETCGDDNTIA SNPVLTSIKK FQNIICSDIA LTNEKIMSLI
     DEIQSQIETI SNENNINLIA INENFNSLCN FILTDYDENI MQISKTQDEV LSEHCEKLQS
     LKILGMDIFT AHSIEKPLHE HTRPEASVIK ALPLLDYPKQ FQIYRDAENK SKDDTSNSRT
     CIPNLSTNEN FPLSQFSPKT PVPVPDQPLP KVLIPKSINS AKSNRSKTLP NTEGTGRESQ
     NNLKRRFTTE PILKGEETEN NDILQNKKLH Q
>P00330 cyt ALCOHOL DEHYDROGENASE I (EC 1.1.1.1).
     SIPETQKGVI FYESHGKLEH KDIPVPKPKA NELLINVKYS GVCHTDLHAW HGDWPLPVKL
     PLVGGHEGAG VVVGMGENVK GWKIGDYAGI KWLNGSCMAC EYCELGNESN CPHADLSGYT
     HDGSFQQYAT ADAVQAAHIP QGTDLAQVAP ILCAGITVYK ALKSANLMAG HWVAISGAAG
     GLGSLAVQYA KAMGYRVLGI DGGEGKEELF RSIGGEVFID FTKEKDIVGA VLKATDGGAH
     GVINVSVSEA AIEASTRYVR ANGTTVLVGM PAGAKCCSDV FNQVVKSISI VGSYVGNRAD
     TREALDFFAR GLVKSPIKVV GLSTLPEIYE KMEKGQIVGR YVVDTSK
>P00331 cyt ALCOHOL DEHYDROGENASE II (EC 1.1.1.1).
     SIPETQKAII FYESNGKLEH KDIPVPKPKP NELLINVKYS GVCHTDLHAW HGDWPLPTKL
     PLVGGHEGAG VVVGMGENVK GWKIGDYAGI KWLNGSCMAC EYCELGNESN CPHADLSGYT
     HDGSFQEYAT ADAVQAAHIP QGTDLAEVAP ILCAGITVYK ALKSANLRAG HWAAISGAAG
     GLGSLAVQYA KAMGYRVLGI DGGPGKEELF TSLGGEVFID FTKEKDIVSA VVKATNGGAH
     GIINVSVSEA AIEASTRYCR ANGTVVLVGL PAGAKCSSDV FNHVVKSISI VGSYVGNRAD
     TREALDFFAR GLVKSPIKVV GLSSLPEIYE KMEKGQIAGR YVVDTSK
>P00358 cyt GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE 2 (EC 1.2.1.12) (GAPDH 2).
     VRVAINGFGR IGRLVMRIAL QRKNVEVVAL NDPFISNDYS AYMFKYDSTH GRYAGEVSHD
     DKHIIVDGHK IATFQERDPA NLPWASLNID IAIDSTGVFK ELDTAQKHID AGAKKVVITA
     PSSTAPMFVM GVNEEKYTSD LKIVSNASCT TNCLAPLAKV INDAFGIEEG LMTTVHSMTA
     TQKTVDGPSH KDWRGGRTAS GNIIPSSTGA AKAVGKVLPE LQGKLTGMAF RVPTVDVSVV
     DLTVKLNKET TYDEIKKVVK AAAEGKLKGV LGYTEDAVVS SDFLGDSNSS IFDAAAGIQL
     SPKFVKLVSW YDNEYGYSTR VVDLVEHVAK A
>P00445 cyt SUPEROXIDE DISMUTASE (CU-ZN) (EC 1.15.1.1).
     VQAVAVLKGD AGVSGVVKFE QASESEPTTV SYEIAGNSPN AERGFHIHEF GDATNGCVSA
     GPHFNPFKKT HGAPTDEVRH VGDMGNVKTD ENGVAKGSFK DSLIKLIGPT SVVGRSVVIH
     AGQDDLGKGD TEESLKTGNA GPRPACGVIG LTN
>P00817 cyt INORGANIC PYROPHOSPHATASE (EC 3.6.1.1) (PYROPHOSPHATE PHOSPHO-
     TYTTRQIGAK NTLEYKVYIE KDGKPVSAFH DIPLYADKEN NIFNMVVEIP RWTNAKLEIT
     KEETLNPIIQ DTKKGKLRFV RNCFPHHGYI HNYGAFPQTW EDPNVSHPET KAVGDNDPID
     VLEIGETIAY TGQVKQVKAL GIMALLDEGE TDWKVIAIDI NDPLAPKLND IEDVEKYFPG
     LLRATNEWFR IYKIPDGKPE NQFAFSGEAK NKKYALDIIK ETHDSWKQLI AGKSSDSKGI
     DLTNVTLPDT PTYSKAASDA IPPASLKADA PIDKSIDKWF FISGSV
>P00924 cyt ENOLASE 1 (EC 4.2.1.11) (2-PHOSPHOGLYCERATE DEHYDRATASE) (2-PHOSPHO-D-
     AVSKVYARSV YDSRGNPTVE VELTTEKGVF RSIVPSGAST GVHEALEMRD GDKSKWMGKG
     VLHAVKNVND VIAPAFVKAN IDVKDQKAVD DFLISLDGTA NKSKLGANAI LGVSLAASRA
     AAAEKNVPLY KHLADLSKSK TSPYVLPVPF LNVLNGGSHA GGALALQEFM IAPTGAKTFA
     EALRIGSEVY HNLKSLTKKR YGASAGNVGD EGGVAPNIQT AEEALDLIVD AIKAAGHDGK
     VKIGLDCASS EFFKDGKYDL DFKNPNSDKS KWLTGPQLAD LYHSLMKRYP IVSIEDPFAE
     DDWEAWSHFF KTAGIQIVAD DLTVTNPKRI ATAIEKKAAD ALLLKVNQIG TLSESIKAAQ
     DSFAAGWGVM VSHRSGETED TFIADLVVGL RTGQIKTGAP ARSERLAKLN QLLRIEEELG
     DNAVFAGENF HHGDKL
>P00925 cyt ENOLASE 2 (EC 4.2.1.11) (2-PHOSPHOGLYCERATE DEHYDRATASE) (2-PHOSPHO-D-
     AVSKVYARSV YDSRGNPTVE VELTTEKGVF RSIVPSGAST GVHEALEMRD EDKSKWMGKG
     VMNAVNNVNN VIAAAFVKAN LDVKDQKAVD DFLLSLDGTA NKSKLGANAI LGVSMAAARA
     AAAEKNVPLY QHLADLSKSK TSPYVLPVPF LNVLNGGSHA GGALALQEFM IAPTGAKTFA
     EAMRIGSEVY HNLKSLTKKR YGASAGNVGD EGGVAPNIQT AEEALDLIVD AIKAAGHDGK
     VKIGLDCASS EFFKDGKYDL DFKNPESDKS KWLTGVELAD MYHSLMKRYP IVSIEDPFAE
     DDWEAWSHFF KTAGIQIVAD DLTVTNPARI ATAIEKKAAD ALLLKVNQIG TLSESIKAAQ
     DSFAANWGVM VSHRSGETED TFIADLVVGL RTGQIKTGAP ARSERLAKLN QLLRIEEELG
     DKAVYAGENF HHGDKL
>P00958 cyt METHIONYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.10) (METHIONINE--TRNA
     SFLISFDKSK KHPAHLQLAN NLKIALALEY ASKNLKPEVD NDNAAMELRN TKEPFLLFDA
     NAILRYVMDD FEGQTSDKYQ FALASLQNLL YHKELPQQHV EVLTNKAIEN YLVELKEPLT
     TTDLILFANV YALNSSLVHS KFPELPSKVH NAVALAKKHV PRDSSSFKNI GAVKIQADLT
     VKPKDSEILP KPNERNILIT SALPYVNNVP HLGNIIGSVL SADIFARYCK GRNYNALFIC
     GTDEYGTATE TKALEEGVTP RQLCDKYHKI HSDVYKWFQI GFDYFGRTTT DKQTEIAQHI
     FTKLNSNGYL EEQSMKQLYC PVHNSYLADR YVEGECPKCH YDDARGDQCD KCGALLDPFE
     LINPRCKLDD ASPEPKYSDH IFLSLDKLES QISEWVEKAS EEGNWSKNSK TITQSWLKDG
     LKPRCITRDL VWGTPVPLEK YKDKVLYVWF DATIGYVSIT SNYTKEWKQW WNNPEHVSLY
     QFMGKDNVPF HTVVFPGSQL GTEENWTMLH HLNTTEYLQY ENGKFSKSRG VGVFGNNAQD
     SGISPSVWRY YLASVRPESS DSHFSWDDFV ARNNSELLAN LGNFVNRLIK FVNAKYNGVV
     PKFDPKKVSN YDGLVKDINE ILSNYVKEME LGHERRGLEI AMSLSARGNQ FLQENKLDNT
     LFSQSPEKSD AVVAVGLNII YAVSSIITPY MPEIGEKINK MLNAPALKID DRFHLAILEG
     HNINKAEYLF QRIDEKKIDE WRAKYGGQQV
>P01095 cyt PROTEASE B INHIBITORS 2 AND 1 (PROTEINASE INHIBITOR I(B)2).
     TKNFIVTLKK NTPDVEAKKF LDSVHHAGGS IVHEFDIIKG YTIKVPDVLH LNKLKEKHND
     VIENVEEDKE VHTN
>P02579 cyt ACTIN.
     MDSEVAALVI DNGSGMCKAG FAGDDAPRAV FPSIVGRPRH QGIMVGMGQK DSYVGDEAQS
     KRGILTLRYP IEHGIVTNWD DMEKIWHHTF YNELRVAPEE HPVLLTEAPM NPKSNREKMT
     QIMFETFNVP AFYVSIQAVL SLYSSGRTTG IVLDSGDGVT HVVPIYAGFS LPHAILRIDL
     AGRDLTDYLM KILSERGYSF STTAEREIVR DIKEKLCYVA LDFEQEMQTA AQSSSIEKSY
     ELPDGQVITI GNERFRAPEA LFHPSVLGLE SAGIDQTTYN SIMKCDVDVR KELYGNIVMS
     GGTTMFPGIA ERMQKEITAL APSSMKVKII APPERKYSVW IGGSILASLT TFQQMWISKQ
     EYDESGPSIV HHKCF
>P02829 cyt HEAT SHOCK PROTEIN HSP82.
     MASETFEFQA EITQLMSLII NTVYSNKEIF LRELISNASD ALDKIRYKSL SDPKQLETEP
     DLFIRITPKP EQKVLEIRDS GIGMTKAELI NNLGTIAKSG TKAFMEALSA GADVSMIGQF
     GVGFYSLFLV ADRVQVISKS NDDEQYIWES NAGGSFTVTL DEVNERIGRG TILRLFLKDD
     QLEYLEEKRI KEVIKRHSEF VAYPIQLVVT KEVEKEVPIP EEEKKDEEKK DEEKKDEDDK
     KPKLEEVDEE EEKKPKTKKV KEEVQEIEEL NKTKPLWTRN PSDITQEEYN AFYKSISNDW
     EDPLYVKHFS VEGQLEFRAI LFIPKRAPFD LFESKKKKNN IKLYVRRVFI TDEAEDLIPE
     WLSFVKGVVD SEDLPLNLSR EMLQQNKIMK VIRKNIVKKL IEAFNEIAED SEQFEKFYSA
     FSKNIKLGVH EDTQNRAALA KLLRYNSTKS VDELTSLTDY VTRMPEHQKN IYYITGESLK
     AVEKSPFLDA LKAKNFEVLF LTDPIDEYAF TQLKEFEGKT LVDITKDFEL EETDEEKAER
     EKEIKEYEPL TKALKEILGD QVEKVVVSYK LLDAPAAIRT GQFGWSANME RIMKAQALRD
     SSMSSYMSSK KTFEISPKSP IIKELKKRVD EGGAQDKTVK DLTKLLYETA LLTSGFSLDE
     PTSFASRINR LISLGLNIDE DEETETAPEA STAAPVEEVP ADTEMEEVD
>P02994 cyt ELONGATION FACTOR 1-ALPHA (EF-1-ALPHA).
     MGKEKSHINV VVIGHVDSGK STTTGHLIYK CGGIDKRTIE KFEKEAAELG KGSFKYAWVL
     DKLKAERERG ITIDIALWKF ETPKYQVTVI DAPGHRDFIK NMITGTSQAD CAILIIAGGV
     GEFEAGISKD GQTREHALLA FTLGVRQLIV AVNKMDSVKW DESRFQEIVK ETSNFIKKVG
     YNPKTVPFVP ISGWNGDNMI EATTNAPWYK GWEKETKAGV VKGKTLLEAI DAIEQPSRPT
     DKPLRLPLQD VYKIGGIGTV PVGRVETGVI KPGMVVTFAP AGVTTEVKSV EMHHEQLEQG
     VPGDNVGFNV KNVSVKEIRR GNVCGDAKND PPKGCASFNA TVIVLNHPGQ ISAGYSPVLD
     CHTAHIACRF DELLEKNDRR SGKKLEDHPK FLKSGDAALV KFVPSKPMCV EAFSEYPPLG
     RFAVRDMRQT VAVGVIKSVD KTEKAAKVTK AAQKAAKK
>P03965 cyt CARBAMOYL-PHOSPHATE SYNTHASE, ARGININE-SPECIFIC, LARGE CHAIN
     MTSIYTSTEP TNSAFTTEDY KPQLVEGVNS VLVIGSGGLS IGQAGEFDYS GSQAIKALKE
     DNKFTILVNP NIATNQTSHS LADKIYYLPV TPEYITYIIE LERPDAILLT FGGQTGLNCG
     VALDESGVLA KYNVKVLGTP IKTLITSEDR DLFASALKDI NIPIAESFAC ETVDEALEAA
     ERVKYPVIVR SAYALGGLGS GFANNASEMK ELAAQSLSLA PQILVEKSLK GWKEVEYEVV
     RDRVGNCITV CNMENFDPLG VHTGDSMVFA PSQTLSDEEF HMLRSAAIKI IRHLGVIGEC
     NVQYALQPDG LDYRVIEVNA RLSRSSALAS KATGYPLAYT AAKIGLGYTL PELPNPITKT
     TVANFEPSLD YIVAKIPKWD LSKFQYVDRS IGSSMKSVGE VMAIGRNYEE AFQKALRQVD
     PSLLGFQGST EFGDQLDEAL RTPTDRRVLA IGQALIHENY TVERVNELSK IDKWFLYKCM
     NIVNIYKELE SVKSLSDLSK DLLQRAKKLG FSDKQIAVTI NKHASTNINE LEIRSLRKTL
     GIIPFVKRID TLAAEFPAQT NYLYTTYNAT KNDVEFNENG MLVLGSGVYR IGSSVEFDWC
     AVNTAKTLRD QGKKTIMINY NPETVSTDFD EVDRLYFEEL SYERVMDIYE LEQSEGCIIS
     VGGQLPQNIA LKLYDNGCNI MGTNPNDIDR AENRHKFSSI LDSIDVDQPE WSELTSVEEA
     KLFASKVNYP VLIRPSYVLS GAAMSVVNNE EELKAKLTLA SDVSPDHPVV MSKFIEGAQE
     IDVDAVAYNG NVLVHAISEH VENAGVHSGD ASLVLPPQHL SDDVKIALKD IADKVAKAWK
     ITGPFNMQII KDGEHTLKVI ECNIRASRSF PFVSKVLGVN FIEIAVKAFL GGDIVPKPVD
     LMLNKKYDYV ATKVPQFSFT RLAGADPFLG VEMASTGEVA SFGRDLIESY WTAIQSTMNF
     HVPLPPSGIL FGGDTSREYL GQVASIVATI GYRIYTTNET TKTYLQEHIK EKNAKVSLIK
     FPKNDKRKLR ELFQEYDIKA VFNLASKRAE STDDVDYIMR RNAIDFAIPL FNEPQTALLF
     AKCLKAKIAE KIKILESHDV IVPPEVRSWD EFIGFKAY
>P04173 cyt 3-ISOPROPYLMALATE DEHYDROGENASE (EC 1.1.1.85) (BETA-IPM DEHYDROGENASE)
     MSAPKKIVVL PGDHVGQEIT AEAIKVLKAI SDVRSNVKFD FENHLIGGAA IDATGVPLPD
     EALEASKKVD AVLLGAVGGP KWGTGSVRPE QGLLKIRKEL QLYANLRPCN FASDSLLDLS
     PIKPQFAKGT DFVVVRELVG GIYFGKRKED DGDGVAWDSE QYTVPEVQRI TRMAAFMALQ
     HEPPLPIWSL DKANVLASSR LWRKTVEETI KNEFPTLKVQ HQLIDSAAMI LVKNPTHLNG
     IIITSNMFGD IISDEASVIP GSLGLLPSAS LASLPDKNTA FGLYEPCHGS APDLPKNKVD
     PIATILSAAM MLKLSLNLPE EGKAIEDAVK KVLDAGIRTG DLGGSNSTTE VGDAVAEEVK
     KILA
>P04801 cyt THREONYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.3) (THREONINE--TRNA
     MSASEAGVTE QVKKLSVKDS SNDAVKPNKK ENKKSKQQSL YLDPEPTFIE ERIEMFDRLQ
     KEYNDKVASM PRVPLKIVLK DGAVKEATSW ETTPMDIAKG ISKSLADRLC ISKVNGQLWD
     LDRPFEGEAN EEIKLELLDF ESDEGKKVFW HSSAHVLGES CECHLGAHIC LGPPTDDGFF
     YEMAVRDSMK DISESPERTV SQADFPGLEG VAKNVIKQKQ KFERLVMSKE DLLKMFHYSK
     YKTYLVQTKV PDGGATTVYR CGKLIDLCVG PHIPHTGRIK AFKLLKNSSC YFLGDATNDS
     LQRVYGISFP DKKLMDAHLK FLAEASMRDH RKIGKEQELF LFNEMSPGSC FWLPHGTRIY
     NTLVDLLRTE YRKRGYEEVI TPNMYNSKLW ETSGHWANYK ENMFTFEVEK ETFGLKPMNC
     PGHCLMFKSR ERSYRELPWR VADFGVIHRN EFSGALSGLT RVRRFQQDDA HIFCTHDQIE
     SEIENIFNFL QYIYGVFGFE FKMELSTRPE KYVGKIETWD AAESKLESAL KKWGGNWEIN
     AGDGAFYGPK IDIMISDALR RWHQCATIQL DFQLPNRFEL EFKSKDQDSE SYERPVMIHR
     AILGSVERMT AILTEHFAGK WPFWLSPRQV LVVPVGVKYQ GYAEDVRNKL HDAGFYADVD
     LTGNTLQKKV RNGQMLKYNF IFIVGEQEMN EKSVNIRNRD VMEQQGKNAT VSVEEVLKQL
     RNLKDEKRGD NVLA
>P04802 cyt ASPARTYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.12) (ASPARTATE--TRNA
     SQDENIVKAV EESAEPAQVI LGEDGKPLSK KALKKLQKEQ EKQRKKEERA LQLEAEREAR
     EKKAAAEDTA KDNYGKLPLI QSRDSDRTGQ KRVKFVDLDE AKDSDKEVLF RARVHNTRQQ
     GATLAFLTLR QQASLIQGLV KANKEGTISK NMVKWAGSLN LESIVLVRGI VKKVDEPIKS
     ATVQNLEIHI TKIYTISETP EALPILLEDA SRSEAEAEAA GLPVVNLDTR LDYRVIDLRT
     VTNQAIFRIQ AGVCELFREY LATKKFTEVH TPKLLGAPSE GGSSVFEVTY FKGKAYLAQS
     PQFNKQQLIV ADFERVYEIG PVFRAENSNT HRHMTEFTGL DMEMAFEEHY HEVLDTLSEL
     FVFIFSELPK RFAHEIELVR KQYPVEEFKL PKDGKMVRLT YKEGIEMLRA AGKEIGDFED
     LSTENEKFLG KLVRDKYDTD FYILDKFPLE IRPFYTMPDP ANPKYSNSYD FFMRGEEILS
     GAQRIHDHAL LQERMKAHGL SPEDPGLKDY CDGFSYGCPP HAGGGIGLER VVMFYLDLKN
     IRRASLFPRD PKRLRP
>P05150 cyt ORNITHINE CARBAMOYLTRANSFERASE (EC 2.1.3.3) (OTCASE) (ORNITHINE
     MSTTASTPSS LRHLISIKDL SDEEFRILVQ RAQHFKNVFK ANKTNDFQSN HLKLLGRTIA
     LIFTKRSTRT RISTEGAATF FGAQPMFLGK EDIQLGVNES FYDTTKVVSS MVSCIFARVN
     KHEDILAFCK DSSVPIINSL CDKFHPLQAI CDLLTIIENF NISLDEVNKG INSKLKMAWI
     GDANNVINDM CIACLKFGIS VSISTPPGIE MDSDIVDEAK KVAERNGATF ELTHDSLKAS
     TNANILVTDT FVSMGEEFAK QAKLKQFKGF QINQELVSVA DPNYKFMHCL PRHQEEVSDD
     VFYGEHSIVF EEAENRLYAA MSAIDIFVNN KGNFKDLK
>P06106 cyt O-ACETYLHOMOSERINE SULFHYDRYLASE (EC 4.2.99.10) (OAH SULFHYDRYLASE) /
     PSHFDTVQLH AGQENPGDNA HRSRAVPIYA TTSYVFENSK HGSQLFGLEV PGYVYSRFQN
     PTSNVLEERI AALEGGAAAL AVSSGQAAQT LAIQGLAHTG DNIVSTSYLY GGTYNQFKIS
     FKRFGIEARF VEGDNPEEFE KVFDERTKAV YLETIGNPKY NVPDFEKIVA IAHKHGIPVV
     VDNTFGAGGY FCQPIKYGAD IVTHSATKWI GGHGTTIGGI IVDSGKFPWK DYPEKFPQFS
     QPAEGYHGTI YNEAYGNLAY IVHVRTELLR DLGPLMNPFA SFLLLQGVET LSLRAERHGE
     NALKLAKWLE QSPYVSWVSY PGLASHSHHE NAKKYLSNGF GGVLSFGVKD LPNADKETDP
     FKLSGAQVVD NLKLASNLAN VGDAKTLVIA PYFTTHKQLN DKEKLASGVT KDLIRVSVGI
     EFIDDIIADF QQSFETVFAG QKP
>P06115 cyt CATALASE T (EC 1.11.1.6).
     MPIRSISSAS QMNVFGKKEE KQEKVYSLQN GFPYSHHPYA SQYSRPDGPI LLQDFHLLEN
     IASFDRERVP ERVVHAKGGG CRLEFELTDS LSDITYAAPY QNVGYKCPGL VRFSTVGGES
     GTPDTARDPR GVSFKFYTEW GNHDWVFNNT PVFFLRDAIK FPVFIHSQKR DPQSHLNQFQ
     DTTIYWDYLT LNPESIHQIT YMFGDRGTPA SWASMNAYSG HSFIMVNKEG KDTYVQFHVL
     SDTGFETLTG DKAAELSGSH PDYNQAKLFT QLQNGEKPKF NCYVQTMTPE QATKFRYSVN
     DLTKIWPHKE FPLRKFGTIT LTENVDNYFQ EIEQVAFSPT NTCIPGIKPS NDSVLQARLF
     SYPDTQRHRL GANYQQLPVN RPRNLGCPYS KGDSQYTAEQ CPFKAVNFQR DGPMSYYNFG
     PEPNYISSLP NQTLKFKNED NDEVSDKFKG IVLDEVTEVS VRKQEQDQIR NEHIVDAKIN
     QYYYVYGISP LDFEQPRALY EKVYNDEQKK LFVHNVVCHA CKIKDPKVKK RVTQYFGLLN
     EDLGKVIAEC LGVPWEPVDL EGYAKTWSIA SAN
>P07170 cyt ADENYLATE KINASE CYTOSOLIC (EC 2.7.4.3) (ATP-AMP TRANSPHOSPHORYLASE).
     MSSSESIRMV LIGPPGAGKG TQAPNLQERF HAAHLATGDM LRSQIAKGTQ LGLEAKKIMD
     QGGLVSDDIM VNMIKDELTN NPACKNGFIL DGFPRTIPQA EKLDQMLKEQ GTPLEKAIEL
     KVDDELLVAR ITGRLIHPAS GRSYHKIFNP PKEDMKDDVT GEALVQRSDD NADALKKRLA
     AYHAQTEPIV DFYKKTGIWA GVDASQPPAT VWADILNKLG KD
>P07245 cyt C-1-TETRAHYDROFOLATE SYNTHASE, CYTOPLASMIC (METHYLENETETRAHYDROFOLATE
     MAGQVLDGKA CAQQFRSNIA NEIKSIQGHV PGFAPNLAII QVGNRPDSAT YVRMKRKAAE
     EAGIVANFIH LDESATEFEV LRYVDQLNED PHTHGIIVQL PLPAHLDEDR ITSRVLAEKD
     VDGFGPTNIG ELNKKNGHPF FLPCTPKGII ELLHKANVTI EGSRSVVIGR SDIVGSPVAE
     LLKSLNSTVT ITHSKTRDIA SYLHDADIVV VAIGQPEFVK GEWFKPRDGT SSDKKTVVID
     VGTNYVADPS KKSGFKCVGD VEFNEAIKYV HLITPVPGGV GPMTVAMLMQ NTLIAAKRQM
     EESSKPLQIP PLPLKLLTPV PSDIDISRAQ QPKLINQLAQ ELGIYSHELE LYGHYKAKIS
     PKVIERLQTR QNGKYILVSG ITPTPLGEGK STTTMGLVQA LTAHLGKPAI ANVRQPSLGP
     TLGVKGGAAG GGYSQVIPMD EFNLHLTGDI HAIGAANNLL AAAIDTRMFH ETTQKNDATF
     YNRLVPRKNG KRKFTPSMQR RLNRLGIQKT NPDDLTPEEI NKFARLNIDP DTITIKRVVD
     INDRMLRQIT IGQAPTEKNH TRVTGFDITV ASELMAILAL SKDLRDMKER IGRVVVAADV
     NRSPVTVEDV GCTGALTALL RDAIKPNLMQ TLEGTPVLVH AGPFANISIG ASSVIADRVA
     LKLVGTEPEA KTEAGYVVTE AGFDFTMGGE RFFNIKCRSS GLTPNAVVLV ATVRALKSHG
     GAPDVKPGQP LPSAYTEENI EFVEKGAANM CKQIANIKQF GVPVVVAINK FETDTEGEIA
     AIRKAALEAG AFEAVTSNHW AEGGKGAIDL AKAVIEASNQ PVDFHFLYDV NSSVEDKLTT
     IVQKMYGGAA IDILPEAQRK IDMYKEQGFG NLPICIAKTQ YSLSHDATLK GVPTGFTFPI
     RDVRLSNGAG YLYALAAEIQ TIPGLATYAG YMAVEVDDDG EIDGLF
>P07258 cyt CARBAMOYL-PHOSPHATE SYNTHASE, ARGININE-SPECIFIC, SMALL CHAIN
     MSSAATKATF CIQNGPSFEG ISFGANKSVA GETVFTTSLV GYPESMTDPS YRGQILVFTQ
     PLIGNYGVPS GEARDEYNLL KYFESPHIHV VGIVVAEYAY QYSHWTAVES LAQWCQREGV
     AAITGVDTRE LVQYLREQGS SLGRITLADH DPVPYVNPMK TNLVAQVTTK KPFHVSALPG
     KAKANVALID CGVKENIIRC LVKRGANVTV FPYDYRIQDV ASEFDGIFLS NGPGNPELCQ
     ATISNVRELL NNPVYDCIPI FGICLGHQLL ALASGASTHK LKYGNRAHNI PAMDLTTGQC
     HITSQNHGYA VDPETLPKDQ WKPYFVNLND KSNEGMIHLQ RPIFSTQFHP EAKGGPLDTA
     ILFDKFFDNI EKYQLQSQAK SSISLKVTYS TDKSRLQSIN VTKLAKERVL F
>P07277 cyt MEVALONATE KINASE (EC 2.7.1.36) (MVK).
     MSLPFLTSAP GKVIIFGEHS AVYNKPAVAA SVSALRTYLL ISESSAPDTI ELDFPDISFN
     HKWSINDFNA ITEDQVNSQK LAKAQQATDG LSQELVSLLD PLLAQLSESF HYHAAFCFLY
     MFVCLCPHAK NIKFSLKSTL PIGAGLGSSA SISVSLALAM AYLGGLIGSN DLEKLSENDK
     HIVNQWAFIG EKCIHGTPSG IDNAVATYGN ALLFEKDSHN GTINTNNFKF LDDFPAIPMI
     LTYTRIPRST KDLVARVRVL VTEKFPEVMK PILDAMGECA LQGLEIMTKL SKCKGTDDEA
     VETNNELYEQ LLELIRINHG LLVSIGVSHP GLELIKNLSD DLRIGSTKLT GAGGGGCSLT
     LLRRDITQEQ IDSFKKKLQD DFSYETFETD LGGTGCCLLS AKNLNKDLKI KSLVFQLFEN
     KTTTKQQIDD LLLPGNTNLP WTS
>P07283 cyt PHOSPHOMANNOMUTASE (EC 5.4.2.8) (PMM).
     MSIAEFAYKE KPETLVLFDV DGTLTPARLT VSEEVRKTLA KLRNKCCIGF VGGSDLSKQL
     EQLGPNVLDE FDYSFSENGL TAYRLGKELA SQSFINWLGE EKYNKLAVFI LRYLSEIDLP
     KRRGTFLEFR NGMINVSPIG RNASTEERNE FERYDKEHQI RAKFVEALKK EFPDYGLTFS
     IGGQISFDVF PAGWDKTYCL QHVEKDGFKE IHFFGDKTMV GGNDYEIFVD ERTIGHSVQS
     PDDTVKILTE LFNL
>P07284 cyt SERYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.11) (SERINE--TRNA
     MLDINQFIED KGGNPELIRQ SQKARNASVE IVDEIISDYK DWVKTRFELD ELNKKFNKLQ
     KDIGLKFKNK EDASGLLAEK EKLTQQKKEL TEKEQQEDKD LKKKVFQVGN IVHPSVVVSN
     DEENNELVRT WKPEDLEAVG PIASVTGKPA SLSHHEILLR LDGYDPDRGV KICGHRGYFF
     RNYGVFLNQA LINYGLQFLA AKGYIPLQAP VMMNKELMSK TAQLSEFDEE LYKVIDGEDE
     KYLIATSEQP ISAYHSGEWF EKPQEQLPIH YVGYSSCFRR EAGSHGKDAW GVFRVHAFEK
     IEQFVITEPE KSWEEFEKMI SYSEEFYKSL KLPYRIVGIV SGELNNAAAK KYDLEAWFPY
     QKEYKELVSC SNCTDYQSRN LEIRCGIKKM GDREKKYVHC LNSTLAATQR ALCCILENYQ
     TEDGLVVPEV LRKYIPGEPE FLPFVNELPK NSTSSKDKKK KN
>P07991 cyt ORNITHINE AMINOTRANSFERASE (EC 2.6.1.13) (ORNITHINE--OXO-ACID
     MSEATLSSKQ TIEWENKYSA HNYHPLPVVF HKAKGAHVWD PEGKLYLDFL SAYSAVNQGH
     CHPHIIKALT EQAQTLTLSS RAFHNDVYAQ FAKFVTEFFG FETVLPMNTG AEAVETALKL
     ARRWGYMKKN IPQDKAIILG AEGNFHGRTF GAISLSTDYE DSKLHFGPFV PNVASGHSVH
     KIRYGHAEDF VPILESPEGK NVAAIILEPI QGEAGIVVPP ADYFPKVSAL CRKHNVLLIV
     DEIQTGIGRT GELLCYDHYK AEAKPDIVLL GKALSGGVLP VSCVLSSHDI MSCFTPGSHG
     STFGGNPLAS RVAIAALEVI RDEKLCQRAA QLGSSFIAQL KALQAKSNGI ISEVRGMGLL
     TAIVIDPSKA NGKTAWDLCL LMKDHGLLAK PTHDHIIRLA PPLVISEEDL QTGVETIAKC
     IDLL
>P08524 cyt FARNESYL PYROPHOSPHATE SYNTHETASE (FPP SYNTHETASE) (FPS) (FARNESYL
     MASEKEIRRE RFLNVFPKLV EELNASLLAY GMPKEACDWY AHSLNYNTPG GKLNRGLSVV
     DTYAILSNKT VEQLGQEEYE KVAILGWCIE LLQAYFLVAD DMMDKSITRR GQPCWYKVPE
     VGEIAINDAF MLEAAIYKLL KSHFRNEKYY IDITELFHEV TFQTELGQLM DLITAPEDKV
     DLSKFSLKKH SFIVTFKTAY YSFYLPVALA MYVAGITDEK DLKQARDVLI PLGEYFQIQD
     DYLDCFGTPE QIGKIGTDIQ DNKCSWVINK ALELASAEQR KTLDENYGKK DSVAEAKCKK
     IFNDLKIEQL YHEYEESIAK DLKAKISQVD ESRGFKADVL TAFLNKVYKR SK
>P09435 cyt HEAT SHOCK PROTEIN SSA3.
     MSRAVGIDLG TTYSCVAHFS NDRVEIIAND QGNRTTPSYV AFTDTERLIG DAAKNQAAIN
     PHNTVFDAKR LIGRKFDDPE VTTDAKHFPF KVISRDGKPV VQVEYKGETK TFTPEEISSM
     VLSKMKETAE NYLGTTVNDA VVTVPAYFND SQRQATKDAG TIAGMNVLRI INEPTAAAIA
     YGLDKKGRAE HNVLIFDLGG GTFDVSLLSI DEGVFEVKAT AGDTHLGGED FDNRLVNHLA
     TEFKRKTKKD ISNNQRSLRR LRTAAERAKR ALSSSSQTSI EIDSLFEGMD FYTSLTRARF
     EELCADLFRS TLEPVEKVLK DSKLDKSQID EIVLVGGSTR IPKIQKLVSD FFNGKEPNRS
     INPDEAVAYG AAVQAAILTG DQSTKTQDLL LLDVAPLSLG IETAGGIMTK LIPRNSTIPT
     KKSETFSTYA DNQPGVLIQV FEGERTRTKD NNLLGKFELS GIPPAPRGVP QIDVTFDIDA
     NGILNVSALE KGTGKSNKIT ITNDKGRLSK DDIDRMVSEA EKYRADDERE AERVQAKNQL
     ESYAFTLKNT INEASFKEKV GEDDAKRLET ASQETIDWLD ASQAASTDEY KDRQKELEGI
     ANPIMTKFYG AGAGAGPGAG ESGGFPGSMP NSGATGGGED TGPTVEEVD
>P10591 cyt HEAT SHOCK PROTEIN SSA1 (HEAT SHOCK PROTEIN YG100).
     SKAVGIDLGT TYSCVAHFAN DRVDIIANDQ GNRTTPSFVA FTDTERLIGD AAKNQAAMNP
     SNTVFDAKRL IGRNFNDPEV QADMKHFPFK LIDVDGKPQI QVEFKGETKN FTPEQISSMV
     LGKMKETAES YLGAKVNDAV VTVPAYFNDS QRQATKDAGT IAGLNVLRII NEPTAAAIAY
     GLDKKGKEEH VLIFDLGGGT FDVSLLSIED GIFEVKATAG DTHLGGEDFD NRLVNHFIQE
     FKRKNKKDLS TNQRALRRLR TACERAKRTL SSSAQTSVEI DSLFEGIDFY TSITRARFEE
     LCADLFRSTL DPVEKVLRDA KLDKSQVDEI VLVGGSTRIP KVQKLVTDYF NGKEPNRSIN
     PDEAVAYGAA VQAAILTGDE SSKTQDLLLL DVAPLSLGIE TAGGVMTKLI PRNSTIPTKK
     SEIFSTYADN QPGVLIQVFE GERAKTKDNN LLGKFELSGI PPAPRGVPQI EVTFDVDSNG
     ILNVSAVEKG TGKSNKITIT NDKGRLSKED IEKMVAEAEK FKEEDEKESQ RIASKNQLES
     IAYSLKNTIS EAGDKLEQAD KDTVTKKAEE TISWLDSNTT ASKEEFDDKL KELQDIANPI
     MSKLYQAGGA PGGAAGGAPG GFPGGAPPAP EAEGPTVEEV D
>P10592 cyt HEAT SHOCK PROTEIN SSA2.
     SKAVGIDLGT TYSCVAHFSN DRVDIIANDQ GNRTTPSFVG FTDTERLIGD AAKNQAAMNP
     ANTVFDAKRL IGRNFNDPEV QGDMKHFPFK LIDVDGKPQI QVEFKGETKN FTPEQISSMV
     LGKMKETAES YLGAKVNDAV VTVPAYFNDS QRQATKDAGT IAGLNVLRII NEPTAAAIAY
     GLDKKGKEEH VLIFDLGGGT FDVSLLSIED GIFEVKATAG DTHLGGEDFD NRLVNHFIQE
     FKRKNKKDLS TNQRALRRLR TACERAKRTL SSSAQTSVEI DSLFEGIDFY TSITRARFEE
     LCADLFRSTL DPVEKVLRDA KLDKSQVDEI VLVGGSTRIP KVQKLVTDYF NGKEPNRSIN
     PDEAVAYGAA VQAAILTGDE SSKTQDLLLL DVAPLSLGIE TAGGVMTKLI PRNSTIPTKK
     SEVFSTYADN QPGVLIQVFE GERAKTKDNN LLGKFELSGI PPAPRGVPQI EVTFDVDSNG
     ILNVSAVEKG TGKSNKITIT NDKGRLSKED IEKMVAEAEK FKEEDEKESQ RIASKNQLES
     IAYSLKNTIS EAGDKLEQAD KDAVTKKAEE TIAWLDSNTT ATKEEFDDQL KELQEVANPI
     MSKLYQAGGA PEGAAPGGFP GGAPPAPEAE GPTVEEVD
>P11154 cyt PYRUVATE CARBOXYLASE 1 (EC 6.4.1.1) (PYRUVIC CARBOXYLASE 1) (PCB 1).
     MSQRKFAGLR DNFNLLGEKN KILVANRGEI PIRIFRTAHE LSMQTVAIYS HEDRLSTHKQ
     KADEAYVIGE VGQYTPVGAY LAIDEIISIA QKHQVDFIHP GYGFLSENSE FADKVVKAGI
     TWIGPPAEVI DSVGDKVSAR NLAAKANVPT VPGTPGPIET VEEALDFVNE YGYPVIIKAA
     FGGGGRGMRV VREGDDVADA FQRATSEART AFGNGTCFVE RFLDKPKHIE VQLLADNHGN
     VVHLFERDCS VQRRHQKVVE VAPAKTLPRE VRDAILTDAV KLAKECGYRN AGTAEFLVDN
     QNRHYFIEIN PRIQVEHTIT EEITGIDIVA AQIQIAAGAS LPQLGLFQDK ITTRGFAIQC
     RITTEDPAKN FQPDTGRIEV YRSAGGNGVR LDGGNAYAGT IISPHYDSML VKCSCSGSTY
     EIVRRKMIRA LIEFRIRGVK TNIPFLLTLL TNPVFIEGTY WTTFIDDTPQ LFQMVSSQNR
     AQKLLHYLAD VAVNGSSIKG QIGLPKLKSN PSVPHLHDAQ GNVINVTKSA PPSGWRQVLL
     EKGPAEFARQ VRQFNGTLLM DTTWRDAHQS LLATRVRTHD LATIAPTTAH ALAGRFALEC
     WGGATFDVAM RFLHEDPWER LRKLRSLVPN IPFQMLLRGA NGVAYSSLPD NAIDHFVKQA
     KDNGVDIFRV FDALNDLEQL KVGVDAVKKA GGVVEATVCF SGDMLQPGKK YNLDYYLEIA
     EKIVQMGTHI LGIKDMAGTM KPAAAKLLIG SLRAKYPDLP IHVHTHDSAG TAVASMTACA
     LAGADVVDVA INSMSGLTSQ PSINALLASL EGNIDTGINV EHVRELDAYW AEMRLLYSCF
     EADLKGPDPE VYQHEIPGGQ LTNLLFQAQQ LGLGEQWAET KRAYREANYL LGDIVKVTPT
     SKVVGDLAQF MVSNKLTSDD VRRLANSLDF PDSVMDFFEG LIGQPYGGFP EPFRSDVLRN
     KRRKLTCRPG LELEPFDLEK IREDLQNRFG DVDECDVASY NMYPRVYEDF QKMRETYGDL
     SVLPTRSFLS PLETDEEIEV VIEQGKTLII KLQAVGDLNK KTGEREVYFD LNGEMRKIRV
     ADRSQKVETV TKSKADMHDP LHIGAPMAGV IVEVKVHKGS LIKKGQPVAV LSAMKMEMII
     SSPSDGQVKE VFVSDGENVD SSDLLVLLED QVPVETKA
>P11353 cyt COPROPORPHYRINOGEN III OXIDASE (EC 1.3.3.3) (COPROPORPHYRINOGENASE)
     MPAPQDPRNL PIRQQMEALI RRKQAEITQG LESIDTVKFH ADTWTRGNDG GGGTSMVIQD
     GTTFEKGGVN VSVVYGQLSP AAVSAMKADH KNLRLPEDPK TGLPVTDGVK FFACGLSMVI
     HPVNPHAPTT HLNYRYFETW NQDGTPQTWW FGGGADLTPS YLYEEDGQLF HQLHKDALDK
     HDTALYPRFK KWCDEYFYIT HRKETRGIGG IFFDDYDERD PQEILKMVED CFDAFLPSYL
     TIVKRRKDMP YTKEEQQWQA IRRGRYVEFN LIYDRGTQFG LRTPGSRVES ILMSLPEHAS
     WLYNHHPAPG SREAKLLEVT TKPREWVK
>P11745 cyt RAN GTPASE ACTIVATING PROTEIN 1 (PROTEIN INVOLVED IN RNA
     MATLHFVPQH EEEQVYSISG KALKLTTSDD IKPYLEELAA LKTCTKLDLS GNTIGTEASE
     ALAKCIAENT QVRESLVEVN FADLYTSRLV DEVVDSLKFL LPVLLKCPHL EIVNLSDNAF
     GLRTIELLED YIAHAVNIKH LILSNNGMGP FAGERIGKAL FHLAQNKKAA SKPFLETFIC
     GRNRLENGSA VYLALGLKSH SEGLKVVKLY QNGIRPKGVA TLIHYGLQYL KNLEILDLQD
     NTFTKHASLI LAKALPTWKD SLFELNLNDC LLKTAGSDEV FKVFTEVKFP NLHVLKFEYN
     EMAQETIEVS FLPAMEKGNL PELEKLEING NRLDEDSDAL DLLQSKFDDL EVDDFEEVDS
     EDEEGEDEED EDEDEKLEEI ETERLEKELL EVQVDDLAER LAETEIK
>P11986 cyt MYO-INOSITOL-1-PHOSPHATE SYNTHASE (EC 5.5.1.4) (IPS).
     MTEDNIAPIT SVKRLVTDKC TYKDNELLTK YSYENAVVTK TASGRFDVTP TVQDYVFKLD
     FEKKPEKLGI MLIGLGGNNG STLVASVLAN KHNVEFQTKA KGVKQPNYFG SMTQCSTLKL
     GIDAEGNDVY APFNSLLPMV SPKHFVVSGW DINNADLYEA MQRSQVLEYD LQQRLKAKMS
     LVKPLPSIYY PDFIAANQDE RANQCINLDE KGNVTTRGKW THLQRIRRDI QNFKEENALD
     KVIVLWTANT ERYVEVSPGV NDTMENLLQS IKNDHEEIAP STIFAAASIL EGVPYINGSP
     QNTFVPGLVQ LAEHEGTFIA GDDLKSGQTK LKSVLAQFLV DAGIKPVSIA SYNHLGNNDG
     YNLSAPKQFR SKEISKSSVI DDIIASNDIL YNDKLGKKVD HCIVIKYMKP VGDSKVAMDE
     YYSELMLGGH NRISIHNVCE DSLLATALII DLLVMTEFCT RVSYKKVDPV KEDAGKFENF
     YPVLTFLSYW LKAPLTRPGF HPVNGLNKQR TALENFLRLL IGLPSQNELR FEERLL
>P12385 cyt EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR SUBUNIT 1 (ERF1) (OMNIPOTENT
     MDNEVEKNIE IWKVKKLVQS LEKARGNGTS MISLVIPPKG LIPLYQKMLT DEYGTASNIK
     SRVNRLSVLS AITSTQQKLK LYNTLPKNGL VLYCGDIITE DGKEKKVTFD IEPYKPINTS
     LYLCDNKFHT EVLSELLQAD DKFGFIVMDG QGTLFGSVSG NTRTVLHKFT VDLPKKHGRG
     GQSALRFARL REEKRHNYVR KVAEVAVQNF ITNDKVNVKG LILAGSADFK TDLAKSELFD
     PRLACKVISI VDVSYGGENG FNQAIELSAE ALANVKYVQE KKLLEAYFDE ISQDTGKFCY
     GIDDTLKALD LGAVEKLIVF ENLETIRYTF KDAEDNEVIK FAEPEAKDKS FAIDKATGQE
     MDVVSEEPLI EWLAANYKNF GATLEFITDK SSEGAQFVTG FGGIGAMLRY KVNFEQLVDE
     SEDEYYDEDE GSDYDFI
>P12612 cyt T-COMPLEX PROTEIN 1, ALPHA SUBUNIT (TCP-1-ALPHA) (CCT-ALPHA).
     MSQLFNNSRS DTLFLGGEKI SGDDIRNQNV LATMAVANVV KSSLGPVGLD KMLVDDIGDF
     TVTNDGATIL SLLDVQHPAG KILVELAQQQ DREIGDGTTS VVIIASELLK RANELVKNKI
     HPTTIITGFR VALREAIRFI NEVLSTSVDT LGKETLINIA KTSMSSKIIG ADSDFFSNMV
     VDALLAVKTQ NSKGEIKYPV KAVNVLKAHG KSATESLLVP GYALNCTVAS QAMPKRIAGG
     NVKIACLDLN LQKARMAMGV QINIDDPEQL EQIRKREAGI VLERVKKIID AGAQVVLTTK
     GIDDLCLKEF VEAKIMGVRR CKKEDLRRIA RATGATLVSS MSNLEGEETF ESSYLGLCDE
     VVQAKFSDDE CILIKGTSKH SSSSIILRGA NDYSLDEMER SLHDSLSVVK RTLESGNVVP
     GGGCVEAALN IYLDNFATTV GSREQLAIAE FAAALLIIPK TLAVNAAKDS SELVAKLRSY
     HAASQMAKPE DVKRRSYRNY GLDLIRGKIV DEIHAGVLEP TISKVKSLKS ALEACVAILR
     IDTMITVDPE PPKEDPHDH
>P12709 cyt GLUCOSE-6-PHOSPHATE ISOMERASE (GPI) (EC 5.3.1.9) (PHOSPHOGLUCOSE
     SNNSFTNFKL ATELPAWSKL QKIYESQGKT LSVKQEFQKD AKRFEKLNKT FTNYDGSKIL
     FDYSKNLVND EIIAALIELA KEANVTGLRD AMFKGEHINS TEDRAVYHVA LRNRANKPMY
     VDGVNVAPEV DSVLKHMKEF SEQVRSGEWK GYTGKKITDV VNIGIGGSDL GPVMVTEALK
     HYAGVLDVHF VSNIDGTHIA ETLKVVDPET TLFLIASKTF TTAETITNAN TAKNWFLSKT
     GNDPSHIAKH FAALSTNETE VAKFGIDTKN MFGFESWVGG RYSVWSAIGL SVALYIGYDN
     FEAFLKGAEA VDNHFTQTPL EDNIPLLGGL LSVWYNNFFG AQTHLVAPFD QYLHRFPAYL
     QQLSMESNGK SVTRGNVFTD YSTGSILFGE PATNAQHSFF QLVHQGTKLI PSDFILAAQS
     HNPIENKLHQ KMLASNFFAQ AEALMVGKDE EQVKAEGATG GLVPHKVFSG NRPTTSILAQ
     KITPATLGAL IAYYEHVTFT EGAIWNINSF DQWGVELGKV LAKVIGKELD NSSTISTHDA
     STNGLINQFK EWM
>P12945 cyt N-TERMINAL ACETYLTRANSFERASE 1 (EC 2.3.1.88) (AMINO-TERMINAL, ALPHA-
     SRKRSTKPKP AAKIALKKEN DQFLEALKLY EGKQYKKSLK LLDAILKKDG SHVDSLALKG
     LDLYSVGEKD DAASYVANAI RKIEGASASP ICCHVLGIYM RNTKEYKESI KWFTAALNNG
     STNKQIYRDL ATLQSQIGDF KNALVSRKKY WEAFLGYRAN WTSLAVAQDV NGERQQAINT
     LSQFEKLAEG KISDSEKYEH SECLMYKNDI MYKAASDNQD KLQNVLKHLN DIEPCVFDKF
     GLLERKATIY MKLGQLKDAS IVYRTLIKRN PDNFKYYKLL EVSLGIQGDN KLKKALYGKL
     EQFYPRCEPP KFIPLTFLQD KEELSKKLRE YVLPQLERGV PATFSNVKPL YQRRKSKVSP
     LLEKIVLDYL SGLDPTQDPI PFIWTNYYLS QHFLFLKDFP KAQEYIDAAL DHTPTLVEFY
     ILKARILKHL GLMDTAAGIL EEGRQLDLQD RFINCKTVKY FLRANNIDKA VEVASLFTKN
     DDSVNGIKDL HLVEASWFIV EQAEAYYRLY LDRKKKLDDL ASLKKEVESD KSEQIANDIK
     ENQWLVRKYK GLALKRFNAI PKFYKQFEDD QLDFHSYCMR KGTPRAYLEM LEWGKALYTK
     PMYVRAMKEA SKLYFQMHDD RLKRKSDSLD ENSDEIQNNG QNSSSQKKKA KKEAAAMNKR
     KETEAKSVAA YPSDQDNDVF GEKLIETSTP MEDFATEFYN NYSMQVREDE RDYILDFEFN
     YRIGKLALCF ASLNKFAKRF GTTSGLFGSM AIVLLHATRN DTPFDPILKK VVTKSLEKEY
     SENFPLNEIS NNSFDWLNFY QEKFGKNDIN GLLFLYRYRD DVPIGSSNLK EMIISSLSPL
     EPHSQNEILQ YYL
>P14065 cyt GCY PROTEIN (EC 1.1.1.-).
     MPATLHDSTK ILSLNTGAQI PQIGLGTWQS KENDAYKAVL TALKDGYRHI DTAAIYRNED
     QVGQAIKDSG VPREEIFVTT KLWCTQHHEP EVALDQSLKR LGLDYVDLYL MHWPARLDPA
     YIKNEDILSV PTKKDGSRAV DITNWNFIKT WELMQELPKT GKTKAVGVSN FSINNLKDLL
     ASQGNKLTPA ANQVEIHPLL PQDELINFCK SKGIVVEAYS PLGSTDAPLL KEPVILEIAK
     KNNVQPGHVV ISWHVQRGYV VLPKSVNPDR IKTNRKIFTL STEDFEAINN ISKEKGEKRV
     VHPNWSPFEV FK
>P14126 cyt 60S RIBOSOMAL PROTEIN L3 (TRICHODERMIN RESISTANCE PROTEIN) (YL1)
     SHRKYEAPRH GHLGFLPRKR AASIRARVKA FPKDDRSKPV ALTSFLGYKA GMTTIVRDLD
     RPGSKFHKRE VVEAVTVVDT PPVVVVGVVG YVETPRGLRS LTTVWAEHLS DEVKRRFYKN
     WYKSKKKAFT KYSAKYAQDG AGIERELARI KKYASVVRVL VHTQIRKTPL AQKKAHLAEI
     QLNGGSISEK VDWAREHFEK TVAVDSVFEQ NEMIDAIAVT KGHGFEGVTH RWGTKKLPRK
     THRGLRKVAC IGAWHPAHVM WSVARAGQRG YHSRTSINHK IYRVGKGDDE ANGATSFDRT
     KKTITPMGGF VHYGEIKNDF IMVKGCIPGN RKRIVTLRKS LYTNTSRKAL EEVSLKWIDT
     ASKFGKGRFQ TPAEKHAFMG TLKKDL
>P14743 cyt GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE (EC 2.3.1.97) (PEPTIDE
     MSEEDKAKKL ENLLKLLQLN NDDTSKFTQE QKKAMKDHKF WRTQPVKDFD EKVVEEGPID
     KPKTPEDISD KPLPLLSSFE WCSIDVDNKK QLEDVFVLLN ENYVEDRDAG FRFNYTKEFF
     NWALKSPGWK KDWHIGVRVK ETQKLVAFIS AIPVTLGVRG KQVPSVEINF LCVHKQLRSK
     RLTPVLIKEI TRRVNKCDIW HALYTAGIVL PAPVSTCRYT HRPLNWKKLY EVDFTGLPDG
     HTEEDMIAEN ALPAKTKTAG LRKLKKEDID QVFELFKRYQ SRFELIQIFT KEEFEHNFIG
     EESLPLDKQV IFSYVVEQPD GKITDFFSFY SLPFTILNNT KYKDLGIGYL YYYATDADFQ
     FKDRFDPKAT KALKTRLCEL IYDACILAKN ANMDVFNALT SQDNTLFLDD LKFGPGDGFL
     NFYLFNYRAK PITGGLNPDN SNDIKRRSNV GVVML
>P14832 cyt PEPTIDYL-PROLYL CIS-TRANS ISOMERASE (EC 5.2.1.8) (PPIASE) (ROTAMASE)
     SQVYFDVEAD GQPIGRVVFK LYNDIVPKTA ENFRALCTGE KGFGYAGSPF HRVIPDFMLQ
     GGDFTAGNGT GGKSIYGGKF PDENFKKHHD RPGLLSMANA GPNTNGSQFF ITTVPCPWLD
     GKHVVFGEVV DGYDIVKKVE SLGSPSGATK ARIVVAKSGE L
>P15180 cyt LYSYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.6) (LYSINE--TRNA LIGASE)
     SQQDNVKAAA EGVANLHLDE ATGEMVSKSE LKKRIKQRQV EAKKAAKKAA AQPKPASKKK
     TDLFADLDPS QYFETRSRQI QELRKTHEPN PYPHKFHVSI SNPEFLAKYA HLKKGETLPE
     EKVSIAGRIH AKRESGSKLK FYVLHGDGVE VQLMSQLQDY CDPDSYEKDH DLLKRGDIVG
     VEGYVGRTQP KKGGEGEVSV FVSRVQLLTP CLHMLPADHF GFKDQETRYR KRYLDLIMNK
     DARNRFITRS EIIRYIRRFL DQRKFIEVET PMMNVIAGGA TAKPFITHHN DLDMDMYMRI
     APELFLKQLV VGGLDRVYEI GRQFRNEGID MTHNPEFTTC EFYQAYADVY DLMDMTELMF
     SEMVKEITGS YIIKYHPDPA DPAKELELNF SRPWKRINMI EELEKVFNVK FPSGDQLHTA
     ETGEFLKKIL VDNKLECPPP LTNARMLDKL VGELEDTCIN PTFIFGHPQM MSPLAKYSRD
     QPGLCERFEV FVATKEICNA YTELNDPFDQ RARFEEQARQ KDQGDDEAQL VDETFCNALE
     YGLPPTGGWG CGIDRLAMFL TDSNTIREVL LFPTLKPDVL REEVKKEEEN
>P15303 cyt PROTEIN TRANSPORT PROTEIN SEC23.
     MDFETNEDIN GVRFTWNVFP STRSDANSNV VPVGCLYTPL KEYDELNVAP YNPVVCSGPH
     CKSILNPYCV IDPRNSSWSC PICNSRNHLP PQYTNLSQEN MPLELQSTTI EYITNKPVTV
     PPIFFFVVDL TSETENLDSL KESIITSLSL LPPNALIGLI TYGNVVQLHD LSSETIDRCN
     VFRGDREYQL EALTEMLTGQ KPTGPGGAAS HLPNAMNKVT PFSLNRFFLP LEQVEFKLNQ
     LLENLSPDQW SVPAGHRPLR ATGSALNIAS LLLQGCYKNI PARIILFASG PGTVAPGLIV
     NSELKDPLRS HHDIDSDHAQ HYKKACKFYN QIAQRVAANG HTVDIFAGCY DQIGMSEMKQ
     LTDSTGGVLL LTDAFSTAIF KQSYLRLFAK DEEGYLKMAF NGNMAVKTSK DLKVQGLIGH
     ASAVKKTDAN NISESEIGIG ATSTWKMASL SPYHSYAIFF EIANTAANSN PMMSAPGSAD
     RPHLAYTQFI TTYQHSSGTN RIRVTTVANQ LLPFGTPAIA ASFDQEAAAV LMARIAVHKA
     ETDDGADVIR WLDRTLIKLC QKYADYNKDD PQSFRLAPNF SLYPQFTYYL RRSQFLSVFN
     NSPDETAFYR HIFTREDTTN SLIMIQPTLT SFSMEDDPQP VLLDSISVKP NTILLLDTFF
     FILIYHGEQI AQWRKAGYQD DPQYADFKAL LEEPKLEAAE LLVDRFPLPR FIDTEAGGSQ
     ARFLLSKLNP SDNYQDMARG GSTIVLTDDV SLQNFMTHLQ QVAVSGQA
>P15496 cyt ISOPENTENYL-DIPHOSPHATE DELTA-ISOMERASE (EC 5.3.3.2) (IPP ISOMERASE).
     TADNNSMPHG AVSSYAKLVQ NQTPEDILEE FPEIIPLQQR PNTRSSETSN DESGETCFSG
     HDEEQIKLMN ENCIVLDWDD NAIGAGTKKV CHLMENIEKG LLHRAFSVFI FNEQGELLLQ
     QRATEKITFP DLWTNTCCSH PLCIDDELGL KGKLDDKIKG AITAAVRKLD HELGIPEDET
     KTRGKFHFLN RIHYMAPSNE PWGEHEIDYI LFYKINAKEN LTVNPNVNEV RDFKWVSPND
     LKTMFADPSY KFTPWFKIIC ENYLFNWWEQ LDDLSEVEND RQIHRML
>P15624 cyt PHENYLALANYL-TRNA SYNTHETASE ALPHA CHAIN CYTOPLASMIC (EC 6.1.1.20)
     PTVSVNKQQL FDLLGKNYTS QEFDELCFEF GMEMDEDTTE EALKTGEEPE LKLDISANRY
     DLLCIEGISQ SLNEYLERKE RPDYKLSKPT TKLIIDKSTE QIRPFATAAV LRNIKLNEKS
     YASFIALQDK LHANLCRNRS LVAMGTHDLD SIEGPFHYRA LPPKDIKFVP LNQTQEFTGD
     KLIEFYKSPE QKNNIGRYVH IIEDSPVFPV IMDSKDRVCS LPPLINSEHS KISVNTRNIL
     IDITATDKTK AEIVLNILTT MFSRYCDEPF TVEPVEIVSE HNGQSRLAPN FNDRIMDVSI
     KYINSCLGLD QSADEIAHCL KKMSLHAVQS KEDKDILHVD IPVTRPDILH ACDIMEDAAV
     GYGFNNLPKG EKLSNANFIA KPLPINKVSD IFRVASSQAT WVEVLPLTLC SHDENFKFLR
     QSDNGDLAVK LANPKTLEYQ VVRTTLLPGI LKTVKENRKH SLPIKVFETG DVVFKDDKLE
     RKAYNERHWA AIYVGKNSGF EIIQGLLGKI MQTFRTEWIA DYGAAASGRG YWIEEDDSVK
     TYFPGRGAKV MFRSKEGAEP KQIGHLGVLH PEVMMNFDVP FAASFVEVNA EVFL
>P15625 cyt PHENYLALANYL-TRNA SYNTHETASE BETA CHAIN CYTOPLASMIC (EC 6.1.1.20)
     SDFQLEILKK LDELDEIKST LATFPQHGSQ DVLSALNSLK AHNKLEFSKV DTVTYDLTKE
     GAQILNEGSY EIKLVKLIQE LGQLQIKDVM SKLGPQVGKV GQARAFKNGW IAKNASNELE
     LSAKLQNTDL NELTDETQSI LAQIKNNSHL DSIDAKILND LKKRKLIAQG KITDFNVTKG
     PEFSTDLTKL ETDLTSDMVS TNAYKDLKFK PYNFNSQGVQ ISSGALHPLN KVREEFRQIF
     FSMGFTEMPS NQYVETGFWN FDALYVPQQH PARDLQDTFY IKDPLTADLP DDKTYMDNIK
     AVHEQGRFGS IGYRYNWKPE ECQKLVLRTH STAISARMLH DLAKDPKPTR LFSIDRVFRN
     EAVDATHLAE FHQVEGVLAD YNITLGDLIK FMEEFFERMG VTGLRFKPTY NPYTEPSMEI
     FSWHEGLQKW VEIGNSGMFR PEMLESMGLP KDLRVLGWGL SLERPTMIKY KVQNIRELLG
     HKVSLDFIET NPAARLDEDL YE
>P15705 cyt HEAT SHOCK PROTEIN STI1.
     MSLTADEYKQ QGNAAFTAKD YDKAIELFTK AIEVSETPNH VLYSNRSACY TSLKKFSDAL
     NDANECVKIN PSWSKGYNRL GAAHLGLGDL DEAESNYKKA LELDASNKAA KEGLDQVHRT
     QQARQAQPDL GLTQLFADPN LIENLKKNPK TSEMMKDPQL VAKLIGYKQN PQAIGQDLFT
     DPRLMTIMAT LMGVDLNMDD INQSNSMPKE PETSKSTEQK KDAEPQSDST TSKENSSKAP
     QKEESKESEP MEVDEDDSKI EADKEKAEGN KFYKARQFDE AIEHYNKAWE LHKDITYLNN
     RAAAEYEKGE YETAISTLND AVEQGREMRA DYKVISKSFA RIGNAYHKLG DLKKTIEYYQ
     KSLTEHRTAD ILTKLRNAEK ELKKAEAEAY VNPEKAEEAR LEGKEYFTKS DWPNAVKAYT
     EMIKRAPEDA RGYSNRAAAL AKLMSFPEAI ADCNKAIEKD PNFVRAYIRK ATAQIAVKEY
     ASALETLDAA RTKDAEVNNG SSAREIDQLY YKASQQRFQP GTSNETPEET YQRAMKDPEV
     AAIMQDPVMQ SILQQAQQNP AALQEHMKNP EVFKKIQTLI AAGIIRTGR
>P16639 cyt ARGINYL-TRNA--PROTEIN TRANSFERASE (EC 2.3.2.8) (ARGINYLTRANSFERASE).
     MSDRFVIWAP SMHNEPAAKC GYCHGNKGGN MDQLFALDSW AHRYMNKMDV VKIENCTIGS
     FVEHMDVATY DRMCNMGFRR SGKFLYKVDP LRNCCRLYTI RTAPQELNMT KELKKCISRF
     ATRITSEDYC PAAVASSDFV GKIVNAEMNS KTFYTRFEPA LYSEEKYHLF VKYQEKVHQD
     YNNSPKSFKR FLCDTPFGPE AVLGTQESWE QLNNWQRMKP GEKLKHMGPV HECYYYEGKL
     IAITVSDILP SGISSVYFIW DPDYSKWSLG KLSALRDLAI IQRTNLQYYY LGYYIEDCPK
     MNYKANYGAE VLDVCHSKYI PLKPIQDMIS RGKLFVIGEE ETKVTKELYL VDSETGRGEG
     FPTDNVVKYK NIAEEIYGVG GCAFKSANES ALELKELYGI PYEEEDLDTI YHLKEHNGHA
     PNGIPNVVPG LLPLWELLDI MQSGKITDLE GRLFLFEIET EGIRPLINFY SEPPNVKKRI
     CDVIRLFGFE TCMKAVILYS EQM
>P17324 cyt L-SERINE DEHYDRATASE (EC 4.2.1.13) (L-SERINE DEAMINASE).
     MEMTHYEKTP LIRQVFNNGK TNSWFYVKHE ILQPGGSFKS RGIGHLIRKS NQQPLSEGSG
     KLAVFSSSGG NAGLAAATAC RSMALNCSVV VPKTTKPRMV KKIQSAGAKV IIHGDHWGEA
     DEYLRHKLMA QESQHGSKTL YVHPFDNETI WEGHSTIVDE IIEQLKENDI SLPRVKALVC
     SVGGGGLFSG IIKGLDRNHL AEKIPVVAVE TAGCDVLNKS LKKGSPVTLE KLTSVATSLA
     SPYIASFAFE SFNKYGCKSV VLSDQDVLAT CLRYADDYNF IVEPACGASL HLCYHPEILE
     DILEQKIYED DIVIIIACGG SCMTYEDLVK ASSTLNVS
>P18759 cyt VESICULAR-FUSION PROTEIN SEC18.
     MFKIPGFGKA AANHTPPDMT NMDTRTRHLK VSNCPNNSYA LANVAAVSPN DFPNNIYIII
     DNLFVFTTRH SNDIPPGTIG FNGNQRTWGG WSLNQDVQAK AFDLFKYSGK QSYLGSIDID
     ISFRARGKAV STVFDQDELA KQFVRCYESQ IFSPTQYLIM EFQGHFFDLK IRNVQAIDLG
     DIEPTSAVAT GIETKGILTK QTQINFFKGR DGLVNLKSSN SLRPRSNAVI RPDFKFEDLG
     VGGLDKEFTK IFRRAFASRI FPPSVIEKLG ISHVKGLLLY GPPGTGKTLI ARKIGTMLNA
     KEPKIVNGPE ILSKYVGSSE ENIRNLFKDA EAEYRAKGEE SSLHIIIFDE LDSVFKQRGS
     RGDGTGVGDN VVNQLLAKMD GVDQLNNILV IGMTNRKDLI DSALLRPGRF EVQVEIHLPD
     EKGRLQIFDI QTKKMRENNM MSDDVNLAEL AALTKNFSGA EIEGLVKSAS SFAINKTVNI
     GKGATKLNTK DIAKLKVTRE DFLNALNDVT PAFGISEEDL KTCVEGGMML YSERVNSILK
     NGARYVRQVR ESDKSRLVSL LIHGPAGSGK TALAAEIALK SGFPFIRLIS PNELSGMSES
     AKIAYIDNTF RDAYKSPLNI LVIDSLETLV DWVPIGPRFS NNILQMLKVA LKRKPPQDRR
     LLIMTTTSAY SVLQQMDILS CFDNEIAVPN MTNLDELNNV MIESNFLDDA GRVKVINELS
     RSCPNFNVGI KKTLTNIETA RHDEDPVNEL VELMTQSA
>P20081 cyt FK506-BINDING PROTEIN (FKBP) (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)
     MSEVIEGNVK IDRISPGDGA TFPKTGDLVT IHYTGTLENG QKFDSSVDRG SPFQCNIGVG
     QVIKGWDVGI PKLSVGEKAR LTIPGPYAYG PRGFPGLIPP NSTLVFDVEL LKVN
>P20424 cyt SIGNAL RECOGNITION PARTICLE 54 KD PROTEIN HOMOLOG (SRP54).
     MVLADLGKRI NSAVNNAISN TQDDFTTSVD VMLKGIVTAL LESDVNIALV SKLRNNIRSQ
     LLSENRSEKS TTNAQTKKLI QKTVFDELCK LVTCEGSEEK AFVPKKRKTN IIMFVGLQGS
     GKTTSCTKLA VYYSKRGFKV GLVCADTFRA GAFDQLKQNA IRARIPFYGS YTETDPAKVA
     EEGINKFKKE KFDIIIVDTS GRHHQEEELF QEMIEISNVI KPNQTIMVLD ASIGQAAEQQ
     SKAFKESSDF GAIILTKMDG HARGGGAISA VAATNTPIIF IGTGEHIHDL EKFSPKSFIS
     KLLGIGDIES LFEQLQTVSN KEDAKATMEN IQKGKFTLLD FKKQMQTIMK MGPLSNIAQM
     IPGMSNMMNQ VGEEETSQKM KKMVYVLDSM TKEELESDGR MFIEEPTRMV RVAKGSGTSV
     FEVEMILMQQ QMMARMAQTA TQQQPGAPGA NARMPGMPNM PGMPNMPGMP NMPGMPKVTP
     QMMQQAQQKL KQNPGLMQNM MNMFGGGMGG GMGGGMPDMN EMMKMMQDPQ MQQMAKQFGM
     G
>P20485 cyt CHOLINE KINASE (EC 2.7.1.32).
     MVQESRPGSV RSYSVGYQAR SRSSSQRRHS LTRQRSSQRL IRTISIESDV SNITDDDDLR
     AVNEGVAGVQ LDVSETANKG PRRASATDVT DSLGSTSSEY IEIPFVKETL DASLPSDYLK
     QDILNLIQSL KISKWYNNKK IQPVAQDMNL VKISGAMTNA IFKVEYPKLP SLLLRIYGPN
     IDNIIDREYE LQILARLSLK NIGPSLYGCF VNGRFEQFLE NSKTLTKDDI RNWKNSQRIA
     RRMKELHVGV PLLSSERKNG SACWQKINQW LRTIEKVDQW VGDPKNIENS LLCENWSKFM
     DIVDRYHKWL ISQEQGIEQV NKNLIFCHND AQYGNLLFTA PVMNTPSLYT APSSTSLTSQ
     SSSLFPSSSN VIVDDIINPP KQEQSQDSKL VVIDFEYAGA NPAAYDLANH LSEWMYDYNN
     AKAPHQCHAD RYPDKEQVLN FLYSYVSHLR GGAKEPIDEE VQRLYKSIIQ WRPTVQLFWS
     LWAILQSGKL EKKEASTAIT REEIGPNGKK YIIKTEPESP EEDFVENDDE PEAGVSIDTF
     DYMAYGRDKI AVFWGDLIGL GIITEEECKN FSSFKFLDTS YL
>P20604 cyt SERINE/THREONINE PROTEIN PHOSPHATASE PP1-1 (EC 3.1.3.16).
     MVSRGPDEWL ETIKKCQALT ENEMKQLCEM VKELLMEESN IQPVQTPVTV CGDIHGQFHD
     LLELFRTAGG FPDDINYIFL GDYVDRGYYS LETFTLLMCL KVKYPAKITL VRGNHESRQI
     TQVYGFYEEC LNKYGSTTVW KYCCQVFDFL TLAAIIDGKI LCVHGGLSPE IRMLDQIRVL
     SRAQEVPHEG GFSDLLWSDP DNVEAWQVSP RGAGWLFGSK VAREFNHVNG LNLIARAHQL
     VMEGFKYHFP EKDVVTVWSA PNYCYRCGNV ASVMKVDEDL EPTFKIFSAV PDDYIRESTA
     NHNNQRAGYF L
>P21576 cyt VACUOLAR SORTING PROTEIN 1.
     MDEHLISTIN KLQDALAPLG GGSQSPIDLP QITVVGSQSS GKSSVLENIV GRDFLPRGTG
     IVTRRPLVLQ LINRRPKKSE HAKVNQTANE LIDLNINDDD KKKDESGKHQ NEGQSEDNKE
     EWGEFLHLPG KKFYNFDEIR KEIVKETDKV TGANSGISSV PINLRIYSPH VLTLTLVDLP
     GLTKVPVGDQ PPDIERQIKD MLLKYISKPN AIILSVNAAN TDLANSDGLK LAREVDPEGT
     RTIGVLTKVD LMDQGTDVID ILAGRVIPLR YGYIPVINRG QKDIEHKKTI REALENERKF
     FENHPSYSSK AHYCGTPYLA KKLNSILLHH IRQTLPEIKA KIEATLKKYQ NELINLGPET
     MDSASSVVLS MITDFSNEYA GILDGEAKEL SSQELSGGAR ISYVFHETFK NGVDSLDPFD
     QIKDSDIRTI MYNSSGSAPS LFVGTEAFEV LVKQQIRRFE EPSLRLVTLV FDELVRMLKQ
     IISQPKYSRY PALREAISNQ FIQFLKDATI PTNEFVVDII KAEQTYINTA HPDLLKGSQA
     MVMVEEKLHP RQVAVDPKTG KPLPTQPSSS KAPVMEEKSG FFGGFFSTKN KKKLAALESP
     PPVLKATGQM TERETMETEV IKLLISSYFS IVKRTIADII PKALMLKLIV KSKTDIQKVL
     LEKLYGKQDI EELTKENDIT IQRRKECKKM VEILRNASQI VSSV
>P22133 cyt MALATE DEHYDROGENASE, CYTOPLASMIC (EC 1.1.1.37).
     PHSVTPSIEQ DSLKIAILGA AGGIGQSLSL LLKAQLQYQL KESNRSVTHI HLALYDVNQE
     AINGVTADLS HIDTPISVSS HSPAGGIENC LHNASIVVIP AGVPRKPGMT RDDLFNVNAG
     IISQLGDSIA ECCDLSKVFV LVISNPVNSL VPVMVSNILK NHPQSRNSGI ERRIMGVTKL
     DIVRASTFLR EINIESGLTP RVNSMPDVPV IGGHSGETII PLFSQSNFLS RLNEDQLKYL
     IHRVQYGGDE VVKAKNGKGS ATLSMAHAGY KCVVQFVSLL LGNIEQIHGT YYVPLKDANN
     FPIAPGADQL LPLVDGADYF AIPLTITTKG VSYVDYDIVN RMNDMERNQM LPICVSQLKK
     NIDKGLEFVA SRSASS
>P22202 cyt HEAT SHOCK PROTEIN SSA4.
     SKAVGIDLGT TYSCVAHFAN DRVEIIANDQ GNRTTPSYVA FTDTERLIGD AAKNQAAMNP
     HNTVFDAKRL IGRKFDDPEV TNDAKHYPFK VIDKGGKPVV QVEYKGETKT FTPEEISSMI
     LTKMKETAEN FLGTEVKDAV VTVPAYFNDS QRQATKDAGT IAGLNVLRII NEPTAAAIAY
     GLDKKSQKEH NVLIFDLGGG TFDVSLLSID EGVFEVKATA GDTHLGGEDF DSRLVNFLAE
     EFKRKNKKDL TTNQRSLRRL RTAAERAKRT LSSSAQTSIE IDSLFEGIDF YTSITRARFE
     ELCADLFRST LEPVEKVLAD SKLDKSQIDE IVLVGGSTRI PKVQKLVSDF FNGKEPNRSI
     NPDEAVAYGA AVQAAILTGD QSSTTQDLLL LDVAPLSLGI ETAGGIMTKL IPRNSTIPTK
     KSEVFSTYAD NQPGVLIQVF EGERTRTKDN NLLGKFELSG IPPAPRGVPQ IEVTFDIDAN
     GILNVSAVEK GTGKSNKITI TNDKGRLSKE DIDKMVAEAE KFKAEDEQEA QRVQAKNQLE
     SYAFTLKNSV SENNFKEKVG EEDARKLEAA AQDAINWLDA SQAASTEEYK ERQKELEGVA
     NPIMSKFYGA AGGAPGAGPV PGAGAGPTGA PDNGPTVEEV D
>P22203 cyt VACUOLAR ATP SYNTHASE SUBUNIT E (EC 3.6.1.34) (V-ATPASE E SUBUNIT)
     MSSAITALTP NQVNDELNKM QAFIRKEAEE KAKEIQLKAD QEYEIEKTNI VRNETNNIDG
     NFKSKLKKAM LSQQITKSTI ANKMRLKVLS AREQSLDGIF EETKEKLSGI ANNRDEYKPI
     LQSLIVEALL KLLEPKAIVK ALERDVDLIE SMKDDIMREY GEKAQRAPLE EIVISNDYLN
     KDLVSGGVVV SNASDKIEIN NTLEERLKLL SEEALPAIRL ELYGPSKTRK FFD
>P23542 cyt ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC (EC 2.6.1.1) (TRANSAMINASE A).
     SATLFNNIEL LPPDALFGIK QRYGQDQRAT KVDLGIGAYR DDNGKPWVLP SVKAAEKLIH
     NDSSYNHEYL GITGLPSLTS NAAKIIFGTQ SDAFQEDRVI SVQSLSGTGA LHISAKFFSK
     FFPDKLVYLS KPTWANHMAI FENQGLKTAT YPYWANETKS LDLNGFLNAI QKAPEGSIFV
     LHSCAHNPTG LDPTSEQWVQ IVDAIASKNH IALFDTAYQG FATGDLDKDA YAVRLGVEKL
     STVSPVFVCQ SFAKNAGMYG ERVGCFHLAL TKQAQNKTIK PAVTSQLAKI IRSEVSNPPA
     YGAKIVAKLL ETPELTEQWH KDMVTMSSRI TKMRHALRDH LVKLGTPGNW DHIVNQCGMF
     SFTGLTPQMV KRLEETHAVY LVASGRASIA GLNQGNVEYV AKAIDEVVRF YTIEAKL
>P23643 cyt VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN VPS3.
     MVKKKTNNDK GKEVKENEGK LDIDSESSPH ERENDKKKTE DDSLRATESE ETNTHNANPN
     ETVRADKFSQ EESRPIEDSP HTDKNTAQES CQPSSAEDNV INTDITSLNE KTSTNDEQEK
     GLPLKISEGP FTISTLLDNV PSDLIYTCCE AYENHIFLGT TTGDLLHYFE LERGNYMLVS
     QTKFDAESNS KIDKILLLPK VEGALILCDN ELVLFILPEF APRPNTTRLK GISDVVICNF
     SRSSKAYRIY AFHAEGVRLL KISADSLVLT KAFNFKLIDK ACAHEETLMV SKLNSYELIN
     LKSSQVIPLF RISETDEDLE PIITSFNEQS EFLVCSGGGS YDSGAMALVV NHHGDIIKGT
     IVLKNYPRNV IVEFPYIIAE SAFQSVDIYS ALPSEKSQLL QSITTSGSDL KISKSDNVFT
     NTNNSEEFKE KIFNKLRLEP LTHSDNKFRI ERERAFVEES YEEKTSLIVY NNLGIHLLVP
     TPMVLRFTSC EESEIDNIED QLKKLAKKDL TKFEHIEAKY LMSLLLFLMT LHYDHIEDEV
     MKKWCDFSDK VDIRILFYMF GWKVYSEIWC FHGLINIVER LKSLKLTNKC ENILKMLLMM
     KNELKKKNKT GLLTNDFDDI MKTIDITLFK LRLEKKETIT VDMFERESYD EIIREINLHD
     DKLPRIELLI EIYKEKGEYL KALNLLREAG DYISLVSFIE ENLKKLPEDY IKERIADDLL
     LTLKQGDENT EECAIKKVLK ILDMACINKN DFLNKIPAEE TSLKVSFIEQ LGVQNSNDSK
     FLFNYYLAKL REIINQSNIW SILGDFIKEY KDDFAYDKTD ITNFIHIKLK HSLQCENFSK
     YYEKCENLKS ENEKDDEFIN FTFDEISKID KEHILTLLFF PNELTNWVSS EELLKIYLSF
     NDFRSVEKYI GKQNLVAVMK QYLDISSLNY SVELVTNLLQ RNFELLDDTD IQLKILETIP
     SVFPVQTISE LLLKVLIKYQ EKKEESNLRK CLLKNQISIS DELSRNFDSQ G
>P24521 cyt PHOSPHOMEVALONATE KINASE (EC 2.7.4.2).
     MSELRAFSAP GKALLAGGYL VLDTKYEAFV VGLSARMHAV AHPYGSLQGS DKFEVRVKSK
     QFKDGEWLYH ISPKSGFIPV SIGGSKNPFI EKVIANVFSY FKPNMDDYCN RNLFVIDIFS
     DDAYHSQEDS VTEHRGNRRL SFHSHRIEEV PKTGLGSSAG LVTVLTTALA SFFVSDLENN
     VDKYREVIHN LAQVAHCQAQ GKIGSGFDVA AAAYGSIRYR RFPPALISNL PDIGSATYGS
     KLAHLVDEED WNITIKSNHL PSGLTLWMGD IKNGSETVKL VQKVKNWYDS HMPESLKIYT
     ELDHANSRFM DGLSKLDRLH ETHDDYSDQI FESLERNDCT CQKYPEITEV RDAVATIRRS
     FRKITKESGA DIEPPVQTSL LDDCQTLKGV LTCLIPGAGG YDAIAVITKQ DVDLRAQTAN
     DKRFSKVQWL DVTQADWGVR KEKDPETYLD K
>P25044 cyt PROTEIN-TYROSINE PHOSPHATASE 1 (EC 3.1.3.48) (PTPASE 1).
     MAAAPWYIRQ RDTDLLGKFK FIQNQEDGRL REATNGTVNS RWSLGVSIEP RNDARNRYVN
     IMPYERNRVH LKTLSGNDYI NASYVKVNVP GQSIEPGYYI ATQGPTRKTW DQFWQMCYHN
     CPLDNIVIVM VTPLVEYNRE KCYQYWPRGG VDDTVRIASK WESPGGANDM TQFPSDLKIE
     FVNVHKVKDY YTVTDIKLTP TDPLVGPVKT VHHFYFDLWK DMNKPEEVVP IMELCAHSHS
     LNSRGNPIIV HCSAGVGRTG TFIALDHLMH DTLDFKNITE RSRHSDRATE EYTRDLIEQI
     VLQLRSQRMK MVQTKDQFLF IYHAAKYLNS LSVNQ
>P25644 cyt TOPOISOMERASE II-ASSOCIATED PROTEIN PAT1.
     MSFFGLENSG NARDGPLDFE ESYKGYGEHE LEENDYLNDE TFGDNVQVGT DFDFGNPHSS
     GSSGNAIGGN GVGATARSYV AATAEGISGP RTDGTAAAGP LDLKPMESLW STAPPPAMAP
     SPQSTMAPAP APQQMAPLQP ILSMQDLERQ QRQMQQQFMN FHAMGHPQGL PQGPPQQQFP
     MQPASGQPGP SQFAPPPPPP GVNVNMNQMP MGPVQVPVQA SPSPIGMSNT PSPGPVVGAT
     KMPLQSGRRS KRDLSPEEQR RLQIRHAKVE KILKYSGLMT PRDKDFITRY QLSQIVTEDP
     YNEDFYFQVY KIIQRGGITS ESNKGLIARA YLEHSGHRLG GRYKRTDIAL QRMQSQVEKA
     VTVAKERPSK LKDQQAAAGN SSQDNKQANT VLGKISSTLN SKNPRRQLQI PRQQPSSDPD
     ALKDVTDSLT NVDLASSGSS STGSSAAAVA SKQRRRSSYA FNNGNGATNL NKSGGKKFIL
     ELIETVYEEI LDLEANLRNG QQTDSTAMWE ALHIDDSSYD VNPFISMLSF DKGIKIMPRI
     FNFLDKQQKL KILQKIFNEL SHLQIIILSS YKTTPKPTLT QLKKVDLFQM IILKIIVSFL
     SNNSNFIEIM GLLLQLIRNN NVSFLTTSKI GLNLITILIS RAALIKQDSS RSNILSSPEI
     STWNEIYDKL FTSLESKIQL IFPPREYNVH IMRLQNDKFM DEAYFGQFLA SLALSGKLNH
     QRIIIDEVRD EIFATINEAE TLQKKEKELS VLPQRSQELD TELKSIIYNK EKLYQDLNLF
     LNVMGLVYRD GEISELK
>P26321 cyt 60S RIBOSOMAL PROTEIN L1 (L5) (YL3) (RIBOSOMAL 5 S RNA-BINDING
     MAFQKDAKSS AYSSRFQTPF RRRREGKTDY YQRKRLVTQH KAKYNTPKYR LVVRFTNKDI
     ICQIISSTIT GDVVLAAAYS HELPRYGITH GLTNWAAAYA TGLLIARRTL QRLGLDETYK
     GVEEVEGEYE LTEAVEDGPR PFKVFLDIGL QRTTTGARVF GALKGASDGG LYVPHSENRF
     PGWDFETEEI DPELLRSYIF GGHVSQYMEE LADDDEERFS ELFKGYLADD IDADSLEDIY
     TSAHEAIRAD PAFKPTEKKF TKEQYAAESK KYRQTKLSKE ERAARVAAKI AALAGQQ
>P26637 cyt LEUCYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.4) (LEUCINE--TRNA
     MSSGLVLENT ARRDALIAIE KKYQKIWAEE HQFEIDAPSI EDEPITMDSE ELHRTYPKFM
     SSMAYPYMNG VMHAGHCFTL SKVEFSIGFE RMNGKRALFP LGFHCTGMPI LACADKLKRE
     AELFGKNFDN VPAEEEEIKE ETPAEKDHED VTKFKAKKSK AAAKKGRGKY QFEIMLQLGI
     PREEIIKFAD AKYWLTYFPP LCESDCTSLG ARIDWRRSFV TTDANPYYDA FIRWQMNKLK
     AAGKIKFGER YTIYSEKDGQ ACMDHDRQSG EGVTPQEYIG VKIEALEFAD DAAKIIDSSS
     DLDKSKKFYF VAATLRPETM YGQTCCFVSP TIEYGIFDAG DSYFITTERA FKNMSYQKLT
     PKRGFYKPIV TVPGKAFIGT KIHAPQSVYP ELRILPMETV IATKGTGVVT CVPSNSPDDY
     ITTKDLLHKP EYYGIKPEWI DHEIVPIMHT EKYGDLTAKA IVEEKKIQSP KDKNLLAEAK
     KIAYKEDYYT GTMIYGPYKG EKVEQAKNKV KADMIAAGEA FVYNEPESQV MSRSGDDCIV
     SLEDQWYVDY GEESWKKQAI ECLEGMQLFA PEVKNAFEGV LDWLKNWAVC RTYGLGTRLP
     WDEKYLVESL SDSTIYQSFY TIAHLLFKDY YGNEIGPLGI SADQMTDEVF DYIFQHQDDV
     KNTNIPLPAL QKLRREFEYF YPLDVSISGK DLIPNHLTFF IYTHVALFPK KFWPKGIRAN
     GHLMLNNSKM SKSTGNFMTL EQTVEKFGAD AARIAFADAG DTVEDANFDE SNANAAILRL
     FNLKEWAEEI TKESNLRTGE ITDFFDIAFE HEMNALIEKT YEQYALTNYK NALKYGLFDF
     QAARDYYREA SGVMHKDLIA RYIETQALLL APIAPHFAEY IYREVLGNQT SVQNAKFPRA
     SKPVDKGVLA ALDYLRNLQR SIREGEGQAL KKKKGKSAEI DASKPVKLTL LISESFPEWQ
     SQCVEIVRKL FSEQTLDDNK KVREHIEPKE MKRAMPFISL LKQRLANEKP EDVFERELQF
     SEIDTVKAAA RNVKKAAQAL KIAEFSAISF PYGAKTGKDI FTGEEVEIPP VTKIVENAVP
     GNPGVVFQNI
>P28272 cyt DIHYDROOROTATE DEHYDROGENASE (EC 1.3.3.1) (DIHYDROOROTATE OXIDASE)
     MTASLTTKFL NNTYENPFMN ASGVHCMTTQ ELDELANSKA GAFITKSATT LEREGNPEPR
     YISVPLGSIN SMGLPNEGID YYLSYVLNRQ KNYPDAPAIF FSVAGMSIDE NLNLLRKIQD
     SEFNGITELN LSCPNVPGKP QVAYDFDLTK ETLEKVFAFF KKPLGVKLPP YFDFAHFDIM
     AKILNEFPLA YVNSINSIGN GLFIDVEKES VVVKPKNGFG GIGGEYVKPT ALANVRAFYT
     RLRPEIKVIG TGGIKSGKDA FEHLLCGASM LQIGTELQKE GVKIFERIEK ELKDIMEAKG
     YTSIDQFRGK LNSI
>P29461 cyt PROTEIN-TYROSINE PHOSPHATASE 2 (EC 3.1.3.48) (PTPASE 2).
     MDRIAQQYRN GKRDNNGNRM ASSAISEKGH IQVNQTRTPG QMPVYRGETI NLSNLPQNQI
     KPCKDLDDVN IRRNNSNRHS KILLLDLCAG PNTNSFLGNT NAKDITVLSL PLPSTLVKRS
     NYPFENLLKN YLGSDEKYIE FTKIIKDYDI FIFSDSFSRI SSCLKTTFCL IEKFKKFICH
     FFPSPYLKFF LLEGSLNDSK APSLGKNKKN CILPKLDLNL NVNLTSRSTL NLRINIPPPN
     DSNKIFLQSL KKDLIHYSPN SLQKFFQFNM PADLAPNDTI LPNWLKFCSV KENEKVILKK
     LFNNFETLEN FEMQRLEKCL KFKKKPLHQK QLSQKQRGPQ STDDSKLYSL TSLQRQYKSS
     LKSNIQKNQK LKLIIPKNNT SSSPSPLSSD DTIMSPINDY ELTEGIQSFT KNRYSNILPY
     EHSRVKLPHS PKPPAVSEAS TTETKTDKSY PMCPVDAKNH SCKPNDYINA NYLKLTQINP
     DFKYIATQAP LPSTMDDFWK VITLNKVKVI ISLNSDDELN LRKWDIYWNN LSYSNHTIKL
     QNTWENICNI NGCVLRVFQV KKTAPQNDNI SQDCDLPHNG DLTSITMAVS EPFIVYQLQY
     KNWLDSCGVD MNDIIKLHKV KNSLLFNPQS FITSLEKDVC KPDLIDDNNS ELHLDTANSS
     PLLVHCSAGC GRTGVFVTLD FLLSILSPTT NHSNKIDVWN MTQDLIFIIV NELRKQRISM
     VQNLTQYIAC YEALLNYFAL QKQIKNALPC
>P29509 cyt THIOREDOXIN REDUCTASE (EC 1.6.4.5).
     VHNKVTIIGS GPAAHTAAIY LARAEIKPIL YEGMMANGIA AGGQLTTTTE IENFPGFPDG
     LTGSELMDRM REQSTKFGTE IITETVSKVD LSSKPFKLWT EFNEDAEPVT TDAIILATGA
     SAKRMHLPGE ETYWQKGISA CAVCDGAVPI FRNKPLAVIG GGDSACEEAQ FLTKYGSKVF
     MLVRKDHLRA STIMQKRAEK NEKIEILYNT VALEAKGDGK LLNALRIKNT KKNEETDLPV
     SGLFYAIGHT PATKIVAGQV DTDEAGYIKT VPGSSLTSVP GFFAAGDVQD SKYRQAITSA
     GSGCMAALDA EKYLTSLE
>P29952 cyt MANNOSE-6-PHOSPHATE ISOMERASE (EC 5.3.1.8) (PHOSPHOMANNOSE ISOMERASE)
     SNKLFRLDAG YQQYDWGKIG SSSAVAQFAA HSDPSVQIEQ DKPYAELWMG THSKMPSYNH
     ESKESLRDII SKNPSAMLGK DIIDKFHATN ELPFLFKVLS IEKVLSIQAH PDKALGKILH
     AQDPKNYPDD NHKPEMAIAV TDFEGFCGFK PLQEIADELK RIPELRNIVG EETSRNFIEN
     IQPSAQKGSP EDEQNKKLLQ AVFSRVMNAS DDKIKIQARS LVERSKNSPS DFNKPDLPEL
     IQRLNKQFPD DVGLFCGCLL LNHCRLNAGE AIFLRAKDPH AYISGDIMEC MAASDNVVRA
     GFTPKFKDVK NLVSMLTYTY DPVEKQKMQP LKFDRSSGNG KSVLYNPPIE EFAVLETTFD
     EKLGQRHFEG VDGPSILITT KGNGYIKADG QKLKAEPGFV FFIAPHLPVD LEAEDEAFTT
     YRAFVEPN
>P31373 cyt CYSTATHIONINE GAMMA-LYASE (EC 4.4.1.1) (GAMMA-CYSTATHIONASE).
     TLQESDKFAT KAIHAGEHVD VHGSVIEPIS LSTTFKQSSP ANPIGTYEYS RSQNPNRENL
     ERAVAALENA QYGLAFSSGS ATTATILQSL PQGSHAVSIG DVYGGTHRYF TKVANAHGVE
     TSFTNDLLND LPQLIKENTK LVWIETPTNP TLKVTDIQKV ADLIKKHAAG QDVILVVDNT
     FLSPYISNPL NFGADIVVHS ATKYINGHSD VVLGVLATNN KPLYERLQFL QNAIGAIPSP
     FDAWLTHRGL KTLHLRVRQA ALSANKIAEF LAADKENVVA VNYPGLKTHP NYDVVLKQHR
     DALGGGMISF RIKGGAEAAS KFASSTRLFT LAESLGGIES LLEVPAVMTH GGIPKEAREA
     SGVFDDLVRI SVGIEDTDDL LEDIKQALKQ ATN
>P31385 cyt DEP1 PROTEIN.
     MSQQTPQESE QTTAKEQDLD QESVLSNIDF NTDLNHNLNL SEYCISSDAG TEKMDSDEEK
     SLANLPELKY APKLSSLVKQ ETLTESLKRP HEDEKEAIDE AKKMKVPGEN EDESKEEEKS
     QELEEAIDSK EKSTDARDEQ GDEGDNEEEN NEEDNENENE HTAPPALVMP SPIEMEEQRM
     TALKEITDIE YKFAQLRQKL YDNQLVRLQT ELQMCLEGSH PELQVYYSKI AAIRDYKLHR
     AYQRQKYELS CINTETIATR TFIHQDFHKK VTDLRARLLN RTTQTWYDIN KERRDMDIVI
     PDVNYHVPIK LDNKTLSCIT GYAAHDSCAI PASPWQRTSL AKASSTATEP TRWTNSKSLW
     TE
>P32264 cyt GLUTAMATE 5-KINASE (EC 2.7.2.11) (GAMMA-GLUTAMYL KINASE) (GK).
     MKDANESKSY TIVIKLGSSS LVDEKTKEPK LAIMSLIVET VVKLRRMGHK VIIVSSGGIA
     VGLRTMRMNK RPKHLAEVQA IAAIGQGRLI GRWDLLFSQF DQRIAQILLT RNDILDWTQY
     KNAQNTINEL LNMGVIPIVN ENDTLSVREI KFGDNDTLSA ITSALIHADY LFLLTDVDCL
     YTDNPRTNPD AMPILVVPDL SKGLPGVNTA GGSGSDVGTG GMETKLVAAD LATNAGVHTL
     IMKSDTPANI GRIVEYMQTL ELDDENKVKQ AYNGDLTDLQ KREFEKLKAL NVPLHTKFIA
     NDNKHHLKNR EFWILHGLVS KGAVVIDQGA YAALTRKNKA GLLPAGVIDV QGTFHELECV
     DIKVGKKLPD GTLDPDFPLQ TVGKARCNYT SSELTKIKGL HSDQIEEELG YNDSEYVAHR
     ENLAFPPR
>P32288 cyt GLUTAMINE SYNTHETASE (EC 6.3.1.2) (GLUTAMATE--AMMONIA LIGASE).
     AEASIEKTQI LQKYLELDQR GRIIAEYVWI DGTGNLRSKG RTLKKRITSI DQLPEWNFDG
     SSTNQAPGHD SDIYLKPVAY YPDPFRRGDN IVVLAACYNN DGTPNKFNHR HEAAKLFAAH
     KDEEIWFGLE QEYTLFDMYD DVYGWPKGGY PAPQGPYYCG VGAGKVYARD MIEAHYRACL
     YAGLEISGIN AEVMPSQWEF QVGPCTGIDM GDQLWMARYF LHRVAEEFGI KISFHPKPLK
     GDWNGAGCHT NVSTKEMRQP GGMKYIEQAI EKLSKRHAEH IKLYGSDNDM RLTGRHETAS
     MTAFSSGVAN RGSSIRIPRS VAKEGYGYFE DRRPASNIDP YLVTGIMCET VCGAIDNADM
     TKEFERESS
>P32324 cyt ELONGATION FACTOR 2 (EF-2).
     MVAFTVDQMR SLMDKVTNVR NMSVIAHVDH GKSTLTDSLV QRAGIISAAK AGEARFTDTR
     KDEQERGITI KSTAISLYSE MSDEDVKEIK QKTDGNSFLI NLIDSPGHVD FSSEVTAALR
     VTDGALVVVD TIEGVCVQTE TVLRQALGER IKPVVVINKV DRALLELQVS KEDLYQTFAR
     TVESVNVIVS TYADEVLGDV QVYPARGTVA FGSGLHGWAF TIRQFATRYA KKFGVDKAKM
     MDRLWGDSFF NPKTKKWTNK DTDAEGKPLE RAFNMFILDP IFRLFTAIMN FKKDEIPVLL
     EKLEIVLKGD EKDLEGKALL KVVMRKFLPA ADALLEMIVL HLPSPVTAQA YRAEQLYEGP
     ADDANCIAIK NCDPKADLML YVSKMVPTSD KGRFYAFGRV FAGTVKSGQK VRIQGPNYVP
     GKKDDLFIKA IQRVVLMMGR FVEPIDDCPA GNIIGLVGID QFLLKTGTLT TSETAHNMKV
     MKFSVSPVVQ VAVEVKNAND LPKLVEGLKR LSKSDPCVLT YMSESGEHIV AGTGELHLEI
     CLQDLEHDHA GVPLKISPPV VAYRETVESE SSQTALSKSP NKHNRIYLKA EPIDEEVSLA
     IENGIINPRD DFKARARIMA DDYGWDVTDA RKIWCFGPDG NGPNLVIDQT KAVQYLHEIK
     DSVVAAFQWA TKEGPIFGEE MRSVRVNILD VTLHADAIHR GGGQIIPTMR RATYAGFLLA
     DPKIQEPVFL VEIQCPEQAV GGIYSVLNKK RGQVVSEEQR PGTPLFTVKA YLPVNESFGF
     TGELRQATGG QAFPQMVFDH WSTLGSDPLD PTSKAGEIVL AARKRHGMKE EVPGWQEYYD
     KL
>P32327 cyt PYRUVATE CARBOXYLASE 2 (EC 6.4.1.1) (PYRUVIC CARBOXYLASE 2) (PCB 2).
     MSSSKKLAGL RDNFSLLGEK NKILVANRGE IPIRIFRSAH ELSMRTIAIY SHEDRLSMHR
     LKADEAYVIG EEGQYTPVGA YLAMDEIIEI AKKHKVDFIH PGYGFLSENS EFADKVVKAG
     ITWIGPPAEV IDSVGDKVSA RHLAARANVP TVPGTPGPIE TVQEALDFVN EYGYPVIIKA
     AFGGGGRGMR VVREGDDVAD AFQRATSEAR TAFGNGTCFV ERFLDKPKHI EVQLLADNHG
     NVVHLFERDC SVQRRHQKVV EVAPAKTLPR EVRDAILTDA VKLAKVCGYR NAGTAEFLVD
     NQNRHYFIEI NPRIQVEHTI TEEITGIDIV SAQIQIAAGA TLTQLGLLQD KITTRGFSIQ
     CRITTEDPSK NFQPDTGRLE VYRSAGGNGV RLDGGNAYAG ATISPHYDSM LVKCSCSGST
     YEIVRRKMIR ALIEFRIRGV KTNIPFLLTL LTNPVFIEGT YWTTFIDDTP QLFQMVSSQN
     RAQKLLHYLA DLAVNGSSIK GQIGLPKLKS NPSVPHLHDA QGNVINVTKS APPSGWRQVL
     LEKGPSEFAK QVRQFNGTLL MDTTWRDAHQ SLLATRVRTH DLATIAPTTA HALAGAFALE
     CWGGATFDVA MRFLHEDPWE RLRKLRSLVP NIPFQMLLRG ANGVAYSSLP DNAIDHFVKQ
     AKDNGVDIFR VFDALNDLEQ LKVGVNAVKK AGGVVEATVC YSGDMLQPGK KYNLDYYLEV
     VEKIVQMGTH ILGIKDMAGT MKPAAAKLLI GSLRTRYPDL PIHVHSHDSA GTAVASMTAC
     ALAGADVVDV AINSMSGLTS QPSINALLAS LEGNIDTGIN VEHVRELDAY WAEMRLLYSC
     FEADLKGPDP EVYQHEIPGG QLTNLLFQAQ QLGLGEQWAE TKRAYREANY LLGDIVKVTP
     TSKVVGDLAQ FMVSNKLTSD DIRRLANSLD FPDSVMDFFE GLIGQPYGGF PEPLRSDVLR
     NKRRKLTCRP GLELEPFDLE KIREDLQNRF GDIDECDVAS YNMYPRVYED FQKIRETYGD
     LSVLPTKNFL APAEPDEEIE VTIEQGKTLI IKLQAVGDLN KKTGQREVYF ELNGELRKIR
     VADKSQNIQS VAKPKADVHD THQIGAPMAG VIIEVKVHKG SLVKKGESIA VLSAMKMEMV
     VSSPADGQVK DVFIKDGESV DASDLLVVLE EETLPPSQKK
>P32347 cyt UROPORPHYRINOGEN DECARBOXYLASE (EC 4.1.1.37) (UPD).
     MGNFPAPKND LILRAAKGEK VERPPCWIMR QAGRYLPEYH EVKNNRDFFQ TCRDAEIASE
     ITIQPVRRYR GLIDAAIIFS DILVIPQAMG MRVEMLEGKG PHFPEPLRNP EDLQTVLDYK
     VDVLKELDWA FKAITMTRIK LDGEVPLFGF CGGPWTLMVY MTEGGGSRLF RFAKQWINMY
     PELSHKLLQK ITDVAVEFLS QQVVAGAQIL QVFESWGGEL SSVDFDEFSL PYLRQIAERV
     PKRLQELGIM EQIPMIVFAK GSWYALDKLC CSGFDVVSLD WSWDPREAVK INKNRVTLQG
     NLDPGVMYGS KEVITKKVKQ MIEAFGGGKS RYIVNFGHGT HPFMDPDVIK FFLEECHRIG
     SK
>P32356 cyt NEUTRAL TREHALASE (EC 3.2.1.28) (ALPHA,ALPHA-TREHALASE)
     MSQVNTSQGP VAQGRQRRLS SLSEFNDPFS NAEVYYGPPT DPRKQKQAKP AKINRTRTMS
     VFDNVSPFKK TGFGKLQQTR RGSEDDTYSS SQGNRRFFIE DVDKTLNELL AAEDTDKNYQ
     ITIEDTGPKV LKVGTANSYG YKHINIRGTY MLSNLLQELT IAKSFGRHQI FLDEARINEN
     PVNRLSRLIN TQFWNSLTRR VDLNNVGEIA KDTKIDTPGA KNPRIYVPYD CPEQYEFYVQ
     ASQMHPSLKL EVEYLPKKIT AEYVKSVNDT PGLLALAMEE HFNPSTGEKT LIGYPYAVPG
     GRFNELYGWD SYMMALGLLE ANKTDVARGM VEHFIFEINH YGKILNANRS YYLCRSQPPF
     LTEMALVVFK KLGGRSNPDA VDLLKRAFQA SIKEYKTVWT ASPRLDPETG LSRYHPNGLG
     IPPETESDHF DTVLLPYASK HGVTLDEFKQ LYNDGKIKEP KLDEFFLHDR GVRESGHDTT
     YRFEGVCAYL ATIDLNSLLY KYEIDIADFI KEFCDDKYED PLDHSITTSA MWKEMAKIRQ
     EKITKYMWDD ESGFFFDYNT KIKHRTSYES ATTFWALWAG LATKEQAQKM VEKALPKLEM
     LGGLAACTER SRGPISISRP IRQWDYPFGW APHQILAWEG LRSYGYLTVT NRLAYRWLFM
     MTKAFVDYNG IVVEKYDVTR GTDPHRVEAE YGNQGADFKG AATEGFGWVN ASYILGLKYM
     NSHARRALGA CIPPISFFSS LRPQERNLYG L
>P32598 cyt SERINE/THREONINE PROTEIN PHOSPHATASE PP1-2 (EC 3.1.3.16).
     MDSQPVDVDN IIDRLLEVRG SKPGQQVDLE ENEIRYLCSK ARSIFIKQPI LLELEAPIKI
     CGDIHGQYYD LLRLFEYGGF PPESNYLFLG DYVDRGKQSL ETICLLLAYK IKYPENFFIL
     RGNHECASIN RIYGFYDECK RRYNIKLWKT FTDCFNCLPI AAIIDEKIFC MHGGLSPDLN
     SMEQIRRVMR PTDIPDVGLL CDLLWSDPDK DIVGWSENDR GVSFTFGPDV VNRFLQKQDM
     ELICRAHQVV EDGYEFFSKR QLVTLFSAPN YCGEFDNAGA MMSVDESLLC SFQILKPAQK
     SLPRQAGGRK KK
>P32844 cyt EXOCYST COMPLEX COMPONENT SEC6.
     MSSDPLQQVC DLIKGDLSLE RVRDIKEQLL KEKSVVEYQL NKESDKYYGE VEESLKLLNL
     SKNSVTSIKQ QINEVNKLGN DNRFAINRYD ILFRATKLYE TVNTTSSIYD RIYNFVALME
     HIERLLVAEL AEDALETGCP HLLEIHFLLT SARDFQEQVV VMAKEATEDA QRTVMKLFSR
     LSGIISKFDK LLDGLTYDIV EMARAEQISL AIRLFKIYDL EEREDLRIEA IRNIIKKKEI
     EIEKSSIKKL PNSKNTARLQ DETPKVIEYP TNKGLYQEIM SGTISTRTAP RGYKHFLING
     INNSISEMFG EMREKYVGDQ KFDVLDNMDW IFNELIIVKE HIANCCPPHW NIFEVYFDQY
     YKELHSLITD LVESEPETII ILDILAFDKT FQDTLKQDFG FTKSEVKSVI GDKEKETLFK
     DYLNLIVVKM TEWIGNLEKA EFDVFLERST PPHSDSDGLL FLDGTKTCFQ MFTQQVEVAA
     GTNQAKILVG VVERFSDLLT KRQKNWISKI SEEIKKQINY NHKYDIDPES ITPEDECPGG
     LVEYLIAVSN DQMKAADYAV AISSKYGKLV SKVYEKQITN HLEGTLDGFA EVAQCSSLGL
     ITLMFDDLRK PYQEIFSKTW YMGSQAQQIA DTLDEYLLDI KPQMNSVLFV NFIDNVIGET
     IIKFLTALSF EHSFKNKNNK FLEAMKRDFE IFYQLFVKVL DGNESKDTLI TQNFTVMEFF
     MDLSCEPIDS ILDIWQKYLE VYWDSRIDLL VGILKCRKDV SSSERKKIVQ QATEMLHEYR
     RNMEANGVDR EPTLMRRFVL EFEKQ
>P32873 cyt BEM3 PROTEIN.
     MTDNLTTTHG GSTTLELLAQ YNDHRSKKDK SIEHIEKGTC SGKERNPSYD EIFTENIKLK
     LQVQEYETEI ESLEKVIDML QKNREASLEV VLEQVQNDSR DSYVNDQSFV LPPRSAERKA
     HIKSLNLPIP TLSPPLQQGS DVALETSVTP TVPQIGVTSN TSISRKHLQN MILNDEIEAN
     SSFSSPKIIN RSVSSPTKIH SEQLASPAAS VTYTTSRITI KSPNKGSKSP LQERLRSPQN
     PNRMTAVINN HLHSPLKAST SNNLDELTES KSQQLTNDAI QKNDRVYSSI TSSAYTTGTP
     TSAAKSPSSL LEVKEGENKA LGFSPASKEK LDDFTQLLDS SFGEEDLVNT DSKDPLSIKS
     TINESLPPPP APPTFFSPTS SGNIKNSTPL SSHLASPVIL NKKDDNFGAQ SAKNLKKPVL
     TSSLPNLSTK LSTTSQNASL PPNPPVESSS KQKQLGETAS IHSTNTLNTF SSTPQGSLKT
     LRRPHASSVS TVKSVAQSLK SDIPLFVQPE DFGTIQIEVL STLYRDNEDD LSILIAIIDR
     KSGKEMFKFS KSIHKVRELD VYMKSHVPDL PLPTLPDRQL FQTLSPTKVD TRKNILNQYY
     TSIFSVPEFP KNVGLKIAQF ISTDTVMTPP MMDDNVKDGS LLLRRPKTLT GNSTWRVRYG
     ILRDDVLQLF DKNQLTETIK LRQSSIELIP NLPEDRFGTR NGFLITEHKK SGLSTSTKYY
     ICTETSKERE LWLSAFSDYI DPSQSLSLSS SRNANDTDSA SHLSAGTHHS KFGNATISAT
     DTPSYVTDLT QEYNNNNNIS NSSNNIANSD GIDSNPSSHS NFLASSSGNA EEEKDSRRAK
     MRSLFPFKKL TGPASAMNHI GITISNDSDS PTSPDSIIKS PSKKLMEVSS SSNSSTGPHV
     STAIFGSSLE TCLRLSSHKY QNVYDLPSVV YRCLEYLYKN RGIQEEGIFR LSGSSTVIKT
     LQERFDKEYD VDLCRYNESI EAKDDEASPS LYIGVNTVSG LLKLYLRKLP HLLFGDEQFL
     SFKRVVDENH NNPVQISLGF KELIESGLVP HANLSLMYAL FELLVRINEN SKFNKMNLRN
     LCIVFSPTLN IPISMLQPFI TDFACIFQGG EPVKEEEREK VDIHIPQV
>P32893 cyt BETA-GLUCAN SYNTHESIS-ASSOCIATED PROTEIN KRE11 (KILLER TOXIN-
     MECFVPLRCD LDGSNIEQLR QSHLSRKFII FDEQLNLWLW FQGNSQENKR FVLQNMIILI
     NEAQVTRTST IDDYFTQVEN NENLWRLKND CCSKILFKSN VVMNNGYNNQ IKFVFEYKSV
     DANFNNQDSL QDPQAKYTLD KYSSEEILPS FEPVYSWSSA ATKSSKNTNN HLEKNNRATH
     RVSSKNSEVH EADVSRNPNT FTLKLQYPIF SLLNMRLRNI SLKSEHCILS SLDFQTSKAS
     EQLTKKFIYP QEHNSFLKLN FQEISYKLID GTSQIELDPI CPLKVPLTAF SYDSISATFK
     LVLLPKSTQP HRVKITLAYE LELHPNLKLP VRTSWETEVT LKRSMPISST SSQYSSNNNN
     TNHSASFNGA ANNVNSGGLA NLRLGGVSSS RFSLGAASTT SLVNSKLSNV KFKFINSNIK
     VIKGEKFTMR LQIINSSSSP LDLVVYYNNT INPIPSANNV RNSNGINNCG MNNGTIPNSP
     LTLENQYQLH NKYRKIAEGI ILLSNDYKIP VVPPRETYFA DLRFIGIMSG YYGTLSGLKV
     LDLNTNELIE VGNGASVLIQ
>P32917 cyt STE5 PROTEIN.
     MMETPTDNIV SPFHNFGSST QYSGTLSRTP NQIIELEKPS TLSPLSRGKK WTEKLARFQR
     SSAKKKRFSP SPISSSTFSF SPKSRVTSSN SSGNEDGNLM NTPSTVSTDY LPQHPHRTSS
     LPRPNSNLFH ASNSNLSRAN EPPRAENLSD NIPPKVAPFG YPIQRTSIKK SFLNASCTLC
     DEPISNRRKG EKIIELACGH LSHQECLIIS FGTTSKADVR ALFPFCTKCK KDTNKAVQCI
     PENDELKDIL ISDFLIHKIP DSELSITPQS RFPPYSPLLP PFGLSYTPVE RQTIYSQAPS
     LNPNLILAAP PKERNQIPQK KSNYTFLHSP LGHRRIPSGA NSILADTSVA LSANDSISAV
     SNSVRAKDDE TKTTLPLLRS YFIQILLNNF QEELQDWRID GDYGLLRLVD KLMISKDGQR
     YIQCWCFLFE DAFVIAEVDN DVDVLEIRLK NLEVFTPIAN LRMTTLEASV LKCTLNKQHC
     ADLSDLYIVQ NINSDESTTV QKWISGILNQ DFVFNEDNIT STLPILPIIK NFSKDVGNGR
     HETSTFLGLI NPNKVVEVGN VHDNDTVIIR RGFTLNSGEC SRQSTVDSIQ SVLTTISSIL
     SLKREKPDNL AIILQIDFTK LKEEDSLIVV YNSLKALTIK FARLQFCFVD RNNYVLDYGS
     VLHKIDSLDS ISNLKSKSSS TQFSPIWLKN TLYPENIHEH LGIVAVSNSN MEAKKSILFQ
     DYRCFTSFGR RRPNELKIKV GYLNVDYSDK IDELVEASSW TFVLETLCYS FGLSFDEHDD
     DDEEDNDDST DNELDNSSGS LSDAESTTTI HIDSPFDNEN ATANMVNDRN LLTEGEHSNI
     ENLETVASSV QPALIPNIRF SLHSEEEGTN ENENENDMPV LLLSDMDKGI DGITRRSSFS
     SLIESGNNNC PLHMDYI
>P33331 cyt NUCLEAR TRANSPORT FACTOR 2 (NTF-2) (NUCLEAR TRANSPORT FACTOR P10).
     MSLDFNTLAQ NFTQFYYNQF DTDRSQLGNL YRNESMLTFE TSQLQGAKDI VEKLVSLPFQ
     KVQHRITTLD AQPASPNGDV LVMITGDLLI DEEQNPQRFS QVFHLIPDGN SYYVFNDIFR
     LNYSA
>P33401 cyt PHOSPHOGLUCOMUTASE 1 (EC 5.4.2.2) (GLUCOSE PHOSPHOMUTASE 1) (PGM 1).
     MSLLIDSVPT VAYKDQKPGT SGLRKKTKVF MDEPHYTENF IQATMQSIPN GSEGTTLVVG
     GDGRFYNDVI MNKIAAVGAA NGVRKLVIGQ GGLLSTPAAS HIIRTYEEKC TGGGIILTAS
     HNPGGPENDL GIKYNLPNGG PAPESVTNAI WEASKKLTHY KIIKNFPKLN LNKLGKNQKY
     GPLLVDIIDP AKAYVQFLKE IFDFDLIKSF LAKQRKDKGW KLLFDSLNGI TGPYGKAIFV
     DEFGLPAEEV LQNWHPLPDF GGLHPDPNLT YARTLVDRVD REKIAFGAAS DGDGDRNMIY
     GYGPAFVSPG DSVAIIAEYA PEIPYFAKQG IYGLARSFPT SSAIDRVAAK KGLRCYEVPT
     GWKFFCALFD AKKLSICGEE SFGTGSNHIR EKDGLWAIIA WLNILAIYHR RNPEKEASIK
     TIQDEFWNEY GRTFFTRYDY EHIECEQAEK VVALLSEFVS RPNVCGSHFP ADESLTVIDC
     GDFSYRDLDG SISENQGLFV KFSNGTKFVL RLSGTGSSGA TIRLYVEKYT DKKENYGQTA
     DVFLKPVINS IVKFLRFKEI LGTDEPTVRT
>P33891 cyt PROTEIN TRANSPORT PROTEIN TIP20.
     MNGIDDLLNI NDRIKQVQNE RNELASKLQN LKQSLASNDT EVALSEVIAQ DIIEVGASVE
     GLEQLRAKYG DLQILNKLEK VAVQQTQMQA GVDKLDSFER QLDELAEQPP DQFTLDDVKA
     LHSKLTSVFA TVPQINNIDS QYAAYNKLKS KVTGKYNDVI IQRLATNWSN TFDQKLLEAQ
     WDTQKFASTS VGLVKCLREN STKLYQLSLL YLPLEEETQN GDSERPLSRS NNNQEPVLWN
     FKSLANNFNV RFTYHFHATS SSSKIETYFQ FLNDYLAENL YKCINIFHDD CNGLTKPVIH
     EQFINYVLQP IRDKVRSTLF QNDLKTLIVL ISQILATDKN LLNSFHYHGL GLVSLISDEV
     WEKWINYEVE MANRQFINIT KNPEDFPKSS QNFVKLINKI YDYLEPFYDL DFDLLVRYKL
     MTCSLIFMNL TSSYLDYILT VDSLNETRTK EQELYQTMAK LQHVNFVYRK IKSLSSNFIF
     IQLTDIVNST ESKKYNSLFQ NVENDYEKAM STDMQNSIVH RIQKLLKETL RNYFKISTWS
     TLEMSVDENI GPSSVPSAEL VNSINVLRRL INKLDSMDIP LAISLKVKNE LLNVIVNYFT
     ESILKLNKFN QNGLNQFLHD FKSLSSILSL PSHATNYKCM SLHELVKILK LKYDPNNQQF
     LNPEYIKTGN FTSLKEAYSI KYLKDTKIQD ALYRIIYGNI L
>P34760 cyt THIOL-SPECIFIC ANTIOXIDANT PROTEIN (PRP).
     VAQVQKQAPT FKKTAVVDGV FDEVSLDKYK GKYVVLAFIP LAFTFVCPTE IIAFSEAAKK
     FEEQGAQVLF ASTDSEYSLL AWTNIPRKEG GLGPINIPLL ADTNHSLSRD YGVLIEEEGV
     ALRGLFIIDP KGVIRHITIN DLPVGRNVDE ALRLVEAFQW TDKNGTVLPC NWTPGAATIK
     PTVEDSKEYF EAANK
>P36421 cyt TYROSYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.1) (TYROSYL--TRNA
     MSSAATVDPN EAFGLITKNL QEVLNPQIIK DVLEVQKRHL KLYWGTAPTG RPHCGYFVPM
     TKLADFLKAG CEVTVLLADL HAFLDNMKAP LEVVNYRAKY YELTIKAILR SINVPIEKLK
     FVVGSSYQLT PDYTMDIFRL SNIVSQNDAK RAGADVVKQV ANPLLSGLIY PLMQALDEQF
     LDVDCQFGGV DQRKIFVLAE ENLPSLGYKK RAHLMNPMVP GLAQGGKMSA SDPNSKIDLL
     EEPKQVKKKI NSAFCSPGNV EENGLLSFVQ YVIAPIQELK FGTNHFEFFI DRPEKFGGPI
     TYKSFEEMKL AFKEEKLSPP DLKIGVADAI NELLEPIRQE FANNKEFQEA SEKGYPVATP
     QKSKKAKKPK NKGTKYPGAT KTNEIATKLE ETKL
>P36973 cyt ADENINE PHOSPHORIBOSYLTRANSFERASE 2 (EC 2.4.2.7) (APRT 2).
     MSISESYAKE IKTAFRQFTD FPIEGEQFED FLPIIGNPTL FQKLVHTFKT HLEEKFAKEK
     IDFIAGIEAR GLLFGPSLAL ALGVGFVPIR RVGKLPGECA SITFTKLDHE EIFEMQVEAI
     PFDSNVVVVD DVLATGGTAY AAGDLIRQVG AHILEYDFVL VLDSLHGEEK LSAPIFSILH
     S
>P37012 cyt PHOSPHOGLUCOMUTASE 2 (EC 5.4.2.2) (GLUCOSE PHOSPHOMUTASE 2) (PGM 2).
     MSFQIETVPT KPYEDQKPGT SGLRKKTKVF KDEPNYTENF IQSIMEAIPE GSKGATLVVG
     GDGRYYNDVI LHKIAAIGAA NGIKKLVIGQ HGLLSTPAAS HIMRTYEEKC TGGIILTASH
     NPGGPENDMG IKYNLSNGGP APESVTNAIW EISKKLTSYK IIKDFPELDL GTIGKNKKYG
     PLLVDIIDIT KDYVNFLKEI FDFDLIKKFI DNQRSTKNWK LLFDSMNGVT GPYGKAIFVD
     EFGLPADEVL QNWHPSPDFG GMHPDPNLTY ASSLVKRVDR EKIEFGAASD GDGDRNMIYG
     YGPSFVSPGD SVAIIAEYAA EIPYFAKQGI YGLARSFPTS GAIDRVAKAH GLNCYEVPTG
     WKFFCALFDA KKLSICGEES FGTGSNHVRE KDGVWAIMAW LNILAIYNKH HPENEASIKT
     IQNEFWAKYG RTFFTRYDFE KVETEKANKI VDQLRAYVTK SGVVNSAFPA DESLKVTDCG
     DFSYTDLDGS VSDHQGLYVK LSNGARFVLR LSGTGSSGAT IRLYIEKYCD DKSQYQKTAE
     EYLKPIINSV IKFLNFKQVL GTEEPTVRT
>P37291 cyt SERINE HYDROXYMETHYLTRANSFERASE, CYTOSOLIC (EC 2.1.2.1) (SERINE
     MPYTLSDAHH KLITSHLVDT DPEVDSIIKD EIERQKHSID LIASENFTST SVFDALGTPL
     SNKYSEGYPG ARYYGGNEHI DRMEILCQQR ALKAFHVTPD KWGVNVQTLS GSPANLQVYQ
     AIMKPHERLM GLYLPDGGHL SHGYATENRK ISAVSTYFES FPYRVNPETG IIDYDTLEKN
     AILYRPKVLV AGTSAYCRLI DYKRMREIAD KCGAYLMVDM AHISGLIAAG VIPSPFEYAD
     IVTTTTHKSL RGPRGAMIFF RRGVRSINPK TGKEVLYDLE NPINFSVFPG HQGGPHNHTI
     AALATALKQA ATPEFKEYQT QVLKNAKALE SEFKNLGYRL VSNGTDSHMV LVSLREKGVD
     GARVEYICEK INIALNKNSI PGDKSALVPG GVRIGAPAMT TRGMGEEDFH RIVQYINKAV
     EFAQQVQQSL PKDACRLKDF KAKVDEGSDV LNTWKKEIYD WAGEYPLAV
>P38217 cyt IMPORTIN BETA-2 SUBUNIT (KARYOPHERIN BETA-2 SUBUNIT).
     MASTWKPAED YVLQLATLLQ NCMSPNPEIR NNAMEAMENF QLQPEFLNYL CYILIEGESD
     DVLKQHYSLQ DLQNNRATAG MLLKNSMLGG NNLIKSNSHD LGYVKSNIIH GLYNSNNNLV
     SNVTGIVITT LFSTYYRQHR DDPTGLQMLY QLLELTSNGN EPSIKALSKI MEDSAQFFQL
     EWSGNTKPME ALLDSFFRFI SNPNFSPVIR SESVKCINTV IPLQTQSFIV RLDKFLEIIF
     QLAQNDENDL VRAQICISFS FLLEFRPDKL VSHLDGIVQF MLHLITTVNE EKVAIEACEF
     LHAFATSPNI PEHILQPYVK DIVPILLSKM VYNEESIVLL EASNDDDAFL EDKDEDIKPI
     APRIVKKKEA GNGEDADDNE DDDDDDDDED GDVDTQWNLR KCSAATLDVM TNILPHQVMD
     IAFPFLREHL GSDRWFIREA TILALGAMAE GGMKYFNDGL PALIPFLVEQ LNDKWAPVRK
     MTCWTLSRFS PWILQDHTEF LIPVLEPIIN TLMDKKKDVQ EAAISSVAVF IENADSELVE
     TLFYSQLLTS FDKCLKYYKK KNLIILYDAI GRFAEKCALD ETAMQIILPP LIEKWALLSD
     SDKELWPLLE CLSCVASSLG ERFMPMAPEV YNRAFRILCH CVELEAKSHQ DPTIVVPEKD
     FIITSLDLID GLVQGLGAHS QDLLFPQGTK DLTILKIMLE CLQDPVHEVR QSCFALLGDI
     VYFFNSELVI GNLEDFLKLI GTEIMHNDDS DGTPAVINAI WALGLISERI DLNTYIIDMS
     RIILDLFTTN TQIVDSSVME NLSVTIGKMG LTHPEVFSSG AFANDSNWNK WCLSVNALDD
     VEEKSSAYMG FLKIINLTST EVTMSNDTIH KIVTGLSSNV EANVFAQEIY TFLMNHSAQI
     SAINFTPDEI SFLQQFTS
>P38707 cyt PUTATIVE ASPARAGINYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.22)
     MSSLYIKEAT GVDELTTAGS QDHPFKTPAY ALFASQQKSD ATEPKLFVFK TEDNEYQEIS
     ASALKKARKG CDGLKKKAVK QKEQELKKQQ KEAENAAKQL SALNITIKED ESLPAAIKTR
     IYDSYSKVGQ RVKVSGWIHR LRSNKKVIFV VLRDGSGFIQ CVLSGDLALA QQTLDLTLES
     TVTLYGTIVK LPEGKTAPGG VELNVDYYEV VGLAPGGEDS FTNKIAEGSD PSLLLDQRHL
     ALRGDALSAV MKVRAALLKS VRRVYDEEHL TEVTPPCMVQ TQVEGGSTLF KMNYYGEEAY
     LTQSSQLYLE TCLASLGDVY TIQESFRAEK SHTRRHLSEY THIEAELAFL TFDDLLQHIE
     TLIVKSVQYV LEDPIAGPLV KQLNPNFKAP KAPFMRLQYK DAITWLNEHD IKNEEGEDFK
     FGDDIAEAAE RKMTDTIGVP IFLTRFPVEI KSFYMKRCSD DPRVTESVDV LMPNVGEITG
     GSMRIDDMDE LMAGFKREGI DTDAYYWFID QRKYGTCPHG GYGIGTERIL AWLCDRFTVR
     DCSLYPRFSG RCKP
>P38913 cyt FAD SYNTHETASE (EC 2.7.7.2) (FMN ADENYLYLTRANSFERASE) (FAD
     MQLSKAAEMC YEITNSYLHI DQKSQIIAST QEAIRLTRKY LLSEIFVRWS PLNGEISFSY
     NGGKDCQVLL LLYLSCLWEY FFIKAQNSQF DFEFQSFPMQ RLPTVFIDQE ETFPTLENFV
     LETSERYCLS LYESQRQSGA SVNMADAFRD FIKIYPETEA IVIGIRHTDP FGEALKPIQR
     TDSNWPDFMR LQPLLHWDLT NIWSFLLYSN EPICGLYGKG FTSIGGINNS LPNPHLRKDS
     NNPALHFEWE IIHAFGKDAE GERSSAINTS PISVVDKERF SKYHDNYYPG WYLVDDTLER
     AGRIKN
>P38972 cyt PHOSPHORIBOSYLFORMYLGLYCINAMIDINE SYNTHASE (EC 6.3.5.3) (FGAM
     MTDYILPGPK ALSQFRVDNL IKDINSYTNS TSVINELRSC YIHYVNGIAQ NLSEQDTKLL
     EVLLTYDSAL DIANDPLARQ LNDAVANNLP SSALGEDTYL IRVVPRSGTI SPWSSKATNI
     AHVCGLQDKV QRIERGLALL IKTVPGFPLL ENLNDISLKC VYDRMTQQLY LTEPPNTMSI
     FTHEEPKPLV HVPLTPKDTK QSPKDILSKA NTELGLALDS GEMEYLIHAF VETMKRDPTD
     VELFMFAQVN SEHCRHKIFN ADWTIDGIKQ QFTLFQMIRN THKLNPEYTI SAYSDNAAVL
     DSENDAFFFA PNSTTKEWTS TKERIPLLIK VETHNHPTAV SPFPGAATGS GGEIRDEGAT
     GRGSKTKCGL SGFSVSDLLI PGNEQPWELN IGKPYHIASA LDIMIEAPLG SAAFNNEFGR
     PCINGYFRTL TTKVLNHQGK EEIRGFHKPI MIAGGFGTVR PQFALKNTPI TPGSCLIVLG
     GQSMLIGLGG GAASSVASGE GSADLDFASV QRGNPEMERR CQQVIDACVA LGNNNPIQSI
     HDVGAGGLSN ALPELVHDND LGAKFDIRKV LSLEPGMSPM EIWCNESQER YVLGVSPQDL
     SIFEEICKRE RAPFAVVGHA TAEQKLIVED PLLKTTPIDL EMPILFGKPP KMSRETITEA
     LNLPEANLSE IPSLQDAIQR VLNLPSVGSK SFLITIGDRS VTGLIDRDQF VGPWQVPVAD
     VGVTGTSLGE TIISTGEAMA MGEKPVNALI SASASAKLSV AESLLNIFAA DVKSLNHIKL
     SANWMSPASH QGEGSKLYEA VQALGLDLCP ALGVAIPVGK DSMSMKMKWD DKEVTAPLSL
     NITAFAPVFN TSKTWTPLLN RNTDDSVLVL VDLSAKQETK SLGASALLQV YNQVGNKSPT
     VYDNAILKGF LESLIQLHQQ KEDIVLAYHD RSDGGLLITL LEMAFASRCG LEINIDGGDL
     ESQLTNLFNE ELGAVFQISA KNLSKFEKIL NENGVAKEYI SIVGKPSFQS QEIKIINSTT
     NDVIYANSRS ELEQTWSKTS YEMQKLRDNP KTAEEEFASI TDDRDPGLQY ALTYNPADDM
     KIGLELSSQR PKVAILREQG VNGQMEMAWC FQQAGFNSVD VTMTDLLEGR FHLDDFIGLA
     ACGGFSYGDV LGAGAGWAKS VLYHEGVRSQ FSKFFNERQD TFAFGACNGC QFLSRLKDII
     PGCENWPSFE RNVSEQYEAR VCMVQISQEK DNSSEESVFL NGMAGSKLPI AVAHGEGKAT
     FSKSAEQLEK FEKDGLCCIR YVDNYGNVTE RFPFNPNGST NGIAGIKSPN GRVLAMMPHP
     ERVCRLEANS WYPEGKYEEW GGYGPWIRLF RSARRWVG
>P38986 cyt L-ASPARAGINASE I (EC 3.5.1.1) (L-ASPARAGINE AMIDOHYDROLASE I) (ASP I).
     MKSDSVEITT ICPDVENSQF VVQSNCPETI PEILKSQNAA VNGSGIACQQ RSLPRIKILG
     TGGTIASKAI DSSQTAGYHV DLTIQDLLDA IPDISKVCDI EYEQLCNVDS KDINEDILYK
     IYKGVSESLQ AFDGIVITHG TDTLSETAFF IESTIDAGDV PIVFVGSMRP STSVSADGPM
     NLYQAICIAS NPKSRGRGVL VSLNDQISSG YYITKTNANS LDSFNVRQGY LGNFVNNEIH
     YYYPPVKPQG CHKFKLRVDG KHFKLPEVCI LYAHQAFPPA IVNLVADKYD GIVLATMGAG
     SLPEEVNETC MKLSLPIVYS KRSMDGMVPI ANVPKKGSKE DNLIASGYLS PEKSRILLQL
     CLAGNYTLEE IKHVFTGVYG G
>P39076 cyt T-COMPLEX PROTEIN 1, BETA SUBUNIT (TCP-1-BETA) (CCT-BETA).
     MSVQIFGDQV TEERAENARL SAFVGAIAVG DLVKSTLGPK GMDKLLQSAS SNTCMVTNDG
     ATILKSIPLD NPAAKVLVNI SKVQDDEVGD GTTSVTVLSA ELLREAEKLI DQSKIHPQTI
     IEGYRLASAA ALDALTKAAV DNSHDKTMFR EDLIHIAKTT LSSKILSQDK DHFAELATNA
     ILRLKGSTNL EHIQIIKILG GKLSDSFLDE GFILAKKFGN NQPKRIENAK ILIANTTLDT
     DKVKIFGTKF KVDSTAKLAQ LEKAEREKMK NKIAKISKFG INTFINRQLI YDYPEQLFTD
     LGINSIEHAD FEGVERLALV TGGEVVSTFD EPSKCKLGEC DVIEEIMLGE QPFLKFSGCK
     AGEACTIVLR GATDQTLDEA ERSLHDALSV LSQTTKETRT VLGGGCAEMV MSKAVDTEAQ
     NIDGKKSLAV EAFARALRQL PTILADNAGF DSSELVSKLR SSIYNGISTS GLDLNNGTIA
     DMRQLGIVES YKLKRAVVSS ASEAAEVLLR VDNIIRARPR TANRQHM
>P39077 cyt T-COMPLEX PROTEIN 1, GAMMA SUBUNIT (TCP-1-GAMMA) (CCT-GAMMA).
     MQAPVVFMNA SQERTTGRQA QISNITAAKA VADVIRTCLG PKAMLKMLLD PMGGLVLTND
     GHAILREIDV AHPAAKSMLE LSRTQDEEVG DGTTTVIILA GEILAQCAPY LIEKNIHPVI
     IIQALKKALT DALEVIKQVS KPVDVENDAA MKKLIQASIG TKYVIHWSEK MCELALDAVK
     TVRKDLGQTV EGEPNFEIDI KRYVRVEKIP GGDVLDSRVL KGVLLNKDVV HPKMSRHIEN
     PRVVLLDCPL EYKKGESQTN IEIEKEEDWN RILQIEEEQV QLMCEQILAV RPTLVITEKG
     VSDLAQHYLL KGGCSVLRRV KKSDNNRIAR VTGATIVNRV EDLKESDVGT NCGLFKVEMI
     GDEYFSFLDN CKEPKACTIM LRGGSKDILN EIDRNLQDAM AVARNVMLSP SLSPGGGATE
     MAVSVKLAEK AKQLEGIQQW PYQAVADAME CIPRTLIQNA GGDPIRLLSQ LRAKHAQGNF
     TTGIDGDKGK IVDMVSYGIW EPEVIKQQSV KTAIESACLL LRVDDIVSGV RKQE
>P39078 cyt T-COMPLEX PROTEIN 1, DELTA SUBUNIT (TCP-1-DELTA) (CCT-DELTA).
     MSAKVPSNAT FKNKEKPQEV RKANIIAARS VADAIRTSLG PKGMDKMIKT SRGEIIISND
     GHTILKQMAI LHPVARMLVE VSAAQDSEAG DGTTSVVILT GALLGAAERL LNKGIHPTII
     ADSFQSAAKR SVDILLEMCH KVSLSDREQL VRAASTSLSS KIVSQYSSFL APLAVDSVLK
     ISDENSKNVD LNDIRLVKKV GGTIDDTEMI DGVVLTQTAI KSAGGPTRKE KAKIGLIQFQ
     ISPPKPDTEN NIIVNDYRQM DKILKEERAY LLNICKKIKK AKCNVLLIQK SILRDAVNDL
     ALHFLSKLNI MVVKDIEREE IEFLSKGLGC KPIADIELFT EDRLGSADLV EEIDSDGSKI
     VRVTGIRNNN ARPTVSVVIR GANNMIIDET ERSLHDALCV IRCLVKERGL IAGGGAPEIE
     ISRRLSKEAR SMEGVQAFIW QEFASALEVI PTTLAENAGL NSIKVVTELR SKHENGELND
     GISVRRSGTT NTYEEHILQP VLVSTSAITL ASECVKSILR IDDIAFSR
>P39079 cyt T-COMPLEX PROTEIN 1, ZETA SUBUNIT (TCP-1-ZETA) (CCT-ZETA).
     MSLQLLNPKA ESLRRDAALK VNVTSAEGLQ SVLETNLGPK GTLKMLVDGA GNIKLTKDGK
     VLLTEMQIQS PTAVLIARAA AAQDEITGDG TTTVVCLVGE LLRQAHRFIQ EGVHPRIITD
     GFEIARKESM KFLDEFKISK TNLSNDREFL LQVARSSLLT KVDADLTEVL TPIVTDAVLS
     VYDAQADNLD LHMVEIMQMQ HLSPKDTTFI KGLVLDHGGR HPDMPTRVKN AYVLILNVSL
     EYEKTEVNSG FFYSSADQRD KLAASERKFV DAKLKKIIDL KNEVCGMDPD KGFVIINQKG
     IDPMSLDVFA KHNILALRRA KRRNMERLQL VTGGEAQNSV EDLSPQILGF SGLVYQETIG
     EEKFTYVTEN TDPKSCTILI KGSTHYALAQ TKDAVRDGLR AVANVLKDKN IIPGAGAFYI
     ALSRYLRSAN MNKLGAKGKT KTGIEAFAEA LLVIPKTLVK NSGFDPLDVL AMVEDELDDA
     QDSDETRYVG VDLNIGDSCD PTIEGIWDSY RVLRNAITGA TGIASNLLLC DELLRAGRST
     LKETPQ
>P39108 cyt PEROXISOMAL TARGETING SIGNAL 2 RECEPTOR (PTS2 RECEPTOR) (PEROXISOME
     MLRYHMQGFS GYGVQYSPFF DNRLAVAAGS NFGLVGNGKL FILEIDRSGR IVEVNSFLTQ
     DCLFDLAWNE SHENQVLVAQ GDGTLRLFDT TFKEFPIAIF KEHEREVFSC NWNLVNRQNF
     LSSSWDGSIK IWSPLRKQSL MTLTPRPLEI TKMVDPLNAI ILKKKSFTGI SKNRNCVYQA
     QFSPHDQNLV LSCSGNSYAS LFDIRLPSGK NQNNFLVHSG LEALTCDFNK YRPYVVATGG
     VDNAIRIWDI RMLNKNESAT IKRTVPGQLH NSSCINEIPN AHGLAIRKVT WSPHHSNILM
     SASYDMTCRI WRDLSNDGAK ETYKTNSTDA TKGSIFNFTQ HSEFVFGADW SLWGKPGYVA
     STAWDGNLFV WNGLG
>P40069 cyt IMPORTIN BETA-4 SUBUNIT (KARYOPHERIN BETA-4 SUBUNIT) (RAN BINDING
     MDQQFLSQLE QTLHAITSGV GLKEATKTLQ TQFYTQPTTL PALIHILQNG SDDSLKQLAG
     VEARKLVSKH WNAIDESTRA SIKTSLLQTA FSEPKENVRH SNARVIASIG TEELDGNKWP
     DLVPNLIQTA SGEDVQTRQT AIFILFSLLE DFTSSLSGHI DDFLALFSQT INDPSSLEIR
     SLSAQALNHV SALIEEQETI NPVQAQKFAA SIPSVVNVLD AVIKADDTMN AKLIFNCLND
     FLLLDSQLTG NFIVDLIKLS LQIAVNSEID EDVRVFALQF IISSLSYRKS KVSQSKLGPE
     ITVAALKVAC EEIDVDDELN NEDETGENEE NTPSSSAIRL LAFASSELPP SQVASVIVEH
     IPAMLQSANV FERRAILLAI SVAVTGSPDY ILSQFDKIIP ATINGLKDTE PIVKLAALKC
     IHQLTTDLQD EVAKFHEEYL PLIIDIIDSA KNIVIYNYAT VALDGLLEFI AYDAIAKYLD
     PLMNKLFYML ESNESSKLRC AVVSAIGSAA FAAGSAFIPY FKTSVHYLEK FIQNCSQIEG
     MSEDDIELRA NTFENISTMA RAVRSDAFAE FAEPLVNSAY EAIKTDSARL RESGYAFIAN
     LAKVYGENFA PFLKTILPEI FKTLELDEYQ FNFDGDAEDL AAFADSANEE ELQNKFTVNT
     GISYEKEVAS AALSELALGT KEHFLPYVEQ SLKVLNEQVD ESYGLRETAL NTIWNVVKSV
     LLASKVEPES YPKGIPASSY VNADVLAVIQ AARETSMGNL SDEFETSMVI TVMEDFANMI
     KQFGAIIIMD NGDSSMLEAL CMQVLSVLKG THTCQTIDIE EDVPRDEELD ASETEATLQD
     VALEVLVSLS QALAGDFAKV FDNFRPVVFG LFQSKSKNKR SSAVGAASEL ALGMKEQNPF
     VHEMLEALVI RLTSDKSLEV RGNAAYGVGL LCEYASMDIS AVYEPVLKAL YELLSAADQK
     ALAAEDDEAT REIIDRAYAN ASGCVARMAL KNSALVPLEQ TVPALLAHLP LNTGFEEYNP
     IFELIMKLYQ ENSPVITNET PRIIEIFSAV FTKENDRIKL EKESTLGREE NMERLKQFQT
     EEMKHKVIEL LKYLNTTYNG IVAQNPVLAA VIA
>P40106 cyt (DL)-GLYCEROL-3-PHOSPHATASE 2 (EC 3.1.3.-).
     MGLTTKPLSL KVNAALFDVD GTIIISQPAI AAFWRDFGKD KPYFDAEHVI QVSHGWRTFD
     AIAKFAPDFA NEEYVNKLEA EIPVKYGEKS IEVPGAVKLC NALNALPKEK WAVATSGTRD
     MAQKWFEHLG IRRPKYFITA NDVKQGKPHP EPYLKGRNGL GYPINEQDPS KSKVVVFEDA
     PAGIAAGKAA GCKIIGIATT FDLDFLKEKG CDIIVKNHES IRVGGYNAET DEVEFIFDDY
     LYAKDDLLKW
>P40347 cyt LOW MOLECULAR WEIGHT PHOSPHOTYROSINE PROTEIN PHOSPHATASE (EC 3.1.3.48)
     MTIEKPKISV AFICLGNFCR SPMAEAIFKH EVEKANLENR FNKIDSFGTS NYHVGESPDH
     RTVSICKQHG VKINHKGKQI KTKHFDEYDY IIGMDESNIN NLKKIQPEGS KAKVCLFGDW
     NTNDGTVQTI IEDPWYGDIQ DFEYNFKQIT YFSKQFLKKE L
>P40413 cyt T-COMPLEX PROTEIN 1, EPSILON SUBUNIT (TCP-1-EPSILON) (CCT-EPSILON).
     MPDLSNAIVA QDEMGRPFII VKDQGNKKRQ HGLEAKKSHI LAARSVASII KTSLGPRGLD
     KILISPDGEI TITNDGATIL SQMELDNEIA KLLVQLSKSQ DDEIGDGTTG VVVLASALLD
     QALELIQKGI HPIKIANGFD EAAKLAISKL EETCDDISAS NDELFRDFLL RAAKTSLGSK
     IVSKDHDRFA EMAVEAVINV MDKDRKDVDF DLIKMQGRVG GSISDSKLIN GVILDKDFSH
     PQMPKCVLPK EGSDGVKLAI LTCPFEPPKP KTKHKLDISS VEEYQKLQTY EQDKFKEMID
     DVKKAGADVV ICQWGFDDEA NHLLLQNDLP AVRWVGGQEL EHIAISTNGR IVPRFQDLSK
     DKLGTCSRIY EQEFGTTKDR MLIIEQSKET KTVTCFVRGS NKMIVDEAER ALHDSLCVVR
     NLVKDSRVVY GGGAAEVTMS LAVSEEADKQ RGIDQYAFRG FAQALDTIPM TLAENSGLDP
     IGTLSTLKSK QLKEKISNIG VDCLGYGSND MKELFVVDPF IGKKQQILLA TQLCRMILKI
     DNVIISGKDE Y
>P40825 cyt ALANYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.7) (ALANINE--TRNA
     MTIGDKQKWT ATNVRNTFLD YFKSKEHKFV KSSPVVPFDD PTLLFANAGM NQYKPIFLGT
     VDPASDFYTL KRAYNSQKCI RAGGKHNDLE DVGKDSYHHT FFEMLGNWSF GDYFKKEAIT
     YSWTLLTEVY GIPKDRLYVT YFEGDEKLGL EPDTEARELW KNVGVPDDHI LPGNAKDNFW
     EMGDQGPCGP CSEIHYDRIG GRNAASLVNM DDPDVLEVWN LVFIQFNREQ DGSLKPLPAK
     HIDTGMGFER LVSVLQDVRS NYDTDVFTPL FERIQEITSV RPYSGNFGEN DKDGIDTAYR
     VLADHVRTLT FALADGGVPN NEGRGYVLRR ILRRGARYAR KYMNYPIGNF FSTLAPTLIS
     QVQDIFPELA KDPAFLFEIL DEEEASFAKT LDRGERLFEK YASAASKTES KTLDGKQVWR
     LYDTYGFPVD LTELMAEEQG LKIDGPGFEK AKQESYEASK RGGKKDQSDL IKLNVHELSE
     LNDAKVPKTN DEFKYGSANV EGTILKLHDG TNFVDEITEP GKKYGIILDK TCFYAEQGGQ
     EYDTGKIVID DAAEFNVENV QLYNGFVFHT GSLEEGKLSV GDKIIASFDE LRRFPIKNNH
     TGTHILNFAL KETLGNDVDQ KGSLVAPEKL RFDFSHKKAV SNEELKKVED ICNEQIKENL
     QVFYKEIPLD LAKSIDGVRA VFGETYPDPV RVVSVGKPIE ELLANPANEE WTKYSIEFCG
     GTHVNKTGDI KYFVILEESG IAKGIRRIVA VTGTEAFEAQ RLAEQFAADL DAADKLPFSP
     IKEKKLKELG VKLGQLSISV ITKNELKQKF NKIEKAVKDE VKSRAKKENK QTLDEVKTFF
     ETNENAPYLV KFIDISPNAK AITEAINYMK SNDSVKDKSI YLLAGNDPEG RVAHGCYISN
     AALAKGIDGS ALAKKVSSII GGKAGGKGNV FQGMGDKPAA IKDAVDDLES LFKEKLSI
>P41277 cyt (DL)-GLYCEROL-3-PHOSPHATASE 1 (EC 3.1.3.-).
     PLTTKPLSLK INAALFDVDG TIIISQPAIA AFWRDFGKDK PYFDAEHVIH ISHGWRTYDA
     IAKFAPDFAD EEYVNKLEGE IPEKYGEHSI EVPGAVKLCN ALNALPKEKW AVATSGTRDM
     AKKWFDILKI KRPEYFITAN DVKQGKPHPE PYLKGRNGLG FPINEQDPSK SKVVVFEDAP
     AGIAAGKAAG CKIVGIATTF DLDFLKEKGC DIIVKNHESI RVGEYNAETD EVELIFDDYL
     YAKDDLLKW
>P41338 cyt ACETYL-COA ACETYLTRANSFERASE (EC 2.3.1.9) (ACETOACETYL-COA THIOLASE).
     MSQNVYIVST ARTPIGSFQG SLSSKTAVEL GAVALKGALA KVPELDASKD FDEIIFGNVL
     SANLGQAPAR QVALAAGLSN HIVASTVNKV CASAMKAIIL GAQSIKCGNA DVVVAGGCES
     MTNAPYYMPA ARAGAKFGQT VLVDGVERDG LNDAYDGLAM GVHAEKCARD WDITREQQDN
     FAIESYQKSQ KSQKEGKFDN EIVPVTIKGF RGKPDTQVTK DEEPARLHVE KLRSARTVFQ
     KENGTVTAAN ASPINDGAAA VILVSEKVLK EKNLKPLAII KGWGEAAHQP ADFTWAPSLA
     VPKALKHAGI EDINSVDYFE FNEAFSVVGL VNTKILKLDP SKVNVYGGAV ALGHPLGCSG
     ARVVVTLLSI LQQEGGKIGV AAICNGGGGA SSIVIEKI
>P41805 cyt 60S RIBOSOMAL PROTEIN L10 (UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX
     MARRPARCYR YQKNKPYPKS RYNRAVPDSK IRIYDLGKKK ATVDEFPLCV HLVSNELEQL
     SSEALEAARI CANKYMTTVS GRDAFHLRVR VHPFHVLRIN KMLSCAGADR LQQGMRGAWG
     KPHGLAARVD IGQIIFSVRT KDSNKDVVVE GLRRARYKFP GQQKIILSKK WGFTNLDRPE
     YLKKREAGEV KDDGAFVKFL SKKGSLENNI REFPEYFAAQ A
>P41939 cyt ISOCITRATE DEHYDROGENASE (NADP) CYTOPLASMIC (EC 1.1.1.42)
     MTKIKVANPI VEMDGDEQTR IIWHLIRDKL VLPYLDVDLK YYDLSVEYRD QTNDQVTVDS
     ATATLKYGVA VKCATITPDE ARVEEFHLKK MWKSPNGTIR NILGGTVFRE PIIIPRIPRL
     VPQWEKPIII GRHAFGDQYK ATDVIVPEEG ELRLVYKSKS GTHDVDLKVF DYPEHGGVAM
     MMYNTTDSIE GFAKASFELA IERKLPLYST TKNTILKKYD GKFKDVFEAM YARSYKEKFE
     SLGIWYEHRL IDDMVAQMLK SKGGYIIAMK NYDGDVESDI VAQGFGSLGL MTSVLITPDG
     KTFESEAAHG TVTRHFRQHQ QGKETSTNSI ASIFAWTRGI IQRGKLDNTP DVVKFGQILE
     SATVNTVQED GIMTKDLALI LGKSERSAYV TTEEFIDAVE SRLKKEFEAA AL
>P46655 cyt GLUTAMYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.17) (GLUTAMATE--TRNA
     MTKLFSKVKE SIEGIKMPST LTINGKAPIV AYAELIAARI VNALAPNSIA IKLVDDKKAP
     AAKLDDATED VFNKITSKFA AIFDNGDKEQ VAKWVNLAQK ELVIKNFAKL SQSLETLDSQ
     LNLRTFILGG LKYSAADVAC WGALRSNGMC GSIIKNKVDV NVSRWYTLLE MDPIFGEAHD
     FLSKSLLELK KSANVGKKKE THKANFEIDL PDAKMGEVVT RFPPEPSGYL HIGHAKAALL
     NQYFAQAYKG KLIIRFDDTN PSKEKEEFQD SILEDLDLLG IKGDRITYSS DYFQEMYDYC
     VQMIKDGKAY CDDTPTEKMR EERMDGVASA RRDRSVEENL RIFTEEMKNG TEEGLKNCVR
     AKIDYKALNK TLRDPVIYRC NLTPHHRTGS TWKIYPTYDF CVPIVDAIEG VTHALRTIEY
     RDRNAQYDWM LQALRLRKVH IWDFARINFV RTLLSKRKLQ WMVDKDLVGN WDDPRFPTVR
     GVRRRGMTVE GLRNFVLSQG PSRNVINLEW NLIWAFNKKV IDPIAPRHTA IVNPVKIHLE
     GSEAPQEPKI EMKPKHKKNP AVGEKKVIYY KDIVVDKDDA DVINVDEEVT LMDWGNVIIT
     KKNDDGSMVA KLNLEGDFKK TKHKLTWLAD TKDVVPVDLV DFDHLITKDR LEEDESFEDF
     LTPQTEFHTD AIADLNVKDM KIGDIIQFER KGYYRLDALP KDGKPYVFFT IPDGKSVNKY
     GAKK
>P47176 cyt PUTATIVE BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE, CYTOSOLIC
     MTLAPLDASK VKITTTQHAS KPKPNSELVF GKSFTDHMLT AEWTAEKGWG TPEIKPYQNL
     SLDPSAVVFH YAFELFEGMK AYRTVDNKIT MFRPDMNMKR MNKSAQRICL PTFDPEELIT
     LIGKLIQQDK CLVPEGKGYS LYIRPTLIGT TAGLGVSTPD RALLYVICCP VGPYYKTGFK
     AVRLEATDYA TRAWPGGCGD KKLGANYAPC VLPQLQAASR GYQQNLWLFG PNNNITEVGT
     MNAFFVFKDS KTGKKELVTA PLDGTILEGV TRDSILNLAK ERLEPSEWTI SERYFTIGEV
     TERSKNGELL EAFGSGTAAI VSPIKEIGWK GEQINIPLLP GEQTGPLAKE VAQWINGIQY
     GETEHGNWSR VVTDLN
>P48570 cyt HOMOCITRATE SYNTHASE, CYTOSOLIC ISOZYME (EC 4.1.3.21).
     MTAAKPNPYA AKPGDYLSNV NNFQLIDSTL REGEQFANAF FDTEKKIEIA RALDDFGVDY
     IELTSPVASE QSRKDCEAIC KLGLKAKILT HIRCHMDDAK VAVETGVDGV DVVIGTSKFL
     RQYSHGKDMN YIAKSAVEVI EFVKSKGIEI RFSSEDSFRS DLVDLLNIYK TVDKIGVNRV
     GIADTVGCAN PRQVYELIRT LKSVVSCDIE CHFHNDTGCA IANAYTALEG GARLIDVSVL
     GIGERNGITP LGGLMARMIV AAPDYVKSKY KLHKIRDIEN LVADAVEVNI PFNNPITGFC
     AFTHKAGIHA KAILANPSTY EILDPHDFGM KRYIHFANRL TGWNAIKARV DQLNLNLTDD
     QIKEVTAKIK KLGDVRSLNI DDVDSIIKNF HAEVSTPQVL SAKKNKKNDS DVPELATIPA
     AKRTKPSA
>P54115 cyt ALDEHYDE DEHYDROGENASE, CYTOSOLIC (EC 1.2.1.3).
     MTKLHFDTAE PVKITLPNGL TYEQPTGLFI NNKFMKAQDG KTYPVEDPST ENTVCEVSSA
     TTEDVEYAIE CADRAFHDTE WATQDPRERG RLLSKLADEL ESQIDLVSSI EALDNGKTLA
     FKARGDVTIA INCLRDAAAY ADKVNGRTIN TGDGYMNFTT LEPIGVCGQI IPWNFPIMML
     AWKIAPALAM GNVCILKPAA VTPLNALYFA SLCKKVGIPA GVVNIVPGPG RTVGAALTND
     PRIRKLAFTG STEVGKSVAV DSSESNLKKI TLELGGKSAH LVFDDANIKK TLPNLVNGIF
     KNAGQICSSG SRIYVQEGIY DELLAAFKAY LETEIKVGNP FDKANFQGAI TNRQQFDTIM
     NYIDIGKKEG AKILTGGEKV GDKGYFIRPT VFYDVNEDMR IVKEEIFGPV VTVAKFKTLE
     EGVEMANSSE FGLGSGIETE SLSTGLKVAK MLKAGTVWIN TYNDFDSRVP FGGVKQSGYG
     REMGEEVYHA YTEVKAVRIK L
>P54787 cyt VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN VPS9.
     MTDDEKREIL KEFDPFSQLE QANGNPDKDV KFKKDDPNRA AAEETNRDIS AQDKGDEEPF
     YDFQIFIKQL QTPGADPLVK YTKSFLRNFL AQRLLWTVSE EIKLISDFKT FIYDKFTLYE
     PFRSLDNSKM RNAKEGMEKL IMGKLYSRCF SPSLYEILQK PLDDEHMKDL TNDDTLLEKI
     RHYRFISPIM LDIPDTMPNA RLNKFVHLAS KELGKINRFK SPRDKMVCVL NASKVIFGLL
     KHTKLEQNGA DSFIPVLIYC ILKGQVRYLV SNVNYIERFR SPDFIRGEEE YYLSSLQAAL
     NFIMSLTERS LTIDDHEDFE EAYQRNLKQL AEEKEEEEKK KQLEVPDELQ PNGTLLKPLD
     EVTNIVISKF NELFSPIGEP TQEEALKSEQ SNKEEDVSSL IKKIEENERK DTLNTLQNMF
     PDMDPSLIED VCIAKKSRIG PCVDALLSLS E
>Q00955 cyt ACETYL-COA CARBOXYLASE (EC 6.4.1.2) (ACC) (CONTAINS: BIOTIN
     MSEESLFESS PQKMEYEITN YSERHTELPG HFIGLNTVDK LEESPLRDFV KSHGGHTVIS
     KILIANNGIA AVKEIRSVRK WAYETFGDDR TVQFVAMATP EDLEANAEYI RMADQYIEVP
     GGTNNNNYAN VDLIVDIAER ADVDAVWAGW GHASENPLLP EKLSQSKRKV IFIGPPGNAM
     RSLGDKISST IVAQSAKVPC IPWSGTGVDT VHVDEKTGLV SVDDDIYQKG CCTSPEDGLQ
     KAKRIGFPVM IKASEGGGGK GIRQVEREED FIALYHQAAN EIPGSPIFIM KLAGRARHLE
     VQLLADQYGT NISLFGRDCS VQRRHQKIIE EAPVTIAKAE TFHEMEKAAV RLGKLVGYVS
     AGTVEYLYSH DDGKFYFLEL NPRLQVEHPT TEMVSGVNLP AAQLQIAMGI PMHRISDIRT
     LYGMNPHSAS EIDFEFKTQD ATKKQRRPIP KGHCTACRIT SEDPNDGFKP SGGTLHELNF
     RSSSNVWGYF SVGNNGNIHS FSDSQFGHIF AFGENRQASR KHMVVALKEL SIRGDFRTTV
     EYLIKLLETE DFEDNTITTG WLDDLITHKM TAEKPDPTLA VICGAATKAF LASEEARHKY
     IESLQKGQVL SKDLLQTMFP VDFIHEGKRY KFTVAKSGND RYTLFINGSK CDIILRQLSD
     GGLLIAIGGK SHTIYWKEEV AATRLSVDSM TTLLEVENDP TQLRTPSPGK LVKFLVENGE
     HIIKGQPYAE IEVMKMQMPL VSQENGIVQL LKQPGSTIVA GDIMAIMTLD DPSKVKHALP
     FEGMLPDFGS PVIEGTKPAY KFKSLVSTLE NILKGYDNQV IMNASLQQLI EVLRNPKLPY
     SEWKLHISAL HSRLPAKLDE QMEELVARSL RRGAVFPARQ LSKLIDMAVK NPEYNPDKLL
     GAVVEPLADI AHKYSNGLEA HEHSIFVHFL EEYYEVEKLF NGPNVREENI ILKLRDENPK
     DLDKVALTVL SHSKVSAKNN LILAILKHYQ PLCKLSSKVS AIFSTPLQHI VELESKATAK
     VALQAREILI QGALPSVKER TEQIEHILKS SVVKVAYGSS NPKRSEPDLN ILKDLIDSNY
     VVFDVLLQFL THQDPVVTAA AAQVYIRRAY RAYTIGDIRV HEGVTVPIVE WKFQLPSAAF
     STFPTVKSKM GMNRAVSVSD LSYVANSQSS PLREGILMAV DHLDDVDEIL SQSLEVIPRH
     QSSSNGPAPD RSGSSASLSN VANVCVASTE GFESEEEILV RLREILDLNK QELINASIRR
     ITFMFGFKDG SYPKYYTFNG PNYNENETIR HIEPALAFQL ELGRLSNFNI KPIFTDNRNI
     HVYEAVSKTS PLDKRFFTRG IIRTGHIRDD ISIQEYLTSE ANRLMSDILD NLEVTDTSNS
     DLNHIFINFI AVFDISPEDV EAAFGGFLER FGKRLLRLRV SSAEIRIIIK DPQTGAPVPL
     RALINNVSGY VIKTEMYTEV KNAKGEWVFK SLGKPGSMHL RPIATPYPVK EWLQPKRYKA
     HLMGTTYVYD FPELFRQASS SQWKNFSADV KLTDDFFISN ELIEDENGEL TEVEREPGAN
     AIGMVAFKIT VKTPEYPRGR QFVVVANDIT FKIGSFGPQE DEFFNKVTEY ARKRGIPRIY
     LAANSGARIG MAEEIVPLFQ VAWNDAANPD KGFQYLYLTS EGMETLKKFD KENSVLTERT
     VINGEERFVI KTIIGSEDGL GVECLRGSGL IAGATSRAYH DIFTITLVTC RSVGIGAYLV
     RLGQRAIQVE GQPIILTGAP AINKMLGREV YTSNLQLGGT QIMYNNGVSH LTAVDDLAGV
     EKIVEWMSYV PAKRNMPVPI LETKDTWDRP VDFTPTNDET YDVRWMIEGR ETESGFEYGL
     FDKGSFFETL SGWAKGVVVG RARLGGIPLG VIGVETRTVE NLIPADPANP NSAETLIQEP
     GQVWHPNSAF KTAQAINDFN NGEQLPMMIL ANWRGFSGGQ RDMFNEVLKY GSFIVDALVD
     YKQPIIIYIP PTGELRGGSW VVVDPTINAD QMEMYADVNA RAGVLEPQGM VGIKFRREKL
     LDTMNRLDDK YRELRSQLSN KSLAPEVHQQ ISKQLADRER ELLPIYGQIS LQFADLHDRS
     SRMVAKGVIS KELEWTEARR FFFWRLRRRL NEEYLIKRLS HQVGEASRLE KIARIRSWYP
     ASVDHEDDRQ VATWIEENYK TLDDKLKGLK LESFAQDLAK KIRSDHDNAI DGLSEVIKML
     STDDKEKLLK TLK
>Q01766 cyt HALOTOLERANCE PROTEIN HAL1.
     MHFKDLGLHD YTLKNLMYEN NCCKFYDAVD ENNISYVLKF VPSDVTSEGD TFPFVDRFQV
     KEGVFLVYSS NDFGKEGTDY FTYTGSGGNE VHISGTSSEA GIKPQFIETC HPKHLKRGTK
     EQEDINSSTS KKSAVINNFS GEKTPNPRPQ SSNISERETY VGILNVKCKN KNSSKIRSEK
     LVSSVIETKH TPGLASILSK EGTTYPNNAD GKHISIVNPS SKIYHSSHKQ IVKTPIPKSG
     LSPIERCPFN GQNIKCYSPR PLDHESPQRD FNNNFQLRIL KSSVLQRRQS TQNS
>Q01846 cyt STRUCTURAL PROTEIN MDM1.
     MEKVSVSSGN SGLNPSQFYG SNNFRDNIAS LTISIDQIEK ELELLRHLIL KADLTNNQMQ
     LKILKKSQRT LLKELEMKEL LKQQYMVQEN GNSLFRKTKI YIRSYFSENS SNGLKEITYY
     IINIHHFNNG QVSSWDMARR YNEFFELNTY LKKNFRDLMR QLQDLFPSKV KMSLKYHVTK
     TLLYEERKQK LEKYLRELLS ISEICEDNIF RRFLTDPTPF KLNKEYMHDD ILEEPLHEPI
     GSSNSTSNSS SVVDLQSSED GGELNFYEDE RHFFTDSGYP FYSQNKSFVK QICDLFISLF
     ALNKANAGWL RGRAIITVLQ QLLGSTIEKY IKVSIQKLRS EDQVFEAIVT FKNMLWGDNG
     LFERKRNETA EATRSEGERL RTEQLALTSL QRLFADTCGR VVGLRDSHEA AGRVHAMLQN
     PYLNASLLLE ALDAILLDII CND
>Q02046 cyt METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NAD+) (EC 1.5.1.15).
     MSKPGRTILA SKVAETFNTE IINNVEEYKK THNGQGPLLV GFLANNDPAA KMYATWTQKT
     SESMGFRYDL RVIEDKDFLE EAIIQANGDD SVNGIMVYFP VFGNAQDQYL QQVVCKEKDV
     EGLNHVYYQN LYHNVRYLDK ENRLKSILPC TPLAIVKILE FLKIYNNLLP EGNRLYGKKC
     IVINRSEIVG RPLAALLAND GATVYSVDVN NIQKFTRGES LKLNKHHVED LGEYSEDLLK
     KCSLDSDVVI TGVPSENYKF PTEYIKEGAV CINFACTKNF SDDVKEKASL YVPMTGKVTI
     AMLLRNMLRL VRNVELSKEK
>Q02647 cyt DYNEIN LIGHT CHAIN 1, CYTOPLASMIC.
     MSDENKSTPI VKASDITDKL KEDILTISKD ALDKYQLERD IAGTVKKQLD VKYGNTWHVI
     VGKNFGSYVT HEKGHFVYFY IGPLAFLVFK TA
>Q03308 cyt VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN VPS16.
     MKNPSFDWER LKDVFYRSRA IGELKWPTQY EEFKCALSLT VIAVEIQDFI QVYNYFGQLL
     GKINLQRIHE DIIKFEFDKD EKLILVTKSS IKIVKGWSPL TIESVPLQDP TIDTIWDYHN
     GIMLLAKSRD IYKLNGNEWE LLYENKDKKY NLLTKNHWSC NDDSIILLDV DHVYQVSTSN
     GALLKLITDS SWHKVTISSR GFICLYNMKD NKLQIFRDPA RILMEHNLDS TPDDICWCGN
     DTVACSFEDE IKLYGPDGLY VTFWYPFTVT NLRAEVDGLK VITTEKIYFL SRVQPQTSNI
     FRIGSTEPGA MLVDSFSLLE DHAPKAIEIL KNFVLEKGVL DCIAAAIDEF EPKLQKMLLN
     AASYGKASLQ YKSFDASIFV NACNTIKLLN CFRSFGIFLT VEEYRCISLK GVIDRLLKYH
     RYYECIQICK LANERFLLGY VFTEWAKDKI KGSPDMEDDE LLDKIKSRLS VIDMTDTLQM
     VAVAKVAYLE GRFQLSRNLA LLEKNEEARI EQLYNLDDDS IALKECIKVQ NYSLTISLLI
     ALSKKLTNSQ LTKLLIIDMF NNPLYLYYMR MDKAYLYDFY RQTDRFIDLA HVLLQQGKEQ
     QSLHSFLPQI KDLYSQVQNS EVVNNTIEQL QRQEKLWIYQ ESLGKRFAIS FTNMTLDQTL
     SKLIETGQDK QVKEIVKKFK ISEKKLYHLK CKTLVEAKKF DELLQFAQSR KSPIGYMPFY
     TYLKSRGHMD KASPYVNMIP GLSYQEKKKL YVECRGFRDA IQLAGKEKDI PGLKEIYNII
     PPNEPELKAL ANETMSRI
>Q03497 cyt SERINE/THREONINE-PROTEIN KINASE STE20 (EC 2.7.1.-).
     MSNDPSAVSE LPDKDSLDNG ISNDNERAMG GNGDGGDGLR LPRTTGTLNV NALQKGTNAA
     HEAGGYKSMD PAKNAETTND DDNNVVSLDD PIQFTRVSSS SVISGMSSSM SPHSNIDETK
     SLEAVTPNIN TSNITPDHSA DNTFSTINAS ESDHQFNDTL LSKLSLTDST ETIENNATVK
     HQQPVASSTV NSNKSSTDIR RATPVSTPVI SKPSMTTTPR QINSASHSLS NPKHKQHKPK
     VKPSKPEAKS KPVSVKKSFP SKNPLKNSSP PKKQTEKSYY SSSSKKRKSG SNSGTLRMKD
     VFTSFVQNIK RNSQDDKRAS SSSNNSSSSS ITTALRISTP YNAKHIHHVG VDSKTGEYTG
     LPEEWEKLLT SSGISKREQQ QNMQAVMDIV KFYQDVTETN GEDKMFKTFN TTTGLPGSPQ
     VSTPPANSFN KFPPSTSDSH NYGSRTGTPM SNHVMSPTLN TDSSSANGKF IPSRPAPKPP
     SSASASAPII KSPVMNSAAN VSPLKQTHAP TTPNRTSPNR SSISRNATLK KEEQPLPPIP
     PTKSKTSPII STAHTPQQVA QSPKAPAQET VTTPTSKPAQ ARSLSKELNE KKREERERRK
     KQLYAKLNEI CSDGDPSTKY ANLVKIGQGA SGGVYTAYEI GTNVSVAIKQ MNLEKQPKKE
     LIINEILVMK GSKHPNIVNF IDSYVLKGDL WVIMEYMEGG SLTDVVTHCI LTEGQIGAVC
     RETLSGLEFL HSKGVLHRDI KSDNILLSME GDIKLTDFGF CAQINELNLK RTTMVGTPYW
     MAPEVVSRKE YGPKVDIWSL GIMIIEMIEG EPPYLNETPL RALYLIATNG TPKLKEPENL
     SSSLKKFLDW CLCVEPEDRA SATELLHDEY ITEIAEANSS LAPLVKLARL KKVAENMDAD
     EDNDDDNDNE HINKTNNCDD NNDSKETVNL DVTEDDKQK
>Q04120 cyt PROBABLE THIOL-SPECIFIC ANTIOXIDANT PROTEIN 2.
     MVAEVQKQAP PFKKTAVVDG IFEEISLEKY KGKYVVLAFV PLAFSFVCPT EIVAFSDAAK
     KFEDQGAQVL FASTDSEYSL LAWTNLPRKD GGLGPVKVPL LADKNHSLSR DYGVLIEKEG
     IALRGLFIID PKGIIRHITI NDLSVGRNVN EALRLVEGFQ WTDKNGTVLP CNWTPGAATI
     KPDVKDSKEY FKNANN
>Q05506 cyt PROBABLE ARGINYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.19) (ARGININE-
     MASTANMISQ LKKLSIAEPA VAKDSHPDVN IVDLMRNYIS QELSKISGVD SSLIFPALEW
     TNTMERGDLL IPIPRLRIKG ANPKDLAVQW AEKFPCGDFL EKVEANGPFI QFFFNPQFLA
     KLVIPDILTR KEDYGSCKLV ENKKVIIEFS SPNIAKPFHA GHLRSTIIGG FLANLYEKLG
     WEVIRMNYLG DWGKQFGLLA VGFERYGNEE ALVKDPIHHL FDVYVRINKD IEEEGDSIPL
     EQSTNGKARE YFKRMEDGDE EALKIWKRFR EFSIEKYIDT YARLNIKYDV YSGESQVSKE
     SMLKAIDLFK EKGLTHEDKG AVLIDLTKFN KKLGKAIVQK SDGTTLYLTR DVGAAMDRYE
     KYHFDKMIYV IASQQDLHAA QFFEILKQMG FEWAKDLQHV NFGMVQGMST RKGTVVFLDN
     ILEETKEKMH EVMKKNENKY AQIEHPEEVA DLVGISAVMI QDMQGKRINN YEFKWERMLS
     FEGDTGPYLQ YAHSRLRSVE RNASGITQEK WINADFSLLK EPAAKLLIRL LGQYPDVLRN
     AIKTHEPTTV VTYLFKLTHQ VSSCYDVLWV AGQTEELATA RLALYGAARQ VLYNGMRLLG
     LTPVERM
>Q12109 cyt TRYPTOPHANYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.2) (TRYPTOPHAN--
     MSNDETVEKV TQQVSELKST DVKEQVVTPW DVEGGVDEQG RAQNIDYDKL IKQFGTKPVN
     EETLKRFKQV TGREPHHFLR KGLFFSERDF TKILDLYEQG KPFFLYTGRG PSSDSMHLGH
     MIPFVFTKWL QEVFDVPLVI ELTDDEKFLF KHKLTINDVK NFARENAKDI IAVGFDPKNT
     FIFSDLQYMG GAFYETVVRV SRQITGSTAK AVFGFNDSDC IGKFHFASIQ IATAFPSSFP
     NVLGLPDKTP CLIPCAIDQD PYFRVCRDVA DKLKYSKPAL LHSRFFPALQ GSTTKMSASD
     DTTAIFMTDT PKQIQKKINK YAFSGGQVSA DLHRELGGNP DVDVAYQYLS FFKDDDVFLK
     ECYDKYKSGE LLSGEMKKLC IETLQEFVKA FQERRAQVDE ETLDKFMVPH KLVWGEKERL
     VAPKPKTKQE KK
>Q12434 cyt RHO GDP-DISSOCIATION INHIBITOR (RHO GDI).
     MAEESTDFSQ FEEERNNDQY KVSAKKTVDE YKNLDAEDES LAKWKESLGL SSDVLPLEFP
     GDKRKVVVQK IQLLVNTEPN PITFDLTNEK TIKELASKRY KIKENSIYKL KIVFKVQHEI
     ITGLRYVQYI KKAGIAVDKI DDHLGSYAPN TKTKPFYEVE LPESEAPSGF LARGNYSAVS
     KFIDDDKTNH LTLNWGVEIV KK
>Q12458 cyt PUTATIVE REDUCTASE 1 (EC 1.1.1.-).
     MPATLKNSSA TLKLNTGASI PVLGFGTWRS VDNNGYHSVI AALKAGYRHI DAAAIYLNEE
     EVGRAIKDSG VPREEIFITT KLWGTEQRDP EAALNKSLKR LGLDYVDLYL MHWPVPLKTD
     RVTDGNVLCI PTLEDGTVDI DTKEWNFIKT WELMQELPKT GKTKAVGVSN FSINNIKELL
     ESPNNKVVPA TNQIEIHPLL PQDELIAFCK EKGIVVEAYS PFGSANAPLL KEQAIIDMAK
     KHGVEPAQLI ISWSIQRGYV VLAKSVNPER IVSNFKIFTL PEDDFKTISN LSKVHGTKRV
     VDMKWGSFPI FQ
>P05453 cyt EUKARYOTIC PEPTIDE CHAIN RELEASE FACTOR GTP-BINDING SUBUNIT (ERF2)
     MSDSNQGNNQ QNYQQYSQNG NQQQGNNRYQ GYQAYNAQAQ PAGGYYQNYQ GYSGYQQGGY
     QQYNPDAGYQ QQYNPQGGYQ QYNPQGGYQQ QFNPQGGRGN YKNFNYNNNL QGYQAGFQPQ
     SQGMSLNDFQ KQQKQAAPKP KKTLKLVSSS GIKLANATKK VGTKPAESDK KEEEKSAETK
     EPTKEPTKVE EPVKKEEKPV QTEEKTEEKS ELPKVEDLKI SESTHNTNNA NVTSADALIK
     EQEEEVDDEV VNDMFGGKDH VSLIFMGHVD AGKSTMGGNL LYLTGSVDKR TIEKYEREAK
     DAGRQGWYLS WVMDTNKEER NDGKTIEVGK AYFETEKRRY TILDAPGHKM YVSEMIGGAS
     QADVGVLVIS ARKGEYETGF ERGGQTREHA LLAKTQGVNK MVVVVNKMDD PTVNWSKERY
     DQCVSNVSNF LRAIGYNIKT DVVFMPVSGY SGANLKDHVD PKECPWYTGP TLLEYLDTMN
     HVDRHINAPF MLPIAAKMKD LGTIVEGKIE SGHIKKGQST LLMPNKTAVE IQNIYNETEN
     EVDMAMCGEQ VKLRIKGVEE EDISPGFVLT SPKNPIKSVT KFVAQIAIVE LKSIIAAGFS
     CVMHVHTAIE EVHIVKLLHK LEKGTNRKSK KPPAFAKKGM KVIAVLETEA PVCVETYQDY
     PQLGRFTLRD QGTTIAIGKI VKIAE
>P21375 cyt OSMOTIC GROWTH PROTEIN 1.
     MIRSVRRVFI YVSIFVLIIV LKRTLSGTDQ TSMKQPVVVI GSGLAGLTTS NRLISKYRIP
     VVLLDKAASI GGNSIKASSG INGAHTDTQQ NLKVMDTPEL FLKDTLHSAK GRGVPSLMDK
     LTKESKSAIR WLQTEFDLKL DLLAQLGGHS VPRTHRSSGK LPPGFEIVQA LSKKLKDISS
     KDSNLVQIML NSEVVDIELD NQGHVTGVVY MDENGNRKIM KSHHVVFCSG GFGYSKEMLK
     EYSPNLIHLP TTNGKQTTGD GQKILSKLGA ELIDMDQVQV HPTGFIDPND RENNWKFLAA
     EALRGLGGIL LHPTTGRRFT NELSTRDTVT MEIQSKCPKN DNRALLVMSD KVYENYTNNI
     NFYMSKNLIK KVSINDLIRQ YDLQTTASEL VTELKSYSDV NTKDTFDRPL IINAFDKDIS
     TESTVYVGEV TPVVHFTMGG VKINEKSQVI KKNSESVLSN GIFAAGEVSG GVHGANRLGG
     SSLLECVVFG KTAADNIAKL Y
>P24004 cyt PEROXISOME BIOSYNTHESIS PROTEIN PAS1 (PEROXIN-1).
     MTTTKRLKFE NLRIQFSNAI VGNFLRLPHS IINVLESTNY AIQEFGIAVH SHNSDIPIVH
     LGWDGHDSGS SENVVLINPV LATVYDLNQK SPLVDLYIQR YDHTHLATEV YVTPETSDDW
     EIIDANAMRF QNGEILHQTR IVTPGETLIC YLEGIVTKFK IDRVEPSMKS ARITDGSLVV
     VAPKVNKTRL VKAEYGHSNK TILKNGAIQL LKKVILRSTV CKMDFPKDNL FVVYISDGAQ
     LPSQKGYASI VKCSLRQSKK SDSDNKSVGI PSKKIGVFIK CDSQIPENHI ALSSHLWDAF
     FTHPMNGAKI KLEFLQMNQA NIISGRNATV NIKYFGKDVP TKSGDQYSKL LGGSLLTNNL
     ILPTEQIIIE IKKGESEQQL CNLNEISNES VQWKVTQMGK EEVKDIIERH LPKHYHVKET
     GEVSRTSKDE DDFITVNSIK KEMVNYLTSP IIATPAIILD GKQGIGKTRL LKELINEVEK
     DHHIFVKYAD CETLHETSNL DKTQKLIMEW CSFCYWYGPS LIVLDNVEAL FGKPQANDGD
     PSNNGQWDNA SKLLNFFINQ VTKIFNKDNK RIRVLFSGKQ KTQINPLLFD KHFVSETWSL
     RAPDKHARAK LLEYFFSKNQ IMKLNRDLQF SDLSLETEGF SPLDLEIFTE KIFYDLQLER
     DCDNVVTREL FSKSLSAFTP SALRGVKLTK ETNIKWGDIG ALANAKDVLL ETLEWPTKYE
     PIFVNCPLRL RSGILLYGYP GCGKTLLASA VAQQCGLNFI SVKGPEILNK FIGASEQNIR
     ELFERAQSVK PCILFFDEFD SIAPKRGHDS TGVTDRVVNQ LLTQMDGAEG LDGVYILAAT
     SRPDLIDSAL LRPGRLDKSV ICNIPTESER LDILQAIVNS KDKDTGQKKF ALEKNADLKL
     IAEKTAGFSG ADLQGLCYNA YLKSVHRWLS AADQSEVVPG NDNIEYFSIN EHGRREENRL
     RLKTLLQQDV VHETKTSTSA ASELTAVVTI NDLLEACQET KPSISTSELV KLRGIYDRFQ
     KDRNGEMPNG ENSIDIGSRL SLM
>P25349 cyt HYPOTHETICAL 26.4 KD PROTEIN IN CDC10-CIT2 INTERGENIC REGION.
     MVKIAIITYS TYGHIDVLAQ AVKKGVEAAG GKADIYRVEE TLPDEVLTKM NAPQKPEDIP
     VATEKTLLEY DAFLFGVPTR FGNLPAQWSA FWDKTGGLWA KGSLNGKAAG IFVSTSSYGG
     GQESTVKACL SYLAHHGIIF LPLGYKNSFA ELASIEEVHG GSPWGAGTLA GPDGSRTASP
     LELRIAEIQG KTFYETAKKL FPAKEAKPST EKKTTTSDAA KRQTKPAAAT TAEKKEDKGL
     LSCCTVM
>P32337 cyt IMPORTIN BETA-3 SUBUNIT (KARYOPHERIN BETA-3 SUBUNIT) (PROTEIN
     MSALPEEVNR TLLQIVQAFA SPDNQIRSVA EKALSEEWIT ENNIEYLLTF LAEQAAFSQD
     TTVAALSAVL FRKLALKAPP SSKLMIMSKN ITHIRKEVLA QIRSSLLKGF LSERADSIRH
     KLSDAIAECV QDDLPAWPEL LQALIESLKS GNPNFRESSF RILTTVPYLI TAVDINSILP
     IFQSGFTDAS DNVKIAAVTA FVGYFKQLPK SEWSKLGILL PSLLNSLPRF LDDGKDDALA
     SVFESLIELV ELAPKLFKDM FDQIIQFTDM VIKNKDLEPP ARTTALELLT VFSENAPQMC
     KSNQNYGQTL VMVTLIMMTE VSIDDDDAAE WIESDDTDDE EEVTYDHARQ ALDRVALKLG
     GEYLAAPLFQ YLQQMITSTE WRERFAAMMA LSSAAEGCAD VLIGEIPKIL DMVIPLINDP
     HPRVQYGCCN VLGQISTDFS PFIQRTAHDR ILPALISKLT SECTSRVQTH AAAALVNFSE
     FASKDILEPY LDSLLTNLLV LLQSNKLYVQ EQALTTIAFI AEAAKNKFIK YYDTLMPLLL
     NVLKVNNKDN SVLKGKCMEC ATLIGFAVGK EKFHEHSQEL ISILVALQNS DIDEDDALRS
     YLEQSWSRIC RILGDDFVPL LPIVIPPLLI TAKATQDVGL IEEEEAANFQ QYPDWDVVQV
     QGKHIAIHTS VLDDKVSAME LLQSYATLLR GQFAVYVKEV MEEIALPSLD FYLHDGVRAA
     GATLIPILLS CLLAATGTQN EELVLLWHKA SSKLIGGLMS EPMPEITQVY HNSLVNGIKV
     MGDNCLSEDQ LAAFTKGVSA NLTDTYERMQ DRHGDGDEYN ENIDEEEDFT DEDLLDEINK
     SIAAVLKTTN GHYLKNLENI WPMINTFLLD NEPILVIFAL VVIGDLIQYG GEQTASMKNA
     FIPKVTECLI SPDARIRQAA SYIIGVCAQY APSTYADVCI PTLDTLVQIV DFPGSKLEEN
     RSSTENASAA IAKILYAYNS NIPNVDTYTA NWFKTLPTIT DKEAASFNYQ FLSQLIENNS
     PIVCAQSNIS AVVDSVIQAL NERSLTEREG QTVISSVKKL LGFLPSSDAM AIFNRYPADI
     MEKVHKWFA
>P32614 cyt HYPOTHETICAL 50.8 KD PROTEIN IN PAU2-GLY1 INTERGENIC REGION.
     MSLSPVVVIG TGLAGLAAAN ELVNKYNIPV TILEKASSIG GNSIKASSGI NGACTETQRH
     FHIEDSPRLF EDDTIKSAKG KGVQELMAKL ANDSPLAIEW LKNEFDLKLD LLAQLGGHSV
     ARTHRSSGKL PPGFEIVSAL SNNLKKLAET KPELVKINLD SKVVDIHEKD GSISAVVYED
     KNGEKHMVSA NDVVFCSGGF GFSKEMLKEY APELVNLPTT NGQQTTGDGQ RLLQKLGADL
     IDMDQIQVHP TGFIDPNDRS SSWKFLAAES LRGLGGILLN PITGRRFVNE LTTRDVVTAA
     IQKVCPQEDN RALLVMGEKM YTDLKNNLDF YMFKKLVQKL TLSQVVSEYN LPITVAQLCE
     ELQTYSSFTT KADPLGRTVI LNEFGSDVTP ETVVFIGEVT PVVHFTMGGA RINVKAQVIG
     KNDERLLKGL YAAGEVSGGV HGANRLGGSS LLECVVFGRT AAESIANDRK
>P32806 cyt GTPASE-ACTIVATING PROTEIN OF YPT6.
     MKDVLQWAID HYETRDQLVQ KGIWKGELYH DSIFKENSRG WLWKALLLCD ENNNCLLTDN
     FKGLDLNQFG LVPVPMLADG DNYDENHNAN VPKRVLHSNV SSSVGIRRLT PVEAVEKHPL
     SDDNDKTKGS LSKGSDEKPL TLRETLEIID LDLSRIMLDD IFQEPKVHAQ MRQLLYNYLL
     IHQSEHLQYK QGFHEILSVI YLQLYHGTDL DNTDLQNVLI IFNKLMNQIE PIFYNEENLI
     NWDKRVFTKI FRICLPDLFS KVFYQPPKTG SGKKKNVDHL IHSNLIWLIR WTRLLFLREL
     PLKYVLIVWD HVLTFNYPLD IFIACTIITL LLSIYDELHE LVSQGDYEHT NNNDEFVELI
     LHFKKIFEKE DASKDDEKFL DLCKVTGNLC ELWYGKNYDD MRLICDTFIN AKFGIKTSDV
     LSMETAKLTI DPNRQSLENK LRERVRQTIL KNKKKISQ
>P35691 cyt TRANSLATIONALLY CONTROLLED TUMOR PROTEIN HOMOLOG (TCTP).
     MIIYKDIFSN DELLSDAYDA KLVDDVIYEA DCAMVNVGGD NIDIGANPSA EGGDDDVEEG
     AEMVNNVVHS FRLQQTAFDK KSFLTYIKGY MKAVKAKLQE TNPEEVPKFE KGAQTYVKKV
     IGSFKDWEFF TGESMDPDAM VVMLNYREDG TTPFVAIWKH GIVEEKI
>P37293 cyt N-TERMINAL ACETYLTRANSFERASE 2 (EC 2.3.1.88) (AMINO-TERMINAL, ALPHA-
     MMVPRISASP VFKRIFLRWG FVTLPIQKTV SHTLRRDFSA PCRSMVKCLL LRPGISVHSA
     QDRKFYSTEE KSSQFDENKS KSNNGKKNEP HGIKGLMAKY GYSALIVYIL LTCVDLPLCF
     LGVHSLGEEK IKIYLNRGKQ LIGMGEPDES KVIQDVRRKQ AHREAVQAEN ADKVEDASRK
     TFNERWQEMK DSTLLAELLI AYGIHKSLII VRVPLTAVLT PSFVKLLQRF GIDLMKKQKK
     VFQTMASGAK IRYKGNNPSD FIKNEGTALD ITKRKPRTKG QKWFDGLM
>P38625 cyt GMP SYNTHASE (GLUTAMINE-HYDROLYSING) (EC 6.3.5.2) (GLUTAMINE
     AAGEQVSNMF DTILVLDFGS QYSHLITRRL REFNIYAEML PCTQKISELG WTPKGVILSG
     GPYSVYAEDA PHVDHAIFDL NVPILGICYG MQELAWINGK QVGRGDKREY GPATLKVIDD
     SNSLFKGMND STVWMSHGDK LHGLPTGYKT IATSDNSPYC GIVHETKPIY GIQFHPEVTH
     STQGKTLLKN FAVDLCHAKQ NWTMENFIDT EINRIRKLVG PTAEVIGAVS GGVDSTVASK
     LMTEAIGDRF HAILVDNGVL RLNEAANVKK TLVEGLGINL MVVDASEEFL SKLKGVTDPE
     KKRKIIGNTF IHVFEREAEK IKPKDGKEIQ FLLQGTLYPD VIESISFKGP SQTIKTHHNV
     GGLLENMKLK LIEPLRELFK DEVRHLGELL GIPHDLVWRH PFPGPGIAIR VLGEVTKEQV
     EIARKADNIY IEEIKKAGLY NQISQAFACL LPVKSVGVMG DQRTYDQVIA LRAIETTDFM
     TADWFPFEHS FLKKVASRIV NEVDGVARVT YDITSKPPAT VEWE
>P38798 cyt NONSENSE-MEDIATED MRNA DECAY PROTEIN 2 (UP-FRAMESHIFT SUPPRESSOR 2).
     MDDGRKKELH DLNTRAWNGE EVFPLKSKKL DSSIKRNTGF IKKLKKGFVK GSESSLLKDL
     SEASLEKYLS EIIVTVTECL LNVLNKNDDV IAAVEIISGL HQRFNGRFTS PLLGAFLQAF
     ENPSVDIESE RDELQRITRV KGNLRVFTEL YLVGVFRTLD DIESKDAIPN FLQKKTGRKD
     PLLFSILREI LNYKFKLGFT TTIATAFIKK FAPLFRDDDN SWDDLIYDSK LKGALQSLFK
     NFIDATFARA TELHKKVNKL QREHQKCQIR TGKLRDEYVE EYDKLLPIFI RFKTSAITLG
     EFFKLEIPEL EGASNDDLKE TASPMITNQI LPPNQRLWEN EDTRKFYEIL PDISKTVEES
     QSSKTEKDSN VNSKNINLFF TDLEMADCKD IIDDLSNRYW SSYLDNKATR NRILKFFMET
     QDWSKLPVYS RFIATNSKYM PEIVSEFINY LDNGFRSQLH SNKINVKNII FFSEMIKFQL
     IPSFMIFHKI RTLIMYMQVP NNVEILTVLL EHSGKFLLNK PEYKELMEKM VQLIKDKKND
     RQLNMNMKSA LENIITLLYP PSVKSLNVTV KTITPEQQFY RILIRSELSS LDFKHIVKLV
     RKAHWDDVAI QKVLFSLFSK PHKISYQNIP LLTKVLGGLY SYRRDFVIRC IDQVLENIER
     GLEINDYGQN MHRISNVRYL TEIFNFEMIK SDVLLDTIYH IIRFGHINNQ PNPFYLNYSD
     PPDNYFRIQL VTTILLNINR TPAAFTKKCK LLLRFFEYYT FIKEQPLPKE TEFRVSSTFK
     KYENIFGNTK FERSENLVES ASRLESLLKS LNAIKSKDDR VKGSSASIHN GKESAVPIES
     ITEDDEDEDD ENDDGVDLLG EDEDAEISTP NTESAPGKHQ AKQDESEDED DEDDDEDDDD
     DDDDDDDDGE EGDEDDDEDD DDEDDDDEEE EDSDSDLEYG GDLDADRDIE MKRMYEEYER
     KLKDEEERKA EEELERQFQK MMQESIDARK SEKVVASKIP VISKPVSVQK PLLLKKSEEP
     SSSKETYEEL SKPKKIAFTF LTKSGKKTQS RILQLPTDVK FVSDVLEEEE KLKTERNKIK
     KIVLKRSFD
>P39742 cyt TRANSLOCATION PROTEIN SEC72 (P23).
     VTLEYNANSK LITASDAVVA LSTETNIDQI NVLTTSLIGE TNPNFTPQPN EALSKMIKGL
     FESGMKNLQQ KKLNEALKNV SLAIEMAQRK RAPWEAFAIQ LPELHFMLRS KIDLCLILGK
     HLEALQDLDF LLGTGLIQPD VFVRKADCLL KLRQWEEARA TCERGLALAP EDMKLRALLI
     ETARNLAEYN GE
>P39965 cyt PROBABLE PROLYL-TRNA SYNTHETASE, CYTOPLASMIC (EC 6.1.1.15) (PROLINE--
     MLKYRTLSRS CHIFHPKSLS NNTLKSETTQ ELLQTVGFVR RSQVGLFQWL PLGLRSLNKV
     SNAIRNRMDS DGGAIEVSLS AISSKALWQA TDRWNNSELF KLKDSKGKQY CLTATCEEDI
     TDLMKNYIAS YKDMPITIYQ MTRKYRDEIR PRGGILRGRE FLMKDAYSFA SNEEDAFASF
     QKLDDTYNKI FKDLKIPFVS AWADSGDIGG EFSKEFHLIH ESGEDTLMSC KHCGDISTLD
     MSQSYPEKDG QYSGDVDCKY ALTKDHSTLI CFYYPKDRQL NWNLALNAMD KDIDLTLRNK
     PNDHVLQVYE KDNEDIMFSK ILRVMDCRLN SKSNFPDFPL KKYLKNNFGQ ISDVSIVDAQ
     ENEICGKCEE GRLEPLKSIE VGHIFLLGNK YSKPLNVKFV DKENKNETFV HMGCYGIGVS
     RLVGAIAELG RDSNGFRWPA IMAPYKVSIC TGPNNPENSQ RLQDVKSELL NDPTMQNLQN
     DILDQFNEKL GIGARIKLSH AMGIPLCVIV GSKSWPNVEI EVRGIRWGEK DLWRKQFEKR
     CSELQWKCTK NEHGIEKHTV PIQHLAEVIG VLLKDM
>P41921 cyt GLUTATHIONE REDUCTASE (EC 1.6.4.2) (GR) (GRASE).
     MLSATKQTFR SLQIRTMSTN TKHYDYLVIG GGSGGVASAR RAASYGAKTL LVEAKALGGT
     CVNVGCVPKK VMWYASDLAT RVSHANEYGL YQNLPLDKEH LTFNWPEFKQ KRDAYVHRLN
     GIYQKNLEKE KVDVVFGWAR FNKDGNVEVQ KRDNTTEVYS ANHILVATGG KAIFPENIPG
     FELGTDSDGF FRLEEQPKKV VVVGAGYIGI ELAGVFHGLG SETHLVIRGE TVLRKFDECI
     QNTITDHYVK EGINVHKLSK IVKVEKNVET DKLKIHMNDS KSIDDVDELI WTIGRKSHLG
     MGSENVGIKL NSHDQIIADE YQNTNVPNIY SLGDVVGKVE LTPVAIAAGR KLSNRLFGPE
     KFRNDKLDYE NVPSVIFSHP EAGSIGISEK EAIEKYGKEN IKVYNSKFTA MYYAMLSEKS
     PTRYKIVCAG PNEKVVGLHI VGDSSAEILQ GFGVAIKMGA TKADFDNCVA IHPTSAEELV
     TMR
>P42943 cyt T-COMPLEX PROTEIN 1, ETA SUBUNIT (TCP-1-ETA) (CCT-ETA).
     MNFGSQTPTI VVLKEGTDAS QGKGQIISNI NACVAVQEAL KPTLGPLGSD ILIVTSNQKT
     TISNDGATIL KLLDVVHPAA KTLVDISRAQ DAEVGDGTTS VTILAGELMK EAKPFLEEGI
     SSHLIMKGYR KAVSLAVEKI NELAVDITSE KSSGRELLER CARTAMSSKL IHNNADFFVK
     MCVDAVLSLD RNDLDDKLIG IKKIPGGAME ESLFINGVAF KKTFSYAGFE QQPKKFNNPK
     ILSLNVELEL KAEKDNAEVR VEHVEDYQAI VDAEWQLIFE KLRQVEETGA NIVLSKLPIG
     DLATQFFADR NIFCAGRVSA DDMNRVIQAV GGSIQSTTSD IKPEHLGTCA LFEEMQIGSE
     RYNLFQGCPQ AKTCTLLLRG GAEQVIAEVE RSLHDAIMIV KRALQNKLIV AGGGATEMEV
     SKCLRDYSKT IAGKQQMIIN AFAKALEVIP RQLCENAGFD AIEILNKLRL AHSKGEKWYG
     VVFETENIGD NFAKFVWEPA LVKINALNSA TEATNLILSV DETITNKGSE SANAGMMPPQ
     GAGRGRGMPM
>P47079 cyt T-COMPLEX PROTEIN 1, THETA SUBUNIT (TCP-1-THETA) (CCT-THETA).
     MSLRLPQNPN AGLFKQGYNS YSNADGQIIK SIAAIRELHQ MCLTSMGPCG RNKIIVNHLG
     KIIITNDAAT MLRELDIVHP AVKVLVMATE QQKIDMGDGT NLVMILAGEL LNVSEKLISM
     GLSAVEIIQG YNMARKFTLK ELDEMVVGEI TDKNDKNELL KMIKPVISSK KYGSEDILSE
     LVSEAVSHVL PVAQQAGEIP YFNVDSIRVV KIMGGSLSNS TVIKGMVFNR EPEGHVKSLS
     EDKKHKVAVF TCPLDIANTE TKGTVLLHNA QEMLDFSKGE EKQIDAMMKE IADMGVECIV
     AGAGVGELAL HYLNRYGILV LKVPSKFELR RLCRVCGATP LPRLGAPTPE ELGLVETVKT
     MEIGGDRVTV FKQEQGEISR TSTIILRGAT QNNLDDIERA IDDGVAAVKG LMKPSGGKLL
     PGAGATEIEL ISRITKYGER TPGLLQLAIK QFAVAFEVVP RTLAETAGLD VNEVLPNLYA
     AHNVTEPGAV KTDHLYKGVD IDGESDEGVK DIREENIYDM LATKKFAINV ATEAATTVLS
     IDQIIMAKKA GGPRAPQGPR PGNWDQED
>P49435 cyt ADENINE PHOSPHORIBOSYLTRANSFERASE 1 (EC 2.4.2.7) (APRT 1).
     MSIASYAQEL KLALHQYPNF PSEGILFEDF LPIFRNFGLF QKLIDAFKLH LEEAFPEVKI
     DYIVGLESRG FLFGPTLALA LGVGFVPVRK AGKLPGECFK ATYEKEYGSD LFEIQKNAIP
     AGSNVIIVDD IIATGGSAAA AGELVEQLEA NLLEYNFVME LDFLKGRSKL NAPVFTLLNA
     QKEALKK
>P52892 cyt PUTATIVE ALANINE AMINOTRANSFERASE (EC 2.6.1.2) (GLUTAMIC--PYRUVIC
     MTMTHQQDLK GVFTAKDLDF KPAGKITKKD LNTGVTKAEY AVRGAIPTRA DELKEELKKN
     PEVLPFDDII NANIGNPQQL DQKPLTFTRQ VLAILEYPEI LRVGHNELAS LNLFSRDALE
     RAERLLNDIG GSIGAYSHSQ GVPGIRQTVA DFITRRDGGE PATPEDIYLT TGASSAATSL
     LSLLCKDSQT GLLIPIPQYP LYTASASLFN AQVLPYYLDE ESNWSTNSDE IEKVVQDALK
     KQIRPSVLIV INPGNPTGAV LSEETIARIC LIAAKYGITI ISDEVYQENI FNDVKFHSMK
     KVLRKLQHLY PGKFDNVQLA SLHSISKGFM DECGQRGGYM EIIGFSQEIR DALFKLMSIS
     ICSVVTGQAV VDLMVKPPQP GDESYEQDHD ERLKIFHEMR TRANLLYETF KELEGIECQK
     PQGAMYLFPR LVLPKKALCE SERLGIEPDE FYCTSLLEST GICTVPGSGF GQRPGTYHVR
     TTFLAPGTKW IQDWKEFHQD FFSKYRN
>Q00055 cyt GLYCEROL-3-PHOSPHATE DEHYDROGENASE (NAD+) 1 (EC 1.1.1.8).
     MSAAADRLNL TSGHLNAGRK RSSSSVSLKA AEKPFKVTVI GSGNWGTTIA KVVAENCKGY
     PEVFAPIVQM WVFEEEINGE KLTEIINTRH QNVKYLPGIT LPDNLVANPD LIDSVKDVDI
     IVFNIPHQFL PRICSQLKGH VDSHVRAISC LKGFEVGAKG VQLLSSYITE ELGIQCGALS
     GANIATEVAQ EHWSETTVAY HIPKDFRGEG KDVDHKVLKA LFHRPYFHVS VIEDVAGISI
     CGALKNVVAL GCGFVEGLGW GNNASAAIQR VGLGEIIRFG QMFFPESREE TYYQESAGVA
     DLITTCAGGR NVKVARLMAT SGKDAWECEK ELLNGQSAQG LITCKEVHEW LETCGSVEDF
     PLFEAVYQIV YNNYPMKNLP DMIEELDLHE D
>Q01389 cyt SERINE/THREONINE PROTEIN KINASE BCK1/SLK1/SSP31 (EC 2.7.-.-).
     MPFLRKIAGT AHTHSRSDSN SSVKFGHQPT SSVASTKSSS KSPRATSRKS IYDDIRSQFP
     NLTPNSTSSQ FYESTPVIEQ SFNWTTDDHI SAGTLENPTS FTNSSYKNDN GPSSLSDSRK
     SSGGNSVNSL SFDKLILSWD PTDPDEWTMH RVTSWFKFHD FPESWILFFK KHQLFGHRFI
     KLLAYDNFAV YEKYLPQTKT ASYTRFQQLL KKTMTKNVTN SHIRQKSASK LKSSRSSSES
     IKSKLKNSKS QEDISNSRST SESALSPTKS GPSKTDEKNF LHSTSTHQKT KSASSLYRRS
     FISLRGSSSS NASSAKSPSN IKLSIPARPH SIIESNSTLT KSASPPASPS YPSIFRRHHK
     SSSSESSLLN SLFGSGIGEE APTKPNPQGH SLSSENLAKG KSKHYETNVS SPLKQSSLPT
     SDDKGNLWNK FKRKSQIGVP SPNTVAYVTS QETPSLKSNS STATLTVQTA DVNIPSPSSS
     PPPIPKTANR SLEVISTEDT PKISSTTASF KETYPDCINP DKTVPVPVNN QKYSVKNFLL
     DQKFYPLKKT GLNDSENKYI LVTKDNVSFV PLNLKSVAKL SSFKESALTK LGINHKNVTF
     HMTDFDCDIG AAIPDDTLEF LKKSLFLNTS GKIYIKDQMK LQQKPKPAPL TSENNVPLKS
     VKSKSSMRSG TSSLIASTDD VSIVTSSSDI TSFDEHASGS GRRYPQTPSY YYDRVSNTNP
     TEELNYWNIK EVLSHEENAP KMVFKTSPKL ELNLPDKGSK LNIPTPITEN ESKSSFQVLR
     KDEGTEIDFN HRRESPYTKP ELAPKREAPK PPANTSPQRT LSTSKQNKPI RLVRASTKIS
     RSKRSKPLPP QLLSSPIEAS SSSPDSLTSS YTPASTHVLI PQPYKGANDV MRRLKTDQDS
     TSTSPSLKMK QKVNRSNSTV STSNSIFYSP SPLLKRGNSK RVVSSTSAAD IFEENDITFA
     DAPPMFDSDD SDDDSSSSDD IIWSKKKTAP ETNNENKKDE KSDNSSTHSD EIFYDSQTQD
     KMERKMTFRP SPEVVYQNLE KFFPRANLDK PITEGIASPT SPKSLDSLLS PKNVASSRTE
     PSTPSRPVPP DSSYEFIQDG LNGKNKPLNQ AKTPKRTKTI RTIAHEASLA RKNSVKLKRQ
     NTKMWGTRMV EVTENHMVSI NKAKNSKGEY KEFAWMKGEM IGKGSFGAVY LCLNVTTGEM
     MAVKQVEVPK YSSQNEAILS TVEALRSEVS TLKDLDHLNI VQYLGFENKN NIYSLFLEYV
     AGGSVGSLIR MYGRFDEPLI KHLTTQVLKG LAYLHSKGIL HRDMKADNLL LDQDGICKIS
     DFGISRKSKD IYSNSDMTMR GTVFWMAPEM VDTKQGYSAK VDIWSLGCIV LEMFAGKRPW
     SNLEVVAAMF KIGKSKSAPP IPEDTLPLIS QIGRNFLDAC FEINPEKRPT ANELLSHPFS
     EVNETFNFKS TRLAKFIKSN DKLNSSKLRI TSQENKTE
>Q07084 cyt OSOMOLARITY TWO-COMPONENT SYSTEM PROTEIN SSK1.
     MLNSALLWKV WLRIDNSTDE VNQPIAVQFD EIDTVDDLKS RFFQKLSSTR WREINDNASI
     AIGLYAPKFD NQADNTSSNN TNDNSCRSKS NGAGSGANLS VNSNTKSSVS PTAGSFGLSK
     DLAKDRNVLQ HPKPTQKRGA LYDAFAAVPT VAATTNVDFP PNEAPMLSPQ RPYSTSPKQF
     PATTKSPLLR FASVSPYPKF HSDNQIMASA GLTYVSPHNK NKYTRPLIRK GLNFTTESVN
     DCTYKIIFEP DELAINIYKE LFGTMGSQPA SQPLLIFSNV NLRQDVPPLD ILNVVDYVPT
     NEEISQQKTQ PTDHGAVGVF HLDDHISPGE QGLKQTIGDK ADLKGKDGNS SPQEFKLITD
     EEQLRRASQE LKDEEKDAES PWQAILLLPK GYKGGVDFRN KPVAHTDSSF NNEDTITHSE
     LEVNTGSPSQ ESGSLNEAGI GITQPMSEVQ RRKEDVTPAS PILTSSQTPH YSNSLYNAPF
     AVSSPPDPLP NLFTTTSEKV FPKINVLIVE DNVINQAILG SFLRKHKISY KLAKNGQEAV
     NIWKEGGLHL IFMDLQLPVL SGIEAAKQIR DFEKQNGIGI QKSLNNSHSN LEKGTSKRFS
     QAPVIIVALT ASNSQMDKRK ALLSGCNDYL TKPVNLHWLS KKITEWGCMQ ALIDFDSWKQ
     GESRMTDSVL VKSPQKPIAP SNPHSFKQAT SMTPTHSPVR KNSNLSPTQI EL
>Q10740 cyt PROBABLE LEUKOTRIENE A-4 HYDROLASE (EC 3.3.2.6) (LTA-4 HYDROLASE)
     MFLLPFVIRH SSSIYLPTLR FRGLLTVISR NIHISTPHKM LPLSIEQRRP SRSPEYDQST
     LSNYKDFAVL HTDLNLSVSF EKSAISGSVT FQLKKLHEGK NKSDELHLDT SYLDVQEVHI
     DGSKADFQIE QRKEPLGSRL VINNASCNDN FTLNIQFRTT DKCTALQWLN SKQTKGGKPY
     VFSQLEAIHA RSLFPCFDTP SVKSTFTASI ESPLPVVFSG IRIEDTSKDT NIYRFEQKVP
     IPAYLIGIAS GDLSSAPIGP RSTVYTEPFR LKDCQWEFEN DVEKFIQTAE KIIFEYEWGT
     YDILVNVDSY PYGGMESPNM TFATPTLIAH DRSNIDVIAH ELAHSWSGNL VTNCSWNHFW
     LNEGWTVYLE RRIIGAIHGE PTRHFSALIG WSDLQNSIDS MKDPERFSTL VQNLNDNTDP
     DDAFSTVPYE KGFNLLFHLE TILGGKAEFD PFIRHYFKKF AKKSLDTFQF LDTLYEFYPE
     KKEILDSVDW ETWLYKPGMP PRPHFITALA DNVYQLADKW VEMAQHLKTT EDFRSEFNAI
     DIKDFNSNQL VLFLETLTQN GHSNKKPKDF DWAKFPVASR ALLDIYQDNI VKSQNAEVVF
     KMFKFQIFAK LQEEYKHLAD WLGTVGRMKF VRPGYRLLNS VDRRLALATF DKFKDTYHPI
     CKALVKQDLG L
>P22213 cyt SLY1 PROTEIN.
     MAVEEIASRK DISLRDMQIS AILKMLFLNK DLNNNDNITT ITDDIFNQQE IIWKVLILDI
     KSTATISSVL RVNDLLKAGI TVHSLIKQDR SPLPDVPAIY FVSPTKENID IIVNDLKSDK
     YSEFYINFTS SLPRNLLEDL AQQVSITGKS DKIKQVYDQY LDFIVTEPEL FSLEISNAYL
     TLNDPKTTEE EITGLCANIA DGLFNTVLTI NSIPIIRAAK GGPAEIIAEK LGTKLRDFVI
     NTNSSSTSTL QGNDSLERGV LIILDRNIDF ASMFSHSWIY QCMVFDIFKL SRNTVTIPLE
     SKENGTDNTT AKPLATKKYD IEPNDFFWME NSHLPFPEAA ENVEAALNTY KEEAAEITRK
     TGVTNISDLD PNSNNDTVQI QEVVKKLPEL TAKKNTIDTH MNIFAALLSQ LESKSLDTFF
     EVEQDPGSTK TRSRFLDILK DGKTNNLEDK LRSFIVLYLT STTGLPKDFV QNVENYFKEN
     DYDINALKYV YKLREFMQLS NMSLQNKSLE DGSDSAFKPS NLTLSGIYGL TEGKLQGGVG
     SLISGIKKLL PEKKTIPITN VVDAIMDPLN SSQKNLETTD SYLYIDPKIT RGSHTRKPKR
     QSYNKSLVFV VGGGNYLEYQ NLQEWAHSQL HNPKKVMYGS TAITTPAEFL NEISRLGASN
     SSNNDA
>P11075 cyt PROTEIN TRANSPORT PROTEIN SEC7.
     MSEQNSVVNA EKGDGEISSN VETASSVNPS VKPQNAIKEE AKETNGEDQK CKGPENAGST
     AETKETSNDA TNGMKTPEET EDTNDKRHDD EGEDGDEDED EDEDEDEDNG DEDDEDVDSS
     SSETSSEDGE DSESVSGEST ESSSGEDEES DESDGNTSNS SSGDESGSEE EEEEEEEEEE
     EENAGEPAIA HQDSVPTNDS TAPRSTHTRN ISLSSNGSNT NSTIILVKTT LETILNDKDI
     KKNSNAQKAI ERTLQKFKEF DPQTTNNPHY VDSILVFEAL RASCRTKSSK VQSLALDCLS
     KLFSFRSLDE TLLVNPPDSL ASNDQRQDAA DGITPPPKQK IIDAAIDTIS DCFQGEGTDD
     RVELQIVRAL SSCILEEDSS SLCHGASLLK AIRTIYNVFV FSLNPSNQGI AQATLTQIIS
     SVYDKIDLKQ STSSAVSLST KNHQQQSAIE LSEASENAET PAPLTLENMD KLNDDEERLM
     DAQQPDSIAI TNQDLAVKDA FLVFRVMAKI CAKPLETELD MRSHAVRSKL LSLHIIYSII
     KDHIDVFLSH NIFLPGKERV CFIDSIRQYL RLVLSRNAAS PLAPVFEVTL EIMWLLIANL
     RADFVKEIPV FLTEIYFPIS ELTTSTSQQK RYFLSVIQRI CNDPRTLVEF YLNYDCNPGM
     PNVMEITVDY LTRLALTRVE ITQTQRSYYD EQISKSLSTY NFSQLPLLTS SNLSSSPDVG
     QVNLLFPLDF ALKMVSLNCI VSVLRSLSSW AHKALNPNTH TANKVLLNTT SSARQESRSS
     LSNDVRSSIM TSNDDFKPTY EDEESRSLSS QNIDADDPTQ FENLKLRKTA LSECIAIFNN
     KPKKAIPVLI KKGFLKDDSP ISIAKWLLET EGLDMAAVGD YLGEGDDKNI AIMHAFVDEF
     DFTGMSIVDA LRSFLQSFRL PGEGQKIDRF MLKFAERFVD QNPGVFSKAD TAYVLSYSLI
     MLNTDLHSSQ IKNKMSLQEF LENNEGIDNG RDLPRDFLEG LFNEIANNEI KLISEQHQAM
     LSGDTNLVQQ QQSAFNFFNS RDLTREAYNQ VSKEISSKTE LVFKNLNKNK GGPDVYYAAS
     HVEHVKSIFE TLWMSFLAAL TPPFKDYDDI DTTNKCLEGL KISIKIASTF RINDARTSFV
     GALVQFCNLQ NLEEIKVKNV NAMVILLEVA LSEGNYLEGS WKDILLVVSQ MERLQLISKG
     IDRDTVPDVA QARVANPRVS YESSRSNNTS FFDVWGKKAT PTELAQEKHH NQTLSPEISK
     FISSSELVVL MDNIFTKSSE LSGNAIVDFI KALTAVSLEE IESSENASTP RMFSLQKMVD
     VCYYNMDRIK LEWTPLWAVM GKAFNKIATN SNLAVVFFAI DSLRQLSMRF LDIEELSGFE
     FQHDFLKPFE YTVQNSGNTE VQEMIIECFR NFILTKSESI KSGWKPILES LQYTARSSTE
     SIVLKTQLLV SNDIVTNHFE NVFSQEDAFS ELVGVFREIT KNKRFQKLSL HALESLRKMT
     QNVADICFYN ENKTEEERKH NDALLRGKDI FQDVWFPMLF CFNDTIMTAE DLEVRSRALN
     YMFDALVAYG GKFNDDFWEK ICKKLLFPIF GVLSKHWEVN QFNSHDDLSV WLSTTLIQAL
     RNLIALFTHY FESLNRMLDG FLGLLVSCIC QENDTIARIG RSCLQQLILQ NVSKFNEYHW
     NQIGDVFDKL FDLTTANELF DYDPLQQGRK SSVSHHQTTN DTSQHSDDDS NDRRENDSNI
     SETVERAHQE ESSEDVGGDM VETLNGQTKL NNGNSVPTVK DELNPKPASL SIPKKTKHMK
     RNESNEDIRR RINIKNSIVV KCVLQLLMIE LLNELFENED FAHCIPYKEA IRITRLLEKS
     YEFSRDFNED YGLRTRLVEA RVVDKIPNLL KQETSAAAVL LDIMFQLYLN DDEKKADLIT
     RLITICIQVV EGYVSLDDRT MERSINAWRS VIVEILQGYY EFDDEDFRLY CPAMYALVIQ
     ILDKSVPTEL RHAIKQFLSR VGELYLSTD
>P11484 cyt HEAT SHOCK PROTEIN SSB1 (COLD-INDUCIBLE PROTEIN YG101).
     AEGVFQGAIG IDLGTTYSCV ATYESSVEII ANEQGNRVTP SFVAFTPEER LIGDAAKNQA
     ALNPRNTVFD AKRLIGRRFD DESVQKDMKT WPFKVIDVDG NPVIEVQYLE ETKTFSPQEI
     SAMVLTKMKE IAEAKIGKKV EKAVITVPAY FNDAQRQATK DAGAISGLNV LRIINEPTAA
     AIAYGLGAGK SEKERHVLIF DLGGGTFDVS LLHIAGGVYT VKSTSGNTHL GGQDFDTNLL
     EHFKAEFKKK TGLDISDDAR ALRRLRTAAE RAKRTLSSVT QTTVEVDSLF DGEDFESSLT
     RARFEDLNAA LFKSTLEPVE QVLKDAKISK SQIDEVVLVG GSTRIPKVQK LLSDFFDGKQ
     LEKSINPDEA VAYGAAVQGA ILTGQSTSDE TKDLLLLDVA PLSLGVGMQG DMFGIVVPRN
     TTVPTIKRRT FTTCADNQTT VQFPVYQGER VNCKENTLLG EFDLKNIPMM PAGEPVLEAI
     FEVDANGILK VTAVEKSTGK SSNITISNAV GRLSSEEIEK MVNQAEEFKA ADEAFAKKHE
     ARQRLESYVA SIEQTVTDPV LSSKLKRGSK SKIEAALSDA LAALQIEDPS ADELRKAEVG
     LKRVVTKAMS SR
>P40150 cyt HEAT SHOCK PROTEIN SSB2.
     AEGVFQGAIG IDLGTTYSCV ATYESSVEII ANEQGNRVTP SFVAFTPQER LIGDAAKNQA
     ALNPRNTVFD AKRLIGRRFD DESVQKDMKT WPFKVIDVDG NPVIEVQYLE ETKTFSPQEI
     SAMVLTKMKE IAEAKIGKKV EKAVITVPAY FNDAQRQATK DAGAISGLNV LRIINEPTAA
     AIAYGLGAGK SEKERHVLIF DLGGGTFDVS LLHIAGGVYT VKSTSGNTHL GGQDFDTNLL
     EHFKAEFKKK TGLDISDDAR ALRRLRTAAE RAKRTLSSVT QTTVEVDSLF DGEDFESSLT
     RARFEDLNAA LFKSTLEPVE QVLKDAKISK SQIDEVVLVG GSTRIPKVQK LLSDFFDGKQ
     LEKSINPDEA VAYGAAVQGA ILTGQSTSDE TKDLLLLDVA PLSLGVGMQG DIFGIVVPRN
     TTVPTIKRRT FTTVSDNQTT VQFPVYQGER VNCKENTLLG EFDLKNIPMM PAGEPVLEAI
     FEVDANGILK VTAVEKSTGK SSNITISNAV GRLSSEEIEK MVNQAEEFKA ADEAFAKKHE
     ARQRLESYVA SIEQTVTDPV LSSKLKRGSK SKIEAALSDA LAALQIEDPS ADELRKAEVG
     LKRVVTKAMS SR
>P15442 cyt PROTEIN KINASE GCN2 (EC 2.7.1.-).
     MTPMYPYTAP EIEFKNVQNV MDSQLQMLKS EFKKIHNTSR GQEIIFEITS FTQEKLDEFQ
     NVVNTQSLED DRLQRIKETK EQLEKEEREK QQETIKKRSD EQRRIDEIVQ RELEKRQDDD
     DDLLFNRTTQ LDLQPPSEWV ASGEAIVFSK TIKAKLPNNS MFKFKAVVNP KPIKLTSDIF
     SFSKQFLVKP YIPPESPLAD FLMSSEMMEN FYYLLSEIEL DNSYFNTSNG KKEIANLEKE
     LETVLKAKHD NVNRLFGYTV ERMGRNNATF VWKIRLLTEY CNYYPLGDLI QSVGFVNLAT
     ARIWMIRLLE GLEAIHKLGI VHKCINLETV ILVKDADFGS TIPKLVHSTY GYTVLNMLSR
     YPNKNGSSVE LSPSTWIAPE LLKFNNAKPQ RLTDIWQLGV LFIQIISGSD IVMNFETPQE
     FLDSTSMDET LYDLLSKMLN NDPKKRLGTL ELLPMKFLRT NIDSTINRFN LVSESVNSNS
     LELTPGDTIT VRGNGGRTLS QSSIRRRSFN VGSRFSSINP ATRSRYASDF EEIAVLGQGA
     FGQVVKARNA LDSRYYAIKK IRHTEEKLST ILSEVMLLAS LNHQYVVRYY AAWLEEDSMD
     ENVFESTDEE SDLSESSSDF EENDLLDQSS IFKNRTNHDL DNSNWDFISG SGYPDIVFEN
     SSRDDENEDL DHDTSSTSSS ESQDDTDKES KSIQNVPRRR NFVKPMTAVK KKSTLFIQME
     YCENRTLYDL IHSENLNQQR DEYWRLFRQI LEALSYIHSQ GIIHRDLKPM NIFIDESRNV
     KIGDFGLAKN VHRSLDILKL DSQNLPGSSD NLTSAIGTAM YVATEVLDGT GHYNEKIDMY
     SLGIIFFEMI YPFSTGMERV NILKKLRSVS IEFPPDFDDN KMKVEKKIIR LLIDHDPNKR
     PGARTLLNSG WLPVKHQDEV IKEALKSLSN PSSPWQQQVR ESLFNQSYSL TNDILFDNSV
     PTSTPFANIL RSQMTEEVVK IFRKHGGIEN NAPPRIFPKA PIYGTQNVYE VLDKGGTVLQ
     LQYDLTYPMA RYLSKNPSLI SKQYRMQHVY RPPDHSRSSL EPRKFGEIDF DIISKSSSES
     GFYDAESLKI IDEILTVFPV FEKTNTFFIL NHADILESVF NFTNIDKAQR PLVSRMLSQV
     GFARSFKEVK NELKAQLNIS STALNDLELF DFRLDFEAAK KRLYKLMIDS PHLKKIEDSL
     SHISKVLSYL KPLEVARNVV ISPLSNYNSA FYKGGIMFHA VYDDGSSRNM IAAGGRYDTL
     ISFFARPSGK KSSNTRKAVG FNLAWETIFG IAQNYFKLAS GNRIKKRNRF LKDTAVDWKP
     SRCDVLISSF SNSLLDTIGV TILNTLWKQN IKADMLRDCS SVDDVVTGAQ QDGIDWILLI
     KQQAYPLTNH KRKYKPLKIK KLSTNVDIDL DLDEFLTLYQ QETGNKSLIN DSLTLGDKAD
     EFKRWDENSS AGSSQEGDID DVVAGSTNNQ KVIYVPNMAT RSKKANKREK WVYEDAARNS
     SNMILHNLSN APIITVDALR DETLEIISIT SLAQKEEWLR KVFGSGNNST PRSFATSIYN
     NLSKEAHKGN RWAILYCHKT GKSSVIDLQR
>P36022 cyt DYNEIN HEAVY CHAIN, CYTOSOLIC (DYHC).
     MCKNEARLAN ELIEFVAATV TGIKNSPKEN EQAFIDYLHC QYLERFQFFL GLLDGREFDT
     LFVFLFEELD RTIVTIDIGE EAIYDANLAN KKYSTLLIIK SRSVIVDAEP IATQISAIYL
     PGPVNAGNLA SIITHGVSSV FGQLIKSDTK TYSVETIDKT RRKLDDISKQ FQQLHTSIET
     PDLLAMVPSI IKLAVSKGAT SHDYANYLPS NDLESMRFLN ILQSIANKWF LVLKQTLAID
     RDIKNGSFLD EVEFWSNFYE VLKSLIEQTQ SQEFQVCLSV LTNAKRFHNL TNLLNEGSLS
     DKFKLADKYN QFLSSIPIDE VRQASNLEDL QELFPVLASS LKKFRYSGYP VQRFVVLMDK
     ISQEVMDAIL SNLSDLFQLE YGSFLGLYEK SAGMIEEWDD IVQDVNLLIR EDLRKRAPQE
     LLIQKLTFTS ASVKATLDEI LSTRKRFFSL AETIKSISPS TYHEEIQRLY HPFEQIHDIS
     VNFRLKLEQA ESEFSKNMLD LEKKLQNTLA SFMDSDHCPT EKLSYLVKFK PLMELCPRIK
     VKVLENQQIL LLEIKKDIRQ LETGLELLPK ILHVEALNNI PPISARISYF LNVQSRIDNI
     VQYLEALFGS NWNDTLEGRS ISTSIVQLRK ETNPHDVFLH WLGNFPEKAT ANLLTTPILK
     LIRNNEDDYE LKVNFDFALA AAYSELRSLT YMAFQVPSHI VRIARTYMYL YPRAINLVEL
     IQTFFSLSKS LSYTFYTNIF LKRNVQTVWL LLQQILITPW ESLQEESSEM SCSVHSLARL
     EKSIDGILSD YQILKNSEPQ FAKEFSGLKS FDGTADDLHE VEEIISNIQA IFENLFTKGL
     TNVSDHISTF NNLIISIILE KVRLNLKKMH FPKHVLKLSF NEGRITSSPS LAAMKRSLLK
     DIEALLNKVV LINFLHDPDH PLSTTLTFNS LVIKLKDDIQ NCIEQVQNLH CKINSYVKEW
     QKMEFLWQIT EEAFLEVVDN STQRCFGILK GLLDSQSKFD LIISRNNFSK NLVLHTEDAQ
     RHIRSKMDSW ILYVSKHLLT IYERDARKLH EDMNRDREAV EDMDINFTSL KNITVIIEAV
     NVNKRHLTER DIQIKLLGSV MRALTKLKVR FPSHFVYIDQ LDNDFSSLRQ SLSYVEQELQ
     KHRVVIAKSL EEGVENINNL SQSLNESWSV RKPISPTLTP PEALKILEFF NESITKLKKK
     MHSVAAAAKM LLIPVVLNDQ LTHVVEEVKT YDLVWRSIKN LWEDVQRTFE TPWCRVDVLL
     LQSDLANFLR RADELPRAVK QFEMYKSLFS QVNMLTSVNK ILVELKDGAL KPRHWNMIFR
     DIGKRQIQKN LLDKLEFSLK DVMVLNLTLN EILLTKIIER AQKEFVIEKS LNRIKKFWKE
     AQYEVIEHSS GLKLVREWDV LEQACKEDLE ELVSMKASNY YKIFEQDCLD LESKLTKLSE
     IQVNWVEVQF YWLDLYGILG ENLDIQNFLP LETSKFKSLT SEYKMITTRA FQLDTTIEVI
     HIPNFDTTLK LTIDSLKMIK SSLSTFLERQ RRQFPRFYFL GNDDLLKIIG SGKHHDQVSK
     FMKKMFGSIE SIIFLEDFIT GVRSVEGEVL NLNEKIELKD SIQAQEWLNI LDTEIKLSVF
     TQFRDCLGQL KDGTDIEVVV SKYIFQAILL SAQVMWTELV EKCLQTNQFS KYWKEVDMKI
     KGLLDKLNKS SDNVKKKIEA LLVEYLHFNN VIGQLKNCST KEEARLLWAK VQKFYQKNDT
     LDDLNSVFIS QSGYLLQYKF EYIGIPERLI YTPLLLIGFA TLTDSLHQKY GGCFFGPAGT
     GKTETVKAFG QNLGRVVVVF NCDDSFDYQV LSRLLVGITQ IGAWGCFDEF NRLDEKVLSA
     VSANIQQIQN GLQVGKSHIT LLEEETPLSP HTAVFITLNP GYNGRSELPE NLKKSFREFS
     MKSPQSGTIA EMILQIMGFE DSKSLASKIV HFLELLSSKC SSMNHYHFGL RTLKGVLRNC
     SPLISEFGEG EKTVVESLKR VILPSLGDTD ELVFKDELSK IFDSAGTPLN SKAIVQCLKD
     AGQRSGFSMS EEFLKKCMQF YYMQKTQQAL ILVGKAGCGK TATWKTVIDA MAIFDGHANV
     VYVIDTKVLT KESLYGSMLK ATLEWRDGLF TSILRRVNDD ITGTFKNSRI WVVFDSDLDP
     EYVEAMNSVL DDNKILTLPN GERLPIPPNF RILFETDNLD HTTPATITRC GLLWFSTDVC
     SISSKIDHLL NKSYEALDNK LSMFELDKLK DLISDSFDMA SLTNIFTCSN DLVHILGVRT
     FNKLETAVQL AVHLISSYRQ WFQNLDDKSL KDVITLLIKR SLLYALAGDS TGESQRAFIQ
     TINTYFGHDS QELSDYSTIV IANDKLSFSS FCSEIPSVSL EAHEVMRPDI VIPTIDTIKH
     EKIFYDLLNS KRGIILCGPP GSGKTMIMNN ALRNSSLYDV VGINFSKDTT TEHILSALHR
     HTNYVTTSKG LTLLPKSDIK NLVLFCDEIN LPKLDKYGSQ NVVLFLRQLM EKQGFWKTPE
     NKWVTIERIH IVGACNPPTD PGRIPMSERF TRHAAILYLG YPSGKSLSQI YEIYYKAIFK
     LVPEFRSYTE PFARASVHLY NECKARYSTG LQSHYLFSPR ELTRLVRGVY TAINTGPRQT
     LRSLIRLWAY EAWRIFADRL VGVKEKNSFE QLLYETVDKY LPNQDLGNIS STSLLFSGLL
     SLDFKEVNKT DLVNFIEERF KTFCDEELEV PMVIHESMVD HILRIDRALK QVQGHMMLIG
     ASRTGKTILT RFVAWLNGLK IVQPKIHRHS NLSDFDMILK KAISDCSLKE SRTCLIIDES
     NILETAFLER MNTLLANADI PDLFQGEEYD KLLNNLRNKT RSLGLLLDTE QELYDWFVGE
     IAKNLHVVFT ICDPTNNKSS AMISSPALFN RCIINWMGDW DTKTMSQVAN NMVDVIPMEF
     TDFIVPEVNK ELVFTEPIQT IRDAVVNILI HFDRNFYQKM KVGVNPRSPG YFIDGLRALV
     KLVTAKYQDL QENQRFVNVG LEKLNESVLK VNELNKTLSK KSTELTEKEK EARSTLDKML
     MEQNESERKQ EATEEIKKIL KVQEEDIRKR KEVVMKSIQD IEPTILEAQR GVKNIKKQQL
     TEIRSMVNPP SGVKIVMEAV CAILGYQFSN WRDIQQFIRK DDFIHNIVHY DTTLHMKPQI
     RKYMEEEFLS DPNFTYETIN RASKACGPLY QWVNAQINFS KVLENVDPLR QEMKRIEFES
     LKTKANLLAA EEMTQDLEAS IEVSKRKYSL LIRDVEAIKT EMSNVQANLD RSISLVKSLT
     FEKERWLNTT KQFSKTSQEL IGNCIISSIY ETYFGHLNER ERADMLVILK RLLGKFAVKY
     DVNYRFIDYL VTLDEKMKWL ECGLDKNDYF LENMSIVMNS QDAVPFLLDP SSHMITVISN
     YYGNKTVLLS FLEEGFVKRL ENAIRFGSVV IIQDGEFFDP IISRLISREF NHAGNRVTVE
     IGDHEVDVSG DFKLFIHSCD PSGDIPIFLR SRVRLVHFVT NKESIETRIF DITLTEENAE
     MQRKREDLIK LNTEYKLKLK NLEKRLLEEL NNSQGNMLEN DELMVTLNNL KKEAMNIEKK
     LSESEEFFPQ FDNLVEEYSI IGKHSVKIFS MLEKFGQFHW FYGISIGQFL SCFKRVFIKK
     SRETRAARTR VDEILWLLYQ EVYCQFSTAL DKKFKMIMAM TMFCLYKFDI ESEQYKEAVL
     TMIGVLSESS DGVPKLTVDT NNDLRYLWDY VTTKSYISAL NWFKNEFFVD EWNIADVVAN
     SENNYFTMAS ERDVDGTFKL IELAKASKES LKIIPLGSIE NLNYAQEEIS KSKIEGGWIL
     LQNIQMSLSW VKTYLHKHVE ETKAAEEHEK FKMFMTCHLT GDKLPAPLLQ RTDRFVYEDI
     PGILDTVKDL WGSQFFTGKI SGVWSVYCTF LLSWFHALIT ARTRLVPHGF SKKYYFNDCD
     FQFASVYLEN VLATNSTNNI PWAQVRDHIA TIVYGGKIDE EKDLEVVAKL CAHVFCGSDN
     LQIVPGVRIP QPLLQQSEEE ERARLTAILS NTIEPADSLS SWLQLPRESI LNYERLQAKE
     VASSTEQLLQ EM
>P32497 cyt NUCLEAR TRANSPORT PROTEIN NIP1.
     MSRFFSSNYE YDVASSSSEE DLLSSSEEDL LSSSSSESEL DQESDDSFFN ESESESEADV
     DSDDSDAKPY GPDWFKKSEF RKQGGGSNKF LKSSNYDSSD EESDEEDGKK VVKSAKEKLL
     DEMQDVYNKI SQAENSDDWL TISNEFDLIS RLLVRAQQQN WGTPNIFIKV VAQVEDAVNN
     TQQADLKNKA VARAYNTTKQ RVKKVSRENE DSMAKFRNDP ESFDKEPTAD LDISANGFTI
     SSSQGNDQAV QEDFFTRLQT IIDSRGKKTV NQQSLISTLE ELLTVAEKPY EFIMAYLTLI
     PSRFDASANL SYQPIDQWKS SFNDISKLLS ILDQTIDTYQ VNEFADPIDF IEDEPKEDSD
     GVKRILGSIF SFVERLDDEF MKSLLNIDPH SSDYLIRLRD EQSIYNLILR TQLYFEATLK
     DEHDLERALT RPFVKRLDHI YYKSENLIKI METAAWNIIP AQFKSKFTSK DQLDSADYVD
     NLIDGLSTIL SKQNNIAVQK RAILYNIYYT ALNKDFQTAK DMLLTSQVQT NINQFDSSLQ
     ILFNRVVVQL GLSAFKLCLI EECHQILNDL LSSSHLREIL GQQSLHRISL NSSNNASADE
     RARQCLPYHQ HINLDLIDVV FLTCSLLIEI PRMTAFYSGI KVKRIPYSPK SIRRSLEHYD
     KLSFQGPPET LRDYVLFAAK SMQKGNWRDS VKYLREIKSW ALLPNMETVL NSLTERVQVE
     SLKTYFFSFK RFYSSFSVAK LAELFDLPEN KVVEVLQSVI AELEIPAKLN DEKTIFVVEK
     GDEITKLEEA MVKLNKEYKI AKERLNPPSN RR
>P32602 cyt VESICULAR-FUSION PROTEIN SEC17.
     MSDPVELLKR AEKKGVPSSG FMKLFSGSDS YKFEEAADLC VQAATIYRLR KELNLAGDSF
     LKAADYQKKA GNEDEAGNTY VEAYKCFKSG GNSVNAVDSL ENPIQIFTHR GQFRRGANFK
     FELGEILEND LHDYAKAIDC YELAGEWYAQ DQSVALSNKC FIKCADLKAL DGQYIEASDI
     YSKLIKSSMG NRLSQWSLKD YFLKKGLCQL AATDAVAART LQEGQSEDPN FADSRESNFL
     KSLIDAVNEG DSEQLSEHCK EFDNFMRLDK WKITILNKIK ESIQQQEDDL L
>Q04491 cyt PROTEIN TRANSPORT PROTEIN SEC13.
     MVVIANAHNE LIHDAVLDYY GKRLATCSSD KTIKIFEVEG ETHKLIDTLT GHEGPVWRVD
     WAHPKFGTIL ASCSYDGKVL IWKEENGRWS QIAVHAVHSA SVNSVQWAPH EYGPLLLVAS
     SDGKVSVVEF KENGTTSPII IDAHAIGVNS ASWAPATIEE DGEHNGTKES RKFVTGGADN
     LVKIWKYNSD AQTYVLESTL EGHSDWVRDV AWSPTVLLRS YLASVSQDRT CIIWTQDNEQ
     GPWKKTLLKE EKFPDVLWRA SWSLSGNVLA LSGGDNKVTL WKENLEGKWE PAGEVHQ
>P52910 cyt ACETYL-COENZYME A SYNTHETASE 2 (EC 6.2.1.1) (ACETATE--COA LIGASE 2)
     MTIKEHKVVY EAHNVKALKA PQHFYNSQPG KGYVTDMQHY QEMYQQSINE PEKFFDKMAK
     EYLHWDAPYT KVQSGSLNNG DVAWFLNGKL NASYNCVDRH AFANPDKPAL IYEADDESDN
     KIITFGELLR KVSQIAGVLK SWGVKKGDTV AIYLPMIPEA VIAMLAVARI GAIHSVVFAG
     FSAGSLKDRV VDANSKVVIT CDEGKRGGKT INTKKIVDEG LNGVDLVSRI LVFQRTGTEG
     IPMKAGRDYW WHEEAAKQRT YLPPVSCDAE DPLFLLYTSG STGSPKGVVH TTGGYLLGAA
     LTTRYVFDIH PEDVLFTAGD VGWITGHTYA LYGPLTLGTA SIIFESTPAY PDYGRYWRII
     QRHKATHFYV APTALRLIKR VGEAEIAKYD TSSLRVLGSV GEPISPDLWE WYHEKVGNKN
     CVICDTMWQT ESGSHLIAPL AGAVPTKPGS ATVPFFGINA CIIDPVTGVE LEGNDVEGVL
     AVKSPWPSMA RSVWNHHDRY MDTYLKPYPG HYFTGDGAGR DHDGYYWIRG RVDDVVNVSG
     HRLSTSEIEA SISNHENVSE AAVVGIPDEL TGQTVVAYVS LKDGYLQNNA TEGDAEHITP
     DNLRRELILQ VRGEIGPFAS PKTIILVRDL PRTRSGKIMR RVLRKVASNE AEQLGDLTTL
     ANPEVVPAII SAVENQFFSQ KKK
>P11709 cyt NUCLEAR FUSION PROTEIN BIK1.
     MDRYQRKIGC FIQIPNLGRG QLKYVGPVDT KAGMFAGVDL LANIGKNDGS FMGKKYFQTE
     YPQSGLFIQL QKVASLIEKA SISQTSRRTT MEPLSIPKNR SIVRLTNQFS PMDDPKSPTP
     MRSFRITSRH SGNQQSMDQE ASDHHQQQEF GYDNREDRME VDSILSSDRK ANHNTTSDWK
     PDNGHMNDLN SSEVTIELRE AQLTIEKLQR KQLHYKRLLD DQRMVLEEVQ PTFDRYEATI
     QEREKEIDHL KQQLELERRQ QAKQKQFFDA ENEQLLAVVS QLHEEIKENE ERNLSHNQPT
     GANEDVELLK KQLEQLRNIE DQFELHKTKW AKEREQLKMH NDSLSKEYQN LSKELFLTKP
     QDSSSEEVAS LTKKLEEANE KIKQLEQAQA QTAVESLPIF DPPAPVDTTA GRQQWCEHCD
     TMGHNTAECP HHNPDNQQFF
>P39518 cyt LONG-CHAIN-FATTY-ACID--COA LIGASE 2 (EC 6.2.1.3) (LONG-CHAIN ACYL-COA
     MAAPDYALTD LIESDPRFES LKTRLAGYTK GSDEYIEELY SQLPLTSYPR YKTFLKKQAV
     AISNPDNEAG FSSIYRSSLS SENLVSCVDK NLRTAYDHFM FSARRWPQRD CLGSRPIDKA
     TGTWEETFRF ESYSTVSKRC HNIGSGILSL VNTKRKRPLE ANDFVVAILS HNNPEWILTD
     LACQAYSLTN TALYETLGPN TSEYILNLTE APILIFAKSN MYHVLKMVPD MKFVNTLVCM
     DELTHDELRM LNESLLPVKC NSLNEKITFF SLEQVEQVGC FNKIPAIPPT PDSLYTISFT
     SGTTGLPKGV EMSHRNIASG IAFAFSTFRI PPDKRNQQLY DMCFLPLAHI FERMVIAYDL
     AIGFGIGFLH KPDPTVLVED LKILKPYAVA LVPRILTRFE AGIKNALDKS TVQRNVANTI
     LDSKSARFTA RGGPDKSIMN FLVYHRVLID KIRDSLGLSN NSFIITGSAP ISKDTLLFLR
     SALDIGIRQG YGLTETFAGV CLSEPFEKDV GSCGAIGISA ECRLKSVPEM GYHADKDLKG
     ELQIRGPQVF ERYFKNPNET SKAVDQDGWF STGDVAFIDG KGRISVIDRV KNFFKLAHGE
     YIAPEKIENI YLSSCPYITQ IFVFGDPLKT FLVGIVGVDV DAAQPILAAK HPEVKTWTKE
     VLVENLNRNK KLRKEFLNKI NKCTDGLQGF EKLHNIKVGL EPLTLEDDVV TPTFKIKRAK
     ASKFFKDTLD QLYAEGSLVK TEKL
>P25628 end STEROL O-ACYLTRANSFERASE 1 (EC 2.3.1.26) (STEROL-ESTER SYNTHASE 1).
     MTETKDLLQD EEFLKIRRLN SAEANKRHSV TYDNVILPQE SMEVSPRSST TSLVEPVEST
     EGVESTEAER VAGKQEQEEE YPVDAHMQKY LSHLKSKSRS RFHRKDASKY VSFFGDVSFD
     PRPTLLDSAI NVPFQTTFKG PVLEKQLKNL QLTKTKTKAT VKTTVKTTEK TDKADAPPGE
     KLESNFSGIY VFAWMFLGWI AIRCCTDYYA SYGSAWNKLE IVQYMTTDLF TIAMLDLAMF
     LCTFFVVFVH WLVKKRIINW KWTGFVAVSI FELAFIPVTF PIYVYYFDFN WVTRIFLFLH
     SVVFVMKSHS FAFYNGYLWD IKQELEYSSK QLQKYKESLS PETREILQKS CDFCLFELNY
     QTKDNDFPNN ISCSNFFMFC LFPVLVYQIN YPRTSRIRWR YVLEKVCAII GTIFLMMVTA
     QFFMHPVAMR CIQFHNTPTF GGWIPATQEW FHLLFDMIPG FTVLYMLTFY MIWDALLNCV
     AELTRFADRY FYGDWWNCVS FEEFSRIWNV PVHKFLLRHV YHSSMGALHL SKSQATLFTF
     FLSAVFHEMA MFAIFRRVRG YLFMFQLSQF VWTALSNTKF LRARPQLSNV VFSFGVCSGP
     SIIMTLYLTL
>P32352 end C-8 STEROL ISOMERASE (DELTA-8--DELTA-7 STEROL ISOMERASE).
     MKFFPLLLLI GVVGYIMNVL FTTWLPTNYM FDPKTLNEIC NSVISKHNAA EGLSTEDLLQ
     DVRDALASHY GDEYINRYVK EEWVFNNAGG AMGQMIILHA SVSEYLILFG TAVGTEGHTG
     VHFADDYFTI LHGTQIAALP YATEAEVYTP GMTHHLKKGY AKQYSMPGGS FALELAQGWI
     PCMLPFGFLD TFSSTLDLYT LYRTVYLTAR DMGKNLLQNK KF
>P32803 end ENDOSOMAL P24B PROTEIN PRECURSOR (24 KD ENDOMEMBRANE PROTEIN) (BASIC
     MASFATKFVI ACFLFFSASA HNVLLPAYGR RCFFEDLSKG DELSISFQFG DRNPQSSSQL
     TGDFIIYGPE RHEVLKTVRD TSHGEITLSA PYKGHFQYCF LNENTGIETK DVTFNIHGVV
     YVDLDDPNTN TLDSAVRKLS KLTREVKDEQ SYIVIRERTH RNTAESTNDR VKWWSIFQLG
     VVIANSLFQI YYLRRFFEVT SLV
>P33767 end DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN GLYCOSYLTRANSFERASE BETA
     MRTDWNFFFC ILLQAIFVVG TQTSRTLVLY DQSTEPLEEY SVYLKDLEQR NYKLEYLDIN
     STSTTVDLYD KEQRLFDNII VFPTKGGKNL ARQIPVKQLI KFFENEGNIL CMSSPGAVPN
     TIRLFLNELG IYPSPKGHVI RDYFSPSSEE LVVSSNHLLN KYVYNARKSE DFVFGESSAA
     LLENREQIVP ILNAPRTSFT ESKGKCNSWT SGSQGFLVVG FQNLNNARLV WIGSSDFLKN
     KNQDSNQEFA KELLKWTFNE KSVIKSVHAV HSHADGTSYD EEPYKIKDKV IYSVGFSEWN
     GEEWLPHIAD DIQFELRQVD PYYRLTLSPS GNDSETQYYT TGEFILPDRH GVFTFLTDYR
     KIGLSFTTDK DVKAIRHLAN DEYPRSWEIS NSWVYISAIC GVIVAWIFFV VSFVTTSSVG
     KKLETFKKTN
>P39524 end PROBABLE CALCIUM-TRANSPORTING ATPASE 3 (EC 3.6.1.38) (ENDOPLASMIC
     MNDDRETPPK RKPGEDDTLF DIDFLDDTTS HSGSRSKVTN SHANGYYIPP SHVLPEETID
     LDADDDNIEN DVHENLFMSN NHDDQTSWNA NRFDSDAYQP QSLRAVKPPG LFARFGNGLK
     NAFTFKRKKG PESFEMNHYN AVTNNELDDN YLDSRNKFNI KILFNRYILR KNVGDAEGNG
     EPRVIHINDS LANSSFGYSD NHISTTKYNF ATFLPKFLFQ EFSKYANLFF LCTSAIQQVP
     HVSPTNRYTT IGTLLVVLIV SAMKECIEDI KRANSDKELN NSTAEIFSEA HDDFVEKRWI
     DIRVGDIIRV KSEEPIPADT IILSSSEPEG LCYIETANLD GETNLKIKQS RVETAKFIDV
     KTLKNMNGKV VSEQPNSSLY TYEGTMTLND RQIPLSPDQM ILRGATLRNT AWIFGLVIFT
     GHETKLLRNA TATPIKRTAV EKIINRQIIR LFTVLIVLIL ISSIGNVIMS TADAKHLSYL
     YLEGTNKAGL FFKDFLTFWI LFSNLVPISL FVTVELIKYY QAFMIGSDLD LYYEKTDTPT
     VVRTSSLVEE LGQIEYIFSD KTGTLTRNIM EFKSCSIAGH CYIDKIPEDK TATVEDGIEV
     GYRKFDDLKK KLNDPSDEDS PIINDFLTLL ATCHTVIPEF QSDGSIKYQA ASPDEGALVQ
     GGADLGYKFI IRKGNSVTVL LEETGEEKEY QLLNICEFNS TRKRMSAIFR FPDGSIKLFC
     KGADTVILER LDDEANQYVE ATMRHLEDYA SEGLRTLCLA MRDISEGEYE EWNSIYNEAA
     TTLDNRAEKL DEAANLIEKN LILIGATAIE DKLQDGVPET IHTLQEAGIK IWVLTGDRQE
     TAINIGMSCR LLSEDMNLLI INEETRDDTE RNLLEKINAL NEHQLSTHDM KSLALVIDGK
     SLGFALEPEL EDYLLTVAKL CKAVICCRVS PLQKALVVKM VKRKSSSLLL AIASGANDVS
     MIQAAHVGVG ISGMEGMQAA RSADIALGQF KFLKKLLLVH GSWSYQRISV AILYSFYKNT
     ALYMTQFWYV FANAFSGQSI MESWTMSFYN LFFTVWPPFV IGVFDQFVSS RLLERYPQLY
     KLGQKGQFFS VYIFWGWIIN GFFHSAIVFI GTILIYRYGF ALNMHGELAD HWSWGVTVYT
     TSVIIVLGKA ALVTNQWTKF TLIAIPGSLL FWLIFFPIYA SIFPHANISR EYYGVVKHTY
     GSGVFWLTLI VLPIFALVRD FLWKYYKRMY EPETYHVIQE MQKYNISDSR PHVQQFQNAI
     RKVRQVQRMK KQRGFAFSQA EEGGQEKIVR MYDTTQKRGK YGELQDASAN PFNDNNGLGS
     NDFESAEPFI ENPFADGNQN SNRFSSSRDD ISFDI
>P40350 end DOLICHYL-PHOSPHATE BETA-GLUCOSYLTRANSFERASE (EC 2.4.1.117).
     MRALRFLIEN RNTVFFTLLV ALVLSLYLLV YLFSHTPRPP YPEELKYIAI DEKGHEVSRA
     LPNLNEHQDD EEIFLSVVIP SYNETGRILL MLTDAISFLK EKYGSRWEIV IVDDGSTDNT
     TQYCLKICKE QFKLNYEQFR IIKFSQNRGK GGAVRQGFLH IRGKYGLFAD ADGASKFSDV
     EKLIDAISKI ETSSTDLKTT KPAVAIGSRA HMVNTEAVIK RSMIRNCLMY GFHTLVFIFG
     IRSIKDTQCG FKLFNRAAIL KIFPYLHTEG WIFDVEILIL AIRKRIQIEE IPISWHEVDG
     SKMALAIDSI KMAKDLVIIR MAYLLGIYRD NKKC
>P40351 end GLUCOSYLTRANSFERASE ALG8 (EC 2.4.1.-).
     MKGDRSRQNM AVTKKAKLKK NDEPKKVLKT AATEKGEGSK RYSLWNFWIS TLFLKLLLIP
     DYFSTDFDVH RNWLAITNKL PISEWYYEHT SQWTLDYPPF FAYFEWFLSQ FVPKSVRDDG
     CLDIVEIGKF GLPTIVFQRL TVIFSEILLF VILQIYINTT KLSERSQSFV VASSIVLSPG
     FLIIDHIHFQ YNGFLFAILI GSIVAAKNKR YILCAVLYTT AICFKHIFLY LAPCYFVFLL
     RAYVLNVNNF KFKSYKDFLF LIRWANLLKL ATVVVGIFTI CFLPFAHQMP QVLSRLFPFS
     RGLTHAYWAP NFWALYSFMD KILTTVMLKL PYVHTFATKF IKPPLIPQNI KEINERLAAN
     NNGSKGLVQD VFFVILPQIP PKLTFILTIF YQVLAVLPLL FDPSFKRFVG SLTLCGLASF
     LFGWHVHEKA IMLVIIPFTF LVGFDRRLLV PFMLVASAGY VSLYPLLYKG QDFFIKTLYT
     YVWCIIYFAA FRKTTKISSS VERRIFFLDR LALTYIFSLL PIVTVLQILD EVKWRYSFLQ
     KFEFLGLMIY SVYCSLGIIS SWFALSWLYN FDELLWQ
>P53629 end STEROL O-ACYLTRANSFERASE 2 (EC 2.3.1.26) (STEROL-ESTER SYNTHASE 2).
     MDKKKDLLEN EQFLRIQKLN AADAGKRQSI TVDDEGELYG LDTSGNSPAN EHTATTITQN
     HSVVASNGDV AFIPGTATEG NTEIVTEEVI ETDDNMFKTH VKTLSSKEKA RYRQGSSNFI
     SYFDDMSFEH RPSILDGSVN EPFKTKFVGP TLEKEIRRRE KELMAMRKNL HHRKSSPDAV
     DSVGKNDGAA PTTVPTAATS ETVVTVETTI ISSNFSGLYV AFWMAIAFGA VKALIDYYYQ
     HNGSFKDSEI LKFMTTNLFT VASVDLLMYL STYFVVGIQY LCKWGVLKWG TTGWIFTSIY
     EFLFVIFYMY LTENILKLHW LSKIFLFLHS LVLLMKMHSF AFYNGYLWGI KEELQFSKSA
     LAKYKDSIND PKVIGALEKS CEFCSFELSS QSLSDQTQKF PNNISAKSFF WFTMFPTLIY
     QIEYPRTKEI RWSYVLEKIC AIFGTIFLMM IDAQILMYPV AMRALAVRNS EWTGILDRLL
     KWVGLLVDIV PGFIVMYILD FYLIWDAILN CVAELTRFGD RYFYGDWWNC VSWADFSRIW
     NIPVHKFLLR HVYHSSMSSF KLNKSQATLM TFFLSSVVHE LAMYVIFKKL RFYLFFFQML
     QMPLVALTNT KFMRNRTIIG NVIFWLGICM GPSVMCTLYL TF
>P15367 end SIGNAL SEQUENCE PROCESSING PROTEIN SEC11 (EC 3.4.-.-).
     MNLRFELQKL LNVCFLFASA YMFWQGLAIA TNSASPIVVV LSGSMEPAFQ RGDILFLWNR
     NTFNQVGDVV VYEVEGKQIP IVHRVLRQHN NHADKQFLLT KGDNNAGNDI SLYANKKIYL
     NKSKEIVGTV KGYFPQLGYI TIWISENKYA KFALLGMLGL SALLGGE
>P21147 end ACYL-COA DESATURASE 1 (EC 1.14.99.5) (STEAROYL-COA DESATURASE 1)
     MPTSGTTIEL IDDQFPKDDS ASSGIVDEVD LTEANILATG LNKKAPRIVN GFGSLMGSKE
     MVSVEFDKKG NEKKSNLDRL LEKDNQEKEE AKTKIHISEQ PWTLNNWHQH LNWLNMVLVC
     GMPMIGWYFA LSGKVPLHLN VFLFSVFYYA VGGVSITAGY HRLWSHRSYS AHWPLRLFYA
     IFGCASVEGS AKWWGHSHRI HHRYTDTLRD PYDARRGLWY SHMGWMLLKP NPKYKARADI
     TDMTDDWTIR FQHRHYILLM LLTAFVIPTL ICGYFFNDYM GGLIYAGFIR VFVIQQATFC
     INSLAHYIGT QPFDDRRTPR DNWITAIVTF GEGYHNFHHE FPTDYRNAIK WYQYDPTKVI
     IYLTSLVGLA YDLKKFSQNA IEEALIQQEQ KKINKKKAKI NWGPVLTDLP MWDKQTFLAK
     SKENKGLVII SGIVHDVSGY ISEHPGGETL IKTALGKDAT KAFSGGVYRH SNAAQNVLAD
     MRVAVIKESK NSAIRMASKR GEIYETGKFF
>P27825 end CALNEXIN HOMOLOG PRECURSOR.
     MKFSAYLWWL FLNLALVKGT SLLSNVTLAE DSFWEHFQAY TNTKHLNQEW ITSEAVNNEG
     SKIYGAQWRL SQGRLQGSAW DKGIAVRTGN AAAMIGHLLE TPINVSETDT LVVQYEIKLD
     NSLTCGGAFI KLMSGFMNVE ALKHYAPDTE GVELVFGPDY CAPEINGVQF AINKVDKITH
     ESKLRYLQEM PLSKLTDTSQ SHLYTLIIDE SAQSFQILID GKTVMVREHI EDKKKVNFEP
     PITPPLMIPD VSVAKPHDWD DRIRIPDPEA VKLSDRDERD PLMIPHPDGT EPPEWNSSIP
     EYILDPNAQK PSWWKELEHG EWIPPMIKNP LCTAERGCGQ QIPGLINNAK YKGPGELNEI
     INPNYMGEWH PPEIENPLYY EEQHPLRIEN VISGVILEFW SGSPNMLISN IYVGKNVTEA
     QIIGNKTWLM RDRAFRGSDG PTERKFMNSR LGNLQTTFHN ERESPNPFDR IIDRILEQPL
     KFVLTAAVVL LTTSVLCCVV FT
>P29704 end FARNESYL-DIPHOSPHATE FARNESYLTRANSFERASE (EC 2.5.1.21) (SQUALENE
     MGKLLQLALH PVEMKAALKL KFCRTPLFSI YDQSTSPYLL HCFELLNLTS RSFAAVIREL
     HPELRNCVTL FYLILRALDT IEDDMSIEHD LKIDLLRHFH EKLLLTKWSF DGNAPDVKDR
     AVLTDFESIL IEFHKLKPEY QEVIKEITEK MGNGMADYIL DENYNLNGLQ TVHDYDVYCH
     YVAGLVGDGL TRLIVIAKFA NESLYSNEQL YESMGLFLQK TNIIRDYNED LVDGRSFWPK
     EIWSQYAPQL KDFMKPENEQ LGLDCINHLV LNALSHVIDV LTYLAGIHEQ STFQFCAIPQ
     VMAIATLALV FNNREVLHGN VKIRKGTTCY LILKSRTLRG CVEIFDYYLR DIKSKLAVQD
     PNFLKLNIQI SKIEQFMEEM YQDKLPPNVK PNETPIFLKV KERSRYDDEL VPTQQEEEYK
     FNMVLSIILS VLLGFYYIYT LHRA
>P32353 end C-5 STEROL DESATURASE (EC 1.-.-.-).
     MDLVLEVADH YVLDDLYAKV LPASLAANIP VKWQKLLGLN SGFSNSTILQ ETLNSKNAVK
     ECRRFYGQVP FLFDMSTTSF ASLLPRSSIL REFLSLWVIV TIFGLLLYLF TASLSYVFVF
     DKSIFNHPRY LKNQMAMEIK LAVSAIPWMS MLTVPWFVME LNGHSKLYMK IDYENHGVRK
     LIIEYFTFIF FTDCGVYLAH RWLHWPRVYR ALHKPHHKWL VCTPFASHSF HPVDGFLQSI
     SYHIYPLILP LHKVSYLILF TFVNFWTVMI HDGQYLSNNP AVNGTACHTV HHLYFNYNYG
     QFTTLWDRLG GSYRRPDDSL FDPKLRDAKE TWDAQVKEVE HFIKEVEGDD NDRIYENDPN
     TKKNN
>P32472 end FK506-BINDING PROTEIN PRECURSOR (FKBP-13) (FKBP-15) (PEPTIDYL-PROLYL
     MMFNIYLFVT FFSTILAGSL SDLEIGIIKR IPVEDCLIKA MPGDKVKVHY TGSLLESGTV
     FDSSYSRGSP IAFELGVGRV IKGWDQGVAG MCVGEKRKLQ IPSSLAYGER GVPGVIPPSA
     DLVFDVELVD VKSAA
>P38179 end PUTATIVE DOL-P-MAN DEPENDENT ALPHA(1-3)-MANNOSYLTRANSFERASE
     MEGEQSPQGE KSLQRKQFVR PPLDLWQDLK DGVRYVIFDC RANLIVMPLL ILFESMLCKI
     IIKKVAYTEI DYKAYMEQIE MIQLDGMLDY SQVSGGTGPL VYPAGHVLIY KMMYWLTEGM
     DHVERGQVFF RYLYLLTLAL QMACYYLLHL PPWCVVLACL SKRLHSIYVL RLFNDCFTTL
     FMVVTVLGAI VASRCHQRPK LKKSLALVIS ATYSMAVSIK MNALLYFPAM MISLFILNDA
     NVILTLLDLV AMIAWQVAVA VPFLRSFPQQ YLHCAFNFGR KFMYQWSINW QMMDEEAFND
     KRFHLALLIS HLIALTTLFV TRYPRILPDL WSSLCHPLRK NAVLNANPAK TIPFVLIASN
     FIGVLFSRSL HYQFLSWYHW TLPILIFWSG MPFFVGPIWY VLHEWCWNSY PPNSQASTLL
     LALNTVLLLL LALTQLSGSV ALAKSHLRTT SSMEKKLN
>P38819 end HYPOTHETICAL 24.2 KD PROTEIN IN CDC12-ORC6 INTERGENIC REGION
     MKYNIVHGIC LLFAITQAVG AVHFYAKSGE TKCFYEHLSR GNLLIGDLDL YVEKDGLFEE
     DPESSLTITV DETFDNDHRV LNQKNSHTGD VTFTALDTGE HRFCFTPFYS KKSATLRVFI
     ELEIGNVEAL DSKKKEDMNS LKGRVGQLTQ RLSSIRKEQD AIREKEAEFR NQSESANSKI
     MTWSVFQLLI LLGTCAFQLR YLKNFFVKQK VV
>P39704 end HYPOTHETICAL 24.1 KD PROTEIN IN SPO7-SSA1 INTERGENIC REGION PRECURSOR.
     MIKSTIALPS FFIVLILALV NSVAASSSYA PVAISLPAFS KECLYYDMVT EDDSLAVGYQ
     VLTGGNFEID FDITAPDGSV ITSEKQKKYS DFLLKSFGVG KYTFCFSNNY GTALKKVEIT
     LEKEKTLTDE HEADVNNDDI IANNAVEEID RNLNKITKTL NYLRAREWRN MSTVNSTESR
     LTWLSILIII IIAVISIAQV LLIQFLFTGR QKNYV
>P40312 end CYTOCHROME B5.
     MPKVYSYQEV AEHNGPENFW IIIDDKVYDV SQFKDEHPGG DEIIMDLGGQ DATESFVDIG
     HSDEALRLLK GLYIGDVDKT SERVSVEKVS TSENQSKGSG TLVVILAILM LGVAYYLLNE
>P53008 end PROTEIN CWH41.
     MLISKSKMFK TFWILTSIVL LASATVDISK LQEFEEYQKF TNESLLWAPY RSNCYFGMRP
     RYVHESPLIM GIMWFNSLSQ DGLHSLRHFA TPQDKLQKYG WEVYDPRIGG KEVFIDEKNN
     LNLTVYFVKS KNGENWSVRV QGEPLDPKRP STASVVLYFS QNGGEIDGKS SLAMIGHDGP
     NDMKFFGYSK ELGEYHLTVK DNFGHYFKNP EYETMEVAPG SDCSKTSHLS LQIPDKEVWK
     ARDVFQSLVS DSIRDILEKE ETKQRPADLI PSVLTIRNLY NFNPGNFHYI QKTFDLTKKD
     GFQFDITYNK LGTTQSISTR EQVTELITWS LNEINARFDK QFSFGEGPDS IESVEVKRRF
     ALETLSNLLG GIGYFYGNQL IDRETEFDES QFTEIKLLNA KEEGPFELFT SVPSRGFFPR
     GFYWDEGFHL LQIMEYDFDL AFEILASWFE MIEDDSGWIA REIILGNEAR SKVPQEFQVQ
     NPNIANPPTL LLAFSEMLSR AIENIGDFNS DSYHQVMFNS RTAKFMTNNL EANPGLLTEY
     AKKIYPKLLK HYNWFRKSQT GLIDEYEEIL EDEGIWDKIH KNEVYRWVGR TFTHCLPSGM
     DDYPRAQPPD VAELNVDALA WVGVMTRSMK QIAHVLKLTQ DEQRYAQIEQ EVVENLDLLH
     WSENDNCYCD ISIDPEDDEI REFVCHEGYV SVLPFALKLI PKNSPKLEKV VALMSDPEKI
     FSDYGLLSLS RQDDYFGKDE NYWRGPIWMN INYLCLDAMR YYYPEVILDV AGEASNAKKL
     YQSLKINLSN NIYKVWEEQG YCYENYSPID GHGTGAEHFT GWTALVVNIL GRF
>P53045 end C-4 METHYL STEROL OXIDASE (EC 1.-.-.-).
     MSAVFNNATL SGLVQASTYS QTLQNVAHYQ PQLNFMEKYW AAWYSYMNND VLATGLMFFL
     LHEFMYFFRC LPWFIIDQIP YFRRWKLQPT KIPSAKEQLY CLKSVLLSHF LVEAIPIWTF
     HPMCEKLGIT VEVPFPSLKT MALEIGLFFV LEDTWHYWAH RLFHYGVFYK YIHKQHHRYA
     APFGLSAEYA HPAETLSLGF GTVGMPILYV MYTGKLHLFT LCVWITLRLF QAVDSHSGYD
     FPWSLNKIMP FWAGAEHHDL HHHYFIGNYA SSFRWWDYCL DTESGPEAKA SREERMKKRA
     ENNAQKKTN
>P53198 end HYPOTHETICAL 25.3 KD PROTEIN IN PMC1-TFG2 INTERGENIC REGION PRECURSOR.
     MLSHYIFLAF VLLPFRVSAF YFYGYGGDRK CFLKELSKDT LLKGSYNLEV YDDKLADYAL
     PSYNDYGIVI DVEEVFDNNH RVVHQQGSPS GDFSFLALES GEYKICLQSR VNNWVGKTKT
     KLEIEFEVGF EAMLDMQRKE TLESLHGKVS ILNSKIVDIR REQQLMRERE ESFRDISESV
     NSRAMWWTVT QVTLLIIICV WQMKSLRSFF VKQKVL
>P53868 end PROBABLE MANNOSYLTRANSFERASE ALG9 (EC 2.4.1.-).
     MNCKAVTISL LLLLFLTRVY IQPTFSLISD CDETFNYWEP LNLLVRGFGK QTWEYSPEYS
     IRSWAFLLPF YCILYPVNKF TDLESHWNFF ITRACLGFFS FIMEFKLHRE IAGSLALQIA
     NIWIIFQLFN PGWFHASVEL LPSAVAMLLY VGATRHSLRY LSTGSTSNFT KSLAYNFLAS
     ILGWPFVLIL SLPLCLHYLF NHRIISTIRT AFDCCLIFSL TAFAVIVTDS IFYGKLAPVS
     WNILFYNVIN ASEESGPNIF GVEPWYYYPL NLLLNFPLPV LVLAILGIFH LRLWPLWASL
     FTWIAVFTQQ PHKEERFLYP IYGLITLSAS IAFYKVLNLF NRKPILKKGI KLSVLLIVAG
     QAMSRIVALV NNYTAPIAVY EQFSSLNQGG VKAPVVNVCT GREWYHFPSS FLLPDNHRLK
     FVKSGFDGLL PGDFPESGSI FKKIRTLPKG MNNKNIYDTG KEWPITRCDY FIDIVAPINL
     TKDVFNPLHL MDNWNKLACA AFIDGENSKI LGRAFYVPEP INRIMQIVLP KQWNQVYGVR
     YIDYCLFEKP TETTN
>P54837 end HYPOTHETICAL 24.1 KD PROTEIN IN TAF40-SPT5 INTERGENIC REGION
     MQVLQLWLTT LISLVVAVQG LHFDIAASTD PEQVCIRDFV TEGQLVVADI HSDGSVGDGQ
     KLNLFVRDSV GNEYRRKRDF AGDVRVAFTA PSSTAFDVCF ENQAQYRGRS LSRAIELDIE
     SGAEARDWNK ISANEKLKPI EVELRRVEEI TDEIVDELTY LKNREERLRD TNESTNRRVR
     NFSILVIIVL SSLGVWQVNY LKNYFKTKHI I
>Q12001 end GLUCOSYLTRANSFERASE ALG6 (EC 2.4.1.-).
     MAIGKRLLVN KPAEESFYAS PMYDFLYPFR PVGNQWLPEY IIFVCAVILR CTIGLGPYSG
     KGSPPLYGDF EAQRHWMEIT QHLPLSKWYW YDLQYWGLDY PPLTAFHSYL LGLIGSFFNP
     SWFALEKSRG FESPDNGLKT YMRSTVIISD ILFYFPAVIY FTKWLGRYRN QSPIGQSIAA
     SAILFQPSLM LIDHGHFQYN SVMLGLTAYA INNLLDEYYA MAAVCFVLSI CFKQMALYYA
     PIFFAYLLSR SLLFPKFNIA RLTVIAFATL ATFAIIFAPL YFLGGGLKNI HQCIHRIFPF
     ARGIFEDKVA NFWCVTNVFV KYKERFTIQQ LQLYSLIATV IGFLPAMIMT LLHPKKHLLP
     YVLIACSMSF FLFSFQVHEK TILIPLLPIT LLYSSTDWNV LSLVSWINNV ALFTLWPLLK
     KDGLHLQYAV SFLLSNWLIG NFSFITPRFL PKSLTPGPSI SSINSDYRRR SLLPYNVVWK
     SFIIGTYIAM GFYHFLDQFV APPSKYPDLW VLLNCAVGFI CFSIFWLWSY YKIFTSGSKS
     MKDL
>P16474 end 78 KD GLUCOSE REGULATED PROTEIN HOMOLOG PRECURSOR (GRP 78)
     MFFNRLSAGK LLVPLSVVLY ALFVVILPLQ NSFHSSNVLV RGADDVENYG TVIGIDLGTT
     YSCVAVMKNG KTEILANEQG NRITPSYVAF TDDERLIGDA AKNQVAANPQ NTIFDIKRLI
     GLKYNDRSVQ KDIKHLPFNV VNKDGKPAVE VSVKGEKKVF TPEEISGMIL GKMKQIAEDY
     LGTKVTHAVV TVPAYFNDAQ RQATKDAGTI AGLNVLRIVN EPTAAAIAYG LDKSDKEHQI
     IVYDLGGGTF DVSLLSIENG VFEVQATSGD THLGGEDFDY KIVRQLIKAF KKKHGIDVSD
     NNKALAKLKR EAEKAKRALS SQMSTRIEID SFVDGIDLSE TLTRAKFEEL NLDLFKKTLK
     PVEKVLQDSG LEKKDVDDIV LVGGSTRIPK VQQLLESYFD GKKASKGINP DEAVAYGAAV
     QAGVLSGEEG VEDIVLLDVN ALTLGIETTG GVMTPLIKRN TAIPTKKSQI FSTAVDNQPT
     VMIKVYEGER AMSKDNNLLG KFELTGIPPA PRGVPQIEVT FALDANGILK VSATDKGTGK
     SESITITNDK GRLTQEEIDR MVEEAEKFAS EDASIKAKVE SRNKLENYAH SLKNQVNGDL
     GEKLEEEDKE TLLDAANDVL EWLDDNFETA IAEDFDEKFE SLSKVAYPIT SKLYGGADGS
     GAADYDDEDE DDDGDYFEHD EL
>P22023 end KILLER TOXIN-RESISTANCE PROTEIN 5 PRECURSOR.
     MRLLALVLLL LCAPLRAWTY SLRYGIPESA QVWSILVHLL GDVDNQLLTN LYPLVTGLDD
     EIDIQENLVA LTSNVLRERY DKEDVADLLE LYASLYPMGM IQHDISSNAE QDDANSSYFV
     LNGNRYEKPD DVFYLKSKDL TIQQKVPDVD VIQPYDVVIG TNSEAPILIL YGCPTVIDSD
     FEEFNRNLFM EAMNGEGKFR FIWRSTCSLD GKSVEYPLTH PLEITLQNGS RMSSIPQLKK
     ILYTVPKEIL VGADNDDQLH DLEPEELREL DLRVTSLISE FYQYKKDITA TLNFTKSIVN
     NFPLISKQLI KVSSVNKDII TSNEELNSKG FDYNMLGLYI NGQNWKITSL TPYNLLTALK
     TEYQSLLKIT NLLQELEPSK CILDSKFLLN KFSQFSLGKL QNLQPIKMDL HTIPGFSESV
     IYFNDIESDP QYDELVNSVQ AFFDKSKFGE LPEIKQNWSE IIFVIDFARL EDSEVKEALG
     GLVRAVNVVS QGYPQRVGLL PFSSDSDKSV VNKIYELKNS TDNLTELKSF LETMLLADGL
     SANAKHSKHI PVPDVFHLLD ELQIDETSII INGEIYPFRK NAWNYLIAKV IKKDTEFIRK
     ELSNSSPKNK QISVRDLLHY KSANLRHNKY TPNYFADSVY SSVNNTALES VCSERIGYYT
     KNEEYNLLHT ITLVDDFGSI HALKRLRNLL HTSFVGVRIR IIHVGDISDI WYQLRGSLSQ
     KDPIGSINTF IDALKLKKVK SHTYKKSGLN QLGLHKWLPD IPLFELQKGS FIALNGRFIH
     LDQNEVPETE HFEAIIKREA LRTIDSVFAL DLLFPGFSQE IINPDLIEMI SSILTRLFYQ
     GTHIYNNGID YTTESSLPRM DLSEFFRPNN LTMFEDGKSA SIDLLLILDP LEERTQMILS
     LVEQFRPLKF VNIQVILMPT LELNIVPIRR IYVDDADIVK SITSEDSRSD PEVDIEMDVP
     NSFIVDNNYR IKKLLIELHS FSSKTVLSTG NIDGMGGVCL ALVDSAGNII DKTTTMKTFG
     YGQFHTDKFL KGCYIKSCDS RYTVQSFSTD GHPDFIPSDS LDILSYNPQK IAVKISEEPT
     HEEEYEEGRN NDTIINIFTI LESGPDEEER YMQMILSILS KCPETQKVNF FILDQPFISD
     TLRKSCEYIN SSDEMRGNVI FLNYEWPQWL RPQRFSSRRR DVSRFLFLDV LLPQNISKVL
     YMSPTEVPLD PFDIFQFQGL KRAPLGLFRM SGDGYWKEGY WEKMLRENNL EFYSTEPAFL
     VNLERFRELD AGDKYRIHYQ RISTDAMSLV NIGQDLVNNL QLEVPIRFLK GSYKKKLVIN
     DECVSEWKKK INKFASSPGD EDVPGESVSS KYQDSDNAAP LHDEL
>P32474 end ENDOPLASMIC RETICULUM PROTEIN EUG1 PRECURSOR (POSSIBLE PROTEIN
     MQVTTRFISA IVSFCLFASF TLAENSARAT PGSDLLVLTE KKFKSFIESH PLVLVEFFAP
     WCLHSQILRP HLEEAASILK EHNVPVVQID CEANSMVCLQ QTINTYPTLK IFKNGRIFDG
     QVYRGVKITD EITQYMIQLY EASVIYLNSE DEIQPYLENA TLPVVINRGL TGLNETYQEV
     ALDLAEDYVF LSLLDSEDKS LSIHLPNTTE PILFDGNVDS LVGNSVALTQ WLKVVILPYF
     TDIEPDLFPK YISSNLPLAY FFYTSEEELE DYTDLFTQLG KENRGQINFI ALNSTMFPHH
     VRFLNMREQF PLFAIHNMIN NLKYGLPQLP EEEYAKLEKP QPLDRDMIVQ LVKDYREGTA
     KPIVKSEEIP KEQKSNVYKI VGKTHDDIVH DDDKDVLVKY YATWCIHSKR FAPIYEEIAN
     VLASDESVRD KILIAEVDSG ANDILSFPVT GYPTIALYPA GNNSKPIIFN KIRNLEDVFE
     FIKESGTHHI DGQAIYDKLH QAKDSEVSTE DTVHDEL
>P35176 end PEPTIDYL-PROLYL CIS-TRANS ISOMERASE D PRECURSOR (EC 5.2.1.8) (PPIASE)
     MKLQFFSFIT LFACLFTTAI FAKEDTAEDP EITHKVYFDI NHGDKQIGRI VMGLYGLTTP
     QTVENFYQLT ISRDPKMGYL NSIFHRVIPN FMIQGGDFTH RSGIGGKSIF GNTFKDENFD
     VKHDKPGRLS MANRGKNTNG SQFFITTVPC PWLDGKHVVF GEVLDGMDVV HYIENVKTDS
     RNMPVKEVII VESGELETVP LDNKDAAKLQ EEIKAEASEA AHDEL
>P36016 end HEAT SHOCK PROTEIN 70 HOMOLOG LHS1 PRECURSOR.
     MRNVLRLLFL TAFVAIGSLA AVLGVDYGQQ NIKAIVVSPQ APLELVLTPE AKRKEISGLS
     IKRLPGYGKD DPNGIERIYG SAVGSLATRF PQNTLLHLKP LLGKSLEDET TVTLYSKQHP
     GLEMVSTNRS TIAFLVDNVE YPLEELVAMN VQEIANRANS LLKDRDARTE DFVNKMSFTI
     PDFFDQHQRK ALLDASSITT GIEETYLVSE GMSVAVNFVL KQRQFPPGEQ QHYIVYDMGS
     GSIKASMFSI LQPEDTTQPV TIEFEGYGYN PHLGGAKFTM DIGSLIENKF LETHPAIRTD
     ELHANPKALA KINQAAEKAK LILSANSEAS INIESLINDI DFRTSITRQE FEEFIADSLL
     DIVKPINDAV TKQFGGYGTN LPEINGVILA GGSSRIPIVQ DQLIKLVSEE KVLRNVNADE
     SAVNGVVMRG IKLSNSFKTK PLNVVDRSVN TYSFKLSNES ELYDVFTRGS AYPNKTSILT
     NTTDSIPNNF TIDLFENGKL FETITVNSGA IKNSYSSDKC SSGVAYNITF DLSSDRLFSI
     QEVNCICQSE NDIGNSKQIK NKGSRLAFTS EDVEIKRLSP SERSRLHEHI KLLDKQDKER
     FQFQENLNVL ESNLYDARNL LMDDEVMQNG PKSQVEELSE MVKVYLDWLE DASFDTDPED
     IVSRIREIGI LKKKIELYMD SAKEPLNSQQ FKGMLEEGHK LLQAIETHKN TVEEFLSQFE
     TEFADTIDNV REEFKKIKQP AYVSKALSTW EETLTSFKNS ISEIEKFLAK NLFGEDLREH
     LFEIKLQFDM YRTKLEEKLR LIKSGDESRL NEIKKLHLRN FRLQKRKEEK LKRKLEQEKS
     RNNNETESTV INSADDKTTI VNDKTTESNP SSEEDILHDE L
>P17967 end PROTEIN DISULFIDE ISOMERASE PRECURSOR (PDI) (EC 5.3.4.1) / DOLICHYL-
     MKFSAGAVLS WSSLLLASSV FAQQEAVAPE DSAVVKLATD SFNEYIQSHD LVLAEFFAPW
     CGHCKNMAPE YVKAAETLVE KNITLAQIDC TENQDLCMEH NIPGFPSLKI FKNSDVNNSI
     DYEGPRTAEA IVQFMIKQSQ PAVAVVADLP AYLANETFVT PVIVQSGKID ADFNATFYSM
     ANKHFNDYDF VSAENADDDF KLSIYLPSAM DEPVVYNGKK ADIADADVFE KWLQVEALPY
     FGEIDGSVFA QYVESGLPLG YLFYNDEEEL EEYKPLFTEL AKKNRGLMNF VSIDARKFGR
     HAGNLNMKEQ FPLFAIHDMT EDLKYGLPQL SEEAFDELSD KIVLESKAIE SLVKDFLKGD
     ASPIVKSQEI FENQDSSVFQ LVGKNHDEIV NDPKKDVLVL YYAPWCGHCK RLAPTYQELA
     DTYANATSDV LIAKLDHTEN DVRGVVIEGY PTIVLYPGGK KSESVVYQGS RSLDSLFDFI
     KENGHFDVDG KALYEEAQEK AAEEADADAE LADEEDAIHD EL
>Q12404 end DISULFIDE ISOMERASE MPD1 PRECURSOR (EC 5.3.4.1).
     MLFLNIIKLL LGLFIMNEVK AQNFYDSDPH ISELTPKSFD KAIHNTNYTS LVEFYAPWCG
     HCKKLSSTFR KAAKRLDGVV QVAAVNCDLN KNKALCAKYD VNGFPTLMVF RPPKIDLSKP
     IDNAKKSFSA HANEVYSGAR TLAPIVDFSL SRIRSYVKKF VRIDTLGSLL RKSPKLSVVL
     FSKQDKISPV YKSIALDWLG KFDFYSISNK KLKQLTDMNP TYEKTPEIFK YLQKVIPEQR
     QSDKSKLVVF DADKDKFWEY EGNSINKNDI SKFLRDTFSI TPNEGPFSRR SEYIAYLKTG
     KKPIKKNHSS SGNKHDEL
>P32916 end SIGNAL RECOGNITION PARTICLE RECEPTOR ALPHA SUBUNIT HOMOLOG (SR-ALPHA)
     MFDQLAVFTP QGQVLYQYNC LGKKFSEIQI NSFISQLITS PVTRKESVAN ANTDGFDFNL
     LTINSEHKNS PSFNALFYLN KQPELYFVVT FAEQTLELNQ ETQQTLALVL KLWNSLHLSE
     SILKNRQGQN EKNKHNYVDI LQGIEDDLKK FEQYFRIKYE ESIKQDHINP DNFTKNGSVP
     QSHNKNTKKK LRDTKGKKQS TGNVGSGRKW GRDGGMLDEM NHEDAAKLDF SSSNSHNSSQ
     VALDSTINKD SFGDRTEGGD FLIKEIDDLL SSHKDEITSG NEAKNSGYVS TAFGFLQKHV
     LGNKTINESD LKSVLEKLTQ QLITKNVAPE AADYLTQQVS HDLVGSKTAN WTSVENTARE
     SLTKALTQIL TPGVSVDLLR EIQSKRSKKD EEGKCDPYVF SIVGVNGVGK STNLSKLAFW
     LLQNNFKVLI VACDTFRSGA VEQLRVHVEN LAQLMDDSHV RGSKNKRGKT GNDYVELFEA
     GYGGSDLVTK IAKQAIKYSR DQNFDIVLMD TAGRRHNDPT LMSPLKSFAD QAKPDKIIMV
     GEALVGTDSV QQAKNFNDAF GKGRNLDFFI ISKCDTVGEM LGTMVNMVYA TGIPILFVGV
     GQTYTDLRTL SVKWAVNTLM S
>P33296 end UBIQUITIN-CONJUGATING ENZYME E2-28.4 KD (EC 6.3.2.19) (UBIQUITIN-
     MATKQAHKRL TKEYKLMVEN PPPYILARPN EDNILEWHYI ITGPADTPYK GGQYHGTLTF
     PSDYPYKPPA IRMITPNGRF KPNTRLCLSM SDYHPDTWNP GWSVSTILNG LLSFMTSDEA
     TTGSITTSDH QKKTLARNSI SYNTFQNVRF KLIFPEVVQE NVETLEKRKL DEGDAANTGD
     ETEDPFTKAA KEKVISLEEI LDPEDRIRAE QALRQSENNS KKDGKEPNDS SSMVYIGIAI
     FLFLVGLFMK
>P36057 end PUTATIVE SIGNAL RECOGNITION PARTICLE RECEPTOR BETA SUBUNIT (SR-BETA).
     MLSNTLIIAC LLVIGTTIAL IAVQKASSKT GIKQKSYQPS IIIAGPQNSG KTSLLTLLTT
     DSVRPTVVSQ EPLSAADYDG SGVTLVDFPG HVKLRYKLSD YLKTRAKFVK GLIFMVDSTV
     DPKKLTTTAE FLVDILSITE SSCENGIDIL IACNKSELFT ARPPSKIKDA LESEIQKVIE
     RRKKSLNEVE RKINEEDYAE NTLDVLQSTD GFKFANLEAS VVAFEGSINK RKISQWREWI
     DEKL
>P07286 end UDP-N-ACETYLGLUCOSAMINE--DOLICHYL-PHOSPHATE N-
     MLRLFSLALI TCLIYYSKNQ GPSALVAAVG FGIAGYLATD MLIPRVGKSF IKIGLFGKDL
     SKPGRPVLPE TIGAIPAAVY LFVMFIYIPF IFYKYMVITT SGGGHRDVSV VEDNGMNSNI
     FPHDKLSEYL SAILCLESTV LLGIADDLFD LRWRHKFFLP AIAAIPLLMV YYVDFGVTHV
     LIPGFMERWL KKTSVDLGLW YYVYMASMAI FCPNSINILA GVNGLEVGQC IVLAILALLN
     DLLYFSMGPL ATRDSHRFSA VLIIPFLGVS LALWKWNRWP ATVFVGDTYC YFAGMVFAVV
     GILGHFSKTM LLLFIPQIVN FIYSCPQLFK LVPCPRHRLP KFNEKDGLMY PSRANLKEEP
     PKSIFKPILK LLYCLHLIDL EFDENNEIIS TSNMTLINLT LVWFGPMRED KLCNTILKLQ
     FCIGILALLG RHAIGAIIFG HDNLWTVR
>P12683 end 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE 1 (EC 1.1.1.34) (HMG-
     MPPLFKGLKQ MAKPIAYVSR FSAKRPIHII LFSLIISAFA YLSVIQYYFN GWQLDSNSVF
     ETAPNKDSNT LFQECSHYYR DSSLDGWVSI TAHEASELPA PHHYYLLNLN FNSPNETDSI
     PELANTVFEK DNTKYILQED LSVSKEISST DGTKWRLRSD RKSLFDVKTL AYSLYDVFSE
     NVTQADPFDV LIMVTAYLMM FYTIFGLFND MRKTGSNFWL SASTVVNSAS SLFLALYVTQ
     CILGKEVSAL TLFEGLPFIV VVVGFKHKIK IAQYALEKFE RVGLSKRITT DEIVFESVSE
     EGGRLIQDHL LCIFAFIGCS MYAHQLKTLT NFCILSAFIL IFELILTPTF YSAILALRLE
     MNVIHRSTII KQTLEEDGVV PSTARIISKA EKKSVSSFLN LSVVVIIMKL SVILLFVFIN
     FYNFGANWVN DAFNSLYFDK ERVSLPDFIT SNASENFKEQ AIVSVTPLLY YKPIKSYQRI
     EDMVLLLLRN VSVAIRDRFV SKLVLSALVC SAVINVYLLN AARIHTSYTA DQLVKTEVTK
     KSFTAPVQKA STPVLTNKTV ISGSKVKSLS SAQSSSSGPS SSSEEDDSRD IESLDKKIRP
     LEELEALLSS GNTKQLKNKE VAALVIHGKL PLYALEKKLG DTTRAVAVRR KALSILAEAP
     VLASDRLPYK NYDYDRVFGA CCENVIGYMP LPVGVIGPLV IDGTSYHIPM ATTEGCLVAS
     AMRGCKAINA GGGATTVLTK DGMTRGPVVR FPTLKRSGAC KIWLDSEEGQ NAIKKAFNST
     SRFARLQHIQ TCLAGDLLFM RFRTTTGDAM GMNMISKGVE YSLKQMVEEY GWEDMEVVSV
     SGNYCTDKKP AAINWIEGRG KSVVAEATIP GDVVRKVLKS DVSALVELNI AKNLVGSAMA
     GSVGGFNAHA ANLVTAVFLA LGQDPAQNVE SSNCITLMKE VDGDLRISVS MPSIEVGTIG
     GGTVLEPQGA MLDLLGVRGP HATAPGTNAR QLARIVACAV LAGELSLCAA LAAGHLVQSH
     MTHNRKPAEP TKPNNLDATD INRLKDGSVT CIKS
>P12684 end 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE 2 (EC 1.1.1.34) (HMG-
     MSLPLKTIVH LVKPFACTAR FSARYPIHVI VVAVLLSAAA YLSVTQSYLN EWKLDSNQYS
     TYLSIKPDEL FEKCTHYYRS PVSDTWKLLS SKEAADIYTP FHYYLSTISF QSKDNSTTLP
     SLDDVIYSVD HTRYLLSEEP KIPTELVSEN GTKWRLRNNS NFILDLHNIY RNMVKQFSNK
     TSEFDQFDLF IILAAYLTLF YTLCCLFNDM RKIGSKFWLS FSALSNSACA LYLSLYTTHS
     LLKKPASLLS LVIGLPFIVV IIGFKHKVRL AAFSLQKFHR ISIDKKITVS NIIYEAMFQE
     GAYLIRDYLF YISSFIGCAI YARHLPGLVN FCILSTFMLV FDLLLSATFY SAILSMKLEI
     NIIHRSTVIR QTLEEDGVVP TTADIIYKDE TASEPHFLRS NVAIILGKAS VIGLLLLINL
     YVFTDKLNAT ILNTVYFDST IYSLPNFINY KDIGNLSNQV IISVLPKQYY TPLKKYHQIE
     DSVLLIIDSV SNAIRDQFIS KLLFFAFAVS ISINVYLLNA AKIHTGYMNF QPQSNKIDDL
     VVQQKSATIE FSETRSMPAS SGLETPVTAK DIIISEEIQN NECVYALSSQ DEPIRPLSNL
     VELMEKEQLK NMNNTEVSNL VVNGKLPLYS LEKKLEDTTR AVLVRRKALS TLAESPILVS
     EKLPFRNYDY DRVFGACCEN VIGYMPIPVG VIGPLIIDGT SYHIPMATTE GCLVASAMRG
     CKAINAGGGA TTVLTKDGMT RGPVVRFPTL IRSGACKIWL DSEEGQNSIK KAFNSTSRFA
     RLQHIQTCLA GDLLFMRFRT TTGDAMGMNM ISKGVEYSLK QMVEEYGWED MEVVSVSGNY
     CTDKKPAAIN WIEGRGKSVV AEATIPGDVV KSVLKSDVSA LVELNISKNL VGSAMAGSVG
     GFNAHAANLV TALFLALGQD PAQNVESSNC ITLMKEVDGD LRISVSMPSI EVGTIGGGTV
     LEPQGAMLDL LGVRGPHPTE PGANARQLAR IIACAVLAGE LSLCSALAAG HLVQSHMTHN
     RKTNKANELP QPSNKGPPCK TSALL
>P16603 end NADPH-CYTOCHROME P450 REDUCTASE (EC 1.6.2.4) (CPR).
     PFGIDNTDFT VLAGLVLAVL LYVKRNSIKE LLMSDDGDIT AVSSGNRDIA QVVTENNKNY
     LVLYASQTGT AEDYAKKFSK ELVAKFNLNV MCADVENYDF ESLNDVPVIV SIFISTYGEG
     DFPDGAVNFE DFICNAEAGA LSNLRYNMFG LGNSTYEFFN GAAKKAEKHL SAAGAIRLGK
     LGEADDGAGT TDEDYMAWKD SILEVLKDEL HLDEQEAKFT SQFQYTVLNE ITDSMSLGEP
     SAHYLPSHQL NRNADGIQLG PFDLSQPYIA PIVKSRELFS SNDRNCIHSE FDLSGSNIKY
     STGDHLAVWP SNPLEKVEQF LSIFNLDPET IFDLKPLDPT VKVPFPTPTT IGAAIKHYLE
     ITGPVSRQLF SSLIQFAPNA DVKEKLTLLS KDKDQFAVEI TSKYFNIADA LKYLSDGAKW
     DTVPMQFLVE SVPQMTPRYY SISSSSLSEK QTVHVTSIVE NFPNPELPDA PPVVGVTTNL
     LRNIQLAQNN VNIAETNLPV HYDLNGPRKL FANYKLPVHV RRSNFRLPSN PSTPVIMIGP
     GTGVAPFRGF IRERVAFLES QKKGGNNVSL GKHILFYGSR NTDDFLYQDE WPEYAKKLDG
     SFEMVVAHSR LPNTKKVYVQ DKLKDYEDQV FEMINNGAFI YVCGDAKGMA KGVSTALVGI
     LSRGKSITTD EATELIKMLK TSGRYQEDVW
>P21825 end TRANSLOCATION PROTEIN SEC62.
     MVAEQTQENM SAVGPGSNAG ASVNGGSATA IATLLRNHKE LKQRQGLFQA KQTDFFRYKR
     FVRALHSEEY ANKSARQPEI YPTIPSNKIE DQLKSREIFI QLIKAQMVIP VKKLHSQECK
     EHGLKPSKDF PHLIVSNKAQ LEADEYFVWN YNPRTYMDYL IVIGVVSIIL ALVCYPLWPR
     SMRRGSYYVS LGAFGILAGF FAVAILRLIL YVLSLIVYKD VGGFWIFPNL FEDCGVLESF
     KPLYGFGEKD TYSYKKKLKR MKKKQAKRES NKKKAINEKA EQN
>P32361 end SERINE/THREONINE-PROTEIN KINASE IRE1 PRECURSOR (EC 2.7.1.-).
     MRLLRRNMLV LTLLVCVFSS IISCSIPLSS RTSRRQIVED EVASTKKLNF NYGVDKNINS
     PIPAPRTTEG LPNMKLSSYP TPNLLNTADN RRANKKGRRA ANSISVPYLE NRSLNELSLS
     DILIAADVEG GLHAVDRRNG HIIWSIEPEN FQPLIEIQEP SRLETYETLI IEPFGDGNIY
     YFNAHQGLQK LPLSIRQLVS TSPLHLKTNI VVNDSGKIVE DEKVYTGSMR TIMYTINMLN
     GEIISAFGPG SKNGYFGSQS VDCSPEEKIK LQECENMIVI GKTIFELGIH SYDGASYNVT
     YSTWQQNVLD VPLALQNTFS KDGMCIAPFR DKSLLASDLD FRIARWVSPT FPGIIVGLFD
     VFNDLRTNEN ILVPHPFNPG DHESISSNKV YLDQTSNLSW FALSSQNFPS LVESAPISRY
     ASSDRWRVSS IFEDETLFKN AIMGVHQIYN NEYDHLYENY EKTNSLDTTH KYPPLMIDSS
     VDTTDLHQNN EMNSLKEYMS PEDLEAYRKK IHEQISRELD EKNQNSLLLK FGSLVYRIIE
     TGVFLLLFLI FCAILQRFKI LPPLYVLLSK IGFMPEKEIP IVESKSLNCP SSSENVTKPF
     DMKSGKQVVF EGAVNDGSLK SEKDNDDADE DDEKSLDLTT EKKKRKRGSR GGKKGRKSRI
     ANIPNFEQSL KNLVVSEKIL GYGSSGTVVF QGSFQGRPVA VKRMLIDFCD IALMEIKLLT
     ESDDHPNVIR YYCSETTDRF LYIALELCNL NLQDLVESKN VSDENLKLQK EYNPISLLRQ
     IASGVAHLHS LKIIHRDLKP QNILVSTSSR FTADQQTGAE NLRILISDFG LCKKLDSGQS
     SFRTNLNNPS GTSGWRAPEL LEESNNLQCQ VETEHSSSRH TVVSSDSFYD PFTKRRLTRS
     IDIFSMGCVF YYILSKGKHP FGDKYSRESN IIRGIFSLDE MKCLHDRSLI AEATDLISQM
     IDHDPLKRPT AMKVLRHPLF WPKSKKLEFL LKVSDRLEIE NRDPPSALLM KFDAGSDFVI
     PSGDWTVKFD KTFMDNLERY RKYHSSKLMD LLRALRNKYH HFMDLPEDIA ELMGPVPDGF
     YDYFTKRFPN LLIGVYMIVK ENLSDDQILR EFLYS
>P32915 end PROTEIN TRANSPORT PROTEIN SEC61 ALPHA SUBUNIT.
     MSSNRVLDLF KPFESFLPEV IAPERKVPYN QKLIWTGVSL LIFLILGQIP LYGIVSSETS
     DPLYWLRAML ASNRGTLLEL GVSPIITSSM IFQFLQGTQL LQIRPESKQD RELFQIAQKV
     CAIILILGQA LVVVMTGNYG APSDLGLPIC LLLIFQLMFA SLIVMLLDEL LSKGYGLGSG
     ISLFTATNIA EQIFWRAFAP TTVNSGRGKE FEGAVIAFFH LLAVRKDKKR ALVEAFYRTN
     LPNMFQVLMT VAIFLFVLYL QGFRYELPIR STKVRGQIGI YPIKLFYTSN TPIMLQSALT
     SNIFLISQIL FQKYPTNPLI RLIGVWGIRP GTQGPQMALS GLAYYIQPLM SLSEALLDPI
     KTIVYITFVL GSCAVFSKTW IEISGTSPRD IAKQFKDQGM VINGKRETSI YRELKKIIPT
     AAAFGGATIG ALSVGSDLLG TLGSGASILM ATTTIYGYYE AAAKEGGFTK NLVPGFSDLM
>P33754 end TRANSLOCATION PROTEIN SEC66 (HSS1 PROTEIN).
     MSEFNETKFS NNGTFFETEE PIVETKSISV YTPLIYVFIL VVSLVMFASS YRKKQAKKIS
     EQPSIFDEND AHDLYFQIKE MSENEKIHEK VLKAALLNRG AESVRRSLKL KELAPQINLL
     YKNGSIGEDY WKRFETEVKL IELEFKDTLQ EAERLQPGWV QLFVMVCKEI CFNQALSRRY
     QSILKRKEVC IKEWELKINN DGRLVN
>P33775 end DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE 1
     MSEEKTYKRV EQDDPVPELD IKQGPVRPFI VTDPSAELAS LRTMVTLKEK LLVACLAVFT
     AVIRLHGLAW PDSVVFDEVH FGGFASQYIR GTYFMDVHPP LAKMLYAGVA SLGGFQGDFD
     FENIGDSFPS TTPYVLMRFF SASLGALTVI LMYMTLRYSG VRMWVALMSA ICFAVENSYV
     TISRYILLDA PLMFFIAAAV YSFKKYEMYP ANSLNAYKSL LATGIALGMA SSSKWVGLFT
     VTWVGLLCIW RLWFMIGDLT KSSKSIFKVA FAKLAFLLGV PFALYLVFFY IHFQSLTLDG
     DGASFFSPEF RSTLKNNKIP QNVVADVGIG SIISLRHLST MGGYLHSHSH NYPAGSEQQQ
     STLYPHMDAN NDWLLELYNA PGESLTTFQN LTDGTKVRLF HTVTRCRLHS HDHKPPVSES
     SDWQKEVSCY GYSGFDGDAN DDWVVEIDKK NSAPGVAQER VIALDTKFRL RHAMTGCYLF
     SHEVKLPAWG FEQQEVTCAS SGRHDLTLWY VENNSNPLLP EDTKRISYKP ASFISKFIES
     HKKMWHINKN LVEPHVYESQ PTSWPFLLRG ISYWGENNRN VYLLGNAIVW WAVTAFIGIF
     GLIVITELFS WQLGKPILKD SKVVNFHVQV IHYLLGFAVH YAPSFLMQRQ MFLHHYLPAY
     YFGILALGHA LDIIVSYVFR SKRQMGYAVV ITFLAASVYF FKSFSPIIYG TPWTQELCQK
     SQWLSGWDYN CNTYFSSLEE YKNQTLTKRE SQPAATSTVE EITIEGDGPS YEDLMNEDGK
     KIFKDTEGNE LDPEVVKKML EEEGANILKV EKRAVLE
>P39012 end GAA1 PROTEIN.
     MALLEKLHRR IVDMGLVPRI IALLPVISML CALFGFISIA ILPMDGQYRR TYISENALMP
     SQAYSYFRES EWNILRGYRS QIKEMVNMTS MERNNLMGSW LQEFGTKTAI YENEQYGETL
     YGVMHAPRGD GTEAMVLAVP WFNSDDEFNI GGAALGVSLA RFFSRWPVWS KNIIVVFSEN
     PRAALRSWVE AYHTSLDLTG GSIEAAVVLD YSSTEDFFEY VEISYDGLNG ELPNLDLVNI
     AISITEHEGM KVSLHGLPSD QLTNNNFWSR LKILCLGIRD WALSGVKKPH GNEAFSGWRI
     QSVTLKAHGN SGHDITTFGR IPEAMFRSIN NLLEKFHQSF FFYLLLAPRQ FVSISSYLPS
     AVALSIAFAI SSLNAFINNA YANISLFSEY NLVALLVWFV SLVISFVVSQ AFLLIPSSGL
     LMTISMASCF LPLILSRKIH ISEPLSYRLK NVAFLYFSLV STSLLMINFA MALLIGTLAF
     PMTFVKTIVE SSSEHEVTTQ SSNPIKTEPK DEIELVENHM DTTPATPQQQ KQKLKNLVLL
     ILTNPFISIT LFGLFFDDEF HGFDIINKLV SAWLDLKCWS WFVLCIGWLP CWLLILASSF
     ESKSVVVRSK EKQS
>P41543 end DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN GLYCOSYLTRANSFERASE ALPHA
     MRQVWFSWIV GLFLCFFNVS SAAQYEPPAT WENVDYKRTI DVSNAYISET IEITIKNIAS
     EPATEYFTAF ESGIFSKVSF FSAYFTNEAT FLNSQLLANS TTAPGDDGES EIRYGIIQFP
     NAISPQEEVS LVIKSFYNTV GIPYPEHVGM SEEQHLLWET NRLPLSAYDT KKASFTLIGS
     SSFEEYHPPN DESLLGKANG NSFEFGPWED IPRFSSNETL AIVYSHNAPL NQVVNLRRDI
     WLSHWASTIQ FEEYYELTNK AAKLSKGFSR LELMKQIQTQ NMRQTHFVTV LDMLLPEGAT
     DHYFTDLVGL VSTSHAERDH FFIRPRFPIF GGWNYNFTVG WTNKLSDFLH VSSGSDEKFV
     ASIPILNGPP DTVYDNVELS VFLPEGAEIF DIDSPVPFTN VSIETQKSYF DLNKGHVKLT
     FSYRNLISQV ANGQVLIKYD YPKSSFFKKP LSIACYIFTA LMGVFVLKTL NMNVTN
>P41806 end VACUOLAR ATPASE ASSEMBLY INTEGRAL MEMBRANE PROTEIN VMA21.
     MAVDVPRAVI NKLMLFTAAM VVLPVLTFFI IQQFTPNTLI SGGLAAAMAN VVLIVYIVVA
     FREDTEDHKV DGNKKED
>Q02774 end SECRETORY COMPONENT PROTEIN SHR3.
     MFSYSDFCSI GTAMILSATT FLMGVFFSNM PYDYHLLFNP NSTQEHFDLA LRHYQILHET
     PLPVIVTLCV VAGIGLVGGT IKVFKPNPEL QMFEYCSLGL YVLAICVFLT NVKTGIDCSV
     SHNWEKLRNQ GLAVIASSNI ILLVMFAGVI ILQIGLWYSN WDLQKRLKEF YAQEEREAAN
     AGKKTEKVDN AKKNDNKSKG AQKRKNAKK
>P32341 end VACUOLAR ATPASE ASSEMBLY INTEGRAL MEMBRANE PROTEIN VMA12 (PROTEIN
     MFEIKLNDRI TEFLRKFKNS AKSNEGIDED IDLFLKRHAI PMQSLLFYVK EYRKDSDLQC
     SIKELLKPLE FEFKPKAVRG LHYSEDFKKK LEFLKYQEQE LEYQSMVKRS KSVFSLQEDD
     ELTPSQINKQ IKEQVTTVFN VLVSVISVVV AIWYWTGSST NFPVHVRLLL CLFFGILVLV
     ADVVVYNSYL KKLEEAKVKE KTKVEKKKVL SKITL
>P20048 end DOLICHOL KINASE (EC 2.7.1.108).
     MVAIIPHASF TTIKLTQKTE GSQMPTEEIC KINMRTRKFD VGGNSRDFEC FYSNFVQTVI
     LLGTFFYCVE RLQPWSIVTA DISYKQIFVN VFVVCLIMVG LIFTKYWQHG YKSLPKFDTI
     YSLYLPFMVS LLFDTSSTVI NTILILSVLN SYRWRTQLVV IILQLCLIFF NFEAGDRLKN
     IISIVINSLL SLILKYIGQL KSLDNIDSNL FSILLTNILY VSEAGTVHFR ILKGIILALT
     TIISINYVLK KVMHFKPFML SISFAIGLPL FANTFIHLED GENPLLWLVK YILESTIRQK
     ILFAWSSILI LSIPSILIEK DSLSLNTSRK LWHFIIFLLI IPSFQMDSNF VKIALSGTIP
     VFLSIEYIRF QNLPPLGSAI ELQLRRFADD RDHSGPLIIS YLYLLFGIST PLLMNNSPMG
     LIGLGIGDSL ASIIGKRYGR IRWKGTQKTL EGTLAFIVTS FIVCLVLLRF DKAAIFNHLT
     TLQLLTLCTL SGVLEGNSVL NDNILIPAFM MICEKLITL
>P31382 end DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE 2
     MSSSSSTGYS KNNAAHIKQE NTLRQRESSS ISVSEELSSA DERDAEDFSK EKPAAQSSLL
     RLESVVMPVI FTALALFTRM YKIGINNHVV WDEAHFGKFG SYYLRHEFYH DVHPPLGKML
     VGLSGYLAGY NGSWDFLLEI YPDYLDYVKM RLFNASFSAL CVPLAYFTAK AIGFSLPTVW
     LMTVLVLFEN SYSTLGRFIL LDSMLLFFTV ASFFSFVMFH NQRSKPFSRK WWKWLLITGI
     SLGCTISVKM VGLFIITMVG IYTVIDLWTF LADKSMSWKT YINHWLARIF GLIIVPFCIF
     LLCFKIHFDL LSHSGTGDAN MPSLFQARLV GSDVGQGPRD IALGSSVVSI KNQALGGSLL
     HSHIQTYPDG SNQQQVTCYG YKDANNEWFF NRERGLPSWS ENETDIEYLK PGTSYRLVHK
     STGRNLHTHP VAAPVSKTQW EVSGYGDNVV GDNKDNWVIE IMDQRGDEDP EKLHTLTTSF
     RIKNLEMGCY LAQTGNSLPE WGFRQQEVVC MKNPFKRDKR TWWNIETHEN ERLPPRPEDF
     QYPKTNFLKD FIHLNLAMMA TNNALVPDPD KFDYLASSAW QWPTLNVGLR LCGWGDDNPK
     YFLLGTPAST WASSVAVLAF MATVVILLIR WQRQYVDLRN PSNWNVFLMG GFYPLLAWGL
     HYMPFVIMSR VTYVHHYLPA LYFALIILAY CFDAGLQKWS RSKCGRIMRF VLYAGFMALV
     IGCFWYFSPI SFGMEGPSSN FRYLNWFSTW DIADKQEA
>P42934 end DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE 6
     MSKAKGTGFS SIDTEDENLR ERYVNQPKAN ASDIQDEQLD CFEQLEEKHR TKKNEEYTAL
     KILRDVIGPL LLTITSFYLR FQHIDQNNYV VWDEAHFGKF GSYYIKHEYY HDVHPPLGKM
     LIALSEWMAG FDGQFDFSSN NAYPENVNFK LMRQFNATFG ALCTPVAFFT AKWMGFNYFT
     VYLIATMVTL EHSYIVLSKF ILLDSMLLFF SMTTFACMIK LYTLRKQQMT KKWSLWMLLT
     GLSIGCVCSV KWVGLFITVV VGLYTCIELF LLYCDKELPR IKYYKHWLIR IINLIVIPFL
     IYLYCFKIHF VLLYKSGTGD STTNTLFQIN LEGTQIEAGP RDVAFGSELT IRSHGLSPNL
     LHSHIQVYPE GSGQRQITGY GFADSNNVWK FEFSRSSGLE LDQNGTLNGK IIPITDGVEV
     RLSHKNTGSN LHSHDVPSHV SRGNYEVSGY GSQSVGDEKD DWIVEIVKQM DSPNPVYSNE
     NSTILHPVST FFRLRHKVLG CYLASTGLTY PAWGFKQAEI VCKDSWSRRD KSTWWNVEDH
     WNHNLETAED YVPPKSNFWT DFILTNFAMA SSNNALVPDE DKYDSLSSDA WEWPTLHKGL
     RMCSWAGYIT RYYLMGSPFN TWISTVSLII FPFIILFILY RWRRQTLYLS DDQIWQITIQ
     GIFPFISWMT HYLPFAMMGR VTYVHHYVPA LYFAMLVFGF VLDFTLTRVH WMVKYPIYLS
     LFGGCIYIYN LFAPICQGMH GDKAEYLPLQ WLSTWDIAP
>P46964 end DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN GLYCOSYLTRANSFERASE
     AKAPKANTPK VTSTSSAVLT DFQETFKTSK RAYFAQIEKY PKLKLIDTFC FFLVLLGVIQ
     CTFIILIRDN FPFNAFLAGF IICVGQFVLL MSLRLQLCNS FPGISKNRAF AEFIVASLIL
     HFVCLHFIN
>P46971 end DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE 4
     MSVPKKRNHG KLPPSTKDVD DPSLKYTKAA PKCEQVAEHW LLQPLPEPES RYSFWVTIVT
     LLAFAARFYK IWYPKEVVFD EVHFGKFASY YLERSYFFDV HPPFAKMMIA FIGWLCGYDG
     SFKFDEIGYS YETHPAPYIA YRSFNAILGT LTVPIMFNTL KELNFRAITC AFASLLVAID
     TAHVTETRLI LLDAILIISI AATMYCYVRF YKCQLRQPFT WSWYIWLHAT GLSLSFVIST
     KYVGVMTYSA IGFAAVVNLW QLLDIKAGLS LRQFMRHFSK RLNGLVLIPF VIYLFWFWVH
     FTVLNTSGPG DAFMSAEFQE TLKDSPLSVD SKTVNYFDII TIKHQDTDAF LHSHLARYPQ
     RYEDGRISSA GQQVTGYTHP DFNNQWEVLP PHGSDVGKGQ AVLLNQHIRL RHVATDTYLL
     AHDVASPFYP TNEEITTVTL EEGDGELYPE TLFAFQPLKK SDEGHVLKSK TVSFRLFHVD
     TSVALWTHND ELLPDWGFQQ QEINGNKKVI DPSNNWVVDE IVNLDEVRKV YIPKVVKPLP
     FLKKWIETQK SMFEHNNKLS SEHPFASEPY SWPGSLSGVS FWTNGDEKKQ IYFIGNIIGW
     WFQVISLAVF VGIIVADLIT RHRGYYALNK MTREKLYGPL MFFFVSWCCH YFPFFLMARQ
     KFLHHYLPAH LIACLFSGAL WEVIFSDCKS LDLEKDEDIS GASYERNPKV YVKPYTVFLV
     CVSCAVAWFF VYFSPLVYGD VSLSPSEVVS REWFDIELNF SK
>P47190 end DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE 3
     MPYRVATGYS EKSTDDDLIW RTPIVKEELE DADNFLKDDA ELYDKVKNES AVSHLDTIVM
     PIIFTVLGMF TRMYKIGRNN HVVWDEAHFG KFGSYYLRHE FYHDVHPPLG KMLVGLSGYL
     AGYNGSWDFP SGEVYPDYID YVKMRLFQAM FSSLCVPLAY FTGRAIGFSR LSVWLFTILV
     IFENSYATLG KFILLDSMLL FFTVSSYFCL AKFHTMRKSP FSARWWLWLC LTGLNLGCAI
     SVKMVGLFII SVVGIYTISE LWNLLSDRSV SWKVYVNHWL ARIFGLIIIP VCVFLLCFKI
     HFDLLSNSGP GDSTMPSLFQ ASLNGTKVGK GPRDVALGSS IISIKNQALG GALLHSHVQP
     FPEGSEQQQV TVYGYSDANN EWFFQRIRGV EPWTDAHNKT IEFVKGGEMY RLMHRLTGKN
     LHTHEVPAPI SKSEYEVSAY GDVDLGDYKD NWIIEIVEQV GEEDPTLLHP LSTSFRIKNS
     ILGCYLAQSG KHLPEWGFRQ GEVVCLKHAS KRDKRTWWNI ETHENERLPQ GEDFVYPKTS
     FFRNFMQLNS AMMATNNALV PNPEKFNGIA SSAWQWPTLN VGVRLCEWSE KSIKYFLLGS
     PASVWPSSIA VCALIIHVIF LTLKWQRQCV ILSDPVERDV FVMAAFYPLL AWLLHYMPFV
     VMSRVVYAHH YLPTLYFALM ILSYYFDMIT KRWATRNTGK FLRLGAYIVY GSIVIAGFFY
     FSPFSFGMDG PVDDYAYLAW LPTWQIVEDI RNT
>P48439 end DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN GLYCOSYLTRANSFERASE GAMMA
     MNWLFLVSLV FFCGVSTHPA LAMSSNRLLK LANKSPKKII PLKDSSFENI LAPPHENAYI
     VALFTATAPE IGCSLCLELE SEYDTIVASW FDDHPDAKSS NSDTSIFFTK VNLEDPSKTI
     PKAFQFFQLN NVPRLFIFKP NSPSILDHSV ISISTDTGSE RMKQIIQAIK QFSQVNDFSL
     HLPMDWTPII TSTIITFITV LLFKKQSKLM FSIISSRIIW ATLSTFFIIC MISAYMFNQI
     RNTQLAGVGP KGEVMYFLPN EFQHQFAIET QVMVLIYGTL AALVVVLVKG IQFLRSHLYP
     ETKKAYFIDA ILASFCALFI YVFFAALTTV FTIKSPAYPF PLLRLSAPFK
>P52867 end DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE 5
     MNKEHLLKVD PIPDVTIKRG PLRSFLITKP CDNLSSLRTV TSSKEKLLVG CLLIFTAIVR
     LHNISLPNSV VFGENEVGTF VSQYVNNIFF TDVHPPLVAM LYATVSSVFG YKGLFNYGNI
     GTEYTANVPY VAMRFFSATL GIVSVLVLYL TLRVSGVKIA VAAICAVCFA IENSFVTLSR
     FTLIEGPFVF FMACAVYFFR RSELYLPNSC KANKSLLAAS IALGFAVSSK WAGLFTIAWA
     GIIVLWRVWF MIGDLSRPIG SSIKYMAFQF TCLLAIPAFI YFLIFSVHIK TLNVNGISSS
     FFPAEFRKTL KYNNVIKETV AEVAVGSAVS LNHVGTAGGY LHSHLHNYPA GSMQQQVTLY
     PHIDQNNKWI IELAEHPNEN VTSFQNLTDG TIIKLRQLKN GCRLHSHDHK PPVSQNADWQ
     KEVSCYGYEG FEGDINDDWI IEIDKKRSEP GPAQEHIRAI ETKFRLKHYL TGCYLFSHPE
     KLPEWGFGQQ EVTCAYFARE DLTSWYIEEN ENEISLPNPE KVSYKKMSFW QKFVAIHKFM
     FYLNNYMDTS HAYSSEPKTW PLMLRGIDFW NENGREVYFL GNAVLWWSVT AFICTFIIGV
     AVELLAWKLG VNILRDKHII NFHYQVFQYL LGFAAHYFPY FFVGQKLFLY DYLPAYYFGI
     LAFGHALDLI STYISNKRNN TGYIVVAIFM VVCFYFFSEH SPLIYATGWS SNLCKRSKWL
     GSWDFYCNSL LLSDSHYELN AES
>Q02795 end DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE--PROTEIN GLYCOSYLTRANSFERASE DELTA
     MQFFKTLAAL VSCISFVLAY VAQDVHVSFP STAGKSRVMI GKVEPRIGID ETVPTTITVE
     DPNEVIQVNF AIESTNKPFQ NTLLIGLPNK NLEMAFEPEI KDNGKLSMYK YRIDLAKLDA
     ALLQEASRSP EPIKATLILA SSTAKPKENL FREILQLNLN FDVDHSDSSL VDKFGIKPEI
     HHIFHAEPKR VAKPIAVIFV LIIFITILSL IVTWLNSCAA AFNNIPTGVT AVYFLGFIAT
     IVGFEVIFAR YYLGTSIFET LFSSLYLGAP GLLTSTKFLR SFGQTI
>Q06644 end DOLICHYL-PHOSPHATE-MANNOSE--PROTEIN MANNOSYLTRANSFERASE 7
     MKDLRLQGPY RKYIPYNIFQ QCGIGHLKTL DYIFAFLIVI TNFTLIWKSH SSSFWNRPWD
     NNSEQELSQL IQFYLDKAFY IHELPPFTIQ FYSIIRRLKI AENLRYVSLF LNSSTLGFLF
     LITRRINCSR LISATGLLIL SNWETFRNEG TIISFDSLEW CLFSVVIYSF ISISIAKLGT
     TNWFANVITL SISLGLAISS KFIGIVTWAF VILSFVRQFD RLISDVKVTT IQIIKFVILC
     LLFVLIIPGS IFIISYSNLL SNFKTDTPQF SKYMSTYFKS YLRGPQVQPS RLYYGSTITL
     RHLDSMVGYL ASHDISYPSD VDEQLVALSF EEFAADNEWL IEHPTLNLSF SEVYHADQLI
     PVEFGQSIKL RHKSTGKLLR ASTAKPPISE QDYDFQISCT KDSNYEGGMD ERWDVLLIKD
     EINNDKKDNA DDKYIKPLQS EIRFYNNGQR CGLLGHDLRL PEWGRFEQEV LCMEYPVIPR
     TTFLIDSVQL PVDFQVPMIE YYIGKISSSA EFNHTLSWSQ FLYLFKEYIF KQYKYNYYIK
     YGKNKVTFED AFAVEKWPIT LDTDSPVWFN FAWYGSLLSM IIFMCVQCKR MISWNPWTTA
     EPSFSIKWEV YNEFGWECIV GWFLHFYIFT MSPHFNLGKK LYFQSFFFSV LCLLESLDCL
     AK
>P00635 exc REPRESSIBLE ACID PHOSPHATASE PRECURSOR (EC 3.1.3.2) (P60).
     MFKSVVYSIL AASLANAGTI PLGKLADVDK IGTQKDIFPF LGGAGPYYSF PGDYGISRDL
     PEGCEMKQLQ MVGRHGERYP TVSLAKTIKS TWYKLSNYTR QFNGSLSFLN DDYEFFIRDD
     DDLEMETTFA NSDDVLNPYT GEMNAKRHAR DFLAQYGYMV ENQTSFAVFT SNSKRCHDTA
     QYFIDGLGDQ FNITLQTVSE AESAGANTLS ACNSCPAWDY DANDDIVNEY DTTYLDDIAK
     RLNKENKGLN LTSTDASTLF SWCAFEVNAK GYSDVCDIFT KDELVHYSYY QDLHTYYHEG
     PGYDIIKSVG SNLFNASVKL LKQSEIQDQK VWLSFTHDTD ILNFLTTAGI IDDKNNLTAE
     YVPFMGNTFH RSWYVPQGAR VYTEKFQCSN DTYVRYVIND AVVPIETCST GPGFSCEIND
     FYDYAEKRVA GTDFLKVCNV SSVSNSTELT FYWDWNTTHY NASLLRQ
>P12630 exc BARRIERPEPSIN PRECURSOR (EC 3.4.23.35) (EXTRACELLULAR "BARRIER"
     MSAINHLCLK LILASFAIIN TITALTNDGT GHLEFLLQHE EEMYYATTLD IGTPSQSLTV
     LFDTGSADFW VMDSSNPFCL PNSNTSSYSN ATYNGEEVKP SIDCRSMSTY NEHRSSTYQY
     LENGRFYITY ADGTFADGSW GTETVSINGI DIPNIQFGVA KYATTPVSGV LGIGFPRRES
     VKGYEGAPNE YYPNFPQILK SEKIIDVVAY SLFLNSPDSG TGSIVFGAID ESKFSGDLFT
     FPMVNEYPTI VDAPATLAMT IQGLGAQNKS SCEHETFTTT KYPVLLDSGT SLLNAPKVIA
     DKMASFVNAS YSEEEGIYIL DCPVSVGDVE YNFDFGDLQI SVPLSSLILS PETEGSYCGF
     AVQPTNDSMV LGDVFLSSAY VVFDLDNYKI SLAQANWNAS EVSKKLVNIQ TDGSISGAKI
     ATAEPWSTNE PFTVTSDIYS STGCKSRPFL QSSTASSLIA ETNVQSRNCS TKMPGTRSTT
     VLSKPTQNSA MHQSTGAVTQ TSNETKLELS STMANSGSVS LPTSNSIDKE FEHSKSQTTS
     DPSVAEHSTF NQTFVHETKY RPTHKTVITE TVTKYSTVLI NVCKPTY
>P15703 exc GLUCAN 1,3-BETA-GLUCOSIDASE PRECURSOR (EC 3.2.1.58) (EXO-1,3-BETA-
     MRFSTTLATA ATALFFTASQ VSAIGELAFN LGVKNNDGTC KSTSDYETEL QALKSYTSTV
     KVYAASDCNT LQNLGPAAEA EGFTIFVGVW PTDDSHYAAE KAALQTYLPK IKESTVAGFL
     VGSEALYRND LTASQLSDKI NDVRSVVADI SDSDGKSYSG KQVGTVDSWN VLVAGYNSAV
     IEASDFVMAN AFSYWQGQTM QNASYSFFDD IMQALQVIQS TKGSTDITFW VGETGWPTDG
     TNFESSYPSV DNAKQFWKEG ICSMRAWGVN VIVFEAFDED WKPNTSGTSD VEKHWGVFTS
     SDNLKYSLDC DFS
>P23285 exc PEPTIDYL-PROLYL CIS-TRANS ISOMERASE B PRECURSOR (EC 5.2.1.8) (PPIASE)
     MKFSGLWCWL LLFLSVNVIA SDVGELIDQD DEVITQKVFF DIEHGEEKVG RIVIGLYGKV
     CPKTAKNFYK LSTTTNSKKG FIGSTFHRVI PNFMVQGGDF TDGTGVGGKS IYGDTFPDEN
     FTLKHDRKGR LSMANRGKDT NGSQFFITTT EEASWLDGKH VVFGQVVDGM DVVNYIQHVS
     RDANDKPLEA VKIAKCGEWT PELSS
>P25334 exc PEPTIDYL-PROLYL CIS-TRANS ISOMERASE PRECURSOR (EC 5.2.1.8) (PPIASE)
     MWLKSLLLCL YSLVLCQVHA APSSGKQITS KDVDLQKKYE PSPPATHRGI ITIEYFDPVS
     KSMKEADLTF ELYGTVVPKT VNNFAMLAHG VKAVIEGKDP NDIHTYSYRK TKINKVYPNK
     YIQGGVVAPD VGPFTVYGPK FDDENFYLKH DRPERLAMAY FGPDSNTSEF IITTKADGNE
     ELDGKSVVFG QITSGLDQLM DAIQYTETDE YGKPQHELRF LYFVLEILKI SNILDLHAAY
     TEKVEKFRNG DVSVGSTLEN IFRNDKAYTP LTTSTGTTAY DLNHPISRAL MCLTVLGLCF
     IAYKGMHEKP HTVSLRHK
>P29029 exc ENDOCHITINASE PRECURSOR (EC 3.2.1.14).
     MSLLYIILLF TQFLLLPTDA FDRSANTNIA VYWGQNSAGT QESLATYCES SDADIFLLSF
     LNQFPTLGLN FANACSDTFS DGLLHCTQIA EDIETCQSLG KKVLLSLGGA SGSYLFSDDS
     QAETFAQTLW DTFGEGTGAS ERPFDSAVVD GFDFDIENNN EVGYSALATK LRTLFAEGTK
     QYYLSAAPQC PYPDASVGDL LENADIDFAF IQFYNNYCSV SGQFNWDTWL TYAQTVSPNK
     NIKLFLGLPG SASAAGSGYI SDTSLLESTI ADIASSSSFG GIALWDASQA FSNELNGEPY
     VEILKNLLTS ASQTATTTVA TSKTSAASTS SASTSSASTS QKKTTQSTTS TQSKSKVTLS
     PTASSAIKTS ITQTTKTLTS STKTKSSLGT TTTESTLNSV AITSMKTTLS SQITSAALVT
     PQTTTTSIVS SAPIQTAITS TLSPATKSSS VVSLQTATTS TLSPTTTSTS SGSTSSGSTS
     SDSTARTLAK ELNAQYAAGK LNGKSTCTEG EIACSADGKF AVCDHSAWVY MECASGTTCY
     AYDSGDSVYT QCNFSYLESN YF
>P32478 exc 150 KD HEAT SHOCK GLYCOPROTEIN PRECURSOR.
     MQYKKTLVAS ALAATTLAAY APSEPWSTLT PTATYSGGVT DYASLRYCRS TNLHYIQRII
     CSTTASSKAK RAASQIGDGQ VQAATTTASV STKSTAAAVS QIGDGQIQAT TKTTAAAVSQ
     IGDGQIQATT KTTSAKTTAA AVSQISDGQI QATTTTLAPK STAAAVSQIG DGQVQATTTT
     LAPKSTAAAV SQIGDGQVQA TTKTTAAAVF QIGDGQVLAT TKTTRAAVSQ IGDGQVQATT
     KTTAAAVSQI GDGQVQATTK TTAAAVSQIT DGQVQATTKT TQAASQVSDG QVQATTATSA
     SAAATSTDPV DAVSCKTSGT LEMNLKGGIL TDGKGRIGSI VANRQFQFDG PPPQAGAIYA
     AGWSITPDGN LAIGDNDVFY QCLSGTFYNL YDEHIGSQCT PVHLEAIDLI DC
>P38616 exc PROTEIN YGP1 PRECURSOR (GP38).
     MKFQVVLSAL LACSSAVVAS PIENLFKYRA VKASHSKNIN STLPAWNGSN SSNVTYANGT
     NSTTNTTTAE SSQLQIIVTG GQVPITNSSL THTNYTRLFN SSSALNITEL YNVARVVNET
     IQDKSSAGAV VVANAKSLEA VSFFFSIIFD TEKPIVVTED SAYAIPVANN KNATKRGVLS
     VTSDKLVYSG VFTPPTACSY GAGLPVAIVD DQDEVKWFFD ASKPTLISSD SIIRKEYSNF
     TTPYGLLENG VPIVPIVYDG GYSSSLIDSL SSAVQGLVVV SSGSTNSTSS TIESTEIPVV
     YAQANTPLNF IDNKDVPKNA VGAGYLSPIK AQILLSIAAV NGVTSKSALE SIFP
>P39005 exc CELL WALL SYNTHESIS PROTEIN KRE9 PRECURSOR.
     MRLQRNSIIC ALVFLVSFVL GDVNIVSPSS KATFSPSGGT VSVPVEWMDN GAYPSLSKIS
     TFTFSLCTGP NNNIDCVAVL ASKITPSELT QDDKVYSYTA EFASTLTGNG QYYIQVFAQV
     DGQGYTIHYT PRFQLTSMGG VTAYTYSATT EPTPQTSIQT TTTNNAQATT IDSRSFTVPY
     TKQTGTSRFA PMQMQPNTKV TATTWTRKFA TSAVTYYSTF GSLPEQATTI TPGWSYTISS
     GVNYATPASM PSDNGGWYKP SKRLSLSARK INMRKV
>P39105 exc LYSOPHOSPHOLIPASE PRECURSOR (EC 3.1.1.5) (PHOSPHOLIPASE B).
     MKLQSLLVSA AVLTSLTENV NAWSPNNSYV PANVTCDDDI NLVREASGLS DNETEWLKKR
     DAYTKEALHS FLNRATSNFS DTSLLSTLFG SNSSNMPKIA VACSGGGYRA MLSGAGMLAA
     MDNRTDGANE HGLGGLLQGA TYLAGLSGGN WLTSTLAWNN WTSVQAIVDN TTESNSIWDI
     SHSILTPDGI NIFKTGSRWD DISDDVQDKK DAGFNISLAD VWGRALAYNF WPSLHRGGVG
     YTWSTLREAD VFKNGEMPFP ITVADGRYPG TTVINLNATL FEFNPFEMGS WDPTLNAFTD
     VKYLGTNVTN GKPVNKGQCI AGFDNTGFIT ATSSTLFNQF LLRLNSTDLP SFIANLATDF
     LEDLSDNSDD IAIYAPNPFK EANFLQKNAT SSIIESEYLF LVDGGEDNQN IPLVPLLQKE
     RELDVIFALD NSADTDDYWP DGASLVNTYQ RQFGSQGLNL SFPYVPDVNT FVNLGLNKKP
     TFFGCDARNL TDLEYIPPLI VYIPNSRHSF NGNQSTFKMS YSDSERLGMI KNGFEAATMG
     NFTDDSDFLG CVGCAIIRRK QQNLNATLPS ECSQCFTNYC WNGTIDSRSV SGVGNDDYSS
     SASLSASAAA ASASASASAS ASASASGSST HKKNAGNALV NYSNLNTNTF IGVLSVISAV
     FGLI
>P50112 exc CELL WALL SYNTHESIS PROTEIN KNH1 PRECURSOR.
     MLIVLFLTLF CSVVFRTAYC DVAIVAPEPN SVYDLSGTSQ AVVKVKWMHT DNTPQEKDFV
     RYTFTLCSGT NAMIEAMATL QTLSASDLTD NEFNAIIENT VGTDGVYFIQ VFAQTAIGYT
     IHYTNRFKLK GMIGTKAANP SMITIAPEAQ TRITTGDVGA TIDSKSFTVP YNLQTGVVKY
     APMQLQPATK VTAKTWKRKY ATSEVTYYYT LRNSVDQHTT VTPGWSYIIT ADSNYATAPM
     PADNGGWYNP RKRLSLTARK VNALRHR
>Q03178 exc PIR1 PROTEIN PRECURSOR.
     MQYKKSLVAS ALVATSLAAY APKDPWSTLT PSATYKGGIT DYSSTFGIAV EPIATTASSK
     AKRAAAISQI GDGQIQATTK TTAAAVSQIG DGQIQATTKT KAAAVSQIGD GQIQATTKTT
     SAKTTAAAVS QIGDGQIQAT TKTKAAAVSQ IGDGQIQATT KTTAAAVSQI GDGQIQATTK
     TTAAAVSQIG DGQIQATTNT TVAPVSQITD GQIQATTLTS ATIIPSPAPA PITNGTDPVT
     AETCKSSGTL EMNLKGGILT DGKGRIGSIV ANRQFQFDGP PPQAGAIYAA GWSITPEGNL
     AIGDQDTFYQ CLSGNFYNLY DEHIGTQCNA VHLQAIDLLN C
>Q03180 exc PIR3 PROTEIN PRECURSOR.
     MQYKKPLVVS ALAATSLAAY APKDPWSTLT PSATYKGGIT DYSSSFGIAI EAVATSASSV
     ASSKAKRAAS QIGDGQVQAA TTTAAVSKKS TAAAVSQITD GQVQAAKSTA AAASQISDGQ
     VQAAKSTAAA VSQITDGQVQ AAKSTAAAVS QITDGQVQAA KSTAAAASQI SDGQVQAAKS
     TAAAVSQITD GQVQAAKSTA AAASQISDGQ VQATTSTKAA ASQITDGQIQ ASKTTSGASQ
     VSDGQVQATA EVKDANDPVD VVSCNNNSTL SMSLSKGILT DRKGRIGSIV ANRQFQFDGP
     PPQAGAIYAA GWSITPEGNL ALGDQDTFYQ CLSGDFYNLY DKHIGSQCHE VYLQAIDLID
     C
>P33890 exc COLD SHOCK INDUCED PROTEIN TIR2 PRECURSOR (SERINE-RICH PROTEIN 2).
     MAYIKIALLA AIAALASAQT QEEIDELNVI LNDVKSNLQE YISLAEDSSS GFSLSSLPSG
     VLDIGLALAS ATDDSYTTLY SEVDFAAVSK MLTMVPWYSS RLLPELESLL GTSTTAASST
     EASSAATSSA VASSSETTSS AVASSSEATS SAVASSSEAS SSAATSSAVA SSSEATSSTV
     ASSTKAASST KASSSAVSSA VASSTKASAI SQISDGQVQA TSTVSEQTEN GAAKAVIGMG
     AGVMAAAAML L
>P36170 exc HYPOTHETICAL 122.2 KD PROTEIN IN SIR1 3'REGION PRECURSOR.
     MPVAARYIFL TGLFLLSVAN VALGTTEACL PAGEKKNGMT INFYQYSLKD SSTYSNPSYM
     AYGYADAEKL GSVSGQTKLS IDYSIPCNGA SDTCACSDDD ATEYSASQVV PVKRGVKLCS
     DNTTLSSKTE KRENDDCDQG AAYWSSDLFG FYTTPTNVTV EMTGYFLPPK TGTYTFGFAT
     VDDSAILSVG GNVAFECCKQ EQPPITSTDF TINGIKPWNA DAPTDIKGST YMYAGYYYPI
     KIVYSNAVSW GTLPVSVVLP DGTEVNDDFE GYVFSFDDNA TQAHCSVPNP AEHARTCVSS
     ATSSWSSSEV CTECTETEST SYVTPYVTSS SWSSSEVCTE CTETESTSTS TPYVTSSSSS
     SSEVCTECTE TESTSYVTPY VSSSTAAANY TSSFSSSSEV CTECTETEST STSTPYVTSS
     SWSSSEVCTE CTETESTSYV TPYVSSSTAA ANYTSSFSSS SEVCTECTET ESTSTSTPYV
     TSSSSSSSEV CTECTETEST SYVTPYVSSS TAAANYTSSF SSSSEVCTEC TETESTSTST
     PYVTSSSWSS SEVCTECTET ESTSYVTPYV SSSTAAANYT SSFSSSSEVC TECTETESTS
     TSTPYATSST GTATSFTAST SNTMTSLVQT DTTVSFSLSS TVSEHTNAPT SSVESNASTF
     ISSNKGSVKS YVTSSIHSIT PMYPSNQTVT SSSVVSTPIT SESSESSASV TILPSTITSE
     FKPSTMKTKV VSISSSPTNL ITSYDTTSKD STVGSSTSSV SLISSISLPS SYSASSEQIF
     HSSIVSSNGQ ALTSFSSTKV SSSESSESHR TSPTTSSESG IKSSGVEIES TSTSSFSFHE
     TSTASTSVQI SSQFVTPSSP ISTVAPRSTG LNSQTESTNS SKETMSSENS ASVMPSSSAT
     SPKTGKVTSD ETSSGFSRDR TTVYRMTSET PSTNEQTTLI TVSSCESNSC SNTVSSAVVS
     TATTTINGIT TEYTTWCPLS ATELTTVSKL ESEEKTTLIT VTSCESGVCS ETASPAIVST
     ATATVNDVVT VYSTWSPQAT NKLAVSSDIE NSASKASFVS EAAETKSISR NNNFVPTSGT
     TSIETHTTTT SNASENSDNV SASEAVSSKS VTNPVLISVS QQPRGTPASS MIGSSTASLE
     MSSYLGIANH LLTNSGISIF IASLLLAIV
>P46999 exc HYPOTHETICAL 19.0 KD PROTEIN IN TPK1-FAR1 INTERGENIC REGION PRECURSOR.
     MHYKKAFLAS LLSSIALTAY APPEPWATLT PSSKMDGGTT EYRTSFGLAV IPFTVTESKV
     KRNVISQIND GQVQVTTQKL PHPVSQIGDG QIQVTTQKVP PVVSHIVSQI GDGQLQITTA
     KNVVTKSTIA VPSKTVTATA TSTATAVSQI HDGQVQVTIS SASSSSVLSK SKLRANKETK
>P47000 exc HYPOTHETICAL 30.8 KD PROTEIN IN TPK1-FAR1 INTERGENIC REGION PRECURSOR.
     MQYKKTLVAS ALAATTLAAY APSEPWSTLT PTATYSGGVT DYASTFGIAV QPISTTSSAS
     SAATTASSKA KRAASQIGDG QVQAATTTAS VSTKSTAAAV SQIGDGQIQA TTKTTAAAVS
     RDGQIQATTK TTSAKTTAAA VSQISDGQIQ ATTTTLAPKS TAAAVSQIGD GQVQATTKTT
     AAAVSQIGDG QVQATTKTTA AAVSQIGDGQ VQATTKTTAA AVSQIGDGQV QATTKTTAAA
     VSQITDGQVQ ATTKTTQAAS QVSDGQVQAT TAWLLVTMMS STNVCPVLST TCTTNTLVVN
     VLQSTWKLSI
>P47001 exc HYPOTHETICAL 23.2 KD PROTEIN IN TPK1-FAR1 INTERGENIC REGION PRECURSOR.
     MQFKNVALAA SVAALSATAS AEGYTPGEPW STLTPTGSIS CGAAEYTTTF GIAVQAITSS
     KAKRDVISQI GDGQVQATSA ATAQATDSQA QATTTATPTS SEKISSSASK TSTNATSSSC
     ATPSLKDSSC KNSGTLELTL KDGVLTDAKG RIGSIVANRQ FQFDGPPPQA GAIYAAGWSI
     TEDGYLALGD SDVFYQCLSG NFYNLYDQNV AEQCSAIHLE AVSLVDC
>Q03674 exc PUTATIVE LYSOPHOSPHOLIPASE PRECURSOR (EC 3.1.1.5) (PHOSPHOLIPASE B).
     MQLRNILQAS SLISGLSLAA DSSSTTGDGY APSIIPCPSD DTSLVRNASG LSTAETDWLK
     KRDAYTKEAL HSFLSRATSN FSDTSLLSTL FSSNSSNVPK IGIACSGGGY RAMLGGAGMI
     AAMDNRTDGA NEHGLGGLLQ SSTYLSGLSG GNWLTGTLAW NNWTSVQEIV DHMSESDSIW
     NITKSIVNPG GSNLTYTIER WESIVQEVQA KSDAGFNISL SDLWARALSY NFFPSLPDAG
     SALTWSSLRD VDVFKNGEMP LPITVADGRY PGTTVINLNA TLFEFTPFEM GSWDPSLNAF
     TDVKYLGTNV TNGKPVNKDQ CVSGYDNAGF VIATSASLFN EFSLEASTST YYKMINSFAN
     KYVNNLSQDD DDIAIYAANP FKDTEFVDRN YTSSIVDADD LFLVDGGEDG QNLPLVPLIK
     KERDLDVVFA LDISDNTDES WPSGVCMTNT YERQYSKQGK GMAFPYVPDV NTFLNLGLTN
     KPTFFGCDAK NLTDLEYIPP LVVYIPNTKH SFNGNQSTLK MNYNVTERLG MIRNGFEAAT
     MGNFTDDSNF LGCIGCAIIR RKQESLNATL PPECTKCFAD YCWNGTLSTS ANPELSGNST
     YQSGAIASAI SEATDGIPIT ALLGSSTSGN TTSNSTTSTS SNVTSNSNSS SNTTLNSNSS
     SSSISSSTAR SSSSTANKAN AAAISYANTN TLMSLLGAIT ALFGLI
>Q08108 exc PUTATIVE LYSOPHOSPHOLIPASE PRECURSOR (EC 3.1.1.5) (PHOSPHOLIPASE B).
     MIRPLCSKII ISYIFAISQF LLAANAWSPT DSYVPGTVSC PDDINLVREA TSISQNESAW
     LEKRNKVTSV ALKDFLTRAT ANFSDSSEVL SKLFNDGNSE NLPKIAVAVS GGGYRSMLTG
     AGVLAAMDNR TEGAYEHGLG GLLQSTTYLS GASGGNWLVG TLALNNWTSV QDILNNMQND
     DSIWDLSDSI VTPGGINIFK TAKRWDHISN AVESKQNADY NTSLADIWGR ALAYNFFPSL
     NRGGIGLTWS SIRDFPVFQN AEMPFPISVA DGRYPGTKVI NLNATVFEFN PFEMGSWDPS
     LNSFANVKYL GTNVSNGVPL ERGKCTAGFD NAGFIMGTSS TLFNQFLLRI NSTHLPSFIT
     RLARHFLKDL SQDFNDIAVY SPNPFKDTKF LDSDYTTSIV DSDSLFLVDG GEDDENVPVL
     PLIQKERDVD IIFAVDNSAD MRLAWPDGSS LVHTYERQFV KQGQGMSFPY VPDTNTFVNL
     GLNKKPTFFG CDANNLTDLQ YIPPLVVYLP NAEYSFNSNQ SAFKLSYSES QRRSMIQNGF
     EIATRNNFTD DPEFMGCVGC AIIRRKQQAL NITLPPECET CFKNYCWNGT LDTTPLPDVE
     KDVHHSFINV NSFNSSIGQE ESLYAGSSAS QSSSSSSSSS SSSEIPSATA TLEKKAATNS
     GSHLSGISVK FSAMIMLTLL MFTGAV
>P11163 exc L-ASPARAGINASE II PRECURSOR (EC 3.5.1.1) (L-ASPARAGINE
     MRSLNTLLLS LFVAMSSGAP LLKIREEKNS SLPSIKIFGT GGTIASKGST SATTAGYSVG
     LTVNDLIEAV PSLAEKANLD YLQVSNVGSN SLNYTHLIPL YHGISEALAS DDYAGAVVTH
     GTDTMEETAF FLDLTINSEK PVCIAGAMRP ATATSADGPM NLYQAVSIAA SEKSLGRGTM
     ITLNDRIASG FWTTKMNANS LDTFRADEQG YLGYFSNDDV EFYYPPVKPN GWQFFDISNL
     TDPSEIPEVI ILYSYQGLNP ELIVKAVKDL GAKGIVLAGS GAGSWTATGS IVNEQLYEEY
     GIPIVHSRRT ADGTVPPDDA PEYAIGSGYL NPQKSRILLQ LCLYSGYGMD QIRSVFSGVY
     GG
>P13586 gol CALCIUM-TRANSPORTING ATPASE 1 (EC 3.6.1.38) (GOLGI CA2+-ATPASE).
     MSDNPFNASL LDEDSNRERE ILDATAEALS KPSPSLEYCT LSVDEALEKL DTDKNGGLRS
     SNEANNRRSL YGPNEITVED DESLFKKFLS NFIEDRMILL LIGSAVVSLF MGNIDDAVSI
     TLAIFIVVTV GFVQEYRSEK SLEALNKLVP AECHLMRCGQ ESHVLASTLV PGDLVHFRIG
     DRIPADIRII EAIDLSIDES NLTGENEPVH KTSQTIEKSS FNDQPNSIVP ISERSCIAYM
     GTLVKEGHGK GIVVGTGTNT SFGAVFEMMN NIEKPKTPLQ LTMDKLGKDL SLVSFIVIGM
     ICLVGIIQGR SWLEMFQISV SLAVAAIPEG LPIIVTVTLA LGVLRMAKRK AIVRRLPSVE
     TLGSVNVICS DKTGTLTSNH MTVSKLWCLD SMSNKLNVLS LDKNKKTKNS NGNLKNYLTE
     DVRETLTIGN LCNNASFSQE HAIFLGNPTD VALLEQLANF EMPDIRNTVQ KVQELPFNSK
     RKLMATKILN PVDNKCTVYV KGAFERILEY STSYLKSKGK KTEKLTEAQK ATINECANSM
     ASEGLRVFGF AKLTLSDSST PLTEDLIKDL TFTGLIGMND PPRPNVKFAI EQLLQGGVHI
     IMITGDSENT AVNIAKQIGI PVIDPKLSVL SGDKLDEMSD DQLANVIDHV NIFARATPEH
     KLNIVRALRK RGDVVAMTGD GVNDAPALKL SDIGVSMGRI GTDVAKEASD MVLTDDDFST
     ILTAIEEGKG IFNNIQNFLT FQLSTSVAAL SLVALSTAFK LPNPLNAMQI LWINILMDGP
     PAQSLGVEPV DHEVMKKPPR KRTDKILTHD VMKRLLTTAA CIIVGTVYIF VKEMAEDGKV
     TARDTTMTFT CFVFFDMFNA LACRHNTKSI FEIGFFTNKM FNYAVGLSLL GQMCAIYIPF
     FQSIFKTEKL GISDILLLLL ISSSVFIVDE LRKLWTRKKN EEDSTYFSNV
>P27809 gol GLYCOLIPID 2-ALPHA-MANNOSYLTRANSFERASE (EC 2.4.1.131) (ALPHA-1,2-
     MALFLSKRLL RFTVIAGAVI VLLLTLNSNS RTQQYIPSSI SAAFDFTSGS ISPEQQVISE
     ENDAKKLEQS ALNSEASEDS EAMDEESKAL KAAAEKADAP IDTKTTMDYI TPSFANKAGK
     PKACYVTLVR NKELKGLLSS IKYVENKINK KFPYPWVFLN DEPFTEEFKE AVTKAVSSEV
     KFGILPKEHW SYPEWINQTK AAEIRADAAT KYIYGGSESY RHMCRYQSGF FWRHELLEEY
     DWYWRVEPDI KLYCDINYDV FKWMQENEKV YGFTVSIHEY EVTIPTLWQT SMDFIKKNPE
     YLDENNLMSF LSNDNGKTYN LCHFWSNFEI ANLNLWRSPA YREYFDTLDH QGGFFYERWG
     DAPVHSIAAA LFLPKDKIHY FSDIGYHHPP YDNCPLDKEV YNSNNCECDQ GNDFTFQGYS
     CGKEYYDAQG LVKPKNWKKF RE
>P32486 gol BETA-GLUCAN SYNTHESIS-ASSOCIATED PROTEIN KRE6 (KILLER TOXIN-
     MPLRNLTETH NFSSTNLDTD GTGDDHDGAP LSSSPSFGQQ NDNSTNDNAG LTNPFMGSDE
     ESNARDGESL SSSVHYQPQG SDSSLLHDNS RLDLSQNKGV SDYKGYYSRN NSRAVSTAND
     NSFLQPPHRA IASSPSLNSN LSKNDILSPP EFDRYPLVGS RVTSMTQLNH HGRSPTSSPG
     NESSASFSSN PFLGEQDFSP FGGYPASSFP LMIDEKEEDD YLHNPDPEEE ARLDRRRFID
     DFKYMDKRSA SGLAGVLLLF LAAIFIFIVL PALTFTGAID HESNTEEVTY LTQYQYPQLS
     AIRTSLVDPE TPDTAKTREA MDGSKWELVF SDEFNAEGRT FYDGDDPYWT APDVHYDATK
     DLEWYSPDAS TTVNGTLQLR MDAFKNHGLY YRSGMLQSWN KVCFTQGALE ISANLPNYGR
     VSGLWPGLWT MGNLGRPGYL ASTQGVWPYS YESCDAGITP NQSSPDGISY LPGQKLSICT
     CDVEDHPNQG VGRGAPEIDV LEGETDTKIG VGIASQSLQI APFDIWYMPD YDFIEVYNFT
     TTTMNTYAGG PFQQAVSAVS TLNVTWYEFG EYGGYFQKYA IEYLNDDDNG YIRWFVGDTP
     TYTIHAKALH PDGNIGWRRI SKEPMSIILN LGISNNWAYI DWQYIFFPVV MSIDYVRIYQ
     PSNAISVTCD PSDYPTYDYI QSHLNAFQNA NLTTWEDAGY TFPKNILTGK CTSSKFKLSS
>P32621 gol GUANOSINE-DIPHOSPHATASE (EC 3.6.1.42) (GDPASE).
     MAPIFRNYRF AIGAFAVIML ILLIKTSSIG PPSIARTVTP NASIPKTPED ISILPVNDEP
     GYLQDSKTEQ NYPELADAVK SQTSQTCSEE HKYVIMIDAG STGSRVHIYK FDVCTSPPTL
     LDEKFDMLEP GLSSFDTDSV GAANSLDPLL KVAMNYVPIK ARSCTPVAVK ATAGLRLLGD
     AKSSKILSAV RDHLEKDYPF PVVEGDGVSI MGGDEEGVFA WITTNYLLGN IGANGPKLPT
     AAVFDLGGGS TQIVFEPTFP INEKMVDGEH KFDLKFGDEN YTLYQFSHLG YGLKEGRNKV
     NSVLVENALK DGKILKGDNT KTHQLSSPCL PPKVNATNEK VTLESKETYT IDFIGPDEPS
     GAQCRFLTDE ILNKDAQCQS PPCSFNGVHQ PSLVRTFKES NDIYIFSYFY DRTRPLGMPL
     SFTLNELNDL ARIVCKGEET WNSVFSGIAG SLDELESDSH FCLDLSFQVS LLHTGYDIPL
     QRELRTGKKI ANKEIGWCLG ASLPLLKADN WKCKIQSA
>P32906 gol MANNOSYL-OLIGOSACCHARIDE ALPHA-1,2-MANNOSIDASE (EC 3.2.1.113)
     MKNSVGISIA TIVAIIAAIY YVPWYEHFER KSPGAGEMRD RIESMFLESW RDYSKHGWGY
     DVYGPIEHTS HNMPRGNQPL GWIIVDSVDT LMLMYNSSTL YKSEFEAEIQ RSEHWINDVL
     DFDIDAEVNV FETTIRMLGG LLSAYHLSDV LEVGNKTVYL NKAIDLGDRL ALAFLSTQTG
     IPYSSINLHS GQAVKNHADG GASSTAEFTT LQMEFKYLAY LTGNRTYWEL VERVYEPLYK
     NNDLLNTYDG LVPIYTFPDT GKFGASTIRF GSRGDSFYEY LLKQYLLTHE TLYYDLYRKS
     MEGMKKHLLA QSKPSSLWYI GEREQGLHGQ LSPKMDHLVC FMGGLLASGS TEGLSIHEAR
     RRPFFSLSLE RKSDWDLAKG ITDTCYQMYK QSSSGLAPEI VVFNDGNIKQ DGWWRSSVGD
     FFVKPLDRHN LQRPETVESI MFMYHLSHDH KYREWGAEIA TSFFENTCVD CNDPKLRRFT
     SLSDCITLPT KKSNNMESFW LAETLKYLYI LFLDEFDLTK VVFNTEAHPF PVLDEEILKS
     QSLTTGWSL
>P23642 gol VANADATE RESISTANCE PROTEIN.
     MGMFFNLRSN IKKKAMDNGL SLPISRNGSS NNIKDKRSEH NSNSLKGKYR YQPRSTPSKF
     QLTVSITSLI IIAVLSLYLF ISFLSGMGIG VSTQNGRSLL GSSKSSENYK TIDLEDEEYY
     DYDFEDIDPE VISKFDDGVQ HYLISQFGSE VLTPKDDEKY QRELNMLFDS TVEEYDLSNF
     EGAPNGLETR DHILLCIPLR NAADVLPLMF KHLMNLTYPH ELIDLAFLVS DCSEGDTTLD
     ALIAYSRHLQ NGTLSQIFQE IDAVIDSQTK GTDKLYLKYM DEGYINRVHQ AFSPPFHENY
     DKPFRSVQIF QKDFGQVIGQ GFSDRHAVKV QGIRRKLMGR ARNWLTANAL KPYHSWVYWR
     DADVELCPGS VIQDLMSKNY DVIVPNVWRP LPTFLGTEQP YDLNSWMESQ EALALAKTLD
     EDDVIVEGYA EYPTWRVHLA YIRDAEGDPN EAVDLDGVGG VSILAKAKIF RNGVQFPAFT
     FENHAETEAF GKMAKKMGYR VGGLPHYTIW HIYEPSDDDL KEIASREREK RRQSE
>P31109 gol SYNAPTOBREVIN HOMOLOG 1.
     MSSSTPFDPY ALSEHDEERP QNVQSKSRTA ELQAEIDDTV GIMRDNINKV AERGERLTSI
     EDKADNLAVS AQGFKRGANR VRKAMWYKDL KMKMCLALVI IILLVVIIVP IAVHFSR
>P32629 gol AMINONITROPHENYL PROPANEDIOL RESISTANCE PROTEIN.
     MKYNNRKLSF NPTTVSIAGT LLTVFFLTRL VLSFFSISLF QLVTFQGIFK PYVPDFKNTP
     SVEFYDLRNY QGNKDGWQQG DRILFCVPLR DASEHLPMFF NHLNTMTYPH NLIDLSFLVS
     DSSDNTMGVL LSNLQMAQSQ QDKSKRFGNI EIYEKDFGQI IGQSFSDRHG FGAQGPRRKL
     MARARNWLGS VALKPYHSWV YWRDVDVETI PTTIMEDLMH HDKDVIVPNV WRPLPDWLGN
     IQPYDLNSWK ESEGGLQLAD SLDEDAVIVE GYPEYATWRP HLAYMRDPNG NPEDEMELDG
     IGGVSILAKA KVFRTGSHFP AFSFEKHAET EAFGRLSRRM NYNVIGLPHY VIWHIYEPSS
     DDLKHMAWMA EEEKRKLEEE RIREFYNKIW EIGFEDVRDQ WNEERDSILK NIDSTLNNKV
     TVDWSEEGDG SELVDSKGDF VSPNNQQQQQ QQQQQQQQQQ QQQQQQQLDG NPQGKPLDDN
     DKNKKKHPKE VPLDFDPDRN
>P33328 gol SYNAPTOBREVIN HOMOLOG 2.
     MSSSVPYDPY VPPEESNSGA NPNSQNKTAA LRQEIDDTVG IMRDNINKVA ERGERLTSIE
     DKADNLAISA QGFKRGANRV RKQMWWKDLK MRMCLFLVVI ILLVVIIVPI VVHFS
>P38166 gol SFT2 PROTEIN.
     MSEEPPSDQV NSLRDSLNRW NQTRQQNSQG FNESAKTLFS SWADSLNTRA QDIYQTLPVS
     RQDLVQDQEP SWFQLSRTER MVLFVCFLLG ATACFTLCTF LFPVLAAKPR KFGLLWTMGS
     LLFVLAFGVL MGPLAYLKHL TARERLPFSM FFFATCFMTI YFAAFSKNTV LTITCALLEL
     VAVIYYAISY FPFGATGLRM LSSAGVNSAR GVLRI
>P39106 gol ALPHA-1,3-MANNOSYLTRANSFERASE (EC 2.4.1.-).
     MLALRRFILN QRSLRSCTIP ILVGALIIIL VLFQLVTHRN DALIRSSNVN STNKKTLKDA
     DPKVLIEAFG SPEVDPVDTI PVSPLELVPF YDQSIDTKRS SSWLINKKGY YKHFNELSLT
     DRCKFYFRTL YTLDDEWTNS VKKLEYSIND NEGVDEGKDA NGNPMDEKSE RLYRRKYDMF
     QAFERIRAYD RCFMQANPVN IQEIFPKSDK MSKERVQSKL IKTLNATFPN YDPDNFKKYD
     QFEFEHKMFP FINNFTTETF HEMVPKITSP FGKVLEQGFL PKFDHKTGKV QEYFKYEYDP
     SKTFWANWRD MSAKVAGRGI VLSLGSNQFP LAVKFIASLR FEGNTLPIQV VYRGDELSQE
     LVDKLIYAAR SPDFKPVENN YDNSTNVPQE IWFLDVSNTI HPKWRGDFGS YKSKWLVVLL
     NLLQEFVFLD IDAISYEKID NYFKTTEYQK TGTVFYRERA LRENVNERCI ARYETLLPRN
     LESKNFQNSL LIDPDHALNE CDNTLTTEEY IFKAFFHHRR QHQLEAGLFA VDKSKHTIPL
     VLAAMIHLAK NTAHCTHGDK ENFWLGFLAA GHTYALQGVY SGAIGDYVKK TDLNGKRQEA
     AVEICSGQIA HMSTDKKTLL WVNGGGTFCK HDNAAKDDWK KDGDFKKFKD QFKTFEEMEK
     YYYITPISSK YVILPDPKSD DWHRASAGAC GGYIWCATHK TLLKPYSYNH RTTHGELITL
     DEEQRLHIDA VNTVWSHANK DNTRSFTEEE IKELENSRHE QS
>P39107 gol MNN9 PROTEIN.
     MSLSLVSYRL RKNPWVNIFL PVLAIFLIYI IFFQRDQSLL GLNGQSISQH KWAHEKENTF
     YFPFTKKYKM PKYSYKKKSG WLFNDHVEDI IPEGHIAHYD LNKLHSTSEA AVNKEHILIL
     TPMQTFHQQY WDNLLQLNYP RELIELGFIT PRTATGDLAL KKLENAIKKV QTDKKTQRFS
     KITILRQNSQ SFDKLMEKER HALDVQKERR AAMALARNEL LFSTIGPHTS WVLWLDADII
     ETPPSLIQDM TKHNKAILAA NIYQRFYDEE KKQPSIRPYD FNNWQESDTG LEIASQMGDD
     EIIVEGYAEI ATYRPLMAHF YDANGVPGEE MALDGVGGGC TLVKAEVHRD GAMFPNFPFY
     HLIETEGFAK MAKRLNYDVF GLPNYLVYHI EEENH
>P50108 gol GALACTOSYLTRANSFERASE MNN10 (EC 2.4.1.-) (BUD EMERGENCE DELAY PROTEIN
     MSSVPYNSQL PISNHLEYDE DEKKSRGSKL GLKYKMIYWR KTLCSSLARW RKLILLISLA
     LFLFIWISDS TISRNPSTTS FQGQNSNDNK LSNTGSSINS KRYVPPYSKR SRWSFWNQDP
     RIVIILAANE GGGVLRWKNE QEWAIEGISI ENKKAYAKRH GYALTIKDLT TSKRYSHEYR
     EGWQKVDILR QTFREFPNAE WFWWLDLDTM IMEPSKSLEE HIFDRLETLA DRELKSFNPL
     NLRDDIPYVD YSEEMEFLIT QDCGGFNLGS FLIKNSEWSK LLLDMWWDPV LYEQKHMVWE
     HREQDALEAL YENEPWIRSR IGFLPLRTIN AFPPGACSEY SGDSRYFYSE KDHDFVVNMA
     GCNFGRDCWG EMQYYTTLME KLNRKWYTRF FFP
>P43682 gol SFT1 PROTEIN (P14).
     MSNSRYSQTE SNNDRKLEGL ANKLATFRNI NQEIGDRAVS DSSVINQMTD SLGSMFTDIK
     NSSSRLTRSL KAGNSIWRMV GLALLIFFIL YTLFKLF
>P24280 gol SEC14 CYTOSOLIC FACTOR (PHOSPHATIDYLINOSITOL/PHOSPHATIDYLCHOLINE
     VTQQEKEFLE SYPQNCPPDA LPGTPGNLDS AQEKALAELR KLLEDAGFIE RLDDSTLLRF
     LRARKFDVQL AKEMFENCEK WRKDYGTDTI LQDFHYDEKP LIAKFYPQYY HKTDKDGRPV
     YFEELGAVNL HEMNKVTSEE RMLKNLVWEY ESVVQYRLPA CSRAAGHLVE TSCTIMDLKG
     ISISSAYSVM SYVREASYIS QNYYPERMGK FYIINAPFGF STAFRLFKPF LDPVTVSKIF
     ILGSSYQKEL LKQIPAENLP VKFGGKSEVD ESKGGLYLSD IGPWRDPKYI GPEGEAPEAF
     SMK
>P13134 gol KEXIN PRECURSOR (EC 3.4.21.61) (KEX2 PROTEASE) (PROTEINASE YSCF).
     MKVRKYITLC FWWAFSTSAL VSSQQIPLKD HTSRQYFAVE SNETLSRLEE MHPNWKYEHD
     VRGLPNHYVF SKELLKLGKR SSLEELQGDN NDHILSVHDL FPRNDLFKRL PVPAPPMDSS
     LLPVKEAEDK LSINDPLFER QWHLVNPSFP GSDINVLDLW YNNITGAGVV AAIVDDGLDY
     ENEDLKDNFC AEGSWDFNDN TNLPKPRLSD DYHGTRCAGE IAAKKGNNFC GVGVGYNAKI
     SGIRILSGDI TTEDEAASLI YGLDVNDIYS CSWGPADDGR HLQGPSDLVK KALVKGVTEG
     RDSKGAIYVF ASGNGGTRGD NCNYDGYTNS IYSITIGAID HKDLHPPYSE GCSAVMAVTY
     SSGSGEYIHS SDINGRCSNS HGGTSAAAPL AAGVYTLLLE ANPNLTWRDV QYLSILSAVG
     LEKNADGDWR DSAMGKKYSH RYGFGKIDAH KLIEMSKTWE NVNAQTWFYL PTLYVSQSTN
     STEETLESVI TISEKSLQDA NFKRIEHVTV TVDIDTEIRG TTTVDLISPA GIISNLGVVR
     PRDVSSEGFK DWTFMSVAHW GENGVGDWKI KVKTTENGHR IDFHSWRLKL FGESIDSSKT
     ETFVFGNDKE EVEPAATEST VSQYSASSTS ISISATSTSS ISIGVETSAI PQTTTASTDP
     DSDPNTPKKL SSPRQAMHYF LTIFLIGATF LVLYFMFFMK SRRRIRRSRA ETYEFDIIDT
     DSEYDSTLDN GTSGITEPEE VEDFDFDLSD EDHLASLSSS ENGDAEHTID SVLTNENPFS
     DPIKQKFPND ANAESASNKL QELQPDVPPS SGRS
>P32319 gol VACUOLAR PROTEIN SORTING/TARGETING PROTEIN PEP1 PRECURSOR (VACUOLAR
     MILLHFVYSL WALLLIPLTN AEEFTPKVTK TIAQDSFDIL SFDDSNTLIR KQDTSVTISF
     DDGETWEKVE GIEGEITWIY IDPFNRHDRA VATAMNGSYL YITNDQGKSW ERITLPDSGE
     SISPRECYIE THPLNKNYFL AKCNYCEKTE VNNDNEENSG DEEGQFEIFN ITRCTDKVFA
     SNDGGKSFSE IKSSLERNEN SPISISDCGF AKTSKDSDLE SSDTSIICLF QNMQLIMDEF
     SSPYTESKLV LTTDWGKSLK EFDQFKDKVV NGYRILKSHM VVLTQGDRYN DMSSMDVWVS
     NDLSNFKMAY MPTQLRHSMQ GEIYEDAMGR IILPMSRERS DQEEDKGIVS EILISDSQGL
     KFSPIPWTAN EVFGYINFYQ PTYLKGTMIA SLYPLSRRRN RKGKAKGVKS KGVTKISVDN
     GLTWTMLKVV DPDNADSFDC DITDFENCSL QNMFYTREGS TPTAGILMTT GIVGDGSVFD
     WGDQRTFISR DGGLTWKLAF DFPCLYAVGD YGNVIVAIPY NADEDDDPQS EFYYSLDQGK
     TWTEYQLETT IYPNEVMNTT PDGSGAKFIL NGFTLAHMDG TTNFIYAIDF STAFNDKTCE
     ENDFEDWNLA EGKCVNGVKY KIRRRKQDAQ CLVKKVFEDL QLFETACDKC TEADYECAFE
     FVRDATGKCV PDYNLIVLSD VCDKTKKKTV PVKPLQLVKG DKCKKPMTVK SVDISCEGVP
     KKGTNDKEIV VTENKFDFKI QFYQYFDTVT DESLLMINSR GEAYISHDGG QTIKRFDSNG
     ETIIEVVFNP YYNSSAYLFG SKGSIFSTHD RGYSFMTAKL PEARQLGMPL DFNAKAQDTF
     IYYGGKNCES ILSPECHAVA YLTNDGGETF TEMLDNAIHC EFAGSLFKYP SNEDMVMCQV
     KEKSSQTRSL VSSTDFFQDD KNTVFENIIG YLSTGGYIIV AVPHENNELR AYVTIDGTEF
     AEAKFPYDED VGKQEAFTIL ESEKGSIFLH LATNLVPGRD FGNLLKSNSN GTSFVTLEHA
     VNRNTFGYVD FEKIQGLEGI ILTNIVSNSD KVAENKEDKQ LKTKITFNEG SDWNFLKPPK
     RDSEGKKFSC SSKSLDECSL HLHGYTERKD IRDTYSSGSA LGMMFGVGNV GPNLLPYKEC
     STFFTTDGGE TWAEVKKTPH QWEYGDHGGI LVLVPENSET DSISYSTDFG KTWKDYKFCA
     DKVLVKDITT VPRDSALRFL LFGEAADIGG SSFRTYTIDF RNIFERQCDF DITGKESADY
     KYSPLGSKSN CLFGHQTEFL RKTDENCFIG NIPLSEFSRN IKNCSCTRQD FECDYNFYKA
     NDGTCKLVKG LSPANAADVC KKEPDLIEYF ESSGYRKIPL STCEGGLKLD APSSPHACPG
     KEKEFKEKYS VSAGPFAFIF ISILLIIFFA AWFVYDRGIR RNGGFARFGE IRLGDDGLIE
     NNNTDRVVNN IVKSGFYVFS NIGSLLQHTK TNIAHAISKI RGRFGNRTGP SYSSLIHDQF
     LDEADDLLAG HDEDANDLSS FMDQGSNFEI EEDDVPTLEE EHTSYTDQPT TTDVPDTLPE
     GNEENIDRPD STAPSNENQ
>P07246 mit ALCOHOL DEHYDROGENASE III PRECURSOR (EC 1.1.1.1).
     MLRTSTLFTR RVQPSLFSRN ILRLQSTAAI PKTQKGVIFY ENKGKLHYKD IPVPEPKPNE
     ILINVKYSGV CHTDLHAWHG DWPLPVKLPL VGGHEGAGVV VKLGSNVKGW KVGDLAGIKW
     LNGSCMTCEF CESGHESNCP DADLSGYTHD GSFQQFATAD AIQAAKIQQG TDLAEVAPIL
     CAGVTVYKAL KEADLKAGDW VAISGAAGGL GSLAVQYATA MGYRVLGIDA GEEKEKLFKK
     LGGEVFIDFT KTKNMVSDIQ EATKGGPHGV INVSVSEAAI SLSTEYVRPC GTVVLVGLPA
     NAYVKSEVFS HVVKSINIKG SYVGNRADTR EALDFFSRGL IKSPIKIVGL SELPKVYDLM
     EKGKILGRYV VDTSK
>P09440 mit C-1-TETRAHYDROFOLATE SYNTHASE MITOCHONDRIAL PRECURSOR (C1-THF
     MLSRLSLLSN SRAFQQARWR IYRLKVSPTV HASQYHILSG RKLAQSIREK ANDEIQAIKL
     KHPNFKPTLK IIQVGARPDS STYVRMKLKA SKDSNVDCII EKLPAEITEV ELLKKISDIN
     DDDSIHGLLI QLPLPRHLDE TTITNAVDFK KDVDGFHRYN AGELAKKGGK PYFIPCTPYG
     CMKLLEEAHV KLDGKNAVVL GRSSIVGNPI ASLLKNANAT VTVCHSHTRN IAEVVSQADI
     VIAACGIPQY VKSDWIKEGA VVIDVGINYV PDISKKSGQK LVGDVDFDSV KEKTSYITPV
     PGGVGPMTVA MLVSNVLLAA KRQFVESEKL PVIKPLPLHL ESPVPSDIDI SRAQSPKHIK
     QVAEELGIHS HELELYGHYK AKISPNIFKR LESRENGKYV LVAGITPTPL GEGKSTTTMG
     LVQALSAHLG KPSIANVRQP SLGPTLGVKG GAAGGGYAQV IPMDEFNLHL TGDIHAISAA
     NNLLAAAIDT RMFHEATQKN DSTFYKRLVP RKKGIRKFTP SMQRRLKRLD IEKEDPDALT
     PEEVKRFARL NINPDTITIR RVVDINDRML RQITIGEAAT EKGFTRTTGF DITVASELMA
     ILALSKSLHE MKERIGRMVI GADYDNKPVT VEDIGCTGAL TALLRDAIKP NLMQTLEGTP
     VMVHAGPFAN ISIGASSVIA DLMALKLVGS EKNPLNDKNI HEPGYVVTEA GFDFAMGGER
     FFDIKCRSSG LVPDAVVLVA TVRALKSHGG APNVKPGQSL PKEYTEENID FVAKGVSNLV
     KQIENIKTFG IPVVVAINRF ETDSQAEIEV IKKAALNAGA SHAVTSNHWM EGGKGAVELA
     HAVVDATKEP KNFNFLYDVN SSIEDKLTSI VQKMYGGAKI EVSPEAQKKI DTYKKQGFGN
     LPICIAKTQY SLSHDPSLKG VPRGFTFPIR DVRASIGAGY LYALAAEIQT IPGLSTYAGY
     MAVEVDDDGE IEGLF
>P15801 mit DNA POLYMERASE GAMMA (EC 2.7.7.7) (MITOCHONDRIAL DNA POLYMERASE
     MTKLMVRSEC MLRMVRRRPL RVQFCARWFS TKKNTAEAPR INPVGIQYLG ESLQRQVFGS
     CGGKDEVEQS DKLMELSKKS LKDHGLWGKK TLITDPISFP LPPLQGRSLD EHFQKIGRFN
     SEPYKSFCED KFTEMVARPA EWLRKPGWVK YVPGMAPVEV AYPDEELVVF DVETLYNVSD
     YPTLATALSS TAWYLWCSPF ICGGDDPAAL IPLNTLNKEQ VIIGHNVAYD RARVLEEYNF
     RDSKAFFLDT QSLHIASFGL CSRQRPMFMK NNKKKEAEVE SEVHPEISIE DYDDPWLNVS
     ALNSLKDVAK FHCKIDLDKT DRDFFASTDK STIIENFQKL VNYCATDVTA TSQVFDEIFP
     VFLKKCPHPV SFAGLKSLSK CILPTKLNDW NDYLNSSESL YQQSKVQIES KIVQIIKDIV
     LLKDKPDFYL KDPWLSQLDW TTKPLRLTKK GVPAKCQKLP GFPEWYRQLF PSKDTVEPKI
     TIKSRIIPIL FKLSWENSPV IWSKESGWCF NVPHEQVETY KAKNYVLADS VSQEEEEIRT
     HNLGLQCTGV LFKVPHPNGP TFNCTNLLTK SYNHFFEKGV LKSESELAHQ ALQINSSGSY
     WMSARERIQS QFVVPSCKFP NEFQSLSAKS SLNNEKTNDL AIIIPKIVPM GTITRRAVEN
     AWLTASNAKA NRIGSELKTQ VKAPPGYCFV GADVDSEELW IASLVGDSIF NVHGGTAIGW
     MCLEGTKNEG TDLHTKTAQI LGCSRNEAKI FNYGRIYGAG AKFASQLLKR FNPSLTDEET
     KKIANKLYEN TKGKTKRSKL FKKFWYGGSE SILFNKLESI AEQETPKTPV LGCGITYSLM
     KKNLRANSFL PSRINWAIQS SGVDYLHLLC CSMEYIIKKY NLEARLCISI HDEIRFLVSE
     KDKYRAAMAL QISNIWTRAM FCQQMGINEL PQNCAFFSQV DIDSVIRKEV NMDCITPSNK
     TAIPHGEALD INQLLDKSNS KLGKPNLDID SKVSQYAYNY REPVFEEYNK SYTPEFLKYF
     LAMQVQSDKR DVNRLEDEYL RECTSKEYAR DGNTAEYSLL DYIKDVEKGK RTKVRIMGSN
     FLDGTKNAKA DQRIRLPVNM PDYPTLHKIA NDSAIPEKQL LENRRKKENR IDDENKKKLT
     RKKNTTPMER KYKRVYGGRK AFEAFYECAN KPLDYTLETE KQFFNIPIDG VIDDVLNDKS
     NYKKKPSQAR TASSSPIRKT AKAVHSKKLP ARKSSTTNRN LVELERDITI SREY
>P18496 mit ATP10 PROTEIN.
     MSFLDKFLKP MMATASPKEY QIKQLVKPIG LTQAPRKSTK YSQGNSLRDM FDSEKTNHRV
     KELAVEFSKS GLYDVQVFQK TKGKLFIAPV SYWKEDKALF FPHLIGTAMD GTKQQNIEDM
     LRGKTSIVRL FSTASGDKLS SSYFQGIVDD NKKTDYLTEA DARLSLNDSN VQIIEVNLVE
     NAVKSALVKT LARWANRVPS WRQPFYFEYS RGQWPFSVRE ELFCNNVFSG YVFLVDQQLK
     IRWAACGEAT PSEKEALWKF AKRL
>P18544 mit ACETYLORNITHINE AMINOTRANSFERASE PRECURSOR (EC 2.6.1.11) (ACOAT).
     MFKRYLSSTS SRRFTSILEE KAFQVTTYSR PEDLCITRGK NAKLYDDVNG KEYIDFTAGI
     AVTALGHANP KVAEILHHQA NKLVHSSNLY FTKECLDLSE KIVEKTKQFG GQHDASRVFL
     CNSGTEANEA ALKFAKKHGI MKNPSKQGIV AFENSFHGRT MGALSVTWNS KYRTPFGDLV
     PHVSFLNLND EMTKLQSYIE TKKDEIAGLI VEPIQGEGGV FPVEVEKLTG LKKICQDNDV
     IVIHDEIQCG LGRSGKLWAH AYLPSEAHPD IFTSAKALGN GFPIAATIVN EKVNNALRVG
     DHGTTYGGNP LACSVSNYVL DTIADEAFLK QVSKKSDILQ KRLREIQAKY PNQIKTIRGK
     GLMLGAEFVE PPTEVIKKAR ELGLLIITAG KSTVRFVPAL TIEDELIEEG MDAFEKAIEA
     VYA
>P22135 mit ATP12 PROTEIN PRECURSOR.
     MLPSLRKGCF IVNSIRLKLP RFYSLNAQPL GTDNTIENNT PTETNRLSKT SQKFWEKVSL
     NRDVEKGKIA LQLDGRTIKT PLGNGIIVDN AKSLLAYLLK LEWSSLSSLS IKTHSLPLTS
     LVARCIDLQM TNEPGCDPQL VAKIGGNSDV IKNQLLRYLD TDTLLVFSPM NEFEGRLRNA
     QNELYIPIIK GMEEFLRNFS SESNIRLQIL DADIHGLRGN QQSDIVKNAA KKYMSSLSPW
     DLAILEKTVL TTKSFICGVL LLENKKDTAN LIPALKTDMD NIVRAATLET IFQVEKWGEV
     EDTHDVDKRD IRRKIHTAAI AAFKQ
>P22136 mit ATP13 PROTEIN PRECURSOR.
     MWINRLVKHP SYSVLRFYTK RLCTVSVKSL REFGVLPNST ICHSVYPRRT YVMGRAVIND
     ILIKKSYSTH TVCAIDRSKD ENNGSAYDKF EAKGIPIDVH TLKRIISSSG MDESEFSKSI
     SYLFAKTVDP EPKDVLSLED LSFLLSKLYT QRFQIRRICR DINAKYSEFW FKLFSLYAEK
     VDAKRNQVNL RNTKLDACEI FDANLMIKNF IELGQLGKAQ KILSFILDRN PDILLSPKNA
     DISTIVHFLQ LRCGALAPYW KIPDNSEQKQ GFLRKMVRLG AKNTSIRLSS TYKAMDHQTL
     LKIADLALQE KKLLNSEDLL STLIQSFGHL GQTQILERCI EHIWQISPQE FPSHVVIKHR
     GCYPSSKILV SILVSFYFND HDLHRGLSIL DSFIKHYPDV KLDALFWRRL FQLSHFAWTP
     ANDKKATSVV RCWHLMKQWY ASKRLRPSVD YETLRQLYDI MKKTGNFPLG IDVLRSFKPG
     IERTRAENAG KVNNIIIKYQ KCIIKELVNR GRFSAVREFI DSYGFDRKMT KDLNIFCANR
     MFLRSKKMKN KIENKKEREK VRLDSFDDDE DDGMIIGSLW
>P32453 mit ATP11 PROTEIN PRECURSOR.
     MWRLTRKIGT RIHISNQLSP IFNKAIGTVP VFRFYSSSPE QKYRKKLLEE AQKQGFNSIE
     ELKNHLKETI ESKKREFNKI DPLKELEDYQ QKTQMENNNS KHLMTKSRSP LDPSAPKVPF
     KTLDSFLDVG KLKDLSKQEV EFLWRARWAQ KDNTLCAVIP VSVYDKMMAN ARNNPIFVLP
     LPRQVQSEDA KPNEEQGMEL HYIQWQFVGP QTTHCMMTSL AEYKLHQEFA RPHTTLQFHS
     DLVKDKGIVF MNGHVEPDTN VNVQDAQLLL LNVQRFYGAM GEETPVAKQR VQLLRDFSKA
     SPGFTVEKLI SLSQSMEN
>P32463 mit ACYL CARRIER PROTEIN, MITOCHONDRIAL PRECURSOR (ACP) (NADH-UBIQUINONE
     MFRSVCRISS RVAPSAYRTI MGRSVMSNTI LAQRFYSANL SKDQVSQRVI DVIKAFDKNS
     PNIANKQISS DTQFHKDLGL DSLDTVELLV AIEEEFDIEI PDKVADELRS VGETVDYIAS
     NPDAN
>P32839 mit BCS1 PROTEIN.
     MSDKPIDIQY DKQATPNLSG VITPPTNETG NDSVREKLSK LVGDAMSNNP YFAAGGGLMI
     LGTGLAVARS GIIKASRVLY RQMIVDLEIQ SKDKSYAWFL TWMAKHPQRV SRHLSVRTNY
     IQHDNGSVST KFSLVPGPGN HWIRYKGAFI LIKRERSAKM IDIANGSPFE TVTLTTLYRD
     KHLFDDILNE AKDIALKTTE GKTVIYTSFG PEWRKFGQPK AKRMLPSVIL DSGIKEGILD
     DVYDFMKNGK WYSDRGIPYR RGYLLYGPPG SGKTSFIQAL AGELDYNICI LNLSENNLTD
     DRLNHLMNNM PERSILLLED IDAAFNKRSQ TGEQGFHSSV TFSGLLNALD GVTSSEETIT
     FMTTNHPEKL DAAIMRPGRI DYKVFVGNAT PYQVEKMFMK FYPGETDICK KFVNSVKELD
     ITVSTAQLQG LFVMNKDAPH DALKMVSSLR NANHIF
>P38891 mit PROBABLE BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE PRECURSOR
     MLQRHSLKLG KFSIRTLATG APLDASKLKI TRNPNPSKPR PNEELVFGQT FTDHMLTIPW
     SAKEGWGTPH IKPYGNLSLD PSACVFHYAF ELFEGLKAYR TPQNTITMFR PDKNMARMNK
     SAARICLPTF ESEELIKLTG KLIEQDKHLV PQGNGYSLYI RPTMIGTSKG LGVGTPSEAL
     LYVITSPVGP YYKTGFKAVR LEATDYATRA WPGGVGDKKL GANYAPCILP QLQAAKRGYQ
     QNLWLFGPEK NITEVGTMNV FFVFLNKVTG KKELVTAPLD GTILEGVTRD SVLTLARDKL
     DPQEWDINER YYTITEVATR AKQGELLEAF GSGTAAVVSP IKEIGWNNED IHVPLLPGEQ
     CGALTKQVAQ WIADIQYGRV NYGNWSKTVA DLN
>P38909 mit CYTOCHROME C MITOCHONDRIAL IMPORT FACTOR CYC2.
     MKSENSLNPS EKYNFEECNV LKEPFKNRKE ETKKRKSSML WKNYVLSSSR ITRRLHKSPR
     KSSFSKNFFI TGCLLTVGAV SSYLTYRYTS ERENKHELSP SYFVKYKISH KRDIDSSHFL
     LEVTPLFKQK VNIWSLMTAE NLWSVEIKQP EVMVVRNYTP LPLKFNPASK EIEILKDGDN
     ADGKLSFYIK KYENGEVARW LHHLPKGHII EIRGPFIDYE FPHLPNELKR SRDCLYMDNR
     NERGNNVREN SQFIYQPYDI MMFTAGTGIV TALQLLLTES PFRGTIKLFH TDKNIKQLGP
     LYPILLRLQA SNRVQLKIFE TDRQTKQDVL KSIQKSITKP YPYKGLLPFS NVNNKNIMPV
     LALVCGPESY ISSISGRKYD LNQGPVGGLL SKEGWNSDNV YKLS
>Q01217 mit ARG5,6 PROTEIN PRECURSOR (CONTAINS: N-ACETYL-GAMMA-GLUTAMYL-PHOSPHATE
     MPSASLLVST KRLNASKFQK FVSSLNKSTI AGFASVPLRA PPSVAFTRKK VGYSKRYVSS
     TNGFSATRST VIQLLNNIST KREVEQYLKY FTSVSQQQFA VIKVGGAIIS DNLHELASCL
     AFLYHVGLYP IVLHGTGPQV NGRLEAQGIE PDYIDGIRIT DEHTMAVVRK CFLEQNLKLV
     TALEQLGVRA RPITSGVFTA DYLDKDKYKL VGNIKSVTKE PIEASIKAGA LPILTSLAET
     ASGQMLNVNA DVAAGELARV FEPLKIVYLN EKGGIINGST GEKISMINLD EEYDDLMKQS
     WVKYGTKLKI REIKELLDYL PRSSSVAIIN VQDLQKELFT DSGAGTMIRR GYKLVKRSSI
     GEFPSADALR KALQRDAGIS SGKESVASYL RYLENSDFVS YADEPLEAVA IVKKDTNVPT
     LDKFVCSDAA WLNNVTDNVF NVLRRDFPAL QWVVSENDAN IAWHFDKSQG SYLKGGKVLF
     WYGIDDINTI SELVENFVKS CDTASTLNSS ASSGVFANKK SARSYSTRST PRPEGVNTNP
     GRVALIGARG YTGKNLVSLI NGHPYLEVAH VSSRELKGQK LQDYTKSEII YESLQIQDIR
     KLEEQNAVDF WVMALPNKVC EPFVETIQSV HGKSKIIDLS ADHRFVSESD WAYGLPELND
     RAKIANAAKI ANPGCYATGS QLTISPLTKY INGLPTVFGV SGYSGAGTKP SPKNDPKFLN
     NNLIPYALSD HIHEREISAR IGHNVAFMPH VGQWFQGISL TVSIPIKKGS LSIDEIRKLY
     RNFYEDEKLV HVIDDIPLVK DIEGTHGVVI GGFKLNDAED RVVVCATIDN LLKGAATQCL
     QNINLAMGYG EYAGIPENKI IGV
>Q01802 mit ASPARTATE AMINOTRANSFERASE, MITOCHONDRIAL PRECURSOR (EC 2.6.1.1)
     MLRTRLTNCS LWRPYYTSSL SRVPRAPPDK VLGLSEHFKK AKNVNKIDLT VGIYKDGWGK
     VTTFPSVAKA QKLIESHLEL NKNLSYLPIT GSKEFQENVM KFLFKESCPQ FGPFYLAHDR
     ISFVQTLSGT GALAVAAKFL ALFISRDIWI PDPSWANHKN IFQNNGFENI YRYSYYKDGQ
     IDIDGWIEQL KTFAYNNQQE NNKNPPCIIL HACCHNPTGL DPTKEQWEKI IDTIYELKMV
     PIVDMAYQGL ESGNLLKDAY LLRLCLNVNK YPNWSNGIFL CQSFAKNMGL YGERVGSLSV
     ITPATANNGK FNPLQQKNSL QQNIDSQLKK IVRGMYSSPP GYGSRVVNVV LSDFKLKQQW
     FKDVDFMVQR LHHVRQEMFD RLGWPDLVNF AQQHGMFYYT RFSPKQVEIL RNNSFVYLTG
     DGRLSLSGVN DSNVDYLCES LEAVSKMDKL A
>Q04728 mit GLUTAMATE N-ACETYLTRANSFERASE PRECURSOR (EC 2.3.1.35) (ORNITHINE
     MRISSTLLQR SKQLIDKYAL YVPKTGSFPK GFEVGYTASG VKKNGSLDLG VILNTNKSRP
     STAAAVFTTN KFKAAPVLTS KKVLETARGK NINAIVVNSG CANSVTGDLG MKDAQVMIDL
     VNDKIGQKNS TLVMSTGVIG QRLQMDKIST GINKIFGEEK FGSDFNSWLN VAKSICTTDT
     FPKLVTSRFK LPSGTEYTLT GMAKGAGMIC PNMATLLGFI VTDLPIESKA LQKMLTFATT
     RSFNCISVDG DMSTNDTICM LANGAIDTKE INEDSKDFEQ VKLQVTEFAQ RLAQLVVRDG
     EGSTKFVTVN VKNALHFEDA KIIAESISNS MLVKTALYGQ DANWGRILCA IGYAKLNDLK
     SLDVNKINVS FIATDNSEPR ELKLVANGVP QLEIDETRAS EILALNDLEV SVDLGTGDQA
     AQFWTCDLSH EYVTINGDYR S
>P00927 mit THREONINE DEHYDRATASE PRECURSOR (EC 4.2.1.16) (THREONINE DEAMINASE).
     MSATLLKQPL CTVVRQGKQS KVSGLNLLRL KAHLHRQHLS PSLIKLHSEL KLDELQTDNT
     PDYVRLVLRS SVYDVINESP ISQGVGLSSR LNTNVILKRE DLLPVFSFKL RGAYNMIAKL
     DDSQRNQGVI ACSAGNHAQG VAFAAKHLKI PATIVMPVCT PSIKYQNVSR LGSQVVLYGN
     DFDEAKAECA KLAEERGLTN IPPFDHPYVI AGQGTVAMEI LRQVRTANKI GAVFVPVGGG
     GLIAGIGAYL KRVAPHIKII GVETYDAATL HNSLQRNQRT PLPVVGTFAD GTSVRMIGEE
     TFRVAQQVVD EVVLVNTDEI CAAVKDIFED TRSIVEPSGA LSVAGMKKYI STVHPEIDHT
     KNTYVPILSG ANMNFDRLRF VSERAVLGEG KEVFMLVTLP DVPGAFKKMQ KIIHPRSVTE
     FSYRYNEHRH ESSSEVPKAY IYTSFSVVDR EKEIKQVMQQ LNALGFEAVD ISDNELAKSH
     GRYLVGGASK VPNERIISFE FPERPGALTR FLGGLSDSWN LTLFHYRNHG ADIGKVLAGI
     SVPPRENLTF QKFLEDLGYT YHDETDNTVY QKFLKY
>P01097 mit ATPASE INHIBITOR, MITOCHONDRIAL PRECURSOR.
     MLPRSALARS LQLQRGVAAR FYSEGSTGTP RGSGSEDSFV KRERATEDFF VRQREKEQLR
     HLKEQLEKQR KKIDSLENKI DSMTK
>P01098 mit ATPASE STABILIZING FACTOR 9 KD, MITOCHONDRIAL PRECURSOR.
     MLNRCISRNT RLPVNLRIAS RFYSDGPLGG AGPGNPQDIF IKRERAKEDY YARQQEREQL
     AHVKEQLKEH KKKLENLENK INNLSK
>P02992 mit ELONGATION FACTOR TU, MITOCHONDRIAL PRECURSOR.
     MSALLPRLLT RTAFKASGKL LRLSSVISRT FSQTTTSYAA AFDRSKPHVN IGTIGHVDHG
     KTTLTAAITK TLAAKGGANF LDYAAIDKAP EERARGITIS TAHVEYETAK RHYSHVDCPG
     HADYIKNMIT GAAQMDGAII VVAATDGQMP QTREHLLLAR QVGVQHIVVF VNKVDTIDDP
     EMLELVEMEM RELLNEYGFD GDNAPIIMGS ALCALEGRQP EIGEQAIMKL LDAVDEYIPT
     PERDLNKPFL MPVEDIFSIS GRGTVVTGRV ERGNLKKGEE LEIVGHNSTP LKTTVTGIEM
     FRKELDSAMA GDNAGVLLRG IRRDQLKRGM VLAKPGTVKA HTKILASLYI LSKEEGGRHS
     GFGENYRPQM FIRTADVTVV MRFPKEVEDH SMQVMPGDNV EMECDLIHPT PLEVGQRFNI
     REGGRTVGTG LITRIIE
>P03874 mit CYTOCHROME B PRE-MRNA PROCESSING PROTEIN 2.
     MVNWQTLFMV SLRRQGSSSR YRYKFNMENI THQVFPRCKQ AFKKTNLSYE YCDLEGVLYN
     ISLTDLQKLL LRDINAPREH AFKIVRTDLT QKSSKKRIQH WERIAPMFDH PLSLYEKLFS
     EMDEDFKPSF EWQQLIRVRC KDDKLKLQRV IWPKSIFSNF CRGIGVKKST YDRLLEQNNG
     EVPMFVNPAN AKPLPLFQVS DEAMIGEFDG IGIFPYFVDK HREFFVTEVD KLKTKIASPL
     CTLNERKRIE KANAGRILAN EEGKPFYLDA NSATTRIAGG NVVTLKQLLE RSVSHKTLWS
     KQSNKDRTCP GDILRATILS NDFSIRQLRA EFCKNFILYN IFTILQRNKK SIRSFSGNDN
     APSFQFSWNV WDSYIWKQYQ ETESMKIPTD QASLINYKTK YDSFLHDLQT YSALVISEMK
     WNQFSIFQND ETTLSRFEHI TLILQTVLTK SKMIRIFQPN LYKFMQDDLR PTLMELVGFT
     ESINATIEPG FANEQSLQSA NGLKKLANQL LYFEQEIYGE KFRVNRPIQL RPITLSANYK
     IVILDKKNAI PEIFQTLLKF MTQITTYFVK DLSEVELHGH MHCIDKKMLD KSKFMYLYEE
     KSNEEVKAAS PQKEKIVDNI IGLLSNDEEH
>P06168 mit KETOL-ACID REDUCTOISOMERASE PRECURSOR (EC 1.1.1.86) (ACETOHYDROXY-ACID
     MLRTQAARLI CNSRVITAKR TFALATRAAA YSRPAARFVK PMITTRGLKQ INFGGTVETV
     YERADWPREK LLDYFKNDTF ALIGYGSQGY GQGLNLRDNG LNVIIGVRKD GASWKAAIED
     GWVPGKNLFT VEDAIKRGSY VMNLLSDAAQ SETWPAIKPL LTKGKTLYFS HGFSPVFKDL
     THVEPPKDLD VILVAPKGSG RTVRSLFKEG RGINSSYAVW NDVTGKAHEK AQALAVAIGS
     GYVYQTTFER EVNSDLYGER GCLMGGIHGM FLAQYDVLRE NGHSPSEAFN ETVEEATQSL
     YPLIGKYGMD YMYDACSTTA RRGALDWYPI FKNALKPVFQ DLYESTKNGT ETKRSLEFNS
     QPDYREKLEK ELDTIRNMEI WKVGKEVRKL RPENQ
>P07271 mit MITOCHONDRIAL DNA REPAIR AND RECOMBINATION PROTEIN PIF1 PRECURSOR.
     MPKWIRSTLN HIIPRRPFIC SFNSFLLLKN VSHAKLSFSM SSRGFRSNNF IQAQLKHPSI
     LSKEDLDLLS DSDDWEEPDC IQLETEKQEK KIITDIHKED PVDKKPMRDK NVMNFINKDS
     PLSWNDMFKP SIIQPPQLIS ENSFDQSSQK KSRSTGFKNP LRPALKKESS FDELQNNSIS
     QERSLEMINE NEKKKMQFGE KIAVLTQRPS FTELQNDQDD SNLNPHNGVK VKIPICLSKE
     QESIIKLAEN GHNIFYTGSA GTGKSILLRE MIKVLKGIYG RENVAVTAST GLAACNIGGI
     TIHSFAGILG KGDADKLYKK VGRRSRKHLR RWENIGALVV DEISMLDAEL LDKLDFIARK
     IRKNHQPFGG IQLIFCGDFF QLPPVSKDPN RPTKFAFESK AWKEGVKMTI MLQKVFRQRG
     DVKFIEMLNR MRLGNIDDET EREFKKLSRP LPDDEIIPAE LYSTRMEVER ANNSRLSKLP
     GQVHIFNAID GGALEDEELK ERLLQNFLAP KELHLKVGAQ VMMVKNLDAT LVNGSLGKVI
     EFMDPETYFC YEALTNDPSM PPEKLETWAE NPSKLKAAME REQSDGEESA VASRKSSVKE
     GFAKSDIGEP VSPLDSSVFD FMKRVKTDDE VVLENIKRKE QLMQTIHQNS AGKRRLPLVR
     FKASDMSTRM VLVEPEDWAI EDENEKPLVS RVQLPLMLAW SLSIHKSQGQ TLPKVKVDLR
     RVFEKGQAYV ALSRAVSREG LQVLNFDRTR IKAHQKVIDF YLTLSSAESA YKQLEADEQV
     KKRKLDYAPG PKYKAKSKSN SPAPISATTQ SNNGIAAMLQ RHSRKRFQLK KESNSNQVHS
     LVSDEPRGQD TEDHILE
>P07342 mit ACETOLACTATE SYNTHASE PRECURSOR (EC 4.1.3.18) (ACETOHYDROXY-ACID
     MIRQSTLKNF AIKRCFQHIA YRNTPAMRSV ALAQRFYSSS SRYYSASPLP ASKRPEPAPS
     FNVDPLEQPA EPSKLAKKLR AEPDMDTSFV GLTGGQIFNE MMSRQNVDTV FGYPGGAILP
     VYDAIHNSDK FNFVLPKHEQ GAGHMAEGYA RASGKPGVVL VTSGPGATNV VTPMADAFAD
     GIPMVVFTGQ VPTSAIGTDA FQEADVVGIS RSCTKWNVMV KSVEELPLRI NEAFEIATSG
     RPGPVLVDLP KDVTAAILRN PIPTKTTLPS NALNQLTSRA QDEFVMQSIN KAADLINLAK
     KPVLYVGAGI LNHADGPRLL KELSDRAQIP VTTTLQGLGS FDQEDPKSLD MLGMHGCATA
     NLAVQNADLI IAVGARFDDR VTGNISKFAP EARRAAAEGR GGIIHFEVSP KNINKVVQTQ
     IAVEGDATTN LGKMMSKIFP VKERSEWFAQ INKWKKEYPY AYMEETPGSK IKPQTVIKKL
     SKVANDTGRH VIVTTGVGQH QMWAAQHWTW RNPHTFITSG GLGTMGYGLP AAIGAQVAKP
     ESLVIDIDGD ASFNMTLTEL SSAVQAGTPV KILILNNEEQ GMVTQWQSLF YEHRYSHTHQ
     LNPDFIKLAE AMGLKGLRVK KQEELDAKLK EFVSTKGPVL LEVEVDKKVP VLPMVAGGSG
     LDEFINFDPE VERQQTELRH KRTGGKH
>P10662 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN MRP1.
     MLRFTGARAI RKYSTRYALE HLKEGAPLKG LFSIEGLQKA WFDRVKYLDA KLNDCTNEAQ
     QKPLETLIHE NSKSASKKHI VNYASSLYNL KFSMSSLQGC IRTPPEECPR LGPEALLQTP
     DFNRTISNEP LTTGNERLQA ALISSFGSLM EFRTLLINSN LAISGDGFTW LVARRQLDKR
     AMRNDMPNRD IEYDKLFILN TYNAGTPFNF STSGVMNELN NQYTNMEKQR AKEAGNLEDS
     EMTAKQAKTK FIYETQQKGF SGKEVSYIPL LAIDASPKTW LTDYGVFGKR EYLERVWDSI
     EWKIVESRLP QRTKIQAFNT L
>P10663 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN MRP2.
     MGNFRFPIKT KLPPGFINAR ILRDNFKRQQ FKENEILVKS LKFIARNMNL PTKLRLEAQL
     KLNALPNYMR STQIKNRCVD SGHARFVLSD FRLCRYQFRE NALKGNLPGV KKGIW
>P12686 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN S13 PRECURSOR.
     MGTITVVINE GPILLIRALH RATTNKKMFR STVWRRFAST GEIAKAKLDE FLIYHKTDAK
     LKPFIYRPKN AQILLTKDIR DPKTREPLQP RPPVKPLSKQ TLNDFIYSVE PNSTELLDWF
     KEWTGTSIRK RAIWTYISPI HVQKMLTASF FKIGKYAHMV GLLYGIEHKF LKAQNPSVFD
     IEHFFNTNIM CALHRNRLKD YKDAEIAQRK LQVAWKKVLN RKNNTGLANI LVATLGRQIG
     FTPELTGLQP VDISLPDIPN SSSGAELKDL LSKYEGIYLI ARTLLDIDQH NAQYLELQEF
     IRQYQNALSE SSDPYDTHLK ALGLLETPPP QESTEKEEK
>P12687 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L2 PRECURSOR (YML2) (YMR6).
     MWNPILLDTS SFSFQKHVSG VFLQVRNATK RAAGSRTSMK DSAGRRLGPK KYEGQDVSTG
     EIIMRQRGTK FYPGENVGIG KDHSIFALEP GVVRYYLDPF HPKRKFIGVA LRRDLKLPSP
     HFEPTVRRFG RFELTNKRAA YKEENSISRK DYLAKPNILK QLEVRESKRK ELQDKLSKVL
     RDELKLDIKD IELATSYLIR VRASLKNGYP IEDARFNSRY YLKEEERLKA RRESWTNEKL
     SESLSKIDEC SDLLNSSTSF NNKLELHQYI SEQEKQALKA KLLEDLEKSQ HLETKKDKNY
     IKALFKDACN FLTLSEEVHL RRKYLKSVFP ETDSTVETKS GKKSIVSRRF DYTKNKVEVI
     ARSRRAFLSK L
>P13433 mit DNA-DIRECTED RNA POLYMERASE MITOCHONDRIAL PRECURSOR (EC 2.7.7.6).
     MLRPAYKSLV KTSLLQRRLI SSKGSKLFKP SPDSTSTILI SEDPLVTGSS PTSSTTSGII
     SSNDFPLFNK NRKDAKSSIS YQWKNPSELE FDPFNKSHAS AVTSMTRTRD VMQLWSLLEA
     CLQSNLMKRA FSILESLYLV PEHKQRFIED YNMYLNSFSK NDPNFPILKM NEKLTNDLET
     SFKDVNYNDK TLAIMIHHAL NFHSTTSSML LKPIISAYLK MSVNGIREIF SCLDILTISD
     LNILMNDLKV ITPSQLPNSV RPILESLTLS PTPVNNIENE EGLNKVEAEN DSKLHKASNA
     SSDSIKKPSL DPLREVSFHG STEVLSKDAE KLIAVDTIGM RVIRHTLLGL SLTPEQKEQI
     SKFKFDANDN VLKMKPTKND DNNNSINFFE IYNSLPTLEE KKAFESALNI FNQDRQKVLE
     NRATEAARER WKHDFEEAKA RGDISIEKNL NVKLWKWYNE MLPLVKEEIN HCRSLLSEKL
     SDKKSLNKVD TNRLGYGPYL TLIDPGKMCV ITILELLKLN STGGVIEGMR TARAVISVGK
     AIEMEFRSEQ VLKSESQAFR DVNKKSPEFK KLVQNAKSVF RSSQIEQSKI LWPQSIRARI
     GSVLISMLIQ VAKVSVQGVD PVTKAKVHGE APAFAHGYQY HNGSKLGVLK IHKTLIRQLN
     GERLIASVQP QLLPMLVEPK PWVNWRSGGY HYTQSTLLRT KDSPEQVAYL KAASDNGDID
     RVYDGLNVLG RTPWTVNRKV FDVVSQVWNK GEGFLDIPGA QDEMVLPPAP PKNSDPSILR
     AWKLQVKTIA NKFSSDRSNR CDTNYKLEIA RAFLGEKLYF PHNLDFRGRA YPLSPHFNHL
     GNDMSRGLLI FWHGKKLGPS GLKWLKIHLS NLFGFDKLPL KDRVAFTESH LQDIKDSAEK
     SLTGDRWWTT ADKPWQALAT CFELNEVMKM DNPEEFISHQ PVHQDGTCNG LQHYAALGGD
     VEGATQVNLV PSDKPQDVYA HVARLVQKRL EIAAEKGDEN AKILKDKITR KVVKQTVMTN
     VYGVTYVGAT FQIAKQLSPI FDDRKESLDF SKYLTKHVFS AIRELFHSAH LIQDWLGESA
     KRISKSIRLD VDEKSFKNGN KPDFMSSVIW TTPLGLPIVQ PYREESKKQV ETNLQTVFIS
     DPFAVNPVNA RRQKAGLPPN FIHSLDASHM LLSAAECGKQ GLDFASVHDS YWTHASDIDT
     MNVVLREQFI KLHEVDLVLR LKEEFDQRYK NYVKIGKLKR STDLAQKIIR IRKDLSRKLG
     RSTTLADEIY FEKKRQELLN SPLIEDRNVG EKMVTTVSLF EDITDLDALE LENGGDENSG
     MSVLLPLRLP EIPPKGDFDV TVLRNSQYFF S
>P14063 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L31 PRECURSOR (YML31).
     MFGPFKLTSP VAGGLLWKIP WRMSTHQKTR QRERLRNVDQ VIKQLTLGLH VQRCQDKGLT
     YQEAMESKKK YKPRSKSLRL LNKPSVFPKE NQMSSKDKYW TFDKKAVGYR KGIHKVPKWT
     KISIRKAPKF F
>P14066 mit CYTOCHROME B TRANSLATIONAL ACTIVATOR PROTEIN CBS1 PRECURSOR.
     MNLDMLRTKV FATTVARISG IRRYIPIRTI NTVTKKNISK IEKLCEVLEV NPDGYKGKER
     IPTKELTKLL YTTSRNMLVR VPMTGDLSTG NTFETRNETL QKLGEQLIHL EINKMLTITF
     TNFNQFNIMN KNFNYIHNLD RARVVNMDSI SWLIKNSLKI NQLAHLRIPA NLPKEMGLTS
     SSNDFQNLND WKVILSFIGY LKLLEIKNDN KKFIESIIKT ICIPLINYHL RKS
>P14905 mit CYTOCHROME B TRANSLATIONAL ACTIVATOR PROTEIN CBS2.
     MSSSIPRVYS LGNSAMTYLL ALRIAQLPSQ PKVPSVVLLL NDQKKLNRFL NNDSKIIVKS
     SNNNKETYHR QFMASCVPPI LSNGEIAPIE NLIVSDPSSK FITAQLSKYN KSLRPETNIL
     FLNPSLNLLE HLHRYRWRFD EARPNLFMGF TTPVDVGTIH QEFQLSLKVK GRIQFHIAKI
     DGFPRMSSTG KSASLSLRGD RQKNEKENNA FYKLFREISR LRSGIGSDLV SFDLHVHGFQ
     DLFFTELEKL ILESCTEPLL AVYDCVYKKE LLKIPGAQDI IKKLISEQLS IIDRSYPSLN
     TNPNYSVIFD KERIFSLVMR DLEVNGHKRA KLAQSLNQLN QTNINELNGF FVSLGKYKKC
     NCKWNDILLT LIKGKQFITK QKALDYHYL
>P14908 mit MITOCHONDRIAL REPLICATION PROTEIN MTF1 (RF1023) (MITOCHONDRIAL
     SVPIPGIKDI SKLKFFYGFK YLWNPTVYNK IFDKLDLTKT YKHPEELKVL DLYPGVGIQS
     AIFYNKYCPR QYSLLEKRSS LYKFLNAKFE GSPLQILKRD PYDWSTYSNL IDEERIFVPE
     VQSSDHINDK FLTVANVTGE GSEGLIMQWL SCIGNKNWLY RFGKVKMLLW MPSTTARKLL
     ARPGMHSRSK CSVVREAFTD TKLIAISDAN ELKGFDSQCI EEWDPILFSA AEIWPTKGKP
     IALVEMDPID FDFDVDNWDY VTRHLMILKR TPLNTVMDSL GHGGQQYFNS RITDKDLLKK
     CPIDLTNDEF IYLTKLFMEW PFKPDILMDF VDMYQTEHSG
>P16965 mit ATPASE STABILIZING FACTOR 15 KD PROTEIN.
     TRTNKWTERE GKADPKYFSH TGNYGESPNH IKKQGSGKGN WGKPGDEIDD LIDNGEIPPV
     FKKDRRGSNL QSHEQKFENV QKE
>P17558 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN PET123 PRECURSOR.
     MGKGAAKYGF KSGVFPTTRS ILKSPTTKQT DIINKVKSPK PKGVLGIGYA KGVKHPKGSH
     RLSPKVNFID VDNLIAKTVA EPQSIKSSNG SAQKVRLQKA ELRRKFLIEA FRKEEARLLH
     KHEYLQKRTK ELEKAKELEL EKLNKEKSSD LTIMTLDKMM SQPLLRNRSP EESELLKLKR
     NYNRSLLNFQ AHKKKLNELL NLYHVANEFI VTESQLLKKI DKVFNDETEE FTDAYDVTSN
     FTQFGNRKLL LSGNTTLQTQ INNAIMGSLS NEKFFDISLV DSYLNKDLKN ISNKIDSKLN
     PTSNGAGNNG NNNNTTNL
>P19262 mit DIHYDROLIPOAMIDE SUCCINYLTRANSFERASE COMPONENT (E2) OF 2-OXOGLUTARATE
     MLSRATRTAA AKSLVKSKVA RNVMAASFVK RHASTSLFKQ ANKVESLGSI YLSGKKISVA
     ANPFSITSNR FKSTSIEVPP MAESLTEGSL KEYTKNVGDF IKEDELLATI ETDKIDIEVN
     SPVSGTVTKL NFKPEDTVTV GEELAQVEPG EAPAEGSGES KPEPTEQAEP SQGVAARENS
     SEETASKKEA APKKEAAPKK EVTEPKKADQ PKKTVSKAQE PPVASNSFTP FPRTETRVKM
     NRMRLRIAER LKESQNTAAS LTTFNEVDMS ALMEMRKLYK DEIIKKTGTK FGFMGLFSKA
     CTLAAKDIPA VNGAIEGDQI VYRDYTDISV AVATPKGLVT PVVRNAESLS VLDIENEIVR
     LSHKARDGKL TLEDMTGGTF TISNGGVFGS LYGTPIINSP QTAVLGLHGV KERPVTVNGQ
     IVSRPMMYLA LTYDHRLLDG REAVTFLKTV KELIEDPRKM LLW
>P19882 mit HEAT SHOCK PROTEIN 60 PRECURSOR (STIMULATOR FACTOR I 66 KD COMPONENT)
     MLRSSVVRSR ATLRPLLRRA YSSHKELKFG VEGRASLLKG VETLAEAVAA TLGPKGRNVL
     IEQPFGPPKI TKDGVTVAKS IVLKDKFENM GAKLLQEVAS KTNEAAGDGT TSATVLGRAI
     FTESVKNVAA GCNPMDLRRG SQVAVEKVIE FLSANKKEIT TSEEIAQVAT ISANGDSHVG
     KLLASAMEKV GKEGVITIRE GRTLEDELEV TEGMRFDRGF ISPYFITDPK SSKVEFEKPL
     LLLSEKKISS IQDILPALEI SNQSRRPLLI IAEDVDGEAL AACILNKLRG QVKVCAVKAP
     GFGDNRKNTI GDIAVLTGGT VFTEELDLKP EQCTIENLGS CDSITVTKED TVILNGSGPK
     EAIQERIEQI KGSIDITTTN SYEKEKLQER LAKLSGGVAV IRVGGASEVE VGEKKDRYDD
     ALNATRAAVE EGILPGGGTA LVKASRVLDE VVVDNFDQKL GVDIIRKAIT RPAKQIIENA
     GEEGSVIIGK LIDEYGDDFA KGYDASKSEY TDMLATGIID PFKVVRSGLV DASGVASLLA
     TTEVAIVDAP EPPAAAGAGG MPGGMPGMPG MM
>P19955 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN YMR-31 PRECURSOR.
     MIATPIRLAK SAYEPMIKFV GTRHPLVKHA TEVVVHPCAT NGMLPGSKEC IPVSKFMENY
     KPFRVVPIKH SANAGLSSSK TSVFVNRPLQ KDELASIFEL PARFRYKPIN EHELESINSG
     GAW
>P19956 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L44 (YML44).
     MITKYFSKVI VRFNPFGKEA KVARLVLAAI PPTQRNMGTQ IQSEIISDYN KVKPLVKVTY
     KDKKEMEVDP SNMNFQELAN HFDRHSKQLD LKHMLEMH
>P20084 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L33 (YML33).
     VFYKVTLSRS LIGVPHTTKS IVKSLGLGKR GSIVYKKVNP AIAGSLAKVK ELVKVEVTEH
     ELTPSQQREL RKSNPGFIVE KRTID
>P21771 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN S28 PRECURSOR.
     MSIVGRNAIL NLRISLCPLF MGKRSFVSSP VSNSAKAVKF LKAQRRKQKN EAKQATLKAS
     TDKVDPVLGR ADTPFITRIM AELKEPLVLS KGYNIEEVDK FLAAIESAKR ERAELSGLNT
     EVVGIEDIEK LEDRREAILR ILSMRNSENK NAIKMAVELA RKEFERFPGD TGSSEVQAAC
     MTVRIQNMAN HIKEHRKDFA NTRNLRILVQ QRQAILRYLK RDNPEKYYWT IQKLGLNDAA
     ITDEFNMDRR YMQDYEFFGD KILIRDSKKV ANQKRKEIRK QKRATF
>P21954 mit ISOCITRATE DEHYDROGENASE (NADP), MITOCHONDRIAL PRECURSOR (EC 1.1.1.42)
     MSMLSRRLFS TSRLAAFSKI KVKQPVVELD GDEMTRIIWD KIKKKLILPY LDVDLKYYDL
     SVESRDATSD KITQDAAEAI KKYGVGIKCA TITPDEARVK EFNLHKMWKS PNGTIRNILG
     GTVFREPIVI PRIPRLVPRW EKPIIIGRHA HGDQYKATDT LIPGPGSLEL VYKPSDPTTA
     QPQTLKVYDY KGSGVAMAMY NTDESIEGFA HSSFKLAIDK KLNLFLSTKN TILKKYDGRF
     KDIFQEVYEA QYKSKFEQLG IHYEHRLIDD MVAQMIKSKG GFIMALKNYD GDVQSDIVAQ
     GFGSLGLMTS ILVTPDGKTF ESEAAHGTVT RHYRKYQKGE ETSTNSIASI FAWSRGLLKR
     GELDNTPALC KFANILESAT LNTVQQDGIM TKDLALACGN NERSAYVTTE EFLDAVEKRL
     QKEIKSIE
>P22353 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L8 (YML8).
     MTVGIARKLS RDKAHRDALL KNLACQLFQH ESIVSTHAKC KEASRVAERI ITWTKRAITT
     SNSVAQAELK SQIQSQLFLA GDNRKLMKRL FSEIAPRYLE RPGGYTRVLR LEPRANDSAP
     QSVLELVDSP VMSESHTVNR GNLKMWLLVK SVINDDANQL PHNPLTLQNL HKVAKFKAEA
     QLHGEIMLIK QVLLKEMSLP YDEALENERT QALLKEVYSS SLPKKTKKPS SYVMVPRP
>P22354 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L20 PRECURSOR (YML20).
     MIGRGVCCRS FHTAGSAWKQ FGFPKTQVTT IYNKTKSASN YKGYLKHRDA PGMYYQPSES
     IATGSVNSET IPRSFMAASD PRRGLDMPVQ STKAKQCPNV LVGKSTVNGK TYHLGPQEID
     EIRKLRLDNP QKYTRKFLAA KYGISPLFVS MVSKPSEQHV QIMESRLQEI QSRWKEKRRI
     AREDRKRRKL LWYQA
>P23369 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L25 (YML25).
     SYKQYFDSLP LKLKSFFQRY PPSIKYSPVS TSTKAINANP FLPNKHPVTQ RFHDPKYSLR
     RMSDVYKLAL RYGVEEFLPP IENTKKLFFE EKYNKKTLMK GVLLPKGHKH ELKLNEKLKK
     REEALKKVDE LIASKKGSKY AKRVEKMKKN QSIGWF
>P25038 mit TRANSLATION INITIATION FACTOR IF-2, MITOCHONDRIAL PRECURSOR (IF-2MT).
     MLRRHGLFWL KTCPRLNVLL NQSIPIPHLL HSRDICQQRW YAKGKRRNQI SKKELKPLNF
     SIPNYISVNK LANLLNCRVE RLIKDLTALG FENITTTYIL SKEYVELILQ EYNFALPNLS
     TSTNLDNVYD ELKSPVNPKL LTKRAPVVTI MGHVDHGKTT IIDYLRKSSV VAQEHGGITQ
     HIGAFQITAP KSGKKITFLD TPGHAAFLKM RERGANITDI IVLVVSVEDS LMPQTLEAIK
     HAKNSGNEMI IAITKIDRIP QPKEREKKIE KVINDLIVQG IPVEKIGGDV QVIPISAKTG
     ENMDLLEESI VLLSEVMDIR AENSPKTIAE GWIIESQVKK QVGNVATVLV KKGTLQKGKI
     LICGNTFCKI KNLIDDKGIP ILKATPSYAT EVLGWKDVPH VGDEVIQVKS EAIAKKFISK
     RQDLIEVQKN SSIVEKLNEE RALAKEQHLN KELEHENTVQ EHEQNTGPKL INYIIKCDVS
     GSAEAVSESI SSLGNDEVRC NVISSSVGIP TESDLKMAQI TESTILCFNL GNLPSEVINN
     RAGIKIKQYN VIYKLIEDVT ETLTENLKPI FEKKIVSTVD VRETFDFRLK KKIIRIAGCK
     VNNGVIKKNS LVQVVRGPNE DVIFDGKIST LKHNKDDVAE VSKGHECGIT FESGFEGFKP
     GDKILVYENV RVPRYL
>P25039 mit ELONGATION FACTOR G, MITOCHONDRIAL 1 PRECURSOR (MEF-G-1).
     MSVQKMMWVP RKMVGGRIPF FTCSKVFSGF SRRSFHESPL ARSTYEEEKV LVDEIKQKLT
     PDDIGICNKL RNIGISAHID SGKTTFTERV LYYTKRIKAI HEVRGRDNVG AKMDSMDLER
     EKGITIQSAA TYCSWDKEGK NYHFNLIDTP GHIDFTIEVE RALRVLDGAV LVVCAVSGVQ
     SQTVTVDRQM RRYNVPRVTF INKMDRMGSD PFRAIEQLNS KLKIPAAAVQ IPVGSESSLS
     GVVDLINRVA IYNKGDNGEI IEKGPVPENL KPLMEEKRQL LIETLADVDD EMAEMFLEEK
     EPTTQQIKDA IRRSTIARSF TPVLMGSALA NTGIQPVLDA IVDYLPNPSE VLNTALDVSN
     NEAKVNLVPA VQQPFVGLAF KLEEGKYGQL TYVRVYQGRL RKGNYITNVK TGKKVKVARL
     VRMHSSEMED VDEVGSGEIC ATFGIDCASG DTFTDGSVQY SMSSMYVPDA VVSLSITSNS
     KDASNFSKAL NRFQKEDPTF RVKFDPESKE TIISGMGELH LEIYVERMRR EYNVDCVTGK
     PQVSYRESIT IPADFDYTHK KQSGGAGQYG RVIGTLSPVD DITKGNIFET AIVGGRIPDK
     YLAACGKGFE EVCEKGPLIG HRVLDVKMPI NDGAIHAVDS NELSFKTATM SAFRDAFLRA
     QPVIMEPIMN VSVTSPNEFQ GNVIGLLNKL QAVIQDTENG HDEFTLKAEC ALSTMFGFAT
     SLRASTQGKG EFSLEFSHYA PTAPHVQKEL ISEFQKKQAK K
>P25270 mit RIBOSE METHYLTRANSFERASE PET56 (EC 2.1.1.-) (MITOCHONDRIAL LARGE
     MTSLTNAVFK RYLAVTPSAH QALKTRIKKK SSSFDKFFPQ QSNSRKKQWE TLNEDKASWF
     KRKYAHVHAR EQDRAADPYG KKKAHVEKLK EIKNQAKLNQ KSHKSKFQNK DIALKLMNDN
     PIFEYVYGTN SVYAALLNPS RNCHSRLLYH GTIPSKFLQI VDELKVTTEL VDKHRLNLLT
     NYGVHNNIAL ETKPLQPVEI AYLGDMDTSS AALSIHELGF NNENIPHELP YGTKTDAKKF
     PLGLYLDEIT DPHNIGAIIR SAYFLGVDFI VMSRRNCSPL TPVVSKTSSG ALELLPIFYV
     DKPLEFFTKS QEMGGWTFIT SHLANATSEK YTVGKTISMH DLNGLCNELP VVLVVGNESQ
     GVRTNLKMRS DFFVEIPFGG IEKGNRAPEP IVDSLNVSVA TALLIDNILT CK
>P25348 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L32 PRECURSOR (YML32).
     MNSLIFGKQL AFHKIVPTTA IGWLVPLGNP SLQIPGQKQL GSIHRWLREK LQQDHKDTED
     KDFFSNNGIL LAVPKKKVSH QKKRQKLYGP GKKQLKMIHH LNKCPSCGHY KRANTLCMYC
     VGQISHIWKT HTAKEEIKPR QEEELSELDQ RVLYPGRRDT KYTKDLKDKD NYLERRVRTL
     KKD
>P25605 mit ACETOLACTATE SYNTHASE SMALL SUBUNIT PRECURSOR (EC 4.1.3.18) (AHAS)
     MLRSLLQSGH RRVVASSCAT MVRCSSSSTS ALAYKQMHRH ATRPPLPTLD TPSWNANSAV
     SSIIYETPAP SRQPRKQHVL NCLVQNEPGV LSRVSGTLAA RGFNIDSLVV CNTEVKDLSR
     MTIVLQGQDG VVEQARRQIE DLVPVYAVLD YTNSEIIKRE LVMARISLLG TEYFEDLLLH
     HHTSTNAGAA DSQELVAEIR EKQFHPANLP ASEVLRLKHE HLNDITNLTN NFGGRVVDIS
     ETSCIVELSA KPTRISAFLK LVEPFGVLEC ARSGMMALPR TPLKTSTEEA ADEDEKISEM
     VDISQLPPG
>P26364 mit ADENYLATE KINASE 2 (EC 2.7.4.3) (ATP-AMP TRANSPHOSPHORYLASE).
     MKADAKQITH LLKPLRLLLL GAPGSGKGTQ TSRLLKQIPQ LSSISSGDIL RQEIKSESTL
     GREATTYIAQ GKLLPDDLIT RLITFRLSAL GWLKPSAMWL LDGFPRTTAQ ASALDELLKQ
     HDASLNLVVE LDVPESTILE RIENRYVHVP SGRVYNLQYN PPKVPGLDDI TGEPLTKRLD
     DTAEVFKKRL EEYKKTNEPL KDYYKKSGIF GTVSGETSDI IFRNY
>P27882 mit ERV1 PROTEIN PRECURSOR (14 KD REGULATORY PROTEIN).
     MKAIDKMTDN PPQEGLSGRK IIYDEDGKPC RSCNTLLDFQ YVTGKISNGL KNLSSNGKLA
     GTGALTGEAS ELMPGSRTYR KVDPPDVEQL GRSSWTLLHS VAASYPAQPT DQQKGEMKQF
     LNIFSHIYPC NWCAKDFEKY IRENAPQVES REELGRWMCE AHNKVNKKLR KPKFDCNFWE
     KRWKDGWDE
>P28239 mit INORGANIC PYROPHOSPHATASE, MITOCHONDRIAL PRECURSOR (EC 3.6.1.1)
     MNLLRMNALT SKARSIERLK QTLNILSIRN HRQFSTIQQG SKYTLGFKKY LTLLNGEVGS
     FFHDVPLDLN EHEKTVNMIV EVPRWTTGKF EISKELRFNP IVQDTKNGKL RFVNNIFPYH
     GYIHNYGAIP QTWEDPTIEH KLGKCDVALK GDNDPLDCCE IGSDVLEMGS IKKVKVLGSL
     ALIDDGELDW KVIVIDVNDP LSSKIDDLEK IEEYFPGILD TTREWFRKYK VPAGKPLNSF
     AFHEQYQNSN KTIQTIKKCH NSWKNLISGS LQEKYDNLPN TERAGNGVTL EDSVKPPSQI
     PPEVQKWYYV
>P28241 mit ISOCITRATE DEHYDROGENASE (NAD), MITOCHONDRIAL SUBUNIT 2 PRECURSOR
     MLRNTFFRNT SRRFLATVKQ PSIGRYTGKP NPSTGKYTVS FIEGDGIGPE ISKSVKKIFS
     AANVPIEWES CDVSPIFVNG LTTIPDPAVQ SITKNLVALK GPLATPIGKG HRSLNLTLRK
     TFGLFANVRP AKSIEGFKTT YENVDLVLIR ENTEGEYSGI EHIVCPGVVQ SIKLITRDAS
     ERVIRYAFEY ARAIGRPRVI VVHKSTIQRL ADGLFVNVAK ELSKEYPDLT LETELIDNSV
     LKVVTNPSAY TDAVSVCPNL YGDILSDLNS GLSAGSLGLT PSANIGHKIS IFEAVHGSAP
     DIAGQDKANP TALLLSSVMM LNHMGLTNHA DQIQNAVLST IASGPENRTG DLAGTATTSS
     FTEAVIKRL
>P28778 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN MRP17.
     MLYELIGLVR ITNSNAPKLE AKELSSTIGK LIIQNRGVVR DIVPMGIRYL PKIMKKDQEK
     HFRAYHFLML FDSSAAVQSE ILRTLKKDPR VIRSSIVKVD LDKQLDRASS LHRSLGKKSI
     LELVNEDYQS I
>P28834 mit ISOCITRATE DEHYDROGENASE (NAD), MITOCHONDRIAL SUBUNIT 1 PRECURSOR
     MLNRTIAKRT LATAAQAERT LPKKYGGRFT VTLIPGDGVG KEITDSVRTI FEAENIPIDW
     ETINIKQTDH KEGVYEAVES LKRNKIGLKG LWHTPADQTG HGSLNVALRK QLDIYANVAL
     FKSLKGVKTR IPDIDLIVIR ENTEGEFSGL EHESVPGVVE SLKVMTRPKT ERIARFAFDF
     AKKYNRKSVT AVHKANIMKL GDGLFRNIIT EIGQKEYPDI DVSSIIVDNA SMQAVAKPHQ
     FDVLVTPSMY GTILGNIGAA LIGGPGLVAG ANFGRDYAVF EPGSRHVGLD IKGQNVANPT
     AMILSSTLML NHLGLNEYAT RISKAVHETI AEGKHTTRDI GGSSSTTDFT NEIINKLSTM
>P30775 mit MITOCHONDRIAL PEPTIDE CHAIN RELEASE FACTOR 1 PRECURSOR (MRF-1).
     MWLSKFQFPS RSIFKGVFLG HKLPLLVRLT STTTNSKSNG SIPTQYTELS PLLVKQAEKY
     EAELKDLDKD LSCGIHFDVN KQKHYAKLSA LTDTFIEYKE KLNELKSLQE MIVSDPSLRA
     EAEQEYAELV PQYETTSSRL VNKLLPPHPF ADKPSLLELR PGVGGIEAMI FTQNLLDMYI
     GYANYRKWKY RIISKNENES GSGIIDAILS IEEAGSYDRL RFEAGVHRVQ RIPSTETKGR
     THTSTAAVVV LPQIGDESAK SIDAYERTFK PGEIRVDIMR ASGKGGQHVN TTDSAVRLTH
     IPSGIVVSMQ DERSQHKNKA KAFTILRARL AEKERLEKEE KERKARKSQV SSTNRSDKIR
     TYNFPQNRIT DHRCGFTLLD LPGVLSGERL DEVIEAMSKY DSTERAKELL ESN
>P31334 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L9 PRECURSOR (YML9).
     MSKFLQGSIF SISKLHVRYS STRPFLVAPS IANSITTEAP AINHSPELAN ARKWLPKRCG
     LITRKKGMMP YFDKSTGERS AATILEVNNV EVIMHRTSEV NGYFACQVGY GSRHLSKVSR
     QMLGHFASKV VNPKEHVAEF RVKDEKGLIP PGTLLKPSFF KEGQYVDVRS VSKGKGFTGV
     MKRYGFKGLR ASHGTSIMHR HGGSYGQNQD PGRVLPGRKM PGHMGNEHVT IQNVKVLKVD
     DENNVIWVKG SVAGPKNSFV KIQDAIKKT
>P32191 mit GLYCEROL-3-PHOSPHATE DEHYDROGENASE MITOCHONDRIAL PRECURSOR
     MFSVTRRRAA GAAAAMATAT GTLYWMTSQG DRPLVHNDPS YMVQFPTAAP PQVSRRDLLD
     RLAKTHQFDV LIIGGGATGT GCALDAATRG LNVALVEKGD FASGTSSKST KMIHGGVRYL
     EKAFWEFSKA QLDLVIEALN ERKHLINTAP HLCTVLPILI PIYSTWQVPY IYMGCKFYDF
     FAGSQNLKKS YLLSKSATVE KAPMLTTDNL KASLVYHDGS FNDSRLNATL AITAVENGAT
     VLNYVEVQKL IKDPTSGKVI GAEARDVETN ELVRINAKCV VNATGPYSDA ILQMDRNPSG
     LPDSPLNDNS KIKSTFNQIA VMDPKMVIPS IGVHIVLPSF YCPKDMGLLD VRTSDGRVMF
     FLPWQGKVLA GTTDIPLKQV PENPMPTEAD IQDILKELQH YIEFPVKRED VLSAWAGVRP
     LVRDPRTIPA DGKKGSATQG VVRSHFLFTS DNGLITIAGG KWTTYRQMAE ETVDKVVEVG
     GFHNLKPCHT RDIKLAGAEE WTQNYVALLA QNYHLSSKMS NYLVQNYGTR SSIICEFFKE
     SMENKLPLSL ADKENNVIYS SEENNLVNFD TFRYPFTIGE LKYSMQYEYC RTPLDFLLRR
     TRFAFLDAKE ALNAVHATVK VMGDEFNWSE KKRQWELEKT VNFIKTFGV
>P32266 mit MGM1 PROTEIN PRECURSOR.
     MSNSTSLRAI PRVANYNTLV RMNASPVRLL ILRRQLATHP AILYSSPYIK SPLVHLHSRM
     SNVHRSAHAN ALSFVITRRS ISHFPKIISK IIRLPIYVGG GMAAAGSYIA YKMEEASSFT
     KDKLDRIKDL GESMKEKFNK MFSGDKSQDG GHGNDGTVPT ATLIAATSLD DDESKRQGDP
     KDDDDEDDDD EDDENDSVDT TQDEMLNLTK QMIEIRTILN KVDSSSAHLT LPSIVVIGSQ
     SSGKSSVLES IVGREFLPKG SNMVTRRPIE LTLVNTPNSN NVTADFPSMR LYNIKDFKEV
     KRMLMELNMA VPTSEAVSEE PIQLTIKSSR VPDLSLVDLP GYIQVEAADQ PIELKTKIRD
     LCEKYLTAPN IILAISAADV DLANSSALKA SKAADPKGLR TIGVITKLDL VDPEKARSIL
     NNKKYPLSMG YVGVITKTPS SINRKHLGLF GEAPSSSLSG IFSKGQHGQS SGEENTNGLK
     QIVSHQFEKA YFKENKKYFT NCQVSTKKLR EKLIKILEIS MSNALEPTST LIQQELDDTS
     YLFKVEFNDR HLTPKSYLLN NIDVLKLGIK EFQEKFHRNE LKSILRAELD QKVLDVLATR
     YWKDDNLQDL SSSKLESDTD MLYWHKKLEL ASSGLTKMGI GRLSTMLTTN AILKELDNIL
     ESTQLKNHEL IKDLVSNTAI NVLNSKYYST ADQVENCIKP FKYEIDLEER DWSLARQHSI
     NLIKEELRQC NSRYQAIKNA VGSKKLANVM GYLENESNLQ KETLGMSKLL LERGSEAIFL
     DKRCKVLSFR LKMLKNKCHS TIEKDRCPEV FLSAVSDKLT STAVLFLNVE LLSDFFYNFP
     IELDRRLTLL GDEQVEMFAK EDPKISRHIE LQKRKELLEL ALEKIDSILV FKKSYKGVSK
     NL
>P32335 mit MSS51 PROTEIN.
     MTVLYAPSGA TQLYFHLLRK SPHNRLVVSH QTRRHLMGFV RNALGLDPPP SPEDPTPENR
     FHPWDQSPSV DLRERAAKIR TLAHCPVTGK DINYTCPLSG IPTHHSREAW EMDKAYHDSK
     KYEILKKVNI YEHDLRSGRP FPEFDFPQQQ GYDKAVNLTN WDLFFYTRSF YSMDTEFQLA
     AVTKMLSYPI TIGSLLHKFS PYSLNPKGPM TLEGLKSLAA LRYTLYPLEN RSLPTTTKNR
     AMRIFILGAR AEAQLPGHVW KQLQFLFPEQ SFEIHFIGPE CLYKRDKQEY VKSTTPVVQR
     VDETLKFIYR TNFFEVFHEA QDFFPYDPYM DVFFTFHPGY ASPESHGSWM GETMKALLET
     KCAIFTTGFN KKDLTDDINL VKSKYGKEMD VLMEPVRNVF GSTKWELNDM NPQEVYQFNM
     YIAGFRGKRY HTIKRQ
>P32387 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L41 PRECURSOR (YML41).
     MPRLTVGTKN MLYPLQKTLA VGSCKPEQVP IRSLASVVES SSKILDKSGS DREVDINVSE
     KIYKWTKAGI EQGKEHFKVG GNKVYFPKAR IILLRPNAKH TPYQAKFIVP KSFNKLDLRD
     YLYHIYGLRA MNITTQLLHG KFNRMNLQTT RFREPQIKKM TIEMEEPFIW PEEPRPDENS
     FWDSTTPDNM EKYREERLNC LGSDANKPGT AFDGVVGPYE RVAQPFIPRF LKREIDNKRE
     RHAAELQRAD KLIALNRYIE DLH
>P32388 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN MRP49 PRECURSOR.
     MSKVAQQLKF LNKISATTRL PQILVDPKKY SGLRLTFQTK NHNGHMGARV FWHNYLPTLQ
     FYNPRMKFDV IRIKNEDKQK SVPCKLEILS HEGSVVETID MRNKMHEDIM KDLLDKIEHV
     PLPENEIIRV GPQESII
>P32445 mit MITOCHONDRIAL SINGLE-STRANDED DNA-BINDING PROTEIN RIM1 PRECURSOR.
     MFLRTQARFF HATTKKMDFS KMSIVGRIGS EFTEHTSANN NRYLKYSIAS QPRRDGQTNW
     YNITVFNEPQ INFLTEYVRK GALVYVEADA ANYVFERDDG SKGTTLSLVQ KDINLLKNGK
     KLEDAEGQEN AASSE
>P32559 mit MITOCHONDRIAL GTPASE MSS1 PRECURSOR.
     MNSASFLQSR LISRSFLVRR SLKRYSGLAK PYTFQQPTIY ALSTPANQTS AIAIIRISGT
     HAKYIYNRLV DSSTVPPIRK AILRNIYSPS SCSVKPHDQK ESKILLDTSL LLYFQAPYSF
     TGEDVLELHV HGGKAVVNSI LKAIGSLHDR SSGKDIRFAL PGDFSRRAFQ NGKFDLTQLE
     GIKDLIDSET ESQRRSALSS FNGDNKILFE NWRETIIENM AQLTAIIDFA DDNSQEIQNT
     DEIFHNVEKN IICLRDQIVT FMQKVEKSTI LQNGIKLVLL GAPNVGKSSL VNSLTNDDIS
     IVSDIPGTTR DSIDAMINVN GYKVIICDTA GIREKSSDKI EMLGIDRAKK KSVQSDLCLF
     IVDPTDLSKL LPEDILAHLS SKTFGNKRII IVVNKSDLVS DDEMTKVLNK LQTRLGSKYP
     ILSVSCKTKE GIESLISTLT SNFESLSQSS ADASPVIVSK RVSEILKNDV LYGLEEFFKS
     KDFHNDIVLA TENLRYASDG IAKITGQAIG IEEILDSVFS KFCIGK
>P32580 mit MITOCHONDRIAL ATP-DEPENDENT RNA HELICASE SUV3 PRECURSOR.
     MALVKYSTVF FPLRSLRLFV SIKKAYYHSE PHSIDLFHDK DWIVKRPKFL NLPKNEHSKL
     DIFQFNFNKS ESNNVYLQDS SFKDNLDKAM QFIYNDKLSS LDAKQVPIKN LAWLKLRDYI
     YQQLKDPKLQ AKTYVPSVSE IIHPSSPGNL ISLLINCNKI SNLVWKSVLK YSLSNNITTL
     DKFIHVLQQT FDHVYEQEIL PMMTNTDDTD GAHNVDITNP AEWFPEARKI RRHIIMHIGP
     TNSGKTYRAL QKLKSVDRGY YAGPLRLLAR EVYDRFHAEK IRCNLLTGEE VIRDLDDRGN
     SAGLTSGTVE MVPINQKFDV VVLDEIQMMS DGDRGWAWTN ALLGVVSKEV HLCGEKSVLP
     LVKSIVKMTG DKLTINEYER LGKLSVEEKP IKDGIKGLRK GDCVVAFSKK KILDLKLKIE
     KDTNLKVAVI YGSLPPETRV QQAALFNNGE YDIMVASDAI GMGLNLSIDR VVFTTNMKYN
     GEELMEMTSS QIKQIGGRAG RFKSRSASGG VPQGFITSFE SKVLKSVRKA IEAPVEYLKT
     AVTWPTDEIC AQLMTQFPPG TPTSVLLQTI SDELEKSSDN LFTLSDLKSK LKVIGLFEHM
     EDIPFFDKLK LSNAPVKDMP MVTKAFTKFC ETIAKRHTRG LLSYRLPFNL LDYNCIPNES
     YSLEVYESLY NIITLYFWLS NRYPNYFIDM ESAKDLKYFC EMIIFEKLDR LKKNPYAHKP
     FGSTRGHLSS SRRRLRT
>P32875 mit LIPOIC ACID SYNTHETASE PRECURSOR (LIP-SYN).
     MYRRSVGVLF VGRNTRWISS TIRCGTSATR PIRSNALNTD SDNASVRVPV GNSTEVENAT
     SQLTGTSGKR RKGNRKRITE FKDALNLGPS FADFVSGKAS KMILDPLEKA RQNTEEAKKL
     PRWLKVPIPK GTNYHKLKGD VKELGLSTVC EEARCPNIGE CWGGKDKSKA TATIMLLGDT
     CTRGCRFCSV KTNRTPSKPD PMEPENTAEA IKRWGLGYVV LTTVDRDDLV DGGANHLAET
     VRKIKQKAPN TLVETLSGDF RGDLKMVDIM AQCGLDVYAH NLETVESLTP HVRDRRATYR
     QSLSVLERAK ATVPSLITKT SIMLGLGETD EQITQTLKDL RNIQCDVVTF GQYMRPTKRH
     MKVVEYVKPE KFDYWKERAL EMGFLYCASG PLVRSSYKAG EAFIENVLKK RNMK
>P32902 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN MRP4.
     MQRHVFARNF RRLSLLRNPS LTKRFQSSAS GAANTPNNND EVMLLQQKLL YDEIRSELKS
     LSQVPEDEIL PELKKSLEQD KLSDKEQQLE AELSDFFRNY ALLNKLFDSK TLDGQSSTTT
     AAATPTKPYP NLIPSANDKP YSSQELFLRQ LNHSMRTAKL GATISKVYYP HKDIFYPPLP
     ENITVESLMS AGVHLGQSTS LWRSSTQSYI YGEYKGIHII DLNQTLSYLK RAAKVVEGVS
     ESGGIILFLG TRQGQKRGLE EAAKKTHGYY VSTRWIPGTL TNSTEISGIW EKQEIDSNDN
     PTERALSPNE TSKQVKPDLL VVLNPTENRN ALLEAIKSRV PTIAIIDTDS EPSLVTYPIP
     GNDDSLRSVN FLLGVLARAG QRGLQNRLAR NNEK
>P32904 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L6 PRECURSOR (YML6).
     MSFIQRRLLS QTLFLRSQVG SLPLYISPEV QVSINALSMP RIIRKGRTSM NISQNITVKG
     PKGELSVEVP DFLHLDKDEK HGKINVTVQN SEDKHQRSMW GTVRSLINNH IIGVTEGHLA
     VLRFVGTGYR AQLENDGKFV NVKVGASIKQ GLDVPEGIVV KTPAPTSLII EGCNKQQVLL
     FAAKLRKFHP PEPYKGKGIY VNDETIKLKD KKIK
>P35191 mit MDJ1 PROTEIN PRECURSOR.
     MAFQQGVLSR CSGVFRHHVG HSRHINNILY RHAIAFASIA PRIPKSSFHT SAIRNNEAFK
     DPYDTLGLKK SATGAEIKKA YYKLAKKYHP DINKEPDAEK KFHDLQNAYE ILSDETKRQQ
     YDQFGPAAFG GGGAAGGAGG GSGSPFGSQF HDFSGFTSAG GSPFGGINFE DLFGAAFGGG
     GRGSGGASRS SSMFRQYRGD PIEIVHKVSF KDAVFGSKNV QLRFSALDPC STCSGTGMKP
     NTHKVSCSTC HGTGTTVHIR GGFQMMSTCP TCNGEGTMKR PQDNCTKCHG EGVQVNRAKT
     ITVDLPHGLQ DGDVVRIPGQ GSYPDIAVEA DLKDSVKLSR GDILVRIRVD KDPNFSIKNK
     YDIWYDKEIP ITTAALGGTV TIPTVEGQKI RIKVAPGTQY NQVISIPNMG VPKTSTIRGD
     MKVQYKIVVK KPQSLAEKCL WEALADVTND DMAKKTMQPG TAAGTAINEE ILKKQKQEEE
     KHAKKDDDNT LKRLENFITN TFRKIKGDKK N
>P35719 mit MITOCHONDRIAL 40S RIBOSOMAL PROTEIN MRP8.
     MSNEIELLQK QVSELQDLVK KQSLIISKTG ERVLELQLDK QKHDVTDFDS KFSKSISKKS
     GSATQFDATD FATNEDLVEL VKELQGELNF IEERSIRRLV NSLKKDDDDV IAPLPNADGD
     IPAISDGVFP KSLKEFKDIP DLKLVRLAKF YERLPPTLKE QEDFENFLEG KVEAFHINET
     TDEEISKELE KFSKDELDDA FNDVARYLGL SLRRGTEIW
>P35996 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L38 (YML38).
     MIFLKSVIKV IDNSGAQLAE CIKVIRKGSP KSPAMVGDRI VCVIQKAKPL TQNITGTANT
     NRVKKGDICH AIVVRSKQRN MCRKDGSTVA FGDTACVLIN KNTGEPLGTR IMANDGCVDR
     TLKDKGYNKI CSLASRVI
>P36525 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L24 PRECURSOR (YML24).
     MQKIFRPFQL TRGFTSSVKN FRQWRLIETR KIAKQPNYQV GDAKPLHMPK ERKKFPDYKY
     GESNIFKQSN KGLYGGSFVQ FGNNISESKA KTRKKWLPNV VKKGLWSETL NRKISIKMTA
     KVLKTISKEG GIDNYLTKEK SARIKELGPT GWKLRYRVLK RKDEIENPPH KDAPIIEMAG
     GKKAKIYYDE IVNGSPRKIS VGRRRLMSFL YPLEKLEYRS VGKDLNYKKF VELFADVPVK
     DILARLEDHK FDLSTITV
>P36526 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L27 PRECURSOR (YML27).
     MKGSPISQFS KTSINALTRP WKKYRDGELF YGLSKVGNKR VPLTTKQGNK TMYKGTRASG
     IGRHTKFGGY VINWKKVRTY VTPDMVNFEL KPYVNANVPP LKHEFKGFSG GPLDPRLQLL
     KIKEYIVNGR VQSEGATDTS CYKERG
>P36527 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L28 (YML28) (FRAGMENT).
     XIFKSKVILV ILAQRVVXQL XVKXASP
>P36528 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L30 PRECURSOR (YML30).
     MKVNLMLKRG LATATATASS APPKIKVGVL LSRIPIIKSE LNELEKKYYE YQSELEKRLM
     WTFPAYFYFK KGTVAEHKFL SLQKGPISKK NGIWFPRGIP DIKHGRERST KQEVKLSDDS
     TVAFSNNQKE QSKDDVNRPV IPNDRITEAD RSNDMKSLER QLSRTLYLLV KDKSGTWKFP
     NFDLSDESKP LHVHAENELK LLSGDQIYTW SVSATPIGVL QDERNRTAEF IVKSHILAGK
     FDLVASKNDA FEDFAWLTKG EISEYVPKDY FNKTEFLLAD N
>P36529 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L34 (YML34) (FRAGMENT).
     ANANRVXXGD IDIAIVVRXK QRNMXXXD
>P37292 mit SERINE HYDROXYMETHYLTRANSFERASE, MITOCHONDRIAL PRECURSOR (EC 2.1.2.1)
     MFPRASALAK CMATVHRRGL LTSGAQSLVS KPVSEGDPEM FDILQQERHR QKHSITLIPS
     ENFTSKAVMD LSGSELQNKY SEGYPGERYY GGNEIIDKSE SLCQARALEL YGLDPAKWGV
     NVQPLSGAPA NLYVYSAIMN VGERLMGLDL PDGGHLSHGY QLKSGTPISF ISKYFQSMPY
     HVDHTTGLID YDNLQVLAKA FRPKVIVAGT SAYSRLIDYA RFKEISQGCG AYLMSDMAHI
     SGLVAANVVP SPFEHSDIVT TTTHKSLRGP RGAMIFFRKG IKSVTKKGKE IPYELEKKIN
     FSVFPGHQGG PHNHTIGAMA VALKQAMSPE FKEYQQKIVD NSKWFAQELT KMGYKLVSGG
     TDNHLIVIDL SGTQVDGARV ETILSALNIA ANKNTIPGDK SALFPSGLRI GTPAMTTRGF
     GREEFSQVAK YIDSAVKLAE NLKTLEPTTK LDARSRLNEF KKLCNESSEV AALSGEISKW
     VGQYPVPGDI
>P38064 mit PROBABLE MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L16 PRECURSOR.
     MFPYLTRMNL SIKMGGLTLK ESSPNAFLNN TTIARRFKHE YAPRFKIVQK KQKGRVPVRT
     GGSIKGSTLQ FGKYGLRLKS EGIRISAQQL KEADNAIMRY VRPLNNGHLW RRLCTNVAVC
     IKGNETRMGK GKGGFDHWMV RVPTGKILFE INGDDLHEKV AREAFRKAGT KLPGVYEFVS
     LDSLVRVGLH SFKNPKDDPV KNFYDENAKK PSKKYLNILK SQEPQYKLFR GR
>P38958 mit PET100 PROTEIN PRECURSOR.
     MGLFNNFKFK YTRAQLEIFR FSFCLLAPVA VMYYIGTDTD KKLNVPGFWP DPATLNQIPK
     EPYEIKAELA RMKKERLEKR LRLEKKIQEE FGLDLEEEKE KIKRDLALKK G
>P39522 mit DIHYDROXY-ACID DEHYDRATASE PRECURSOR (EC 4.2.1.9) (DAD) (2,3-DIHYDROXY
     MGLLTKVATS RQFSTTRCVA KKLNKYSYII TEPKGQGASQ AMLYATGFKK EDFKKPQVGV
     GSCWWSGNPC NMHLLDLNNR CSQSIEKAGL KAMQFNTIGV SDGISMGTKG MRYSLQSREI
     IADSFETIMM AQHYDANIAI PSCDKNMPGV MMAMGRHNRP SIMVYGGTIL PGHPTCGSSK
     ISKNIDIVSA FQSYGEYISK QFTEEEREDV VEHACPGPGS CGGMYTANTM ASAAEVLGLT
     IPNSSSFPAV SKEKLAECDN IGEYIKKTME LGILPRDILT KEAFENAITY VVATGGSTNA
     VLHLVAVAHS AGVKLSPDDF QRISDTTPLI GDFKPSGKYV MADLINVGGT QSVIKYLYEN
     NMLHGNTMTV TGDTLAERAK KAPSLPEGQE IIKPLSHPIK ANGHLQILYG SLAPGGAVGK
     ITGKEGTYFK GRARVFEEEG AFIEALERGE IKKGEKTVVV IRYEGPRGAP GMPEMLKPSS
     ALMGYGLGKD VALLTDGRFS GGSHGFLIGH IVPEAAEGGP IGLVRDGDEI IIDADNNKID
     LLVSDKEMAQ RKQSWVAPPP RYTRGTLSKY AKLVSNASNG CVLDA
>P39677 mit ELONGATION FACTOR G, MITOCHONDRIAL 2 PRECURSOR (MEF-G-2).
     MWKWNVRRWA GARVNISKNR LSVINVGSRY LSTARSPLSK VRNIGIIAHI DAGKTTTTER
     MLYYAGISKH IGDVDTGDTI TDFLEQERSR GITIQSAAIS FPWRNTFAIN LIDTPGHIDF
     TFEVIRALKV IDSCVVILDA VAGVEAQTEK VWKQSKSKPK ICFINKMDRM GASFNHTVND
     LINKFMRGTT TKPVLVNIPY YRKQPTSNDY VFQGVIDVVN GKRLTWNPEN PDEIIVDELD
     GTSLEQCNRC RESMIETLTE YDEDLVQHFL EEAEGDYSKV SAQFLNASIR KLTMKNMIVP
     VLCGASFKNI GVQPLLDAIV NYLPSPIEAE LPELNDKTVP MKYDPKVGCL VNNNKNLCIA
     LAFKVITDPI RGKQIFIRIY SGTLNSGNTV YNSTTGEKFK LGKLLIPHAG TSQPVNILTA
     GQIGLLTGST VENNISTGDT LITHSSKKDG LKSLDKKKEL TLKINSIFIP PPVFGVSIEP
     RTLSNKKSME EALNTLITED PSLSISQNDE TGQTVLNGMG ELHLEIAKDR LVNDLKADVE
     FGQLMVSYKE TINSETNIET YESDDGYRFS LSLLPNSDAL PNCLAYPLGV NENFLIMEKN
     GNWDKEWKYQ VSFESILNSI IASCIVGLQR GGKIANFPLY ACSIKINSDW SVPPDIETPQ
     EILKITRNLI FKALNDLKPE KYNLLEPIMN LDLTIPQSDV GTVLQDLTGA RKAQILSIED
     ESSVSNSGAS TCNSPENSNR IYIPSDAVTT LHATKDKKNT QETSSNVKKI IKAKVPLREI
     TTYTNKLRSL SQGRGEFNIE YSDMEKVTND RLQSILHDL
>P40341 mit MITOCHONDRIAL RESPIRATORY CHAIN COMPLEXES ASSEMBLY PROTEIN RCA1
     MLLLSWSRIA TKVVRRPVRF RSYYGLTHIK SLHTQYRLLN RLQENKSGNK NEDNNEDAKL
     NKEIPTDEEV EAIRKQVEKY IEQTKNNTIP ANWKEQKRKI DESIRRLEDA VLKQESNRIQ
     EERKEKEEEN GPSKAKSNRT KEQGYFEGNN SRNIPPPPPP PPPKPPLNDP SNPVSKNVNL
     FQIGLTFFLL SFLLDLLNSL EEQSEITWQD FREKLLAKGY VAKLIVVNKS MVKVMLNDNG
     KNQADNYGRN FYYFTIGSID SFEHKLQKAQ DELDIDKDFR IPVLYVQEGN WAKAMFQILP
     TVLMIAGIIW LTRRSAQAAG GSRGGIFGLS RSKAKKFNTE TDVKIKFKDV AGCDEAKEEI
     MEFVSFLKEP SRYEKMGAKI PRGAILSGPP GTGKTLLAKA TAGEAGVPFY FVSGSEFVEM
     FVGVGAARVR DLFKTARENA PSIVFIDEID AIGKARQKGN FSGANDEREN TLNQMLVEMD
     GFTPADHVVV LAGTNRPDIL DKALLRPGRF DRHINIDKPE LEGRKAIFAV HLHHLKLAGE
     IFDLKNRLAA LTPGFSGADI ANVCNEAALI AARSDEDAVK LNHFEQAIER VIGGVERKSK
     LLSPEEKKVV AYHEAGHAVC GWYLKYADPL LKVSIIPRGQ GALGYAQYLP GDIFLLTEQQ
     LKDRMTMSLG GRVSEELHFP SVTSGASDDF KKVTSMATAM VTELGMSDKI GWVNYQKRDD
     SDLTKPFSDE TGDIIDSEVY RIVQECHDRC TKLLKEKAED VEKIAQVLLK KEVLTREDMI
     DLLGKRPFPE RNDAFDKYLN DYETEKIRKE EEKNEKRNEP KPSTN
>P46955 mit NCA3 PROTEIN PRECURSOR.
     MKISAALILS SLSSVAFSAP APAPADSHHE DHHKDEKPAV VTVTQYIDSN AATSTVESAA
     TTTTLSSSEK DTSEQKRDGG FQDGTVKCSD FPSVNGIVSL DWLGFGGWAS VMDMDANTSS
     ECKDGYYCSY ACEPGMSKTQ WPSDQPSDGK SVGGLYCKNG YLYRTNTDTS DLCSTDETSA
     KAINKKSDSI ALCRTDYPGS ENMVIPTVVD GGDSQPISVV DEDTYYQWQG KKTSAQYYIN
     NAGVSAEDGC IWGTSGSDVG NWAPLVLGAG STNGETYLSL IPNPNSNQAA NFNVKIVASD
     GANVQGSCAY EDGSFTGDGS DGCTVSVLSG SAEFVFY
>P48015 mit AMINOMETHYLTRANSFERASE PRECURSOR (EC 2.1.2.10) (GLYCINE CLEAVAGE
     MSIIKKIVFK RFNSTLKKTA LHDLHVSLGG TMVPYAGYSM PVLYKGQTHI ESHNWTRTNA
     GLFDVSHMLQ SKLSGPHSVK FLQRVTPTDF NALPVGSGTL SVLLNPQGGV VDDTIITKEN
     DDNEFYIVTN AGCAERDTEF FHDELQNGST LDCQWKIIEG RSLLALQGPK AKDVLEPLLS
     KTAPGKDLKE LFFGQRHEFA LKDGSLVQIA RGGYTGEDGF EISIANEKAV EFAEQLLANP
     VMKPIGLAAR DSLRLEAGMC LYGHELDESI TPVEAALNWV ISKSRRDLVD QKYWFNGYAK
     IMDQLNNKTY SKVRVGFKYL KKGPAARNGV KIFLPDAETE VGLVTSGSAS PTLNNINIGQ
     AYVQKGYHKK GTKLLVQVRN KFYPIELAKM PLVPTHYYKQ
>Q01926 mit MITOCHONDRIAL RNA SPLICING PROTEIN MRS2 PRECURSOR.
     MNRRLLVRSI SCFQPLSRIT FGRPNTPFLR KYADTSTAAN TNSTILRKQL LSLKPISASD
     SLFISCTVFN SKGNIISMSE KFPKWSFLTE HSLFPRDLRK IDNSSIDIIP TIMCKPNCIV
     INLLHIKALI ERDKVYVFDT TNPSAAAKLS VLMYDLESKL SSTKNNSQFY EHRALESIFI
     NVMSALETDF KLHSQICIQI LNDLENEVNR LKLRHLLIKS KDLTLFYQKT LLIRDLLDEL
     LENDDDLANM YLTVKKSPKD NFSDLEMLIE TYYTQCDEYV QQSESLIQDI KSTEEIVNII
     LDANRNSLML LELKVTIYTL GFTVASVLPA FYGMNLKNFI EESEWGFTSV AVFSIVSALY
     ITKKNFNSLR SVTKMTMYPN SPANSSVYPK TSASIALTNK LKRRRKWWKS TKQRLGVLLY
     GSSYTNKANL SNNKINKGFS KVKKFNMEND IKNKQNRDMI WKWLIEDKKN
>Q02204 mit MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L13 PRECURSOR (YML13).
     MGRRKGGHSM RMSSLLKLHC IRPLPQRSVW LSGYKQKARC IHSSAANGDF MSWFKRKKQE
     EHQEPVKDTK QLIKDIEEGT NEASSQSSSN NKNRLELIPE NFIGEGSRRC KRQKELKLAV
     SSAPFNQWLS RDKITSDNQL DDMILQATEK TLGKVDQDVQ FSDLVAKFQF TKFLQSKSGY
     LIPDYELTTL STPLQFKRYI KEKILPSAND PKLAYKEAEP NAIHPFSDNY ASPNIYVVND
     VTSKEQKSKY DTIMKEIQKL EDDATRKALE TARSA
>Q02773 mit MITOCHONDRIAL RIBONUCLEASE P PROTEIN COMPONENT PRECURSOR (EC 3.1.26.5)
     MAFKSFIYSK GYHRSAAQKK TATSFFDSSY QYLRQNQGLV NSDPVLHASH LHPHPVVVAN
     VNYNNVDDIL HPHDLDSSIN NTNNPLTHEE LLYNQNVSLR SLKQQQSTNY VNNNNNNQHR
     YYSTGPTLPT NQYDPLNFSN RNFQDLSLKT SQPSVQQPQN EYSLLKDENA PVWKEDTEPC
     LNKSTYLQTH IDEINRCYEQ KNYNKINSLY QSLKRNDIVP PLEIFTKVLD SLCKRPLDNN
     DLDNKMYELL TCYQDMINNR LKPPDEIYNI VLLSLFKGSI LAYQFENPNG SDFYKIAIEL
     FNTTTNDPKQ KSVVKFRNFS KDVLDYNLLA MNIYPGHITL SKAQQVIKSS PAFIKDSFYF
     IACFSYAKLT NDKFAIKELY EDFRLSLSSG SPDQGLFDDQ FEIYSVILSS FIETGEVELA
     TNLLDDLVSK IQSSNGLASN ISLLLSSFLI SMSKVDPSKA YEIWFKFHNL NWIPEFSYEF
     YLVFMANSFQ DWNLTKKIYD YIFPMERNLS PLKKQKLSDY LLHPIGVDSI TTSLLDYSLQ
     LKDNEVIMKI LEESIVKNFS FDIGIYPFVF NYLREIQCGE DYLMRFIESH AEFIKKSNSI
     NKFQFLNMIV DNFQSQSLLN KISHAKFFKN FVEDFNLENC ELVSYNGLIS CINNFIKIPK
     TIKDFPYILE IHAILVTKLF DFDTYPILQN GNNEVLLKFR DQIEHQFKML AQNFCRLNLD
     PNLLAGVVSQ AMKMVNLDDT ANGQDLLNFF NHPGDWDKSY PLSLGSFIRN SPRGGIREFT
     KLSKEGYCFD YDTYKELIIK RAINKQIIDK CLEVCPDSIE LKNIVNLMIS KIPGRNLTQL
     IINNPKFSKV FVPNLRNDSM LKLIENCESL SNFIRICDFP EKFKSIAIQA ENKNAIELIY
     ERLFDGGKYA DILRYNNIVP VLNLELLLKS CIRSGEFKKY ESLSKKFNDK ISESSKIDIQ
     LEYLINKNDL KGAFTLFEKT PRELRTPHKT MDLYTFALFL DSFNRNITYY ESPENTLQFA
     NILSSQTSFI NLLSTYNLIA HSDHLMNFNV GGMAAKVKKE ILNQMLNNLY DSIRLLSPSI
     ENDKSMKEKL REKVKNYCRF KAYLKSPELD MDELKTLVSV ESFLNPFTPS MLFNNLIETI
     YINEHASSLV LQNGLIYSLQ QKGLNKILSY LEESFITSGN DANIEKVREF RSLLRKSKPL
     QA
>P39006 mit PHOSPHATIDYLSERINE DECARBOXYLASE PROENZYME 1 PRECURSOR (EC 4.1.1.65).
     MSIMPVKNAL AQGRTLLMGR MPAVKFSTRM QLRNRTAVLW NRKFSTRLFV QQRRSSGEIV
     DRAKAAAANS GRKQVSMKWV VLTSFTIVLG TILLVSRNDS TEEDATEGKK GRRTRKIKIF
     NNNWLFFCYS TLPLNAMSRL WGQVNSLTLP IWVRPWGYRL YSFLFGVNLD EMEDPDLTHY
     ANLSEFFYRN IKPGTRPVAQ GEDVIASPSD GKILQVGIIN SETGEIEQVK GMTYSIKEFL
     GTHSHPLMSK SASSLDLTSD EEKHREFARV NRIQLAGSED TEQPLLNFKN EGDQSVREFK
     PSVSKNIHLL SQLSLNYFSN GFSCSEPHDT ELFFAVIYLA PGDYHHFHSP VDWVCKVRRH
     FPGDLFSVAP YFQRNFPNLF VLNERVALLG SWKYGFFSMT PVGATNVGSI KLNFDQEFVT
     NSKSDKHLEP HTCYQAVYEN ASKILGGMPL VKGEEMGGFE LGSTVVLCFE APTEFKFDVR
     VGDKVKMGQK LGIIGKNDLK
>P36060 mit NADH-CYTOCHROME B5 REDUCTASE PRECURSOR (EC 1.6.2.2) (P34 / P32).
     MFSRLSRSHS KALPIALGTV AIAAATAFYF ANRNQHSFVF NESNKVFKGD DKWIDLPISK
     IEEESHDTRR FTFKLPTEDS EMGLVLASAL FAKFVTPKGS NVVRPYTPVS DLSQKGHFQL
     VVKHYEGGKM TSHLFGLKPN DTVSFKGPIM KWKWQPNQFK SITLLGAGTG INPLYQLAHH
     IVENPNDKTK VNLLYGNKTP QDILLRKELD ALKEKYPDKF NVTYFVDDKQ DDQDFDGEIS
     FISKDFIQEH VPGPKESTHL FVCGPPPFMN AYSGEKKSPK DQGELIGILN NLGYSKDQVF
     KF
>P08593 mit MSS18 PROTEIN.
     MGLPEVNFLR KNCILVELKL FYQTVYPPKE LYWNNRITAE LSTFSNIKYA RPTFAVNNGT
     FQRTRPKLDL VLASSDIRKL ATVLFNLKAL IMNTKGEEPT LTTMTSVQTN EEKNDNLEQK
     YSSLLDRWNG KVEVHDSPFL QLQRDSNLLF AERPVRYVST TEGEGVDISS EEFFRLEEEQ
     CRRNYDVLVD EHSTPSVGMK DGQYGPNIIH FEPSLYHTYS SLPMSMKFWL NGLEDDETTM
     MNIDEKSAEN LDILLHGFKG FSNKRVKG
>P25719 mit PEPTIDYL-PROLYL CIS-TRANS ISOMERASE C PRECURSOR (EC 5.2.1.8) (PPIASE)
     MFKRSIIQQS RLFSNSASRL GKKVFFDPAV NGTKIGRIEF ELYDNVVPKT AENFRALCTG
     EKGWGYKGVP FHRIIPDFMI QGGDTDLTNG FGGKSIYGSK FADENFVKKH DKAGLLSMAN
     AGPNTNGSQF FITTVPCPWL DGKHVVFGEV TKGMDIVKAI ESYGTASGKP RAEIVIEEAG
     EL
>P27697 mit ABC1 PROTEIN PRECURSOR.
     MVTNMVKLRN LRRLYCSSRL LRTIQNGRIS SVSSISLSKK YTTKSAKEGE ENVERKHEEE
     KKDTLKSSSV PTSRISRLFH YGSLAAGVGM NAAAKGISEV AKGNSPTWKS LILSDSNIDR
     ITNKFSKMRG VALKIGQLLS FQDEKVLPKE LYEILSRVQN SANHMPQRQL EKVMAKELGA
     NWKTKFSKFD KIPMAAASIG QVHAAELPSG QRVVVKIQYP GVKESIDSDL NSLLMLLTAS
     SLLPKGLFLD KTIANARTEL KWECDYNREA RALQKFEALL KDDPAFEVPH VFPEYTTDNI
     ITMTRMEGTE IMKLPKASQE TKNFISENIM RLCLEEIATF KYMQTDPNWA NFLYNGRTKK
     IELLDFGASR PFAEDFILKY RKLLTYATLR DRKGAYEMSV QLGYLTGLES QSMKDAHVDS
     VLTLGEPFRG DVDKSFDFKD QTVSDRIRGN IGLMLNERLC PPPEETYSLH RKFSGIFLLC
     ARMGASVHCA KLFKEIFAYK V
>P27929 mit NAM9 PROTEIN PRECURSOR.
     MPRKANLLKS LARGRVRTSF NKYNLFNLYK KGGVDLKSKS LYQQKWTAKQ ETRAYHGEHL
     TEKRWQTVFK PKLDSVAQLD ASLRGGEIKE TPFLLQTFAV LEKRLDFALF RAMFASSVRQ
     ARQFILHGNV RVNGVKIKHP SYTLKPGDMF SVKPDKVLEA LGAKKPSFQE ALKIDKTQIV
     LWNKYVKEAK TEPKEVWEKK LENFEKMSDS NPKKLQFQEF LRQYNKNLES QQYNALKGCT
     QEGILRKLLN VEKEIGKSNN EPLSIDELKQ GLPEIQDSQL LESLNNAYQE FFKSGEIRRE
     IISKCQPDEL ISLATEMMNP NETTKKELSD GAKSALRSGK RIIAESVKLW TKNITDHFKT
     RMSDISDGSL TFDPKWAKNL KYHDPIKLSE LEGDEPKARK LINLPWQKNY VYGRQDPKKP
     FFTPWKPRPF LSPFAILPHH LEISFKTCHA VYLRDPVARP GQSEVISPFD VPVHERAYMY
     YLRNGK
>P32785 mit PROBABLE METHIONYL-TRNA FORMYLTRANSFERASE PRECURSOR (EC 2.1.2.9).
     MVKMRRITPT RLLFTCRYIS NNASPPVQPL NVLFFGSDTF SNFSLQALNE LRQNNGSCGI
     VDNIQVVTRS PKWCGRQKSI LKYPPIFDMA EKLQLPRPIT CDTKQEMLAL SKLTPSRQGN
     PENDGSGAPF NAIIAVSFGK LIPGDLIRAV PLALNVHPSL LPRHKGSAPI QRALLEGDTY
     TGVTIQTLHP DRFDHGAIVA QTEPLAIATM LSKGRVNDST ADFNSEGLPR RTAILMDQLG
     ALGAQLLGQT LRERLYLPQN RVQAPTAYKP SYAHRITTED KRIHWARDSA AELLNKLETL
     GPLHAFKEAT AARKDAQNSV LKRILFHECK VMRDARLDNG SKPGMFKYDD IKDCILVTCR
     GNLLLCVSRL QFEGFAVERA GQFMARCGKD AAP
>P32899 mit PUTATIVE 40S RIBOSOMAL PROTEIN YHR148W.
     MVRKLKHHEQ KLLKKVDFLE WKQDQGHRDT QVMRTYHIQN REDYHKYNRI CGDIRRLANK
     LSLLPPTDPF RRKHEQLLLD KLYAMGVLTT KSKISDLENK VTVSAICRRR LPVIMHRLKM
     AETIQDAVKF IEQGHVRVGP NLINDPAYLV TRNMEDYVTW VDNSKIKKTL LRYRNQIDDF
     DFS
>P33759 mit PROBABLE MITOCHONDRIAL 40S RIBOSOMAL PROTEIN S5.
     MFKRQLSTSV RYLQHYDESL LSRYYPESLL KSIKLAQQTI PEDTKFRVSR NVEFAPPYLD
     DFTKIHPFWD YKPGMPHLHA QEENNNFSIF RWDQVQQPLP GEGNILPPGV SLPNDGGRKS
     KSADVAAGLH KQTGVDPDYI TRKLTMKPLV MKRVSNQTGK GKIASFYALV VVGDKNGMVG
     LGEGKSREEM SKAIFKAHWD AVRNLKEIPR YENRTIYGDI DFRYHGVKLH LRSAKPGFGL
     RVNHVIFEIC ECAGIKDLSG KVYKSRNDMN IAKGTIEAFT KAQKTLDEVA LGRGKKLVDV
     RKVYYSS
>P33893 mit PET112 PROTEIN PRECURSOR.
     MLRLARFYSL ARTKAIHSHG APFRPEYALK CGLEIHTQLN TKNKLFSQST NSATSLVDAP
     NHHTSYYDIA LPGTQPVLNL EAILFAMKLS LALGSQVNSI SQFDRKHYFY GDQPQGYQLT
     QHYRPFARGG KINLSKELDD IDESAKEIGI LQLQIEQDTG KSHYTETDKD VITLVDLNRS
     NVPLIELVTK PDFSDIKQVR AFIKKYQNLV RHLHISSGDL ETGAMRVDVN LSINEYARVE
     LKNLPNTSSI INAIKYEYQR QVELISVGDT SSLMEPETRG WTGSSTVKLR SKETTIDYRY
     MPDPELPYIN LAPDVISGVR GLMPQLPDDI MRILMKKPYQ LSLKDAKILT YNSNQNDMYN
     HEALRSYYLD TFREFSKLAG ERSNAKLPTN WIIHEFLGDL NKLQIPLAKA KEILAPPVFA
     QFLKLLHEEV ISATSGKMLL FHILENFEQS NCQDLSIPDF SKLIEKFELH AINQVDPQEL
     MDLCNDVIAQ HTDDTFIRNL VTGKKKSSLK FLIGQGMRRS QGRIKANEFE KKFKEILNIQ
     W
>P38120 mit PROBABLE MITOCHONDRIAL 40S RIBOSOMAL PROTEIN S9 PRECURSOR.
     MFSRLSLFRR AALAPAPMRM SFRTIYQKTE DELPRRIVPK LATFYSANPN HEDRINRLER
     LLRKYIKLPS QNNNEAQQTK APWISFDEYA LIGGGTKLKP TQYTQLLYML NKLHNIDPQL
     TNDEITSELS QYYKKSSMLS NNIKIKTLDE FGRSIAVGKR KSSTAKVFVV RGTGEILVNG
     RQLNDYFLKM KDRESIMYPL QVIESVGKYN IFATTSGGGP TGQAESIMHA IAKALVVFNP
     LLKSRLHKAG VLTRDYRHVE RKKPGKKKAR KMPTWVKR
>P39525 mit 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE HOMOLOG (EC 2.3.1.41) (BETA-
     MSRRVVITGL GCVTPLGRSL SESWGNLLSS KNGLTPITSL PNYNEDYKLR EKSIPSTITV
     GKIPENFQNE NSAINKLLFT SQDERRTSSF IKLALRTTYE ALHNAGLLNP NDITINTSLC
     NLDHFGCLIG SGIGSIQDIY QTSLQFHNDN KRINPYFVPK ILTNMAAGNV SIKFNLRGLS
     HSVSTACATG NNSIGDAFNF IRLGMQDICV AGASETSLHP LSLAGFIRAK SITTNGISRP
     FDTQRSGFVL GEGCGMIVME SLEHAQKRNA NIISELVGYG LSSDACHITS PPADGNGAKR
     AIEMALKMAR LEPTDVDYVN AHATSTLLGD KAECLAVASA LLPGRSKSKP LYISSNKGAI
     GHLLGAAGAV ESIFTICSLK DDKMPHTLNL DNVLTLENNE ADKLHFIRDK PIVGANPKYA
     LCNSFGFGGV NTSLLFKKWE GS
>P39726 mit GLYCINE CLEAVAGE SYSTEM H PROTEIN PRECURSOR.
     MKHTTSTMLR TTRLWTTRMP AVSKLFLRNS SGNALNKNKL PFLYSSQGPQ AVRYTSQHEW
     IAVHQDKTAF VGITKYATDS LGDATYVELP EVGTEISQGE SLGSIESVKS ASEIYQPADG
     TVEEINTNLE ENPGVVNEDP MGDGWLVKMK LGEGVNVEQV EGLMSLEQYE KTLVHDD
>P40086 mit CYTOCHROME C OXIDASE ASSEMBLY PROTEIN COX15.
     MLFRNIEVGR QAAKLLTRTS SRLAWQSIGA SRNISTIRQQ IRKTQLYNFK KTVSIRPFSL
     SSPVFKPHVA SESNPIESRL KTSKNVAYWL IGTSGLVFGI VVLGGLTRLT ESGLSITEWK
     PVTGTLPPMN QKEWEEEFIK YKESPEFKLL NSHIDLDEFK FIFFMEWIHR LWGRAIGAVF
     ILPAVYFAVS KKTSGHVNKR LFGLAGLLGL QGFVGWWMVK SGLDQEQLDA RKSKPTVSQY
     RLTTHLGTAF FLYMGMLWTG LEILRECKWI KNPVQAISLF KKLDNPAIGP MRKISLALLA
     VSFLTAMSGG MVAGLDAGWV YNTWPKMGER WFPSSRELMD ENFCRREDKK DLWWRNLLEN
     PVTVQLVHRT CAYVAFTSVL AAHMYAIKKK AVIPRNAMTS LHVMMGVVTL QATLGILTIL
     YLVPISLASI HQAGALALLT SSLVFASQLR KPRAPMRNVI ITLPHSSKVT SGKILSEASK
     LASKPL
>P48360 mit NADPH:ADRENODOXIN OXIDOREDUCTASE HOMOLOG PRECURSOR (ADRENODOXIN
     MSFVQIRHIS SQINRKTVSI VGSGPSGFYT AYHLLKKSPI PLNVTIWEKL PVPFGLSRYG
     VAPDHPEVKN CEETFTTCAE EFSSPTNQKH KFSFVGGITI GKEILLKELL DNQDAVILSY
     GCTGDRKLNI PGELGTKGVF SSREFVNWYN GHPDFAKDKR FTDFDWSKVS KVGIIGNGNV
     ALDITRVLIS NQIDEIWENT DISSLALNLL RRAPVKDVKL IARRDFVHSK FTNKELRELW
     ELEKYGIRGR IDPKFFQKEM FDPSKYDRAF NRRVEMCSEY LKPFNERSKK NYKKAPPPSS
     GYDKFWELDY LKTPLKINRD DFGAINSLSL CNNRLNEDNS LQPLKDVNNI MTYKVDLLIT
     SLGYAGVPMP EFSKLSIGFD KDHIANKQGR VLTSSGEIFP HLYASGWIRK GSQGVIASTM
     QDAFEVGDRV IQDLVVSGAL SLENSIDLSN IKHTTWKDWE RINKKELLRG KKEHKTRSKF
     LTFEELWNGV EGI
>P49095 mit GLYCINE DEHYDROGENASE (DECARBOXYLATING) PRECURSOR (EC 1.4.4.2)
     MLRTRVTALL CRATVRSSTN YVSLARTRSF HSQSILLKTA ATDITSTQYS RIFNPDLKNI
     DRPLDTFARR HLGPSPSDVK KMLKTMGYSD LNAFIEELVP PNILKRRPLK LEAPSKGFCE
     QEMLQHLEKI ANKNHYKVKN FIGKGYYGTI LPPVIQRNLL ESPEWYTSYT PYQPEISQGR
     LEALLNFQTV VSDLTGLPVA NASLLDEGTA AGEAMLLSFN ISRKKKLKYV IDKKLHQQTK
     SVLHTRAKPF NIEIIEVDCS DIKKAVDVLK NPDVSGCLVQ YPATDGSILP PDSMKQLSDA
     LHSHKSLLSV ASDLMALTLL KPPAHYGADI VLGSSQRFGV PMGYGGPHAA FFAVIDKLNR
     KIPGRIVGIS KDRLGKTALR LALQTREQHI KRDKATSNIC TAQALLANVA SSYCVYHGPK
     GLQNISRRIF SLTSILANAI ENDSCPHELI NKTWFDTLTI KLGNGISSEQ LLDKALKEFN
     INLFAVDTTT ISLALDETTT KADVENLLKV FDIENSSQFL SEDYSNSFPR EFQRTDEILR
     NEVFHMHHSE TAMLRYLHRL QSRDLSLANS MIPLGSCTMK LNSTVEMMPI TWPQFSNIHP
     FQPSNQVQGY KELITSLEKD LCSITGFDGI SLQPNSGAQG EYTGLRVIRS YLESKGENHR
     NVCLIPVSAH GTNPASAAMA GLKVVPVNCL QDGSLDLVDL KNKAEQHSKE LAAVMITYPS
     TYGLFEPGIQ HAIDIVHSFG GQVYLDGANM NAQVGLTSPG DLGADVCHLN LHKTFSIPHG
     GGGPAGAPIC VKSHLIPHLP KHDVVDMITG IGGSKSIDSV SSAPYGNALV LPISYAYIKM
     MGNEGLPFSS VIAMLNSNYM MTRLKDHYKI LFVNEMSTLK HCAHEFIVDL REYKAKGVEA
     IDVAKRLQDY GFHAPTLAFP VPGTLMIEPT ESENLEELDR FCDAMISIKE EINALVAGQP
     KGQILKNAPH SLEDLITSSN WDTRGYTREE AAYPLPFLRY NKFWPTVARL DDTYGDMNLI
     CTCPSVEEIA NETE
>P52893 mit PUTATIVE ALANINE AMINOTRANSFERASE, MITOCHONDRIAL PRECURSOR
     MLSLSAKNHF TVSNSITHVI KSYHIRTLTS SAEKMPHITT PFSTSASSTK LKAFRKVRPV
     LQRHSSSWIV AQNHRRSLSG QSSLNDLRHL NRFPHHTLKT SNNEFYPAEQ LTLEDVNENV
     LKAKYAVRGA IPMRAEELKA QLEKDPQSLP FDRIINANIG NPQQLQQKPL TYYRQVLSLL
     QYPELLNQNE QQLVDSKLFK LDAIKRAKSL MEDIGGSVGA YSSSQGVEGI RKSVAEFITK
     RDEGEISYPE DIFLTAGASA AVNYLLSIFC RGPETGVLIP IPQYPLYTAT LALNNSQALP
     YYLDENSGWS TNPEEIETVV KEAIQNEIKP TVLVVINPGN PTGAVLSPES IAQIFEVAAK
     YGTVVIADEV YQENIFPGTK FHSMKKILRH LQREHPGKFD NVQLASLHST SKGVSGECGQ
     RGGYMELTGF SHEMRQVILK LASISLCPVV TGQALVDLMV RPPVEGEESF ESDQAERNSI
     HEKLITRAMT LYETFNSLEG IECQKPQGAM YLFPKIDLPF KAVQEARHLE LTPDEFYCKK
     LLESTGICTV PGSGFGQEPG TYHLRTTFLA PGLEWIKKWE SFHKEFFDQY RD
>P53163 mit PUTATIVE MITOCHONDRIAL 60S RIBOSOMAL PROTEIN L7/L12 PRECURSOR.
     MSLRILAKRS SSIWMKTRVT PALISPITIT TRFNSTTTTA PSHKDDVRPV DPKISKIVQD
     ISQLTLLETS SLINELKTVL NIPEISMPMG GFMAGAAGAG AGNVPSSTGE AGSGAEEEAK
     PEAKTVFTVK LDSFDTKTKA KVIKEVKGLL GLSLVEAKKF VEAAPKVLKE NVAKDDAEKI
     KKTLEDLGAK VSLE
>P53239 mit CYTOCHROME C OXIDASE ASSEMBLY PROTEIN COX18 PRECURSOR.
     MLKRLANRQN GFASFSCSSV GLRYGRTNPS TKRSFSLFQS VADTFLTVHE ASHIPWIVLV
     PLTTMTLRTL VTLPFSIWQR RRILKQQELR KLVQPITPII KLRLAAVTNK KSRNAARISS
     NGSFMPLQLQ NAGVLTPEQI TLLAVKETRK RQKKLFKKYN VPLWKNALLP MVQIPLWVTV
     SMGIRTLTET QLIESFYPSW FSALGFSSFD LSSPLVAMPL LAPILVGTLA VLNVELNGRL
     MFSSSLSSQG IKTISRNSTR VQEAMTSILN VSRLGCVVML AMSSQAPFLL SLYWISSQLF
     SLVQNIILNW IYPYQR
>P53312 mit PROBABLE SUCCINYL-COA LIGASE (GDP-FORMING), BETA-CHAIN PRECURSOR
     MYSRKSLSLI SKCGQLSRLN AQAALQARRH LSIHEYRSAQ LLREYGIGTP EGFPAFTPEE
     AFEAAKKLNT NKLVIKAQAL TGGRGKGHFD TGYKSGVHMI ESPQQAEDVA KEMLNHNLIT
     KQTGIAGKPV SAVYIVKRVD TKHEAYLSIL MDRQTKKPMI IASSQGGMNI EEVAERTPDA
     IKKFSIETSK GLSPQMAKDV AKSLGFSPDA QDEAAKAVSN LYKIFMERDA TQVEINPLSE
     IEHDPTHKIM CTDAKFGFDD NASFRQEKIY SWRDLSQEDP DEVKAKKYDL NFVKLKGNIG
     CLVNGAGLAM ATMDVIKLNG GDPANFLDCG GGATPETIKQ GFELILSNKN VDAIFVNIFG
     GIVRCDYVAL GLVEAARELE VRVPIVARLQ GTKVEEGRDI INKSGVKIYS FDELDPAAKK
     VVELTQN
>P53598 mit PROBABLE SUCCINYL-COA LIGASE (GDP-FORMING), ALPHA-CHAIN PRECURSOR
     MLRSTVSKAS LKICRHFHRE SIPYDKTIKN LLLPKDTKVI FQGFTGKQGT FHASISQEYG
     TNVVGGTNPK KAGQTHLGQP VFASVKDAIK ETGATASAIF VPPPIAAAAI KESIEAEIPL
     AVCITEGIPQ HDMLYIAEML QTQDKTRLVG PNCPGIINPA TKVRIGIQPP KIFQAGKIGI
     ISRSGTLTYE AVQQTTKTDL GQSLVIGMGG DAFPGTDFID ALKLFLEDET TEGIIMLGEI
     GGKAEIEAAQ FLKEYNFSRS KPMPVASFIA GTVAGQMKGV RMGHSGAIVE GSGTDAESKK
     QALRDVGVAV VESPGYLGQA LLDQFAKFK
>Q02771 mit PET117 PROTEIN PRECURSOR.
     MSRASKITFA ASCLITAATV VGVHYVQEME RETLHQGPIK DAKRVEEKRL RKTNGVASLD
     PTKERKRYFN MSEHEEQKEL RKKYETMQPL SGEVVTKDGE VVKESKK
>Q02772 mit PET191 PROTEIN PRECURSOR.
     MVASCKDQKK AVAICLQRSP CVMIERHNPQ ECLDNPELNK DLPELCIAQM KAFLDCKRGI
     VDMTKRFTGN APLSTGKYDQ QYENLCKGKF DPREEMEKLK LLNSQQKD
>Q12122 mit PROBABLE HOMOCITRATE SYNTHASE, MITOCHONDRIAL ISOZYME PRECURSOR
     MSENNEFQSV TESTTAPTTS NPYGPNPADY LSNVKNFQLI DSTLREGEQF ANAFFDTEKK
     IEIARALDDF GVDYIELTSP VASEQSRKDC EAICKLGLKA KILTHIRCHM DDARVAVETG
     VDGVDVVIGT SKFLRQYSHG KDMNYIAKSA VEVIEFVKSK GIEIRFSSED SFRSDLVDLL
     NIYKTVDKIG VNRVGIADTV GCANPRQVYE LIRTLKSVVS CDIECHFHND TGCAIANAYT
     ALEGGARLID VSVLGIGERN GITPLGGLMA RMIVAAPDYV RSKYKLHKIR DIENLVADAV
     EVNIPFNNPI TGFCAFTHKA GIHAKAILAN PSTYEILDPH DFGMKRYIHF ANRLTGWNAI
     KSRVDQLNLN LTDDQIKEVT AKIKKLGDVR PLNIDDVDSI IKDFHAELST PLLKPVNKGT
     DDDNIDISNG HVSKKAKVTK
>P25303 mit SCJ1 PROTEIN.
     MVIRCSTDKT WWIGQKSVHW LAKRSRTMIP KLYIHLILSL LLLPLILAQD YYAILEIDKD
     ATEKEIKSAY RQLSKKYHPD KNAGSEEAHQ KFIEVGEAYD VLSDPEKKKI YDQFGADAVK
     NGGGGGGPGG PGAGGFHDPF DIFERMFQGG HGGPGGGFGQ RQRQRGPMIK VQEKLSLKQF
     YSGSSIEFTL NLNDECDACH GSGSADGKLA QCPDCQGRGV IIQVLRMGIM TQQIQQMCGR
     CGGTGQIIKN ECKTCHGKKV TKKNKFFHVD VPPGAPRNYM DTRVGEAEKG PDFDAGDLVI
     EFKEKDTENM GYRRRGDNLY RTEVLSAAEA LYGGWQRTIE FLDENKPVKL SRPAHVVVSN
     GEVEVVKGFG MPKGSKGYGD LYIDYVVVMP KTFKSGQNML KDEL
>P37267 mit CBP4 PROTEIN PRECURSOR.
     MQCAITPREA VIAKQRQYKH YLGMERPLWV RWLKVYAIGG AIIGSGFLLF KYTTPTDQQL
     ISQLSPELRL QYEREKKLRQ SEQQALMKIV KETSQSDDPI WKTGPLQSPW ERNGDNVQSR
     DHFAKVRAEE VQKEELARIR NELSQLRSET EEKTKEIVQD KQVKSWWRFW
>P18900 mit HEXAPRENYL PYROPHOSPHATE SYNTHETASE PRECURSOR (EC 2.5.1.-) (HPS).
     MFQRSGAAHH IKLISSRRCR FKSSFAVALN AASKLVTPKI LWNNPISLVS KEMNTLAKNI
     VALIGSGHPV LNKVTSYYFE TEGKKVRPLL VLLLSRALSE IPMTERNHLK IDKSDVPEDP
     IYSKPSQNQL FQRPASSISP LHILHGIKPL NPLTKGPEPL PEETFDKQRG ILPKQRRLAE
     IVEMIHTASL LHDDVIDHSD TRRGRPSGNA AFTNKMAVLA GDFLLGRATV SISRLHNPEV
     VELMSNSIAN LVEGEFMQLK NTSIDADIDT IENGHKLLPV PSKKLEVKEH DFRVPSRQQG
     LQLSHDQIIE TAFEYYIHKT YLKTAALISK SCRCAAILSG ASPAVIDECY DFGRNLGICF
     QLVDDMLDFT VSGKDLGKPS GADLKLGIAT APVLFAWKED PSLGPLISRN FSERGDVEKT
     IDSVRLHNGI AKTKILAEEY RDKALQNLRD SLPESDARSA LEFLTNSILT RRK
>P19414 mit ACONITATE HYDRATASE, MITOCHONDRIAL PRECURSOR (EC 4.2.1.3) (CITRATE
     MLSARSAIKR PIVRGLATVS NLTRDSKVNQ NLLEDHSFIN YKQNVETLDI VRKRLNRPFT
     YAEKILYGHL DDPHGQDIQR GVSYLKLRPD RVACQDATAQ MAILQFMSAG LPQVAKPVTV
     HCDHLIQAQV GGEKDLKRAI DLNKEVYDFL ASATAKYNMG FWKPGSGIIH QIVLENYAFP
     GALIIGTDSH TPNAGGLGQL AIGVGGADAV DVMAGRPWEL KAPKILGVKL TGKMNGWTSP
     KDIILKLAGI TTVKGGTGKI VEYFGDGVDT FSATGMGTIC NMGAEIGATT SVFPFNKSMI
     EYLEATGRGK IADFAKLYHK DLLSADKDAE YDEVVEIDLN TLEPYINGPF TPDLATPVSK
     MKEVAVANNW PLDVRVGLIG SCTNSSYEDM SRSASIVKDA AAHGLKSKTI FTVTPGSEQI
     RATIERDGQL ETFKEFGGIV LANACGPCIG QWDRRDIKKG DKNTIVSSYN RNFTSRNDGN
     PQTHAFVASP ELVTAFAIAG DLRFNPLTDK LKDKDGNEFM LKPPHGDGLP QRGYDAGENT
     YQAPPADRST VEVKVSPTSD RLQLLKPFKP WDGKDAKDMP ILIKAVGKTT TDHISMAGPW
     LKYRGHLENI SNNYMIGAIN AENKKANCVK NVYTGEYKGV PDTARDYRDQ GIKWVVIGDE
     NFGEGSSREH AALEPRFLGG FAIITKSFAR IHETNLKKQG LLPLNFKNPA DYDKINPDDR
     IDILGLAELA PGKPVTMRVH PKNGKPWDAV LTHTFNDEQI EWFKYGSALN KIKADEKK
>P00127 mit UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 17 KD PROTEIN (EC 1.10.2.2)
     MGMLELVGEY WEQLKITVVP VVAAAEDDDN EQHEEKAAEG EEKEEENGDE DEDEDEDEDD
     DDDDDEDEEE EEEVTDQLED LREHFKNTEE GKALVHHYEE CAERVKIQQQ QPGYADLEHK
     EDCVEEFFHL QHYLDTATAP RLFDKLK
>P00128 mit UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 14 KD PROTEIN (EC 1.10.2.2)
     MPQSFTSIAR IGDYILKSPV LSKLCVPVAN QFINLAGYKK LGLKFDDLIA EENPIMQTAL
     RRLPEDESYA RAYRIIRAHQ TELTHHLLPR NEWIKAQEDV PYLLPYILEA EAAAKEKDEL
     DNIEVSK
>P00424 mit CYTOCHROME C OXIDASE POLYPEPTIDE VA PRECURSOR (EC 1.9.3.1).
     MLRNTFTRAG GLSRITSVRF AQTHALSNAA VMDLQSRWEN MPSTEQQDIV SKLSERQKLP
     WAQLTEPEKQ AVWYISYGEW GPRRPVLNKG DSSFIAKGVA AGLLFSVGLF AVVRMAGGQD
     AKTMNKEWQL KSDEYLKSKN ANPWGGYSQV QSK
>P00425 mit CYTOCHROME C OXIDASE POLYPEPTIDE VB PRECURSOR (EC 1.9.3.1).
     MLRTSLTKGA RLTGTRFVQT KALSKATLTD LPERWENMPN LEQKEIADNL TERQKLPWKT
     LNNEEIKAAW YISYGEWGPR RPVHGKGDVA FITKGVFLGL GISFGLFGLV RLLANPETPK
     TMNREWQLKS DEYLKSKNAN PWGGYSQVQS K
>P04037 mit CYTOCHROME C OXIDASE POLYPEPTIDE IV PRECURSOR (EC 1.9.3.1).
     MLSLRQSIRF FKPATRTLCS SRYLLQQKPV VKTAQNLAEV NGPETLIGPG AKEGTVPTDL
     DQETGLARLE LLGKLEGIDV FDTKPLDSSR KGTMKDPIII ESYDDYRYVG CTGSPAGSHT
     IMWLKPTVNE VARCWECGSV YKLNPVGVPN DDHHH
>P04710 mit ADP,ATP CARRIER PROTEIN 1 (ADP/ATP TRANSLOCASE 1) (ADENINE NUCLEOTIDE
     MSHTETQTQQ SHFGVDFLMG GVSAAIAKTG AAPIERVKLL MQNQEEMLKQ GSLDTRYKGI
     LDCFKRTATH EGIVSFWRGN TANVLRYFPT QALNFAFKDK IKSLLSYDRE RDGYAKWFAG
     NLFSGGAAGG LSLLFVYSLD YARTRLAADA RGSKSTSQRQ FNGLLDVYKK TLKTDGLLGL
     YRGFVPSVLG IIVYRGLYFG LYDSFKPVLL TGALEGSFVA SFLLGWVITM GASTASYPLD
     TVRRRMMMTS GQTIKYDGAL DCLRKIVQKE GAYSLFKGCG ANIFRGVAAA GVISLYDQLQ
     LIMFGKKFK
>P06182 mit CYTOCHROME C HEME LYASE (EC 4.4.1.17) (CCHL) (HOLOCYTOCHROME-C
     MGWFWADQKT TGKDIGGAAV SSMSGCPVMH ESSSSSPPSS ECPVMQGDND RINPLNNMPE
     LAASKQPGQK MDLPVDRTIS SIPKSPDSNE FWEYPSPQQM YNAMVRKGKI GGSGEVAEDA
     VESMVQVHNF LNEGCWQEVL EWEKPHTDES HVQPKLLKFM GKPGVLSPRA RWMHLCGLLF
     PSHFSQELPF DRHDWIVLRG ERKAEQQPPT FKEVRYVLDF YGGPDDENGM PTFHVDVRPA
     LDSLDNAKDR MTRFLDRMIS GPSSSSSAP
>P07255 mit CYTOCHROME C OXIDASE POLYPEPTIDE VIIA (EC 1.9.3.1).
     TIAPITGTIK RRVIMDIVLG FSLGGVMASY WWWGFHMDKI NKREKFYAEL AERKKQEN
>P07256 mit UBIQUINOL-CYTOCHROME-C REDUCTASE COMPLEX CORE PROTEIN I PRECURSOR
     MLRTVTSKTV SNQFKRSLAT AVATPKAEVT QLSNGIVVAT EHNPSAHTAS VGVVFGSGAA
     NENPYNNGVS NLWKNIFLSK ENSAVAAKEG LALSSNISRD FQSYIVSSLP GSTDKSLDFL
     NQSFIQQKAN LLSSSNFEAT KKSVLKQVQD FEENDHPNRV LEHLHSTAFQ NTPLSLPTRG
     TLESLENLVV ADLESFANNH FLNSNAVVVG TGNIKHEDLV NSIESKNLSL QTGTKPVLKK
     KAAFLGSEVR LRDDTLPKAW ISLAVEGEPV NSPNYFVAKL AAQIFGSYNA FEPASRLQGI
     KLLDNIQEYQ LCDNFNHFSL SYKDSGLWGF STATRNVTMI DDLIHFTLKQ WNRLTISVTD
     TEVERAKSLL KLQLGQLYES GNPVNDANLL GAEVLIKGSK LSLGEAFKKI DAITVKDVKA
     WAGKRLWDQD IAIAGTGQIE GLLDYMRIRS DMSMMRW
>P07257 mit UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX CORE PROTEIN 2 PRECURSOR
     MLSAARLQFA QGSVRRLTVS ARDAPTKIST LAVKVHGGSR YATKDGVAHL LNRFNFQNTN
     TRSALKLVRE SELLGGTFKS TLDREYITLK ATFLKDDLPY YVNALADVLY KTAFKPHELT
     ESVLPAARYD YAVAEQCPVK SAEDQLYAIT FRKGLGNPLL YDGVERVSLQ DIKDFADKVY
     TKENLEVSGE NVVEADLKRF VDESLLSTLP AGKSLVSKSE PKFFLGEENR VRFIGDSVAA
     IGIPVNKASL AQYEVLANYL TSALSELSGL ISSAKLDKFT DGGLFTLFVR DQDSAVVSSN
     IKKIVADLKK GKDLSPAINY TKLKNAVQNE SVSSPIELNF DAVKDFKLGK FNYVAVGDVS
     NLPYLDEL
>P08067 mit UBIQUINOL-CYTOCHROME C REDUCTASE IRON-SULFUR SUBUNIT PRECURSOR
     MLGIRSSVKT CFKPMSLTSK RLISQSLLAS KSTYRTPNFD DVLKENNDAD KGRSYAYFMV
     GAMGLLSSAG AKSTVETFIS SMTATADVLA MAKVEVNLAA IPLGKNVVVK WQGKPVFIRH
     RTPHEIQEAN SVDMSALKDP QTDADRVKDP QWLIMLGICT HLGCVPIGEA GDFGGWFCPC
     HGSHYDISGR IRKGPAPLNL EIPAYEFDGD KVIVG
>P08466 mit MITOCHONDRIAL NUCLEASE (EC 3.1.30.-).
     MCSRILLSGL VGLGAGTGLT YLLLNKHSPT QIIETPYPPT QKPNSNIQSH SFNVDPSGFF
     KYGFPGPIHD LQNREEFISC YNRQTQNPYW VLEHITPESL AARNADRKNS FFKEDEVIPE
     KFRGKLRDYF RSGYDRGHQA PAADAKFSQQ AMDDTFYLSN MCPQVGEGFN RDYWAHLEYF
     CRGLTKKYKS VRIVTGPLYL PKKDPIDNKF RVNYEVIGNP PSIAVPTHFF KLIVAEAPTA
     NPAREDIAVA AFVLPNEPIS NETKLTDFEV PIDALERSTG LELLQKVPPS KKKALCKEVN
     CQIVVRDFSN AAIKQSKDVK LLPPPKKRN
>P08525 mit UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX UBIQUINONE-BINDING PROTEIN
     MGPPSGKTYM GWWGHMGGPK QKGITSYAVS PYAQKPLQGI FHNAVFNSFR RFKSQFLYVL
     IPAGIYWYWW KNGNEYNEFL YSKAGREELE RVNV
>P10174 mit CYTOCHROME C OXIDASE POLYPEPTIDE VII (EC 1.9.3.1).
     ANKVIQLQKI FQSSTKPLWW RHPRSALYLY PFYAIFAVAV VTPLLYIPNA IRGIKAKKA
>P10566 mit MITOCHONDRIAL RNA SPLICING PROTEIN MRS3.
     MVENSSSNNS TRPIPAIPMD LPDYEALPTH APLYHQLIAG AFAGIMEHSV MFPIDALKTR
     IQSANAKSLS AKNMLSQISH ISTSEGTLAL WKGVQSVILG AGPAHAVYFG TYEFCKKNLI
     DSSDTQTHHP FKTAISGACA TTASDALMNP FDTIKQRIQL NTSASVWQTT KQIYQSEGLA
     AFYYSYPTTL VMNIPFAAFN FVIYESSTKF LNPSNEYNPL IHCLCGSISG STCAAITTPL
     DCIKTVLQIR GSQTVSLEIM RKADTFSKAA SAIYQVYGWK GFWRGWKPRI VANMPATAIS
     WTAYECAKHF LMTY
>P18238 mit ADP,ATP CARRIER PROTEIN 3 (ADP/ATP TRANSLOCASE 3) (ADENINE NUCLEOTIDE
     MSSDAKQQET NFAINFLMGG VSAAIAKTAA SPIERVKILI QNQDEMIKQG TLDKKYSGIV
     DCFKRTAKQE GLISFWRGNT ANVIRYFPTQ ALNFAFKDKI KLMFGFKKEE GYGKWFAGNL
     ASGGAAGALS LLFVYSLDFA RTRLAADAKS SKKGGARQFN GLTDVYKKTL KSDGIAGLYR
     GFMPSVVGIV VYRGLYFGMF DSLKPLVLTG SLDGSFLASF LLGWVVTTGA STCSYPLDTV
     RRRMMMTSGQ AVKYNGAIDC LKKIVASEGV GSLFKGCGAN ILRSVAGAGV ISMYDQLQMI
     LFGKKFK
>P18239 mit ADP,ATP CARRIER PROTEIN 2 (ADP/ATP TRANSLOCASE 2) (ADENINE NUCLEOTIDE
     MSSNAQVKTP LPPAPAPKKE SNFLIDFLMG GVSAAVAKTA ASPIERVKLL IQNQDEMLKQ
     GTLDRKYAGI LDCFKRTATQ EGVISFWRGN TANVIRYFPT QALNFAFKDK IKAMFGFKKE
     EGYAKWFAGN LASGGAAGAL SLLFVYSLDY ARTRLAADSK SSKKGGARQF NGLIDVYKKT
     LKSDGVAGLY RGFLPSVVGI VVYRGLYFGM YDSLKPLLLT GSLEGSFLAS FLLGWVVTTG
     ASTCSYPLDT VRRRMMMTSG QAVKYDGAFD CLRKIVAAEG VGSLFKGCGA NILRGVAGAG
     VISMYDQLQM ILFGKKFK
>P21801 mit SUCCINATE DEHYDROGENASE (UBIQUINONE) IRON-SULFUR PROTEIN PRECURSOR
     MLNVLLRRKA FCLVTKKGMA TATTAAATHT PRLKTFKVYR WNPDEPSAKP HLQSYQVDLN
     DCGPMVLDAL LKIKDEQDST LTFRRSCREG ICGSCAMNIG GRNTLACICK IDQNESKQLK
     IYPLPHMFIV KDLVPDLTNF YQQYKSIQPY LQRSSFPKDG TEVLQSIEDR KKLDGLYECI
     LCACCSTSCP SYWWNQEQYL GPAVLMQAYR WLIDSRDQAT KTRKAMLNNS MSLYRCHTIM
     NCTRTCPKGL NPGLAIAEIK KSLAFA
>P22289 mit UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 7.3 KD PROTEIN (EC 1.10.2.2)
     SFSSLYKTFF KRNAVFVGTI FAGAFVFQTV FDTAITSWYE NHNKGKLWKD VKARIAAGDG
     DDDDE
>P23500 mit MITOCHONDRIAL RNA SPLICING PROTEIN MSR4.
     MNTSELSIAE EIDYEALPSH APLHSQLLAG AFAGIMEHSL MFPIDALKTR VQAAGLNKAA
     STGMISQISK ISTMEGSMAL WKGVQSVILG AGPAHAVYFG TYEFCKARLI SPEDMQTHQP
     MKTALSGTIA TIAADALMNP FDTVKQRLQL DTNLRVWNVT KQIYQNEGFA AFYYSYPTTL
     AMNIPFAAFN FMIYESASKF FNPQNSYNPL IHCLCGGISG ATCAALTTPL DCIKTVLQVR
     GSETVSIEIM KDANTFGRAS RAILEVHGWK GFWRGLKPRI VANIPATAIS WTAYECAKHF
     LMKN
>P23641 mit MITOCHONDRIAL PHOSPHATE CARRIER PROTEIN (PHOSPHATE TRANSPORT PROTEIN)
     MSVSAAPAIP QYSVSDYMKF ALAGAIGCGS THSSMVPIDV VKTRIQLEPT VYNKGMVGSF
     KQIIAGEGAG ALLTGFGPTL LGYSIQGAFK FGGYEVFKKF FIDNLGYDTA SRYKNSVYMG
     SAAMAEFLAD IALCPLEATR IRLVSQPQFA NGLVGGFSRI LKEEGIGSFY SGFTPILFKQ
     IPYNIAKFLV FERASEFYYG FAGPKEKLSS TSTTLLNLLS GLTAGLAAAI VSQPADTLLS
     KVNKTKKAPG QSTVGLLAQL AKQLGFFGSF AGLPTRLVMV GTLTSLQFGI YGSLKSTLGC
     PPTIEIGGGG H
>P23833 mit SCO1 PROTEIN PRECURSOR.
     MLKLSRSANL RLVQLPAARL SGNGAKLLTQ RGFFTVTRLW QSNGKKPLSR VPVGGTPIKD
     NGKVREGSIE FSTGKAIALF LAVGGALSYF FNREKRRLET QKEAEANRGY GKPSLGGPFH
     LEDMYGNEFT EKNLLGKFSI IYFGFSNCPD ICPDELDKLG LWLNTLSSKY GITLQPLFIT
     CDPARDSPAV LKEYLSDFHP SILGLTGTFD EVKNACKKYR VYFSTPPNVK PGQDYLVDHS
     IFFYLMDPEG QFVDALGRNY DEKTGVDKIV EHVKSYVPAE QRAKQKEAWY SFLFK
>P28627 mit MITOCHONDRIAL INNER MEMBRANE PROTEASE SUBUNIT 1 (EC 3.4.99.-).
     TVGTLPIWSK TFSYAIRSLC FLHIIHMYAY EFTETRGESM LPTLSATNDY VHVLKNFQNG
     RGIKMGDCIV ALKPTDPNHR ICKRVTGMPG DLVLVDPSTI VNYVGDVLVD EERFGTYIKV
     PEGHVWVTGD NLSHSLDSRT YNALPMGLIM GKIVAANNFD KPFWDGSIRN IWGFKWINNT
     FLDVQAKSN
>P32378 mit PARA-HYDROXYBENZOATE--POLYPRENYLTRANSFERASE PRECURSOR (EC 2.5.1.-)
     MFIWQRKSIL LGRSILGSGR VTVAGIIGSS RKRYTSSSSS SSSPSSKESA PVFTSKELEV
     ARKERLDGLG PFVSRLPKKW IPYAELMRLE KPVGTWLLYL PCSWSILMGA MMQGATLSAT
     AGMLGIFGVG ALVMRGAGCT INDFLDRKLD QRVIRSVERP IASGRVSPRR ALVFLGAQTL
     VGMGVLSLLP AQCWWLGLAS LPIVFTYPLF KRFTYYPQAA LSACFNWGAL LGFPAMGVMS
     WPTMIPLYLS SYLWCMTYDT IYAHQDKKFD IKAGIKSTAL AWGPRTKSIM KAMSASQIAL
     LAVAGLNSGL LWGPGFIGGL GVFAYRLFSM IKKVDLDNPK NCWKYFNANI NTGLYFTYAL
     AVDYILRLFG FL
>P32799 mit CYTOCHROME C OXIDASE POLYPEPTIDE VIA PRECURSOR (EC 1.9.3.1).
     MFRQCAKRYA SSLPPNALKP AFGPPDKVAA QKFKESLMAT EKHAKDTSNM WVKISVWVAL
     PAIALTAVNT YFVEKEHAEH REHLKHVPDS EWPRDYEFMN IRSKPFFWGD GDKTLFWNPV
     VNRHIEHDD
>P32897 mit MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE SUBUNIT TIM23
     MSWLFGDKTP TDDANAAVGG QDTTKPKELS LKQSLGFEPN INNIISGPGG MHVDTARLHP
     LAGLDKGVEY LDLEEEQLSS LEGSQGLIPS RGWTDDLCYG TGAVYLLGLG IGGFSGMMQG
     LQNIPPNSPG KLQLNTVLNH ITKRGPFLGN NAGILALSYN IINSTIDALR GKHDTAGSIG
     AGALTGALFK SSKGLKPMGY SSAMVAAACA VWCSVKKRLL EK
>P33421 mit SUCCINATE DEHYDROGENASE CYTOCHROME B SUBUNIT PRECURSOR.
     MSAMMVKLGL NKSALLLKPS AFSRAAALSS SRRLLFNTAR TNFLSTSPLK NVASEMNTKA
     AIAEEQILNK QRAKRPISPH LTIYQPQLTW YLSSLHRISL VLMGLGFYLF TILFGVSGLL
     GLGLTTEKVS NWYHQKFSKI TEWSIKGSFA YLFAIHYGGA IRHLIWDTAK ELTLKGVYRT
     GYALIGFTAV LGTYLLTL
>P37298 mit SUCCINATE DEHYDROGENASE MEMBRANE ANCHOR SUBUNIT PRECURSOR.
     MMLPRSMKFM TGRRIFHTAT VRAFQSTAKK SLTIPFLPVL PQKPGGVRGT PNDAYVPPPE
     NKLEGSYHWY MEKIFALSVV PLATTAMLTT GPLSTAADSF FSVMLLGYCY MEFNSCITDY
     ISERVYGVWH KYAMYMLGLG SAVSLFGIYK LETENDGVVG LVKSLWDSSE KDNSQKIEAK
     K
>P37299 mit UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 8.5 KD PROTEIN (EC 1.10.2.2)
     AYTSHLSSKT GLHFGRLSLR SLTAYAPNLM LWGGASMLGL FVFTEGWPKF QDTLYKKIPL
     LGPTLEDHTP PEDKPN
>P38152 mit TRICARBOXYLATE TRANSPORT PROTEIN (CITRATE TRANSPORT PROTEIN) (CTP).
     MSSKATKSDV DPLHSFLAGS LAGAAEACIT YPFEFAKTRL QLIDKASKAS RNPLVLIYKT
     AKTQGIGSIY VGCPAFIIGN TAKAGIRFLG FDTIKDLLRD RETGELSGTR GVIAGLGAGL
     LESVAAVTPF EAIKTALIDD KQSATPKYHN NGRGVVRNYS SLVRDKGFSG LYRGVLPVSM
     RQAANQAVRL GCYNKIKTLI QDYTDSPKDK PLSSGLTFLV GAFSGIVTVY STMPLDTVKT
     RMQSLDSTKY SSTMNCFATI FKEEGLKTFW KGATPRLGRL VLSGGIVFTI YEKVLVMLA
>P38300 mit MBA1 PROTEIN PRECURSOR.
     MSVLRSTCLF FPPRSLLISF NKRRLFSTSR LILNKESETT KKKDKSKQQD FNPRHLGVAA
     EIFIPSAYKN LPNVFAHPLI VANALIRRLY TFGLNSVQVA LFRFQSGIKP SFLLWKNKAI
     ETYINVNTSF AHKNLSDIKG LVSLWVQEAL EARSRQLPGN ATLDWQLIKF NAVPKLVSVQ
     PIMIPGMPLE HLQLVYKFDT KQRLIKVNQQ TKKTETLDRD VVDYIAFLCD ATTNDMILMG
     SLFESKPNDK LPKSYEDDAK VAIHRMKVNG DIYRLPPS
>P39515 mit MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE SUBUNIT TIM17
     MSADHSRDPC PIVILNDFGG AFAMGAIGGV VWHGIKGFRN SPLGERGSGA MSAIKARAPV
     LGGNFGVWGG LFSTFDCAVK AVRKREDPWN AIIAGFFTGG ALAVRGGWRH TRNSSITCAC
     LLGVIEGVGL MFQRYAAWQA KPMAPPLPEA PSSQPLQA
>P40416 mit MITOCHONDRIAL TRANSPORTER ATM1 PRECURSOR.
     MLLLPRCPVI GRIVRSKFRS GLIRNHSPVI FTVSKLSTQR PLLFNSAVNL WNQAQKDITH
     KKSVEQFSSA PKVKTQVKKT SKAPTLSELK ILKDLFRYIW PKGNNKVRIR VLIALGLLIS
     AKILNVQVPF FFKQTIDSMN IAWDDPTVAL PAAIGLTILC YGVARFGSVL FGELRNAVFA
     KVAQNAIRTV SLQTFQHLMK LDLGWHLSRQ TGGLTRAMDR GTKGISQVLT AMVFHIIPIS
     FEISVVCGIL TYQFGASFAA ITFSTMLLYS IFTIKTTAWR THFRRDANKA DNKAASVALD
     SLINFEAVKY FNNEKYLADK YNGSLMNYRD SQIKVSQSLA FLNSGQNLIF TTALTAMMYM
     GCTGVIGGNL TVGDLVLINQ LVFQLSVPLN FLGSVYRDLK QSLIDMETLF KLRKNEVKIK
     NAERPLMLPE NVPYDITFEN VTFGYHPDRK ILKNASFTIP AGWKTAIVGS SGSGKSTILK
     LVFRFYDPES GRILINGRDI KEYDIDALRK VIGVVPQDTP LFNDTIWENV KFGRIDATDE
     EVITVVEKAQ LAPLIKKLPQ GFDTIVGERG LMISGGEKQR LAIARVLLKN ARIMFFDEAT
     SALDTHTEQA LLRTIRDNFT SGSRTSVYIA HRLRTIADAD KIIVLDNGRV REEGKHLELL
     AMPGSLYREL WTIQEDLDHL ENELKDQQEL
>P40464 mit MITOCHONDRIAL FAD CARRIER PROTEIN FLX1.
     MVDHQWTPLQ KEVISGLSAG SVTTLVVHPL DLLKVRLQLS ATSAQKAHYG PFMVIKEIIR
     SSANSGRSVT NELYRGLSIN LFGNAIAWGV YFGLYGVTKE LIYKSVAKPG ETQLKGVGND
     HKMNSLIYLS AGASSGLMTA ILTNPIWVIK TRIMSTSKGA QGAYTSMYNG VQQLLRTDGF
     QGLWKGLVPA LFGVSQGALY FAVYDTLKQR KLRRKRENGL DIHLTNLETI EITSLGKMVS
     VTLVYPFQLL KSNLQSFRAN EQKFRLFPLI KLIIANDGFV GLYKGLSANL VRAIPSTCIT
     FCVYENLKHR L
>P46972 mit MITOCHONDRIAL INNER MEMBRANE PROTEASE SUBUNIT 2 (EC 3.4.99.-).
     MFRAGSSKRF LRNTLIAISW VPVLLTINNN VVHIAQVKGT SMQPTLNPQT ETLATDWVLL
     WKFGVKNPSN LSRDDIILFK APTNPRKVYC KRVKGLPFDT IDTKFPYPKP QVNLPRGHIW
     VEGDNYFHSI DSNTFGPISS GLVIGKAITI VWPPSRWGTD LKLSTGRDCI SKRAILE
>P47052 mit PROBABLE SUCCINATE DEHYDROGENASE (UBIQUINONE) FLAVOPROTEIN SUBUNIT 2
     MLSLKKGITK SYILQRTFTS SSVVRQIGEV KSESKPPAKY HIIDHEYDCV VVGAGGAGLR
     AAFGLAEAGY KTACLSKLFP TRSHTVAAQG GINAALGNMH PDDWKSHMYD TVKGSDWLGD
     QDAIHYMTRE APKSVIELEH YGMPFSRTED GRIYQRAFGG QSKDFGKGGQ AYRTCAVADR
     TGHAMLHTLY GQALKNNTHF FIEYFAMDLL THNGEVVGVI AYNQEDGTIH RFRAHKTVIA
     TGGYGRAYFS CTSAHTCTGD GNAMVSRAGF PLEDLEFVQF HPSGIYGSGC LITEGARGEG
     GFLLNSEGER FMERYAPTAK DLASRDVVSR AITMEIRAGR GVGKNKDHIL LQLSHLPPEV
     LKERLPGISE TAAVFAGVDV TQEPIPVLPT VHYNMGGIPT KWTGEALTID EETGEDKVIP
     GLMACGEAAC VSVHGANRLG ANSLLDLVVF GRAVANTIAD TLQPGLPHKP LASNIGHESI
     ANLDKVRNAR GSLKTSQIRL NMQRTMQKDV SVFRTQDTLD EGVRNITEVD KTFEDVHVSD
     KSMIWNSDLV ETLELQNLLT CATQTAVSAS KRKESRGAHA REDYAKRDDV NWRKHTLSWQ
     KGTSTPVKIK YRNVIAHTLD ENECAPVPPA VRSY
>Q00711 mit SUCCINATE DEHYDROGENASE (UBIQUINONE) FLAVOPROTEIN SUBUNIT PRECURSOR
     MLSLKKSALS KLTLLRNTRT FTSSALVRQT QGSVNGSASR SADGKYHIID HEYDCVVIGA
     GGAGLRAAFG LAEAGYKTAC ISKLFPTRSH TVAAQGGINA ALGNMHKDNW KWHMYDTVKG
     SDWLGDQDSI HYMTREAPKS IIELEHYGVP FSRTENGKIY QRAFGGQTKE YGKGAQAYRT
     CAVADRTGHA LLHTLYGQAL RHDTHFFIEY FALDLLTHNG EVVGVIAYNQ EDGTIHRFRA
     HKTIIATGGY GRAYFSCTSA HTCTGDGNAM VSRAGFPLQD LEFVQFHPSG IYGSGCLITE
     GARGEGGFLV NSEGERFMER YAPTAKDLAC RDVVSRAITM EIREGRGVGK KKDHMYLQLS
     HLPPEVLKER LPGISETAAI FAGVDVTKEP IPIIPTVHYN MGGIPTKWNG EALTIDEETG
     EDKVIPGLMA CGEAACVSVH GANRLGANSL LDLVVFGRAV AHTVADTLQP GLPHKPLPSD
     LGKESIANLD KLRNANGSRS TAEIRMNMKQ TMQKDVSVFR TQSSLDEGVR NITAVEKTFD
     DVKTTDRSMI WNSDLVETLE LQNLLTCASQ TAVSAANRKE SRGAHAREDY PNRDDEHWMK
     HTLSWQKDVA APVTLKYRRV IDHTLDEKEC PSVPPTVRAY
>Q01852 mit MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE SUBUNIT TIM44
     MHRSTFIRTS GTSSRTLTAR YRSQYTGLLV ARVLFSTSTT RAQGGNPRSP LQIFRDTFKK
     EWEKSQELQE NIKTLQDASG KLGESEAYKK AREAYLKAQR GSTIVGKTLK KTGETMEHIA
     TKAWESELGK NTRKAAAATA KKLDESFEPV RQTKIYKEVS EVIDDGESSR YGGFITKEQR
     RLKRERDLAS GKRHRAVKSN EDAGTAVVAT NIESKESFGK KVEDFKEKTV VGRSIQSLKN
     KLWDESENPL IVVMRKITNK VGGFFAETES SRVYSQFKLM DPTFSNESFT RHLREYIVPE
     ILEAYVKGDV KVLKKWFSEA PFNVYAAQQK IFKEQDVYAD GRILDIRGVE IVSAKLLAPQ
     DIPVLVVGCR AQEINLYRKK KTGEIAAGDE ANILMSSYAM VFTRDPEQID DDETEGWKIL
     EFVRGGSRQF T
>Q12328 mit MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE SUBUNIT TIM22.
     MVYTGFGLEQ ISPAQKKPYN ELTPEEQGER GAEMIMNFMT SCPGKSVVSG VTGFALGGVL
     GLFMASMAYD TPLHTPTPAN TAATATAGNI GVGGISRTVQ QISDLPFRQQ MKLQFTDMGK
     KSYSSAKNFG YIGMIYAGVE CVIESLRAKN DIYNGVTAGF FTGAGLAYKA GPQAALMGGA
     GFAAFSAAID LYMKSEDGRP PQNDFKE
>Q12375 mit ARG11 PROTEIN.
     MEDSKKKGLI EGAILDIING SIAGACGKVI EFPFDTVKVR LQTQASNVFP TTWSCIKFTY
     QNEGIARGFF QGIASPLVGA CLENATLFVS YNQCSKFLEK HTNVFPLGQI LISGGVAGSC
     ASLVLTPVEL VKCKLQVANL QVASAKTKHT KVLPTIKAII TERGLAGLWQ GQSGTFIRES
     FGGVAWFATY EIVKKSLKDR HSLDDPKRDE SKIWELLISG GSAGLAFNAS IFPADTVKSV
     MQTEHISLTN AVKKIFGKFG LKGFYRGLGI TLFRAVPANA AVFYIFETLS AL
>P32331 mit MITOCHONDRIAL CARRIER PROTEIN YMC1 PRECURSOR.
     MSEEFPSPQL IDDLEEHPQH DNARVVKDLL AGTAGGIAQV LVGQPFDTTK VRLQTSSTPT
     TAMEVVRKLL ANEGPRGFYK GTLTPLIGVG ACVSLQFGVN QAMKRFFHHR NADMSSTLSL
     PQYYACGVTG GIVNSFLASP IEHVRIRLQT QTGSGTNAEF KGPLECIKKL RHNKALLRGL
     TPTILREGHG CGTYFLVYEA LIANQMNKRR GLERKDIPAW KLCIFGALSG TALWLMVYPL
     DVIKSVMQTD NLQKPKFGNS ISSVAKTLYA NGGIGAFFKG FGPTMLRAAP ANGATFATFE
     LAMRLLG
>P32332 mit MITOCHONDRIAL CARRIER PROTEIN PMT.
     MSSDNSKQDK QIEKTAAQKI SKFGSFVAGG LAACIAVTVT NPIELIKIRM QLQGEMSASA
     AKVYKNPIQG MAVIFKNEGI KGLQKGLNAA YIYQIGLNGS RLGFYEPIRS SLNQLFFPDQ
     EPHKVQSVGV NVFSGAASGI IGAVIGSPLF LVKTRLQSYS EFIKIGEQTH YTGVWNGLVT
     IFKTEGVKGL FRGIDAAILR TGAGSSVQLP IYNTAKNILV KNDLMKDGPA LHLTASTISG
     LGVAVVMNPW DVILTRIYNQ KGDLYKGPID CLVKTVRIEG VTALYKGFAA QVFRIAPHTI
     MCLTFMEQTM KLVYSIESRV LGHN
>P38072 mit SCO2 PROTEIN PRECURSOR.
     MLNSSRKYAC RSLFRQANVS IKGLFYNGGA YRRGFSTGCC LRSDNKESPS ARQPLDRLQL
     GDEINEPEPI RTRFFQFSRW KATIALLLLS GGTYAYLSRK RRLLETEKEA DANRAYGSVA
     LGGPFNLTDF NGKPFTEENL KGKFSILYFG FSHCPDICPE ELDRLTYWIS ELDDKDHIKI
     QPLFISCDPA RDTPDVLKEY LSDFHPAIIG LTGTYDQVKS VCKKYKVYFS TPRDVKPNQD
     YLVDHSIFFY LIDPEGQFID ALGRNYDEQS GLEKIREQIQ AYVPKEERER RSKKWYSFIF
     N
>P38087 mit MITOCHONDRIAL CARRIER PROTEIN YMC2 PRECURSOR.
     MSEEFPTPQL LDELEDQQKV TTPNEKRELS SNRVLKDIFA GTIGGIAQVL VGQPFDTTKV
     RLQTATTRTT TLEVLRNLVK NEGVFAFYKG ALTPLLGVGI CVSVQFGVNE AMKRFFQNYN
     ASKNPNMSSQ DVDLSRSNTL PLSQYYVCGL TGGVVNSFLA SPIEQIRIRL QTQTSNGGDR
     EFKGPWDCIK KLKAQGGLMR GLFPTMIRAG HGLGTYFLVY EALVAREIGT GLTRNEIPPW
     KLCLFGAFSG TMLWLTVYPL DVVKSIIQND DLRKPKYKNS ISYVAKTIYA KEGIRAFFKG
     FGPTMVRSAP VNGATFLTFE LVMRFLGEE
>P38127 mit MITOCHONDRIAL CARRIER PROTEIN RIM2.
     MPKKSIEEWE EDAIESVPYL ASDEKGSNYK EATQIPLNLK QSEIENHPTV KPWVHFVAGG
     IGGMAGAVVT CPFDLVKTRL QSDIFLKAYK SQAVNISKGS TRPKSINYVI QAGTHFKETL
     GIIGNVYKQE GFRSLFKGLG PNLVGVIPAR SINFFTYGTT KDMYAKAFNN GQETPMIHLM
     AAATAGWATA TATNPIWLIK TRVQLDKAGK TSVRQYKNSW DCLKSVIRNE GFTGLYKGLS
     ASYLGSVEGI LQWLLYEQMK RLIKERSIEK FGYQAEGTKS TSEKVKEWCQ RSGSAGLAKF
     VASIATYPHE VVRTRLRQTP KENGKRKYTG LVQSFKVIIK EEGLFSMYSG LTPHLMRTVP
     NSIIMFGTWE IVIRLLS
>P38702 mit PUTATIVE MITOCHONDRIAL CARRIER YHR002W.
     MTRDSPDSND SYKHINKNTT QKTSFDRNSF DYIVRSGLAG GISGSCAKTL IAPLDRIKIL
     FQTSNPHYTK YTGSLIGLVE AAKHIWINDG VRGFFQGHSA TLLRIFPYAA VKFVAYEQIR
     NTLIPSKEFE SHWRRLVSGS LAGLCSVFIT YPLDLVRVRL AYETEHKRVK LGRIIKKIYK
     EPASATLIKN DYIPNWFCHW CNFYRGYVPT VLGMIPYAGV SFFAHDLLHD VLKSPFFAPY
     SVLELSEDDE LERVQKKQRR PLRTWAELIS GGLAGMASQT AAYPFEIIRR RLQVSALSPK
     TMYDHKFQSI SEIAHIIFKE RGVRGFFVGL SIGYIKVTPM VACSFFVYER MKWNFGI
>P38921 mit PUTATIVE MITOCHONDRIAL CARRIER PROTEIN PET8.
     MNTFFLSLLS GAAAGTSTDL VFFPIDTIKT RLQAKGGFFA NGGYKGIYRG LGSAVVASAP
     GASLFFISYD YMKVKSRPYI SKLYSQGSEQ LIDTTTHMLS SSIGEICACL VRVPAEVVKQ
     RTQVHSTNSS WQTLQSILRN DNKEGLRKNL YRGWSTTIMR EIPFTCIQFP LYEYLKKTWA
     KANGQSQVEP WKGAICGSIA GGIAAATTTP LDFLKTRLML NKTTASLGSV IIRIYREEGP
     AVFFSGVGPR TMWISAGGAI FLGMYETVHS LLSKSFPTAG EMRA
>P38988 mit PUTATIVE MITOCHONDRIAL CARRIER PROTEIN YHM1/SHM1.
     MPHTDKKQSG LARLLGSASA GIMEIAVFHP VDTISKRLMS NHTKITSGQE LNRVIFRDHF
     SEPLGKRLFT LFPGLGYAAS YKVLQRVYKY GGQPFANEFL NKHYKKDFDN LFGEKTGKAM
     RSAAAGSLIG IGEIVLLPLD VLKIKRQTNP ESFKGRGFIK ILRDEGLFNL YRGWGWTAAR
     NAPGSFALFG GNAFAKEYIL GLKDYSQATW SQNFISSIVG ACSSLIVSAP LDVIKTRIQN
     RNFDNPESGL RIVKNTLKNE GVTAFFKGLT PKLLTTGPKL VFSFALAQSL IPRFDNLLSK
>P39953 mit PUTATIVE MITOCHONDRIAL CARRIER YEL006W.
     MNNGDNKTTL ENSKNASLAN GNYAIPTKLN RLKKNADPRV AAISGALSGA LSAMLVCPFD
     VAKTRLQAQG LQNMTHQSQH YKGFFGTFAT IFKDEGAAGL YKGLQPTVLG YIPTLMIYFS
     VYDFCRKYSV DIFPHSPFLS NASSAITAGA ISTVATNPIW VVKTRLMLQT GIGKYSTHYK
     GTIDTFRKII QQEGAKALYA GLVPALLGML NVAIQFPLYE NLKIRFGYSE STDVSTDVTS
     SNFQKLILAS MLSKMVASTV TYPHEILRTR MQLKSDLPNT VQRHLLPLIK ITYRQEGFAG
     FYSGFATNLV RTVPAAVVTL VSFEYSKKYL TTFFQ
>P40012 mit PROTOPORPHYRINOGEN OXIDASE (EC 1.3.3.4) (PPO).
     MLLPLTKLKP RAKVAVVGGG VSGLCFTYFL SKLRPDVEIT LFESQNRTGG WIYSCNTRDM
     SGNPIMLEKG PRTLRGVSDG TVLIMDTLKD LGKEAVIQSI DKGCIADKKF LLDPSDKLVQ
     VPNSISTTVK FLLNPLGKGL ITGMMGEWFR KKSPHPGQDE SVESICDRRF GNNYISNNMI
     SALLRGIYGD DVSLLSAKRT FKKIYYNELK HGSNTQAMID NMRGKSRSKK TENLHQSLTG
     CLNDYSNAFG KDRSKLLDLS NTLKKYPMLG LAGGLETFPK IVRNALNEFK NVKIVTGNPV
     TQIMKRPANE TTIGLKAKSG DQYETFDHLR LTITPPKIAK LLPKDQNSLS KLLDEIQSNT
     IILVNYYLPN KDVIDADLQG FGYLVPKSNK NPGKLLGVIF DSVIERNFKP LFDKLSTNPN
     ALNKYTKVTA MIGGCMLNEH GVPVVPSREV TINAVKDALN NHLGISNKDL EAGQWEFTIA
     DRCLPRFHVG YDAWQERAER KLQESYGQTV SVGGMGFSRS PGVPDVIVDG FNDALQLSK
>P40035 mit PUTATIVE MITOCHONDRIAL CARRIER YER053C.
     MESNKQPRKI QLYTKEFYAT CTLGGIIACG PTHSSITPLD LVKCRLQVNP KLYTSNLQGF
     RKIIANEGWK KVYTGFGATF VGYSLQGAGK YGGYEYFKHL YSSWLSPGVT VYLMASATAE
     FLADIMLCPF EAIKVKQQTT MPPFCNNVVD GWKKMYAESG GMKAFYKGIV PLWCRQIPYT
     MCKFTSFEKI VQKIYSVLPK KKEEMNALQQ ISVSFVGGYL AGILCAAVSH PADVMVSKIN
     SERKANESMS VASKRIYQKI GFTGLWNGLM VRIVMIGTLT SFQWLIYDSF KAYVGLPTTG
>P40556 mit PUTATIVE MITOCHONDRIAL CARRIER YIL006W.
     MTQTDNPVPN CGLLPEQQYC SADHEEPLLL HEEQLIFPDH SSQLSSADII EPIKMNSSTE
     SIIGTTLRKK WVPLSSTQIT ALSGAFAGFL SGVAVCPLDV AKTRLQAQGL QTRFENPYYR
     GIMGTLSTIV RDEGPRGLYK GLVPIVLGYF PTWMIYFSVY EFSKKFFHGI FPQFDFVAQS
     CAAITAGAAS TTLTNPIWVV KTRLMLQSNL GEHPTHYKGT FDAFRKLFYQ EGFKALYAGL
     VPSLLGLFHV AIHFPIYEDL KVRFHCYSRE NNTNSINLQR LIMASSVSKM IASAVTYPHE
     ILRTRMQLKS DIPDSIQRRL FPLIKATYAQ EGLKGFYSGF TTNLVRTIPA SAITLVSFEY
     FRNRLENIST MVI
>P43617 mit PUTATIVE MITOCHONDRIAL CARRIER YFR045W.
     MIDHKKLEKN QPVVNAKATF HKVATKSTPV ARIEKLLPAV KHMYQTRGPA AFVQGTTATI
     FRQIANTSIQ FTAYTAFKRL LQARNDKASS VITGLATSFT LVAMTQPIDV VKTRMMSQNA
     KTEYKNTLNC MYRIFVQEGM ATFWKGSIFR FMKVGISGGL TFTVYEQVSL LLGFSSRS
>P48233 mit PUTATIVE MITOCHONDRIAL CARRIER YNL083W.
     MLLKNCETDK QRDIRYACLF KELDVKGNGQ VTLDNLISAF EKNDHPLKGN DEAIKMLFTA
     MDVNKDSVVD LSDFKKYASN AESQIWNGFQ RIDLDHDGKI GINEINRYLS DLDNQSICNN
     ELNHELSNEK VNKFSRFFEW AFPKRKANIA LRGQASHKKN TDNDRSKKTT DSDLYVTYDQ
     WRDFLLLVPR KQGSRLHTAY SYFYLFNEDV DLSSEGDVTL INDFIRGFGF FIAGGISGVI
     SRTCTAPFDR LKVFLIARTD LSSILLNSKT DLLAKNPNAD INKISSPLAK AVKSLYRQGG
     IKAFYVGNGL NVIKVFPESS IKFGSFEVTK KIMTKLEGCR DTKDLSKFST YIAGGLAGMA
     AQFSVYPIDT LKFRVQCAPL DTKLKGNNLL FQTAKDMFRE GGGQIILQRC HSRYSGHISL
     CCIRFGDFFC LKKMVYCQTG KDPEPTTRSG HSKQPGCTSN GCIQWNCRSF CCLSNQSFKN
     KTTSPRNICT SLCV
>P53257 mit PUTATIVE MITOCHONDRIAL CARRIER YGR096W.
     MFKEEDSLRK GQNVAAWKTL LAGAVSGLLA RSITAPMDTI KIRLQLTPAN GLKPFGSQVM
     EVARSMIKNE GIRSFWKGNI PGSLLYVTYG SAQFSSYSLF NRYLTPFGLE ARLHSLVVGA
     FAGITSSIVS YPFDVLRTRL VANNQMHSMS ITREVRDIWK LEGLPGFFKG SIASMTTITL
     TASIMFGTYE TIRIYCDENE KTTAAHKKWE LATLNHSAGT IGGVIAKIIT FPLETIRRRM
     QFMNSKHLEK FSRHSSVYGS YKGYGFARIG LQILKQEGVS SLYRGILVAL SKTIPTTFVS
     FWGYETAIHY LRMY
>P53320 mit PUTATIVE MITOCHONDRIAL CARRIER YGR257C.
     MSDRNTSNSL TLKERMLSAG AGSVLTSLIL TPMDVVRIRL QQQQMIPDCS CDGAAEVPNA
     VSSGSKMKTF TNVGGQNLNN AKIFWESACF QELHCKNSSL KFNGTLEAFT KIASVEGITS
     LWRGISLTLL MAIPANMVYF SGYEYIRDVS PIASTYPTLN PLFCGAIARV FAATSIAPLE
     LVKTKLQSIP RSSKSTKTWM MVKDLLNETR QEMKMVGPSR ALFKGLEITL WRDVPFSAIY
     WSSYELCKER LWLDSTRFAS KDANWVHFIN SFASGCISGM IAAICTHPFD VGKTRWQISM
     MNNSDPKGGN RSRNMFKFLE TIWRTEGLAA LYTGLAARVI KIRPSCAIMI SSYEISKKVF
     GNKLHQ
>Q03829 mit PUTATIVE MITOCHONDRIAL CARRIER YMR166C.
     MNSWNLSSSI PIIHTPHDHP PTSEGTPDQP NNNRKDDKLH KKRGDSDEDL SPIWHCVVSG
     GIGGKIGDSA MHSLDTVKTR QQGAPNVKKY RNMISAYRTI WLEEGVRRGL YGGYMAAMLG
     SFPSAAIFFG TYEYTKRTMI EDWQINDTIT HLSAGFLGDF ISSFVYVPSE VLKTRLQLQG
     RFNNPFFQSG YNYSNLRNAI KTVIKEEGFR SLFFGYKATL ARDLPFSALQ FAFYEKFRQL
     AFKIEQKDGR DGELSIPNEI LTGACAGGLA GIITTPMDVV KTRVQTQQPP SQSNKSYSVT
     HPHVTNGRPA ALSNSISLSL RTVYQSEGVL GFFSGVGPRF VWTSVQSSIM LLLYQMTLRG
     LSNAFPTD
>Q04487 mit PUTATIVE SUCCINATE DEHYDROGENASE CYTOCHROME B SUBUNIT PRECURSOR.
     MKATIQRVTS VFGVPRASVF VPRISTPFIL HNYISNGRMD LFSKEFHNGR VSKSDLWSSN
     KEEELLVSQR KKRPISPHLT VYEPEMSWYL SSLHRISGVL LALGFYAFTI TLGVTTIMGM
     DTTFQDLNKW YHEKMPKWSQ WVAKGSAAYL FAFHFGNGIR HLIWDMGYEL TNRGVIKTGS
     IVLAGTLVLG TYLLAQ
>Q08822 mit PROBABLE ELECTRON TRANSFER FLAVOPROTEIN-UBIQUINONE OXIDOREDUCTASE
     MIKFTNENLI RGIRMTISAK SRHLALGTDM TRKFSLSCRF LNKANLTEEE KELLNEPRAR
     DYVDVCIVGG GPAGLATAIK LKQLDNSSGT GQLRVVVLEK SSVLGGQTVS GAILEPGVWK
     ELFPDEKSDI GIPLPKELAT LVTKEHLKFL KGKWAISVPE PSQMINKGRN YIVSLNQVVG
     YLGEKAEEVG VEVYPGIAVS DLIYDENNAV KGVITKDAGI SKSGKPKETF ERGMEFWARQ
     TVLAEGCHGS LTKQALAKYD LRKGRQHQTY GLGIKEVWEV KPENFNKGFA AHTMGYPLTN
     DVYGGGFQYH FGDGLVTVGL VVGLDYKNPY VSPYKEFQKM KHHPYYSKVL EGGKCIAYAA
     RALNEGGLQS VPKLNFPGGV LVGASAGFMN VPKIKGTHTA MKSGLLAAES IFESIKGLPV
     LEEVEDEDAK MAMFDKEATI NLESYESAFK ESSIYKELYE VRNIRPSFSG KLGGYGGMIY
     SGIDSLILKG KVPWTLKFDE KNDGEILEPA SKYKPIEYPK PDGVISFDIL TSVSRTGTYH
     DDDEPCHLRV PGQDMVKYAE RSFPVWKGVE SRFCPAGVYE FVKDEKSPVG TRLQINSQNC
     IHCKTCDIKA PRQDITWKVP EGGDGPKYTL T
>P07390 mit PET494 PROTEIN.
     MHLKKGKRSI STVWRLLWKR FYSVNSKTNM HFSRSRKKPV TNFTRTNGLL LSCNGDTFPY
     LRTLWRYFNA PGNLMFVTTN IVAFMGIVTY NTLVTISSER AFEEQMMAAQ VSLAKQREEL
     ETTALSLPRD IELRGEEDDI KWEQPDVAHV REDPLVEEQN AKLDTPIKQY TLGDLILNKR
     ENVTDYDSQR AKASIFHMLY AYMLYRDVIQ PTTMTQNNNS EEWRREVELL TKGKEVQGTH
     RRIDVFYDLW NKNFDKIVTS PEKVQNFQLP NWSKYPTILK FICTELHDNS LKTLGEFKQF
     YGKVRSNEVK KLLGLWLYDH SFLFPHNIYD NRTEEDFYDI LINDSMQDNR IFQKYSSIVM
     NPYNERTQLF FPNVNSPSVN KPVPSISLET YTRLLKGYIN LQETGCKYDY NDNIFKLISI
     LKLNCFLQRN KKKHAGPTVR ILLPRDEDRS QILGTISQAE KRTCYQILSK NRDVVALLKR
     ISDIQADSS
>P10355 mit PET122 PROTEIN PRECURSOR.
     MLTITKRLVT TDVRSRILLS SLNGKMSDAL ALLRQQQQTS VDVELLHTML ARAAALAHAD
     TIAYMWYQHV MPRRLPVEGR LLCEMAGVAL YQDRLFLPAQ FLQHYQAMNR DRRTSPEDEL
     IEYELRRIKV EAFARGTMHS TALREKWKVF LQEMDTLPGQ PPLRLRDFPQ MTKAMGIALM
     QQDEQAAALA LFGRQPLVIK NEWSLPLLLA GVLWHVPGPA QARRVLAEFR QSYRGLPLLD
     AELVIKRRGF EINT
>P10834 mit PET54 PROTEIN.
     MKASSKAIKL VLDHLKSTGR VLGSVESGNS ATISEKTASV NKQQQLQEKK PSVLQYRSYN
     PYLVKEDFLS ILPENLYKKR GQFTNELDFQ LMKVRDPKYF QFKDQYYLFF NDYNSLTEYI
     KLTKHSRINK IRVKMTPLAQ PLPTLLTKLQ RYSKNLYNAF RSSEQYFEGL NEKVDVSGEF
     TTNQLRSILD SVEEIENKSV LVWNIPTKLR SHDILNYFWF YNIRSSFKIY WDDEMKRNLR
     FISFENSHDA YRFKRNYHGL LAKELLTLSE KGDAADYSLE MDDSKILIEH LSE
>P16622 mit FERROCHELATASE PRECURSOR (EC 4.99.1.1) (PROTOHEME FERRO-LYASE) (HEME
     MLSRTIRTQG SFLRRSQLTI TRSFSVTFNM QNAQKRSPTG IVLMNMGGPS KVEETYDFLY
     QLFADNDLIP ISAKYQKTIA KYIAKFRTPK IEKQYREIGG GSPIRKWSEY QATEVCKILD
     KTCPETAPHK PYVAFRYAKP LTAETYKQML KDGVKKAVAF SQYPHFSYST TGSSINELWR
     QIKALDSERS ISWSVIDRWP TNEGLIKAFS ENITKKLQEF PQPVRDKVVL LFSAHSLPMD
     VVNTGDAYPA EVAATVYNIM QKLKFKNPYR LVWQSQVGPK PWLGAQTAEI AEFLGPKVDG
     LMFIPIAFTS DHIETLHEID LGVIGESEYK DKFKRCESLN GNQTFIEGMA DLVKSHLQSN
     QLYSNQLPLD FALGKSNDPV KDLSLVFGNH EST
>P07143 mit CYTOCHROME C1, HEME PROTEIN PRECURSOR.
     MFSNLSKRWA QRTLSKSFYS TATGAASKSG KLTQKLVTAG VAAAGITAST LLYADSLTAE
     AMTAAEHGLH APAYAWSHNG PFETFDHASI RRGYQVYREV CAACHSLDRV AWRTLVGVSH
     TNEEVRNMAE EFEYDDEPDE QGNPKKRPGK LSDYIPGPYP NEQAARAANQ GALPPDLSLI
     VKARHGGCDY IFSLLTGYPD EPPAGVALPP GSNYNPYFPG GSIAMARVLF DDMVEYEDGT
     PATTSQMAKD VTTFLNWCAE PEHDERKRLG LKTVIILSSL YLLSIWVKKF KWAGIKTRKF
     VFNPPKPRK
>Q00873 mit CYTOCHROME C1 HEME LYASE (EC 4.4.1.-) (CC1HL).
     MMSSDQQGKC PVDEETKKLW LREHGNEAHP GATAPGNQLE CSANPQDNDK TPEYHTTVDL
     SQSREVSTIP RTNSDRNWIY PSEKQFYEAM MKKNWDPNSD DMKVVVPLHN SINERVWNYI
     KSWEDKQGGE ACGGIKLTNF KGDSKKLTPR AWFRSRILHL AKPFDRHDWQ IDRCGKTVDY
     VIDFYSTDLN DANSQQQPLI YLDVRPKLNS FEGFRLRFWK SLGF
>P80235 mit PUTATIVE MITOCHONDRIAL CARNITINE O-ACETYLTRANSFERASE (EC 2.3.1.7).
     MPNLKRLPIP PLQDTLNRYL ARVETLQDER QNRRTRRTVL SAENLDALNT LHERLLEYDA
     RLAESNPESS YIEQFWYDAY LLYDATVVLN VNPYFQLQDD PTIKDTPETA AQGPYGAHTV
     QVRRAARLTT SILKFIRQIR HGTLRTDTVR GKTPLSMDQY ERLFGSSRIP PGPGEPSCHL
     QTDATSHHVV AMYRGQFYWF DVLDTRNEPI FATPEQLEWN LYSIIMDAES AGSGSAPFGV
     FTTESRRVWS NIRDYLFHAD DCTNWRNLKL IDSALFVVCL DDVAFAADQQ DELTRSMLCG
     TSTINLDPHQ HQPPLNVQTG TCLNRWYDKL QLIVTKNGKA GINFEHTGVD GHTVLRLATD
     IYTDSILSFA RGVTKNVVDI FSDDDGKPSS SSSLASAAHS ANLITIPRKL EWRTDNFLQS
     SLHFAETRIS DLISQYEFVN LDFSNYGASH IKTVFKCSPD AFVQQVFQVA YFALYGRFET
     VYEPAMTKAF QNGRTEAIRS VTGQSKLFVK SLLDQDASDA TKIQLLHDAC TAHSQITREC
     SQGLGQDRHL YALYCLWNQW YKDKLELPPI FRDKSWTTMQ NNVLSTSNCG NPCLKASGFG
     PVTANGFGIG YIIRDHSVSV VVSSRHRQTA RFASLMEKSL LEIDRIFKRQ QARTAKPAAR
     ATASANTKSE DMKYLLSGYD YFDVSVSG
>P32340 mit ROTENONE-INSENSITIVE NADH-UBIQUINONE OXIDOREDUCTASE PRECURSOR
     MLSKNLYSNK RLLTSTNTLV RFASTRSTGV ENSGAGPTSF KTMKVIDPQH SDKPNVLILG
     SGWGAISFLK HIDTKKYNVS IISPRSYFLF TPLLPSAPVG TVDEKSIIEP IVNFALKKKG
     NVTYYEAEAT SINPDRNTVT IKSLSAVSQL YQPENHLGLH QAEPAEIKYD YLISAVGAEP
     NTFGIPGVTD YGHFLKEIPN SLEIRRTFAA NLEKANLLPK GDPERRRLLS IVVVGGGPTG
     VEAAGELQDY VHQDLRKFLP ALAEEVQIHL VEALPIVLNM FEKKLSSYAQ SHLENTSIKV
     HLRTAVAKVE EKQLLAKTKH EDGKITEETI PYGTLIWATG NKARPVITDL FKKIPEQNSS
     KRGLAVNDFL QVKGSNNIFA IGDNAFAGLP PTAQVAHQEA EYLAKNFDKM AQIPNFQKNL
     SSRKDKIDLL FEENNFKPFK YNDLGALAYL GSERAIATIR SGKRTFYTGG GLMTFYLWRI
     LYLSMILSAR SRLKVFFDWI KLAFFKRDFF KGL
>P00175 mit CYTOCHROME B2 PRECURSOR (EC 1.1.2.3) (L-LACTATE DEHYDROGENASE
     MLKYKPLLKI SKNCEAAILR ASKTRLNTIR AYGSTVPKSK SFEQDSRKRT QSWTALRVGA
     ILAATSSVAY LNWHNGQIDN EPKLDMNKQK ISPAEVAKHN KPDDCWVVIN GYVYDLTRFL
     PNHPGGQDVI KFNAGKDVTA IFEPLHAPNV IDKYIAPEKK LGPLQGSMPP ELVCPPYAPG
     ETKEDIARKE QLKSLLPPLD NIINLYDFEY LASQTLTKQA WAYYSSGAND EVTHRENHNA
     YHRIFFKPKI LVDVRKVDIS TDMLGSHVDV PFYVSATALC KLGNPLEGEK DVARGCGQGV
     TKVPQMISTL ASCSPEEIIE AAPSDKQIQW YQLYVNSDRK ITDDLVKNVE KLGVKALFVT
     VDAPSLGQRE KDMKLKFSNT KAGPKAMKKT NVEESQGASR ALSKFIDPSL TWKDIEELKK
     KTKLPIVIKG VQRTEDVIKA AEIGVSGVVL SNHGGRQLDF SRAPIEVLAE TMPILEQRNL
     KDKLEVFVDG GVRRGTDVLK ALCLGAKGVG LGRPFLYANS CYGRNGVEKA IEILRDEIEM
     SMRLLGVTSI AELKPDLLDL STLKARTVGV PNDVLYNEVY EGPTLTEFED A
>P19516 mit CYTOCHROME C OXIDASE ASSEMBLY PROTEIN COX11.
     MIRICPIVRS KVPLLGTFLR SDSWLAPHAL ALRRAICKNV ALRSYSVNSE QPKHTFDISK
     LTRNEIQQLR ELKRARERKF KDRTVAFYFS SVAVLFLGLA YAAVPLYRAI CARTGFGGIP
     ITDRRKFTDD KLIPVDTEKR IRISFTSEVS QILPWKFVPQ QREVYVLPGE TALAFYKAKN
     YSDKDIIGMA TYSIAPGEAA QYFNKIQCFC FEEQKLAAGE EIDMPVFFFI DPDFASDPAM
     RNIDDIILHY TFFRAHYGDG TAVSDSKKEP EMNADEKAAS LANAAILSPE VIDTRKDNSN
>P00044 mit CYTOCHROME C, ISO-1.
     TEFKAGSAKK GATLFKTRCL QCHTVEKGGP HKVGPNLHGI FGRHSGQAEG YSYTDANIKK
     NVLWDENNMS EYLTNPKKYI PGTKMAFGGL KKEKDRNDLI TYLKKACE
>P00045 mit CYTOCHROME C, ISO-2.
     MAKESTGFKP GSAKKGATLF KTRCQQCHTI EEGGPNKVGP NLHGIFGRHS GQVKGYSYTD
     ANINKNVKWD EDSMSEYLTN PKKYIPGTKM AFAGLKKEKD RNDLITYMTK AAK
>P00431 mit CYTOCHROME C PEROXIDASE PRECURSOR (EC 1.11.1.5) (CCP).
     MTTAVRLLPS LGRTAHKRSL YLFSAAAAAA AAATFAYSQS QKRSSSSPGG GSNHGWNNWG
     KAAALASTTP LVHVASVEKG RSYEDFQKVY NAIALKLRED DEYDNYIGYG PVLVRLAWHT
     SGTWDKHDNT GGSYGGTYRF KKEFNDPSNA GLQNGFKFLE PIHKEFPWIS SGDLFSLGGV
     TAVQEMQGPK IPWRCGRVDT PEDTTPDNGR LPDADKDADY VRTFFQRLNM NDREVVALMG
     AHALGKTHLK NSGYEGPWGA ANNVFTNEFY LNLLNEDWKL EKNDANNEQW DSKSGYMMLP
     TDYSLIQDPK YLSIVKEYAN DQDKFFKDFS KAFEKLLENG ITFPKDAPSP FIFKTLEEQG
     L
>P00447 mit SUPEROXIDE DISMUTASE PRECURSOR (MN) (EC 1.15.1.1).
     MFAKTAAANL TKKGGLSLLS TTARRTKVTL PDLKWDFGAL EPYISGQINE LHYTKHHQTY
     VNGFNTAVDQ FQELSDLLAK EPSPANARKM IAIQQNIKFH GGGFTNHCLF WENLAPESQG
     GGEPPTGALA KAIDEQFGSL DELIKLTNTK LAGVQGSGWA FIVKNLSNGG KLDVVQTYNQ
     DTVTGPLVPL VAIDAWEHAY YLQYQNKKAD YFKAIWNVVN WKEASRRFDA GKI
>P00890 mit CITRATE SYNTHASE, MITOCHONDRIAL PRECURSOR (EC 4.1.3.7).
     MSAILSTTSK SFLSRGSTRQ CQNMQKALFA LLNARHYSSA SEQTLKERFA EIIPAKAEEI
     KKFKKEHGKT VIGEVLLEQA YGGMRGIKGL VWEGSVLDPE EGIRFRGRTI PEIQRELPKA
     EGSTEPLPEA LFWLLLTGEI PTDAQVKALS ADLAARSEIP EHVIQLLDSL PKDLHPMAQF
     SIAVTALESE SKFAKAYAQG VSKKEYWSYT FEDSLDLLGK LPVIASKIYR NVFKDGKITS
     TDPNADYGKN LAQLLGYENK DFIDLMRLYL TIHSDHEGGN VSAHTTHLVG SALSSPYLSL
     AAGLNGLAGP LHGRANQEVL EWLFKLREEV KGDYSKETIE KYLWDTLNAG RVVPGYGHAV
     LRKTDPRYTA QREFALKHFP DYELFKLVST IYEVAPGVLT KHGKTKNPWP NVDSHSGVLL
     QYYGLTEASF YTVLFGVARA IGVLPQLIID RAVGAPIERP KSFSTEKYKE LVKKIESKN
>P04803 mit TRYPTOPHANYL-TRNA SYNTHETASE, MITOCHONDRIAL (EC 6.1.1.2) (TRYPTOPHAN--
     MSNKQAVLKL ISKRWISTVQ RADFKLNSEA LHSNATVFSM IQPTGCFHLG NYLGATRVWT
     DLCELKQPGQ ELIFGVADLH AITVPKPDGE MFRKFRHEAV ASILAVGVDP EKASVIYQSA
     IPQHSELHWL LSTLASMGLL NRMTQWKSKS NIKQSTNGDY LVNDSDVGKV RLGLFSYPVL
     QAADILLYKS THVPVGDDQS QHLELTRHLA EKFNKMYKKN FFPKPVTMLA QTKKVLSLST
     PEKKMSKSDP NHDSVIFLND EPKAIQKKIR KALTDSISDR FYYDPVERPG VSNLINIVSG
     IQRKSIEDVV EDVSRFNNYR DFKDYVSEVI IEELKGPRTE FEKYINEPTY LHSVVESGMR
     KAREKAAKNL ADIHKIMGF
>P07236 mit THREONYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.3)
     MKIQLVRWHC SRNALWNRAF YSTRKATKNA SSATPATMTS MVSQRQDLFM TDPLSPGSMF
     FLPNGAKIFN KLIEFMKLQQ KFKFGFNEVV TPLIYKKTLW EKSGHWENYA DDMFKVETTD
     EEKEEYGLKP MNCPGHCLIF GKKDRSYNEL PLRFSDFSPL HRNEASGALS GLTRLRKFHQ
     DDGHIFCTPS QVKSEIFNSL KLIDIVYNKI FPFVKGGSGA ESNYFINFST RPDHFIGDLK
     VWNHAEQVLK EILEESGKPW KLNPGDGAFY GPKLDIMVTD HLRKTHQVAT IQLDFQLPER
     FDLKFKDQDN SYKRPIMIHR ATFGSIERFM ALLIDSNEGR WPFWLNPYQA VIIPVNTKNV
     QQLDMCTALQ KKLRNELEAD DMEPVPLNDW HFNVDLDIRN EPVGYRIKSA ILKNYSYLII
     VGDEEVQLQK YNIRERDNRK SFEKLTMSQI WEKFIELEKN YK
>P07275 mit DELTA-1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE PRECURSOR (EC 1.5.1.12)
     MLSARCLKSI YFKRSFSQLG HIKPPKHIRN EPVKPFRNID LKDWDLLRAS LMKFKSSSLE
     VPLVINGERI YDNNERALFP QTNPANHQQV LANVTQATEK DVMNAVKAAK DAKKDWYNLP
     FYDRSAIFLK AADLISTKYR YDMLAATMLG QGKNVYQAEI DCITELSDFF RYYVKYASDL
     YAQQPVESAD GTWNKAEYRP LEGFVYAVSP FNFTAIAANL IGAPALMGNT VVWKPSQTAA
     LSNYLLMTVL EEAGLPKGVI NFIPGDPVQV TDQVLADKDF GALHFTGSTN VFKSLYGKIQ
     SGVVEGKYRD YPRIIGETGG KNFHLVHPSA NISHAVLSTI RGTFEFQGQK CSAASRLYLP
     ESKSEEFLSD MFGILQSQNV VPMNTSASPI SGGNLRGFMG PVIHEQSFDK LVKVIEDAKK
     DPELEILYGG QYDKSQGWFV GPTVIKAKRP DHPYMSTEFF GPILTVYEYP DTEFNEICDI
     IDNTSQYALT GAIFAKDRKA IEYADEKLKF SAGNFYINDK CTGAVVSQQW FGGARMSGTD
     DKAGGPNILS RFVSIRNTKE NFYELTDFKY PSNYE
>P08425 mit PHENYLALANYL-TRNA SYNTHETASE MITOCHONDRIAL PRECURSOR (EC 6.1.1.20)
     MEVTSMFLNR MMKTRTGLYR LYSTLKVPHV EINGIKYKTD PQTTNVTDSI IKLTDRSLHL
     KESHPVGILR DLIEKKLNSV DNTFKIFNNF KPVVTTMENF DSLGFPKDHP GRSKSDTYYI
     NETHLLRTHT SAHELECFQK IRNDSDNIKS GFLISADVYR RDEIDKTHYP VFHQMEGATI
     WKRTKADVGV KEPMYIEKIR EDIRQVENLL NKENVKITVD DDTIPLKENN PKQEYMSDLE
     VDLCSQHLKR SIELIVSEVF NKKISSMIKN KANNTPKELK VRWINAYFPW TAPSWEIEVW
     WQGEWLELCG CGLIRQDVLL RAGYKPSETI GWAFGLGLDR IAMLLFEIPD IRLLWSRDER
     FSRQFSKGLI TSFKPYSKHP GSFRDVAFWL PEDKPDIHQV HENDLMEIIR NIAGDLVESV
     KLVDSFTHPK TGRKSMCYRI NYQSMDRNLT NAEVNTLQDM VCSKLVKEYS VELR
>P08468 mit PET111 PROTEIN PRECURSOR.
     MLQRRFISSS GIKRLLHRES NKVMHTVFFK VRYYSTELIK KKHKEDIEDW VKAQLKDSST
     ISGVYESRNK LDWMDSITKS PSSLDILKNQ YNIVKDKDFG ILWKQKFESA DPDILMTIIS
     LSTNQKVLFS IQQLLILINS LHFLKRDYDI GQIYTTYEQF TPLLASHTDK GTYGQFIEIM
     LVVQHNLHHF DVCETLFAEY IKYCKVKPQM ISLGLNSFIR SNNTQLAVEF YTQAITNPDT
     FPITEKQLFE FLRCMERYLD MSSMKHIFYL WLKVKCGDEQ SSSTNLPSFK TLAIIHRMLL
     RFSNTDELND FLTNPVVLST GYTSSVQFEL IEFCHSLYCI KGDRTKSIDD SILMERVDKF
     ITRLNNNIST RKELYMSVVQ AYVSTNNFEN LKVILEKIQR DNDISIDGSF HLCISRYFVN
     TNQFEGLFKY YRSVVKTTDG KTRLRPAFIQ QLWSCAVNVY PMLAKEITND LLVTLKRSQY
     SKCLTWVYTF LQENAHIHTR KINGGEDSSL SGFNAVDFER FEEFKKKVSH NDVYGAELVI
     SNSLKEGIAP QFSFLYSVLA LCLRNSLTGL ARVVDVILRT RFRYIPLKVD ILWLKWEIIS
     NYRSFEKLSA EHLKELEFKL KEFERVHQKE LSVQNYLQLT QICFHTRDFK YACYLISQAR
     KNLDTSNNKQ WMMYYMTSLK LASRMHESER FSRILKDWNC NHRASLITPG CIRQIKGFMK
     YFEKRPAYIS TAASIDNKEI KDRIDELVLR YVDYKYQGLE NMRKLTLFLK EWFDEEISLL
     KLEQNERKMK LFEENKKEEE
>P09368 mit PROLINE OXIDASE PRECURSOR (EC 1.5.3.-).
     MIASKSSLLV TKSRIPSLCF PLIKRSYVSK TPTHSNTAAN LMVETPAANA NGNSVMAPPN
     SINFLQTLPK KELFQLGFIG IATLNSFFLN TIIKLFPYIP IPVIKFFVSS LYCGGENFKE
     VIECGKRLQK RGISNMMLSL TIENSEGTKS LSSTPVDQIV KETISSVHNI LLPNIIGQLE
     SKPINDIAPG YIALKPSALV DNPHEVLYNF SNPAYKAQRD QLIENCSKIT KEIFELNQSL
     LKKYPERKAP FMVSTIDAEK YDLQENGVYE LQRILFQKFN PTSSKLISCV GTWQLYLRDS
     GDHILHELKL AQENGYKLGL KLVRGAYIHS EKNRNQIIFG DKTGTDENYD RIITQVVNDL
     IINGEDSYFG HLVVASHNYQ SQMLVTNLLK STQDNSYAKS NIVLGQLLGM ADNVTYDLIT
     NHGAKNIIKY VPWGPPLETK DYLLRRLQEN GDAVRSDNGW PLIKAIAKSI PKRVGL
>P09624 mit DIHYDROLIPOAMIDE DEHYDROGENASE PRECURSOR (EC 1.8.1.4).
     MLRIRSLLNN KRAFSSTVRT LTINKSHDVV IIGGGPAGYV AAIKAAQLGF NTACVEKRGK
     LGGTCLNVGC IPSKALLNNS HLFHQMHTEA QKRGIDVNGD IKINVANFQK AKDDAVKQLT
     GGIELLFKKN KVTYYKGNGS FEDETKIRVT PVDGLEGTVK EDHILDVKNI IVATGSEVTP
     FPGIEIDEEK IVSSTGALSL KEIPKRLTII GGGIIGLEMG SVYSRLGSKV TVVEFQPQIG
     ASMDGEVAKA TQKFLKKQGL DFKLSTKVIS AKRNDDKNVV EIVVEDTKTN KQENLEAEVL
     LVAVGRRPYI AGLGAEKIGL EVDKRGRLVI DDQFNSKFPH IKVVGDVTFG PMLAHKAEEE
     GIAAVEMLKT GHGHVNYNNI PSVMYSHPEV AWVGKTEEQL KEAGIDYKIG KFPFAANSRA
     KTNQDTEGFV KILIDSKTER ILGAHIIGPN AGEMIAEAGL ALEYGASAED VARVCHAHPT
     LSEAFKEANM AAYDKAIHC
>P09950 mit 5-AMINOLEVULINIC ACID SYNTHASE, MITOCHONDRIAL PRECURSOR (EC 2.3.1.37)
     MQRSIFARFG NSSAAVSTLN RLSTTAAPHA KNGYATATGA GAAAATATAS STHAAAAAAA
     AANHSTQESG FDYEGLIDSE LQKKRLDKSY RYFNNINRLA KEFPLAHRQR EADKVTVWCS
     NDYLALSKHP EVLDAMHKTI DKYGCGAGGT RNIAGHNIPT LNLEAELATL HKKEGALVFS
     SCYVANDAVL SLLGQKMKDL VIFSDELNHA SMIVGIKHAN VKKHIFKHND LNELEQLLQS
     YPKSVPKLIA FESVYSMAGS VADIEKICDL ADKYGALTFL DEVHAVGLYG PHGAGVAEHC
     DFESHRASGI ATPKTNDKGG AKTVMDRVDM ITGTLGKSFG SVGGYVAASR KLIDWFRSFA
     PGFIFTTTLP PSVMAGATAA IRYQRCHIDL RTSQQKHTMY VKKAFHELGI PVIPNPSHIV
     PVLIGNADLA KQASDILINK HQIYVQAINF PTVARGTERL RITPTPGHTN DLSDILINAV
     DDVFNELQLP RVRDWESQGG LLGVGESGFV EESNLWTSSQ LSLTNDDLNP NVRDPIVKQL
     EVSSGIKQ
>P10507 mit MITOCHONDRIAL PROCESSING PEPTIDASE BETA SUBUNIT PRECURSOR
     MFSRTASKFR NTRRLLSTIS SQIPGTRTSK LPNGLTIATE YIPNTSSATV GIFVDAGSRA
     ENVKNNGTAH FLEHLAFKGT QNRSQQGIEL EIENIGSHLN AYTSRENTVY YAKSLQEDIP
     KAVDILSDIL TKSVLDNSAI ERERDVIIRE SEEVDKMYDE VVFDHLHEIT YKDQPLGRTI
     LGPIKNIKSI TRTDLKDYIT KNYKGDRMVL AGAGAVDHEK LVQYAQKYFG HVPKSESPVP
     LGSPRGPLPV FCRGERFIKE NTLPTTHIAI ALEGVSWSAP DYFVALATQA IVGNWDRAIG
     TGTNSPSPLA VAASQNGSLA NSYMSFSTSY ADSGLWGMYI VTDSNEHNVQ LIVNEILKEW
     KRIKSGKISD AEVNRAKAQL KAALLLSLDG STAIVEDIGR QVVTTGKRLS PEEVFEQVDK
     ITKDDIIMWA NYRLQNKPVS MVALGNTSTV PNVSYIEEKL NQ
>P10849 mit NAM1 PROTEIN PRECURSOR (MITOCHONDRIAL TRANSCRIPTION FACTOR 2).
     MIRTSSILKN CNYRYIHCIH RCLLNEANLK DRKTHNVERV SNEKTFEQAL EEERKVFGEL
     FEAGARVENM RHTNASKIID KYYNGLQDNS EGTSVKKEKI VFNHSQRAQR KLPNKDHEFL
     KETAGNDYVY ERAEPSAIST KTISEQTRTL LEKIFDEDNS INKSNRELLN LNLRKGSGME
     ALRQPVAHSN VKFSEEVMQE IGNKIRYQTT LDQVLEPHID YLREAVKSDY DLLRYLKQSL
     DIYKKRNKDL ELKMNAESSN IFEDIRSACI NKPAELPKPL AMTLPYIIVK SLRLGDFDFP
     ADRKYTLISY VYNECKNNMD ASLYLTICNV DFYNLLVQLL WENFQEIRYL RRVVTEMSVN
     GVIGNIETVD ILDKIVKEMR SLNEDVFLEA GEQLSADEEV SSSANKIVNV GVLWNKDTNN
     DLLIVENYLK SLKKNLTRDR
>P11325 mit LEUCYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.4)
     MLSRPSSRFL STKRGPGPAV KKLIAIGEKW KQKTTRGLPK QDTLNSGSKY ILCQFPYPSG
     ALHIGHLRVY VISDSLNRFY KQKGYNVIHP MGWDAFGLPA ENAAIERSIN PAIWTRDNIA
     KMKQQMQSML ANFDWDREIT TCDPEYYKFT QWIFLKLFEN GLAYRKEAEI NWDPVDMTVL
     ANEQVDAQGR SWRSGAIVEK KQLKQWFLGI TKFAPKLKKH LNQLKDWPSN VKQMQKNWIG
     ESVGAELVFK VADPKFENLI VFTTRPETLF AVQYVALALD HPIVQKYCEE MPDLKEFIQK
     SDQLPNDTKE GFQLPNIKAV NPLTKEEVPI FAAPYVVSSY GSAPSAVMGC PGHDNRDFEF
     WQTNCPGEHI KTCIAPFFDD ASKVTEQERQ RIIDTVPFTS TDGVLTKECG EHSGVLTVVA
     RKSIMGMLNS EGLSKSVVRY KIRDWLISRQ RYWGTPIPII HCDNCGPVPV PESDLPVKLP
     ELEGLDTKGN PLSTIDEFVN VACPSCGSPA KRETDTMDTF IDSSWYYFRF LDPKNTSKPF
     DREIASKNMP VDIYIGGVEH AILHLLYSRF IAKFLGSINA WSDPAGIFEP FKKLVTQGMV
     QGKTYVDPDS GKFLKPDELT FVNDSPDGNT VIIKSNGKVP VVSYEKMSKS KYNGADPNEC
     ILRHGPDATR AHILFQSPIA DALNWDESKI VGIERWLQKV LHLTKNILSL EKDLAISKDY
     KTPTDLNDAE VKFHNDFQRF LKSITESFEV NLSLNTVISD YMKLTNILES ALKKGEVRNE
     MIVQNLQKLV TVIYPAVPSI SEEAAEMINS QMEWNQYRWP EVERTTESKF KKFQIVVNGR
     VKFMYTADKN FLKLGRDAVI ETLMNLPEGR MYLMNKKIKK FVMKFNVISF LFHK
>P11914 mit MITOCHONDRIAL PROCESSING PEPTIDASE ALPHA SUBUNIT PRECURSOR
     MLRNGVQRLY SNIARTDNFK LSSLANGLKV ATSNTPGHFS ALGLYIDAGS RFEGRNLKGC
     THILDRLAFK STEHVEGRAM AETLELLGGN YQCTSSRENL MYQASVFNQD VGKMLQLMSE
     TVRFPKITEQ ELQEQKLSAE YEIDEVWMKP ELVLPELLHT AAYSGETLGS PLICPRELIP
     SISKYYLLDY RNKFYTPENT VAAFVGVPHE KALELTEKYL GDWQSTHPPI TKKVAQYTGG
     ESCIPPAPVF GNLPELFHIQ IGFEGLPIDH PDIYALATLQ TLLGGGGSFS AGGPGKGMYS
     RLYTHVLNQY YFVENCVAFN HSYSDSGIFG ISLSCIPQAA PQAVEVIAQQ MYNTFANKDL
     RLTEDEVSRA KNQLKSSLLM NLESKLVELE DMGRQVLMHG RKIPVNEMIS KIEDLKPDDI
     SRVAEMIFTG NVNNAGNGKG RATVVMQGDR GSFGDVENVL KAYGLGNSSS SKNDSPKKKG
     WF
>P12695 mit DIHYDROLIPOAMIDE ACETYLTRANSFERASE COMPONENT (E2) OF PYRUVATE
     MSAFVRVVPR ISRSSVLTRS LRLQLRCYAS YPEHTIIGMP ALSPTMTQGN LAAWTKKEGD
     QLSPGEVIAE IETDKAQMDF EFQEDGYLAK ILVPEGTKDI PVNKPIAVYV EDKADVPAFK
     DFKLEDSGSD SKTSTKAQPA EPQAEKKQEA PAEETKTSAP EAKKSDVAAP QGRIFASPLA
     KTIALEKGIS LKDVHGTGPR GRITKADIES YLEKSSKQSS QTSGAAAATP AAATSSTTAG
     SAPSPSSTAS YEDVPISTMR SIIGERLLQS TQGIPSYIVS SKISISKLLK LRQSLNATAN
     DKYKLSINDL LVKAITVAAK RVPDANAYWL PNENVIRKFK NVDVSVAVAT PTGLLTPIVK
     NCEAKGLSQI SNEIKELVKR ARINKLAPEE FQGGTICISN MGMNNAVNMF TSIINPPQST
     ILAIATVERV AVEDAAAENG FSFDNQVTIT GTFDHRTIDG AKGAEFMKEL KTVIENPLEM
     LL
>P15179 mit ASPARTYL-TRNA SYNTHETASE, MITOCHONDRIAL (EC 6.1.1.12) (ASPARTATE--TRNA
     MLARSRVCLQ TITRRLADFP EANAIKKKFL FRKDTSTIKQ LKGLSSGQKI VLNGWIEQKP
     KRVGKNLIFG LLRDSNGDII QLVDNKSLLK GFTLEDVVQA VGILSLKRKL SNEDADEYEV
     QLEDITVLNA SNKKPAQMQD FKLSAIYPPE FRYLQLRNPK YQDFLKKRSS ISKEIRNSFN
     NFDFTEVETP MLFKATPEGA REFLVPTRTK RSDGKPSFYA LDQSPQQYKQ LLMASGVNKY
     YQMARCFRDE DLRADRQPEF TQVDMEMAFA NSEDVMKIIE KTVSGVWSKF SKKRGLLTLD
     SKGTLVPAKK ENGTVSIFRM TYEQAMTSYG IDKPDLRAPD LKIINLGEFN AFSHLNKKFP
     VFEVIILRSA FSNMEEYKER WSFLTNNSNY NYRVPIVLPI ENDEQANSNW FENFHAIATF
     ENPHLITKFL KLKKGDIVCG CTREPNHSIF ENPTPLGRLR QLVLQSEHGK NIYHAVNKDV
     ASWIVDFPLF SPVIIEDKSG KKEKLAYPEY EKDRLCSTHH PFTMVKLKDY EKLEKTPEKC
     LGRHYDLVVN GVELGGGSTR IHDPRLQDYI FEDILKIDNA YELFGHLLNA FDMGTPPHAG
     FAIGFDRMCA MICETESIRD VIAFPKSITG ADLVVKSPSV IPESILEPYN IKYSNSKK
>P15424 mit ATP-DEPENDENT RNA HELICASE MSS116 PRECURSOR.
     MLTSILIKGR TPVLASRNLL AALSNCNHIT WAVSRRLYND GNRDQRNFGR NQRNNNSNRY
     RNSRFNSRPR TRSREDDDEV HFDKTTFSKL IHVPKEDNSK EVTLDSLLEE GVLDKEIHKA
     ITRMEFPGLT PVQQKTIKPI LSSEDHDVIA RAKTGTGKTF AFLIPIFQHL INTKFDSQYM
     VKAVIVAPTR DLALQIEAEV KKIHDMNYGL KKYACVSLVG GTDFRAAMNK MNKLRPNIVI
     ATPGRLIDVL EKYSNKFFRF VDYKVLDEAD RLLEIGFRDD LETISGILNE KNSKSADNIK
     TLLFSATLDD KVQKLANNIM NKKECLFLDT VDKNEPEAHE RIDQSVVISE KFANSIFAAV
     EHIKKQIKER DSNYKAIIFA PTVKFTSFLC SILKNEFKKD LPILEFHGKI TQNKRTSLVK
     RFKKDESGIL VCTDVGARGM DFPNVHEVLQ IGVPSELANY IHRIGRTARS GKEGSSVLFI
     CKDELPFVRE LEDAKNIVIA KQEKYEPSEE IKSEVLEAVT EEPEDISDIV ISLISSYRSC
     IKEYRFSERR ILPEIASTYG VLLNDPQLKI PVSRRFLDKL GLSRSPIGKA MFEIRDYSSR
     DGNNKSYDYD DDSEISFRGN KNYNNRSQNR DYDDEPFRRS NNNRRSFSRS NDKNNYSSRN
     SNIY
>P16387 mit PYRUVATE DEHYDROGENASE E1 COMPONENT, ALPHA SUBUNIT PRECURSOR
     MLAASFKRQP SQLVRGLGAV LRTPTRIGHV RTMATLKTTD KKAPEDIEGS DTVQIELPES
     SFESYMLEPP DLSYETSKAT LLQMYKDMVI IRRMEMACDA LYKAKKIRGF CHLSVGQEAI
     AVGIENAITK LDSIITSYRC HGFTFMRGAS VKAVLAELMG RRAGVSYGKG GSMHLYAPGF
     YGGNGIVGAQ VPLGAGLAFA HQYKNEDACS FTLYGDGASN QGQVFESFNM AKLWNLPVVF
     CCENNKYGMG TAASRSSAMT EYFKRGQYIP GLKVNGMDIL AVYQASKFAK DWCLSGKGPL
     VLEYETYRYG GHSMSDPGTT YRTRDEIQHM RSKNDPIAGL KMHLIDLGIA TEAEVKAYDK
     SARKYVDEQV ELADAAPPPE AKLSILFEDV YVKGTETPTL RGRIPEDTWD FKKQGFASRD
>P16451 mit PYRUVATE DEHYDROGENASE PROTEIN X COMPONENT PRECURSOR.
     MLSAISKVST LKSCTRYLTK CNYHASAKLL AVKTFSMPAM SPTMEKGGIV SWKYKVGEPF
     SAGDVILEVE TDKSQIDVEA LDDGKLAKIL KDEGSKDVDV GEPIAYIADV DDDLATIKLP
     QEANTANAKS IEIKKPSADS TEATQQHLKK ATVTPIKTVD GSQANLEQTL LPSVSLLLAE
     NNISKQKALK EIAPSGSNGR LLKGDVLAYL GKIPQDSVNK VTEFIKKNER LDLSNIKPIQ
     LKPKIAEQAQ TKAADKPKIT PVEFEEQLVF HAPASIPFDK LSESLNSFMK EAYQFSHGTP
     LMDTNSKYFD PIFEDLVTLS PREPRFKFSY DLMQIPKANN MQDTYGQEDI FDLLTGSDAT
     ASSVRPVEKN LPEKNEYILA LNVSVNNKKF NDAEAKAKRF LDYVRELESF
>P17505 mit MALATE DEHYDROGENASE, MITOCHONDRIAL PRECURSOR (EC 1.1.1.37).
     MLSRVAKRAF SSTVANPYKV TVLGAGGGIG QPLSLLLKLN HKVTDLRLYD LKGAKGVATD
     LSHIPTNSVV KGFTPEEPDG LNNALKDTDM VLIPAGVPRK PGMTRDDLFA INASIVRDLA
     AATAESAPNA AILVISNPVN STVPIVAQVL KNKGVYNPKK LFGVTTLDSI RAARFISEVE
     NTDPTQERVN VIGGHSGITI IPLISQTNHK LMSDDKRHEL IHRIQFGGDE VVKAKNGAGS
     ATLSMAHAGA KFANAVLSGF KGERDVIEPS FVDSPLFKSE GIEFFASPVT LGPDGIEKIH
     PIGELSSEEE EMLQKCKETL KKNIEKGVNF VASK
>P20967 mit 2-OXOGLUTARATE DEHYDROGENASE E1 COMPONENT PRECURSOR (EC 1.2.4.2)
     MLRFVSSQTC RYSSRGLLKT SLLKNASTVK IVGRGLATTG TDNFLSTSNA TYIDEMYQAW
     QKDPSSVHVS WDAYFKNMSN PKIPATKAFQ APPSISNFPQ GTEAAPLGTA MTGSVDENVS
     IHLKVQLLCR AYQVRGHLKA HIDPLGISFG SNKNNPVPPE LTLDYYGFSK HDLDKEINLG
     PGILPRFARD GKSKMSLKEI VDHLEKLYCS SYGVQYTHIP SKQKCDWLRE RIEIPEPYQY
     TVDQKRQILD RLTWATSFES FLSTKFPNDK RFGLEGLESV VPGIKTLVDR SVELGVEDIV
     LGMAHRGRLN VLSNVVRKPN ESIFSEFKGS SARDDIEGSG DVKYHLGMNY QRPTTSGKYV
     NLSLVANPSH LESQDPVVLG RTRALLHAKN DLKEKTKALG VLLHGDAAFA GQGVVYETMG
     FLTLPEYSTG GTIHVITNNQ IGFTTDPRFA RSTPYPSDLA KAIDAPIFHV NANDVEAVTF
     IFNLAAEWRH KFHTDAIIDV VGWRKHGHNE TDQPSFTQPL MYKKIAKQKS VIDVYTEKLI
     SEGTFSKKDI DEHKKWVWNL FEDAFEKAKD YVPSQREWLT AAWEGFKSPK ELATEILPHE
     PTNVPESTLK ELGKVLSSWP EGFEVHKNLK RILKNRGKSI ETGEGIDWAT GEALAFGTLV
     LDGQNVRVSG EDVERGTFSQ RHAVLHDQQS EAIYTPLSTL NNEKADFTIA NSSLSEYGVM
     GFEYGYSLTS PDYLVMWEAQ FGDFANTAQV IIDQFIAGGE QKWKQRSGLV LSLPHGYDGQ
     GPEHSSGRLE RFLQLANEDP RYFPSEEKLQ RQHQDCNFQV VYPTTPANLF HILRRQQHRQ
     FRKPLALFFS KQLLRHPLAR SSLSEFTEGG FQWIIEDIEH GKSIGTKEET KRLVLLSGQV
     YTALHKRRES LGDKTTAFLK IEQLHPFPFA QLRDSLNSYP NLEEIVWCQE EPLNMGSWAY
     TEPRLHTTLK ETDKYKDFKV RYCGRNPSGA VAAGSKSLHL AEEDAFLKDV FQQS
>P22281 mit ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL 1 PRECURSOR (EC 1.2.1.3).
     MLATRNLVPI IRASIKWRIK LSALHYCMSD AETSEALLED NSAYINNEKH NLFLEKIFSD
     YQPFKHDNRT QVSCSQHMRD YRPLLTLSSA TRSVLFSLLA SDMSIILSIS PNTGILLCIG
     HLLASDIEDV VIVLSRGSPL VDLASTRIFK LAQNGTLRFA IKRTTFQELR FLRKSKDENV
     MEAATRGIIT IRQLYYENKV LPLRFTGNVA THIEENLEFE EQITWRTHVD SSIFPNTRCA
     YPSGYGPSAK IPCLSHKPND ILAYTGSTLV GRVVSKLAPE QVMKKVTLES GGKSTMAVFI
     QHDVTWAVEN TQFGVFDRQG QCCIAQSGYT VHRSTLSQIV ENNLEKDPSY VLHVDTESDI
     RGPFILKIHF ESIPRRINSA KAENSKVLCG GPRENSVYLY PTLSATLTDE CRIMKEEVFA
     PIITILCVKT VDEAIQRGNN SKFGLAAYVT KENVHGIILS TALKTVKLFI ICVHLASYQI
     PFGGNKNSGM GAELGKRALE NYTEGNHVLP VSLVKETLAP NTETASPARW PIH
>P22438 mit METHIONYL-TRNA SYNTHETASE, MITOCHONDRIAL (EC 6.1.1.10) (METHIONINE--
     MQCRSIVHRL YSKVSHVTTP IFYPNAKPHL GHLYSSLLSD VYHRWQLFKG NLSFFTTGTD
     EHGLKIQCAS ESNGFDQPKK FVDKLYPEFV QLDKIYGINY TRFIRTTDPD HIENVMKLWE
     LCLKNGYIYM GEHKGWYSIS DETFYPESKV IKDPKNDGKY LNTESKNEVV YQSETNYFFR
     LSLFNKKIVD HIRKNPDFIF PASKRDQILK ELETGGTLPD LSISRPSARL KWGIPTPNDP
     SQKVYVWFDA LCNYLSSIGG IPSILSNATE VVSRHYSDKS NVKGQLLIPY PKEVQRNTIH
     VIGKDIAKFH TVYWPSFLLA AGLPLPRQIV VHGHWLCNGM KMSKSLGNVV DPIDMARYYG
     ADIVRWFLLE NSKLEEDGDF QEAKLYETRE LLVSKWGNLI NRCCGSKFNI ERAVMKFSDK
     ANFQFQEIFQ NEPIVSERIE NLAKLLNKSQ EVFDEKIAIF QYPQLLRHVW SIINDANTLV
     QNSKPWEREL DQQDNIIFLA METSRILSIL CQSIIPSLSQ SFLDRIDVSK EKRTINYARL
     GSDKTYGKQS NKKGREVPLK KIPFRLQEEQ TNMRS
>P25345 mit ASPARAGINYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.22)
     MFHAFTFLKG GRFYSSLTVK SLYEQVHHTS HDPISINGWI KSIRLLKRIA FLDLQDGTSV
     NPLRIVIPLT NTDEVQFLKI LKTGQTLSIS NATWQSTPNR KQPFELQIKN PVKSIKLVGP
     VSENYPLQKK YQTLRYLRSL PTLKYRTAYL SAILRLRSFV EFQFMLYFQK NHFTKVSPPI
     LTSNDCEGAG ELFQVSTNTS PTASSYFGKP TYLTVSTQLH LEILALSLSR CWTLSPCFRA
     EKSDTPRHLS EFWMLEVEMC FVNSVNELTS FVETTIKHII KACIDNQQEL LPKQFISSQE
     NNASSELSIN QETQQIKTRW EDLINEKWHN ITYTNAIEIL KKRHNEVSHF KYEPKWGQPL
     QTEHEKFLAG EYFKSPVFVT DYPRLCKPFY MKQNSTPDDT VGCFDLLVPG MGEIIGGSLR
     EDDYDKLCRE MKARGMNRSG ELDWYVSLRK EGSAPHGGFG LGFERFISYL YGNHNIKDAI
     PFYRTSAESI DF
>P32048 mit LYSYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.6)
     MNVLLKRRSL TFAPRWLWCK CRSSRSRPYS LAHAVDTSKM EATRRNGQIV KDLGRYYPSM
     SESALHDLCQ EYKEVTIADF NERFLGNPAT LHHEDNPNLL LSINGRIKSI RFSGQKIVFI
     DLYNGSSGLK NDTQLQLIVN YNKIGGSSED KANFSEYMNF LKKGDYIKAL GYPGFSQSRV
     KMLSLICNKL PIVLSVSQLP LPSRLNDETK IKSNRVVDYQ LNGTQTLLVR ARIIKLLRKF
     LDDRNFVEVE TPILSSKSNG AMAKPFITSS KDFDHLELRI APELWLKRLI ISGLQKVYEI
     GKVFRNEGID STHNAEFSTL EFYETYMSMD DIVTRTEDLF KFLITNLQKF FQDTRLPVPK
     TFSELHLALS ENNWKFRKVE FLPTLNKELG IDLMNSGLDI NKPSELLKAL PKDIAKKYFP
     SADNTGQLSS LQILNKLSDV FLEQRHCQST LPTVIYHQPA ILSPLAKTDP QNKQVTKRFE
     VFIKGKEYIN AYEEENCPQL QLQKFLQQKQ INELTGNKTE TLSPVIDYQY VETMKYGMPP
     VGGFGLGIDR LCMLFCDKKR IEEVLPFGCV DDVNRQ
>P32473 mit PYRUVATE DEHYDROGENASE E1 COMPONENT, BETA SUBUNIT PRECURSOR
     MFSRLPTSLA RNVARRAPTS FVRPSAAAAA LRFSSTKTMT VREALNSAMA EELDRDDDVF
     LIGEEVAQYN GAYKVSKGLL DRFGERRVVD TPITEYGFTG LAVGAALKGL KPIVEFMSFN
     FSMQAIDHVV NSAAKTHYMS GGTQKCQMVF RGPNGAAVGV GAQHSQDFSP WYGSIPGLKV
     LVPYSAEDAR GLLKAAIRDP NPVVFLENEL LYGESFEISE EALSPEFTLP YKAKIEREGT
     DISIVTYTRN VQFSLEAAEI LQKKYGVSAE VINLRSIRPL DTEAIIKTVK KTNHLITVES
     TFPSFGVGAE IVAQVMESEA FDYLDAPIQR VTGADVPTPY AKELEDFAFP DTPTIVKAVK
     EVLSIE
>P32891 mit D-LACTATE DEHYDROGENASE (CYTOCHROME) PRECURSOR (EC 1.1.2.4)
     MLWKRTCTRL IKPIAQPRGR LVRRSCYRYA STGTGSTDSS SQWLKYSVIA SSATLFGYLF
     AKNLYSRETK EDLIEKLEMV KKIDPVNSTL KLSSLDSPDY LHDPVKIDKV VEDLKQVLGN
     KPENYSDAKS DLDAHSDTYF NTHHPSPEQR PRIILFPHTT EEVSKILKIC HDNNMPVVPF
     SGGTSLEGHF LPTRIGDTIT VDLSKFMNNV VKFDKLDLDI TVQAGLPWED LNDYLSDHGL
     MFGCDPGPGA QIGGCIANSC SGTNAYRYGT MKENIINMTI VLPDGTIVKT KKRPRKSSAG
     YNLNGLFVGS EGTLGIVTEA TVKCHVKPKA ETVAVVSFDT IKDAAACASN LTQSGIHLNA
     MELLDENMMK LINASESTDR CDWVEKPTMF FKIGGRSPNI VNALVDEVKA VAQLNHCNSF
     QFAKDDDEKL ELWEARKVAL WSVLDADKSK DKSAKIWTTD VAVPVSQFDK VIHETKKDMQ
     ASKLINAIVG HAGDGNFHAF IVYRTPEEHE TCSQLVDRMV KRALNAEGTC TGEHGVGIGK
     REYLLEELGE APVDLMRKIK LAIDPKRIMN PDKIFKTDPN EPANDYR
>P33416 mit MITOCHONDRIAL HEAT SHOCK PROTEIN 78 PRECURSOR.
     MLRQATKAPI QKYLQRTQLL RRSTPRIYTI VQCKRSICSF NARPRVANKL LSDIKTNALN
     EVAISTCALK SSYGLPNFKR TYVQMRMDPN QQPEKPALEQ FGTNLKKLAR DGKLDPVIGR
     DEEIARAIQI LSRRTKNNPC LIGRAGVGKT ALIDGLAQRI VAGEVPDSLK DKDLVALDLG
     SLIAGAKYRG EFEERLKKVL EEIDKANGKV IVFIDEVHML LGLGKTDGSM DASNILKPKL
     ARGLACISAT TLDEFKIIEK DPALSRRFQP ILLNEPSVSD TISILRGLKE RYEVHHGVRI
     TDTALVSAAV LSNRYITDRF LPDKAIDLVD EACAVLRLQH ESKPDEIQKL DRAIMKIQIE
     LESLKKETDP VSVERREALE KDLEMKNDEL NRLTKIWDAE RAEIESIKNA KANLEQARIE
     LEKCQREGVY TKASELRYSR IPDLEKKVAL SEKSKDGDKV NLLHDSVTSD DISKVVAKMT
     GIPTETVMKG DKDRLLYMEN SLKERVVGQD EAIAAISDAV RLQRAGLTSE KRPIASFMFL
     GPTGTGKTKL TKALAEFLFD DESNVIRFDM SEFQEKHTVS RLIGAPPGYV LSESGGQLTE
     AVRRKPYPVV LFDEFEKAHP DVSKLLLQVL DEGKLTDSLG HHVDFRNTII VMTSNIGQDI
     LLNDTKLGDD GKIDTATKNK VIEAMKRSYP PEFINRIDDI LVFNRLSKKV LRSIVDIRIA
     EIQDRLAEKR MKIDLTDEAK DWLTDKGYDQ LYGARPLNRL IHRQILNSMA TFLLKGQIRN
     GETVRVVVKD TKLVVLPNHE EGEVVEEEAE K
>P35999 mit MITOCHONDRIAL INTERMEDIATE PEPTIDASE PRECURSOR (EC 3.4.24.59) (MIP).
     MLRTIILKAG SNASIPSPSR QNKLLRFFAT AGAVSRTSPG SIKKIFDDNS YWRNINGQDA
     NNSKISQYLF KKNKTGLFKN PYLTSPDGLR KFSQVSLQQA QELLDKMRND FSESGKLTYI
     MNLDRLSDTL CRVIDLCEFI RSTHPDDAFV RAAQDCHEQM FEFMNVLNTD VSLCNILKSV
     LNNPEVSSKL SAEELKVGKI LLDDFEKSGI YMNPDVREKF IQLSQEISLV GQEFINHTDY
     PGSNSVKIPC KDLDNSKVST FLLKQLNKDV KGQNYKVPTF GYAAYALLKS CENEMVRKKL
     WTALHSCSDK QVKRLSHLIK LRAILANLMH KTSYAEYQLE GKMAKNPKDV QDFILTLMNN
     TIEKTANELK FIAELKAKDL KKPLTTNTDE ILKLVRPWDR DYYTGKYFQL NPSNSPNAKE
     ISYYFTLGNV IQGLSDLFQQ IYGIRLEPAI TDEGETWSPD VRRLNVISEE EGIIGIIYCD
     LFERNGKTSN PAHFTVCCSR QIYPSETDFS TIQVGENPDG TYFQLPVISL VCNFSPILIA
     SKKSLCFLQL SEVETLFHEM GHAMHSMLGR THMQNISGTR CATDFVELPS ILMEHFAKDI
     RILTKIGKHY GTGETIQADM LQRFMKSTNF LQNCETYSQA KMAMLDQSFH DEKIISDIDN
     FDVVENYQAL ERRLKVLVDD QSNWCGRFGH LFGYGATYYS YLFDRTIASK IWYALFEDDP
     YSRKNGDKFK KHLLKWGGLK DPWKCIADVL ECPMLEKGGS DAMEFIAQSH KS
>P36775 mit MITOCHONDRIAL ATP-DEPENDENT PROTEASE PRECURSOR (EC 3.4.21.-).
     MLRTRTTKTL STVARTTRAI QYYRSIAKTA AVSQRRFAST LTVRDVENIK PSHIIKSPTW
     QEFQHQLKDP RYMEHFAQLD AQFARHFMAT NSGKSILAKD DSTSQKKDED VKIVPDEKDT
     DNDVEPTRDD EIVNKDQEGE ASKNSRSSAS GGGQSSSSRS DSGDGSSKQK PPKDVPEVYP
     QMLALPIARR PLFPGFYKAV VISDERVMKA IKEMLDRQQP YIGAFMLKNS EEDTDVITDK
     NDVYDVGVLA QITSAFPSKD EKTGTETMTA LLYPHRRIKI DELFPPNEEK EKSKEQAKDT
     DTETTVVEDA NNPEDQESTS PATPKLEDIV VERIPDSELQ HHKRVEATEE ESEELDDIQE
     GEDINPTEFL KNYNVSLVNV LNLEDEPFDR KSPVINALTS EILKVFKEIS QLNTMFREQI
     ATFSASIQSA TTNIFEEPAR LADFAAAVSA GEEDELQDIL SSLNIEHRLE KSLLVLKKEL
     MNAELQNKIS KDVETKIQKR QREYYLMEQL KGIKRELGID DGRDKLIDTY KERIKSLKLP
     DSVQKIFDDE ITKLSTLETS MSEFGVIRNY LDWLTSIPWG KHSKEQYSIP RAKKILDEDH
     YGMVDVKDRI LEFIAVGKLL GKVDGKIICF VGPPGVGKTS IGKSIARALN RKFFRFSVGG
     MTDVAEIKGH RRTYIGALPG RVVQALKKCQ TQNPLILIDE IDKIGHGGIH GDPSAALLEV
     LDPEQNNSFL DNYLDIPIDL SKVLFVCTAN SLETIPRPLL DRMEVIELTG YVAEDKVKIA
     EQYLVPSAKK SAGLENSHVD MTEDAITALM KYYCRESGVR NLKKHIEKIY RKAALQVVKK
     LSIEDSPTSS ADSKPKESVS SEEKAENNAK SSSEKTKDNN SEKTSDDIEA LKTSEKINVS
     ISQKNLKDYV GPPVYTTDRL YETTPPGVVM GLAWTNMGGC SLYVESVLEQ PLHNCKHPTF
     ERTGQLGDVM KESSRLAYSF AKMYLAQKFP ENRFFEKASI HLHCPEGATP KDGPSAGVTM
     ATSFLSLALN KSIDPTVAMT GELTLTGKVL RIGGLREKAV AAKRSGAKTI IFPKDNLNDW
     EELPDNVKEG LEPLAADWYN DIFQKLFKDV NTKEGNSVWK AEFEILDAKK EKD
>P38523 mit GRPE PROTEIN HOMOLOG PRECURSOR.
     MRAFSAATVR ATTRKSFIPM APRTPFVTPS FTKNVGSMRR MRFYSDEAKS EESKENNEDL
     TEEQSEIKKL ESQLSAKTKE ASELKDRLLR SVADFRNLQQ VTKKDIQKAK DFALQKFAKD
     LLESVDNFGH ALNAFKEEDL QKSKEISDLY TGVRMTRDVF ENTLRKHGIE KLDPLGEPFD
     PNKHEATFEL PQPDKEPGTV FHVQQLGFTL NDRVIRPAKV GIVKGEEN
>P38714 mit ARGINYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.19)
     MFGIVYLKNR SLLCKNPFSS YPRYGFMPSF DTQFSNQFRK LEINIGRKRY SSKTLNTKYT
     DQPEGPIYPL DVLRLDISKA LHDISGIDHS LILNALESTN SMDRGDLLLP LPKIKVADPV
     AVANRWAIEL STHGCIGKVC AKGPFLQFFL DQRYLIQSTV PNILLQKGKY GQKKSRHQKK
     VVVEFSSPNI AKPFHAGHLR STIIGGFLSN LYEAMGWSVT RMNYLGDWGR QFGLLAVGFK
     RYGDEKTLQK QPIQHLFDVY VKINMDLAKE EINGNSKCGI SGEARSFFKN LENGDENAIK
     IWNRFRSLSI HHYIQTYSRL NINFDIFSGE SQVSKESMNE ALDIFRKNNL VKEIDGALVI
     DLTQWSKRLG RVVVQKSDGT TLYLTRDVGA AIERKKNLHF DKMVYVISSQ QDLYMSQFFM
     ILKKMNFEWA KDLQHINFGM VQGMSTRKGN VVFLDTILDE ARDKALQIME NNKMKISQVD
     NPQRVADLIG VSAIIIQDTK SKRINNYEFN WNRMLSFEGD TGPYLQYTHS RLRSLERTSS
     DFTTDMLIHA DFSNLNEPQL VELVRLLAQY PDVLRRAFET QEPATIVTYL FKVCHQVSSC
     YKKIWVSGKP ADIAIPRLAV YSASRQVLHN AMSLLGLVPV DRM
>P38910 mit 10 KD HEAT SHOCK PROTEIN, MITOCHONDRIAL (HSP10) (10 KD CHAPERONIN).
     MSTLLKSAKS IVPLMDRVLV QRIKAQAKTA SGLYLPEKNV EKLNQAEVVA VGPGFTDANG
     NKVVPQVKVG DQVLIPQFGG STIKLGNDDE VILFRDAEIL AKIAKD
>P46367 mit POTASSIUM-ACTIVATED ALDEHYDE DEHYDROGENASE PRECURSOR (EC 1.2.1.3).
     MFSRSTLCLK TSASSIGRLQ LRYFSHLPMT VPIKLPNGLE YEQPTGLFIN NKFVPSKQNK
     TFEVINPSTE EEICHIYEGR EDDVEEAVQA ADRAFSNGSW NGIDPIDRGK ALYRLAELIE
     QDKDVIASIE TLDNGKAISS SRGDVDLVIN YLKSSAGFAD KIDGRMIDTG RTHFSYTKRQ
     PLGVCGQIIP WNFPLLMWAW KIAPALVTGN TVVLKTAEST PLSALYVSKY IPQAGIPPGV
     INIVSGFGKI VGEAITNHPK IKKVAFTGST ATGRHIYQSA AAGLKKVTLE LGGKSPNIVF
     ADAELKKAVQ NIILGIYYNS GEVCCAGSRV YVEESIYDKF IEEFKAASES IKVGDPFDES
     TFQGAQTSQM QLNKILKYVD IGKNEGATLI TGGERLGSKG YFIKPTVFGD VKEDMRIVKE
     EIFGPVVTVT KFKSADEVIN MANDSEYGLA AGIHTSNINT ALKVADRVNA GTVWINTYND
     FHHAVPFGGF NASGLGREMS VDALQNYLQV KAVRAKLDE
>P48525 mit GLUTAMYL-TRNA SYNTHETASE, MITOCHONDRIAL (EC 6.1.1.17) (GLUTAMATE--TRNA
     MIMLRIPTRS YCSPSKLIKG VGLSPLKKSL LSKKIKEDIH PSLPVRTRFA PSPTGFLHLG
     SLRTALYNYL LARNTNGQFL LRLEDTDQKR LIEGAEENIY EILKWCNINY DETPIKQSER
     KLIYDKYVKI LLSSGKAYRC FCSKERLNDL RHSAMELKPP SMASYDRCCA HLGEEEIKSK
     LAQGIPFTVR FKSPERYPTF TDLLHGQINL QPQVNFNDKR YDDLILVKSD KLPTYHLANV
     VDDHLMGITH VIRGEEWLPS TPKHIALYNA FGWACPKFIH IPLLTTVGDK KLSKRKGDMS
     ISDLKRQGVL PEALINFCAL FGWSPPRDLA SKKHECFSME ELETIFNLNG LTKGNAKVDD
     KKLWFFNKHF LQKRILNPST LRELVDDIMP SLESIYNTST ISREKVAKIL LNCGGSLSRI
     NDFHDEFYYF FEKPKYNDND AVTKFLSKNE SRHIAHLLKK LGQFQEGTDA QEVESMVETM
     YYENGFSRKV TYQAMRFALA GCHPGAKIAA MIDILGIKES NKRLSEGLQF LQREKK
>P48526 mit ISOLEUCYL-TRNA SYNTHETASE, MITOCHONDRIAL (EC 6.1.1.5) (ISOLEUCINE--
     MKRSRLVPQH IFSIISKRYL AKHAYQKTLN LPKTKFPNRS NLEITLRELI PKSSQLVYKE
     QLRDFFEEFS KLNTTDEKLE FIKEKLFILH DGPPYANGEL HLGHALNKIL KDIINRYQLS
     QGKYIFYKPG WDCHGLPIEI KALKDLSAQQ IESISPLKIR SMALKHAQKA IKRQRETFQH
     FAILTDWETP YLTMDKDYEI NQLNIFKEMY ERGLIKRQNK PVYWGTETRT ALAEGELEYN
     ENHKSIAAYV KFPLEKKSQM DLCKKLGITN NLPIYCLIWT STPWTLLSNR AICFNQDFSY
     SLLRLNSELI LVETGSIDKL GLTTNSFETI KQFQGTHLNG LYYQNLLVDD KVGRPLLHGA
     HVTSGTGTGL VHTAPGHGQD DYLIGIQNGL EIYSPVDHQG RYQLNELPQS VRSIVRDEGD
     LTKGRQVLDA ETAKIILCKL SDLNLLYKSH EYTHSYPYDW RSKKPVIIRA TPQWFADLHD
     VKNLALESIS RVKFCPKRGY SRLSSFMKSR NEWCISRQRS WGIPILSFYK KSEPDSVLMN
     SEILAHAIEK IKQKGINAWF NDKDNDMKEW LPEKYHDVAH EYCRSQDTMD VWFDSGSSWS
     VIKDFYEKSL KLSKLPSPLY QVCLEGSDQH RGWFQSSLLT KVASSNVPVA PYEEVITHGF
     TLDENGLKMS KSVGNTISPE AIIRGDENLG LPALGVDGLR YLIAQSNFTT DIVAGPTVMK
     HVGEALKKVR LTFRYLLSNL QKSQDFNLLP IEQLRRVDQY TLYKINELLE TTREHYQKYN
     FSKVLITLQY HLNNELSAFY FDISKDILYS NQISSLARRQ VQTTLVHILN AYRAILAPIL
     PVMVQEVWKY IPEGWLQGQE HIDINPMRGK WPFLDSNTEI VTSFENFELK ILKQFQEEFK
     RLSLEEGVTK TTHSHVTIFT KHHLPFSSDE LCDILQSSAV DILQMDDNNN SLPTIELGSG
     INVQILVERS KRHNCPRCWK ANSAEEDKLC DRCKEAVDHL MS
>P48527 mit TYROSYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.1)
     MLELRSCSNL VNSSRRLVPL VTYSGLSAIT LPKSRFYSQP SALEVQGTSD SRSDNILDEL
     KQRGLVSQVS QPESFLRTKL NGNDKIKLYC GVDPTAQSLH LGNLVPLMVL LHFYVKGHDI
     VTVIGGATGK VGDPSGRKTE RDVMENDIRQ SNVASISQQL QRFFKNGLEY YRNRCALTED
     VPSGKYTPRN NFNWWKDIKM LDFLADFGRH IRVQSMLARD SISSRLQTKN GLGFNEFTYQ
     VLQAYDFYHL YKEENVTIQV GGNDQWGNIT AGIDLINRIQ PIKNKGLPFG ITVPLLTTAT
     GEKFGKSAGN AVFIDPSINT AYDVYQFFYN TLDADVPKFL KIFTFLNSSE IKKIVETHIK
     SPSLRYGQTL LAKEVTDMLY GVGSGSDSEA LSNIIFGRYD GTLSAAKLVD LCKKARILQY
     ADREIDLIKL ICKLVNCSVS EARRKLSQGS VYLHHSKSKV NENISNLAPF LIDDRVLILR
     IGKQKCFIIE MR
>P27680 mit HEXAPRENYLDIHYDROXYBENZOATE METHYLTRANSFERASE PRECURSOR (EC 2.1.1.114)
     MGFIMLLRSR FLKVIHVRKQ LSACSRFAIQ TQTRCKSTDA SEDEVKHFQE LAPTWWDTDG
     SQRILHKMNL TRLDFVQRTV RNQVKIQNPE IFVPGFNYKE FLPEYVCDNI QREMQESIET
     NLDKRPEVSV LDVGCGGGIL SESLARLKWV KNVQGIDLTR DCIMVAKEHA KKDPMLEGKI
     NYECKALEDV TGQFDIITCM EMLEHVDMPS EILRHCWSRL NPEKGILFLS TINRDLISWF
     TTIFMGENVL KIVPKGTHHL SKYINSKEIL AWFNDNYSGQ FRLLDLKGTM YLPYQGWVEH
     DCSDVGNYFM AIQRLN
>P32522 mit PET309 PROTEIN PRECURSOR.
     MKRCAPAVLR NYNYKKGIWS TGVPDHIRKL LRDKSTSPLC SQDERNLVSY FMARGSVPLK
     SVGSGLTKKA TTSITSNSAT TTFERQYLIK YLYRHQAYGN VIKIAQKFLY TTIGSQRLLK
     QDASLPELKK FLLSLLILQR GIQLDQAISD IIQRFLLTQK TMVIDLINSI FSRMVIMNMH
     EEAVYKWVKW MKLVNGHCEF TNYMENKIVL RNFLSFMRQS NVRPDYLSYL KAIQLTQGPA
     IASQFATTLL FLLTYIRKFS SAEAVWNYKC EHNLPIVSSD LTCILKTYCH MQKFNLVSST
     YWKYPDAQHD QNQFDYLLVA HSRLHNWDAL QQQFNALFGI GKLPSIQHYG ILMYTMARIG
     ELDSVNKLYT QLLRRGMIPT YAVLQSLLYA HYKVGDFAAC FSHFELFKKY DITPSTATHT
     IMLKVYRGLN DLDGAFRILK RLSEDPSVEI TEGHFALLIQ MCCKTTNHLI AQELFNLMTE
     HYNIQHTGKS ISALMDVYIE SNRPTEAIAL FEKHSKNLSW RDGLISVYNK AIKAYIGLRN
     ANKCEELFDK ITTSKLAVNS EFYKMMIKFL VTLNEDCETA LSIIDQLIKH SVIKVDATHF
     EIIMEAYDKE GYRDGIINLY KTMSQNKVPA NSKILYYILK AVAKKSLQNN EEIKETINMV
     EDIMENAANG TLDVTYNKLH PSVMAWPMRM IVKHDSPQRA LELYNRYNEL FFKKHDWISN
     NNKFVMMRSL LVLLAQIEQW KDFETLFAKY MDRIENIENL PSSTTPNIKL RSIFSGLFPY
     KVSQLIAMNK IDELPLLWKK LREKGFILDN ISWNSAVEAL FKDPRTLSYG MKIVDDTLIH
     GYNLIHKFRL LTKLSEDKTQ SSDKSWPTLK MKEKEPNKFQ PRLYLKSDTY NSIMRQLDTY
     LDGIDDLKTL EDQVRDFISN YKYFMKDYLL MPRSKINKWE QIEMRHLSYF KELRKSKRVL
     PVSKF
>P32872 mit ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL 2 PRECURSOR (EC 1.2.1.3).
     MSKSKTKTDK RNQSSLSRIK LSALHYCMSD AEPSIAYLQD NSAFINNEWH NLVLEKIFPV
     YNPSTEEDIT QVSEKSQHDS TEEDITQVSE KSQHDDDKAV VDISERGRLL NILADLIERD
     RDILAAIEHL DNGKPFDEAY LLDLASVLKE LRYTAGWADK LHGTLRFAIT IPTFQDLRFL
     RYTRHEPVGV CGEIIPWNIP LLMYIWKIGP ALAAGNTVVL KPEELTPLTA LTVATLIKEA
     GFPPGVVNVV SGYGPTAGAA CLSHKDNDKL AFTGSTLVGK VVMKAAAKSN LKKVTLELGG
     KSPMIVFIDA DLDWAVENAH FGVFFNQGQC CIAQSRITVH ESIYDEIVER DLEKAKKQVL
     GNPFESDTRY GPQILKIEFD SIPRLINSAK AEGAKVLCGG GRDDSCVGYY IQPTVFADVT
     DEMRIAKEEI FGPVITISRF KSVDEAIKRV DNTKYGLAAY VFTKDKAIRI SAALKAGTVW
     VNCVHVASYQ IPFGGNKNSG MGRELGEYGL E
>P40047 mit ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL 3 PRECURSOR (EC 1.2.1.3).
     MLSRTRAAAP NSRIFTRSLL RLYSQAPLRV PITLPNGFTY EQPTGLFTNG EFVASKQKKT
     FDVINPSNEE KITTVYKAME DDVDEAVAAL KKLLKRSVYC RAGVRAKALF NLADLVEKHQ
     ETLAAIESMD NGKSLFCARG DVALVSKYLR SCGGWADKIY GNVIDTGKNH FTYSIKEPLG
     VCGQIIPWNF PLLMWSWKIG PALATGNTVV LKPAETTPLS ALFASQLCQE AGIPAGVVNI
     LPGSGRVVGE RLSAHPDVKK IAFTGSTATG RHIMKVAADT VKKVTLELGG KSPNIVFADA
     DLDKAVKNIA FGIFYNSGEV CCAGSRIYIQ DTVYEEVLQK LKDYTESLKV GDPFDEEVFQ
     GAQTSDKQLH KILDYVDVAK SEGARLVTGG ARHGSKGYFV KPTVFADVKE DMRIVKEEVF
     GPIVTVSKFS TVDEVIAMAN DSQYGLAAGI HTNDINKAVD VSKRVKAGTV WINTYNNFHQ
     NVPFGGFGQS GIGREMGEAA LSNYTQTKSV RIAIDKPIR
>P42940 mit PROBABLE ELECTRON TRANSFER FLAVOPROTEIN BETA-SUBUNIT (BETA-ETF).
     MSAKQQLRIL VPVKRVVDFQ IKPRVNKTLT GIETSGIKFS INPFDDIAVE EAIRIKEKNK
     SLVESTHAVS IGSAKAQDIL RNCLAKGIDT CSLIDSVGKE NIEPLAIAKI LKAVVEKKGS
     NLVLMGKQAI DDDCNNTGQM LAGLLNWPQA TNAAKVEFLD NGRVQVTREI DDGEEVIEAS
     LPMVITTDLR LNTPRYVGLP KLMKAKKKPI EKLDIAKDFP EINIEPQLKI VSMEEPKTKS
     PGVKLNSVDE LIEKLKEVKA I
>P47065 mit PET130 PROTEIN.
     MKIFSTLLSQ KPKGKLVIRP STTIHSSDPF SKFIVTKNTE PLSLGDLRKS DSGNSAVCLN
     AENTILSTLT DLQKEEERNW DPVKFVAGKL RGVISPIQAY VTIGKKFSPN SLVYTSRFFQ
     LHYFPEDHFM SCFRKSKPAI TVKSNKKFYL NGKVFNKDKE YFNETRISKA NEVELSKIQT
     AMTRLTNRHR NSIPSEFAYL RRDLKLKVKT TFIKEWCKLN GDKAIREYVN LNRSPNINPA
     SMKGKPKKSF LDNLGRSTVG TAKDGYYLYI VSIFPDKDML GEFNDEVNRS VQKVANLDWD
     GFLTPKKGTK GKNWVESFND SINVQTINKI LEINKFPFEL RREQTEG
>Q12480 mit PROBABLE ELECTRON TRANSFER FLAVOPROTEIN ALPHA-SUBUNIT PRECURSOR
     MFKSLAAVLP RASKAKFLQK NYASTLAFIE SSKDGSVSRS SLSLLAAAQK LSNPITAVIT
     GSKAEKTAEA LKSSYSCSNL EKLVIFEDSK LDTCLPEQLT PLLVKLLKGG DYSHFVVSNS
     SVGKSVLPRV GALLDVQPVC EVTVIKDPKT FIRPIYAGNI ISTIECQAEK KLLIIRASAF
     PPIAEGSMDS VTIEKRTDIP PCDLNVTWVK TILTKSERPE LTSAQNVVTG GRALKDKETF
     EKLLSPLADV LHAAIGATRA SVDNGLCDNS LQIGQTGKVV APNLYIAIGV SGAVQHLAGM
     KDSKVIVAIN NDPDAPIFNV ADYGLQGDLY KIVPELTEKL GKYK
>P12398 mit MITOCHONDRIAL HEAT SHOCK PROTEIN SSC1 PRECURSOR (ENDONUCLEASE SCEI 75
     MLAAKNILNR SSLSSSFRIA TRLQSTKVQG SVIGIDLGTT NSAVAIMEGK VPKIIENAEG
     SRTTPSVVAF TKEGERLVGI PAKRQAVVNP ENTLFATKRL IGRRFEDAEV QRDIKQVPYK
     IVKHSNGDAW VEARGQTYSP AQIGGFVLNK MKETAEAYLG KPVKNAVVTV PAYFNDSQRQ
     ATKDAGQIVG LNVLRVVNEP TAAALAYGLE KSDSKVVAVF DLGGGTFDIS ILDIDNGVFE
     VKSTNGDTHL GGEDFDIYLL REIVSRFKTE TGIDLENDRM AIQRIREAAE KAKIELSSTV
     STEINLPFIT ADASGPKHIN MKFSRAQFET LTAPLVKRTV DPVKKALKDA GLSTSDISEV
     LLVGGMSRMP KVVETVKSLF GKDPSKAVNP DEAVAIGAAV QGAVLSGEVT DVLLLDVTPL
     SLGIETLGGV FTRLIPRNTT IPTKKSQIFS TAAAGQTSVE IRVFQGEREL VRDNKLIGNF
     TLAGIPPAPK GVPQIEVTFD IDADGIINVS ARDKATNKDS SITVAGSSGL SENEIEQMVN
     DAEKFKSQDE ARKQAIETAN KADQLANDTE NSLKEFEGKV DKAEAQKVRD QITSLKELVA
     RVQGGEEVNA EELKTKTEEL QTSSMKLFEQ LYKNDSNNNN NNNGNNAESG ETKQ
>P21560 mit CBP3 PROTEIN PRECURSOR.
     MMSVNRFTSG RLPVFLRKSP FYYSRAYLHQ TCVFKQNKET AQDSPELLAK SSHLNSKPLD
     VSNKAPVKTA QNKIPLAHSK YESSKYELPK WKEALGELVI RAFHLDMDRV RAGPVAGSYY
     YKICKEQGLQ YEDEPLSETA KYFYEDLKLP RTFSQWFQIT VLHEWILFVR MRAMPFKYGR
     NYQQKLVDRT FSDIELRLFE EMKVNSGRIA DQYLKDFNTQ LRGAIFAYDE GFATDDGTLA
     TAVWRNLFGG RKNIDMVHLE SVVRYIYSQL YVLSRLSDRE FATGKFKFVP PGVKVEKLTP
     KQEEELKAKT IAKYEALDKD PKTLPSERSR LSYTN
>P32798 mit COBALT UPTAKE PROTEIN COT1.
     MKLGSKQVKI ISLLLLDTVF FGIEITTGYL SHSLALIADS FHMLNDIISL VVALWAVNVA
     KNRNPDSTYT YGWKRAEILG ALINAVFLIA LCVSILIEAL QRIIAPPVIE NPKFVLYVGV
     AGLISNTVGL FLFHDNDQEH GHGHGHSHGG IFADHEMHMP SSHTHTHAHV DGIENTTPMD
     STDNISEIMP NAIVDSFMNE NTRLLTPENA SKTPSYSTSS HTIASGGNYT EHNKRKRSLN
     MHGVFLHVLG DALGNIGVML SAFFIWKTDY SWKYYTDPLV SLIITGIIFS SALPLSCKAS
     KILLQATPST LSGDQVEGDL LKIPGIIAIH DFHIWNLTES IFIASLHIQL DISPEQFTDL
     AKIVRSKLHR YGIHSATLQP EFITREVTST ERAGDSQGDH LQNDPLSLRP KTYGTGISGS
     TCLIDDAANC NTADCLEDH
>P04840 mit OUTER MITOCHONDRIAL MEMBRANE PROTEIN PORIN 1 (VOLTAGE-DEPENDENT ANION-
     MSPPVYSDIS RNINDLLNKD FYHATPAAFD VQTTTANGIK FSLKAKQPVK DGPLSTNVEA
     KLNDKQTGLG LTQGWSNTNN LQTKLEFANL TPGLKNELIT SLTPGVAKSA VLNTTFTEPF
     FTARGAFDLC LKSPTFVGDL TMAHEGIVGG AEFGYDISAG SISRYAMALS YFAKDYSLGA
     TLNNEQITTV DFFQNVNAFL QVGAKATMNC KLPNSNVNIE FATRYLPDAS SQVKAKVSDS
     GIVTLAYKQL LRPGVTLGVG SSFDALKLSE PVHKLGWSLS FDA
>P07213 mit MITOCHONDRIAL PRECURSOR PROTEINS IMPORT RECEPTOR (70 KD MITOCHONDRIAL
     MKSFITRNKT AILATVAATG TAIGAYYYYN QLQQQQQRGK KNTINKDEKK DTKDSQKETE
     GAKKSTAPSN PPIYPVSSNG EPDFSNKANF TAEEKDKYAL ALKDKGNQFF RNKKYDDAIK
     YYNWALELKE DPVFYSNLSA CYVSVGDLKK VVEMSTKALE LKPDYSKVLL RRASANEGLG
     KFADAMFDLS VLSLNGDFND ASIEPMLERN LNKQAMSKLK EKFGDIDTAT ATPTELSTQP
     AKERKDKQEN LPSVTSMASF FGIFKPELTF ANYDESNEAD KELMNGLSNL YKRSPESYDK
     ADESFTKAAR LFEEQLDKNN EDEKLKEKLA ISLEHTGIFK FLKNDPLGAH EDIKKAIELF
     PRVNSYIYMA LIMADRNDST EYYNYFDKAL KLDSNNSSVY YHRGQMNFIL QNYDQAGKDF
     DKAKELDPEN IFPYIQLACL AYRENKFDDC ETLFSEAKRK FPEAPEVPNF FAEILTDKND
     FDKALKQYDL AIELENKLDG IYVGIAPLVG KATLLTRNPT VENFIEATNL LEKASKLDPR
     SEQAKIGLAQ MKLQQEDIDE AITLFEESAD LARTMEEKLQ AITFAEAAKV QQRIRSDPVL
     AKKIQETLAK LREQGLM
>P16547 mit MITOCHONDRIAL OUTER MEMBRANE 45 KD PROTEIN.
     MSSRIIVGSA ALAAAITASI MVREQKAKGQ RREGNVSAYY NGQEYGSSAP PQLGKLHNIK
     QGIKEDALSL KDALLGVSQK AREEAPKVTK RVISPEEDAQ TRKQLGQKAK DSSSQSIFNW
     GFSEAERRKA IAIGEFDTAK KRFEEAVDRN EKELLSTVMR EKKAALDRAS IEYERYGRAR
     DFNELSDKLD QQERNSNPLK RLLKNNTGDA NTEEAAARSV QGWGDTAQEF GREELEEAKR
     NASSEPSEAQ KRLDELKKIK EKGWFGYNKG EQSEQQIAER VARGLEGWGE TAAQLSKDEM
     DDLRWNYENS KKQLDKNVSD AMDSLSKAKE DLKQYGSHWW SGWTSKVDND KQALKDEAQK
     KYDEALKKYD EAKNKFKEWN DKGDGKFWSS KKD
>P18409 mit MITOCHONDRIAL INHERITANCE COMPONENT MDM10.
     MLPYMDQVLR AFYQSTHWST QNSYEDITAT SRTLLDFRIP SAIHLQISNK STPNTFNSLD
     FSTRSRINGS LSYLYSDAQQ LEKFMRNSTD IPLQDATETY RQLQPNLNFS VSSANTLSSD
     NTTVDNDKKL LHDSKFVKKS LYYGRMYYPS SDLEAMIIKR LSPQTQFMLK GVSSFKESLN
     VLTCYFQRDS HRNLQEWIFS TSDLLCGYRV LHNFLTTPSK FNTSLYNNSS LSLGAEFWLG
     LVSLSPGCST TLRYYTHSTN TGRPLTLTLS WNPLFGHISS TYSAKTGTNS TFCAKYDFNL
     YSIESNLSFG CEFWQKKHHL LETNKNNNDK LEPISDELVD INPNSRATKL LHENVPDLNS
     AVNDIPSTLD IPVHKQKLLN DLTYAFSSSL RKIDEERSTI EKFDNKINSS IFTSVWKLST
     SLRDKTLKLL WEGKWRGFLI SAGTELVFTR GFQESLSDDE KNDNAISISA TDTENGNIPV
     FPAKFGIQFQ YST
>P23644 mit MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM40 (MITOCHONDRIAL IMPORT-
     MSAPTPLAEA SQIPTIPALS PLTAKQSKGN FFSSNPISSF VVDTYKQLHS HRQSLELVNP
     GTVENLNKEV SRDVFLSQYF FTGLRADLNK AFSMNPAFQT SHTFSIGSQA LPKYAFSALF
     ANDNLFAQGN IDNDLSVSGR LNYGWDKKNI SKVNLQISDG QPTMCQLEQD YQASDFSVNV
     KTLNPSFSEK GEFTGVAVAS FLQSVTPQLA LGLETLYSRT DGSAPGDAGV SYLTRYVSKK
     QDWIFSGQLQ ANGALIASLW RKVAQNVEAG IETTLQAGMV PITDPLMGTP IGIQPTVEGS
     TTIGAKYEYR QSVYRGTLDS NGKVACFLER KVLPTLSVLF CGEIDHFKND TKIGCGLQFE
     TAGNQELLML QQGLDADGNP LQALPQL
>P28737 mit MSP1 PROTEIN (TAT-BINDING HOMOLOG 4).
     MSRKFDLKTI TDLSVLVGTG ISLYYLVSRL LNDVESGPLS GKSRESKAKQ SLQWEKLVKR
     SPALAEVTLD AYERTILSSI VTPDEINITF QDIGGLDPLI SDLHESVIYP LMMPEVYSNS
     PLLQAPSGVL LYGPPGCGKT MLAKALAKES GANFISIRMS SIMDKWYGES NKIVDAMFSL
     ANKLQPCIIF IDEIDSFLRE RSSTDHEVTA TLKAEFMTLW DGLLNNGRVM IIGATNRIND
     IDDAFLRRLP KRFLVSLPGS DQRYKILSVL LKDTKLDEDE FDLQLIADNT KGFSGSDLKE
     LCREAALDAA KEYIKQKRQL IDSGTIDVND TSSLKIRPLK TKDFTKKLRM DATSTLSSQP
     LD
>P33448 mit MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM6 (MITOCHONDRIAL IMPORT-SITE
     MDGMFAMPGA AAGAASPQQP KSRFQAFKES PLYTIALNGA FFVAGVAFIQ SPLMDMLAPQ
     L
>P35180 mit MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM20 (MITOCHONDRIAL 20 KD OUTER
     MSQSNPILRG LAITTAIAAL SATGYAIYFD YQRRNSPQFR KVLRQRAKEQ AKMEEQAKTH
     AKEVKLQKVT EFLSMELAKD PIPSDPSERE ATFTTNVENG ERLSMQQGKE LEAASKFYKA
     LTVYPQPADL LGIYQRSIPE AIYEYIILMI AILPPANVAS FVKGVVGSKA ESDAVAEAND
     IDD
>P41800 mit MITOCHONDRIAL OUTER MEMBRANE PROTEIN MMM1.
     MTDSENESTE TDSLMTFDDY ISKELPEHLQ RLIMENLKGS TTNDLKQTSN NSEFNVSKNG
     SFKGLDDAIQ ALQMQSVLHP SSLGSLATSS KFSGWSFAQG FFVGQLSIVL LFIFFLKFFI
     FSDEPSKSKN PKPAASRHRS KFKEYPFISR EFLTSLVRKG AKQHYELNEE AENEHLQELA
     LILEKTYYNV DVHPAESLDW FNVLVAQIIQ QFRSEAWHRD NILHSLNDFI GRKSPDLPEY
     LDTIKITELD TGDDFPIFSN CRIQYSPNSG NKKLEAKIDI DLNDHLTLGV ETKLLLNYPK
     PGIAALPINL VVSIVRFQAC LTVSLTNAEE FASTSNGSSS ENGMEGNSGY FLMFSFSPEY
     RMEFEIKSLI GSRSKLENIP KIGSVIEYQI KKWFVERCVE PRFQFVRLPS MWPRSKNTRE
     EKPTEL
>P49334 mit MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM22 (MITOCHONDRIAL 22 KD OUTER
     VELTEIKDDV VQLDEPQFSR NQAIVEEKAS ATNNDVVDDE DDSDSDFEDE FDENETLLDR
     IVALKDIVPP GKRQTISNFF GFTSSFVRNA FTKSGNLAWT LTTTALLLGV PLSLSILAEQ
     QLIEMEKTFD LQSDANNILA QGEKDAAATA N
>P50110 mit MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM37 (MITOCHONDRIAL 37 KD OUTER
     MVKGSVHLWG KDGKASLISV DSIALVWFIK LCTSEEAKSM VAGLQIVFSN NTDLSSDGKL
     PVLILDNGTK VSGYVNIVQF LHKNICTSKY EKGTDYEEDL AIVRKKDRLL EYSLLNYVDV
     EISRLTDYQL FLNTKNYNEY TKKLFSKLLY FPMWYNTPLQ LRSQARENCE EIIGSLTLED
     DEEFVESKAM ESASQLAQSK TFKIAHKNKI KGKQELQQVK YNLQFDNRLQ SCVSNWLAAR
     KKLDDSVILS SDLLFLANLY VQLGLPDGNR IRSKLEQTFG SELLNSMSNK IDDFVHRPSN
     NLEQRDPQFR EQGNVVMSLY NLACKYI
>P53507 mit MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM7 (TRANSLOCASE OF OUTER
     SFLPSFILSD ESKERISKIL TLTHNVAHYG WIPFVLYLGW AHTSNRPNFL NLLSPLPSV
>P40478 mit OUTER MITOCHONDRIAL MEMBRANE PROTEIN PORIN 2 (VOLTAGE-DEPENDENT ANION-
     MALRFFNDIS RDVNGLFNRD FFHTNPLSLN ISTTTENGVN FTLKAKQGVT EGPIQTSVEG
     RFYDRKEGVS LSQSWSNQNR LNTRIEFSKI APGWKGDVNA FLTPQSIKNA KFNLSYAQKS
     FAARTSIDIL QPKDFVGSVT LGHRGFVGGT DIAYDTAAGL CARYAMSIGY LAREYSFILS
     TNNRQCATAS FFQNVNRYLQ VGTKATLQSK TSSNMNIEFV TRYVPDSISQ VKAKIADSGL
     TTLSYKRNLN KDISLGVGMS FNALQLTEPV HKFGWSLSFS P
>P80967 mit MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM5.
     MFGLPQQEVS EEEKRAHQEQ TEKTLKQAAY VAAFLWVSPM IWHLVKKQWK
>Q02486 mit ARS-BINDING FACTOR 2 PRECURSOR.
     MNSYSLLTRS FHESSKPLFN LASTLLKASK RTQLRNELIK QGPKRPTSAY FLYLQDHRSQ
     FVKENPTLRP AEISKIAGEK WQNLEADIKE KYISERKKLY SEYQKAKKEF DEKLPPKKPA
     GPFIKYANEV RSQVFAQHPD KSQLDLMKII GDKWQSLDQS IKDKYIQEYK KAIQEYNARY
     PLN
>P31376 mit HYPOTHETICAL 74.1 KD PROTEIN IN CYS3-MDM10 INTERGENIC REGION
     MRFGSNARRR QVRMPAVLRT RSKESSIEQK PASRTRTRSR RGKRGRDDDD DDDDEESDDA
     YDEVGNDYDE YASRAKLATN RPFEIVAGLP ASVELPNYNS SLTHPQSIKN SGVLYDSLVS
     SRRTWVQGEM FELYWRRPKK IVSESTPAAT ESPTSGTIPL IRDKMQKMCD CVMSGGPHTF
     KVRLFILKND KIEQKWQDEQ ELKKKEKELK RKNDAEAKRL RMEERKRQQM QKKIAKEQKL
     QLQKENKAKQ KLEQEALKLK RKEEMKKLKE QNKNKQGSPS SSMHDPRMIM NLNLMAQEDP
     KLNTLMETVA KGLANNSQLE EFKKFIEIAK KRSLEENPVN KRPSVTTTRP APPSKAKDVA
     EDHRLNSITL VKSSKTAATE PEPKKADDEN AEKQQSKEAK TTAESTQVDV KKEEEDVKEK
     GVKSEDTQKK EDNQVVPKRK RRKNAIKEDK DMQLTAFQQK YVQGAEIILE YLEFTHSRYY
     LPKKSVVEFL EDTDEIIISW IVIHNSKEIE KFKTKKIKAK LKADQKLNKE DAKPGSDVEK
     EVSFNPLFEA DCPTPLYTPM TMKLSGIHKR FNQIIRNSVS PMEEVVKEME KILQIGTRLS
     GYNLWYQLDG YDDEALSESL RFELNEWEHA MRSRRHKR
>P31378 mit HYPOTHETICAL 45.6 KD PROTEIN IN TPD3-DEP1 INTERGENIC REGION
     MQKISKYSSM AILRKRPLVK TETGPESELL PEKRTKIKQE EVVPQPVDID WVKSLPNKQY
     FEWIVVRNGN VPNRWATPLD PSILVTPAST KVPYKFQETY ARMRVLRSKI LAPVDIIGGS
     SIPVTVASKC GISKEQISPR DYRLQVLLGV MLSSQTKDEV TAMAMLNIMR YCIDELHSEE
     GMTLEAVLQI NETKLDELIH SVGFHTRKAK YILSTCKILQ DQFSSDVPAT INELLGLPGV
     GPKMAYLTLQ KAWGKIEGIC VDVHVDRLTK LWKWVDAQKC KTPDQTRTQL QNWLPKGLWT
     EINGLLVGFG QIITKSRNLG DMLQFLPPDD PRSSLDWDLQ SQLYKEIQQN IMSYPKWVKY
     LEGKRELNVE AEINVKHEEK TVEETMVKLE NDISVKVED
>P21592 mit CYTOCHROME C OXIDASE ASSEMBLY PROTEIN COX10 PRECURSOR.
     MSYFPRTYAH LMRNVLAHNK GNIYLQIGTQ LHDTQIKIRF NGVRYISRNH GGKQQHINTA
     PIEFTPNFGY GDRTSNCNKK VESTAMKTLR CTDDISTSSG SEATTDASTQ LPFNVKLVDP
     MVRKSKRPSH AISEGLNMKT LKKKVIMPYL QLTKPRLTIL VMLSAICSYA LSPYPASVNE
     LLCLTVGTTL CSGSANAINM GREPEFDRQM VRTQARPVVR GDVTPTQAFE FAALIGTLGV
     SILYFGVNPT VAILGASNIA LYGWAYTSMK RKHIINTWLG ALVGMVPPLM GWAAASPLSH
     PGSWCLAGLL FAWQFPHFNT LSHNIRNEYK NAGYVMTAWK NPLLNARVSL RYSILMFPLC
     FGLSYFNITD WYYQIDSGLI NAWLTFWAFK FYWQQRINYS AKTLKDNVKF NKGLSVANIY
     ARKTFMASVL HLPAILILAI IHKKGRWDWI YPGEAKRPQE RF
>P39103 mit CYTOCHROME C OXIDASE ASSEMBLY PROTEIN COX14.
     MSKYAWYTRV TDTLHRLTVL TLVGGTLYMS GGLAYTLYMN GKKYEQQVTQ QKALEEDNQQ
     LQSPTAPPTE
>P20107 mit ZINC/CADMIUM RESISTANCE PROTEIN.
     MITGKELRII SLLTLDTVFF LLEITIGYMS HSLALIADSF HMLNDIISLL VALWAVDVAK
     NRGPDAKYTY GWKRAEILGA LINAVFLIAL CFSIMIEALQ RLIEPQEIQN PRLVLYVGVA
     GLISNVVGLF LFHDHGSDSL HSHSHGSVES GNNDLDIESN ATHSHSHASL PNDNLAIDED
     AISSPGPSGQ IGEVLPQSVV NRLSNESQPL LNHDDHDHSH ESKKPGHRSL NMHGVFLHVL
     GDALGNIGVI AAALFIWKTE YSWRYYSDPI VSLIITIIIF SSALPLSRRA SRILLQATPS
     TISADQIQRE ILAVPGVIAV HDFHVWNLTE SIYIASIHVQ IDCAPDKFMS SAKLIRKIFH
     QHGIHSATVQ PEFVSGDVNE DIRRRFSIIA GGSPSSSQEA FDSHGNTEHG RKKRSPTAYG
     ATTASSNCIV DDAVNCNTSN CL
>P38778 mit TRANSPORTER PROTEIN SMF2.
     MTSQEYEPIQ WSDESQTNND SVNDAYADVN TTHESRRRTT LQPNSTSQSM IGTLRKYARF
     IGPGLMVSVS YMDPGNYSTA VAAGSAHRYK LLFSVLVSNF MAAFWQYLCA RLGAVTGLDL
     AQNCKKHLPF GLNITLYILA EMAIIATDLA EVVGTAISLN ILFHIPLALG VILTVVDVLI
     VLLAYKPNGS MKGIRIFEAF VSLLVVLTVV CFTVELFYAK LGPAKEIFSG FLPSKAVFEG
     DGLYLSLAIL GATVMPHSLY LGSGVVQPRL REYDIKNGHY LPDANDMDNN HDNYRPSYEA
     ISETLHFTIT ELLISLFTVA LFVNCAILIV SGATLYGSTQ NAEEADLFSI YNLLCSTLSK
     GAGTVFVLAL LFSGQSAGIV CTLSGQMVSE GFLNWTVSPA LRRSATRAVA ITPCLILVLV
     AGRSGLSGAL NASQVVLSLL LPFVSAPLLY FTSSKKIMRV QLNRTKELSR TTDKKPVADR
     TEDDETIELE EMGIGSSSQE RSLVSPAPEY KDMSNGMIVT VLAIIVWLII SGLNFYMLLG
     FTTGKEVHL
>P38925 mit TRANSPORTER PROTEIN SMF1/ESP1.
     MVNVGPSHAA VAVDASEARK RNISEEVFEL RDKKDSTVVI EGEAPVRTFT SSSSNHERED
     TYVSKRQVMR DIFAKYLKFI GPGLMVSVAY IDPGNYSTAV DAGASNQFSL LCIILLSNFI
     AIFLQCLCIK LGSVTGLDLS RACREYLPRW LNWTLYFFAE CAVIATDIAE VIGTAIALNI
     LIKVPLPAGV AITVVDVFLI MFTYKPGASS IRFIRIFECF VAVLVVGVCI CFAIELAYIP
     KSTSVKQVFR GFVPSAQMFD HNGIYTAISI LGATVMPHSL FLGSALVQPR LLDYDVKHGN
     YTVSEEQDKV KKSKSTEEIM EEKYFNYRPT NAAIKYCMKY SMVELSITLF TLALFVNCAI
     LVVAGSTLYN SPEADGADLF TIHELLSRNL APAAGTIFML ALLLSGQSAG VVCTMSGQIV
     SEGHINWKLQ PWQRRLATRC ISIIPCLVIS ICIGREALSK ALNASQVVLS IVLPFLVAPL
     IFFTCKKSIM KTEITVDHTE EDSHNHQNNN DRSAGSVIEQ DGSSGMEIEN GKDVKIVYMA
     NNWIITVIAI IVWLFLSLLN VYAIVQLGMS HGDIS
>P39952 mit CYTOCHROME OXIDASE BIOGENESIS PROTEIN OXA1 PRECURSOR.
     MFKLTSRLVT SRFAASSRLA TARTIVLPRP HPSWISFQAK RFNSTGPNAN DVSEIQTQLP
     SIDELTSSAP SLSASTSDLI ANTTQTVGEL SSHIGYLNSI GLAQTWYWPS DIIQHVLEAV
     HVYSGLPWWG TIAATTILIR CLMFPLYVKS SDTVARNSHI KPELDALNNK LMSTTDLQQG
     QLVAMQRKKL LSSHGIKNRW LAAPMLQIPI ALGFFNALRH MANYPVDGFA NQGVAWFTDL
     TQADPYLGLQ VITAAVFISF TRLGGETGAQ QFSSPMKRLF TILPIISIPA TMNLSSAVVL
     YFAFNGAFSV LQTMILRNKW VRSKLKITEV AKPRTPIAGA SPTENMGIFQ SLKHNIQKAR
     DQAERRQLMQ DNEKKLQESF KEKRQNSKIK IVHKSNFINN KK
>P05085 nuc ARGININE METABOLISM REGULATION PROTEIN II.
     MGISSKNGPK KMGRAKTFTG CWTCRGRKVK CDLRHPHCQR CEKSNLPCGG YDIKLRWSKP
     MQFDPYGVPI PQNSPATTTN LSGSVDEPQY QRRNIDFVRY DEEYVYHEDM DDELTMLHTP
     PIEKISDNKT WIIKKFGVFK GTDKIDKQYA PRKKRNRKRV AKSLESSASI SLSSLPSSST
     ISFPIRHIED KLRNKGHVKT GILSANDGVP PTPNLLDYDW NNLNITGYEW ISSELRDDAL
     LSAVTLQGHH LGHTQPQEIS LEENSNVVSG EEHVNAKEHG CAFEADNQGS STLPNKAASA
     NDKLYQQNLK LLFQKNSSNS EEPDPQALID DVFVNIEPRS LPASDLNKIT LAPPNEESRM
     PKSMLELTSY SSDLPPELVD IIPKTDLTVH GLARFLLNHY FNNVADKMTV VVLEKNPWKT
     LYFPRALMAL GDLAGLGQSS NSRNALLNAL LAVSCFHLQS KYPRNYKLQK YFLGLGIELR
     NQASNFLRLC LNTKSSIPEK YKDVLTAILS MNSIDVVWGT MADCQDHLAL CEDFVESRMK
     LRPNISEKTK TLHRIFSFLK LIQDSTALDK VRAKEIVILP SEEDDNYKPL DTSNATTSSS
     EPRVDVVQEG LFREALNEND GKIHIEFVKE PITNVSADST PSSTTPPIFT NIATESYYNK
     SDISKLVSKT DENIIGTDSL YGLPNSLILL FSDCVRIVRH NEYYNLTYLP VPRKFNELSL
     NFEKRLLKWK SEWNFHQENS EGKSFINSTA EALYHHTMSF YFSLIIYYFT MARSLNCQFL
     QNYVAKVLDH LNAMEELVDQ KKVKIVPLIW QGFMAGCACT DENRQQEFRR WAAKLAESGV
     GSYWGARQVM LEVWRRRKED EPGDNWYSVY KDWEMNLMLS
>P07248 nuc REGULATORY PROTEIN ADR1.
     MANVEKPNDC SGFPVVDLNS CFSNGFNNEK QEIEMETDDS PILLMSSSAS RENSNTFSVI
     QRTPDGKIIT TNNNMNSKIN KQLDKLPENL RLNGRTPSGK LRSFVCEVCT RAFARQEHLK
     RHYRSHTNEK PYPCGLCNRC FTRRDLLIRH AQKIHSGNLG ETISHTKKVS RTITKARKNS
     ASSVKFQTPT YGTPDNGNFL NRTTANTRRK ASPEANVKRK YLKKLTRRAS FSAQSASSYA
     LPDQSSLEQH PKDRVKFSTP ELVPLDLKNP ELDSSFDLNM NLDLNLNLDS NFNIALNRSD
     SSGSTMNLDY KLPESANNYT YSSGSPTRAY VGANTNSKNA SFNDADLLSS SYWIKAYNDH
     LFSVSESDET SPMNSELNDT KLIVPDFKST IHHLKDSRSS SWTVAIDNNS NNNKVSDNQP
     DFVDFQELLD NDTLGNDLLE TTAVLKEFEL LHDDSVSATA TSNEIDLSHL NLSNSPISPH
     KLIYKNKEGT NDDMLISFGL DHPSNREDDL DKLCNMTRDV QAIFSQYLKG EESKRSLEDF
     LSTSNRKEKP DSGNYTFYGL DCLTLSKISR ALPASTVNNN QPSHSIESKL FNEPMRNMCI
     KVLRYYEKFS HDSSESVMDS NPNLLSKELL MPAVSELNEY LDLFKNNFLP HFPIIHPSLL
     DLDLDSLQRY TNEDGYDDAE NAQLFDRLSQ GTDKEYDYEH YQILSISKIV CLPLFMATFG
     SLHKFGYKSQ TIELYEMSRR ILHSFLETKR RCRSTTVNDS YQNIWLMQSL ILSFMFALVA
     DYLEKIDSSL MKRQLSALCS TIRSNCLPTI SANSEKSINN NNEPLTFGSP LQYIIFESKI
     RCTLMAYDFC QFLKCFFHIK FDLSIKEKDV ETIYIPDNES KWASESIICN GHVVQKQNFY
     DFRNFYYSFT YGHLHSIPEF LGSSMIYYEY DLRKGTKSHV FLDRIDTKRL ERSLDTSSYG
     NDNMAATNKN IAILIDDTII LKNNLMSMRF IKQIDRSFTE KVRKGQIAKI YDSFLNSVRL
     NFLKNYSVEV LCEFLVALNF SIRNISSLYV EEESDCSQRM NSPELPRIHL NNQALSVFNL
     QGYYYCFILI IKFLLDFEAT PNFKLLRIFI ELRSLANSIL LPTLSRLYPQ EFSGFPDVVF
     TQQFINKDNG MLVPGLSANE HHNGASAAVK TKLAKKINVE GLAMFINEIL VNSFNDTSFL
     NMEDPIRNEF SFDNGHRAVT DLPRSAHFLS DTGLEGINFS GLNDSHQTVS TLNLLRYGEN
     HSSKHKNGGK GQGFAEKYQL SLKYVTIAKL FFTNVKENYI HCHMLDKMAS DFHTLENHLK
     GNS
>P07249 nuc ARGININE METABOLISM REGULATION PROTEIN I.
     MTSNSDGSST SPVEKPITGD VETNEPTKPI RRLSTPSPEQ DQEGDFDEED DDDKFSVSTS
     TPTPTITKTK DSSDTSTVTR RKQPIRYIEN KTRRHVTFSK RRHGIMKKAY ELSVLTGANI
     LLLILANSGL VYTFTTPKLE PVVREDEGKS LIRACINASD TPDATDTSPA QEQSPAN
>P09547 nuc TRANSCRIPTION REGULATORY PROTEIN ADR6 (SWI/SNF COMPLEX COMPONENT
     MDFFNLNNNN NNNNTTTTTT TTNNNNTNNN NTNNNNNPAN NTNNNNSTGH SSNTNNNTNN
     NNTNTGASGV DDFQNFFDPK PFDQNLDSNN NNSNSNNNDN NNSNTVASST NFTSPTAVVN
     NAAPANVTGG KAANFIQNQS PQFNSPYDSN NSNTNLNSLS PQAILAKNSI IDSSNLPLQA
     QQQLYGGNNN NNSTGIANDN VITPHFITNV QSISQNSSSS TPNTNSNSTP NANQQFLPFN
     NSASNNGNLT SNQLISNYAA SNSMDRSSSA SNEFVPNTSD NNNNSNNHNM RNNSNNKTSN
     NNNVTAVPAA TPANTNNSTS NANTVFSERA AMFAALQQKQ QQRFQALQQQ QQQQQNQQQQ
     NQQPQQQQQQ QQNPKFLQSQ RQQQQRSILQ SLNPALQEKI STELNNKQYE LFMKSLIENC
     KKRNMPLQSI PEIGNRKINL FYLYMLVQKF GGADQVTRTQ QWSMVAQRLQ ISDYQQLESI
     YFRILLPYER HMISQEGIKE TQAKRIFLQQ FLQELLKKVQ QQQQAAALAN ANNNINSASS
     APTPAAPGAS VPATAAPGTE AGIVPVSANT PKSLNSNINI NVNNNNIGQQ QVKKPRKQRV
     KKKTKKELEL ERKEREDFQK RQQKLLEDQQ RQQKLLLETK LRQQYEIELK KLPKVYKRSI
     VRNYKPLINR LKHYNGYDIN YISKIGEKID SNKPIFLFAP ELGAINLHAL SMSLQSKNLG
     EINTALNTLL VTSADSNLKI SLVKYPELLD SLAILGMNLL SNLSQNVVPY HRNTSDYYYE
     DAGSNQYYVT QHDKMVDKIF EKVNNNATLT PNDSNDEKVT ILVDSLTGNQ LPTPTPTEME
     PDLDTECFIS MQSTSPAVKQ WDLLPEPIRF LPNQFPLKIH RTPYLTSLKK IKDEIDDPFT
     KINTRGAEDP KVLINDQLST ISMILRNISF SDNNSRIMSR NFYLKRFISD LLWLVLIHPE
     NFTCNRKILN FKKDLVIVLS NISHLLEIAS SIDCLLILIL VISFGQPKLN PMASSSSFGS
     ESLTFNEFQL QWGKYQTFGV DILAKLFSLE KPNLNYFKSI LLNKNTGNNL YDRNSNNNHK
     DKKLLRRLLN LYNDNNKNNN NRHNLLNDVV SFLFSAIPLQ QVLSQSADPS LLIDQFSPVI
     SQSLTSILVI VQKILPLSNE VFEISENNSD SNSNNNGNKD SSFNFNKNLP FVWLSSEENI
     GSGLLKLSEI ILNINNSTSK NTLLQQQNYS KVLLPSINIS CVQLIKCLVE KSICFENCLN
     NDPEILKKIA SIPNLFPTDL EIFQLFTNPS VDIQIINQYQ LLYNLKNDIL TNLE
>P14164 nuc TRANSCRIPTION FACTOR BAF1 (ARS BINDING FACTOR 1) (PROTEIN ABF1)
     MDKLVVNYYE YKHPIINKDL AIGAHGGKKF PTLGAWYDVI NEYEFQTRCP IILKNSHRNK
     HFTFACHLKN CPFKVLLSYA GNAASSETSS PSANNNTNPP GTPDHIHHHS NNMNNEDNDN
     NNGSNNKASN DSKLDFVTDD LEYHLANIHP DDTNDKVESR SNEVNGNNDD DADANNIFKQ
     QGVTIKNDTE DDSINKASID RGLDDESGPT HGNDSGNHRH NEEDDVHTQM TKNYSDVVND
     EDINVAIANA VANVDSQSNN KHDGKDDDAT NNNDGQDNTN NNDHNNNSNI NNNNVGSHGI
     SSHSPSSIRD TSMNLDVFNS ATDDIPGPFV VTKIEPYHSH PLEDNLSLGK FILTKIPKIL
     QNDLKFDQIL ESSYNNSNHT VSKFKVSHYV EESGLLDILM QRYGLTAEDF EKRLLSQIAR
     RITTYKARFV LKKKKMGEYN DLQPSSSSNN NNNNDGELSG TNLRSNSIDY AKHQEISSAG
     TSSNTTKNVN NNKNDSNDDN NGNNNNDASN LMESVLDKTS SHRYQPKKMP SVNKWSKPDQ
     ITHSDVSMVG LDESNDGGNE NVHPTLAEVD AQEARETAQL AIDKINSYKR SIDDKNGDGH
     NNSSRNVVDE NLINDMDSED AHKSKRQHLS DITLEERNED DKLPHEVAEQ LRLLSSHLKE
     VENLHQNNDD DVDDVMVDVD VESQYNKNTN HHNNHHSQPH HDEEDVAGLI GKADDEEDLS
     DENIQPELRG Q
>P15315 nuc TRANSCRIPTIONAL ACTIVATOR PROTEIN ACE1 (COPPER-FIST TRANSCRIPTION
     MVVINGVKYA CETCIRGHRA AQCTHTDGPL QMIRRKGRPS TTCGHCKELR RTKNFNPSGG
     CMCASARRPA VGSKEDETRC RCDEGEPCKC HTKRKSSRKS KGGSCHRRAN DEAAHVNGLG
     IADLDVLLGL NGRSSDVDMT TTLPSLKPPL QNGEIKADSI DNLDLASLDP LEQSPSISME
     PVSINETGSA YTTTNTALND IDIPFSINEL NELYKQVSSH NSHSQ
>P21192 nuc METALLOTHIONEIN EXPRESSION ACTIVATOR.
     MDNVVDPWYI NPSGFAKDTQ DEEYVQHHDN VNPTIPPPDN YILNNENDDG LDNLLGMDYY
     NIDDLLTQEL RDLDIPLVPS PKTGDGSSDK KNIDRTWNLG DENNKVSHYS KKSMSSHKRG
     LSGTAIFGFL GHNKTLSISS LQQSILNMSK DPQPMELINE LGNHNTVKNN NDDFDHIREN
     DGENSYLSQV LLKQQEELRI ALEKQKEVNE KLEKQLRDNQ IQQEKLRKVL EEQEEVAQKL
     VSGATNSNSK PGSPVILKTP AMQNGRMKDN AIIVTTNSAN GGYQFPPPTL ISPRMSNTSI
     NGSPSRKYHR QRYPNKSPES NGLNLFSSNS GYLRDSELLS FSPQNYNLNL DGLTYNDHNN
     TSDKNNNDKK NSTGDNIFRL FEKTSPGGLS ISPRINGNSL RSPFLVGTDK SRDDRYAAGT
     FTPRTQLSPI HKKRESVVST VSTISQLQDD TEPIHMRNTQ NPTLRNANAL ASSSVLPPIP
     GSSNNTPIKN SLPQKHVFQH TPVKAPPKNG SNLAPLLNAP DLTDHQLEIK TPIRNNSHCE
     VESYPQVPPV THDIHKSPTL HSTSPLPDEI IPRTTPMKIT KKPTTLPPGT IDQYVKELPD
     KLFECLYPNC NKVFKRRYNI RSHIQTHLQD RPYSCDFPGC TKAFVRNHDL IRHKISHNAK
     KYICPCGKRF NREDALMVHR SRMICTGGKK LEHSINKKLT SPKKSLLDSP HDTSPVKETI
     ARDKDGSVLM KMEEQLRDDM RKHGLLDPPP STAAHEQNSN RTLSNETDAL
>P22035 nuc MYB-LIKE DNA-BINDING PROTEIN BAS1.
     MSNISTKDIR KSKPKRGSGF DLLEVTESLG YQTHRKNGRN SWSKDDDNML RSLVNESAKE
     LGYENGLEDV KTIQQSNHLS KCIAWDVLAT RFKHTVRTSK DVRKRWTGSL DPNLKKGKWT
     QEEDEQLLKA YEEHGPHWLS ISMDIPGRTE DQCAKRYIEV LGPGSKGRLR EWTLEEDLNL
     ISKVKAYGTK WRKISSEMEF RPSLTCRNRW RKIITMVVRG QASEVITKAI KENKNIDMTD
     GKLRQHPIAD SDIRSDSTPN KEEQLQLSQQ NNPSLIKQDI LNVKENESSK LPRLKDNDGP
     ILNDSKPQAL PPLKEISAPP PIRMTQVGQT HTSGSIRSKV SLPIEGLSQM NKQSPGGISD
     SPQTSLPPAF NPASLDEHMM NSNSISDSPK HAYSTVKTRE PNSSSTQWKF TLKDGQGLSI
     SNGTIDSTKL VKELVDQAKK YSLKISIHQH IHNHYVTSTD HPVSSNTGLS NIGNINGNPL
     LMDSFPHMGR QLGNGLPGLN SNSDTFNPEY RTSLDNMDSD FLSRTPNYNA FSLEATSHNP
     ADNANELGSQ SNRETNSPSV FYPQANTLIP TNSTATNNEI IQGNVSANSM SPNFNGTNGK
     APSSTASYTT SGSEMPPDVG PNRIAHFNYL PPTIRPHLGS SDATRGADLN KLLNPSPNSV
     RSNGSKTKKK EKRKSESSQH HSSSSVTTNK FNHIDQSEIS RTTSRSDTPL RDEDGLDFWE
     TLRSLATTNP NPPVEKSAEN DGAKPQVVHQ GIGSHTEDSS LGSHSGGYDF FNELLDKKAD
     TLHNEAKKTS EHDMTSGGST DNGSVLPLNP S
>P22936 nuc DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE (EC 4.2.99.18) (AP
     PSTPSFVRSA VSKYKFGAHM SGAGGISNSV TNAFNTGCNS FAMFLKSPRK WVSPQYTQEE
     IDKFKKNCAT YNYNPLTDVL PHGQYFINLA NPDREKAEKS YESFMDDLNR CEQLGIGLYN
     LHPGSTLKGD HQLQLKQLAS YLNKAIKETK FVKIVLENMA GTGNLVGSSL VDLKEVIGMI
     EDKSRIGVCI DTCHTFAAGY DISTTETFNN FWKEFNDVIG FKYLSAVHLN DSKAPLGANR
     DLHERLGQGY LGIDVFRMIA HSEYLQGIPI VLETPYENDE GYGNEIKLME WLESKSESEL
     LEDKEYKEKN DTLQKLGAKS RKEQLDKFEV KQKKRAGGTK RKKATAEPSD NDILSQMTKK
     RKTKKE
>P32357 nuc A1 CISTRON SPLICING FACTOR AAR2.
     MNTVPFTSAP IEVTIGIDQY SFNVKENQPF HGIKDIPIGH VHVIHFQHAD NSSMRYGYWF
     DCRMGNFYIQ YDPKDGLYKM MEERDGAKFE NIVHNFKERQ MMVSYPKIDE DDTWYNLTEF
     VQMDKIRKIV RKDENQFSYV DSSMTTVQEN ELLKSSLQKA GSKMEAKNED DPAHSLNYTV
     INFKSREAIR PGHEMEDFLD KSYYLNTVML QGIFKNSSNY FGELQFAFLN AMFFGNYGSS
     LQWHAMIELI CSSATVPKHM LDKLDEILYY QIKTLPEQYS DILLNERVWN ICLYSSFQKN
     SLHNTEKIME NKYPELLGKD NEDDALIYGI SDEERDDEDD EHNPTIVGGL YYQRP
>P32504 nuc CENTROMERE DNA-BINDING PROTEIN COMPLEX CBF3 SUBUNIT A (KINETOCHORE
     MRSSILFLLK LMKIMDVQQQ QEAMSSEDRF QELVDSLKPR TAHQYKTYYT KYIQWCQLNQ
     IIPTPEDNSV NSVPYKDLPI SAELIHWFLL DTLITDDKPG EKREETEDLD EEEENSFKIA
     TLKKIIGSLN FLSKLCKVHE NPNANIDTKY LESVTKLHTH WIDSQKAITT NETNNTNTQV
     LCPPLLKVSL NLWNPETNHL SEKFFKTCSE KLRFLVDFQL RSYLNLSFEE RSKIRFGSLK
     LGKRDRDAII YHKVTHSAEK KDTPGHHQLL ALLPQDCPFI CPQTTLAAYL YLRFYGIPSV
     SKGDGFPNLN ADENGSLLQD IPILRGKSLT TYPREETFSN YYTTVFRYCH LPYKRREYFN
     KCNLVYPTWD EDTFRTFFNE ENHGNWLEQP EAFAFPDKIP FDFKKIMNFK SPYTSYSTNA
     KKDPFPPPKD LLVQIFPEID EYKRHDYEGL SQNSRDFLDL MEVLRERFLS NLPWIYKFFP
     NHDIFQDPIF GNSDFQSYFN DKTIHSKGSP ILSFDILPGF NKIYKNKTNF YSLLIERPSQ
     LTFASSHNPD THPTQKQESE GPLQMSQLDT TQLNELLKQQ SFEYVQFQTL SNFQILLSVF
     NKIFEKLEMK KSSRGYILHQ LNLFKITLDE RIKKSKIDDA DKFIRDNQPI KKEENIVNED
     GPNTSRRTKR PKQIRLLSIA DSSDESSTED SNVFKKDGES IEDGAYGENE DENDSEMQEQ
     LKSMINELIN SKISTFLRDQ MDQFELKINA LLDKILEEKV TRIIEQKLGS HTGKFSTLKR
     PQLYMTEEHN VGFDMEVPKK LRTSGKYAET VKDNDDHQAM STTASPSPEQ DQEAKSYTDE
     QEFMLDKSID SIEGIILEWF TPNAKYANQC VHSMNKSGNK SWRANCEALY KERKSIVEFY
     IYLVNHESLD RYKAVDICEK LRDQNEGSFS RLAKFLRKWR HDHQNSFDGL LVYLSN
>P35203 nuc CENTROMERE DNA-BINDING PROTEIN COMPLEX CBF3 SUBUNIT C (KINETOCHORE
     PSFNPVRFLE LPIDIRKEVY FHLDGNFCGA HPYPIDILYK SNDVELPGKP SYKRSKRSKK
     LLRYMYPVFA TYLNIFEYSP QLIEKWLEYA FWLRYDCLVL DCFKVNHLYD GTLIDALEWT
     YLDNELRLAY FNKASMLEVW YTFKEYKKWV IDSVAFDELD LLNVSNIQFN IDNLTPQLVD
     KCLSILEQKD LFATIGEVQF GQDEEVGEEK DVDVSGANSD ENSSPSSTIK NKKRSASKRS
     HSDNGNVGAT HNQLTSISVI RTIRSMESMK SLRKITVRGE KLYELLINFH GFRDNPGKTI
     SYIVKRRINE IRLSRMNQIS RTGLADFTRW DNLQKLVLSR VAYIDLNSIV FPKNFKSLTM
     KRVSKIKWWN IEENILKELK VDKRTFKSLY IKEDDSKFTK FFNLRHTRIK ELDKSEINQI
     TYLRCQAIVW LSFRTLNHIK LQNVSEVFNN IIVPRALFDS KRVEIYRCEK ISQVLVI
>P36093 nuc PUTATIVE TRANSCRIPTION FACTOR PHD1.
     MYHVPEMRLH YPLVNTQSNA AITPTRSYDN TLPSFNELSH QSTINLPFVQ RETPNAYANV
     AQLATSPTQA KSGYYCRYYA VPFPTYPQQP QSPYQQAVLP YATIPNSNFQ PSSFPVMAVM
     PPEVQFDGSF LNTLHPHTEL PPIIQNTNDT SVARPNNLKS IAAASPTVTA TTRTPGVSST
     SVLKPRVITT MWEDENTICY QVEANGISVV RRADNNMING TKLLNVTKMT RGRRDGILRS
     EKVREVVKIG SMHLKGVWIP FERAYILAQR EQILDHLYPL FVKDIESIVD ARKPSNKASL
     TPKSSPAPIK QEPSDNKHEI ATEIKPKSID ALSNGASTQG AGELPHLKIN HIDTEAQTSR
     AKNELS
>P39113 nuc REGULATORY PROTEIN CAT8.
     MANNNSDRQG LEPRVIRTLG SQALSGPSIS NRTSSSEANP HFSKNVKEAM IKTASPTPLS
     TPIYRIAQAC DRCRSKKTRC DGKRPQCSQC AAVGFECRIS DKLLRKAYPK GYTESLEERV
     RELEAENKRL LALCDIKEQQ ISLVSQSRPQ TSTDNTINGN FKHDLKDAPL NLSSTNIYLL
     NQTVNKQLQN GKMDGDNSGS AMSPLGAPPP PPHKDHLCDG VSCTNHLHVK PTSTSLNDPT
     AISFEQDEAP GLPAVKALKS MTTHQRSTQL ATLVSLSIPR STEEILFIPQ LLTRIRQIFG
     FNSKQCLYTV SLLSSLKNRL PAPRLLAPST STKLKEKDED KKLDDDSAFV KRFQSTNLSE
     FVDLKKFLIS LKFNINSFSK QSEKPANDQD DELLSLTEIK ELLHLFFKFW SNQVPILNND
     HFLIYFNNFV EVVKHLSTEN LETNNTTKST VTTNHEIFAL KLLMMLQMGL LVKIKMEKIK
     YTVPKNPKAK YARLMAYYHQ LSLIIPKNPY FLNMSTTSLP SLQLLSLASF YYLNVGDISA
     IYGVRGRIVS MAQQLRLHRC PSAVLSVHSN PVLQKFEQSE RRLLFWAIYY VDVFASLQLG
     VPRLLKDFDI ECALPISDVE YKDQLSMENE KADKKAKKIQ LQGQVSSFSL QIIRFAKILG
     NILDSIFKRG MMDERITSEV ALVHENALDN WRNQLPEMYY FQITVNGTVN LDEIRATNQR
     NTETKFDKKD IILFEKKILL LFYFLAKSMI HLPVIATKPL PKNVDNATKK KQSMFNNDSK
     GATNQDHMIL DVDMTSPAIR TSSSYIILQQ ATNATLTIFQ AINSMYLPLP LNVSRTLIRF
     SLLCARGSLE YTKGGALFLD NKNLLLDTIK DIENDRLLDL PGIASWHTLK LFDMSINLLL
     KAPNVKVERL DKFLEKKLNY YNRLMGLPPA TTTSLKPLFG SQSKNSLENR QRTPNVKREN
     PEHEYLYGND SNNNNNSEAG HSPMTNTTNG NKRLKYEKDA KRNAKDGGIS KGENAHNFQN
     DTKKNMSTSN LFPFSFSNTD LTALFTHPEG PNCTNTNNGN VDVCNRASTD ATDANIENLS
     FLNMAPFLQT GNSNIGQNTI ENKPMHMDAI FSLPSNLDLM KDNMDSKPEQ LEPVIKQNPE
     NSKNNQFHQK GKSTNMEKNN LSFNNKSNYS LTKLMRLLNN DNSFSNISIN NFLYQNDQNS
     ASADPGTNKK AVTNAGANFK PPSTGSNTSQ GSILGSTKHG MDNCDFNDLG NFNNFMTNVN
     YSGVDYDYIV DASLGLAPLL VDTPDISNTN TTSTTSNRSK NSIILDTTFN DDLDRSRMNA
     REVLNPTDSI LSQGMVSSVS TRNTSNQRSL SSGNDSKGDS SSQENSKSAT GNQLDTPSTL
     FQMRRTSSGP SASHRGPRRP QKNRYNTDRS KSSGGGSSNT DNVSDLFQWQ NAK
>P41695 nuc CHECKPOINT SERINE/THREONINE-PROTEIN KINASE BUB1 (EC 2.7.1.-).
     MNLDLGSTVR GYESDKDTFP QSKGVSSSQK EQHSQLNQTK IAYEQRLLND LEDMDDPLDL
     FLDYMIWIST SYIEVDSESG QEVLRSTMER CLIYIQDMET YRNDPRFLKI WIWYINLFLS
     NNFHESENTF KYMFNKGIGT KLSLFYEEFS KLLENAQFFL EAKVLLELGA ENNCRPYNRL
     LRSLSNYEDR LREMNIVENQ NSVPDSRERL KGRLIYRTAP FFIRKFLTSS LMTDDKENRA
     NLNSNVGVGK SAPNVYQDSI VVADFKSETE RLNLNSSKQP SNQRLKNGNK KTSIYADQKQ
     SNNPVYKLIN TPGRKPERIV FNFNLIYPEN DEEFNTEEIL AMIKGLYKVQ RRGKKHTEDY
     TSDKNRKKRK LDVLVERRQD LPSSQPPVVP KSTRIEVFKD DDNPSQSTHH KNTQVQVQTT
     TSILPLKPVV DGNLAHETPV KPSLTSNASR SPTVTAFSKD AINEVFSMFN QHYSTPGALL
     DGDDTTTSKF NVFENFTQEF TAKNIEDLTE VKDPKQETVS QQTTSTNETN DRYERLSNSS
     TRPEKADYMT PIKETTETDV VPIIQTPKEQ IRTEDKKSGD NTETQTQLTS TTIQSSPFLT
     QPEPQAEKLL QTAEHSEKSK EHYPTIIPPF TKIKNQPPVI IENPLSNNLR AKFLSEISPP
     LFQYNTFYNY NQELKMSSLL KKIHRVSRNE NKNPIVDFKK TGDLYCIRGE LGEGGYATVY
     LAESSQGHLR ALKVEKPASV WEYYIMSQVE FRLRKSTILK SIINASALHL FLDESYLVLN
     YASQGTVLDL INLQREKAID GNGIMDEYLC MFITVELMKV LEKIHEVGII HGDLKPDNCM
     IRLEKPGEPL GAHYMRNGED GWENKGIYLI DFGRSFDMTL LPPGTKFKSN WKADQQDCWE
     MRAGKPWSYE ADYYGLAGVI HSMLFGKFIE TIQLQNGRCK LKNPFKRYWK KEIWGVIFDL
     LLNSGQASNQ ALPMTEKIVE IRNLIESHLE QHAENHLRNV ILSIEEELSH FQYKGKPSRR
     F
>P52286 nuc CENTROMERE DNA-BINDING PROTEIN COMPLEX CBF3 SUBUNIT D (SUPPRESSOR OF
     VTSNVVLVSG EGERFTVDKK IAERSLLLKN YLNDMHDSNL QNNSDSESDS DSETNHKSKD
     NNNGDDDDED DDEIVMPVPN VRSSVLQKVI EWAEHHRDSN FPDEDDDDSR KSAPVDSWDR
     EFLKVDQEML YEIILAANYL NIKPLLDAGC KVVAEMIRGR SPEEIRRTFN IVNDFTPEEE
     AAIRRENEWA EDR
>Q02336 nuc POTENTIAL TRANSCRIPTIONAL ADAPTOR.
     MSNKFHCDVC SADCTNRVRV SCAICPEYDL CVPCFSQGSY TGKHRPYHDY RIIETNSYPI
     LCPDWGADEE LQLIKGAQTL GLGNWQDIAD HIGSRGKEEV KEHYLKYYLE SKYYPIPDIT
     QNIHVPQDEF LEQRRHRIES FRERPLEPPR KPMASVPSCH EVQGFMPGRL EFETEFENEA
     EGPVKDMVFE PDDQPLDIEL KFAILDIYNS RLTTRAEKKR LLFENHLMDY RKLQAIDKKR
     SKEAKELYNR IKPFARVMTA QDFEEFSKDI LEELHCRARI QQLQEWRSNG LTTLEAGLKY
     ERDKQARISS FEKFGASTAA SLSEGNSRYR SNSAHRSNAE YSQNYSENGG RKKNMTISDI
     QHAPDYALLS NDEQQLCIQL KILPKPYLVL KEVMFRELLK TGGNLSKSAC RELLNIDPIK
     ANRIYDFFQS QNWM
>P01366 nuc MATING-TYPE PROTEIN A-1.
     MDDICSMAEN INRTLFNILG TEIDEINLNT NNLYNFIMES NLTKVEQHTL HKNISNNRLE
     IYHHIKKEKS PKGKSSISPQ ARAFLEQVFR RKQSLNSKEK EEVAKKCGIT PLQVRVWFIN
     KRMRSK
>P01367 nuc MATING-TYPE PROTEIN ALPHA-2 (ALPHA-2 REPRESSOR).
     MNKIPIKDLL NPQITDEFKS SILDINKKLF SICCNLPKLP ESVTTEEEVE LRDILGFLSR
     ANKNRKISDE EKKLLQTTSQ LTTTITVLLK EMRSIENDRS NYQLTQKNKS ADGLVFNVVT
     QDMINKSTKP YRGHRFTKEN VRILESWFAK NIENPYLDTK GLENLMKNTS LSRIQIKNWV
     SNRRRKEKTI TIAPELADLL SGEPLAKKKE
>P02293 nuc HISTONE H2B.1.
     SAKAEKKPAS KAPAEKKPAA KKTSTSTDGK KRSKARKETY SSYIYKVLKQ THPDTGISQK
     SMSILNSFVN DIFERIATEA SKLAAYNKKS TISAREIQTA VRLILPGELA KHAVSEGTRA
     VTKYSSSTQA
>P02294 nuc HISTONE H2B.2.
     SSAAEKKPAS KAPAEKKPAA KKTSTSVDGK KRSKVRKETY SSYIYKVLKQ THPDTGISQK
     SMSILNSFVN DIFERIATEA SKLAAYNKKS TISAREIQTA VRLILPGELA KHAVSEGTRA
     VTKYSSSTQA
>P03069 nuc GENERAL CONTROL PROTEIN GCN4 (AMINO ACID BIOSYNTHESIS REGULATORY
     MSEYQPSLFA LNPMGFSPLD GSKSTNENVS ASTSTAKPMV GQLIFDKFIK TEEDPIIKQD
     TPSNLDFDFA LPQTATAPDA KTVLPIPELD DAVVESFFSS STDSTPMFEY ENLEDNSKEW
     TSLFDNDIPV TTDDVSLADK AIESTEEVSL VPSNLEVSTT SFLPTPVLED AKLTQTRKVK
     KPNSVVKKSH HVGKDDESRL DHLGVVAYNR KQRSIPLSPI VPESSDPAAL KRARNTEAAR
     RSRARKLQRM KQLEDKVEEL LSKNYHLENE VARLKKLVGE R
>P04050 nuc DNA-DIRECTED RNA POLYMERASE II LARGEST SUBUNIT (EC 2.7.7.6) (B220).
     MVGQQYSSAP LRTVKEVQFG LFSPEEVRAI SVAKIRFPET MDETQTRAKI GGLNDPRLGS
     IDRNLKCQTC QEGMNECPGH FGHIDLAKPV FHVGFIAKIK KVCECVCMHC GKLLLDEHNE
     LMRQALAIKD SKKRFAAIWT LCKTKMVCET DVPSEDDPTQ LVSRGGCGNT QPTIRKDGLK
     LVGSWKKDRA TGDADEPELR VLSTEEILNI FKHISVKDFT SLGFNEVFSR PEWMILTCLP
     VPPPPVRPSI SFNESQRGED DLTFKLADIL KANISLETLE HNGAPHHAIE EAESLLQFHV
     ATYMDNDIAG QPQALQKSGR PVKSIRARLK GKEGRIRGNL MGKRVDFSAR TVISGDPNLE
     LDQVGVPKSI AKTLTYPEVV TPYNIDRLTQ LVRNGPNEHP GAKYVIRDSG DRIDLRYSKR
     AGDIQLQYGW KVERHIMDND PVLFNRQPSL HKMSMMAHRV KVIPYSTFRL NLSVTSPYNA
     DFDGDEMNLH VPQSEETRAE LSQLCAVPLQ IVSPQSNKPC MGIVQDTLCG IRKLTLRDTF
     IELDQVLNML YWVPDWDGVI PTPAIIKPKP LWSGKQILSV AIPNGIHLQR FDEGTTLLSP
     KDNGMLIIDG QIIFGVVEKK TVGSSNGGLI HVVTREKGPQ VCAKLFGNIQ KVVNFWLLHN
     GFSTGIGDTI ADGPTMREIT ETIAEAKKKV LDVTKEAQAN LLTAKHGMTL RESFEDNVVR
     FLNEARDKAG RLAEVNLKDL NNVKQMVMAG SKGSFINIAQ MSACVGQQSV EGKRIAFGFV
     DRTLPHFSKD DYSPESKGFV ENSYLRGLTP QEFFFHAMGG REGLIDTAVK TAETGYIQRR
     LVKALEDIMV HYDNTTRNSL GNVIQFIYGE DGMDAAHIEK QSLDTIGGSD AAFEKRYRVD
     LLNTDHTLDP SLLESGSEIL GDLKLQVLLD EEYKQLVKDR KFLREVFVDG EANWPLPVNI
     RRIIQNAQQT FHIDHTKPSD LTIKDIVLGV KDLQENLLVL RGKNEIIQNA QRDAVTLFCC
     LLRSRLATRR VLQEYRLTKQ AFDWVLSNIE AQFLRSVVHP GEMVGVLAAQ SIGEPATQMT
     LNTFHFAGVA SKKVTSGVPR LKEILNVAKN MKTPSLTVYL EPGHAADQEQ AKLIRSAIEH
     TTLKSVTIAS EIYYDPDPRS TVIPEDEEII QLHFSLLDEE AEQSFDQQSP WLLRLELDRA
     AMNDKDLTMG QVGERIKQTF KNDLFVIWSE DNDEKLIIRC RVVRPKSLDA ETEAEEDHML
     KKIENTMLEN ITLRGVENIE RVVMMKYDRK VPSPTGEYVK EPEWVLETDG VNLSEVMTVP
     GIDPTRIYTN SFIDIMEVLG IEAGRAALYK EVYNVIASDG SYVNYRHMAL LVDVMTTQGG
     LTSVTRHGFN RSNTGALMRC SFEETVEILF EAGASAELDD CRGVSENVIL GQMAPIGTGA
     FDVMIDEESL VKYMPEQKIT EIEDGQDGGV TPYSNESGLV NADLDVKDEL MFSPLVDSGS
     NDAMAGGFTA YGGADYGEAT SPFGAYGEAP TSPGFGVSSP GFSPTSPTYS PTSPAYSPTS
     PSYSPTSPSY SPTSPSYSPT SPSYSPTSPS YSPTSPSYSP TSPSYSPTSP SYSPTSPSYS
     PTSPSYSPTS PSYSPTSPSY SPTSPSYSPT SPSYSPTSPA YSPTSPSYSP TSPSYSPTSP
     SYSPTSPSYS PTSPNYSPTS PSYSPTSPGY SPGSPAYSPK QDEQKHNENE NSR
>P04051 nuc DNA-DIRECTED RNA POLYMERASE III LARGEST SUBUNIT (EC 2.7.7.6) (C160).
     MKEVVVSETP KRIKGLEFSA LSAADIVAQS EVEVSTRDLF DLEKDRAPKA NGALDPKMGV
     SSSSLECATC HGNLASCHGH FGHLKLALPV FHIGYFKATI QILQGICKNC SAILLSETDK
     RQFLHELRRP GVDNLRRMGI LKKILDQCKK QRRCLHCGAL NGVVKKAAAG AGSAALKIIH
     DTFRWVGKKS APEKDIWVGE WKEVLAHNPE LERYVKRCMD DLNPLKTLNL FKQIKSADCE
     LLGIDATVPS GRPETYIWRY LPAPPVCIRP SVMMQDSPAS NEDDLTVKLT EIVWTSSLIK
     AGLDKGISIN NMMEHWDYLQ LTVAMYINSD SVNPAMLPGS SNGGGKVKPI RGFCQRLKGK
     QGRFRGNLSG KRVDFSGRTV ISPDPNLSID EVAVPDRVAK VLTYPEKVTR YNRHKLQELI
     VNGPNVHPGA NYLLKRNEDA RRNLRYGDRM KLAKNLQIGD VVERHLEDGD VVLFNRQPSL
     HRLSILSHYA KIRPWRTFRL NECVCTPYNA DFDGDEMNLH VPQTEEARAE AINLMGVKNN
     LLTPKSGEPI IAATQDFITG SYLISHKDSF YDRATLTQLL SMMSDGIEHF DIPPPAIMKP
     YYLWTGKQVF SLLIKPNHNS PVVINLDAKN KVFVPPKSKS LPNEMSQNDG FVIIRGSQIL
     SGVMDKSVLG DGKKHSVFYT ILRDYGPQEA ANAMNRMAKL CARFLGNRGF SIGINDVTPA
     DDLKQKKEEL VEIAYHKCDE LITLFNKGEL ETQPGCNEEQ TLEAKIGGLL SKVREEVGDV
     CINELDNWNA PLIMATCGSK GSTLNVSQMV AVVGQQIISG NRVPDGFQDR SLPHFPKNSK
     TPQSKGFVRN SFFSGLSPPE FLFHAISGRE GLVDTAVKTA ETGYMSRRLM KSLEDLSCQY
     DNTVRTSANG IVQFTYGGDG LDPLEMEGNA QPVNFNRSWD HAYNITFNNQ DKGLLPYAIM
     ETANEILGPL EERLVRYDNS GCLVKREDLN KAEYVDQYDA ERDFYHSLRE YINGKATALA
     NLRKSRGMLG LLEPPAKELQ GIDPDETVPD NVKTSVSQLY RISEKSVRKF LEIALFKYRK
     ARLEPGTAIG AIGAQSIGEP GTQMTLKTFH FAGVASMNVT LGVPRIKEII NASKVISTPI
     INAVLVNDND ERAARVVKGR VEKTLLSDVA FYVQDVYKDN LSFIQVRIDL GTIDKLQLEL
     TIEDIAVAIT RASKLKIQAS DVNIIGKDRI AINVFPEGYK AKSISTSAKE PSENDVFYRM
     QQLRRALPDV VVKGLPDISR AVINIRDDGK RELLVEGYGL RDVMCTDGVI GSRTTTNHVL
     EVFSVLGIEA ARYSIIREIN YTMSNHGMSV DPRHIQLLGD VMTYKGEVLG ITRFGLSKMR
     DSVLQLASFE KTTDHLFDAA FYMKKDAVEG VSECIILGQT MSIGTGSFKV VKGTNISEKD
     LVPKRCLFES LSNEAALKAN
>P04386 nuc REGULATORY PROTEIN GAL4.
     MKLLSSIEQA CDICRLKKLK CSKEKPKCAK CLKNNWECRY SPKTKRSPLT RAHLTEVESR
     LERLEQLFLL IFPREDLDMI LKMDSLQDIK ALLTGLFVQD NVNKDAVTDR LASVETDMPL
     TLRQHRISAT SSSEESSNKG QRQLTVSIDS AAHHDNSTIP LDFMPRDALH GFDWSEEDDM
     SDGLPFLKTD PNNNGFFGDG SLLCILRSIG FKPENYTNSN VNRLPTMITD RYTLASRSTT
     SRLLQSYLNN FHPYCPIVHS PTLMMLYNNQ IEIASKDQWQ ILFNCILAIG AWCIEGESTD
     IDVFYYQNAK SHLTSKVFES GSIILVTALH LLSRYTQWRQ KTNTSYNFHS FSIRMAISLG
     LNRDLPSSFS DSSILEQRRR IWWSVYSWEI QLSLLYGRSI QLSQNTISFP SSVDDVQRTT
     TGPTIYHGII ETARLLQVFT KIYELDKTVT AEKSPICAKK CLMICNEIEE VSRQAPKFLQ
     MDISTTALTN LLKEHPWLSF TRFELKWKQL SLIIYVLRDF FTNFTQKKSQ LEQDQNDHQS
     YEVKRCSIML SDAAQRTVMS VSSYMDNHNV TPYFAWNCSY YLFNAVLVPI KTLLSNSKSN
     AENNETAQLL QQINTVLMLL KKLATFKIQT CEKYIQVLEE VCAPFLLSQC AIPLPHISYN
     NSNGSAIKNI VGSATIAQYP TLPEENVNNI SVKYVSPGSV GPSPVPLKSG ASFSDLVKLL
     SNRPPSRNSP VTIPRSTPSH RSVTPFLGQQ QQLQSLVPLT PSALFGGANF NQSGNIADSS
     LSFTFTNSSN GPNLITTQTN SQALSQPIAS SNVHDNFMNN EITASKIDDG NNSKPLSPGW
     TDQTAYNAFG ITTGMFNTTT MDDVYNYLFD DEDTPPNPKK E
>P04819 nuc DNA LIGASE I (EC 6.5.1.1) (POLYDEOXYRIBONUCLEOTIDE SYNTHASE (ATP)).
     MRRLLTGCLL SSARPLKSRL PLLMSSSLPS SAGKKPKQAT LARFFTSMKN KPTEGTPSPK
     KSSKHMLEDR MDNVSGEEEY ATKKLKQTAV THTVAAPSSM GSNFSSIPSS APSSGVADSP
     QQSQRLVGEV EDALSSNNND HYSSNIPYSE VCEVFNKIEA ISSRLEIIRI CSDFFIKIMK
     QSSKNLIPTT YLFINRLGPD YEAGLELGLG ENLLMKTISE TCGKSMSQIK LKYKDIGDLG
     EIAMGARNVQ PTMFKPKPLT VGEVFKNLRA IAKTQGKDSQ LKKMKLIKRM LTACKGIEAK
     FLIRSLESKL RIGLAEKTVL ISLSKALLLH DENREDSPDK DVPMDVLESA QQKIRDAFCQ
     VPNYEIVINS CLEHGIMNLD KYCTLRPGIP LKPMLAKPTK AINEVLDRFQ GETFTSEYKY
     DGERAQVHLL NDGTMRIYSR NGENMTERYP EINITDFIQD LDTTKNLILD CEAVAWDKDQ
     GKILPFQVLS TRKRKDVELN DVKVKVCLFA FDILCYNDER LINKSLKERR EYLTKVTKVV
     PGEFQYATQI TTNNLDELQK FLDESVNHSC EGLMVKMLEG PESHYEPSKR SRNWLKLKKD
     YLEGVGDSLD LCVLGAYYGR GKRTGTYGGF LLGCYNQDTG EFETCCKIGT GFSDEMLQLL
     HDRLTPTIID GPKATFVFDS SAEPDVWFEP TTLFEVLTAD LSLSPIYKAG SATFDKGVSL
     RFPRFLRIRE DKGVEDATSS DQIVELYENQ SHMQN
>P04911 nuc HISTONE H2A.1.
     SGGKGGKAGS AAKASQSRSA KAGLTFPVGR VHRLLRRGNY AQRIGSGAPV YLTAVLEYLA
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DDELNKLLGN VTIAQGGVLP NIHQNLLPKK
     SAKATKASQE L
>P04912 nuc HISTONE H2A.2.
     SGGKGGKAGS AAKASQSRSA KAGLTFPVGR VHRLLRRGNY AQRIGSGAPV YLTAVLEYLA
     AEILELAGNA ARDNKKTRII PRHLQLAIRN DDELNKLLGN VTIAQGGVLP NIHQNLLPKK
     SAKTAKASQE L
>P06100 nuc GENERAL NEGATIVE REGULATOR OF TRANSCRIPTION SUBUNIT 2.
     MEKFGLKALV PLLKLEDKEL SSTYDHSMTL GADLSSMLYS LGIPRDSQDH RVLDTFQSPW
     AETSRSEVEP RFFTPESFTN IPGVLQSTVT PPCFNSIQND QQRVALFQDE TLFFLFYKHP
     GTVIQELTYL ELRKRNWRYH KTLKAWLTKD PMMEPIVSAD GLSERGSYVF FDPQRWEKCQ
     RDFLLFYNAI M
>P06104 nuc UBIQUITIN-CONJUGATING ENZYME E2-20 KD (EC 6.3.2.19) (UBIQUITIN-PROTEIN
     MSTPARRRLM RDFKRMKEDA PPGVSASPLP DNVMVWNAMI IGPADTPYED GTFRLLLEFD
     EEYPNKPPHV KFLSEMFHPN VYANGEICLD ILQNRWTPTY DVASILTSIQ SLFNDPNPAS
     PANVEAATLF KDHKSQYVKR VKETVEKSWE DDMDDMDDDD DDDDDDDDDE AD
>P06701 nuc REGULATORY PROTEIN SIR3 (SILENT INFORMATION REGULATOR 3).
     MAKTLKDLDG WQVIITDDQG RVIDDNNRRR SRKRGGENVF LKRISDGLSF GKGESVIFND
     NVTETYSVYL IHEIRLNTLN NVVEIWVFSY LRWFELKPKL YYEQFRPDLI KEDHPLEFYK
     DKFFNEVNKS ELYLTAELSE IWLKDFIAVG QILPESQWND SSIDKIEDRD FLVRYACEPT
     AEKFVPIDIF QIIRRVKEME PKQSDEYLKR VSVPVSGQKT NRQVMHKMGV ERSSKRLAKK
     PSMKKIKIEP SADDDVNNGN IPSQRGTSTT HGSISPQEES VSPNISSASP SALTSPTDSS
     KILQKRSISK ELIVSEEIPI NSSEQESDYE PNNETSVLSS KPGSKPEKTS TELVDGRENF
     VYANNPEVSD DGGLEEETDE VSSESSDEAI IPVNKRRGAH GSELSSKIRK IHIQETQEFS
     KNYTTETDNE MNGNGKPGIP RGNTKIHSMN ENPTPEKGNA KMIDFATLSK LKKKYQIILD
     RFAPDNQVTD SSQLNKLTDE QSSLDVAGLE DKFRKACSSS GRETILSNFN ADINLEESIR
     ESLQKRELLK SQVEDFTRIF LPIYDSLMSS QNKLFYITNA DDSTKFQLVN DVMDELITSS
     ARKELPIFDY IHIDALELAG MDALYEKIWF AISKENLCGD ISLEALNFYI TNVPKAKKRK
     TLILIQNPEN LLSEKILQYF EKWISSKNSK LSIICVGGHN VTIREQINIM PSLKAHFTEI
     KLNKVDKNEL QQMIITRLKS LLKPFHVKVN DKKEMTIYNN IREGQNQKIP DNVIVINHKI
     NNKITQLIAK NVANVSGSTE KAFKICEAAV EISKKDFVRK GGLQKGKLVV SQEMVPRYFS
     EAINGFKDET ISKKIIGMSL LMRTFLYTLA QETEGTNRHT LALETVLIKM VKMLRDNPGY
     KASKEIKKVI CGAWEPAITI EKLKQFSWIS VVNDLVGEKL VVVVLEEPSA SIMVELKLPL
     EINYAFSMDE EFKNMDCI
>P06774 nuc HAP2 TRANSCRIPTIONAL ACTIVATOR.
     MSADETDAKF HPLETDLQSD TAAATSTAAA SRSPSLQEKP IEMPLDMGKA PSPRGEDQRV
     TNEEDLFLFN RLRASQNRVM DSLEPQQQSQ YTSSSVSTME PSADFTSFSA VTTLPPPPHQ
     QQQQQQQQQQ QQQLVVQAQY TQNQPNLQSD VLGTAIAEQP FYVNAKQYYR ILKRRYARAK
     LEEKLRISRE RKPYLHESRH KHAMRRPRGE GGRFLTAAEI KAMKSKKSGA SDDPDDSHED
     KKITTKIIQE QPHATSTAAA ADKKT
>P06777 nuc DNA REPAIR PROTEIN RAD1.
     MSQLFYQGDS DDELQEELTR QTTQASQSSK IKNEDEPDDS NHLNEVENED SKVLDDDAVL
     YPLIPNEPDD IETSKPNIND IRPVDIQLTL PLPFQQKVVE NSLITEDALI IMGKGLGLLD
     IVANLLHVLA TPTSINGQLK RALVLVLNAK PIDNVRIKEA LEELSWFSNT GKDDDDTAVE
     SDDELFERPF NVVTADSLSI EKRRKLYISG GILSITSRIL IVDLLSGIVH PNRVTGMLVL
     NADSLRHNSN ESFILEIYRS KNTWGFIKAF SEAPETFVME FSPLRTKMKE LRLKNVLLWP
     RFRVEVSSCL NATNKTSHNK VIEVKVSLTN SMSQIQFGLM ECLKKCIAEL SRKNPELALD
     WWNMENVLDI NFIRSIDSVM VPNWHRISYE SKQLVKDIRF LRHLLKMLVT SDAVDFFGEI
     QLSLDANKPS VSRKYSESPW LLVDEAQLVI SYAKKRIFYK NEYTLEENPK WEQLIHILHD
     ISHERMTNHL QGPTLVACSD NLTCLELAKV LNASNKKRGV RQVLLNKLKW YRKQREETKK
     LVKEVQSQDT FPENATLNVS STFSKEQVTT KRRRTRGASQ VAAVEKLRNA GTNVDMEVVF
     EDHKLSEEIK KGSGDDLDDG QEENAANDSK IFEIQEQENE ILIDDGDAEF DNGELEYVGD
     LPQHITTHFN KDLWAEHCNE YEYVDRQDEI LISTFKSLND NCSLQEMMPS YIIMFEPDIS
     FIRQIEVYKA IVKDLQPKVY FMYYGESIEE QSHLTAIKRE KDAFTKLIRE NANLSHHFET
     NEDLSHYKNL AERKLKLSKL RKSNTRNAGG QQGFHNLTQD VVIVDTREFN ASLPGLLYRY
     GIRVIPCMLT VGDYVITPDI CLERKSISDL IGSLQNNRLA NQCKKMLKYY AYPTLLIEFD
     EGQSFSLEPF SERRNYKNKD ISTVHPISSK LSQDEIQLKL AKLVLRFPTL KIIWSSSPLQ
     TVNIILELKL GREQPDPSNA VILGTNKVRS DFNSTAKGLK DGDNESKFKR LLNVPGVSKI
     DYFNLRKKIK SFNKLQKLSW NEINELINDE DLTDRIYYFL RTEKEEQEQE STDENLESPG
     KTTDDNALHD HHNDVPEAPV
>P06786 nuc DNA TOPOISOMERASE II (EC 5.99.1.3).
     MSTEPVSASD KYQKISQLEH ILKRPDTYIG SVETQEQLQW IYDEETDCMI EKNVTIVPGL
     FKIFDEILVN AADNKVRDPS MKRIDVNIHA EEHTIEVKND GKGIPIEIHN KENIYIPEMI
     FGHLLTSSNY DDDEKKVTGG RNGYGAKLCN IFSTEFILET ADLNVGQKYV QKWENNMSIC
     HPPKITSYKK GPSYTKVTFK PDLTRFGMKE LDNDILGVMR RRVYDINGSV RDINVYLNGK
     SLKIRNFKNY VELYLKSLEK KRQLDNGEDG AAKSDIPTIL YERINNRWEV AFAVSDISFQ
     QISFVNSIAT TMGGTHVNYI TDQIVKKISE ILKKKKKKSV KSFQIKNNMF IFINCLIENP
     AFTSQTKEQL TTRVKDFGSR CEIPLEYINK IMKTDLATRM FEIADANEEN ALKKSDGTRK
     SRITNYPKLE DANKAGTKEG YKCTLVLTEG DSALSLAVAG LAVVGRDYYG CYPLRGKMLN
     VREASADQIL KNAEIQAIKK IMGLQHRKKY EDTKSLRYGH LMIMTDQDHD GSHIKGLIIN
     FLESSFPGLL DIQGFLLEFI TPIIKVSITK PTKNTIAFYN MPDYEKWREE ESHKFTWKQK
     YYKGLGTSLA QEVREYFSNL DRHLKIFHSL QGNDKDYIDL AFSKKKADDR KEWLRQYEPG
     TVLDPTLKEI PISDFINKEL ILFSLADNIR SIPNVLDGFK PGQRKVLYGC FKKNLKSELK
     VAQLAPYVSE CTAYHHGEQS LAQTIIGLAQ NFVGSNNIYL LLPNGAFGTR ATGGKDAAAA
     RYIYTELNKL TRKIFHPADD PLYKYIQEDE KTVEPEWYLP ILPMILVNGA EGIGTGWSTY
     IPPFNPLEII KNIRHLMNDE ELEQMHPWFR GWTGTIEEIE PLRYRMYGRI EQIGDNVLEI
     TELPARTWTS TIKEYLLLGL SGNDKIKPWI KDMEEQHDDN IKFIITLSPE EMAKTRKIGF
     YERFKLISPI SLMNMVAFDP HGKIKKYNSV NEILSEFYYV RLEYYQKRKD HMSERLQWEV
     EKYSFQVKFI KMIIEKELTV TNKPRNAIIQ ELENLGFPRF NKEGKPYYGS PNDEIAEQIN
     DVKGATSDEE DEESSHEDTE NVINGPEELY GTYEYLLGMR IWSLTKERYQ KLLKQKQEKE
     TELENLLKLS AKDIWNTDLK AFEVGYQEFL QRDAEARGGN VPNKGSKTKG KGKRKLVDDE
     DYDPSKKNKK STARKGKKIK LEDKNFERIL LEQKLVTKSK APTKIKKEKT PSVSETKTEE
     EENAPSSTSS SSIFDIKKED KDEGELSKIS NKFKKISTIF DKMGSTSATS KENTPEQDDV
     ATKKNQTTAK KTAVKPKLAK KPVRKQQKVV ELSGESDLEI LDSYTDREDS NKDEDDAIPQ
     RSRRQRSSRA ASVPKKSYVE TLELSDDSFI EDDEEENQGS DVSFNEED
>P06838 nuc DNA REPAIR PROTEIN RAD10.
     MNNTDPTSFE SILAGVAKLR KEKSGADTTG SQSLEIDASK LQQQEPQTSR RINSNQVINA
     FNQQKPEEWT DSKATDDYNR KRPFRSTRPG KTVLVNTTQK ENPLLNHLKS TNWRYVSSTG
     INMIYYDYLV RGRSVLFLTL TYHKLYVDYI SRRMQPLSRN ENNILIFIVD DNNSEDTLND
     ITKLCMFNGF TLLLAFNFEQ AAKYIEYLNL
>P06839 nuc DNA REPAIR HELICASE RAD3.
     MKFYIDDLPV LFPYPKIYPE QYNYMCDIKK TLDVGGNSIL EMPSGTGKTV SLLSLTIAYQ
     MHYPEHRKII YCSRTMSEIE KALVELENLM DYRTKELGYQ EDFRGLGLTS RKNLCLHPEV
     SKERKGTVVD EKCRRMTNGQ AKRKLEEDPE ANVELCEYHE NLYNIEVEDY LPKGVFSFEK
     LLKYCEEKTL CPYFIVRRMI SLCNIIIYSY HYLLDPKIAE RVSNEVSKDS IVIFDEAHNI
     DNVCIESLSL DLTTDALRRA TRGANALDER ISEVRKVDSQ KLQDEYEKLV QGLHSADILT
     DQEEPFVETP VLPQDLLTEA IPGNIRRAEH FVSFLKRLIE YLKTRMKVLH VISETPKSFL
     QHLKQLTFIE RKPLRFCSER LSLLVRTLEV TEVEDFTALK DIATFATLIS TYEEGFLLII
     EPYEIENAAV PNPIMRFTCL DASIAIKPVF ERFSSVIITS GTISPLDMYP RMLNFKTVLQ
     KSYAMTLAKK SFLPMIITKG SDQVAISSRF EIRNDPSIVR NYGSMLVEFA KITPDGMVVF
     FPSYLYMESI VSMWQTMGIL DEVWKHKLIL VETPDAQETS LALETYRKAC SNGRGAILLS
     VARGKVSEGI DFDHQYGRTV LMIGIPFQYT ESRILKARLE FMRENYRIRE NDFLSFDAMR
     HAAQCLGRVL RGKDDYGVMV LADRRFSRKR SQLPKWIAQG LSDADLNLST DMAISNTKQF
     LRTMAQPTDP KDQEGVSVWS YEDLIKHQNS RKDQGGFIEN ENKEGEQDED EDEDIEMQ
>P06843 nuc SPT2 PROTEIN (NEGATIVE REGULATOR OF TY TRANSCRIPTION).
     MSFLSKLSQI RKSTTASKAQ VQDPLPKKND EEYSLLPKNY IRDEDPAVKR LKELRRQELL
     KNGALAKKSG VKRKRGTSSG SEKKKIERND DDEGGLGIRF KRSIGASHAP LKPVVRKKPE
     PIKKMSFEEL MKQAENNEKQ PPKVKSSEPV TKERPHFNKP GFKSSKRPQK KASPGATLRG
     VSSGGNSIKS SDSPKPVKLN LPTNGFAQPN RRLKEKLESR KQKSRYQDDY DEEDNDMDDF
     IEDDEDEGYH SKSKHSNGPG YDRDEIWAMF NRGKKRSEYD YDELEDDDME ANEMEILEEE
     EMARKMARLE DKREEAWLKK HEEEKRRRKK GIR
>P07269 nuc REGULATORY PROTEIN PHO2 (GENERAL REGULATORY FACTOR 10).
     MMEEFSYDHD FNTHFATDLD YLQHDQQQQQ QQQHDQQHNQ QQQPQPQPIQ TQNLEHDHDQ
     HTNDMSASSN ASDSGPQRPK RTRAKGEALD VLKRKFEINP TPSLVERKKI SDLIGMPEKN
     VRIWFQNRRA KLRKKQHGSN KDTIPSSQSR DIANDYDRGS TDNNLVTTTS TSSIFHDEDL
     TFFDRIPLNS NNNYYFFDIC SITVGSWNRM KSGALQRRNF QSIKELRNLS PIKINNIMSN
     ATDLMVLISK KNSEINYFFS AMANNTKILF RIFFPLSSVT NCSLTLETDD DIINSNNTSD
     KNNSNTNNDD DNDDNSNEDN DNSSEDKRNA KDNFGELKLT VTRSPTFAVY FLNNAPDEDP
     NLNNQWSICD DFSEGRQVND AFVGGSNIPH TLKGLQKSLR FMNSLILDYK SSNEILPTIN
     TAIPTAAVPQ QNIAPPFLNT NSSATDSNPN TNLEDSLFFD HDLLSSSITN TNNGQGSNNG
     RQASKDDTLN LLDTTVNSNN NHNANNEENH LAQEHLSNDA DIVANPNDHL LSLPTDSELP
     NTPDFLKNTN ELTDEHRWI
>P07270 nuc PHOSPHATE SYSTEM POSITIVE REGULATORY PROTEIN PHO4.
     MGRTTSEGIH GFVDDLEPKS SILDKVGDFI TVNTKRHDGR EDFNEQNDEL NSQENHNSSE
     NGNENENEQD SLALDDLDRA FELVEGMDMD WMMPSHAHHS PATTATIKPR LLYSPLIHTQ
     SAVPVTISPN LVATATSTTS ANKVTKNKSN SSPYLNKRRG KPGPDSATSL FELPDSVIPT
     PKPKPKPKQY PKVILPSNST RRVSPVTAKT SSSAEGVVVA SESPVIAPHG SSHSRSLSKR
     RSSGALVDDD KRESHKHAEQ ARRNRLAVPL HELASLIPAE WKQQNVSAAP SKATTVEAAC
     RYIRHLQQNG ST
>P07272 nuc PYRIMIDINE PATHWAY REGULATORY PROTEIN 1.
     MKQKKFNSKK SNRTDLSKRG DSPNIGISKS RTACKRCRLK KIKCDQEFPS CKRCAKLEVP
     CVSLDPATGK DVPRSYVFFL EDRLAVMMRV LKEYGVDPTK IRGNIPATSD DEPFDLKKYS
     SVSSLGEEGI LPHNGLLADY LVQKGNSMAS SAITSKSMAS PQTINVQRKE FLVNSKKQDG
     SALLPETGSP MTSDARAEEL RRCNKEISAL GTMRESSFNS FLGDSSGISF AKLVFTATNF
     RQDSGDDVLD EDIKQREQKY NGYAEAENNP HFDPLELPPR HAAEVMISRF FVDTNSQLPL
     LHRELFLKKY FEPIYGPWNP NIALASDQTG INSAFEIPIT SAFSAHTEPK RENVTEKIDV
     CSSVDVPWYD TWETSQKVNM RPIVELPTKF HIPYFFLNII FAIGHATQVL KSDITTVATY
     KRRATKYIAS LFSSSDRLEA LAGTLLMVIY SIMRPNVPGV WYTMGSVLRL TVDLGLHSEK
     INKNYDAFTR EIRRRLFWCV YSLDRQICSY FGRPFGIPEE SITTRYPSLL DDSFITLTNR
     EIDDYSDLPS PNPSSKVIAL AMYKIRRIQA SIVRILYAPG AELPRRFMDL ESWRIETYNE
     LERWFQVDVP KNFEMMNCKF NSIWFDLNYH YSKSILYGLS PKFPTLNDTA FKIVLDSTKG
     TIDVFYNLCV NKKIGYTWVA VHNMFMTGMT YLYVNFYSKN NINDCQEKVS EYTEKVLIVL
     KNLIGFCESA KTCYTSYKIL SSVVIKLKFM QINDAKGIFS DSNPLTSQAN RMSSYDKKTN
     VLGFDDGTFD NKVFNRTNFE EKAPFDIPLD EFFTELEKHS NVSQFNTLDV SEGNQVINES
     ASTNTSSALN CQSYTNNQDI MDILFQVTSG SVWDEFFVRS GNGNEGESSY DISKGKNSES
     GGIF
>P07273 nuc TRANSCRIPTION ELONGATION FACTOR S-II (DNA STRAND TRANSFER PROTEIN
     MDSKEVLVHV KNLEKNKSND AAVLEILHVL DKEFVPTEKL LRETKVGVEV NKFKKSTNVE
     ISKLVKKMIS SWKDAINKNK RSRQAQQHHQ DHAPGNAEDK TTVGESVNGV QQPASSQSDA
     MKQDKYVSTK PRNSKNDGVD TAIYHHKLRD QVLKALYDVL AKESEHPPQS ILHTAKAIES
     EMNKVNNCDT NEAAYKARYR IIYSNVISKN NPDLKHKIAN GDITPEFLAT CDAKDLAPAP
     LKQKIEEIAK QNLYNAQGAT IERSVTDRFT CGKCKEKKVS YYQLQTRSAD EPLTTFCTCE
     ACGNRWKFS
>P07276 nuc DNA REPAIR PROTEIN RAD2.
     MGVHSFWDIA GPTARPVRLE SLEDKRMAVD ASIWIYQFLK AVRDQEGNAV KNSHITGFFR
     RICKLLYFGI RPVFVFDGGV PVLKRETIRQ RKERRQGKRE SAKSTARKLL ALQLQNGSND
     NVKNSTPSSG SSVQIFKPQD EWDLPDIPGF KYDKEDARVN SNKTFEKLMN SINGDGLEDI
     DLDTINPASA EFEELPKATQ YLILSSLRLK SRLRMGYSKE QLETIFPNSM DFSRFQIDMV
     KRRNFFTQKL INTTGFQDGG ASKLNEEVIN RISGQKSKEY KLTKTNNGWI LGLGANDGSD
     AQKAIVIDDK DAGALVKQLD SNAEDGDVLR WDDLEDNSLK IVRHESSNAT TAPQKRSNRS
     EDEGCDSDEC EWEEVELKPK NVKFVEDFSL KAARLPYMGQ SLNNAGSKSF LDKRHDQASP
     SKTTPTMRIS RISVEDDDED YLKQIEEIEM MEAVQLSKME KKPEADDKSK IAKPVTSKGT
     EARPPIVQYG LLGAQPDSKQ PYHVTNLNSK SESVIKRTSK TVLSEFRPPS QQEDKGAILT
     EGEQNLNFIS HKIPQFDFNN ENSLLFQKNT ESNVSQEATK EKSPIPEMPS WFSSTASQQL
     YNPYNTTNFV EDKNVRNEQE SGAETTNKGS SYELLTGLNA TEILERESEK ESSNDENKDD
     DLEVLSEELF EDVPTKSQIS KEAEDNDSRK VESINKEHRK PLIFDYDFSE DEEDNIVENM
     IKEQEEFDTF KNTTLSTSAE RNVAENAFVE DELFEQQMKD KRDSDEVTMD MIKEVQELLS
     RFGIPYITAP MEAEAQCAEL LQLNLVDGII TDDSDVFLFG GTKIYKNMFH EKNYVEFYDA
     ESILKLLGLD RKNMIELAQL LGSDYTNGLK GMGPVSSIEV IAEFGNLKNF KDWYNNGQFD
     KRKQETENKF EKDLRKKLVN NEIILDDDFP SVMVYDAYMR PEVDHDTTPF VWGVPDLDML
     RSFMKTQLGW PHEKSDEILI PLIRDVNKRK KKGKQKRINE FFPREYISGD KKLNTSKRIS
     TATGKLKKRK M
>P07703 nuc DNA-DIRECTED RNA POLYMERASES I AND III 40 KD POLYPEPTIDE (EC 2.7.7.6)
     MSNIVGIEYN RVTNTTSTDF PGFSKDAENE WNVEKFKKDF EVNISSLDAR EANFDLINID
     TSIANAFRRI MISEVPSVAA EYVYFFNNTS VIQDEVLAHR IGLVPLKVDP DMLTWVDSNL
     PDDEKFTDEN TIVLSLNVKC TRNPDAPKGS TDPKELYNNA HVYARDLKFE PQGRQSTTFA
     DCPVVPADPD ILLAKLRPGQ EISLKAHCIL GIGGDHAKFS PVSTASYRLL PQINILQPIK
     GESARRFQKC FPPGVIGIDE GSDEAYVKDA RKDTVSREVL RYEEFADKVK LGRVRNHFIF
     NVESAGAMTP EEIFFKSVRI LKNKAEYLKN CPITQ
>P08518 nuc DNA-DIRECTED RNA POLYMERASE II 140 KD POLYPEPTIDE (EC 2.7.7.6) (B150)
     MSDLANSEKY YDEDPYGFED ESAPITAEDS WAVISAFFRE KGLVSQQLDS FNQFVDYTLQ
     DIICEDSTLI LEQLAQHTTE SDNISRKYEI SFGKIYVTKP MVNESDGVTH ALYPQEARLR
     NLTYSSGLFV DVKKRTYEAI DVPGRELKYE LIAEESEDDS ESGKVFIGRL PIMLRSKNCY
     LSEATESDLY KLKECPFDMG GYFIINGSEK VLIAQERSAG NIVQVFKKAA PSPISHVAEI
     RSALEKGSRF ISTLQVKLYG REGSSARTIK ATLPYIKQDI PIVIIFRALG IIPDGEILEH
     ICYDVNDWQM LEMLKPCVED GFVIQDRETA LDFIGRRGTA LGIKKEKRIQ YAKDILQKEF
     LPHITQLEGF ESRKAFFLGY MINRLLLCAL DRKDQDDRDH FGKKRLDLAG PLLAQLFKTL
     FKKLTKDIFR YMQRTVEEAH DFNMKLAINA KTITSGLKYA LATGNWGEQK KAMSSRAGVS
     QVLNRYTYSS TLSHLRRTNT PIGRDGKLAK PRQLHNTHWG LVCPAETPEG QACGLVKNLS
     LMSCISVGTD PMPIITFLSE WGMEPLEDYV PHQSPDATRV FVNGVWHGVH RNPARLMETL
     RTLRRKGDIN PEVSMIRDIR EKELKIFTDA GRVYRPLFIV EDDESLGHKE LKVRKGHIAK
     LMATEYQDIE GGFEDVEEYT WSSLLNEGLV EYIDAEEEES ILIAMQPEDL EPAEANEEND
     LDVDPAKRIR VSHHATTFTH CEIHPSMILG VAASIIPFPD HNQSPRNTYQ SAMGKQAMGV
     FLTNYNVRMD TMANILYYPQ KPLGTTRAME YLKFRELPAG QNAIVAIACY SGYNQEDSMI
     MNQSSIDRGL FRSLFFRSYM DQEKKYGMSI TETFEKPQRT NTLRMKHGTY DKLDDDGLIA
     PGVRVSGEDV IIGKTTPISP DEEELGQRTA YHSKRDASTP LRSTENGIVD QVLVTTNQDG
     LKFVKVRVRT TKIPQIGDKF ASRHGQKGTI GITYRREDMP FTAEGIVPDL IINPHAIPSR
     MTVAHLIECL LSKVAALSGN EGDASPFTDI TVEGISKLLR EHGYQSRGFE VMYNGHTGKK
     LMAQIFFGPT YYQRLRHMVD DKIHARARGP MQVLTRQPVE GRSRDGGLRF GEMERDCMIA
     HGAASFLKER LMEASDAFRV HICGICGLMT VIAKLNHNQF ECKGCDNKID IYQIHIPYAA
     KLLFQELMAM NITPRLYTDR SRDF
>P08638 nuc REGULATORY PROTEIN LEU3.
     MEGRSDFVAT SQSGSEMSHS ETRNRTGMNA RKRKFACVEC RQQKSKCDAH ERAPEPCTKC
     AKKNVPCILK RDFRRTYKRA RNEAIEKRFK ELTRTLTNLT SDEILKKIEE EQEIVLDNSN
     FTKEKVKQLR KSAFETTEIE PRSYKTLRGE PISYSTNRRH TDSSPLTLLS SSTNFDPVHS
     TNVMTDDQLK CLPKSLGDVY LSSSDIAELF QEFATKYHQF LPVVDLSKGA ERIYHLSPCL
     FWVILLIGLR RKFGATDLMT RLSVLVKSVL SEITISPIIR YTPSDKDEPV LNVASVYSVQ
     AFLLYTFWPP LTSSLSADTS WNTIGTAMFQ ALRVGLNCAG FSKEYASANS ELVNEQIRTW
     ICCNVVSQTV ASSFGFPAYV SFDYLVISSI RVPNSKSQVD IPNELRQMAQ IARFENQIVN
     TMNSTPASVT GMVSQEEKQP LLHVLNQQLS QLEISLEENN LDDIRKFLLL VAKVHLLTYY
     FTDVTSQSAG KSNGNIYEGS YSIMELDTSF ETKRGLVKVY NAAVNFLIHA NSMWEHDPTI
     IKYFPGLFVL NIWQSACIIS KLIHSSLHSM LDVNSGKKAY NNAISLTFNA SVLKYDMAYR
     SSGIMRSIWS LFANMYDAWK NDQKEGGGRL NNDFNLGITI KSRMSVNVFF DCLYILKEKC
     GMAKLERETK VSTAYNVDEE EEEDEDEEGE EEEEEEELSS KVPENMDSQQ LRTRKFTNVR
     HPEKKARKII ETIPLDPNPI NAGSTSSGSS LTTPNSQVAN TISYRGILNK MSPREQLNHA
     NLDSSVSTDI KDTEAVNEPL PIGRNAEHPA NQPPLSITQM QENTLPATQA NSSLLETYPI
     VQSNPVTTTI KESPNSIMAG WDNWESDMVW RDVDILMNEF AFNPKV
>P09091 nuc MATING-TYPE PROTEIN A-1, INCOMPLETELY SPLICED.
     MDDICSMAEN INRTLFNILG TEIDEINLNT NNLYNFIMES NLTKVEQHTL HKNISNNRLE
     IYHHIKKEKS PKGKSSISPQ ARAFLEQVFR RKQSLNSKEK EEVAKKCGIT PLQVRVWVCN
     MRIKLKYILY
>P09798 nuc CELL DIVISION CONTROL PROTEIN 16.
     MKFCLYCCHC YIVICGKATH YYKSSKATSN LKSSNRVLMR NPMSPSEQHS QHNSTLAASP
     FVSNVSAART QQSLPTDAQN DRLQQPWNRT NTATSPYQSL ANSPLIQKLQ ANIMTPHQPS
     ANSNSNSNSI TGNVVNDNNL LASMSKNSMF GSTIPSTLRK VSLQREYKDS VDGVVRDEDN
     DEDVHNNGDA AANANNDRES KLGHNGPLTT TTLTTTTTAT QLDVSELSAI ERLRLWRFDA
     LMQHMYRTAE YIADKVYNIS NDPDDAFWLG QVYYNNNQYV RAVELITRNN LDGVNILCRY
     LLGLSFVKLQ RFDDALDVIG EYNPFSEDPS TTAANTMSNN GNNSNTSQPV TDGGIKMESS
     LCFLRGKIYF AQNNFNKARD AFREAILVDI KNFEAFEMLL SKNLLTPQEE WDLFDSLDFK
     EFGEDKEIMK NLYKINLSKY INTEDITKSN EILAKDYKLA DNVDVVRSKV DICYTQCKFN
     ECLELCETVL ENDEFNTNIL PAYIGCLYEL SNKNKLFLLS HRLAETFPKS AITWFSVATY
     YMSLDRISEA QKYYSKSSIL DPSFAAAWLG FAHTYALEGE QDQALTAYST ASRFFPGMHL
     PKLFLGMQFM AMNSLNLAES YFVLAYDICP NDPLVLNEMG VMYFKKNEFV KAKKYLKKAL
     EVVKDLDPSS RTTISIQLNL GHTYRKLNEN EIAIKCFRCV LEKNDKNSEI HCSLGYLYLK
     TKKLQKAIDH LHKSLYLKPN NSSATALLKN ALELNVTLSL DASHPLIDKS NLMSQASKDK
     ASLNKKRSSL TYDPVNMAKR LRTQKEIFDQ NNKALRKGGH DSKTGSNNAD DDFDADMELE
>P10508 nuc MALTOSE FERMENTATION REGULATORY PROTEIN MAL6R.
     MGIAKQSCDC CRVRRVKCDR NKPCNRCIQR NLNCTYLQPL KKRGPKSIRA GSLKKIAEVQ
     MVSMNNNIMA APVVCKKVPK NLIDQCLRLR LYHDNLYVIW PMLSYDDLHK LLEEKYDDRC
     AYWFLVSLSA ATLSDLQIEI EYEEGVTFTG EQLCTLCMLS RQFFDDLSNS DIFRIMTYYC
     LHRCYAQFAD TRTSYRLSCE AVGLIIKIAG FHREETYEFL PFGEQQLRRK VYYLLLMTER
     FYAVYIKCVT SLDATIAPPL PEVVTDPRLS LESFLEVIRV FTIPGKCFYD ALATNCVDDS
     CTEDSLKRIR NELHTTSLDI EPWSYGYIDF LFSRHWVRTL AWKLVLHMKG MRMNFLSNTN
     NTHIPVEIAR DMLGDTFLTP KNLYDVHGPG IPMKALEIAN ALVDVVNKYD HNMKLEAWNV
     LYDVSKFVFS LKHCNNKMFD RFSTKCQGAL ITLPISKPLQ LNDNSKDEDD IIP
>P10862 nuc DNA REPAIR PROTEIN RAD18.
     MDHQITTASD FTTTSIPSLY QLDTLLRCHI CKDFLKVPVL TPCGHTFCSL CIRTHLNNQP
     NCPLCLFEFR ESLLRSEFLV SEIIQSYTSL RSSLLDALRI PKPTPVPENE EVPGPENSSW
     IELISESESD SVNAADDDLQ IVATSERKLA KRSMTDILPL SSKPSKRNFA MFRSERIKKK
     SKPNEQMAQC PICQQFYPLK ALEKTHLDEC LTLQSLGKKP KISTTFPTES NPHNKSSSRF
     KVRTPEVDKS SCGETSHVDK YLNSMMSAEH QRLPKINFTS MTQSQIKQKL SSLGLSTNGT
     RQNMIKRYNH YEMLWNSNFC DSLEPVDEAE LKRQLLSWDV SHNKTPQNSS NKGGISKLMI
     MKSNGKSSSY RKLLENFKND KFNRKGWMVM FRKDFARLIR EAKMKIKTGS SDSSGSVGHS
     NDGDGVEKVQ SDQGTEDQQM EKDQDTVINE DRVAGERNLP NEDSTDADLS RELMDLNEYS
     KDPPGNN
>P10961 nuc HEAT SHOCK FACTOR PROTEIN (HSF) (HEAT SHOCK TRANSCRIPTION FACTOR)
     MNNAANTGTT NESNVSDAPR IEPLPSLNDD DIEKILQPND IFTTDRTDAS TTSSTAIEDI
     INPSLDPQSA ASPVPSSSFF HDSRKPSTST HLVRRGTPLG IYQTNLYGHN SRENTNPNST
     LLSSKLLAHP PVPYGQNPDL LQHAVYRAQP SSGTTNAQPR QTTRRYQSHK SRPAFVNKLW
     SMLNDDSNTK LIQWAEDGKS FIVTNREEFV HQILPKYFKH SNFASFVRQL NMYGWHKVQD
     VKSGSIQSSS DDKWQFENEN FIRGREDLLE KIIRQKGSSN NHNSPSGNGN PANGSNIPLD
     NAAGSNNSNN NISSSNSFFN NGHLLQGKTL RLMNEANLGD KNDVTAILGE LEQIKYNQIA
     ISKDLLRINK DNELLWQENM MARERHRTQQ QALEKMFRFL TSIVPHLDPK MIMDGLGDPK
     VNNEKLNSAN NIGLNRDNTG TIDELKSNDS FINDDRNSFT NATTNARNNM SPNNDDNSID
     TASTNTTNRK KNIDENIKNN NDIINDIIFN TNLANNLSNY NSNNNAGSPI RPYKQRYLLK
     NRANSSTSSE NPSLTPFDIE SNNDRKISEI PFDDEEEEET DFRPFTSRDP NNQTSENTFD
     PNRFTMLSDD DLKKDSHTND NKHNESDLFW DNVHRNIDEQ DARLQNLENM VHILSPGYPN
     KSFNNKTSST NTNSNMESAV NVNSPGFNLQ DYLTGESNSP NSVHSVPSNG SGSTPLPMPN
     DNDTEHASTS VNQGENGSGL TPFLTVDDHT LNDNNTSEGS TRVSPDIKFS ATENTKVSDN
     LPSFNDHSYS TQADTAPENA KKRFVEEIPE PAIVEIQDPT EYNDHRLPKR AKK
>P10962 nuc MAK16 PROTEIN.
     MSDEIVWQVI NQSFCSHRIK APNGQNFCRN EYNVTGLCTR QSCPLANSKY ATVKCDNGKL
     YLYMKTPERA HTPAKLWERI KLSKNYTKAL QQIDEHLLHW SKFFRHKCKQ RFTKLTQVMI
     TERRLALREE ERHYVGVAPK VKRREQNRER KALVAAKIEK AIEKELMDRL KSGAYGDKPL
     NVDEKVWKKI MGQMEEENSQ DEEEDWDEEE ESDDGEVEYV ADDGEGEYVD VDDLEKWLAD
     SDREASSASQ SESDSESESD SDSDEENKNS AKRRKKGTSA KTKRPKVEIE YEEEHEVQNA
     EQEVAQ
>P10964 nuc DNA-DIRECTED RNA POLYMERASE I 190 KD POLYPEPTIDE (EC 2.7.7.6) (A190).
     MDISKPVGSE ITSVDFGILT AKEIRNLSAK QITNPTVLDN LGHPVSGGLY DLALGAFLRN
     LCSTCGLDEK FCPGHQGHIE LPVPCYNPLF FNQLYIYLRA SCLFCHHFRL KSVEVHRYAC
     KLRLLQYGLI DESYKLDEIT LGSLNSSMYT DDEAIEDNED EMDGEGSKQS KDISSTLLNE
     LKSKRSEYVD MAIAKALSDG RTTERGSFTA TVNDERKKLV HEFHKKLLSR GKCDNCGMFS
     PKFRKDGFTK IFETALNEKQ ITNNRVKGFI RQDMIKKQKQ AKKLDGSNEA SANDEESFDV
     GRNPTTRPKT GSTYILSTEV KNILDTVFRK EQCVLQYVFH SRPNLSRKLV KADSFFMDVL
     VVPPTRFRLP SKLGEEVHEN SQNQLLSKVL TTSLLIRDLN DDLSKLQKDK VSLEDRRVIF
     SRLMNAFVTI QNDVNAFIDS TKAQGRTSGK VPIPGVKQAL EKKEGLFRKH MMGKRVNYAA
     RSVISPDPNI ETNEIGVPPV FAVKLTYPEP VTAYNIAELR QAVINGPDKW PGATQIQNED
     GSLVSLIGMS VEQRKALANQ LLTPSSNVST HTLNKKVYRH IKNRDVVLMN RQPTLHKASM
     MGHKVRVLPN EKTLRLHYAN TGAYNADFDG DEMNMHFPQN ENARAEALNL ANTDSQYLTP
     TSGSPVRGLI QDHISAGVWL TSKDSFFTRE QYQQYIYGCI RPEDGHTTRS KIVTLPPTIF
     KPYPLWTGKQ IITTVLLNVT PPDMPGINLI SKNKIKNEYW GKGSLENEVL FKDGALLCGI
     LDKSQYGASK YGIVHSLHEV YGPEVAAKVL SVLGRLFTNY ITATAFTCGM DDLRLTAEGN
     KWRTDILKTS VDTGREAAAE VTNLDKDTPA DDPELLKRLQ EILRDNNKSG ILDAVTSSKV
     NAITSQVVSK CVPDGTMKKF PCNSMQAMAL SGAKGSNVNV SQIMCLLGQQ ALEGRRVPVM
     VSGKTLPSFK PYETDAMAGG YVKGRFYSGI KPQEYYFHCM AGREGLIDTA VKTSRSGYLQ
     RCLTKQLEGV HVSYDNSIRD ADGTLVQFMY GGDAIDITKE SHMTQFEFCL DNYYALLKKY
     NPSALIEHLD VESALKYSKK TLKYRKKHSK EPHYKQSVKY DPVLAKYNPA KYLGSVSENF
     QDKLESFLDK NSKLFKSSDG VNEKKFRALM QLKYMRSLIN PGEAVGIIAS QSVGEPSTQM
     TLNTFHFAGH GAANVTLGIP RLREIVMTAS AAIKTPQMTL PIWNDVSDEQ ADTFCKSISK
     VLLSEVIDKV IVTETTGTSN TAGGNAARSY VIHMRFFDNN EYSEEYDVSK EELQNVISNQ
     FIHLLEAAIV KEIKKQKRTT GPDIGVAVPR LQTDVANSSS NSKRLEEDND EEQSHKKTKQ
     AVSYDEPDED EIETMREAEK SSDEEGIDSD KESDSDSEDE DVDMNEQINK SIVEANNNMN
     KVQRDRQSAI ISHHRFITKY NFDDESGKWC EFKLELAADT EKLLMVNIVE EICRKSIIRQ
     IPHIDRCVHP EPENGKRVLV TEGVNFQAMW DQEAFIDVDG ITSNDVAAVL KTYGVEAARN
     TIVNEINNVF SRYAISVSFR HLDLIADMMT RQGTYLAFNR QGMETSTSSF MKMSYETTCQ
     FLTKAVLDNE REQLDSPSAR IVVGKLNNVG TGSFDVLAKV PNAA
>P11632 nuc NONHISTONE CHROMOSOMAL PROTEIN 6A.
     MVTPREPKKR TTRKKKDPNA PKRALSAYMF FANENRDIVR SENPDITFGQ VGKKLGEKWK
     ALTPEEKQPY EAKAQADKKR YESEKELYNA TLA
>P11633 nuc NONHISTONE CHROMOSOMAL PROTEIN 6B.
     MAATKEAKQP KEPKKRTTRR KKDPNAPKRG LSAYMFFANE NRDIVRSENP DVTFGQVGRI
     LGERWKALTA EEKQPYESKA QADKKRYESE KELYNATRA
>P11746 nuc PHEROMONE RECEPTOR TRANSCRIPTION FACTOR (GRM/PRTF PROTEIN).
     MSDIEEGTPT NNGQQKERRK IEIKFIENKT RRHVTFSKRK HGIMKKAFEL SVLTGTQVLL
     LVVSETGLVY TFSTPKFEPI VTQQEGRNLI QACLNAPDDE EEDEEEDGDD DDDDDDDGND
     MQRQQPQQQQ PQQQQQVLNA HANSLGHLNQ DQVPAGALKQ EVKSQLLGGA NPNQNSMIQQ
     QQHHTQNSQP QQQQQQQPQQ QMSQQQMSQH PRPQQGIPHP QQSQPQQQQQ QQQQLQQQQQ
     QQQQQPLTGI HQPHQQAFAN AASPYLNAEQ NAAYQQYFQE PQQGQY
>P11938 nuc DNA-BINDING PROTEIN RAP1 (SBF-E) (REPRESSOR/ACTIVATOR SITE BINDING
     MSSPDDFETA PAEYVDALDP SMVVVDSGSA AVTAPSDSAA EVKANQNEEN TGATAAETSE
     KVDQTEVEKK DDDDTTEVGV TTTTPSIADT AATANIASTS GASVTEPTTD DTAADEKKEQ
     VSGPPLSNMK FYLNRDADAH DSLNDIDQLA RLIRANGGEV LDSKPRESKE NVFIVSPYNH
     TNLPTVTPTY IKACCQSNSL LNMENYLVPY DNFREVVDSR LQEESHSNGV DNSNSNSDNK
     DSIRPKTEII STNTNGATED STSEKVMVDA EQQARLQEQA QLLRQHVSST ASITSGGHND
     LVQIEQPQKD TSNNNNSNVN DEDNDLLTQD NNPQTADEGN ASFQAQRSMI SRGALPSHNK
     ASFTDEEDEF ILDVVRKNPT RRTTHTLYDE ISHYVPNHTG NSIRHRFRVY LSKRLEYVYE
     VDKFGKLVRD DDGNLIKTKV LPPSIKRKFS ADEDYTLAIA VKKQFYRDLF QIDPDTGRSL
     ITDEDTPTAI ARRNMTMDPN HVPGSEPNFA AYRTQSRRGP IAREFFKHFA EEHAAHTENA
     WRDRFRKFLL AYGIDDYISY YEAEKAQNRE PEPMKNLTNR PKRPGVPTPG NYNSAAKRAR
     NYSSQRNVQP TANAASANAA AAAAAAASNS YAIPENELLD EDTMNFISSL KNDLSNISNS
     LPFEYPHEIA EAIRSDFSNE DIYDNIDPDT ISFPPKIATT DLFLPLFFHF GSTRQFMDKL
     HEVISGDYEP SQAEKLVQDL CDETGIRKNF STSILTCLSG DLMVFPRYFL NMFKDNVNPP
     PNVPGIWTHD DDESLKSNDQ EQIRKLVKKH GTGRMEMRKR FFEKDLL
>P12351 nuc CYP1 ACTIVATORY PROTEIN.
     MSNTPYNSSV PSIASMTQSS VSRSPNMHTA TTPGANTSSN SPPLHMSSDS SKIKRKRNRI
     PLSCTICRKR KVKCDKLRPH CQQCTKTGVA HLCHYMEQTW AEEAEKELLK DNELKKLRER
     VKSLEKTLSK VHSSPSSNSL KSYNTPESSN LFMGSDEHTT LVNANTGSAS SASHMHQQQQ
     QQQQQEQQQD FSRSANANAN SSSLSISNKY DNDELDLTKD FDLLHIKSNG TIHLGATHWL
     SIMKGDPYLK LLWGHIFAMR EKLNEWYYQK NSYSKLKSSK CPINHAQAPP SAAAAATRKC
     PVDHSAFSSG MVAPKEETPL PRKCPVDHTM FSSGMIPPRE DTSSQKRCPV DHTMYSAGMM
     PPKDETPSPF STKAMIDHNK HTMNPPQSKC PVDHRNYMKD YPSDMANSSS NPASRCPIDH
     SSMKNTAALP ASTHNTIPHH QPQSGSHARS HPAQSRKHDS YMTESEVLAT LCEMLPPKRV
     IALFIEKFFK HLYPAIPILD EQNFKNHVNQ MLSLSSMNPT VNNFGMSMPS SSTLENQPIT
     QINLPKLSDS CNLGILIIIL RLTWLSIPSN SCEVDLGEES GSFLVPNESS NMSASALTSM
     AKEESLLLKH ETPVEALELC QKYLIKFDEL SSISNNNVNL TTVQFAIFYN FYMKSASNDL
     TTLTNTNNTG MANPGHDSES HQILLSNITQ MAFSCGLHRD PDNFPQLNAT IPATSQDVSN
     NGSKKANPST NPTLNNNMSA ATTNSSSRSG SADSRSGSNP VNKKENQVSI ERFKHTWRKI
     WYYIVSMDVN QSLSLGSPRL LRNLRDFSDT KLPSASRIDY VRDIKELIIV KNFTLFFQID
     LCIIAVLNHI LNVSLARSVR KFELDSLINL LKNLTYGTEN VNDVVSSLIN KGLLPTSEGG
     SVDSNNDEIY GLPKLPDILN HGQHNQNLYA DGRNTSSSDI DKKLDLPHES TTRALFFSKH
     MTIRMLLYLL NYILFTHYEP MGSEDPGTNI LAKEYAQEAL NFAMDGYRNC MIFFNNIRNT
     NSLFDYMNVI LSYPCLDIGH RSLQFIVCLI LRAKCGPLTG MRESSIITNG TSSGFNSSVE
     DEDVKVKQES SDELKKDDFM KDVNLDSGDS LAEILMSRML LFQKLTKQLS KKYNYAIRMN
     KSTGFFVSLL DTPSKKSDSK SGGSSFMLGN WKHPKVSNMS GFLAGDKDQL QKCPVYQDAL
     GFVSPTGANE GSAPMQGMSL QGSTARMGGT QLPPIRSYKP ITYTSSNLRR MNETGEAEAK
     RRRFNDGYID NNSNNDIPRG ISPKPSNGLS SVQPLLSSFS MNQLNGGTIP TVPSLTNITS
     QMGALPSLDR ITTNQINLPD PSRDEAFDNS IKQMTPMTSA FMNANTTIPS STLNGNMNMN
     GAGTANTDTS ANGSALSTLT SPQGSDLASN SATQYKPDLE DFLMQNSNFN GLMINPSSLV
     EVVGGYNDPN NLGRNDAVDF LPVDNVEIDG LVDFYRADFP IWE
>P12383 nuc PLEIOTROPIC DRUG RESISTANCE REGULATORY PROTEIN 1.
     MRGLTPKNGV HIETGPDTES SADSSNFSTG FSGKIRKPRS KVSKACDNCR KRKIKCNGKF
     PCASCEIYSC ECTFSTRQGG ARIKNLHKTS LEGTTVQVKE ETDSSSTSFS NPQRCTDGPC
     AVEQPTKFFE NFKLGGRSSG DNSGSDGKND DDVNRNGFYE DDSESQATLT SLQTTLKNLK
     EMAHLGTHVT SAIESIELQI SDLLKRWEPK VRTKELATTK FYPNKSIETQ LMKNKYCDVV
     HLTRYAAWSN NKKDQDTSSQ PLIDEIFGLY SPFQFLSLQG IGKCFQNYRS KSKCEIFPRT
     AKETIYIMLR FFDVCFHHIN QGCVSIANPL ENYLQKMNLL PSTPSSISSA GSPNTAHTKS
     HVALVINHLP QPFVRNITGI SNSELLSEMN NDISMFGILL KMLDMHKNSY KNFLMEITSN
     PSVAKNTQSI DVLQEFIHYC QAGEALIALC YSYYNSTLYN YVDFTCDITH LEQLLYFLDL
     LFWLSEIYGF EKVLNVAVHF VSRVGLSRWE FYVGLDENFA ERRRNLWWKA FYFEKTLASK
     LGYPSNIDDS KINCLLPKNF RDVGFLDNRD FIENVHLVRR SEAFDNMCIS DLKYYGELAV
     LQIVSHFSSS VLFNEKFTSI RNTSKPSVVR EKLLFEVLEI FNETEMKYDA IKEQTGKLFD
     IAFSKDSTEL KVSREDKIMA SKFVLFYEHH FCRMVNESDN IVARLCVHRR PSILIENLKI
     YLHKIYKSWT DMNKILLDFD NDYSVYRSFA HYSISCIILV SQAFSVAEFI KVNDVVNMIR
     VFKRFLDIKI FSENETNEHV FNSQSFKDYT RAFSFLTIVA RIMLLAYGES SSTNLDVISK
     YIDENAPDLK GIIELVLDTN SCAYRFLLEP VQKSGFHLTV SQMLKNRKFQ EPLMSNEDNK
     QMKHNSGKNL NPDLPSLKTG ISCLLNGIES PQLPFNGRSA PSPVRNNSLP EFAQLPSFRS
     LSVSDMINPD YAQPTNGQNN SQVQSNKPIN AQQQIPTSVQ VPFMNTNEIN NNNNKNNINN
     INNNNSNNFS ATSFNLGTLD EFVNNGDLED LYSILWSDVY PDS
>P12904 nuc NUCLEAR PROTEIN SNF4 (REGULATORY PROTEIN CAT3).
     MKPTQDSQEK VSIEQQLAVE SIRKFLNSKT SYDVLPVSYR LIVLDTSLLV KKSLNVLLQN
     SIVSAPLWDS KTSRFAGLLT TTDFINVIQY YFSNPDKFEL VDKLQLDGLK DIERALGVDQ
     LDTASIHPSR PLFEACLKML ESRSGRIPLI DQDEETHREI VVSVLTQYRI LKFVALNCRE
     THFLKIPIGD LNIITQDNMK SCQMTTPVID VIQMLTQGRV SSVPIIDENG YLINVYEAYD
     VLGLIKGGIY NDLSLSVGEA LMRRSDDFEG VYTCTKNDKL STIMDNIRKA RVHRFFVVDD
     VGRLVGVLTL SDILKYILLG SN
>P12954 nuc ATP-DEPENDENT DNA HELICASE SRS2 (EC 3.6.1.-).
     MSSNNDLWLH LVSQLNTQQR AAALFDYTRG LQVIAGPGTG KTKVLTSRVA YLILHHHIHP
     RDIIVTTFTN KAANEMKERL QEMLRGAGVN ISELLIGTFH SICLKILYRF GHLVDLQKDW
     RIIDEKEIDV ILDDMIEKVP DQIRDYASSI TRKVNLCMPS KNGDEWTIHP KLTQETDIKA
     KINAILPEEY ILDSNHDAAL GYFYQIYQSE LSKKNTLDFD DLLMYTFRLL TRVRVLSNIK
     HVLVDEFQDT NGIQLDLMFL FAKGNHHLSR GMTIVGDPDQ SIYAFRNALA HNFLEMGRKC
     PIEYSTIILV ENYRSSQKIL NTSEILITQQ NKGRQNRAPL RAQFDLDFPP VYMNFPAYFL
     EAPSLVRELL YLKALPNLFT FNDFAILVRQ RRQIKRIESA LIEHRIPYKI IRGHSFWDSK
     ETRAMLNLLK LIFSPNDKHA ILASLLYPAR GLGPATGEKI KNALDTLATD VSCFQILKDI
     SSKKIMLDIP TKGRSVIADF ISMIENCQLL LQSTLLGGLS DLFDKLYELS GLKVRILGTR
     MVRKKMSQFE KSEPNLLNAR HKNIELLKNY FLALLSKSES SDKEKNEAIK AATDEAEPIE
     NKVITPKEYL RNFFNSLSLH SDAAEEEESE SNKDAKIKRE KNGFVTISTI HGAKGLEWPV
     VFIPGCEEGI IPCVFNDDKK DESEEDEEED QENSKKDASP KKTRVLSVED SIDEERRMFF
     VAQTRAKYLL YLSNTVTVED VDRPRIASRF LTTDLIKAMS DSQKLFESTN SIKKLYRILN
     KKPPAEDDKL FSLDQLRKDY NQFIENRRER MIWQGIQMND VYGIQLSRNK LLGSVSDFTS
     AADQLRLETQ NSIFPQKKLI EKSRPSKING NYAPKSRVKS PEKRYAPETT SFHSPTKKKV
     YAPQYVSTTN VPSRQEFHSS TGKNIPFLRR EDRSITDISP RSSTRSLKGA SPNKTSHMSD
     DLMRPSPTRK DKVTRNIHFA TAGTFRIETQ SNVDELHPPE YSNKSGQSLT SSEFSGFSSA
     CSNSDQPTNL IEDINNELDL SDEELLNDIS IERRRELLGS KKTKKIKPKT RNRKSKRGDK
     VKVEEVIDLK SEFEEDDSRN TTAAELLHNP DDTTVDNRPI ISNAKFLADA AMKKTQKFSK
     KVKNEPASSQ MDIFSQLSRA KKKSKLNNGE IIVID
>P13382 nuc DNA POLYMERASE ALPHA (EC 2.7.7.7) (DNA POLYMERASE I).
     MSSKSEKLEK LRKLQAARNG TSIDDYEGDE SDGDRIYDEI DEKEYRARKR QELLHDDFVV
     DDDGVGYVDR GVEEDWREVD NSSSDEDTGN LASKDSKRKK NIKREKDHQI TDMLRTQHSK
     STLLAHAKKS QKKSIPIDNF DDILGEFESG EVEKPNILLP SKLRENLNSS PTSEFKSSIK
     RVNGNDESSH DAGISKKVKI DPDSSTDKYL EIESSPLKLQ SRKLRYANDV QDLLDDVENS
     PVVATKRQNV LQDTLLANPP SAQSLADEED DEDSDEDIIL KRRTMRSVTT TRRVNIDSRS
     NPSTSPFVTA PGTPIGIKGL TPSKSLQSNT DVATLAVNVK KEDVVDPETD TFQMFWLDYC
     EVNNTLILFG KVKLKDDNCV SAMVQINGLC RELFFLPREG KTPTDIHEEI IPLLMDKYGL
     DNIRAKPQKM KYSFELPDIP SESDYLKVLL PYQTPKSSRD TIPSDLSSDT FYHVFGGNSN
     IFESFVIQNR IMGPCWLDIK GADFNSIRNA SHCAVEVSVD KPQNITPTTT KTMPNLRCLS
     LSIQTLMNPK ENKQEIVSIT LSAYRNISLD SPIPENIKPD DLCTLVRPPQ STSFPLGLAA
     LAKQKLPGRV RLFNNEKAML SCFCAMLKVE DPDVIIGHRL QNVYLDVLAH RMHDLNIPTF
     SSIGRRLRRT WPEKFGRGNS NMNHFFISDI CSGRLICDIA NEMGQSLTPK CQSWDLSEMY
     QVTCEKEHKP LDIDYQNPQY QNDVNSMTMA LQENITNCMI SAEVSYRIQL LTLTKQLTNL
     AGNAWAQTLG GTRAGRNEYI LLHEFSRNGF IVPDKEGNRS RAQKQRQNEE NADAPVNSKK
     AKYQGGLVFE PEKGLHKNYV LVMDFNSLYP SIIQEFNICF TTVDRNKEDI DELPSVPPSE
     VDQGVLPRLL ANLVDRRREV KKVMKTETDP HKRVQCDIRQ QALKLTANSM YGCLGYVNSR
     FYAKPLAMLV TNKGREILMN TRQLAESMNL LVVYGDTDSV MIDTGCDNYA DAIKIGLGFK
     RLVNERYRLL EIDIDNVFKK LLLHAKKKYA ALTVNLDKNG NGTTVLEVKG LDMKRREFCP
     LSRDVSIHVL NTILSDKDPE EALQEVYDYL EDIRIKVETN NIRIDKYKIN MKLSKDPKAY
     PGGKNMPAVQ VALRMRKAGR VVKAGSVITF VITKQDEIDN AADTPALSVA ERAHALNEVM
     IKSNNLIPDP QYYLEKQIFA PVERLLERID SFNVVRLSEA LGLDSKKYFR REGGNNNGED
     INNLQPLETT ITDVERFKDT VTLELSCPSC DKRFPFGGIV SSNYYRVSYN GLQCKHCEQL
     FTPLQLTSQI EHSIRAHISL YYAGWLQCDD STCGIVTRQV SVFGKRCLND GCTGVMRYKY
     SDKQLYNQLL YFDSLFDCEK NKKQELKPIY LPDDLDYPKE QLTESSIKAL TEQNRELMET
     GRSVVQKYLN DCGRRYVDMT SIFDFMLN
>P13393 nuc TRANSCRIPTION INITIATION FACTOR TFIID (TATA-BOX FACTOR) (TATA
     ADEERLKEFK EANKIVFDPN TRQVWENQNR DGTKPATTFQ SEEDIKRAAP ESEKDTSATS
     GIVPTLQNIV ATVTLGCRLD LKTVALHARN AEYNPKRFAA VIMRIREPKT TALIFASGKM
     VVTGAKSEDD SKLASRKYAR IIQKIGFAAK FTDFKIQNIV GSCDVKFPIR LEGLAFSHGT
     FSSYEPELFP GLIYRMVKPK IVLLIFVSGK IVLTGAKQRE EIYQAFEAIY PVLSEFRKM
>P13434 nuc HAP3 TRANSCRIPTIONAL ACTIVATOR (UAS2 REGULATORY PROTEIN A).
     MNTNESEHVS TSPEDTQENG GNASSSGSLQ QISTLREQDR WLPINNVARL MKNTLPPSAK
     VSKDAKECMQ ECVSELISFV TSEASDRCAA DKRKTINGED ILISLHALGF ENYAEVLKIY
     LAKYRQQQAL KNQLMYEQDD EEVP
>P13574 nuc STE12 PROTEIN.
     MKVQITNSRT EEILKVQANN ENDEVSKATP GEVEESLRLI GDLKFFLATA PVNWQENQII
     RRYYLNSGQG FVSCVFWNNL YYITGTDIVK CCLYRMQKFG REVVQKKKFE EGIFSDLRNL
     KCGIDATLEQ PKSEFLSFLF RNMCLKTQKK QKVFFWFSVA HDKLFADALE RDLKRESLNQ
     PSTTKPVNEP ALSFSYDSSS DKPLYDQLLQ HLDSRRPSST TKSDNSPPKL ESENFKDNEL
     VTVTNQPLLG VGLMDDDAPE SPSQINDFIP QKLIIEPNTL ELNGLTEETP HDLPKNTAKG
     RDEEDFPLDY FPVSVEYPTE ENAFDPFPPQ AFTPAAPSMP ISYDNVNERD SMPVNSLLNR
     YPYQLSVAPT FPVPPSSSRQ HFMTNRDFYS SNNNKEKLVS PSDPTSYMKY DEPVMDFDES
     RPNENCTNAK SHNSGQQTKQ HQLYSNNFQQ SYPNGMVPGY YPKMPYNPMG GDPLLDQAFY
     GADDFFFPPE GCDNNMLYPQ TATSWNVLPP QAMQPAPTYV GRPYTPNYRS TPGSAMFPYM
     QSSNSMQWNT AVSPYSSRAP STTAKNYPPS TFYSQNINQY PRRRTVGMKS SQGNVPTGNK
     QSVGKSAKIS KPLHIKTSAY QKQYKINLET KARPSAGDED SAHPDKNKEI SMPTPDSNTL
     VVQSEEGGAH SLEVDTNRRS DKNLPDAT
>P14064 nuc HAP4 TRANSCRIPTIONAL ACTIVATOR.
     MTAKTFLLQA SASRPRSNHF KNEHNNIPLA PVPIAPNTNH HNNSSLEFEN DGSKKKKKSS
     LVVRTSKHWV LPPRPRPGRR SSSHNTLPAN NTNNILNVGP NSRNSSNNNN NNNIISNRKQ
     ASKEKRKIPR HIQTIDEKLI NDSNYLAFLK FDDLENEKFH SSASSISSPS YSSPSFSSYR
     NRKKSEFMDD ESCTDVETIA AHNSLLTKNH HIDSSSNVHA PPTKKSKLND FDLLSLSSTS
     SSATPVPQLT KDLNMNLNFH KIPHKASFPD SPADFSPADS VSLIRNHSLP TNLQVKDKIE
     DLNEIKFFND FEKLEFFNKY AKVNTNNDVN ENNDLWNSYL QSMDDTTGKN SGNYQQVDND
     DNMSLLNLPI LEETVSSGQD DKVEPDEEDI WNYLPSSSSQ QEDSSRALKK NTNSEKANIQ
     AKNDETYLFL QDQDESADSH HHDELGSEIT LADNKFSYLP PTLEELMEEQ DCNNGRSFKN
     FMFSNDTGID GSAGTDDDYT KVLKSKKIST SKSNANLYDL NDNNNDATAT NELDQSSFID
     DLDEDVDFLK VQVF
>P14291 nuc RED1 PROTEIN.
     MEGLKKKIFG VCLKNDLAQT RNETKGIHYG LMTLETSKQL QEFLHLLVIK REVIQNFELL
     FHIINVAVKI TDSNLPSDDI WHFILKLRFS SEINIDEDSK VLNYLLETGI AMENPVSWKC
     LAVISSILSS VPQSKKIITN LIETEHAKKI GQLFDNIQDL QQGNFLVEIL SNCFKKSASN
     SKKVEKIPQL WQSRSKNKFF FENEFYPFSS KNGSLQTCQF LCNNFMSTLS FTGILRQVSY
     SGSETLKNLR IFKKKDDENS YFIQCIYNKI YLWLDEKAPL EFERKKIRIT KNLKNKIQIK
     LRQPFHECVR TTADKTALLF NKTKGFQLEF EDEKLGETFF HNVNNIPKIS EVQNFLVLDY
     IEEEPENEGE EEEQIGRADE QKEDEEEESL DELSTPMVYP IKSSIPHNHN EKVQLVTPDR
     SVSIRSDEWD LKSNTEDEEG NVLADLKISS TKETKRQTDY VHIDSEDQSP VVSAQMRKMR
     RESTKTLEIL RQEFKDKDVQ NKEDQSEQIQ NPFVNTSSLV VGKSCLVNPK EKPNIDQTVV
     GITELKSNSS IKKRDINILD TIFGQPPSKK QKQFHKKEKK KQQKKLTNFK PIIDVPSQDK
     RNLRSNAPTK PKSIKVSKLR TDKKVTGEKS SPETAAEKVD DQTVRSNDEQ AMSRATKEKC
     FPDVNEGKEI TKDDAKVSLE SKKNNETFVD SSVVEKHTPP DKDCNNCNIT DILESTTVID
     LQSPHGLSAP GQNTFTNKLQ EQIYSSINHF SNELVRKISI INQELNKKIL KELSEKYQKL
     FSELQDNFQN DTNEMLKFMG EIKDMMNLPE DQLVHAIRTR KFDNNKR
>P14682 nuc UBIQUITIN-CONJUGATING ENZYME E2-34 KD (EC 6.3.2.19) (UBIQUITIN-PROTEIN
     MSSRKSTASS LLLRQYRELT DPKKAIPSFH IELEDDSNIF TWNIGVMVLN EDSIYHGGFF
     KAQMRFPEDF PFSPPQFRFT PAIYHPNVYR DGRLCISILH QSGDPMTDEP DAETWSPVQT
     VESVLISIVS LLEDPNINSP ANVDAAVDYR KNPEQYKQRV KMEVERSKQD IPKGFIMPTS
     ESAYISQSKL DEPESNKDMA DNFWYDSDLD DDENGSVILQ DDDYDDGNNH IPFEDDDVYN
     YNDNDDDDER IEFEDDDDDD DDSIDNDSVM DRKQPHKAED ESEDVEDVER VSKKI
>P14736 nuc DNA REPAIR PROTEIN RAD4.
     MNEDLPKEYF ELIRKALNEK EAEKAPLSRR RRVRRKNQPL PDAKKKFKTG LNELPRESVV
     TVNLDSSDDG VVTVPTDDSV EEIQSSEEDY DSEEFEDVTD GNEVAGVEDI SVEIKPSSKR
     NSDARRTSRN VCSNEERKRR KYFHMLYLVC LMVHGFIRNE WINSKRLSRK LSNLVPEKVF
     ELLHPQKDEE LPLRSTRKLL DGLKKCMELW QKHWKITKKY DNVGIYMRTW KEIEMSANNK
     RKFKTLKRSD FLRAVSKGHG DPDISVQGFV AMLRACNVNA RLIMSCQPPD FTNMKIDTSL
     NGNNAYKDMV KYPIFWCEVW DKFSKKWITV DPVNLKTIEQ VRLHSKLAPK GVACCERNML
     RYVIAYDRKY GCRDVTRRYA QWMNSKVRKR RITKDDFGEK WFRKVITALH HRKRTKIDDY
     EDQYFFQRDE SEGIPDSVQD LKNHPYYVLE QDIKQTQIVK PGCKECGYLK VHGKVGKVLK
     VYAKRDIADL KSARQWYMNG RILKTGSRCK KVIKRTVGRP KGEAEEEDER LYSFEDTELY
     IPPLASASGE ITKNTFGNIE VFAPTMIPGN CCLVENPVAI KAARFLGVEF APAVTSFKFE
     RGSTVKPVLS GIVVAKWLRE AIETAIDGIE FIQEDDNRKE HLLGALESWN TLLLKLRIRS
     KLNSTYGKIA EEEPNVTKEQ NIADNHDNTE TFMGGGFLPG IANHEARPYS EPSEPEDSLD
     YVSVDKAEES ATDDDVGEDY SDFMKELEMS EESD
>P14922 nuc GLUCOSE REPRESSION MEDIATOR PROTEIN.
     MNPGGEQTIM EQPAQQQQQQ QQQQQQQQQQ AAVPQQPLDP LTQSTAETWL SIASLAETLG
     DGDRAAMAYD ATLQFNPSSA KALTSLAHLY RSRDMFQRAA ELYERALLVN PELSDVWATL
     GHCYLMLDDL QRAYNAYQQA LYHLSNPNVP KLWHGIGILY DRYGSLDYAE EAFAKVLELD
     PHFEKANEIY FRLGIIYKHQ GKWSQALECF RYILPQPPAP LQEWDIWFQL GSVLESMGEW
     QGAKEAYEHV LAQNQHHAKV LQQLGCLYGM SNVQFYDPQK ALDYLLKSLE ADPSDATTWY
     HLGRVHMIRT DYTAAYDAFQ QAVNRDSRNP IFWCSIGVLY YQISQYRDAL DAYTRAIRLN
     PYISEVWYDL GTLYETCNNQ LSDALDAYKQ AARLDVNNVH IRERLEALTK QLENPGNINK
     SNGAPTNASP APPPVILQPT LQPNDQGNPL NTRISAQSAN ATASMVQQQH PAQQTPINSS
     ATMYSNGASP QLQAQAQAQA QAQAQAQAQA QAQAQAQAQA QAQAQAQAQA QAQAQAHAQA
     QAQAQAKAQA QAQAQAQQQQ QQQQQQQQQQ QQQQQQQQQQ QQQQQQQLQP LPRQQLQQKG
     VSVQMLNPQQ GQPYITQPTV IQAHQLQPFS TQAMEHPQSS QLPPQQQQLQ SVQHPQQLQG
     QPQAQAPQPL IQHNVEQNVL PQKRYMEGAI HTLVDAAVSS STHTENNTKS PRQPTHAIPT
     QAPATGITNA EPQVKKQKLN SPNSNINKLV NTATSIEENA KSEVSNQSPA VVESNTNNTS
     QEEKPVKANS IPSVIGAQEP PQEASPAEEA TKAASVSPST KPLNTEPESS SVQPTVSSES
     STTKANDQST AETIELSTAT VPAEASPVED EVRQHSKEEN GTTEASAPST EEAEPAASRD
     AEKQQDETAA TTITVIKPTL ETMETVKEEA KMREEEQTSQ EKSPQENTLP RENVVRQVEE
     DENYDD
>P15436 nuc DNA POLYMERASE DELTA LARGE CHAIN (EC 2.7.7.7) (DNA POLYMERASE III).
     MSEKRSLPMV DVKIDDEDTP QLEKKIKRQS IDHGVGSEPV STIEIIPSDS FRKYNSQGFK
     AKDTDLMGTQ LESTFEQDVS QMEHDMADQE EHDLSSFERK KLPTDFDPSL YDISFQQIDA
     EQSVLNGIKD ENTSTVVRFF GVTSEGHSVL CNVTGFKNYL YVPAPNSSDA NDQEQINKFV
     HYLNETFDHA IDSIEVVSKQ SIWGYSGDTK LPFWKIYVTY PHMVNKLRTA FERGHLSFNS
     WFSNGTTTYD NIAYTLRLMV DCGIVGMSWI TLPKGKYSMI EPNNRVSSCQ LEVSINYRNL
     IAHPAEGDWS HTAPLRIMSF DIECAGRIGV FPEPEYDPVI QIANVVSIAG AKKPFIRNVF
     TLNTCSPITG SMIFSHATEE EMLSNWRNFI IKVDPDVIIG YNTTNFDIPY LLNRAKALKV
     NDFPYFGRLK TVKQEIKESV FSSKAYGTRE TKNVNIDGRL QLDLLQFIQR EYKLRSYTLN
     AVSAHFLGEQ KEDVHYSIIS DLQNGDSETR RRLAVYCLKD AYLPLRLMEK LMALVNYTEM
     ARVTGVPFSY LLARGQQIKV VSQLFRKCLE IDTVIPNMQS QASDDQYEGA TVIEPIRGYY
     DVPIATLDFN SLYPSIMMAH NLCYTTLCNK ATVERLNLKI DEDYVITPNG DYFVTTKRRR
     GILPIILDEL ISARKRAKKD LRDEKDPFKR DVLNGRQLAL KISANSVYGF TGATVGKLPC
     LAISSSVTAY GRTMILKTKT AVQEKYCIKN GYKHDAVVVY GDTDSVMVKF GTTDLKEAMD
     LGTEAAKYVS TLFKHPINLE FEKAYFPYLL INKKRYAGLF WTNPDKFDKL DQKGLASVRR
     DSCSLVSIVM NKVLKKILIE RNVDGALAFV RETINDILHN RVDISKLIIS KTLAPNYTNP
     QPHAVLAERM KRREGVGPNV GDRVDYVIIG GNDKLYNRAE DPLFVLENNI QVDSRYYLTN
     QLQNPIISIV APIIGDKQAN GMFVVKSIKI NTGSQKGGLM SFIKKVEACK SCKGPLRKGE
     GPLCSNCLAR SGELYIKALY DVRDLEEKYS RLWTQCQRCA GNLHSEVLCS NKNCDIFYMR
     VKVKKELQEK VEQLSKW
>P15873 nuc PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA).
     MLEAKFEEAS LFKRIIDGFK DCVQLVNFQC KEDGIIAQAV DDSRVLLVSL EIGVEAFQEY
     RCDHPVTLGM DLTSLSKILR CGNNTDTLTL IADNTPDSII LLFEDTKKDR IAEYSLKLMD
     IDADFLKIEE LQYDSTLSLP SSEFSKIVRD LSQLSDSINI MITKETIKFV ADGDIGSGSV
     IIKPFVDMEH PETSIKLEMD QPVDLTFGAK YLLDIIKGSS LSDRVGIRLS SEAPALFQFD
     LKSGFLQFFL APKFNDEE
>P16370 nuc DNA-DIRECTED RNA POLYMERASE II 45 KD POLYPEPTIDE (EC 2.7.7.6) (B44.5).
     MSEEGPQVKI REASKDNVDF ILSNVDLAMA NSLRRVMIAE IPTLAIDSVE VETNTTVLAD
     EFIAHRLGLI PLQSMDIEQL EYSRDCFCED HCDKCSVVLT LQAFGESEST TNVYSKDLVI
     VSNLMGRNIG HPIIQDKEGN GVLICKLRKG QELKLTCVAK KGIAKEHAKW GPAAAIEFEY
     DPWNKLKHTD YWYEQDSAKE WPQSKNCEYE DPPNEGDPFD YKAQADTFYM NVESVGSIPV
     DQVVVRGIDT LQKKVASILL ALTQMDQDKV NFASGDNNTA SNMLGSNEDV MMTGAEQDPY
     SNASQMGNTG SGGYDNAW
>P16522 nuc CELL DIVISION CONTROL PROTEIN 23.
     MNDDSQDKII HDIRIQLRKA ATELSRWKLY GSSKWAAEAL AGLAEAIDVD QTHSLADESP
     LRNKQGVPKQ MFEIPQNGFG LSETEYDLYL LGSTLFDAKE FDRCVFFLKD VTNPYLKFLK
     LYSKFLSWDK KSQESMENIL TTGKFTDEMY RANKDGDGSG NEDINQSGHQ RANLKMVSNE
     HESQSNISSI LKEINTFLES YEIKIDDDEA DLGLALLYYL RGVILKQEKN ISKAMSSFLK
     SLSCYSFNWS CWLELMDCLQ KVDDALLLNN YLYQNFQFKF SENLGSQRTI EFNIMIKFFK
     LKVFEELNGQ LEDYFEDLEF LLQVFPNFTF LKAYNATISY NNLDYVTAES RFDDIVKQDP
     YRLNDLETYS NILYVMQKNS KLAYLAQFVS QIDRFRPETC CIIANYYSAR QEHEKSIMYF
     RRALTLDKKT TNAWTLMGHE FVELSNSHAA IECYRRAVDI CPRDFKAWFG LGQAYALLDM
     HLYSLYYFQK ACTLKPWDRR IWQVLGECYS KTGNKVEAIK CYKRSIKASQ TVDQNTSIYY
     RLAQLYEELE DLQECKKFMM KCVDVEELLE GIVTDETVKA RLWLAIFEIK AGNYQLAYDY
     AMGVSSGTSQ EIEEARMLAR ECRRHM
>P16658 nuc TRNA-SPLICING ENDONUCLEASE BETA-SUBUNIT.
     MSKGRVNQKR YKYPLPIHPV DDLPELILHN PLSWLYWAYR YYKSTNALND KVHVDFIGDT
     TLHITVQDDK QMLYLWNNGF FGTGQFSRSE PTWKARTEAR LGLNDTPLHN RGGTKSNTET
     EMTLEKVTQQ RRLQRLEFKK ERAKLERELL ELRKKGGHID EENILLEKQR ESLRKFKLKQ
     TEDVGIVAQQ QDISESNLRD EDNNLLDENG DLLPLESLEL MPVEAMFLTF ALPVLDISPA
     CLAGKLFQFD AKYKDIHSFV RSYVIYHHYR SHGWCVRSGI KFGCDYLLYK RGPPFQHAEF
     CVMGLDHDVS KDYTWYSSIA RVVGGAKKTF VLCYVERLIS EQEAIALWKS NNFTKLFNSF
     QVGEVLYKRW VPGRNRD
>P17106 nuc CENTROMERE-BINDING PROTEIN 1 (CBP-1) (CENTROMERE-BINDING FACTOR 1)
     MNSLANNNKL STEDEEIHSA RKRGYNEEQN YSEARKKQRD QGLLSQESND GNIDSALLSE
     GATLKGTQSQ YESGLTSNKD EKGSDDEDAS VAEAAVAATV NYTDLIQGQE DSSDAHTSNQ
     TNANGEHKDS LNGERAITPS NEGVKPNTSL EGMTSSPMES TQQSKNDMLI PLAEHDRGPE
     HQQDDEDNDD ADIDLKKDIS MQPGRRGRKP TTLATTDEWK KQRKDSHKEV ERRRRENINT
     AINVLSDLLP VRESSKAAIL ARAAEYIQKL KETDEANIEK WTLQKLLSEQ NASQLASANE
     KLQEELGNAY KEIEYMKRVL RKEGIEYEDM HTHKKQENER KSTRSDNPHE A
>P17214 nuc TELOMERE ELONGATION PROTEIN (EC 2.7.7.-).
     MDNEEVNEEC MRLFFKNARA HLDKHLTSRL TCDENAYITF RCFLDGIHRK STRFLEELLL
     KQENMYHNNN YERINDSVIP LVLKLLWLQI HEPTLQWFEH WFHDIMRLSN RRKFRVFRIF
     QKKMIQFFKI THRYYYDIIE HLCAKYDMNS VISNALFAKL NLMQYTDGLS THEKIILNTS
     NPLTFSIVIS LQRCVINLGS THFYKTLLNK PSNKPKSVEG FEKSIRYLNI ASLYLPAVGD
     TYFQRAKIYL ITGKFSLYFF ELVRGALVRI PSKCALNNLK DFILTPDFPE RRRLMKKLAI
     LVSKDLKGEK SFFEGQIVLQ FLSIVEHTLV PQSWNASRAS NCWLLKEHLQ MAALKYHSGN
     INVILENLAA TMGSFDLMFT TRKSKEQKNK LKYADLSERQ VFFLDLSFDF IANIIDVVIK
     PSWQKNMEDF RYLAIIRLLM CWIKSYRSIL QYTHRHRKFC TSFALLLNDL INSPLNCSGN
     IYSHRPKRSY LFREDIIFRE FSCINFALTD FNDDYVYDSP DMINNIIGCP TLTKVLSPKE
     ECVLRIRSII FSGMKFLEKN DTGVIWNASK YKFDLISPNI KIKRQIALSE ISSKINVKTQ
     QERVVSSRKV EAKRDEQQRK RAGKIAVTEL EKQFANVRRT KKLSPLPEKD GVSSELVKHA
     ASRGRKTITG PLSSDFLSYP DEAIDADEDI TVQVPDTPT
>P17883 nuc SUPERKILLER 3 PROTEIN.
     MSDIKQLLKE AKQELTNRDY EETIEISEKV LKLDPDNYFA HIFLGKALSS LPASNNVSSN
     RNLERATNHY VSAAKLVPDN LLAWKGLFLL FRTTEVVPDI LSYDEYFDLC GQYADALLKQ
     EQSQVELIND IKLLKKTHPD CQKAFYQHLK PGSLMAETIG RHLSTPQDAL LNLIKILSNI
     ETTEIGKTLS QNRLKLKASD PDYQIKLNSF SWEIIKNSEI DQLYNQLVNI LADDQKRSEI
     ENQWLEYRIK VLKSMPLDVK KDFFTKVKEM VEDMVLVNHQ SLLAWQKYFE WTDYEDLDNM
     DAPLIIKYFK KFPKDPLAMI LYSWLSSKLS KYDIKSLESA NKPPEGHKKT EKETDIKDVD
     ETNEDEVKDR VEDEVKDRVE DEVKDQDEEA KEDEEEDLDD IEIGLLEEEV VTVLTENIVK
     CKNNILAHRI LCQYYLLTKE YEAALPYIKN GISLIAYNIK DLGVHLPLTK REFSLDLATV
     YTYVDAPKDH NAALKLYDNI LSGDFSNIQA KMGKGIIFIE RKNWKDAMTL LTQVHEQSPN
     NLEVLSELSW SKAHMGYMDE ALAGLDTVIK GIKGMDLRSI DFRALNLWRQ AKVYIMKHAS
     INDAKQENVK CAFKLLIQSI KILDTFAPGF STLGDIYCHY YKDHLRAFKC YFKAFDLDAG
     DYTAAKYITE TYASKPNWQA ASSIASRLIK GEKAKAELRS NNWPFRVVGI AHLEKQEESD
     SIEWFQSALR VDPNDVESWV GLGQAYHACG RIEASIKVFD KAIQLRPSHT FAQYFKAISL
     CDVGEYLESL DILEKVCQEA ATEESFQIGL VEVLMRCSLD LYSQGFLLKS VSIAKDTIER
     IKIIISELKC ENQQVWIYLS QVLRLFIWIE SKVDTLPVES LVSIFENSQF SGSEEIDSVD
     NIKIDTLLDS TTDDNVSIAC KFLILASKYS VSDQKFTDIA GTVRASYWYN IGISELTAFI
     TLKEPQYRDA AIFAFKKSIQ LQSNISETWI GLGIATMDIN FRVSQHCFIK ATALEPKATN
     TWFNLAMLGL KKKDTEFAQQ VLNKLQSLAP QDSSPWLGMA LILEEQGDII GSSKLFAHSF
     ILSNGRSKAA QFMYAKNVLE NHINNGDDER DIETVEKLTT ASIALEQFFK KSPDSQFALQ
     CALLTLERLH HYENANELAN RLIGILEKKF EKTQDERELF NFAIIKGQFA RIHLGLGNFE
     LSIENADLSQ GIISESSDEK SMKTKISNHI CLGLSYFFLN DFDQTLNQFQ ELLSISKDSK
     HLVVLIAKVL YDVGESDTKE IALQELTEYI ATSGADLLVT LTIAAMSILD DKREDLSIIL
     EELKALPLSK QIIDKHKDAP YLIEEITKRL YRNDTGKQVW QRSAYFFPNN LKVWERLDKN
     IQRRIASNGQ NKVTAEEMSK LYCESKNLRS IQRGMFLCPW NVTAVKALNE CF
>P17890 nuc DNA-DIRECTED RNA POLYMERASE III 31 KD POLYPEPTIDE (EC 2.7.7.6) (C31).
     MSSYRGGSRG GGSNYMSNLP FGLGYGDVGK NHITEFPSIP LPINGPITNK ERSLAVKYIN
     FGKTVKDGPF YTGSMSLIID QQENSKSGKR KPNIILDEDD TNDGIERYSD KYLKKRKIGI
     SIDDHPYNLN LFPNELYNVM GINKKKLLAI SKFNNADDVF TGTGLQDENI GLSMLAKLKE
     LAEDVDDAST GDGAAKGSKT GEGEDDDLAD DDFEEDEDEE DDDDYNAEKY FNNGDDDDYG
     DEEDPNEEAA F
>P18412 nuc TY TRANSCRIPTION ACTIVATOR TEC1.
     MSLKEDDFGK DNSRNIESYT GRIFDVYIQK DSYSQSALDD MFPEAVVSTA ACVKNEAEDN
     INLIDTHPQF ELVNTGLGAK SDDLKSPSAK ATFTDKQRKN EVPNISVSNY FPGQSSETSS
     TTESWTIGCD KWSEKVEEAF LEALRLIMKN GTTKIKIRNA NFGRNELISL YIKHKTNEFR
     TKKQISSHIQ VWKKTIQNKI KDSLTLSSKE KELLHLIEHG AEQTTENSNL FYDIFEEIID
     SLPSVSDSGS LTPKNLYVSN NSSGLSVHSK LLTPITASNE KKIENFIKTN AASQAKTPLI
     YAKHIYENID GYKCVPSKRP LEQLSPTELH QGDRPNKASF SNKKAILESA KKIEIEQRKI
     INKYQRISRI QEHESNPEFS SNSNSGSEYE SEEEVVPRSA TVTQLQSRPV PYYKNNGMPY
     SLSKVRGRPM YPRPAEDAYN ANYIQGLPQY QTSYFSQLLL SSPQHYEHSP HQRNFTPSNQ
     SHGNFY
>P18480 nuc TRANSCRIPTION REGULATORY PROTEIN SNF5 (SWI/SNF COMPLEX COMPONENT SNF5)
     MNNQPQGTNS VPNSIGNIFS NIGTPSFNMA QIPQQLYQSL TPQQLQMIQQ RHQQLLRSRL
     QQQQQQQQQT SPPPQTHQSP PPPPQQSQPI ANQSATSTPP PPPAPHNLHP QIGQVPLAPA
     PINLPPQIAQ LPLATQQQVL NKLRQQAIAK NNPQVVNAIT VAQQQVQRQI EQQKGQQTAQ
     TQLEQQRQLL VQQQQQQQLR NQIQRQQQQQ FRHHVQIQQQ QQKQQQQQQQ HQQQQQQQQQ
     QQQQQQQQQQ QQQQQQQQQQ QQQQQQQQGQ IPQSQQVPQV RSMSGQPPTN VQPTIGQLPQ
     LPKLNLPKYQ TIQYDPPETK LPYPTYWSDK KADTDTLLYE QIIQRDKINK YSLIRETNGY
     DPFSIYGFSN KEYISRLWHT LKYYQDLKNT RMKSITSTSQ KIPSASIWGN GYSGYGNGIT
     NTTTRVIPQV EVGNRKHYLE DKLKVYKQAM NETSEQLVPI RLEFDQDRDR FFLRDTLLWN
     KNDKLIKIED FVDDMLRDYR FEDATREQHI DTICQSIQEQ IQEFQGNPYI ELNQDRLGGD
     DLRIRIKLDI VVGQNQLIDQ FEWEISNSDN CPEEFAESMC QELELPGEFV TAIAHSIREQ
     VHMYHKSLAL LGYNFDGSAI EDDDIRSRML PTITLDDVYR PAAESKIFTP NLLQISAAEL
     ERLDKDKDRD TRRKRRQGRS NRRGMLALSG TSASNTSMNG VHNTVAAGNA SSLPPGEILL
     PDIADIPRTF RTPVPSTLMP GGVDVGPSVE SYELRNTTTY KSRPDRPKPV SPPCYIIDHI
     PGHSLLLSIK LPGKVNTKEE FAAAPNDTSS GTNAMLPSPE SLKTKLNSNI RAGVTIPSIP
     NPIANHTVTN SPNPTLQPVI PGGAASKSVP TPSLPIAPPV APHDSEATLL TNSNNGSSNN
     NTQNT
>P18494 nuc NITROGEN REGULATORY PROTEIN GLN3.
     MQDDPENSKL YDLLNSHLDV HGRSNEEPRQ TGDSRSQSSG NTGENEEDIA FASGLNGGTF
     DSMLEALPDD LYFTDFVSPF TAAATTSVTT KTVKDTTPAT NHMDDDIAMF DSLATTQPID
     IAASNQQNGE IAQLWDFNVD QFNMTPSNSS GSATISAPNS FTSDIPQYNH GSLGNSVSKS
     SLFPYNSSTS NSNINQPSIN NNSNTNAQSH HSFNIYKLQN NNSSSSAMNI TNNNNSNNSN
     IQHPFLKKSD SIGLSSSNTT NSVRKNSLIK PMSSTSLANF KRAASVSSSI SNMEPSGQNK
     KPLIQCFNCK TFKTPLWRRS PEGNTLCNAC GLFQKLHGTM RPLSLKSDVI KKRISKKRAK
     QTDPNIAQNT PSAPATASTS VTTTNAKPIR SRKKSLQQNS LSRVIPEEII RDNIGNTNNI
     LNVNRGGYNF NSVPSPVLMN SQSYNSSNAN FNGASNANLN SNNLMRHNSN TVTPNFRRSS
     RRSSTSSNTS SSSKSSSRSV VPILPKPSPN SANSQQFNMN MNLMNTTNNV SAGNSVASSP
     RIISSANFNS NSPLQQNLLS NSFQRQGMNI PRRKMSRNAS YSSSFMAASL QQLHEQQQVD
     VNSNTNTNSN RQNWNSSNSV STNSRSSNFV SQKPNFDIFN TPVDSPSVSR PSSRKSHTSL
     LSQQLQNSES NSFISNHKFN NRLSSDSTSP IKYEADVSAG GKISEDNSTK GSSKESSAIA
     DELDWLKFGI
>P18888 nuc TRANSCRIPTION REGULATORY PROTEIN SNF6 (SWI/SNF COMPLEX COMPONENT
     MGVIKKKRSH HGKASRQQYY SGVQVGGVGS MGAINNNIPS LTSFAEENNY QYGYSGSSAG
     MNGRSLTYAQ QQLNKQRQDF ERVRLRPEQL SNIIHDESDT ISFRSNLLKN FISSNDAFNM
     LSLTTVPCDR IEKSRLFSEK TIRYLMQKQH EMKTQAAELQ EKPLTPLKYT KLIAAAEDGS
     RSTKDMIDAV FEQDSHLRYQ PDGVVVHRDD PALVGKLRGD LREAPADYWT HAYRDVLAQY
     HEAKERIRQK EVTAGEAQDE ASLQQQQQQD LQQQQQVVTT VASQSPHATA TEKEPVPAVV
     DDPLENMFGD YSNEPFNTNF DDEFGDLDAV FF
>P19735 nuc PRE-MRNA SPLICING FACTOR PRP6.
     MERPSFLDQE PPAGYVPGIG RGATGFSTKE KQVVSNDDKG RRIPKRYREN LNNHLQSQPK
     DDEDDEAANV FKTLELKLAQ KKKKRANEKD DDNSVDSSNV KRQFADLKES LAAVTESEWM
     DIPDATDFTR RNKRNRIQEQ LNRKTYAAPD SLIPGNVDLN KLTEEREKLL QSQIDENLAQ
     LTKNASNPIQ VNKPNAATDA LSYLKDLEND RVNSLSDATL EDLQKMRTIL KSYRKADPTN
     PQGWIASARL EEKARKFSVA KKIIENGCQE CPRSSDIWLE NIRLHESDVH YCKTLVATAI
     NFNPTSPLLW FKAIDLESTT VNKYRVVRKA LQEIPRDEGL WKLAVSFEAD KAQVIKMLEK
     ATQFIPQSMD LLTAYTNLQS YHNAKMTLNS FRKILPQEPE IWIISTLLEE RNNPDIPVDK
     LVSLLKEGLL ELSKNGYKAT LSAWLKRAEA LNDAPNSNLT CQAIVYAILE WLRESGEYES
     ELNNVDQILE KMPHSKVQIA VLKKLIQWDP CDTVLWSRLK MATESYHKIE ELLAFFQELL
     FQTKNSDDIR ANMREKSPGL LMMYVSEYWK AQKGDTRQTL VLIDQIIDFA PHNLDLRFFK
     IKLLGRSLQL DELRDFFQQT FSSLEDFKIS GTERLYYKYV NFLRYQDLNE EAIKFLNERC
     LKSFPICHKF FLQLGQIYHS MGNIEMSRET YLSGTRLVPN CPLLWVSLSK IDEIDLKNPV
     RARSILDRGL LKNPDDVLFY IAKIQMEIRL GNLDQAELLV TQALQKFPSN ALLWVEQIKL
     FKHGNKSSLK KTIFQDALRR TQNDHRVLLE IGVSFYAEAQ YETSLKWLER ALKKCSRYGD
     TWVWLFRTYA RLGKDTVDLY NMFDQCEPTY GPEWIAASKN VKMQYCTPRE ILLRLMNDK
>P19736 nuc PRE-MRNA SPLICING FACTOR PRP9.
     MNLLETRRSL LEEMEIIENA IAERIQRNPE LYYHYIQESS KVFPDTKLPR SSLIAENKIY
     KFKKVKRKRK QIILQQHEIN IFLRDYQEKQ QTFNKINRPE ETQEDDKDLP NFERKLQQLE
     KELKNEDENF ELDINSKKDK YALFSSSSDP SRRTNILSDR ARDLDLNEIF TRDEQYGEYM
     ELEQFHSLWL NVIKRGDCSL LQFLDILELF LDDEKYLLTP PMDRKNDRYM AFLLKLSKYV
     ETFFFKSYAL LDAAAVENLI KSDFEHSYCR GSLRSEAKGI YCPFCSRWFK TSSVFESHLV
     GKIHKKNESK RRNFVYSEYK LHRYLKYLND EFSRTRSFVE RKLAFTANER MAEMDILTQK
     YEAPAYDSTE KEGAEQVDGE QRDGQLQEEH LSGKSFDMPL GPDGLPMPYW LYKLHGLDRE
     YRCEICSNKV YNGRRTFERH FNEERHIYHL RCLGIEPSSV FKGITKIKEA QELWKNMQGQ
     SQLTSIAAVP PKPNPSQLKV PTELELEEED EEGNVMSKKV YDELKKQGLV
>P19880 nuc TRANSCRIPTIONAL ACTIVATOR PDR4 (YAP-1 PROTEIN).
     MSVSTAKRSL DVVSPGSLAE FEGSKSRHDE IENEHRRTGT RDGEDSEQPK KKGSKTSKKQ
     DLDPETKQKR TAQNRAAQRA FRERKERKMK ELEKKVQSLE SIQQQNEVEA TFLRDQLITL
     VNELKKYRPE TRNDSKVLEY LARRDPNLHF SKNNVNHSNS EPIDTPNDDI QENVKQKMNF
     TFQYPLDNDN DNDNSKNVGK QLPSPNDPSH SAPMPINQTQ KKLSDATDSS SATLDSLSNS
     NDVLNNTPNS STSMDWLDNV IYTNRFVSGD DGSNSKTKNL DSNMFSNDFN FENQFDEQVS
     EFCSKMNQVC GTRQCPIPKK PISALDKEVF ASSSILSSNS PALTNTWESH SNITDNTPAN
     VIATDATKYE NSFSGFGRLG FDMSANHYVV NDNSTGSTDS TGSTGNKNKK NNNNSDDVLP
     FISESPFDMN QVTNFFSPGS TGIGNNAASN TNPSLLQSSK EDIPFINANL AFPDDNSTNI
     QLQPFSESQS QNKFDYDMFF RDSSKEGNNL FGEFLEDDDD DKKAANMSDD ESSLIKNQLI
     NEEPELPKQY LQSVPGNESE ISQKNGSSLQ NADKINNGND NDNDNDVVPS KEGSLLRCSE
     IWDRITTHPK YSDIDVDGLC SELMAKAKCS ERGVVINAED VQLALNKHMN
>P20095 nuc PRE-MRNA SPLICING FACTOR RNA HELICASE PRP2.
     MSSITSETGK RRVKRTYEVT RQNDNAVRIE PSSLGEEEDK EAKDKNSALQ LKRSRYDPNK
     VFSNTNQGPE KNNLKGEQLG SQKKSSKYDE KITSNNELTT KKGLLGDSEN ETKYASSNSK
     FNVEVTHKIK NAKEIDKINR QRMWEEQQLR NAMAGQSDHP DDITLEGSDK YDYVFDTDAM
     IDYTNEEDDL LPEEKLQYEA RLAQALETEE KRILTIQEAR KLLPVHQYKD ELLQEIKKNQ
     VLIIMGETGS GKTTQLPQYL VEDGFTDQGK LQIAITQPRR VAATSVAARV ADEMNVVLGK
     EVGYQIRFED KTTPNKTVLK YMTDGMLLRE FLTDSKLSKY SCIMIDEAHE RTLATDILIG
     LLKDILPQRP TLKLLISSAT MNAKKFSEFF DNCPIFNVPG RRYPVDIHYT LQPEANYIHA
     AITTIFQIHT TQSLPGDILV FLTGQEEIER TKTKLEEIMS KLGSRTKQMI ITPIYANLPQ
     EQQLKIFQPT PENCRKVVLA TNIAETSLTI DGIRYVIDPG FVKENSYVPS TGMTQLLTVP
     CSRASVDQRA GRAGRVGPGK CFRIFTKWSY LHELELMPKP EITRTNLSNT VLLLLSLGVT
     DLIKFPLMDK PSIPTLRKSL ENLYILGALN SKGTITRLGK MMCEFPCEPE FAKVLYTAAT
     HEQCQGVLEE CLTIVSMLHE TPSLFIGQKR DAAASVLSEV ESDHILYLEI FNQWRNSKFS
     RSWCQDHKIQ FKTMLRVRNI RNQLFRCSEK VGLVEKNDQA RMKIGNIAGY INARITRCFI
     SGFPMNIVQL GPTGYQTMGR SSGGLNVSVH PTSILFVNHK EKAQRPSKYV LYQQLMLTSK
     EFIRDCLVIP KEEWLIDMVP QIFKDLIDDK TNRGRR
>P20433 nuc DNA-DIRECTED RNA POLYMERASE II 32 KD POLYPEPTIDE (EC 2.7.7.6) (B32).
     MNVSTSTFQT RRRRLKKVEE EENAATLQLG QEFQLKQINH QGEEEELIAL NLSEARLVIK
     EALVERRRAF KRSQKKHKKK HLKHENANDE TTAVEDEDDD LDEDDVNADD DDFMHSETRE
     KELESIDVLL EQTTGGNNKD LKNTMQYLTN FSRFRDQETV GAVIQLLKST GLHPFEVAQL
     GSLACDTADE AKTLIPSLNN KISDDELERI LKELSNLETL Y
>P20434 nuc DNA-DIRECTED RNA POLYMERASES I, II, AND III 27 KD POLYPEPTIDE
     MDQENERNIS RLWRAFRTVK EMVKDRGYFI TQEEVELPLE DFKAKYCDSM GRPQRKMMSF
     QANPTEESIS KFPDMGSLWV EFCDEPSVGV KTMKTFVIHI QEKNFQTGIF VYQNNITPSA
     MKLVPSIPPA TIETFNEAAL VVNITHHELV PKHIRLSSDE KRELLKRYRL KESQLPRIQR
     ADPVALYLGL KRGEVVKIIR KSETSGRYAS YRICM
>P20435 nuc DNA-DIRECTED RNA POLYMERASES I, II, AND III 23 KD POLYPEPTIDE
     MSDYEEAFND GNENFEDFDV EHFSDEETYE EKPQFKDGET TDANGKTIVT GGNGPEDFQQ
     HEQIRRKTLK EKAIPKDQRA TTPYMTKYER ARILGTRALQ ISMNAPVFVD LEGETDPLRI
     AMKELAEKKI PLVIRRYLPD GSFEDWSVEE LIVDL
>P20436 nuc DNA-DIRECTED RNA POLYMERASES I, II, AND III 14.5 KD POLYPEPTIDE
     MSNTLFDDIF QVSEVDPGRY NKVCRIEAAS TTQDQCKLTL DINVELFPVA AQDSLTVTIA
     SSLNLEDTPA NDSSATRSWR PPQAGDRSLA DDYDYVMYGT AYKFEEVSKD LIAVYYSFGG
     LLMRLEGNYR NLNNLKQENA YLLIRR
>P21190 nuc MEIOSIS-INDUCING PROTEIN 1.
     MQADMHGKLH AALEDGFFLF PFEQQQQPNI YYDTTTDQED RPCFSFGSTI SPRSWHFEKS
     DKIASSQLQN LVHTQPIHLI NPQILFNEEF LNLENIDSQP ISKETKTTKD CTMATGPERG
     KKSSESTRSS SLSSLFSNDE SASTFHSSFN NHDNFQKSNR NGDDIDISDT IKYETNTNAQ
     KDIKIFQENF EFNEFPYTQD FYPYTTNYTY SKPTNIHESI NSKNTDSYSQ YQDQFPPHTD
     NIHSFNNRHY SNHKSTNCNY YNNTSNNNNA SDNVYEADPF IDEPQVPSYY YPLEIAFDVE
     KSPPPSLQKL NSKELEFLKK LNSKLSRYAA AYSFSSSNDQ DYYDKVRFQE ISYKFSKTYS
>P21538 nuc DNA-BINDING PROTEIN REB1 (QBP).
     MPSGHNDKNA NQESVEEAVL KYVGVGLDHQ NHDPQLHTKD LENKHSKKQN IVESSSDVDV
     NNNDDSNRNE DNNDDSENIS ALNANESSSN VDHANSNEQH NAVMDWYLRQ TAHNQQDDED
     DENNNNTDNG NDSNNHFSQS DIVVDDDDDK NKKDAGVGVD DDHQSMAMAA VAAAYTLSKN
     NNNNNSIAND SNSRKRQHDN GNNHENSQKK RKNNNDDDDR QIGNVDPELT TLGDADDNDT
     NNDVIDRDQL VHKAIIDADS ITQHPDFQQY LNTAADTDDN EKLKHIKDHL MRTHGLNHQN
     KNHNDDTDDL SNSTKQYSEL QKDSMLDSSL NKSRNYMEVL PKVISQDTQP HQQKSPSHDN
     EAGSVDNSEI SQLLQSAATK ASSLVSLSSS SATPSTSRSN NSKAFDKAED AALERFINEY
     EAIERLTRQQ VCERIWSSDR PKDNFWNNIY KVLPYRSSSS IYKHMRRKYH IFEQRGKWTA
     EEEQELAKLC AEKEGQWAEI GKTLGRMPED CRDRWRNYVK CGTNRASNRW SVEEEELLKK
     VISDMLEEAQ QQQSQLHPNL LEEEQHLLQD DQNDHRNNDE DDDDTASAAA AAAAAIQEQQ
     QLLQQKQQDD DDAIAAAAAA ASSSLGDNKD EDKPHDSLGI QLDDNSQNSM VPAPSATSTH
     SKSLSNTIRR HNNKLRKSLM GNGKLDFKDI INWTIVSERM GGTRSRIQCR YKWNKLVKRE
     AIAKIQTVKD DDMLWIFEKL RDLGITEDSQ VDWDELAALK PGMKLNGLEL KLCYERMKKK
     VKGYKQKSIN EISKELVDYF SSNISMKTEN
>P21657 nuc TRANSCRIPTIONAL ACTIVATOR PROTEIN DAL81 (REGULATORY PROTEIN UGA35).
     MDPHQSPADN AASPTKSVKA TTKNSSTNNN VNSNNSNNNS NHDILNFNDN YTTILQHLAN
     DHPNILREKG GSQQQQHQQQ QQQQQQQQQQ QQQQSLDTLL HHYQSLLSKS DNAIAFDDNV
     SNSADHNGSN SNNNNNNNDI SSPGNLMGSC NQCRLKKTKC NYFPDLGNCL ECETSRTKCT
     FSIAPNYLKR TSSGANNNMP TSSNSKRMKN FEDYSNRLPS SMLYRHQQQQ QQQQQQQRIQ
     YPRSSFFVGP ASVFDLNLTK HVRLDNVDQI QLSKTLSLRK VSPTAQFILQ DDFDTTLHSK
     QEYEVDLVEN LVHPHGHLLV EIFFKLIHPF LPILHERVFL EKYSRSYREL TAPLLASIYS
     LALQYWDFHP ALLGFPKPDV TAQLNNIALE TFYARVGRPK LSIIQTGLLI LQCRSECHNN
     WVLCSSVVAL AEELGLGVEC NDWKLPKWEK DLRKRLAWAV WLMDKWCALN EGRQSHLILG
     RNWMIKLLNF DDFPLNSPTI LNSLQNDQSG SSPSSSNDVK NHQIAFGNLP IFNINPTLED
     FKNGTLMFQQ MVSLSIILGE IMDTFYTQGS MTINKSIEQV LKLAKPLQLK LREWYHSLPK
     NLSMSYATPQ KLNSNSTLTL AYFATEITLH RKIICALNPQ TPKELVQVCR TAARTRLVAA
     IEFIRDLKNE HINAFWYNCS TGNLMLIGTF AALLYVTSAT KEEAMIFRDY VRNYTWVLKI
     GSKYFDKLSN ALNNMHLLFA QIPGLLTDEP VVVSPNSNIN SVNPQRSGVQ SQIPIQFNVG
     SPAMTEQGSP LNQWKNLPQE ILQQLNSFPN GTTSTTTPVN PTSRQTQLES QGSPAINSAN
     NNSNNTPLPF APNKSSKKTS QSSPNVTPSH MSRHPPSNTS SPRVNSSTNV NSNTQMNASP
     LTSINETRQE SGDAADEKTA GRERTANEES STELKDDNPN SNQETSATGN QTIKMNDDKN
     VTINTRETPL
>P21827 nuc REGULATOR OF CHROMOSOME CONDENSATION (PRP20 PROTEIN) (PHEROMONE
     MVKRTVATNG DASGAHRAKK MSKTHASHII NAQEDYKHMY LSVQPLDIFC WGTGSMCELG
     LGPLAKNKEV KRPRLNPFLP RDEAKIISFA VGGMHTLALD EESNVWSWGC NDVGALGRDT
     SNAKEQLKDM DADDSSDDED GDLNELESTP AKIPRESFPP LAEGHKVVQL AATDNMSCAL
     FSNGEVYAWG TFRCNEGILG FYQDKIKIQK TPWKVPTFSK YNIVQLAPGK DHILFLDEEG
     MVFAWGNGQQ NQLGRKVMER FRLKTLDPRP FGLRHVKYIA SGENHCFALT KDNKLVSWGL
     NQFGQCGVSE DVEDGALVTK PKRLALPDNV VIRSIAAGEH HSLILSQDGD LYSCGRLDMF
     EVGIPKDNLP EYTYKDVHGK ARAVPLPTKL NNVPKFKSVA AGSHHSVAVA QNGIAYSWGF
     GETYAVGLGP FEDDTEVPTR IKNTATQDHN IILVGCGGQF SVSGGVKLSD EDAEKRADEM
     DD
>P22082 nuc TRANSCRIPTION REGULATORY PROTEIN SNF2 (SWI/SNF COMPLEX COMPONENT SNF2)
     MNIPQRQFSN EEVNRCYLRW QHLRNEHGMN APSVPEFIYL TKVLQFAAKQ RQELQMQRQQ
     QGISGSQQNI VPNSSDQAEL PNNASSHISA SASPHLAPNM QLNGNETFST SAHQSPIMQT
     QMPLNSNGGN NMLPQRQSSV GSLNATNFSP TPANNGENAA EKPDNSNHNN LNLNNSELQP
     QNRSLQEHNI QDSNVMPGSQ INSPMPQQAQ MQQAQFQAQQ AQQAQQAQQA QQAQARLQQG
     RRLPMTMFTA EQSELLKAQI TSLKCLVNRK PIPFEFQAVI QKSINHPPDF KRMLLSLSEF
     ARRRQPTDQN NQSNLNGGNN TQQPGTNSHY NNTNTDNVSG LTRNAPLDSK DENFASVSPA
     GPSSVHNAKN GTLDKNSQTV SGTPITQTES KKEENETISN VAKTAPNSNK THTEQNNPPK
     PQKPVPLNVL QDQYKEGIKV VDIDDPDMMV DSFTMPNISH SNIDYQTLLA NSDHAKFTIE
     PGVLPVGIDT HTATDIYQTL IALNLDTTVN DCLDKLLNDE CTESTRENAL YDYYALQLLP
     LQKAVRGHVL QFEWHQNSLL TNTHPNFLSK IRNINVQDAL LTNQLYKNHE LLKLERKKTE
     AVARLKSMNK SAINQYNRRQ DKKNKRLKFG HRLIATHTNL ERDEQKRAEK KAKERLQALK
     ANDEEAYIKL LDQTKDTRIT HLLRQTNAFL DSLTRAVKDQ QKYTKEMIDS HIKEASEEVD
     DLSMVPKMKD EEYDDDDDNS NVDYYNVAHR IKEDIKKQPS ILVGGTLKDY QIKGLQWMVS
     LFNNHLNGIL ADEMGLGKTI QTISLLTYLY EMKNIRGPYL VIVPLSTLSN WSSEFAKWAP
     TLRTISFKGS PNERKAKQAK IRAGEFDVVL TTFEYIIKER ALLSKVKWVH MIIDEGHRMK
     NAQSKLSLTL NTHYHADYRL ILTGTPLQNN LPELWALLNF VLPKIFNSVK SFDEWFNTPF
     ANTGGQDKIE LSEEETLLVI RRLHKVLRPF LLRRLKKDVE KELPDKVEKV VKCKMSALQQ
     IMYQQMLKYR RLFIGDQNNK KMVGLRGFNN QIMQLKKICN HPFVFEEVED QINPTRETND
     DIWRVAGKFE LLDRILPKLK ATGHRVLIFF QMTQIMDIME DFLRYINIKY LRLDGHTKSD
     ERSELLRLFN APDSEYLCFI LSTRAGGLGL NLQTADTVII FDTDWNPHQD LQAQDRAHRI
     GQKNEVRILR LITTNSVEEV ILERAYKKLD IDGKVIQAGK FDNKSTSEEQ EALLRSLLDA
     EEERRKKRES GVEEEEELKD SEINEILARN DEEMAVLTRM DEDRSKKEEE LGVKSRLLEK
     SELPDIYSRD IGAELKREES ESAAVYNGRG ARERKTATYN DNMSEEQWLR QFEVSDDEKN
     DKQARKQRTK KEDKSEAIDG NGEIKGENID ADNDGPRINN ISAEDRADTD LAMNDDDFLS
     KKRKAGRPRG RPKKVKLEGS ENSEPPALES SPVTGDNSPS EDFMDIPKPR TAGKTSVKSA
     RTSTRGRGRG RGRGRGRGRG RGRPPKARNG LDYVRTPAAA TSPIDIREKV AKQALDLYHF
     ALNYENEAGR KLSDIFLSKP SKALYPDYYM IIKYPVAFDN INTHIETLAY NSLKETLQDF
     HLIFSNARIY NTEGSVVYED SLELEKVVTK KYCEIMGDNS QLDFTEFDEQ YGTRPLVLPP
     VVTSSVAESF TDEADSSMTE ASV
>P22138 nuc DNA-DIRECTED RNA POLYMERASE I 135 KD POLYPEPTIDE (EC 2.7.7.6) (A135)
     MSKVIKPPGQ ARTADFRTLE RESRFINPPK DKSAFPLLQE AVQPHIGSFN ALTEGPDGGL
     LNLGVKDIGE KVIFDGKPLN SEDEISNSGY LGNKLSVSVE QVSIAKPMSN DGVSSAVERK
     VYPSESRQRL TSYRGKLLLK LKWSVNNGEE NLFEVRDCGG LPVMLQSNRC HLNKMSPYEL
     VQHKEESDEI GGYFIVNGIE KLIRMLIVQR RNHPMAIIRP SFANRGASYS HYGIQIRSVR
     PDQTSQTNVL HYLNDGQVTF RFSWRKNEYL VPVVMILKAL CHTSDREIFD GIIGNDVKDS
     FLTDRLELLL RGFKKRYPHL QNRTQVLQYL GDKFRVVFQA SPDQSDLEVG QEVLDRIVLV
     HLGKDGSQDK FRMLLFMIRK LYSLVAGECS PDNPDATQHQ EVLLGGFLYG MILKEKIDEY
     LQNIIAQVRM DINRGMAINF KDKRYMSRVL MRVNENIGSK MQYFLSTGNL VSQSGLDLQQ
     VSGYTVVAEK INFYRFISHF RMVHRGSFFA QLKTTTVRKL LPESWGFLCP VHTPDGSPCG
     LLNHFAHKCR ISTQQSDVSR IPSILYSLGV APASHTFAAG PSLCCVQIDG KIIGWVSHEQ
     GKIIADTLRY WKVEGKTPGL PIDLEIGYVP PSTRGQYPGL YLFGGHSRML RPVRYLPLDK
     EDIVGPFEQV YMNIAVTPQE IQNNVHTHVE FTPTNILSIL ANLTPFSDFN QSPRNMYQCQ
     MGKQTMGTPG VALCHRSDNK LYRLQTGQTP IVKANLYDDY GMDNFPNGFN AVVAVISYTG
     YDMDDAMIIN KSADERGFGY GTMYKTEKVD LALNRNRGDP ITQHFGFGND EWPKEWLEKL
     DEDGLPYIGT YVEEGDPICA YFDDTLNKTK IKTYHSSEPA YIEEVNLIGD ESNKFQELQT
     VSIKYRIRRT PQIGDKFSSR HGQKGVCSRK WPTIDMPFSE TGIQPDIIIN PHAFPSRMTI
     GMFVESLAGK AGALHGIAQD STPWIFNEDD TPADYFGEQL AKAGYNYHGN EPMYSGATGE
     ELRADIYVGV VYYQRLRHMV NDKFQVRSTG PVNSLTMQPV KGRKRHGGIR VGEMERDALI
     GHGTSFLLQD RLLNSSDYTQ ASVCRECGSI LTTQQSVPRI GSISTVCCRR CSMRFEDAKK
     LLTKSEDGEK IFIDDSQIWE DGQGNKFVGG NETTTVAIPF VLKYLDSELS AMGIRLRYNV
     EPK
>P22139 nuc DNA-DIRECTED RNA POLYMERASES I, II, AND III 8.3 KD POLYPEPTIDE
     MIVPVRCFSC GKVVGDKWES YLNLLQEDEL DEGTALSRLG LKRYCCRRMI LTHVDLIEKF
     LRYNPLEKRD
>P22147 nuc STRAND EXCHANGE PROTEIN 1 (KAR(-) ENHANCING MUTATION PROTEIN) (5'-3'
     MGIPKFFRYI SERWPMILQL IEGTQIPEFD NLYLDMNSIL HNCTHGNDDD VTKRLTEEEV
     FAKICTYIDH LFQTIKPKKI FYMAIDGVAP RAKMNQQRAR RFRTAMDAEK ALKKAIENGD
     EIPKGEPFDS NSITPGTEFM AKLTKNLQYF IHDKISNDSK WREVQIIFSG HEVPGEGEHK
     IMNFIRHLKS QKDFNQNTRH CIYGLDADLI MLGLSTHGPH FALLREEVTF GRRNSEKKSL
     EHQNFYLLHL SLLREYMELE FKEIADEMQF EYNFERILDD FILVMFVIGN DFLPNLPDLH
     LNKGAFPVLL QTFKEALLHT DGYINEHGKI NLKRLGVWLN YLSQFELLNF EKDDIDVEWF
     NKQLENISLE GERKRQRVGK KLLVKQQKKL IGSIKPWLME QLQEKLSPDL PDEEIPTLEL
     PKDLDMKDHL EFLKEFAFDL GLFITHSKSK GSYSLKMDLD SINPDETEEE FQNRVNSIRK
     TIKKYQNAII VEDKEELETE KTIYNERFER WKHEYYHDKL KFTTDSEEKV RDLAKDYVEG
     LQWVLYYYYR GCPSWSWYYP HHYAPRISDL AKGLDQDIEF DLSKPFTPFQ QLMAVLPERS
     KNLIPPAFRP LMYDEQSPIH DFYPAEVQLD KNGKTADWEA VVLISFVDEK RLIEAMQPYL
     RKLSPEEKTR NQFGKDLIYS FNPQVDNLYK SPLGGIFSDI EHNHCVEKEY ITIPLDSSEI
     RYGLLPNAKL GAEMLAGFPT LLSLPFTSSL EYNETMVFQQ PSKQQSMVLQ ITDIYKTNNV
     TLEDFSKRHL NKVIYTRWPY LRESKLVSLT DGKTIYEYQE SNDKKKFGFI TKPAETQDKK
     LFNSLKNSML RMYAKQKAVK IGPMEAIATV FPVTGLVRDS DGGYIKTFSP TPDYYPLQLV
     VESVVNEDER YKERGPIPIE EEFPLNSKVI FLGDYAYGGE TTIDGYSSDR RLKITVEKKF
     LDSEPTIGKE RLQMDHQAVK YYPSYIVSKN MHLHPLFLSK ITSKFMITDA TGKHINVGIP
     VKFEARHQKV LGYARRNPRG WEYSNLTLNL LKEYRQTFPD FFFRLSKVGN DIPVLEDLFP
     DTSTKDAMNL LDGIKQWLKY VSSKFIAVSL ESDSLTKTSI AAVEDHIMKY AANIEGHERK
     QLAKVPREAV LNPRSSFALL RSQKFDLGDR VVYIQDSGKV PIFSKGTVVG YTTLSSSLSI
     QVLFDHEIVA GNNFGGRLRT NRGLGLDASF LLNITNRQFI YHSKASKKAL EKKKQSNNRN
     NNTKTAHKTP SKQQSEEKLR KERAHDLLNF IKKDTNEKNS ESVDNKSMGS QKDSKPAKKV
     LLKRPAQKSS ENVQVDLANF EKAPLDNPTV AGSIFNAVAN QYSDGIGSNL NIPTPPHPMN
     VVGGPIPGAN DVADVGLPYN IPPGFMTHPN GLHPLHPHQM PYPNMNGMSI PPPAPHGFGQ
     PISFPPPPPM TNVSDQGSRI VVNEKESQDL KKFINGKQHS NGSTIGGETK NSRKGEIKPS
     SGTNSTECQS PKSQSNAADR DNKKDEST
>P22148 nuc MSN1 PROTEIN (MULTICOPY SUPPRESSOR OF SNF1 PROTEIN 1).
     MASNQHIGAS NLNENEAILT NRVAELERRM SMFEGIFHAL SNRLDLHFKK YDVVVNSQQQ
     QINELTAFLS TLLNDQQRHA EILSEKLSGT LHGVSATSIS LSQTLDPQGF TDGTTAPGAP
     RNYTSVPMNN DQTAHPQNEG AVSNETLFED ILNGNSQEND KSQQQTNSSN SISQENNSTN
     PSVDTRFNKP QNYNSNLVPS LEEYSANPPN NDGGQSQGLY ISSNSSQSRQ SPNLQKVSPN
     HENAVESNAQ ESVPTFEEEQ YETKTGLKRK RIVCTRPFEF IKSPHSVMEV WKEYTEGVNG
     QPSIRKMEAL YQTAWRRDPA VNKRYSRRKV LWKAIQTGLN RGYSLNYVVE ILENSRYVND
     KQKVKQPIGW LCHSSHIPET LK
>P22276 nuc DNA-DIRECTED RNA POLYMERASE III 130 KD POLYPEPTIDE (EC 2.7.7.6)
     MVAATKRRKT HIHKHVKDEA FDDLLKPVYK GKKLTDEINT AQDKWHLLPA FLKVKGLVKQ
     HLDSFNYFVD TDLKKIIKAN QLILSDVDPE FYLKYVDIRV GKKSSSSTKD YLTPPHECRL
     RDMTYSAPIY VDIEYTRGRN IIMHKDVEIG RMPIMLRSNK CILYDADESK MAKLNECPLD
     PGGYFIVNGT EKVILVQEQL SKNRIIVEAD EKKGIVQASV TSSTHERKSK TYVITKNGKI
     YLKHNSIAEE IPIAIVLKAC GILSDLEIMQ LVCGNDSSYQ DIFAVNLEES SKLDIYTQQQ
     ALEYIGAKVK TMRRQKLTIL QEGIEAIATT VIAHLTVEAL DFREKALYIA MMTRRVVMAM
     YNPKMIDDRD YVGNKRLELA GQLISLLFED LFKKFNNDFK LSIDKVLKKP NRAMEYDALL
     SINVHSNNIT SGLNRAISTG NWSLKRFKME RAGVTHVLSR LSYISALGMM TRISSQFEKS
     RKVSGPRALQ PSQFGMLCTA DTPEGEACGL VKNLALMTHI TTDDEEEPIK KLCYVLGVED
     ITLIDSASLH LNYGVYLNGT LIGSIRFPTK FVTQFRHLRR TGKVSEFISI YSNSHQMAVH
     IATDGGRICR PLIIVSDGQS RVKDIHLRKL LDGELDFDDF LKLGLVEYLD VNEENDSYIA
     LYEKDIVPSM THLEIEPFTI LGAVAGLIPY PHHNQSPRNT YQCAMGKQAI GAIAYNQFKR
     IDTLLYLMTY PQQPMVKTKT IELIDYDKLP AGQNATVAVM SYSGYDIEDA LVLNKSSIDR
     GFGRCETRRK TTTVLKRYAN HTQDIIGGMR VDENGDPIWQ HQSLGPDGLG EVGMKVQSGQ
     IYINKSVPTN SADAPNPNNV NVQTQYREAP VIYRGPEPSH IDQVMMSVSD NDQALIKVLL
     RQNRRPELGD KFSSRHGQKG VCGIIVKQED MPFNDQGIVP DIIMNPHGFP SRMTVGKMIE
     LISGKAGVLN GTLEYGTCFG GSKLEDMSKI LVDQGFNYSG KDMLYSGITG ECLQAYIFFG
     PIYYQKLKHM VLDKMHARAR GPRAVLTRQP TEGRSRDGGL RLGEMERDCV IAYGASQLLL
     ERLMISSDAF EVDVCDKCGL MGYSGWCTTC KSAENIIKMT IPYAAKLLFQ ELLSMNIAPR
     LRLEDIFQQ
>P22336 nuc REPLICATION FACTOR-A PROTEIN 1 (RF-A) (SINGLE-STRANDED DNA-BINDING
     MSSVQLSRGD FHSIFTNKQR YDNPTGGVYQ VYNTRKSDGA NSNRKNLIMI SDGIYHMKAL
     LRNQAASKFQ SMELQRGDII RVIIAEPAIV RERKKYVLLV DDFELVQSRA DMVNQTSTFL
     DNYFSEHPNE TLKDEDITDS GNVANQTNAS NAGVPDMLHS NSNLNANERK FANENPNSQK
     TRPIFAIEQL SPYQNVWTIK ARVSYKGEIK TWHNQRGDGK LFNVNFLDTS GEIRATAFND
     FATKFNEILQ EGKVYYVSKA KLQPAKPQFT NLTHPYELNL DRDTVIEECF DESNVPKTHF
     NFIKLDAIQN QEVNSNVDVL GIIQTINPHF ELTSRAGKKF DRRDITIVDD SGFSISVGLW
     NQQALDFNLP EGSVAAIKGV RVTDFGGKSL SMGFSSTLIP NPEIPEAYAL KGWYDSKGRN
     ANFITLKQEP GMGGQSAASL TKFIAQRITI ARAQAENLGR SEKGDFFSVK AAISFLKVDN
     FAYPACSNEN CNKKVLEQPD GTWRCEKCDT NNARPNWRYI LTISIIDETN QLWLTLFDDQ
     AKQLLGVDAN TLMSLKEEDP NEFTKITQSI QMNEYDFRIR AREDTYNDQS RIRYTVANLH
     SLNYRAEADY LADELSKALL A
>P23255 nuc TRANSCRIPTION INITIATION FACTOR TFIID 150 KD SUBUNIT (TAFII-150)
     MMSFSKNATP RAIVSESSTL HEMKFRNFRV AHEKISLDID LATHCITGSA TIIIIPLIQN
     LEYVTFDCKE MTIKDVLVEN RRCDQFIHDD PLQTNLNGLT SQNVLYSDNS IEQSHFLRSK
     FASLNEYPET DSKSQLTIKI PSSIKISLED ANALSNYTPI TPSIKTTPGF QESVFTPITL
     QIEYEIRNPK SGIKFDTVYA DKPWLWNVYT SNGEICSSAS YWVPCVDLLD EKSTWELEFS
     VPRLVKNIGT SKLIGQNGEE SEKEKEDTPE HDEEEEGKPA RVIKDEDKDS NLKNDEEGKN
     SKSKDAQDND EEEEEGESDE EEEEGEEERR NIEESNNPSL RDVIVCCSEY SNIKELPHPI
     DLTKKKCIFQ IINPVAPHHI GWAIGAFNSW SLPLISPPSV DAEDEVEEDK LRENVVDNVN
     DTMDDDIGSD IIPIQIFTLP TQETDELTVI NSTVVCQKII DFYSKEFGSY PFTCYSMVFL
     PTAPSKHMDF AALGICNTRL LYPLEVIDKA FSTTNELAWA LANQWSCVNI TPLDMNDYWC
     CLGIAGYMVF QVTKKLMGNN TYKYQLKRNS EAIVEQDFEK PPIGSTFTGS SRPISWSSKD
     LSFIQLKAPM ILHILDRRMT KTERSFGMSR VLPKIFLQAM SGDLPNNSLT SSHFQHVCER
     VNKSKLENFF NEWVYGSGVP ILRVTQRFNR KRMVIELGIR QVQDEELGHE KVVGEEGFFK
     SALDHLEHPD LNRTECFTGS MTIRIHEHDG TPYEHIVEIK DTFTKIDIQY NTKYRRLRKR
     GGGANDENGV ENNNEEKPIV VDVNCLGNVY MSPEECSRFS LTEFNRTSES NELLKQNEAF
     EWIRIDSDLE WICQMHINQP DYMFSSQLRQ DGDIEAQLEA IRYYEDVVVN GGVKSLVYSS
     ILFRTAIDER YFFGIRLAAC EALSKYVYDP DFTGGVKHLI QIFQILFCLE DSNIPKSNNF
     ENPKLYFLQC NIPKYLAKVK NENGKCPKLV KQFLLDILVY NENGENKYSD DAYVRSLIEN
     VVKVALNEYK DKAYMEKVKT QLLRYENLVN WLSSYESLIK TTIMYAKYKL HKVGAYDFTE
     LTGMIMHTLT LGINNGDISR ESFQNEFLMV LKIMLLEGGL KNKDALVLFT EILCFHEDSY
     IRDKSVDVLS ECVNLVVMDG SLDTISDDIK SSVQSVHNEV KNIKSEDDIE LFLSGHYVDD
     MKIKIEKIGR QNISGLIQIC RDMFKGYSPL KILLWDVLNL PVLSLYQRKQ IHDLVRVMYT
     LINSFVVRLE TPRERRLVAK MNSNEEGKLD IVIKRESILK VHIKKEVTST VEAPKKANKI
     KISLKGDKPV RKVEKQIVKP KVTSKQRKVK SHVNRMGSLP LRFVKIQQQP RVMVHLSSVP
     YSQFVQITKV TSRSFMVKIR TKNDAKN
>P23394 nuc PRE-MRNA SPLICING FACTOR RNA HELICASE PRP28 (HELICASE CA8).
     MARPIDVSQL IAGINKKKGL DENTSGKISK PRFLNKQERS KQERLKENEE SLTPTQSDSA
     KVEIKKVNSR DDSFFNETND KKRNPSKQNG SKFHFSWNES EDTLSGYDPI VSTRAIDLLW
     KGKTPKNAAE SSYMGKHWTE KSLHEMNERD WRILKEDYAI VTKGGTVENP LRNWEELNII
     PRDLLRVIIQ ELRFPSPTPI QRITIPNVCN MKQYRDFLGV ASTGSGKTLA FVIPILIKMS
     RSPPRPPSLK IIDGPKALIL APTRELVQQI QKETQKVTKI WSKESNYDCK VISIVGGHSL
     EEISFSLSEG CDILVATPGR LIDSLENHLL VMKQVETLVL DEADKMIDLG FEDQVTNILT
     KVDINADSAV NRQTLMFTAT MTPVIEKIAA GYMQKPVYAT IGVETGSEPL IQQVVEYADN
     DEDKFKKLKP IVAKYDPPII IFINYKQTAD WLAEKFQKET NMKVTILHGS KSQEQREHSL
     QLFRTNKVQI MIATNVAARG LDIPNVSLVV NFQISKKMDD YIHRIGRTGR AANEGTAVSF
     VSAAEDESLI RELYKYVRKH DPLNSNIFSE AVKNKYNVGK QLSNEIIY
>P23615 nuc TRANSCRIPTION INITIATION PROTEIN SPT6.
     MEETGDSKLV PRDEEEIVND NDETKAPSEE EEGEDVFDSS EEDEDIDEDE DEARKVQEGF
     IVNDDDENED PGTSISKKRR KHKRREREED DRLSEDDLDL LMENAGVERT KASSSSGKFK
     RLKRVGDEGN AAESESDNVA ASRQDSTSKL EDFFSEDEEE EESGLRNGRN NEYGRDEEDH
     ENRNRTADKG GILDELDDFI EDDEFSDEDD ETRQRRIQEK KLLREQSIKQ PTQITGLSSD
     KIDEMYDIFG DGHDYDWALE IENEELENGN DNNEAEEEEI DEETGAIKST KKKISLQDIY
     DLEDLKKNLM TEGDMKIRKT DIPERYQELR AGITDYGNMS SEDQELERNW IAEKISVDKN
     FDANYDLTEF KEAIGNAIKF ITKENLEVPF IYAYRRNYIS SREKDGFLLT EDDLWDIVSL
     DIEFHSLVNK KDYVQRFYAE LHIDDPIVTE YFKNQNTASI AELNSLQDIY DYLEFKYANE
     INEMFINHTG KTGKKHLKNS SYEKFKASPL YQAVSDIGIS AEDVGENISS QHQIHPPVDH
     PSSKPVEVIE SILNANSGDL QVFTSNTKLA IDTVQKYYSL ELSKNTKIRE KVRSDFSKYY
     LADVVLTAKG KKEIQKGSLY EDIKYAINRT PMHFRRDPDV FLKMVEAESL NLLSVKLHMS
     SQAQYIEHLF QIALETTNTS DIAIEWNNFR KLAFNQAMDK IFQDISQEVK DNLTKNCQKL
     VAKTVRHKFM TKLDQAPFIP NVRDPKIPKI LSLTCGQGRF GADAIIAVYV NRKGDFIRDY
     KIVDNPFDKT NPEKFEDTLD NIIQSCQPNA IGINGPNPKT QKFYKRLQEV LHKKQIVDSR
     GHTIPIIYVE DEVAIRYQNS ERAAQEFPNK PPLVKYCIAL ARYMHSPLLE YANLTSEEVR
     SLSIHPHQNL LSSEQLSWAL ETAFVDIVNL VSVEVNKATD NNYYASALKY ISGFGKRKAI
     DFLQSLQRLN EPLLARQQLI THNILHKTIF MNSAGFLYIS WNEKRQKYED LEHDQLDSTR
     IHPEDYHLAT KVAADALEYD PDTIAEKEEQ GTMSEFIELL REDPDRRAKL ESLNLESYAE
     ELEKNTGLRK LNNLNTIVLE LLDGFEELRN DFHPLQGDEI FQSLTGESEK TFFKGSIIPV
     RVERFWHNDI ICTTNSEVEC VVNAQRHAGA QLRRPANEIY EIGKTYPAKV IYIDYANITA
     EVSLLDHDVK QQYVPISYSK DPSIWDLKQE LEDAEEERKL MMAEARAKRT HRVINHPYYF
     PFNGRQAEDY LRSKERGEFV IRQSSRGDDH LVITWKLDKD LFQHIDIQEL EKENPLALGK
     VLIVDNQKYN DLDQIIVEYL QNKVRLLNEM TSSEKFKSGT KKDVVKFIED YSRVNPNKSV
     YYFSLNHDNP GWFYLMFKIN ANSKLYTWNV KLTNTGYFLV NYNYPSVIQL CNGFKTLLKS
     NSSKNRMNNY R
>P24279 nuc MINICHROMOSOME MAINTENANCE PROTEIN 3.
     MEGSTGFDGD ATTFFAPDAV FGDRVRRFQE FLDTFTSYRD SVRSIQVYNS NNAANYNDDQ
     DDADERDLLG DDDGDDLEKE KKAASSTSLN ILPHRIIISL DDLREFDRSF WSGILVEPAY
     FIPPAEKALT DLADSMDDVP HPNASAVSSR HPWKLSFKGS FGAHALSPRT LTAQHLNKLV
     SVEGIVTKTS LVRPKLIRSV HYAAKTGRFH YRDYTDATTT LTTRIPTPAI YPTEDTEGNK
     LTTEYGYSTF IDHQRITVQE MPEMAPAGQL PRSIDVILDD DLVDKTKPGD RVNVVGVFKS
     LGAGGMNQSN SNTLIGFKTL ILGNTVYPLH ARSTGVAARQ MLTDFDIRNI NKLSKKKDIF
     DILSQSLAPS IYGHDHIKKA ILLMLMGGVE KNLENGSHLR GDINILMVGD PSTAKSQLLR
     FVLNTASLAI ATTGRGSSGV GLTAAVTTDR ETGERRLEAG AMVLADRGVV CIDEFDKMTD
     VDRVAIHEVM EQQTVTIAKA GIHTTLNARC SVIAAANPVF GQYDVNRDPH QNIALPDSLL
     SRFDLLFVVT DDINEIRDRS ISEHVLRTHR YLPPGYLEGE PVRERLNLSL AVGEDADINP
     EEHSNSGAGV ENEGEDDEDH VFEKFNPLLQ AGAKLAKNKG NYNGTEIPKL VTIPFLRKYV
     QYAKERVIPQ LTQEAINVIV KNYTDLRNDD NTKKSPITAR TLETLIRLAT AHAKVRLSKT
     VNKVDAKVAA NLLRFALLGE DIGNDIDEEE SEYEEALSKR SPQKSPKKRQ RVRQPASNSG
     SPIKSTPRRS TASSVNATPS SARRILRFQD DEQNAGEDDN DIMSPLPADE EAELQRRLQL
     GLRVSPRRRE HLHAPEEGSS GPLTEVGTPR LPNVSSAGQD DEQQQSVISF DNVEPGTIST
     GRLSLISGII ARLMQTEIFE EESYPVASLF ERINEELPEE EKFSAQEYLA GLKIMSDRNN
     LMVADDKVWR V
>P24783 nuc P68-LIKE PROTEIN.
     MTYGGRDQQY NKTNYKSRGG DFRGGRNSDR NSYNDRPQGG NYRGGFGGRS NYNQPQELIK
     PNWDEELPKL PTFEKNFYVE HESVRDRSDS EIAQFRKENE MTISGHDIPK PITTFDEAGF
     PDYVLNEVKA EGFDKPTGIQ CQGWPMALSG RDMVGIAATG SGKTLSYCLP GIVHINAQPL
     LAPGDGPIVL VLAPTRELAV QIQTECSKFG HSSRIRNTCV YGGVPKSQQI RDLSRGSEIV
     IATPGRLIDM LEIGKTNLKR VTYLVLDEAD RMLDMGFEPQ IRKIVDQIRP DRQTLMWSAT
     WPKEVKQLAA DYLNDPIQVQ VGSLELSASH NITQIVEVVS DFEKRDRLNK YLETASQDNE
     YKTLIFASTK RMCDDITKYL REDGWPALAI HGDKDQRERD WVLQEFRNGR SPIMVATDVA
     ARGIDVKGIN YVINYDMPGN IEDYVHRIGR TGRAGATGTA ISFFTEQNKG LGAKLISIMR
     EANQNIPPEL LKYDRRSYGG GHPRYGGGRG GRGGYGRRGG YGGGRGGYGG NRQRDGGWGN
     RGRSNY
>P25042 nuc ROX1 REPRESSOR (HYPOXIC FUNCTION REPRESSOR) (HEME-DEPENDENT REPRESSION
     MNPKSSTPKI PRPKNAFILF RQHYHRILID EWTAQGVEIP HNSNISKIIG TKWKGLQPED
     KAHWENLAEK EKLEHERKYP EYKYKPVRKS KKKQLLLKEI EQQQQQQQKE QQQQKQSQPQ
     LQQPFNNNIV LMKRAHSLSP SSSVSSSNSY QFQLNNDLKR LPIPSVNTSN YMVSRSLSGL
     PLTHDKTARD LPQLSSQLNS IPYYSAPHDP STRHHYLNVA QAQPRANSTP QLPFISSIIN
     NSSQTPVTTT TTSTTTATSS PGKFSSSPNS SVLENNRLNS INNSNQYLPP PLLPSLQDFQ
     LDQYQQLKQM GPTYIVKPLS HTRNNLLSTT TPTHHHIPHI PNQNIPLHQI INSSNTEVTA
     KTSLVSPK
>P25046 nuc ROX3 NUCLEAR PROTEIN.
     MASRVDETTV PSYYYYVDPE TTYTYQQPNP LQDLISVYGL DDISRQVART NLDGTKAVKL
     RKSYKNQIAD LSGKFSTIPT RENGKGGQIA HILFQNNPDM MIQPPQQGQN MSEQQWREQL
     RNRDIALFQP PNFDWDLCSS VLSQFERSYP SEFANQNQGG AQAPFDIDDL AFDLDGTGKS
     QSGSNSGNNS KKRKNKSSGS SMATPTHSDS HEDMKRRRLE
>P25293 nuc NUCLEOSOME ASSEMBLY PROTEIN.
     MSDPIRTKPK SSMQIDNAPT PHNTPASVLN PSYLKNGNPV RAQAQEQDDK IGTINEEDIL
     ANQPLLLQSI QDRLGSLVGQ DSGYVGGLPK NVKEKLLSLK TLQSELFEVE KEFQVEMFEL
     ENKFLQKYKP IWEQRSRIIS GQEQPKPEQI AKGQEIVESL NETELLVDEE EKAQNDSEEE
     QVKGIPSFWL TALENLPIVC DTITDRDAEV LEYLQDIGLE YLTDGRPGFK LLFRFDSSAN
     PFFTNDILCK TYFYQKELGY SGDFIYDHAE GCEISWKDNA HNVTVDLEMR KQRNKTTKQV
     RTIEKITPIE SFFNFFDPPK IQNEDQDEEL EEDLEERLAL DYSIGEQLKD KLIPRAVDWF
     TGAALEFEFE EDEEEADEDE DEEEDDDHGL EDDDGESAEE QDDFAGRPEQ APECKQS
>P25299 nuc MRNA 3'-END PROCESSING PROTEIN RNA15.
     MNRQSGVNAG VQNNPPSRVV YLGSIPYDQT EEQILDLCSN VGPVINLKMM FDPQTGRSKG
     YAFIEFRDLE SSASAVRNLN GYQLGSRFLK CGYSSNSDIS GVSQQQQQQY NNINGNNNNN
     GNNNNNSNGP DFQNSGNANF LSQKFPELPS GIDVNINMTT PAMMISSELA KKPKEVQLKF
     LQKFQEWTRA HPEDAVSLLE LCPQLSFVTA ELLLTNGICK VDDLIPLASR PQEEASATNN
     NSVNEVVDPA VLNKQKELLK QVLQLNDSQI SILPDDERMA IWDLKQKALR GEFGAF
>P25441 nuc DNA-DIRECTED RNA POLYMERASE III 47 KD POLYPEPTIDE (EC 2.7.7.6) (C53)
     MSSNKGNGRL PSLKDSSSNG GGSAKPSLKF KPKAVARKSK EEREAAASKV KLEEESKRGN
     DKKHFNNKNK RVTGAGGQQR RMAKYLNNTH VISSGPLAAG NFVSEKGDLR RGFIKSEGSG
     SSLVQKGLET IDNGAESSEN EAEDDDNEGV ASKSKKKFNM GKEFEARNLI EDEDDGESEK
     SSDVDMDDEE WRSKRIEQLF PVRPVRVRHE DVETVKREIQ EALSEKPTRE PTPSVKTEPV
     GTGLQSYLEE RERQVNEKLA DLGLEKEFQS VDGKEAAAEL ELLNADHQHI LRKLKKMNNK
     PERFMVFQLP TRLPAFERPA VKEEKEDMET QASDPSKKKK NIKKKDTKDA LSTRELAGKV
     GSIRVHKSGK LSVKIGNVVM DIGKGAETTF LQDVIALSIA DDASSAELLG RVDGKIVVTP
     QI
>P25453 nuc MEIOTIC RECOMBINATION PROTEIN DMC1.
     MSVTGTEIDS DTAKNILSVD ELQNYGINAS DLQKLKSGGI YTVNTVLSTT RRHLCKIKGL
     SEVKVEKIKE AAGKIIQVGF IPATVQLDIR QRVYSLSTGS KQLDSILGGG IMTMSITEVF
     GEFRCGKTQM SHTLCVTTQL PREMGGGEGK VAYIDTEGTF RPERIKQIAE GYELDPESCL
     ANVSYARALN SEHQMELVEQ LGEELSSGDY RLIVVDSIMA NFRVDYCGRG ELSERQQKLN
     QHLFKLNRLA EEFNVAVFLT NQVQSDPGAS ALFASADGRK PIGGHVLAHA SATRILLRKG
     RGDERVAKLQ DSPDMPEKEC VYVIGEKGIT DSSD
>P25502 nuc PROLINE UTILIZATION TRANS-ACTIVATOR.
     MVTDQGSRHS IQSKQPAYVN KQPQKRQQRS SVACLSCRKR HIKCPGGNPC QKCVTSNAIC
     EYLEPSKKIV VSTKYLQQLQ KDLNDKTEEN NRLKALLLER PVSVRGKDNS DDDERHINNA
     PSSDTLEVSS APAAPIFDLM SNSNTASDND NDDDNSNRIT NNRSYDHSLE KYYKKAISIF
     KQPANANGEN GNGANGHEDD DEDDEEISTN FAQRSGRLIE SHNGFHYFVG SSSMTLFGLE
     IQSLVTKYIS VKNFRPLPIN TKNKILNSNL NPAISSFINS NNYLFSSYNF LNPISTIVNL
     NSINDNLSPL MFKIILKSDT DGSSGQEEVI QFQLPSYNYT KLLIDCFINY NDGCFYFFNE
     GLVKCGINKL YLENKWLYYD NTKKALDNEN DPILQAVWFC KILLILAVGE MYLGSINNEM
     LKNYSNQPKL PGSKFFQMGS KIFNCLFSSE RLENVTKKGG IEVLLLYAFF LQVADYTLAS
     YFYFGQALRT CLILGLHVDS QSDTLSRYEI EHHRRLWWTV YMFERMLSSK AGLPLSFTDY
     TISTALPADI DDETIEEKNS HYVFRKAELI SNCVTIVKIN AQILSKLYQR QPETNIIITL
     KVVIKQLLEW RNNLSDSLQV DFTQKDEDFK ISRLSTNMFT EYFQGINLAV RPLLFHFASI
     QLKRFKTSNT FVNLQNYSAT ISSLLTCSLH ASVNTIRSLW SLLQNSMLAM FSYMDREYLF
     TSSCTLLLFN TAFGIHEQTL YHLDHSLEIF TQMRNLGNIP AGLRRAQLLT LMANLDFHGI
     MNDLITKYND ILKFDSMNCE NDNIVEDSNE PKRETEKCKP HKDGDRIDPS IIDCDKSNTN
     TNMIKNESIS NIVSILPEGA KPTLTDYSNG NNDVNDINVN NSEPSTFFDI ITASLENSYQ
     TTLTEKGSQV MEKNMDQLDS VHNLNDDDLQ QLLEDLGNID HSDEKLWKEI TDQAMWLGNT
     MDPTAAAGSE IDFTDYLGP
>P25615 nuc DNA POLYMERASE IV (EC 2.7.7.7) (POL IV).
     SLKGKFFAFL PNPNTSSNKF FKSILEKKGA TIVSSIQNCL QSSRKEVIIL IEDSFVDSDM
     HLTQKDIFQR EAGLNDVDEF LGKIEQSGIQ CVKTSCITKW VQNDKFAFQK DDLIKFQPSI
     IVISDNADDG QSSTDKESEI STDVESERND DSNNKDMIQA SKPLKRLLQE DKGRASLVTD
     KTKYKNNELI IGALKRLTKK YEIEGEKFRA RSYRLAKQSM ENCDFNVRSG EEAHTKLRNI
     GPSIAKKIQV ILDTGVLPGL NDSVGLEDKL KYFKNCYGIG SEIAKRWNLL NFESFCVAAK
     KDPEEFVSDW TILFGWSYYD DWLCKMSRNE CFTHLKKVQK ALRGIDPECQ VELQGSYNRG
     YSKCGDIDLL FFKPFCNDTT ELAKIMETLC IKLYKDGYIH CFLQLTPNLE KLFLKRIVER
     FRTAKIVGYG ERKRWYSSEI IKKFFMGVKF SPRELEELKE MKNDEGTLLI EEEEEEETKL
     NPIDQYMSLN AKDGNYCRRL DFFCCKWDEL GAGRIHYTGS KEYNRWIRIL AAQKGFKLTQ
     HGLFRNNILL ESFNERRIFE LLNLKYAEPE HRNIEWEKKT A
>P25655 nuc GENERAL NEGATIVE REGULATOR OF TRANSCRIPTION SUBUNIT 1.
     MLSATYRDLN TASNLETSKE KQAAQIVIAQ ISLLFTTLNN DNFESVEREI RHILDRSSVD
     IYIKVWERLL TLSSRDILQA GKFLLQENLL HRLLLEFAKD LPKKSTDLIE LLKERTFNNQ
     EFQKQTGITL SLFIDLFDKS ANKDIIESLD RSSQINDFKT IKMNHTNYLR NFFLQTTPET
     LESNLRDLLH SLEGESLNDL LALLLSEILS PGSQNLQNDP TRSWLTPPMV LDATNRGNVI
     ARSISSLQAN QINWNRVFNL MSTKYFLSAP LMPTTASLSC LFAALHDGPV IDEFFSCDWK
     VIFKLDLAIQ LHKWSVQNGC FDLLNAEGTR KVSETIPNTK QSLLYLLSIA SLNLELFLQR
     EELSDGPMLA YFQECFFEDF NYAPEYLILA LVKEMKRFVL LIENRTVIDE ILITLLIQVH
     NKSPSSFKDV ISTITDDSKI VDAAKIIINS DDAPIANFLK SLLDTGRLDT VINKLPFNEA
     FKILPCARQI GWEGFDTFLK TKVSPSNVDV VLESLEVQTK MTDTNAPFRS LKTFDLFAFH
     SLIEVLNKCP LDVLQLQRFE SLEFSLLIRF PRLINFGFGH DEAILANGDI AGINNDIEKE
     MQNYLQKMYS GELAIKDVIE LLRRLRDSDL PRDQEVFTCI THAVIAESTF FQDYPLDALA
     TTSVLFGSMI LFQLLRGFVL DVAFRIIMRF AKEPPESKMF KFAVQAIYAF RIRLAEYPQY
     CKDLLRDVPA LKSQAQVYQS IVEAATLANA PKERSRPVQE MIPLKFFAVD EVSCQINQEG
     APKDVVEKVL FVLNNVTLAN LNNKVDELKK SLTPNYFSWF STYLVTQRAK TEPNYHDLYS
     KVIVAMGSGL LHQFMVNVTL RQLFVLLSTK DEQAIDKKHL KNLASWLGCI TLALNKPIKH
     KNIAFREMLI EAYKENRLEI VVPFVTKILQ RASESKIFKP PNPWTVGILK LLIELNEKAN
     WKLSLTFEVE VLLKSFNLTT KSLKPSNFIN TPEVIETLSG ALGSITLEQQ QTEQQRQIIL
     MQQHQQQMLI YQQRQQQQQQ RQQQQQHHIS ANTIADQQAA FGGEGSISHD NPFNNLLGST
     IFVTHPDLKR VFQMALAKSV REILLEVVEK SSGIAVVTTT KIILKDFATE VDESKLKTAA
     IIMVRHLAQS LARATSIEPL KEGIRSTMQS LAPNLMSLSS SPAEELDTAI NENIGIALVL
     IEKASMDKST QDLADQLMQA IAIRRYHKER RADQPFITQN TNPYSLSLPE PLGLKNTGVT
     PQQFRVYEEF GKNIPNLDVI PFAGLPAHAP PMTQNVGLTQ PQQQQAQMPT QILTSEQIRA
     QQQQQQLQKS RLNQPSQSAQ PPGVNVPNPQ GGIAAVQSDL EQNQRVLVHL MDILVSQIKE
     NATKNNLAEL GDQNQIKTII FQILTFIAKS AQKDQLALKV SQAVVNSLFA TSESPLCREV
     LSLLLEKLCS LSLVARKDVV WWLVYALDSR KFNVPVIRSL LEVNLIDATE LDNVLVTAMK
     NKMENSTEFA MKLIQNTVLS DDPILMRMDF IKTLEHLASS EDENVKKFIK EFEDTKIMPV
     RKGTKTTRTE KLYLVFTEWV KLLQRVENND VITTVFIKQL VEKGVISDTD NLLTFVKSSL
     ELSVSSFKES DPTDEVFIAI DALGSLIIKL LILQGFKDDT RRDYINAIFS VIVLVFAKDH
     SQEGTTFNER PYFRLFSNIL YEWATIRTHN FVRISDSSTR QELIEFDSVF YNTFSGYLHA
     LQPFAFPGFS FAWVTLLSHR MLLPIMLRLP NKIGWEKLML LIIDLFKFLD QYTSKHAVSD
     AVSVVYKGTL RVILGISNDM PSFLIENHYE LMNNLPPTYF QLKNVILSAI PKNMTVPNPY
     DVDLNMEDIP ACKELPEVFF DPVIDLHSLK KPVDNYLRIP SNSLLRTILS AIYKDTYDIK
     KGVGYDFLSV DSKLIRAIVL HVGIEAGIEY KRTSSNAVFN TKSSYYTLLF NLIQNGSIEM
     KYQIILSIVE QLRYPNIHTY WFSFVLMNMF KSDEWNDQKL EVQEIILRNF LKRIIVNKPH
     TWGVSVFFTQ LINNNDINLL DLPFVQSVPE IKLILQQLVK YSKKYTTSEQ DDQSATINRR
     QTPLQSNA
>P26188 nuc METHYLATED-DNA--PROTEIN-CYSTEINE METHYLTRANSFERASE (EC 2.1.1.63) (6-O-
     MHKKKIENGR IFDLNGPTMK ELLYYTFIET EVTGAFLVFR EKTQNLVFAS LGNDKLFLLG
     KVEGFLKKHE KQDTMYDLQE LKEAETYKKS IENYTICLEN KMPLPSGAIP FEFLFGTDFQ
     RKVWNELLNV EHGHVVTYGD IAKRIGKPTA ARSVGRACGS NNLALLVPCH RIVGSNRKLT
     GYKWSCKLKE QLLNNEKENS LSLSRL
>P26343 nuc NITROGEN REGULATORY PROTEIN DAL80 (REGULATORY PROTEIN UGA43).
     MVLSDSLKLP SPTLSAAAGV DDCDGEDHPT CQNCFTVKTP LWRRDEHGTV LCNACGLFLK
     LHGEPRPISL KTDTIKSRNR KKLNNNNVNT NANTHSNDPN KIFKRKKRLL TTGGGSLPTN
     NPKVSILEKF MVSGSIKPLL KPKETVPNTK ECSTQRGKFS LDPCEPSGKN YLYQINGSDI
     YTSNIELTRL PNLSTLLEPS PFSDSAVPEI ELTWKLHNEE EVIKLKTKIS ELELVTDLYK
     KHIFQLNEKC KQLEVELHSR ASVQSHPQH
>P26370 nuc TRANSCRIPTIONAL ACTIVATOR PROTEIN UGA3.
     MNYGVEKLKL KYSKHGCITC KIRKKRCSED KPVCRDCRRL SFPCIYISES VDKQSLKKIK
     ADIQHQLISK KRKHAPDSAQ KAAVATRTRR VGSDEQDNQV YLSKPLEDCI SQKLDSMGLQ
     LYNYYRSHLA NIISIAPMNQ NYYLNIFLPM AHENDGILFA ILAWSANHLS ISSSNELRKD
     EIFVNLANKY TYMSLSHLKT NEGSSACAKL GFLYSLAQIL ILCGSEICQG DVKFWKILLN
     IGKNLIENHV GKDVSRILTT TTEEPSLEER IIFPNFNSVV KYWLIVNFIY HDILNFNTTS
     FPIEQYEKFF QRDQNSLPSS ANFIESIDSP IEEIDPLIGI NKPILLLLGQ VTNLTRFLQT
     MEQEEMLEHG DKILSLQVEI YKLQPSLMAL EHLDDEKKFY YLELFEIMKI STLMFFQLTL
     LKIDKDSLEL QILRNKLDSK LDKVIGTFLE GSLCFPLFIY GVCIQVEDME KKIDLEAKFD
     DILKRYKCYN FQNARLLIRK IWQNEADGIS EHDLVHMIDE LDYNINFA
>P26754 nuc REPLICATION FACTOR-A PROTEIN 2 (RF-A) (DNA BINDING PROTEIN BUF1)
     MATYQPYNEY SSVTGGGFEN SESRPGSGES ETNTRVNTLT PVTIKQILES KQDIQDGPFV
     SHNQELHHVC FVGVVRNITD HTANIFLTIE DGTGQIEVRK WSEDANDLAA GNDDSSGKGY
     GSQVAQQFEI GGYVKVFGAL KEFGGKKNIQ YAVIKPIDSF NEVLTHHLEV IKCHSIASGM
     MKQPLESASN NNGQSLFVKD DNDTSSGSSP LQRILEFCKK QCEGKDANSF AVPIPLISQS
     LNLDETTVRN CCTTLTDQGF IYPTFDDNNF FAL
>P26755 nuc REPLICATION FACTOR-A PROTEIN 3 (RF-A) (REPLICATION PROTEIN A 13 KD
     MASETPRVDP TEISNVNAPV FRIIAQIKSQ PTESQLILQS PTISSKNGSE VEMITLNNIR
     VSMNKTFEID SWYEFVCRNN DDGELGFLIL DAVLCKFKEN EDLSLNGVVA LQRLCKKYPE
     IY
>P27692 nuc TRANSCRIPTION INITIATION PROTEIN SPT5.
     MSDNSDTNVS MQDHDQQFAD PVVVPQSTDT KDENTSDKDT VDSGNVTTTE STERAESTSN
     IPPLDGEEKE AKSEPQQPED NAETAATEQV SSSNGPATDD AQATLNTDSS EANEIVKKEE
     GSDERKRPRE EDTKNSDGDT KDEGDNKDED DDEDDDDDDD DEDDDDEAPT KRRRQERNRF
     LDIEAEVSDD EDEDEDEEDS ELVREGFITH GDDEDDEASA PGARRDDRLH RQLDQDLNKT
     SEEDAQRLAK ELRERYGRSS SKQYRAAAQD GYVPQRFLLP SVDTATIWGV RCRPGKEKEL
     IRKLLKKKFN LDRAMGKKKL KILSIFQRDN YTGRIYIEAP KQSVIEKFCN GVPDIYISQK
     LLIPVQELPL LLKPNKSDDV ALEEGSYVRI KRGIYKGDLA MVDQISENNL EVMLKIVPRL
     DYGKFDEIDP TTQQRKSRRP TFAHRAPPQL FNPTMALRLD QANLYKRDDR HFTYKNEDYI
     DGYLYKSFRI QHVETKNIQP TVEELARFGS KEGAVDLTSV SQSIKKAQAA KVTFQPGDRI
     EVLNGEQRGS KGIVTRTTKD IATIKLNGFT TPLEFPISTL RKIFEPGDHV TVINGEHQGD
     AGLVLMVEQG QVTFMSTQTS REVTITANNL SKSIDTTATS SEYALHDIVE LSAKNVACII
     QAGHDIFKVI DETGKVSTIT KGSILSKINT ARARVSSVDA NGNEIKIGDT IVEKVGSRRE
     GQVLYIQTQQ IFVVSKKIVE NAGVFVVNPS NVEAVASKDN MLSNKMDLSK MNPEIISKMG
     PPSSKTFQQP IQSRGGREVA LGKTVRIRSA GYKGQLGIVK DVNGDKATVE LHSKNKHITI
     DKHKLTYYNR EGGEGITYDE LVNRRGRVPQ ARMGPSYVSA PRNMATGGIA AGAAATSSGL
     SGGMTPGWSS FDGGKTPAVN AHGGSGGGGV SSWGGASTWG GQGNGGASAW GGAGGGASAW
     GGQGTGATST WGGASAWGNK SSWGGASTWA SGGESNGAMS TWGGTGDRSA YGGASTWGGN
     NNNKSTRDGG ASAWGNQDDG NRSAWNNQGN KSNYGGNSTW GGH
>P27705 nuc REGULATORY PROTEIN MIG1 (REGULATORY PROTEIN CAT4).
     MQSPYPMTQV SNVDDGSLLK ESKSKSKVAA KSEAPRPHAC PICHRAFHRL EHQTRHMRIH
     TGEKPHACDF PGCVKRFSRS DELTRHRRIH TNSHPRGKRG RKKKVVGSPI NSASSSATSI
     PDLNTANFSP PLPQQHLSPL IPIAIAPKEN SSRSSTRKGR KTKFEIGESG GNDPYMVSSP
     KTMAKIPVSV KPPPSLALNN MNYQTSSAST ALSSLSNSHS GSRLKLNALS SLQMMTPIAS
     SAPRTVFIDG PEQKQLQQQQ NSLSPRYSNT VILPRPRSLT DFQGLNNANP NNNGSLRAQT
     QSSVQLKRPS SVLSLNDLLV GQRNTNESDS DFTTGGEDEE DGLKDPSNSS IDNLEQDYLQ
     EQSRKKSKTS TPTTMLSRST SGTNLHTLGY VMNQNHLHFS SSSPDFQKEL NNRLLNVQQQ
     QQEQHTLLQS QNTSNQSQNQ NQNQMMASSS SLSTTPLLLS PRVNMINTAI STQQTPISQS
     DSQVQELETL PPIRSLPLPF PHMD
>P27999 nuc DNA-DIRECTED RNA POLYMERASE II 14.2 KD POLYPEPTIDE (EC 2.7.7.6)
     MTTFRFCRDC NNMLYPREDK ENNRLLFECR TCSYVEEAGS PLVYRHELIT NIGETAGVVQ
     DIGSDPTLPR SDRECPKCHS RENVFFQSQQ RRKDTSMVLF FVCLSCSHIF TSDQKNKRTQ
     FS
>P28000 nuc DNA-DIRECTED RNA POLYMERASES I AND III 16 KD POLYPEPTIDE (EC 2.7.7.6)
     MTEDIEQKKT ATEVTPQEPK HIQEEEEQDV DMTGDEEQEE EPDREKIKLL TQATSEDGTS
     ASFQIVEEDH TLGNALRYVI MKNPDVEFCG YSIPHPSENL LNIRIQTYGE TTAVDALQKG
     LKDLMDLCDV VESKFTEKIK SM
>P28519 nuc DNA REPAIR PROTEIN RAD14.
     MTPEQKAKLE ANRKLAIERL RKRGILSSDQ LNRIESRNEP LKTRPLAVTS GSNRDDNAAA
     AVHVPNHNGQ PSALANTNTN TTSLYGSGVV DGSKRDASVL DKRPTDRIRP SIRKQDYIEY
     DFATMQNLNG GYINPKDKLP NSDFTDDQEF ESEFGSKKQK TLQDWKKEQL ERKMLYENAP
     PPEHISKAPK CIECHINIEM DPVLHDVFKL QVCKQCSKEH PEKYALLTKT ECKEDYFLTD
     PELNDEDLFH RLEKPNPHSG TFARMQLFVR CEVEAFAFKK WGGEEGLDEE WQRREEGKAH
     RREKKYEKKI KEMRLKTRAQ EYTNRLREKK HGKAHIHHFS DPVDGGIDED GYQIQRRRCT
     DCGLETEEID I
>P29055 nuc TRANSCRIPTION INITIATION FACTOR IIB (TFIIB) (TRANSCRIPTION FACTOR E).
     MMTRESIDKR AGRRGPNLNI VLTCPECKVY PPKIVERFSE GDVVCALCGL VLSDKLVDTR
     SEWRTFSNDD HNGDDPSRVG EASNPLLDGN NLSTRIGKGE TTDMRFTKEL NKAQGKNVMD
     KKDNEVQAAF AKITMLCDAA ELPKIVKDCA KEAYKLCHDE KTLKGKSMES IMAASILIGC
     RRAEVARTFK EIQSLIHVKT KEFGKTLNIM KNILRGKSED GFLKIDTDNM SGAQNLTYIP
     RFCSHLGLPM QVTTSAEYTA KKCKEIKEIA GKSPITIAVV SIYLNILLFQ IPITAAKVGQ
     TLQVTEGTIK SGYKILYEHR DKLVDPQLIA NGVVSLDNLP GVEKK
>P29056 nuc TRANSCRIPTION FACTOR IIIB 70 KD SUBUNIT (TFIIIB) (B-RELATED FACTOR)
     MPVCKNCHGT EFERDLSNAN NDLVCKACGV VSEDNPIVSE VTFGETSAGA AVVQGSFIGA
     GQSHAAFGGS SALESREATL NNARRKLRAV SYALHIPEYI TDAAFQWYKL ALANNFVQGR
     RSQNVIASCL YVACRKEKTH HMLIDFSSRL QVSVYSIGAT FLKMVKKLHI TELPLADPSL
     FIQHFAEKLD LADKKIKVVK DAVKLAQRMS KDWMFEGRRP AGIAGACILL ACRMNNLRRT
     HTEIVAVSHV AEETLQQRLN EFKNTKAAKL SVQKFRENDV EDGEARPPSF VKNRKKERKI
     KDSLDKEEMF QTSEEALNKN PILTQVLGEQ ELSSKEVLFY LKQFSERRAR VVERIKATNG
     IDGENIYHEG SENETRKRKL SEVSIQNEHV EGEDKETEGT EEKVKKVKTK TSEEKKENES
     GHFQDAIDGY SLETDPYCPR NLHLLPTTDT YLSKVSDDPD NLEDVDDEEL NAHLLNEEAS
     KLKERIWIGL NADFLLEQES KRLKQEADIA TGNTSVKKKR TRRRNNTRSD EPTKTVDAAA
     AIGLMSDLQD KSGLHAALKA AEESGDFTTA DSVKNMLQKA SFSKKINYDA IDGLFR
>P29468 nuc POLY(A) POLYMERASE (EC 2.7.7.19) (PAP) (POLYNUCLEOTIDE
     MSSQKVFGIT GPVSTVGATA AENKLNDSLI QELKKEGSFE TEQETANRVQ VLKILQELAQ
     RFVYEVSKKK NMSDGMARDA GGKIFTYGSY RLGVHGPGSD IDTLVVVPKH VTREDFFTVF
     DSLLRERKEL DEIAPVPDAF VPIIKIKFSG ISIDLICARL DQPQVPLSLT LSDKNLLRNL
     DEKDLRALNG TRVTDEILEL VPKPNVFRIA LRAIKLWAQR RAVYANIFGF PGGVAWAMLV
     ARICQLYPNA CSAVILNRFF IILSEWNWPQ PVILKPIEDG PLQVRVWNPK IYAQDRSHRM
     PVITPAYPSM CATHNITEST KKVILQEFVR GVQITNDIFS NKKSWANLFE KNDFFFRYKF
     YLEITAYTRG SDEQHLKWSG LVESKVRLLV MKLEVLAGIK IAHPFTKPFE SSYCCPTEDD
     YEMIQDKYGS HKTETALNAL KLVTDENKEE ESIKDAPKAY LSTMYIGLDF NIENKKEKVD
     IHIPCTEFVN LCRSFNEDYG DHKVFNLALR FVKGYDLPDE VFDENEKRPS KKSKRKNLDA
     RHETVKRSKS DAASGDNING TTAAVDVN
>P29469 nuc MINICHROMOSOME MAINTENANCE PROTEIN 2.
     MSDNRRRRRE EDDSDSENEL PPSSPQQHFR GGMNPVSSPI GSPDMINPEG DDNEVDDVPD
     IDEVEEQMNE VDLMDDNMYE DYAADHNRDR YDPDQVDDRE QQELSLSERR RIDAQLNERD
     RLLRNVAYID DEDEEQEGAA QLDEMGLPVQ RRRRRRQYED LENSDDDLLS DMDIDPLREE
     LTLESLSNVK ANSYSEWITQ PNVSRTIARE LKSFLLEYTD ETGRSVYGAR IRTLGEMNSE
     SLEVNYRHLA ESKAILALFL AKCPEEMLKI FDLVAMEATE LHYPDYARIH SEIHVRISDF
     PTIYSLRELR ESNLSSLVRV TGVVTRRTGV FPQLKYVKFN CLKCGSILGP FFQDSNEEIR
     ISFCTNCKSK GPFRVNGEKT VYRNYQRVTL QEAPGTVPPG RLPRHREVIL LADLVDVSKP
     GEEVEVTGIY KNNYDGNLNA KNGFPVFATI IEANSIKRRE GNTANEGEEG LDVFSWTEEE
     EREFRKISRD RGIIDKIISS MAPSIYGHRD IKTAVACSLF GGVPKNVNGK HSIRGDINVL
     LLGDPGTAKS QILKYVEKTA HRAVFATGQG ASAVGLTASV RKDPITKEWT LEGGALVLAD
     KGVCLIDEFD KMNDQDRTSI HEAMEQQSIS ISKAGIVTTL QARCSIIAAA NPNGGRYNST
     LPLAQNVSLT EPILSRFDIL CVVRDLVDEE ADERLATFVV DSHVRSHPEN DEDREGEELK
     NNGESAIEQG EDEINEQLNA RQRRLQRQRK KEEEISPIPQ ELLMKYIHYA RTKIYPKLHQ
     MDMDKVSRVY ADLRRESIST GSFPITVRHL ESILRIAESF AKMRLSEFVS SYDLDRAIKV
     VVDSFVDAQK VSVRRQLRRS FAIYTLGH
>P31244 nuc DNA REPAIR PROTEIN RAD16.
     MQEGGFIRRR RTRSTKKSVN YNELSDDDTA VKNSKTLQLK GNSENVNDSQ DEEYRDDATL
     VKSPDDDDKD FIIDLTGSDK ERTATDENTH AIKNDNDEII EIKEERDVSD DDEPLTKKRK
     TTARKKKKKT STKKKSPKVT PYERNTLRLY EHHPELRNVF TDLKNAPPYV PQRSKQPDGM
     TIKLLPFQLE GLHWLISQEE SIYAGGVLAD EMGMGKTIQT IALLMNDLTK SPSLVVAPTV
     ALMQWKNEIE QHTKGQLKIY IYHGASRTTD IKDLQGYDVV LTTYAVLESV FRKQNYGFRR
     KNGLFKQPSV LHNIDFYRVI LDEAHNIKDR QSNTARAVNN LKTQKRWCLS GTPLQNRIGE
     MYSLIRFLNI NPFTKYFCTK CDCASKDWKF TDRMHCDHCS HVIMQHTNFF NHFMLKNIQK
     FGVEGPGLES FNNIQTLLKN IMLRRTKVER ADDLGLPPRI VTVRRDFFNE EEKDLYRSLY
     TDSKRKYNSF VEEGVVLNNY ANIFTLITRM RQLADHPDLV LKRLNNFPGD DIGVVICQLC
     NDEAEEPIES KCHHKFCRLC IKEYVESFME NNNKLTCPVC HIGLSIDLSQ PALEVDLDSF
     KKQSIVSRLN MSGKWQSSTK IEALVEELYK LRSNKRTIKS IVFSQFTSML DLVEWRLKRA
     GFQTVKLQGS MSPTQRDETI KYFMNNIQCE VFLVSLKAGG VALNLCEASQ VFILDPWWNP
     SVEWQSGDRV HRIGQYRPVK ITRFCIEDSI EARIIELQEK KANMIHATIN QDEAAISRLT
     PADLQFLFNN
>P32259 nuc GLOBAL TRANSCRIPTIONAL REGULATOR SIN4.
     MMLGEHLMSW SKTGIIAYSD SQSSNANICL TFLESINGIN WRFHTPQKYV LHPQLHEVQY
     QESSSTLSTH STTTSVNGST TAGVGSTPNF GGNSNKSPPQ FFYNISSIHW NNWFSLPGDM
     LAVCDELGNM TMLITGQRPD RATTYEKLTM VFQDNVYKIY NHVMPLKPVD KLKPMNIERK
     QTRKEYNTSI LEFRWLTSSK SVIVSQFCAF DSSSNTYRSR AQQVPPYGVY HPPFIKYACL
     AIRKNGQIDF WYQFSNSKDH KKITLQLLDT SNQRFKDLQW LEFARITPMN DDQCMLITTY
     SKLSKNISFY KLHVNWNLNA TKPNVLNDPS LKIQFILSTT LDPTDDEGHV LKLENLHVVS
     KSSIEKDPSP EILVLYNVCD TSKSLVKRYR LAPTQLSAEY LVILKPDLNI DRNNSTNQIF
     QSRRYNLRRH SDIVLDKKVT LITSEMFDAF VSFYFEDGTI ESYNQNDWKL ETERLISQSQ
     LGKFKNIIAS PLSAGFNYGK LPLPPSVEWM KVSPSMCGVI VKQYNKKWPQ FYAAVQKNYA
     DPEKDSINAT ALAFGYVKSL HKQISAEDLT IAAKTHILRI SFLDRKRAKE FITTLLKSLY
     SFFNISPDAP KEIMDKIITS RPLQKIMLLQ LELGSCFSQE NIEEMARVIL YLKNVLFAFN
     GVARNFHFAI EQISNNSNQQ QNPKLFQTIF SKQDLIHSLI PVAKWFVKFI TYLTQEILIL
     INDPTNKEYT LVHGIFGAKM SRTLILSILN EIKKVTQIVA KFPETSYPIL NESSTFLKLV
     LSESPVDFEK FETFLVDVNN KFIALCEQQP SQEREFSLLV KAEIPPEYAK VGDFLLQYAN
     NAVISHANAA AVYFADTSGL KISNSEFFNP EIFHLLQPLE EGLIIDTDKL PIKNRTSKSF
     SKLLYDDVTC DKLSVSEISD GKLKRCSRCG SVTRAGNIIS SDKTIVPTSI QTKRWPTMYT
     RLCICSGMLF EMDG
>P32333 nuc PROBABLE HELICASE MOT1.
     MTSRVSRLDR QVILIETGST QVVRNMAADQ MGDLAKQHPE DILSLLSRVY PFLLVKKWET
     RVTAARAVGG IVAHAPSWDP NESDLVGGTN EGSPLDNAQV KLEHEMKIKL EEATQNNQLN
     LLQEDHHLSS LSDWKLNEIL KSGKVLLASS MNDYNVLGKA DDNIRKQAKT DDIKQETSML
     NASDKANENK SNANKKSARM LAMARRKKKM SAKNTPKHPV DITESSVSKT LLNGKNMTNS
     AASLATSPTS NQLNPKLEIT EQADESKLMI ESTVRPLLEQ HEIVAGLVWQ FQGIYELLLD
     NLMSENWEIR HGAALGLREL VKKHAYGVSR VKGNTREENN LRNSRSLEDL ASRLLTVFAL
     DRFGDYVYDT VVAPVRESVA QTLAALLIHL DSTLSIKIFN CLEQLVLQDP LQTGLPNKIW
     EATHGGLLGI RYFVSIKTNF LFAHGLLENV VRIVLYGLNQ SDDDVQSVAA SILTPITSEF
     VKLNNSTIEI LVTTIWSLLA RLDDDISSSV GSIMDLLAKL CDHQEVLDIL KNKALEHPSE
     WSFKSLVPKL YPFLRHSISS VRRAVLNLLI AFLSIKDDST KNWLNGKVFR LVFQNILLEQ
     NPELLQLSFD VYVALLEHYK VKHTEKTLDH VFSKHLQPIL HLLNTPVGEK GKNYAMESQY
     ILKPSQHYQL HPEKKRSISE TTTDSDIPIP KNNEHINIDA PMIAGDITLL GLDVILNTRI
     MGAKAFALTL SMFQDSTLQS FFTNVLVRCL ELPFSTPRML AGIIVSQFCS SWLQKHPEGE
     KLPSFVSEIF SPVMNKQLLN RDEFPVFREL VPSLKALRTQ CQSLLATFVD VGMLPQYKLP
     NVAIVVQGET EAGPHAFGVE TAEKVYGEYY DKMFKSMNNS YKLLAKKPLE DSKHRVLMAI
     NSAKESAKLR TGSILANYAS SILLFDGLPL KLNPIIRSLM DSVKEERNEK LQTMAGESVV
     HLIQQLLENN KVNVSGKIVK NLCGFLCVDT SEVPDFSVNA EYKEKILTLI KESNSIAAQD
     DINLAKMSEE AQLKRKGGLI TLKILFEVLG PSILQKLPQL RSILFDSLSD HENEEASKVD
     NEQGQKIVDS FGVLRALFPF MSDSLRSSEV FTRFPVLLTF LRSNLSVFRY SAARTFADLA
     KISSVEVMAY TIREILPLMN SAGSLSDRQG STELIYHLSL SMETDVLPYV IFLIVPLLGR
     MSDSNEDVRN LATTTFASII KLVPLEAGIA DPKGLPEELV ASRERERDFI QQMMDPSKAK
     PFKLPIAIKA TLRKYQQDGV NWLAFLNKYH LHGILCDDMG LGKTLQTICI IASDQYLRKE
     DYEKTRSVES RALPSLIICP PSLTGHWENE FDQYAPFLKV VVYAGGPTVR LTLRPQLSDA
     DIIVTSYDVA RNDLAVLNKT EYNYCVLDEG HIIKNSQSKL AKAVKEITAN HRLILTGTPI
     QNNVLELWSL FDFLMPGFLG TEKMFQERFA KPIAASRNSK TSSKEQEAGV LALEALHKQV
     LPFMLRRLKE DVLSDLPPKI IQDYYCELGD LQKQLYMDFT KKQKNVVEKD IENSEIADGK
     QHIFQALQYM RKLCNHPALV LSPNHPQLAQ VQDYLKQTGL DLHDIINAPK LSALRTLLFE
     CGIGEEDIDK KASQDQNFPI QNVISQHRAL IFCQLKDMLD MVENDLFKKY MPSVTYMRLD
     GSIDPRDRQK VVRKFNEDPS IDCLLLTTKV GGLGLNLTGA DTVIFVEHDW NPMNDLQAMD
     RAHRIGQKKV VNVYRIITKG TLEEKIMGLQ KFKMNIASTV VNQQNSGLAS MDTHQLLDLF
     DPDNVTSQDN EEKNNGDSQA AKGMEDIANE TGLTGKAKEA LGELKELWDP SQYEEEYNLD
     TFIKTLR
>P32338 nuc ZINC FINGER PROTEIN RME1.
     MSPCYGQNSA IAKGSWNREV LQEVQPIYHW HDFGQNMKEY SASPLEGDSS LPSSLPSSTE
     DCLLLSLENT ITVIAGNQRQ AYDSTSSTEE GTAPQLRPDE IADSTHCITS LVDPEFRDLI
     NYGRQKGANP VFIESNTTEQ SHSQCILGYP QKSHVAQLYH DPKVLSTISE GQTKRGSYHC
     SHCSEKFATL VEFAAHLDEF NLERPCKCPI EQCPWKILGF QQATGLRRHC ASQHIGELDI
     EMEKSLNLKV EKYPGLNCPF PICQKTFRRK DAYKRHVAMV HNNADSRFNK RLKKILNNTK
>P32349 nuc DNA-DIRECTED RNA POLYMERASE III 74 KD POLYPEPTIDE (EC 2.7.7.6) (C74).
     MDELLGEALS AENQTGESTV ESEKLVTPED VMTISSLEQR TLNPDLFLYK ELVKAHLGER
     AASVIGMLVA LGRLSVRELV EKIDGMDVDS VKTTLVSLTQ LRCVKYLQET AISGKKTTYY
     YYNEEGIHIL LYSGLIIDEI ITQMRVNDEE EHKQLVAEIV QNVISLGSLT VEDYLSSVTS
     DSMKYTISSL FVQLCEMGYL IQISKLHYTP IEDLWQFLYE KHYKNIPRNS PLSDLKKRSQ
     AKMNAKTDFA KIINKPNELS QILTVDPKTS LRIVKPTVSL TINLDRFMKG RRSKQLINLA
     KTRVGSVTAQ VYKIALRLTE QKSPKIRDPL TQTGLLQDLE EAKSFQDEAE LVEEKTPGLT
     FNAIDLARHL PAELDLRGSL LSRKPSDNKK RSGSNAAASL PSKKLKTEDG FVIPALPAAV
     SKSLQESGDT QEEDEEEEDL DADTEDPHSA SLINSHLKIL ASSNFPFLNE TKPGVYYVPY
     SKLMPVLKSS VYEYVIASTL GPSAMRLSRC IRDNKLVSEK IINSTALMKE KDIRSTLASL
     IRYNSVEIQE VPRTADRSAS RAVFLFRCKE THSYNFMRQN LEWNMANLLF KKEKLKQENS
     TLLKKANRDD VKGRENELLL PSELNQLKMV NERELNLFAR LSRLLSLWEV FQMA
>P32367 nuc TRANSCRIPTION FACTOR TAU 95 KD SUBUNIT (TFIIIC 95 KD SUBUNIT).
     MPVEEPLATL SSIPDSSADQ APPLIADEFT LDLPRIPSLE LPLNVSTKHS SIQKAIKMCG
     GIEKVKEAFK EHGPIESQHG LQLYLNDDTD SDGSKSYFNE HPVIGKRVPF RDESVILKVT
     MPKGTLSKNN NSVKDSIKSL KDSNKLRVTP VSIVDNTIKF REMSDFQIKL DNVPSAREFK
     SSFGSLEWNN FKSFVNSVPD NDSQPQENIG NLILDRSVKI PSTDFQLPPP PKLSMVGFPL
     LYKYKANPFA KKKKNGVTEV KGTYIKNYQL FVHDLSDKTV IPSQAHEQVL YDFEVAKKTK
     VYPGTKSDSK FYESLEECLK ILRELFARRP IWVKRHLDGI VPKKIHHTMK IALALISYRF
     TMGPWRNTYI KFGIDPRSSV EYAQYQTEYF KIERKLLSSP IVKKNVPKPP PLVFESDTPG
     GIDSRFKFDG KRIPWYLMLQ IDLLIGEPNI AEVFHNVEYL DKANELTGWF KELDLVKIRR
     IVKYELGCMV QGNYEYNKYK LKYFKTMLFV KESMVPENKN SEEGMGVNTN KDADGDINMD
     AGSQMSSNAI EEDKGIAAGD DFDDNGAITE EPDDAALENE EMDTDQNLKV PASIDDDVDD
     VDADEEEQES FDVKTASFQD IINKIAKLDP KTAETMKSEL KGFVDEVDL
>P32389 nuc TRANSCRIPTIONAL ACTIVATOR OF SULFUR METABOLISM MET4.
     MGSTNSLDQF VATASSSSSL VTSSENRRPL IGDVTNRGNT NLYDHAVTPE ILLEQLAYVD
     NFIPSLDNEF SNVDWNVNTT HNNANNNGAD TFSSINANPF DLDEQLAIEL SAFADDSFIF
     PDEDKPSNNN NNSNNGNDDH SNHDVLHEDP STNNRQRNPH FLTQRRNTFL TSQYDQSKSR
     FSSKNKRNGN NGETNNFGDN MQNNHPFEPN FMGSPSQFPA DATNMTSIDH GGFTNVDITS
     TENNTTGDNG VDALSNLLHR TTHTPNRSSP LSNVTSAQNS SSQQRKHSES KVDSNSDNNS
     SNKAPNITVP DYSIIPTSVL VTLLPRVNVP NGAYNSLISA GFDNDQIDAI AAIMAYHHQK
     KIRENNSNNN KNINTNDSQE APILKNINEL LSVLIPPSPA ETRGPTTLST SPSFNEHGVV
     AEASFLSSIL ELGIKHPKSN NIHNQRQPSR NDHKISRESD GNNGNDNVHH NNAVIKSSTT
     RGDEIAKIRS EPTLNASSSD HKENSLKRSH SGDLKNKKVP VDRKYSDNED DEYDDADLHG
     FEKKQLIKKE LGDDDEDLLI QSKKSHQKKK LKEKELESSI HELTEIAASL QKRIHTLETE
     NKLLKNLVLS SGETEGIKKA ESLKKQIFEK VQKE
>P32432 nuc ZINC FINGER PROTEIN SFP1.
     MDFTTMTMAS NMATSTTTTA TSAHASINSS SNFNIDIDSN QNTPSILINN NSDSSNGKNT
     DFNGVNNIHQ KNIMNNTNNV HLYSPNIMDQ TLLTPQDIAK LRRESIAHSQ GMGGVSWGSI
     SVGSWLRDEI ISRRNSIVPA SANGAASAAA SATTTATNTL QIQQPTKRPS VSNPPYHRGY
     SISPQIAYTA YLPNLEKQYC KDYSCCGLSL PGLHDLLRHY EEAHISTSPN TTNMSQIPMN
     SAGNTSSSVR MTNNTSSANY NLQNNMAANT KNAGHKTNTM QAHSSNATNN TSINNMHANL
     QSNMDSNSTI RQSQHPHHQQ NIIQQQLQSN SVNHTSGAVP TPSVMGSATA SSTTANPNVI
     SITGAPNSGL SMANHSQQLH LNGNLVDAVS TNDVFLRTSN SPSRHVPHNK QINSNNNSGI
     NINNNTSHNS NINMGSKNAM VNRPHTFNNY SLNKTSRNPI QHQSRKIDPH QTDLSPLVLV
     QDIDLSFMDD DILGPSNHNS MNSVVNPTTG SHNYNTFHSS VHAKSSQNMV EDQDIDDIDD
     DDDVDDDDDD DDDDDTENGS SSNGKSVHNN NYKMPQQAYI DDPARRLYVM DHEEQKPFKC
     PVIGCEKTYK NQNGLKYHRL HGHQNQKLHE NPDGTFSVID PDSTDSFGDG MGSAKDKPYR
     CEVCGKRYKN LNGLKYHRGH STH
>P32479 nuc HISTONE TRANSCRIPTION REGULATOR 1.
     MELESLTPEI PLPQDLQMPL CSMSRHTGSI TCVKFSPDGK YLASGSDDRI LLIWALDEEQ
     SSQPAFGSEH EREHWTVRKR LVAHDNDIQD ICWAPDSSIL VTVGLDRSVI VWNGSTFEKL
     KRFDVHQSLV KGVVFDPANK YFATTSDDRT MKIFRYHKTG DISFTIEHII TEPFKESPLT
     TYFRRPSWSP MGNILQFRTP LMGPVSSVAI VNRGTWDTNV SLIGHDAPTE VARFNPRLFE
     RNAGVKQKKD DDPENALVGQ NDDKVHHFDK NIDSVVATAG QDKSLAVMST SRPRPILVAF
     DIANKSITDM SWNPDGSLLF VASLDSSITL FKFENNELGK PIPLEKNMEQ LYRYGVDKDS
     LDFPESINQL LLEDQTKSFK HTKISTSKLG ENHPTLATNS ASNQKDNNDA SVSRSEHINI
     LIPKRKKDAI LNKAVTLKSG KKRVAPTLIS TSSSSPFSNG IKKPTLDSKR IENNVKSSTK
     TINSKNTLLN VPEGVEKKIS ISSFPLPRLG IHSLIMGTKE RSAWKISNSE LENDDADNAG
     GKGSDGTSNS IDDIAVLSEE ENDFHRMTLN AKLTQEKIWS EEPTTRCLLQ SDVIPDTDVV
     VLEGGSLDDI AVLEIRNGVE RSIQFDSEAL LDNPTRILGY QGGKRTIETF IPEVIICAIG
     SKDCKCWCLA SANGSIYILS YNGQQRIPKI CLGHKVIKMV TSSKYLLVLT ERGLFFAWDL
     LDLKLVLRNV PILPILNGQP IHGNKVRINK VIKCFRLDGS SCDLLLEVGD PKNVYKWTKD
     LGCWSLYK
>P32480 nuc HISTONE TRANSCRIPTION REGULATOR 2.
     MRLLKYPLDI HNEQVNALAA LGPYIILAGS GGHVMAWRQQ QLVDTAFDRV MIKDLKPEVS
     FQVDQDTTGD IFFITGDLET LYIGSEHRLW GYSGWLCRDT NNINSVEKMN SKLLFECKSP
     STITDVKYDI NLGILFVLLS NENKILLFRH KTFDKLSEIT IDKASKPITG IIDPTGQTFT
     VMTSDRSILV YQINKTGTHK LINKLTQHVQ MYPLHYRISM SPQADILPVI NSVKGVPNNA
     TSCTALLDRN NNYKVTKTLV TPSSNGCRVL VYSPAFYEKP NLKKGTSTRY NLIATSGSTD
     GTILVWNTKR MKPLFNALQV SSTAINDMSW SQDGFTLFAI SNDATLYTFA FQEKDLGVAL
     PQTEIKSLQE VNKKLPKLEE PLAEQIPKSF PENIKLEESA SAAPIPNDIG RSAVGKKPTK
     KKTANNQTNG IKTIQSTSME FNTPSYTVPR DLKRKPKEAT PSNIAPGSKK QKKELQPIDF
     LDTGLLLPNT SFSRIRLATP KIRSTFKYSP INNPNLILDV KNGSGNEQRP TIVKLTSKVL
     DQDQVLFQDF IPKLITICTA GDTFWSFCSE DGSIYIYSDS GRKLMAPLVL GVSISFLEAC
     GTYLLCLTSI GELYCWNIEQ KKLAFPTNTI YPLLNPSLRY SDDILTRAEN ITLCSITKKG
     VPLVTLSNGD GYLFDKNMET WLLVSDGWWA YGSQYWDTTN TTGLSSSKAN TDSFNGSESN
     INEIVSDIKN DNQSIINFLE CKTNDELNRK GRIKNLQRFA RTILMKEGFE NMEEIVTLSH
     LENKILISIR LEEPEEFSKL MMVYCIRLSE LGYMDRLNDV FQWLYDDLPI SGTGSAFADK
     DFKRNLLKKI LIACGDIRQV QRVTTRYAKE MNIIS
>P32495 nuc HIGH MOBILITY GROUP-LIKE NUCLEAR PROTEIN 2.
     MVNGSLGSRE TETSAVKMGK DNKEHKESKE SKTVDNYEAR MPAVLPFAKP LASKKLNKKV
     LKTVKKASKA KNVKRGVKEV VKALRKGEKG LVVIAGDISP ADVISHIPVL CEDHSVPYIF
     IPSKQDLGAA GATKRPTSVV FIVPGSNKKK DGKNKEEEYK ESFNEVVKEV QAL
>P32505 nuc NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN NAB2.
     MSQEQYTENL KVIVAEKLAG IPNFNEDIKY VAEYIVLLIV NGGTVESVVD ELASLFDSVS
     RDTLANVVQT AFFALEALQQ GESAENIVSK IRMMNAQSLG QSDIAQQQQQ QQQQQQPDIA
     QQQPQQQPQQ QPQQQPQQQP QQQPQQQPQQ QPQQQPQLQP LQPQLGTQNA MQTDAPATPS
     PISAFSGVVN AAAPPQFAPV DNSQRFTQRG GGAVGKNRRG GRGGNRGGRN NNSTRFNPLA
     KALGMAGESN MNFTPTKKEG RCRLFPHCPL GRSCPHAHPT KVCNEYPNCP KPPGTCEFLH
     PNEDEELMKE MERTREEFQK RKADLLAAKR KPVQTGIVLC KFGALCSNPS CPFGHPTPAN
     EDAKVIDLMW CDKNLTCDNP ECRKAHSSLS KIKEVKPISQ KKAAPPPVEK SLEQCKFGTH
     CTNKRCKYRH ARSHIMCREG ANCTRIDCLF GHPINEDCRF GVNCKNIYCL FRHPPGRVLP
     EKKGAAPNSN VPTNERPFAL PENAIIENAP PQTSFTHQEQ DTEMN
>P32523 nuc PRE-MRNA SPLICING FACTOR PRP19.
     MLCAISGKVP RRPVLSPKSR TIFEKSLLEQ YVKDTGNDPI TNEPLSIEEI VEIVPSAQQA
     SLTESTNSAT LKANYSIPNL LTSLQNEWDA IMLENFKLRS TLDSLTKKLS TVMYERDAAK
     LVAAQLLMEK NEDSKDLPKS SQQAVAITRE EFLQGLLQSS RDFVARGKLK APKWPILKNL
     ELLQAQNYSR NIKTFPYKEL NKSMYYDKWV CMCRCEDGAL HFTQLKDSKT ITTITTPNPR
     TGGEHPAIIS RGPCNRLLLL YPGNQITILD SKTNKVLREI EVDSANEIIY MYGHNEVNTE
     YFIWADNRGT IGFQSYEDDS QYIVHSAKSD VEYSSGVLHK DSLLLALYSP DGILDVYNLS
     SPDQASSRFP VDEEAKIKEV KFADNGYWMV VECDQTVVCF DLRKDVGTLA YPTYTIPEFK
     TGTVTYDIDD SGKNMIAYSN ESNSLTIYKF DKKTKNWTKD EESALCLQSD TADFTDMDVV
     CGDGGIAAIL KTNDSFNIVA LTP
>P32524 nuc PRE-MRNA SPLICING FACTOR PRP21.
     MEPEDTQLKE DIKTTVNYIK QHGVEFENKL LEDERFSFIK KDDPLHEYYT KLMNEPTDTV
     SGEDNDRKSE REIARPPDFL FSQYDTGISR RDMEVIKLTA RYYAKDKSIV EQMISKDGEA
     RLNFMNSSHP LHKTFTDFVA QYKRVYSFTG QEIKKSKRTI LDNCFERTQY WEFEKDKDRE
     HDKLVELCKI QFAAIPWDKF TQVAKFSIPE DTEIFEGSLD LEQMRLRRVQ TGIKLFDSIK
     PTNEEEKIVS DQGKQKGGDS KGKKRKIRAV GETRLKKSKK
>P32527 nuc ZUOTIN.
     MFSLPTLTSD ITVEVNSSAT KTPFVRRPVE PVGKFFLQHA QRTLRNHTWS EFERIEAEKN
     VKTVDESNVD PDELLFDTEL ADEDLLTHDA RDWKTADLYA AMGLSKLRFR ATESQIIKAH
     RKQVVKYHPD KQSAAGGSLD QDGFFKIIQK AFETLTDSNK RAQYDSCDFV ADVPPPKKGT
     DYDFYEAWGP VFEAEARFSK KTPIPSLGNK DSSKKEVEQF YAFWHRFDSW RTFEFLDEDV
     PDDSSNRDHK RYIERKNKAA RDKKKTADNA RLVKLVERAV SEDPRIKMFK EEEKKEKERR
     KWEREAGARA EAEAKAKAEA EAKAKAESEA KANASAKADK KKAKEAAKAA KKKNKRAIRN
     SAKEADYFGD ADKATTIDEQ VGLIVDSLND EELVSTADKI KANAAGAKEV LKESAKTIVD
     SGKLPSSLLS YFV
>P32529 nuc DNA-DIRECTED RNA POLYMERASE I 13.7 KD POLYPEPTIDE (EC 2.7.7.6)
     MSVVGSLIFC LDCGDLLENP NAVLGSNVEC SQCKAIYPKS QFSNLKVVTT TADDAFPSSL
     RAKKSVVKTS LKKNELKDGA TIKEKCPQCG NEEMNYHTLQ LRSADEGATV FYTCTSCGYK
     FRTNN
>P32561 nuc HISTONE DEACETYLASE (TRANSCRIPTIONAL REGULATORY PROTEIN RPD3).
     MVYEATPFDP ITVKPSDKRR VAYFYDADVG NYAYGAGHPM KPHRIRMAHS LIMNYGLYKK
     MEIYRAKPAT KQEMCQFHTD EYIDFLSRVT PDNLEMFKRE SVKFNVGDDC PVFDGLYEYC
     SISGGGSMEG AARLNRGKCD VAVNYAGGLH HAKKSEASGF CYLNDIVLGI IELLRYHPRV
     LYIDIDVHHG DGVEEAFYTT DRVMTCSFHK YGEFFPGTGE LRDIGVGAGK NYAVNVPLRD
     GIDDATYRSV FEPVIKKIME WYQPSAVVLQ CGGDSLSGDR LGCFNLSMEG HANCVNYVKS
     FGIPMMVVGG GGYTMRNVAR TWCFETGLLN NVVLDKDLPY NEYYEYYGPD YKLSVRPSNM
     FNVNTPEYLD KVMTNIFANL ENTKYAPSVQ LNHTPRDAED LGDVEEDSAE AKDTKGGSQY
     ARDLHVEHDN EFY
>P32566 nuc SMI1 PROTEIN (KILLER TOXIN RESISTANT PROTEIN 4).
     MDLFKRKVKE WVYSLSTDDH YAEYNPDETP TFNMGKRLNS NNGQVNPSQM HLNSVDEEMS
     MGFQNGVPSN EDINIDEFTS TESNDGVSET LLAWRHIDFW TSEHNPDLNA TLSDPCTQND
     ITHAEEDLEV SFPNPVKASF KIHDGQEDLE SMTGTSGLFY GFQLMTLDQV VAMTQAWRNV
     AKNLNKRSQQ GLSHVTSTGS SSSMERLNGN KFKLPNIPDQ KSIPPNAVQP VYAHPAWIPL
     ITDNAGNHIG VDLAPGPNGK YAQIITFGRD FDTKFVIAEN WGEFLLSFAN DLEAGNWYLV
     DDNDDYFSGD GELVFRDKKS NGPIQDYFEV LKRRTWIKYQ ENLRSQQQKS QPDTSLQEQK
     YVPASQKKVA AEQPSTLNAE SIKGEDSGSA DVQSVQDHES VKIVKTEPSE AETTTVNTES
     LGQAEHEIKA DNVDIKQESE RKEDEKQPKV EEKEHVENEH VTESAKKDDD VNKQTEEMNK
     KEENEIRSDD AKVEEAREEF ENIAL
>P32591 nuc TRANSCRIPTION REGULATORY PROTEIN SWI3 (SWI/SNF COMPLEX COMPONENT SWI3)
     MENTLGEGST VNASVDVDQH GNDNNSDSNA NAAVAGVANT DTAGEESQQQ DESLKDEATV
     PNTRDAESEA ITVTAKQQPT MQANKLDSQE TPSTEESRAQ NVFGQDNEDS DNLFGETESS
     VSNNEANTPS IPTNPVDNEN NKPAIKEDST IQDSNGDVKN MEDVKIQKEE EPENNTVIEG
     VKEESQPDEN TKEMDEVEED DEDDDQPMIS PDNSIFGDTK SESKQLGNTS SVANTPSEIP
     DAHKAEQEDI IEKTESVDKK VDSGEERNEQ EREIMNDHSK SANPKKTTIT RVEPETFEIP
     QAHEIVIPSY SKWFNLEKIH SIEVQSLPEF FTNRIPSKTP EVYMRYRNFM VNSYRLNPNE
     YFSVTTARRN VSGDAAALFR LHKFLTKWGL INYQVDSKLL PKNIEPPLTS QYSTRHDAPR
     GLFPFESYKP SVQLPDMAKL KKMMNTSDSE STLYKYLKES KRKYDEITHP PSTTDDENGD
     KNDNGGKMNN EVSTSTSMTG DANLLEEGET SRPLKKVKIL EQIDENWSKE DLQKLLKGIQ
     EFGADWYKVA KNVGNKSPEQ CILRFLQLPI EDKFLYGDGN GKGDNDNGLG PLKYAPHLPF
     SKSENPVLST IAFLVGLVNP KTVQSMTQRA IQSAESIKSQ KEEISDQKPI EHIKEGSEIA
     ISSLGYRSHI FATNEERQMN FLTNELIRLQ MEKLDAKLNH LKKLEKFMEL ERKTLERQQE
     NLLIQRLNFN QNSSKIVNVL SKCLNLISDS NINNSSVAEK EEIRSQIDHF KSMLSKPETL
     SIGKNPFNKP NIETGENHNG QSISNENDVK PISIEAPQFY RYWSA
>P32597 nuc NUCLEAR PROTEIN STH1/NPS1.
     MLQEQSELMS TVMNNTPTTV AALAAVAAAS ETNGKLGSEE QPEITIPKPR SSAQLEQLLY
     RYRAIQNHPK ENKLEIKAIE DTFRNISRDQ DIYETKLDTL RKSIDKGFQY DEDLLNKHLV
     ALQLLEKDTD VPDYFLDLPD TKNDNTTAIE VDYSEKKPIK ISADFNAKAK SLGLESKFSN
     ATKTALGDPD TEIRISARIS NRINELERLP ANLGTYSLDD CLEFITKDDL SSRMDTFKIK
     ALVELKSLKL LTKQKSIRQK LINNVASQAH HNIPYLRDSP FTAAAQRSVQ IRSKVIVPQT
     VRLAEELERQ QLLEKRKKER NLHLQKINSI IDFIKERQSE QWSRQERCFQ FGRLGASLHN
     QMEKDEQKRI ERTAKQRLAA LKSNDEEAYL KLLDQTKDTR ITQLLRQTNS FLDSLSEAVR
     AQQNEAKILH GEEVQPITDE EREKTDYYEV AHRIKEKIDK QPSILVGGTL KEYQLRGLEW
     MVSLYNNHLN GILADEMGLG KTIQSISLIT YLYEVKKDIG PFLVIVPLST ITNWTLEFEK
     WAPSLNTIIY KGTPNQRHSL QHQIRVGNFD VLLTTYEYII KDKSLLSKHD WAHMIIDEGH
     RMKNAQSKLS FTISHYYRTR NRLILTGTPL QNNLPELWAL LNFVLPKIFN SAKTFEDWFN
     TPFANTGTQE KLELTEEETL LIIRRLHKVL RPFLLRRLKK EVEKDLPDKV EKVIKCKLSG
     LQQQLYQQML KHNALFVGAG TEGATKGGIK GLNNKIMQLR KICNHPFVFD EVEGVVNPSR
     GNSDLLFRVA GKFELLDRVL PKFKASGHRV LMFFQMTQVM DIMEDFLRMK DLKYMRLDGS
     TKTEERTEML NAFNAPDSDY FCFLLSTRAG GLGLNLQTAD TVIIFDTDWN PHQDLQAQDR
     AHRIGQKNEV RILRLITTDS VEEVILERAM QKLDIDGKVI QAGKFDNKST AEEQEAFLRR
     LIESETNRDD DDKAELDDDE LNDTLARSAD EKILFDKIDK ERMNQERADA KAQGLRVPPP
     RLIQLDELPK VFREDIEEHF KKEDSEPLGR IRQKKRVYYD DGLTEEQFLE AVEDDNMSLE
     DAIKKRREAR ERRRLRQNGT KENEIETLEN TPEASETSLI ENNSFTAAVD EETNADKETT
     ASRSKRRSSR KKRTISIVTA EDKENTQEES TSQENGGAKV EEEVKSSSVE IINGSESKKK
     KPKLTVKIKL NKTTVLENND GKRAEEKPES KSPAKKTAAK KTKTKSKSLG IFPTVEKLVE
     EMREQLDEVD SHPRTSIFEK LPSKRDYPDY FKVIEKPMAI DIILKNCKNG TYKTLEEVRQ
     ALQTMFENAR FYNEEGSWVY VDADKLNEFT DEWFKEHSS
>P32773 nuc TRANSCRIPTION INITIATION FACTOR IIA LARGE CHAIN (TFIIA 32 KD SUBUNIT).
     MSNAEASRVY EIIVESVVNE VREDFENAGI DEQTLQDLKN IWQKKLTETK VTTFSWDNQF
     NEGNINGVQN DLNFNLATPG VNSSEFNIKE ENTGNEGLIL PNINSNNNIP HSGETNINTN
     TVEATNNSGA TLNTNTSGNT NADVTSQPKI EVKPEIELTI NNANITTVEN IDDESEKKDD
     EEKEEDVEKT RKEKEQIEQV KLQAKKEKRS ALLDTDEVGS ELDDSDDDYL ISEGEEDGPD
     ENLMLCLYDK VTRTKARWKC SLKDGVVTIN RNDYTFQKAQ VEAEWV
>P32774 nuc TRANSCRIPTION INITIATION FACTOR IIA SMALL CHAIN (TFIIA 13.5 KD
     MAVPGYYELY RRSTIGNSLV DALDTLISDG RIEASLAMRV LETFDKVVAE TLKDNTQSKL
     TVKGNLDTYG FCDDVWTFIV KNCQVTVEDS HRDASQNGSG DSQSVISVDK LRIVACNSKK
     SE
>P32776 nuc RNA POLYMERASE II TRANSCRIPTION FACTOR B 73 KD SUBUNIT.
     MSHSGAAIFE KVSGIIAINE DVSPAELTWR STDGDKVHTV VLSTIDKLQA TPASSEKMML
     RLIGKVDESK KRKDNEGNEV VPKPQRHMFS FNNRTVMDNI KMTLQQIISR YKDADIYEEK
     RRREESAQHT ETPMSSSSVT AGTPTPHLDT PQLNNGAPLI NTAKLDDSLS KEKLLTNLKL
     QQSLLKGNKV LMKVFQETVI NAGLPPSEFW STRIPLLRAF ALSTSQKVGP YNVLSTIKPV
     ASSENKVNVN LSREKILNIF ENYPIVKKAY TDNVPKNFKE PEFWARFFSS KLFRKLRGEK
     IMQNDRGDVI IDRYLTLDQE FDRKDDDMLL HPVKKIIDLD GNIQDDPVVR GNRPDFTMQP
     GVDINGNSDG TVDILKGMNR LSEKMIMALK NEYSRTNLQN KSNITNDEED EDNDERNELK
     IDDLNESYKT NYAIIHLKRN AHEKTTDNDA KSSADSIKNA DLKVSNQQML QQLSLVMDNL
     INKLDLNQVV PNNEVSNKIN KRVITAIKIN AKQAKHNNVN SALGSFVDNT SQANELEVKS
     TLPIDLLESC RMLHTTCCEF LKHFYIHFQS GEQKQASTVK KLYNHLKDCI EKLNELFQDV
     LNGDGESMSN TCTAYLKPVL NSITLATHKY DEYFNEYNNN SN
>P32805 nuc ZINC FINGER PROTEIN FZF1 (SULPHITE RESISTANCE PROTEIN 1).
     MTDIGRTKSR NYKCSFDGCE KVYNRPSLLQ QHQNSHTNQK PYHCDEPGCG KKFIRPCHLR
     VHKWTHSQIK PKACTLCQKR FVTNQQLRRH LNSHERKSKL ASRIDRKHEG VNANVKAELN
     GKEGGFDPKL PSGSPMCGEE FSQGHLPGYD DMQVLQCPYK SCQKVTSFND DLINHMLQHH
     IASKLVVPSG DPSLKESLPT SEKSSSTDTT SIPQLSFSTT GTSSSESVDS TTAQTPTDPE
     SYWSDNRCKH SDCQELSPFA SVFDLIDHYD HTHAFIPETL VKYSYIHLYK PSVWDLFEY
>P32807 nuc HIGH AFFINITY DNA-BINDING FACTOR SUBUNIT 1 (KU70 HOMOLOG).
     MRSVTNAFGN SGELNDQVDE TGYRKFDIHE GILFCIELSE TMFKESSDLE YKSPLLEILE
     SLDELMSQLV ITRPGTAIGC YFYYCNREDA KEGIYELFPL RDINATFMKK LNDLLEDLSS
     GRISLYDYFM FQQTGSEKQV RLSVLFTFML DTFLEEIPGQ KQLSNKRVFL FTDIDKPQEA
     QDIDERARLR RLTIDLFDNK VNFATFFIGY ADKPFDNEFY SDILQLGSHT NENTGLDSEF
     DGPSTKPIDA KYIKSRILRK KEVKRIMFQC PLILDEKTNF IVGVKGYTMY THEKAGVRYK
     LVYEHEDIRQ EAYSKRKFLN PITGEDVTGK TVKVYPYGDL DINLSDSQDQ IVMEAYTQKD
     AFLKIIGFRS SSKSIHYFNN IDKSSFIVPD EAKYEGSIRT LASLLKILRK KDKIAILWGK
     LKSNSHPSLY TLSPSSVKDY NEGFYLYRVP FLDEIRKFPS LLSYDDGSEH KLDYDNMKKV
     TQSIMGYFNL RDGYNPSDFK NPLLQKHYKV LHDYLLQIET TFDENETPNT KKDRMMREDD
     SLRKLYYIRN KILESEKSED PIIQRLNKYV KIWNMFYKKF NDDNISIKEE KKPFDKKPKF
     NI
>P32833 nuc ORIGIN RECOGNITION COMPLEX PROTEIN, SUBUNIT 2 (ORIGIN RECOGNITION
     MLNGEDFVEH NDILSSPAKS RNVTPKRVDP HGERQLRRIH SSKKNLLERI SLVGNERKNT
     SPDPALKPKT PSKAPRKRGR PRKIQEELTD RIKKDEKDTI SSKKKRKLDK DTSGNVNEES
     KTSNNKQVME KTGIKEKRER EKIQVATTTY EDNVTPQTDD NFVSNSPEPP EPATPSKKSL
     TTNHDFTSPL KQIIMNNLKE YKDSTSPGKL TLSRNFTPTP VPKNKKLYQT SETKSASSFL
     DTFEGYFDQR KIVRTNAKSR HTMSMAPDVT REEFSLVSNF FNENFQKRPR QKLFEIQKKM
     FPQYWFELTQ GFSLLFYGVG SKRNFLEEFA IDYLSPKIAY SQLAYENELQ QNKPVNSIPC
     LILNGYNPSC NYRDVFKEIT DLLVPAELTR SETKYWGNHV ILQIQKMIDF YKNQPLDIKL
     ILVVHNLDGP SIRKNTFQTM LSFLSVIRQI AIVASTDHIY APLLWDNMKA QNYNFVFHDI
     SNFEPSTVES TFQDVMKMGK SDTSSGAEGA KYVLQSLTVN SKKMYKLLIE TQMQNMGNLS
     ANTGPKRGTQ RTGVELKLFN HLCAADFIAS NEIALRSMLR EFIEHKMANI TKNNSGMEII
     WVPYTYAELE KLLKTVLNTL
>P32835 nuc GTP-BINDING NUCLEAR PROTEIN GSP1/CNR1.
     MSAPAANGEV PTFKLVLVGD GGTGKTTFVK RHLTGEFEKK YIATIGVEVH PLSFYTNFGE
     IKFDVWDTAG QEKFGGLRDG YYINAQCAII MFDVTSRITY KNVPNWHRDL VRVCENIPIV
     LCGNKVDVKE RKVKAKTITF HRKKNLQYYD ISAKSNYNFE KPFLWLARKL AGNPQLEFVA
     SPALAPPEVQ VDEQLMQQYQ QEMEQATALP LPDEDDADL
>P32836 nuc GTP-BINDING NUCLEAR PROTEIN GSP2/CNR2.
     MSAPAQNNAE VPTFKLVLVG DGGTGKTTFV KRHLTGEFEK KYIATIGVEV HPLSFYTNFG
     EIKFDVWDTA GQEKFGGLRD GYYINAQCAI IMFDVTSRIT YKNVPNWHRD LVRVCENIPI
     VLCGNKVDVK ERKVKAKTIT FHRKKNLQYY DISAKSNYNF EKPFLWLARK LAGNPQLEFV
     ASPALAPPEV QVDEQLMHQY QQEMDQATAL PLPDEDDADL
>P32849 nuc DNA REPAIR PROTEIN RAD5.
     MSHIEQEERK RFFNDDLDTS ETSLNFKSEN KESFLFANSH NDDDDDVVVS VSDTTEGEGD
     RSIVPVRREI EEEGQNQFIT ELLRIIPEMP KDLVMELNEK FGSQEEGLSL ALSHYFDHNS
     GTSISKIPSS PNQLNTLSDT SNSTLSPSSF HPKRRRIYGF RNQTRLEDKV TWKRFIGALQ
     VTGMATRPTV RPLKYGSQMK LKRSSEEISA TKVYDSRGRK KASMASLVRI FDIQYDREIG
     RVSEDIAQIL YPLLSSHEIS FEVTLIFCDN KRLSIGDSFI LQLDCFLTSL IFEERNDGES
     LMKRRRTEGG NKREKDNGNF GRTLTETDEE LESRSKRLAL LKLFDKLRLK PILDEQKALE
     KHKIELNSDP EIIDLDNDEI CSNQVTEVHN NLRDTQHEEE TMNLNQLKTF YKAAQSSESL
     KSLPETEPSR DVFKLELRNY QKQGLTWMLR REQEFAKAAS DGEASETGAN MINPLWKQFK
     WPNDMSWAAQ NLQQDHVNVE DGIFFYANLH SGEFSLAKPI LKTMIKGGIL SDEMGLGKTV
     AAYSLVLSCP HDSDVVDKKL FDIENTAVSD NLPSTWQDNK KPYASKTTLI VVPMSLLTQW
     SNEFTKANNS PDMYHEVYYG GNVSSLKTLL TKTKTPPTVV LTTYGIVQNE WTKHSKGRMT
     DEDVNISSGL FSVNFYRIII DEGHNIRNRT TVTSKAVMAL QGKCKWVLTG TPIINRLDDL
     YSLVKFLELD PWRQINYWKT FVSTPFESKN YKQAFDVVNA ILEPVLLRRT KQMKDKDGKP
     LVELPPKEVV IKRLPFSKSQ DLLYKFLLDK AEVSVKSGIA RGDLLKKYST ILVHILRLRQ
     VCCHPGLIGS QDENDEDLSK NNKLVTEQTV ELDSLMRVVS ERFDNSFSKE ELDAMIQRLK
     VKYPDNKSFQ SLECSICTTE PMDLDKALFT ECGHSFCEKC LFEYIEFQNS KNLGLKCPNC
     RNQIDACRLL ALVQTNSNSK NLEFKPYSPA SKSSKITALL KELQLLQDSS AGEQVVIFSQ
     FSTYLDILEK ELTHTFSKDV AKIYKFDGRL SLKERTSVLA DFAVKDYSRQ KILLLSLKAG
     GVGLNLTCAS HAYMMDPWWS PSMEDQAIDR LHRIGQTNSV KVMRFIIQDS IEEKMLRIQE
     KKRTIGEAMD TDEDERRKRR IEEIQMLFE
>P32863 nuc DNA REPAIR AND RECOMBINATION PROTEIN RAD54.
     MARRRLPDRP PNGIGAGERP RLVPRPINVQ DSVNRLTKPF RVPYKNTHIP PAAGRIATGS
     DNIVGGRSLR KRSATVCYSG LDINADEAEY NSQDISFSQL TKRRKDALSA QRLAKDPTRL
     SHIQYTLRRS FTVPIKGYVQ RHSLPLTLGM KKKITPEPRP LHDPTDEFAI VLYDPSVDGE
     MIVHDTSMDN KEEESKKMIK STQEKDNINK EKNSQEERPT QRIGRHPALM TNGVRNKPLR
     ELLGDSENSA ENKKKFASVP VVIDPKLAKI LRPHQVEGVR FLYRCVTGLV MKDYLEAEAF
     NTSSEDPLKS DEKALTESQK TEQNNRGAYG CIMADEMGLG KTLQCIALMW TLLRQGPQGK
     RLIDKCIIVC PSSLVNNWAN ELIKWLGPNT LTPLAVDGKK SSMGGGNTTV SQAIHAWAQA
     QGRNIVKPVL IISYETLRRN VDQLKNCNVG LMLADEGHRL KNGDSLTFTA LDSISCPRRV
     ILSGTPIQND LSEYFALLSF SNPGLLGSRA EFRKNFENPI LRGRDADATD KEITKGEAQL
     QKLSTIVSKF IIRRTNDILA KYLPCKYEHV IFVNLKPLQN ELYNKLIKSR EVKKVVKGVG
     GSQPLRAIGI LKKLCNHPNL LNFEDEFDDE DDLELPDDYN MPGSKARDVQ TKYSAKFSIL
     ERFLHKIKTE SDDKIVLISN YTQTLDLIEK MCRYKHYSAV RLDGTMSINK RQKLVDRFND
     PEGQEFIFLL SSKAGGCGIN LIGANRLILM DPDWNPAADQ QALARVWRDG QKKDCFIYRF
     ISTGTIEEKI FQRQSMKMSL SSCVVDAKED VERLFSSDNL RQLFQKNENT ICETHETYHC
     KRCNAQGKQL KRAPAMLYGD ATTWNHLNHD ALEKTNDHLL KNEHHYNDIS FAFQYISH
>P32892 nuc PUTATIVE ATP-DEPENDENT RNA HELICASE DRS1.
     MVVGTKKYSN LDFVPTISDS EDDVPILDSS DDEKVEAKKT TKKRKGKNNK KKVSEGDNLD
     EDVHEDLDAG FKFDLDADDT TSNFQGWNFL AEGESNKDDA EAFVKKDVDL DKIIRRKGGL
     VKMAHIDSKQ EEETEKEKVE KENDSDDEEL AMDGFGMGAP MNNGDENQSE EEEEEEEKEE
     EEEEEEEQEE MTLEKGGKDD EIDEEDDSEE AKADFYAPET EGDEAKKQMY ENFNSLSLSR
     PVLKGLASLG YVKPSPIQSA TIPIALLGKD IIAGAVTGSG KTAAFMIPII ERLLYKPAKI
     ASTRVIVLLP TRELAIQVAD VGKQIARFVS GITFGLAVGG LNLRQQEQML KSRPDIVIAT
     PGRFIDHIRN SASFNVDSVE ILVMDEADRM LEEGFQDELN EIMGLLPSNR QNLLFSATMN
     SKIKSLVSLS LKKPVRIMID PPKKAATKLT QEFVRIRKRD HLKPALLFNL IRKLDPTGQK
     RIVVFVARKE TAHRLRIIMG LLGMSVGELH GSLTQEQRLD SVNKFKNLEV PVLICTDLAS
     RGLDIPKIEV VINYDMPKSY EIYLHRVGRT ARAGREGRSV TFVGESSQDR SIVRAAIKSV
     EENKSLTQGK ALGRNVDWVQ IEETNKLVES MNDTIEDILV EEKEEKEILR AEMQLRKGEN
     MLKHKKEIQA RPRRTWFQSE SDKKNSKVLG ALSRNKKVTN SKKRKREEAK ADGNGARSYR
     KTKTDRIADQ ERTFKKQKST NSNKKKGFKS RR
>P32910 nuc DNA-DIRECTED RNA POLYMERASE III 36 KD POLYPEPTIDE (EC 2.7.7.6) (C34).
     MSGMIENGLQ LSDNAKTLHS QMMSKGIGAL FTQQELQKQM GIGSLTDLMS IVQELLDKNL
     IKLVKQNDEL KFQGVLESEA QKKATMSAEE ALVYSYIEAS GREGIWSKTI KARTNLHQHV
     VLKCLKSLES QRYVKSVKSV KFPTRKIYML YSLQPSVDIT GGPWFTDGEL DIEFINSLLT
     IVWRFISENT FPNGFKNFEN GPKKNVFYAP NVKNYSTTQE ILEFITAAQV ANVELTPSNI
     RSLCEVLVYD DKLEKVTHDC YRVTLESILQ MNQGEGEPEA GNKALEDEEE FSIFNYFKMF
     PASKHDKEVV YFDEWTI
>P32914 nuc TRANSCRIPTION INITIATION PROTEIN SPT4.
     MSSERACMLC GIVQTTNEFN RDGCPNCQGI FEEAGVSTME CTSPSFEGLV GMCKPTKSWV
     AKWLSVDHSI AGMYAIKVDG RLPAEVVELL PHYKPRDGSQ VE
>P33307 nuc CHROMOSOME SEGREGATION PROTEIN CSE1.
     MSDLETVAKF LAESVIASTA KTSERNLRQL ETQDGFGLTL LHVIASTNLP LSTRLAGALF
     FKNFIKRKWV DENGNHLLPA NNVELIKKEI VPLMISLPNN LQVQIGEAIS SIADSDFPDR
     WPTLLSDLAS RLSNDDMVTN KGVLTVAHSI FKRWRPLFRS DELFLEIKLV LDVFTAPFLN
     LLKTVDEQIT ANENNKASLN ILFDVLLVLI KLYYDFNCQD IPEFFEDNIQ VGMGIFHKYL
     SYSNPLLEDP DETEHASVLI KVKSSIQELV QLYTTRYEDV FGPMINEFIQ ITWNLLTSIS
     NQPKYDILVS KSLSFLTAVT RIPKYFEIFN NESAMNNITE QIILPNVTLR EEDVELFEDD
     PIEYIRRDLE GSDTDTRRRA CTDFLKELKE KNEVLVTNIF LAHMKGFVDQ YMSDPSKNWK
     FKDLYIYLFT ALAINGNITN AGVSSTNNLL NVVDFFTKEI APDLTSNNIP HIILRVDAIK
     YIYTFRNQLT KAQLIELMPI LATFLQTDEY VVYTYAAITI EKILTIRESN TSPAFIFHKE
     DISNSTEILL KNLIALILKH GSSPEKLAEN EFLMRSIFRV LQTSEDSIQP LFPQLLAQFI
     EIVTIMAKNP SNPRFTHYTF ESIGAILNYT QRQNLPLLVD SMMPTFLTVF SEDIQEFIPY
     VFQIIAFVVE QSATIPESIK PLAQPLLAPN VWELKGNIPA VTRLLKSFIK TDSSIFPDLV
     PVLGIFQRLI ASKAYEVHGF DLLEHIMLLI DMNRLRPYIK QIAVLLLQRL QNSKTERYVK
     KLTVFFGLIS NKLGSDFLIH FIDEVQDGLF QQIWGNFIIT TLPTIGNLLD RKIALIGVLN
     MVINGQFFQS KYPTLISSTM NSIIETASSQ SIANLKNDYV DLDNLEEIST FGSHFSKLVS
     ISEKPFDPLP EIDVNNGVRL YVAEALNKYN AISGNTFLNT ILPQLTQENQ VKLNQLLVGN
>P33308 nuc CHROMOSOME SEGREGATION PROTEIN CSE2.
     MNLQNNVLNQ IHQILLPTNP TLDKPNAEAT KEEFSSAENR DEKDYLTNQQ PKNLSTPSTS
     SNGEFIPHIF YSLHQIRKDP NNLSNQLETL TGSIRHRLKL CKSLISENED TKDLLSKSPS
     EWQDIIHQRE QELQIKRDVL DDLYRKLQR
>P33334 nuc PRE-MRNA SPLICING FACTOR PRP8.
     MSGLPPPPPG FEEDSDLALP PPPPPPPGYE IEELDNPMVP SSVNEDTFLP PPPPPPSNFE
     INAEEIVDFT LPPPPPPPGL DELETKAEKK VELHGKRKLD IGKDTFVTRK SRKRAKKMTK
     KAKRSNLYTP KAEMPPEHLR KIINTHSDMA SKMYNTDKKA FLGALKYLPH AILKLLENMP
     HPWEQAKEVK VLYHTSGAIT FVNETPRVIE PVYTAQWSAT WIAMRREKRD RTHFKRMRFP
     PFDDDEPPLS YEQHIENIEP LDPINLPLDS QDDEYVKDWL YDSRPLEEDS KKVNGTSYKK
     WSFDLPEMSN LYRLSTPLRD EVTDKNYYYL FDKKSFFNGK ALNNAIPGGP KFEPLYPREE
     EEDYNEFNSI DRVIFRVPIR SEYKVAFPHL YNSRPRSVRI PWYNNPVSCI IQNDEEYDTP
     ALFFDPSLNP IPHFIDNNSS LNVSNTKENG DFTLPEDFAP LLAEEEELIL PNTKDAMSLY
     HSPFPFNRTK GKMVRAQDVA LAKKWFLQHP DEEYPVKVKV SYQKLLKNYV LNELHPTLPT
     NHNKTKLLKS LKNTKYFQQT TIDWVEAGLQ LCRQGHNMLN LLIHRKGLTY LHLDYNFNLK
     PTKTLTTKER KKSRLGNSFH LMRELLKMMK LIVDTHVQFR LGNVDAFQLA DGIHYILNHI
     GQLTGIYRYK YKVMHQIRAC KDLKHIIYYK FNKNLGKGPG CGFWQPAWRV WLNFLRGTIP
     LLERYIGNLI TRQFEGRSNE IVKTTTKQRL DAYYDLELRN SVMDDILEMM PESIRQKKAR
     TILQHLSEAW RCWKANIPWD VPGMPAPIKK IIERYIKSKA DAWVSAAHYN RERIKRGAHV
     EKTMVKKNLG RLTRLWIKNE QERQRQIQKN GPEITPEEAT TIFSVMVEWL ESRSFSPIPF
     PPLTYKNDTK ILVLALEDLK DVYASKVRLN ASEREELALI EEAYDNPHDT LNRIKKYLLT
     QRVFKPVDIT MMENYQNISP VYSVDPLEKI TDAYLDQYLW YEADQRKLFP NWIKPSDSEI
     PPLLVYKWTQ GINNLSEIWD VSRGQSAVLL ETTLGEMAEK IDFTLLNRLL RLIVDPNIAD
     YITAKNNVVI NFKDMSHVNK YGLIRGLKFA SFIFQYYGLV IDLLLLGQER ATDLAGPANN
     PNEFMQFKSK EVEKAHPIRL YTRYLDRIYM LFHFEEDEGE ELTDEYLAEN PDPNFENSIG
     YNNRKCWPKD SRMRLIRQDV NLGRAVFWEI QSRVPTSLTS IKWENAFVSV YSKNNPNLLF
     SMCGFEVRIL PRQRMEEVVS NDEGVWDLVD ERTKQRTAKA YLKVSEEEIK KFDSRIRGIL
     MASGSTTFTK VAAKWNTSLI SLFTYFREAI VATEPLLDIL VKGETRIQNR VKLGLNSKMP
     TRFPPAVFYT PKELGGLGMI SASHILIPAS DLSWSKQTDT GITHFRAGMT HEDEKLIPTI
     FRYITTWENE FLDSQRVWAE YATKRQEAIQ QNRRLAFEEL EGSWDRGIPR ISTLFQRDRH
     TLAYDRGHRI RREFKQYSLE RNSPFWWTNS HHDGKLWNLN AYRTDVIQAL GGIETILEHT
     LFKGTGFNSW EGLFWEKASG FEDSMQFKKL THAQRTGLSQ IPNRRFTLWW SPTINRANVY
     VGFLVQLDLT GIFLHGKIPT LKISLIQIFR AHLWQKIHES IVFDICQILD GELDVLQIES
     VTKETVHPRK SYKMNSSAAD ITMESVHEWE VSKPSLLHET NDSFKGLITN KMWFDVQLRY
     GDYDSHDISR YVRAKFLDYT TDNVSMYPSP TGVMIGIDLA YNMYDAYGNW FNGLKPLIQN
     SMRTIMKANP ALYVLRERIR KGLQIYQSSV QEPFLNSSNY AELFNNDIKL FVDDTNVYRV
     TVHKTFEGNV ATKAINGCIF TLNPKTGHLF LKIIHTSVWA GQKRLSQLAK WKTAEEVSAL
     VRSLPKEEQP KQIIVTRKAM LDPLEVHMLD FPNIAIRPTE LRLPFSAAMS IDKLSDVVMK
     ATEPQMVLFN IYDDWLDRIS SYTAFSRLTL LLRALKTNEE SAKMILLSDP TITIKSYHLW
     PSFTDEQWIT IESQMRDLIL TEYGRKYNVN ISALTQTEIK DIILGQNIKA PSVKRQKMAE
     LEAARSEKQN DEEAAGASTV MKTKTINAQG EEIVVVASAD YESQTFSSKN EWRKSAIANT
     LLYLRLKNIY VSADDFVEEQ NVYVLPKNLL KKFIEISDVK IQVAAFIYGM SAKDHPKVKE
     IKTVVLVPQL GHVGSVQISN IPDIGDLPDT EGLELLGWIH TQTEELKFMA ASEVATHSKL
     FADKKRDCID ISIFSTPGSV SLSAYNLTDE GYQWGEENKD IMNVLSEGFE PTFSTHAQLL
     LSDRITGNFI IPSGNVWNYT FMGTAFNQEG DYNFKYGIPL EFYNEMHRPV HFLQFSELAG
     DEELEAEQID VFS
>P33339 nuc TRANSCRIPTION FACTOR TAU 131 KD SUBUNIT (TFIIIC 131 KD SUBUNIT).
     MAAGKLKKEQ QNQSAERESA DTGKVNDEDE EHLYGNIDDY KHLIQDEEYD DEDVPHDLQL
     SEDEYNSERD SSLLAEFSDY GEISEDDEED FMNAIREASN FKVKKKKKND KGKSYGRQRK
     ERVLDPEVAQ LLSQANEAFV RNDLQVAERL FNEVIKKDAR NFAAYETLGD IYQLQGRLND
     CCNSWFLAAH LNASDWEFWK IVAILSADLD HVRQAIYCFS RVISLNPMEW ESIYRRSMLY
     KKTGQLARAL DGFQRLYMYN PYDANILREL AILYVDYDRI EDSIELYMKV FNANVERREA
     ILAALENALD SSDEESAAEG EDADEKEPLE QDEDRQMFPD INWKKIDAKY KCIPFDWSSL
     NILAELFLKL AVSEVDGIKT IKKCARWIQR RESQTFWDHV PDDSEFDNRR FKNSTFDSLL
     AAEKEKSYNI PIDIRVRLGL LRLNTDNLVE ALNHFQCLYD ETFSDVADLY FEAATALTRA
     EKYKEAIDFF TPLLSLEEWR TTDVFKPLAR CYKEIESYET AKEFYELAIK SEPDDLDIRV
     SLAEVYYRLN DPETFKHMLV DVVEMRKHQV DETLHRISNE KSSNDTSDIS SKPLLEDSKF
     RTFRKKKRTP YDAERERIER ERRITAKVVD KYEKMKKFEL NSGLNEAKQA SIWINTVSEL
     VDIFSSVKNF FMKSRSRKFV GILRRTKKFN TELDFQIERL SKLAEGDSVF EGPLMEERVT
     LTSATELRGL SYEQWFELFM ELSLVIAKYQ SVEDGLSVVE TAQEVNVFFQ DPERVKMMKF
     VKLAIVLQMD DEEELAENLR GLLNQFQFNR KVLQVFMYSL CRGPSSLNIL SSTIQQKFFL
     RQLKAFDSCR YNTEVNGQAS ITNKEVYNPN KKSSPYLYYI YAVLLYSSRG FLSALQYLTR
     LEEDIPDDPM VNLLMGLSHI HRAMQRLTAQ RHFQIFHGLR YLYRYHKIRK SLYTDLEKQE
     ADYNLGRAFH LIGLVSIAIE YYNRVLENYD DGKLKKHAAY NSIIIYQQSG NVELADHLME
     KYLSI
>P33400 nuc REGULATORY PROTEIN RIM101 (PROTEIN RIM1).
     MVPLEDLLNK ENGTAAPQHS RESIVENGTD VSNVTKKDGL PSPNLSKRSS DCSKRPRIRC
     TTEAIGLNGQ EDERMSPGST SSSCLPYHST SHLNTPPYDL LGASAVSPTT SSSSDSSSSS
     PLAQAHNPAG DDDDADNDGD SEDITLYCKW DNCGMIFNQP ELLYNHLCHD HVGRKSHKNL
     QLNCHWGDCT TKTEKRDHIT SHLRVHVPLK PFGCSTCSKK FKRPQDLKKH LKIHLESGGI
     LKRKRGPKWG SKRTSKKNKS CASDAVSSCS ASVPSAIAGS FKSHSTSPQI LPPLPVGISQ
     HLPSQQQQRA ISLNQLCSDE LSQYKPVYSP QLSARLQTIL PPLYYNNGST VSQGANSRSM
     NVYEDGCSNK TIANATQFFT KLSRNMTNNY ILQQSGGSTE SSSSSGRIPV AQTSYVQPPN
     APSYQSVQGG SSISATANTA TYVPVRLAKY PTGPSLTEHL PPLHSNTAGG VFNRQSQYAM
     PHYPSVRAAP SYSSSGCSIL PPLQSKIPML PSRRTMAGGT SLKPNWEFSL NQKSCTNDII
     MSKLAIEEVD DESEIEDDFV EMLGIVNIIK DYLLCCVMED LDDEESEDKD EENAFLQESL
     EKLSLQNQMG TNSVRILTKY PKILV
>P33411 nuc PRE-MRNA SPLICING FACTOR PRP18.
     MDLDLASILK GEISKKKKEL ANSKGVQPPC TEKFQPHESA NIDETPRQVE QESTDEENLS
     DNQSDDIRTT ISKLENRPER IQEAIAQDKT ISVIIDPSQI GSTEGKPLLS MKCNLYIHEI
     LSRWKASLEA YHPELFLDTK KALFPLLLQL RRNQLAPDLL ISLATVLYHL QQPKEINLAV
     QSYMKLSIGN VAWPIGVTSV AFMLVVHIRK FKEAGMLLT
>P33417 nuc INTRASTRAND CROSSLINK RECOGNITION PROTEIN (STRUCTURE-SPECIFIC
     MNTGISPKQD DASNSNLLNI GQDHSLQYQG LEHNDSQYRD ASHQTPHQYL NQFQAQPQQQ
     QQQQQQQQQQ QQQAPYQGHF QQSPQQQQQN VYYPLPPQSL TQPTSQSQQQ QQQQQQQQYA
     NSNSNSNNNV NVNALPQDFG YMQQTGSGQN YPTINQQQFS EFYNSFLSHL TQKQTNPSVT
     GTGASSNNNS NNNNVSSGNN STSSNPAQLA ASQLNPATAA AAAANNAAGP ASYLSQLPQV
     QRYYPNNMNA LSSLLDPSSA GNAAGNANTA THPGLLPPNL QPQLTHHQQQ MQQQLQLQQQ
     QQLQQQQQLQ QQHQLQQQQQ LQQQHHHLQQ QQQQQQHPVV KKLSSTQSRI ERRKQLKKQG
     PKRPSSAYFL FSMSIRNELL QQFPEAKVPE LSKLASARWK ELTDDQKKPF YEEFRTNWEK
     YRVVRDAYEK TLPPKRPSGP FIQFTQEIRP TVVKENPDKG LIEITKIIGE RWRELDPAKK
     AEYTETYKKR LKEWESCYPD ENDPNGNPTG HSHKAMNMNL NMDTKIMENQ DSIEHITANA
     IDSVTGSNSN STNPNTPVSP PISLQQQPLQ QQQQQQQQQQ HMLLADPTTN GSIIKNE
>P33418 nuc LOS1 PROTEIN.
     MLERIQQLVN AVNDPRSDVA TKRQAIELLN GIKSSENALE IFISLVINEN SNDLLKFYGL
     STLIELMTEG VNANPNGLNL VKFEITKWLK FQVLGNKQTK LPDFLMNKIS EVLTTLFMLM
     YSDCNGNQWN SFFDDLMSLF QVDSAISNTS PSTDGNILLG LEFFNKLCLM INSEIADQSF
     IRSKESQLKN NNIKDWMRDN DIMKLSNVWF QCLKLDEQIV SQCPGLINST LDCIGSFISW
     IDINLIIDAN NYYLQLIYKF LNLKETKISC YNCILAIISK KMKPMDKLAF LNMINLTNEL
     TYYHQAISMN PQIITFDNLE VWESLTKLIT SFGIEFTIII EQVNDDQKLD TLYKQSVISN
     VDSILLEKII PILLEFMNNE FDSITAKTFP FWSNYLAFLK KYKASSPNFV PLHKDFLDNF
     QQICFKRMKF SDDEVTQDDF EEFNETVRFK LKNFQEIIVV IDPSLFLNNI SQEISANLMN
     CKNESWQIFE LTIYQIFNLS ECTKNNYFGL NKNEIMTSQP SLTLVRFLNE LLMMKDFLLA
     IDNEQIQILF MELIVKNYNF IFSTSANTAN ATDDDEKYLL ILNIFMSSFA MFNKRENVRL
     RSWYLFTRFL KLTRINLKKI LFANKNLVNE ITNKISPLLH IKVTSINAQG TDDNDTIFDN
     QLYIFEGIGF IITLNNSSQE LTAATANTPI DYDILDQILT PLFTQLEGCI TQGASPVVIL
     ECHHILMAIG TLARGLHIGL VPENQVNNMV VNKKLINDSL IHKFSNIAEV ILVTFSFFNK
     FENIRDASRF TFARLIPILS NKILPFINKL IELILSSTDL KSWEMIDFLG FLSQLIHMFH
     TDTDCYQLFN QLLTPLINKV HSIIEEIDEQ HDQQSSSNKP IDTAVTATSV NKNIVVTDSY
     RDKILLKKAY CTFLQSFTNN SVTSILLSDI NRAILPVILN DLVTYTPQEI QETSMMKVSL
     NVLCNFIKCF GNGTCLDNDD INKDPNLKID GLNEYFIMKC VPIIFEIPFN PIYKFNIKEG
     NFKTMAYDLA RLLRELFIVS SNPTTNENEC VKYLTQIYLP QIQLPQELTI QLVNMLTTMG
     QKQFEKWFVD NFISVLKQGQ
>P33748 nuc ZINC FINGER PROTEIN MSN2 (MULTICOPY SUPPRESSOR OF SNF1 PROTEIN 2).
     MTVDHDFNSE DILFPIESMS SIQYVENNNP NNINNDVIPY SLDIKNTVLD SADLNDIQNQ
     ETSLNLGLPP LSFDSPLPVT ETIPSTTDNS LHLKADSNKN RDARTIENDS EIKSTNNASG
     SGANQYTTLT SPYPMNDILY NMNNPLQSPS PSSVPQNPTI NPPINTASNE TNLSPQTSNG
     NETLISPRAQ QHTSIKDNRL SLPNGANSNL FIDTNPNNLN EKLRNQLNSD TNSYSNSISN
     SNSNSTGNLN SSYFNSLNID SMLDDYVSSD LLLNDDDDDT NLSRRRFSDV ITNQFPSMTN
     SRNSISHSLD LWNHPKINPS NRNTNLNITT NSTSSSNASP NTTTMNANAD SNIAGNPKNN
     DATIDNELTQ ILNEYNMNFN DNLGTSTSGK NKSACPSSFD ANAMTKINPS QQLQQQLNRV
     QHKQLTSSHN NSSTNMKSFN SDLYSRRQRA SLPIIDDSLS YDLVNKQDED PKNDMLPNSN
     LSSSQQFIKP SMILSDNASV IAKVATTGLS NDMPFLTEEG EQNANSTPNF DLSITQMNMA
     PLSPASSSST SLATNHFYHH FPQQGHHTMN SKIGSSLRRR KSAVPLMGTV PLTNQQNNIS
     SSSVNSTGNG AGVTKERRPS YRRKSMTPSR RSSVVIESTK ELEEKPFHCH ICPKSFKRSE
     HLKRHVRSVH SNERPFACHI CDKKFSRSDN LSQHIKTHKK HGDI
>P33749 nuc ZINC FINGER PROTEIN MSN4 (MULTICOPY SUPPRESSOR OF SNF1 PROTEIN 4).
     MLVFGPNSSF VRHANKKQED SSIMNEPNGL MDPVLSTTNV SATSSNDNSA NNSISSPEYT
     FGQFSMDSPH RTDATNTPIL TATTNTTANN SLMNLKDTAS LATNWKWKNS NNAQFVNDGE
     KQSSNANGKK NGGDKIYSSV ATPQALNDEL KNLEQLEKVF SPMNPINDSH FNENIELSPH
     QHATSPKTNL LEAEPSIYSN LFLDARLPNN ANSTTGLNDN DYNLDDTNND NTNSMQSILE
     DFVSSEEALK FMPDAGRDAR RYSEVVTSSF PSMTDSRNSI SHSIEFWNLN HKNSSNSKPT
     QQIIPEGTAT TERRGSTISP TTTINNSNPN FKLLDHDVSQ ALSGYSMDFS KDSGITKPKS
     ISSSLNRISH SSSTTRQQRA SLPLIHDIES FANDSVMANP LSDSASFLSE ENEDDAFGAL
     NYNSLDATTM SAFDNNVDPF NILKSSPAQD QQFIKPSMML SDNASAAAKL ATSGVDNITP
     TPAFQRRSYD ISMNSSFKIL PTSQAHHAAQ HHQQQPTKQA TVSPNTRRRK SSSVTLSPTI
     SHNNNNGKVP VQPRKRKSIT TIDPNNYDKN KPFKCKDCEK AFRRSEHLKR HIRSVHSTER
     PFACMFCEKK FSRSDNLSQH LKTHKKHGDF
>P33895 nuc MYOSIN-LIKE PROTEIN NUF2 (NUCLEAR FILAMENT-CONTAINING PROTEIN 2)
     MSRNQDVFPI LDLQELVICL QSCDFALATQ ENISRPTSDY MVTLYKQIIE NFMGISVESL
     LNSSNQETGD GHLQEENENI YLDTLNVLVL NKICFKFFEN IGVQDFNMTD LYKPEAQRTQ
     RLLSAVVNYA RFREERMFDC NSFILQMESL LGQLRSKFDD YNLIQQQLKQ YEDVDGDNIP
     DEQELQKLEE QNKELEIQLK KLTKIQETLS IDYNDYKISK QSIFKDLEAL SFQIVELESN
     RDKLIKISNT DMEELSEGIK ELNDLLIQRK KTLDDLTAQQ KNLQDTVTTF ETIISELYDV
     LRIISSEVQE SNRTETELVG LKQNLINNKL KLMNVLETGI MYKLEILQEQ LDLQLKNLEK
     LSQDTKEESR LNDTKLMDLQ IKYENEIKPK IDKTDIFIQE ELISGKINKL NDEIKQLQKD
     FEVEVKEIEI EYSLLSGHIN KYMNEMLEYM Q
>P34072 nuc NEGATIVE REGULATOR OF RAS-CAMP PATHWAY.
     MSREAFDVPN IGTNKFLKVT PNLFTPERLN LFDDVELYLT LIKASKCVEQ GERLHNISWR
     ILNKAVLKEH NINRSKKRDG VKNIYYVLNP NNKQPIKPKQ AAVKQPPLQK ANLPPTTAKQ
     NVLTRPMTSP AIAQGAHDRS LDNPNSTNND VKNDVAPNRQ FSKSTTSGLF SNFADKYQKM
     KNVNHVANKE EPQTIITGFD TSTVITKKPL QSRRSRSPFQ HIGDMNMNCI DNETSKSTSP
     TLENMGSRKS SFPQKESLFG RPRSYKNDQN GQLSLSKTSS RKGKNKIFFS SEDEDSDWDS
     VSNDSEFYAD EDDEEYDDYN EEEADQYYRR QWDKLLFAKN QQNLDSTKSS VSSANTINSN
     TSHDPVRKSL LSGLFLSEAN SNSNNHNTAH SEYASKHVSP TPQSSHSNIG PQPQQNPPSA
     NGIKQQKPSL KTSNVTALAS LSPPQPSNNE RLSMDIQKDF KTDNESNHLY ESNAPLTAQT
     ILPTALSTHM FLPNNIHQQR MAIATGSNTR HRFSRRQSMD IPSKNRNTGF LKTRMEISEE
     EKMVRTISRL DNTSIANSNG NGNDDTSNQR TEALGRKTSN GGRI
>P34087 nuc DNA-DIRECTED RNA POLYMERASE II 19 KD POLYPEPTIDE (EC 2.7.7.6) (B16).
     MFFIKDLSLN ITLHPSFFGP RMKQYLKTKL LEEVEGSCTG KFGYILCVLD YDNIDIQRGR
     ILPTDGSAEF NVKYRAVVFK PFKGEVVDGT VVSCSQHGFE VQVGPMKVFV TKHLMPQDLT
     FNAGSNPPSY QSSEDVITIK SRIRVKIEGC ISQVSSIHAI GSIKEDYLGA I
>P34111 nuc TRANSCRIPTION FACTOR TAU 138 KD SUBUNIT (TFIIIC 138 KD SUBUNIT).
     MVLTIYPDEL VQIVSDKIAS NKGKITLNQL WDISGKYFDL SDKKVKQFVL SCVILKKDIE
     VYCDGAITTK NVTDIIGDAN HSYSVGITED SLWTLLTGYT KKESTIGNSA FELLLEVAKS
     GEKGINTMDL AQVTGQDPRS VTGRIKKINH LLTSSQLIYK GHVVKQLKLK KFSHDGVDSN
     PYINIRDHLA TIVEVVKRSK NGIRQIIDLK RELKFDKEKR LSKAFIAAIA WLDEKEYLKK
     VLVVSPKNPA IKIRCVKYVK DIPDSKGSPS FEYDSNSADE DSVSDSKAAF EDEDLVEGLD
     NFNATDLLQN QGLVMEEKED AVKNEVLLNR FYPLQNQTYD IADKSGLKGI STMDVVNRIT
     GKEFQRAFTK SSEYYLESVD KQKENTGGYR LFRIYDFEGK KKFFRLFTAQ NFQKLTNAED
     EISVPKGFDE LGKSRTDLKT LNEDNFVALN NTVRFTTDSD GQDIFFWHGE LKIPPNSKKT
     PNKNKRKRQV KNSTNASVAG NISNPKRIKL EQHVSTAQEP KSAEDSPSSN GGTVVKGKVV
     NFGGFSARSL RSLQRQRAIL KVMNTIGGVA YLREQFYESV SKYMGSTTTL DKKTVRGDVD
     LMVESEKLGA RTEPVSGRKI IFLPTVGEDA IQRYILKEKD SKKATFTDVI HDTEIYFFDQ
     TEKNRFHRGK KSVERIRKFQ NRQKNAKIKA SDDAISKKST SVNVSDGKIK RRDKKVSAGR
     TTVVVENTKE DKTVYHAGTK DGVQALIRAV VVTKSIKNEI MWDKITKLFP NNSLDNLKKK
     WTARRVRMGH SGWRAYVDKW KKMLVLAIKS EKISLRDVEE LDLIKLLDIW TSFDEKEIKR
     PLFLYKNYEE NRKKFTLVRD DTLTHSGNDL AMSSMIQREI SSLKKTYTRK ISASTKDLSK
     SQSDDYIRTV IRSILIESPS TTRNEIEALK NVGNESIDNV IMDMAKEKQI YLHGSKLECT
     DTLPDILENR GNYKDFGVAF QYRCKVNELL EAGNAIVINQ EPSDISSWVL IDLISGELLN
     MDVIPMVRNV RPLTYTSRRF EIRTLTPPLI IYANSQTKLN TARKSAVKVP LGKPFSRLWV
     NGSGSIRPNI WKQVVTMVVN EIIFHPGITL SRLQSRCREV LSLHEISEIC KWLLERQVLI
     TTDFDGYWVN HNWYSIYEST
>P34161 nuc HOMEOBOX PROTEIN YOX1.
     MSQETKMLPS LSSLLSGTEI SSSPVSPSFT NPRTSFHLDD RGTIKLPPLN TSINRPRSVE
     SALRHTVTSL HENSSAYGDD MLKHTQSDSA LSSQLNSSQE TVDESHENLL LTPLNSKKRD
     YSVSSKKNDI LTPLSAAKSI IIPSASKEKR RAFAFITHSQ ETFPKKEPKI DNAPLARRKR
     RRTSSQELSI LQAEFEKCPA PSKEKRIELA ESCHMTEKAV QIWFQNKRQA VKRQRIATSK
     STTIIQTVSP PSPPLDVHAT PLASRVKADI LRDGSSCSRS SSSSPLENTP PRPHHSLNRR
     SSTPSIKRSQ ALTFHLNPQK KTLTPVKTSP NSRVNKLINS IDHSPSKAKR PVSNPSGSPK
     RKRKFGFKIV DQQPLKDLDP NAFRG
>P34232 nuc MRNA TRANSPORT REGULATOR MTR2.
     MNTNSNTMVM NDANQAQITA TFTKKILAHL DDPDSNKLAQ FVQLFNPNNC RIIFNATPFA
     QATVFLQMWQ NQVVQTQHAL TGVDYHAIPG SGTLICNVNC KVRFDESGRD KMGQDATVPI
     QPNNTGNRNR PNDMNKPRPL WGPYFGISLQ LIIDDRIFRN DFNGVISGFN YNMVYKPEDS
     LLKI
>P35177 nuc TRANSCRIPTIONAL ACTIVATOR SPT7.
     MTERIPIKNY QRTNAKALLK LTEKLFNKNF FDLYLTSQQL VVLEYLLSIS SEEDKLKAWD
     YFLKGNIALN VEKSFPLTQE EEHHGAVSPA VDTRSDDVSS QTIKDNNNTN TNTSISNENH
     VENEIEDKGD NAIANEDNFV NNDESDNVEE DLFKLDLEDL KQQISGTRFI GNLSLKIRYV
     LWQCAIDYIY CDRNEFGDEN DTEYTLLDVE EKEEEEIGKN EKPQNKEGIS KFAEDEDYDD
     EDENYDEDST DVKNVDDPPK NLDSISSSNI EIDDERRLVL NISISKETLS KLKTNNVEEI
     MGNWNKIYHS FEYDKETMIK RLKLEESDKM IEKGKKKRSR SDLEAATDEQ DRENTNDEPD
     TNQKLPTPEG STFSDTGNKR PKQSNLDLTV NLGIENLSLK HLLSSIQQKK SQLGISDYEL
     KHLIMDVRKN RSKWTSDERI GQEELYEACE KVVLELRNYT EHSTPFLNKV SKREAPNYHQ
     IIKKSMDLNT VLKKLKSFQY DSKQEFVDDI MLIWKNCLTY NSDPSHFLRG HAIAMQKKSL
     QLIRMIPNIT IRNRADLEKE IEDMEKDKDY ELDEEEEVAG SGRKGLNMGA HMLAKENGKV
     SEKDSSKTVK DEAPTNDDKL TSVIPEGEKE KDKTASSTVT VHENVNKNEI KENGKNEEQD
     MVEESSKTED SSKDADAAKK DTEDGLQDKT AENKEAGENN EEEEDDDDED EDEDMVDSQS
     YLLEKDDDRD DLEISVWKTV TAKVRAEICL KRTEYFKNGK LNSDSEAFLK NPQRMKRFDQ
     LFLEYKEQKA LESYRQKIEQ NSIMKNGFGT VLKQEDDDQL QFHNDHSLNG NEAFEKQPND
     IELDDTRFLQ EYDISNAIPD IVYEGVNTKT LDKMEDASVD RMLQNGINKQ SRFLANKDLG
     LTPKMNQNIT LIQQIRHICH KISLIRMLQS PLSAQNSRSN PNAFLNNHIY NYTIIDDSLD
     IDPVSQLPTH DYKNNRELIW KFMHKNISKV AMANGFETAH PSAINMLTEI AGDYLSNLIK
     TLKLHHETNS LNRGTNVEML QTTLLENGIN RPDDLFSYVE SEFGKKTKKL QDIKQKLESF
     LRALLRPTLQ ELSERNFEDE SQSFFTGDFA SELTGEDFFG FRELGLEKEF GVLSSSVPLQ
     LLTTQFQTVD GETKVQAKKI QPEESDSIVY KKITKGMLDA GSFWNTLLPL LQKDYERSKA
     YIAKQSKSSA NDKTSMTSTE DNSFALLEED QFVSKKTATK ARLPPTGKIS TTYKKKPIAS
     AFILPEEDLE NDVKADPTTT VNAKVGAEND GDSSLFLRTP QPLDPLDMDD AFDDTNMGSN
     SSFSLSLPRL NQ
>P35187 nuc HELICASE SGS1 (HELICASE TPS1).
     MVTKPSHNLR REHKWLKETA TLQEDKDFVF QAIQKHIANK RPKTNSPPTT PSKDECGPGT
     TNFITSIPAS GPTNTATKQH EVMQTLSNDT EWLSYTATSN QYADVPMVDI PASTSVVSNP
     RTPNGSKTHN FNTFRPHMAS SLVENDSSRN LGSRNNNKSV IDNSSIGKQL ENDIKLEVIR
     LQGSLIMALK EQSKLLLQKC SIIESTSLSE DAKRLQLSRD IRPQLSNMSI RIDSLEKEII
     KAKKDGMSKD QSKGRSQVSS QDDNIISSIL PSPLEYNTSS RNSNLTSTTA TTVTKALAIT
     GAKQNITNNT GKNSNNDSNN DDLIQVLDDE DDIDCDPPVI LKEGAPHSPA FPHLHMTSEE
     QDELTRRRNM RSREPVNYRI PDRDDPFDYV MGKSLRDDYP DVEREEDELT MEAEDDAHSS
     YMTTRDEEKE ENELLNQSDF DFVVNDDLDP TQDTDYHDNM DVSANIQESS QEGDTRSTIT
     LSQNKNVQVI LSSPTAQSVP SNGQNQIGVE HIDLLEDDLE KDAILDDSMS FSFGRQHMPM
     SHSDLELIDS EKENEDFEED NNNNGIEYLS DSDLERFDEE RENRTQVADI QELDNDLKII
     TERKLTGDNE HPPPSWSPKI KREKSSVSQK DEEDDFDDDF SLSDIVSKSN LSSKTNGPTY
     PWSDEVLYRL HEVFKLPGFR PNQLEAVNAT LQGKDVFVLM PTGGGKSLCY QLPAVVKSGK
     THGTTIVISP LISLMQDQVE HLLNKNIKAS MFSSRGTAEQ RRQTFNLFIN GLLDLVYISP
     EMISASEQCK RAISRLYADG KLARIVVDEA HCVSNWGHDF RPDYKELKFF KREYPDIPMI
     ALTATASEQV RMDIIHNLEL KEPVFLKQSF NRTNLYYEVN KKTKNTIFEI CDAVKSRFKN
     QTGIIYCHSK KSCEQTSAQM QRNGIKCAYY HAGMEPDERL SVQKAWQADE IQVICATVAF
     GMGIDKPDVR FVYHFTVPRT LEGYYQETGR AGRDGNYSYC ITYFSFRDIR TMQTMIQKDK
     NLDRENKEKH LNKLQQVMAY CDNVTDCRRK LVLSYFNEDF DSKLCHKNCD NCRNSANVIN
     EERDVTEPAK KIVKLVESIQ NERVTIIYCQ DVFKGSRSSK IVQANHDTLE EHGIGKSMQK
     SEIERIFFHL ITIRVLQEYS IMNNSGFASS YVKVGPNAKK LLTGKMEIKM QFTISAPNSR
     PSTSSSFQAN EDNIPVIAQK STTIGGNVAA NPPRFISAKE HLRSYTYGGS TMGSSHPITL
     KNTSDLRSTQ ELNNLRMTYE RLRELSLNLG NRMVPPVGNF MPDSILKKMA AILPMNDSAF
     ATLGTVEDKY RRRFKYFKAT IADLSKKRSS EDHEKYDTIL NDEFVNRAAA SSNGIAQSTG
     TKSKFFGANL NEAKENEQII NQIRQSQLPK NTTSSKSGTR SISKSSKKSA NGRRGFRNYR
     GHYRGRK
>P35189 nuc TRANSCRIPTION INITIATION FACTOR TFIIF SMALL SUBUNIT (TRANSCRIPTION
     MVATVKRTIR IKTQQHILPE VPPVENFPVR QWSIEIVLLD DEGKEIPATI FDKVIYHLHP
     TFANPNRTFT DPPFRIEEQG WGGFPLDISV FLLEKAGERK IPHDLNFLQE SYEVEHVIQI
     PLNKPLLTEE LAKSGSTEET TANTGTIGKR RTTTNTTAEP KAKRAKTGSA STVKGSVDLE
     KLAFGLTKLN EDDLVGVVQM VTDNKTPEMN VTNNVEEGEF IIDLYSLPEG LLKSLWDYVK
     KNTE
>P35192 nuc METAL BINDING ACTIVATOR 1.
     MIIFNGNKYA CASCIRGHRS STCRHSHRML IKVRTRGRPS PMAIRDAILV DSTSQSTEYE
     NGAQIEGDCC SAMNQQPILF VRASAVRKAR MINGKLHILM EEGFTAHEPK DISTFTDDGN
     KYITETEFLR KHSPKAPATG TISPDSTKSS SSSEKKERSR LQQEPIRHFS NCCKKDKSQN
     PASNGKTNKA PSDDIFTPYG SLESTSAFND ILQENYNSSV PGAHDSSETL TPQSTTTIAA
     PHSSDVASKV EVLTHKGIFL STQCSCEDES CPCVNCLIHR SEEELNSYIQ QSGVPLTNIG
     EAQITDKMMD YLDDCKCTDK ECICPPDNCT CDGCFSHSTN IIPFEKFFFY GILNARLTRK
     TQIKFKGKLV PSKYWWDFLK LQVPLMTDAQ LELLDIHAWF QKLVSNYAPH LSDATTS
>P36012 nuc CHROMATIN ASSIOCIATED PROTEIN CSE4.
     MSSKQQWVSS AIQSDSSGRS LSNVNRLAGD QQSINDRALS LLQRTRATKN LFPRREERRR
     YESSKSDLDI ETDYEDQAGN LEIETENEEE AEMETEVPAP VRTHSYALDR YVRQKRREKQ
     RKQSLKRVEK KYTPSELALY EIRKYQRSTD LLISKIPFAR LVKEVTDEFT TKDQDLRWQS
     MAIMALQEAS EAYLVGLLEH TNLLALHAKR ITIMKKDMQL ARRIRGQFI
>P36094 nuc SPINDLE POLE BODY COMPONENT SPC42.
     MNGSPTPKRY SSKSSRLYDD YYNIPYQYSN PTPMNRDYND VGSRINADKL VPEEYKRNTE
     FINKAVQQNK ELNFKLREKQ NEIFELKKIA ETLRSKLEKY VDITKKLEDQ NLNLQIKISD
     LEKKLSDANS TFKEMRFPKV KDPMVDDDPV SENYDQINVP KHRAPDATGN PRTTNKVSNT
     SDQDSRLKAI ERTLSVLTNY VMRSEDGNND RMSPLPSPLN TILPINNRLN FQEPKRYNPT
     VKVNPSDDDI MMYESAELKR VEEEIEELKR KILVRKKHDL RKLSLNNQLQ ELQSMMDGDD
     NIKLDNVSKH NHATHRHSSQ SSRDYSPSSD ACLECSNDLY EKNRVKPENN MSETFATPTP
     NNR
>P38042 nuc CELL DIVISION CONTROL PROTEIN 27.
     MAVNPELAPF TLSRGIPSFD DQALSTIIQL QDCIQQAIQQ LNYSTAEFLA ELLYAECSIL
     DKSSVYWSDA VYLYALSLFL NKSYHTAFQI SKEFKEYHLG IAYIFGRCAL QLSQGVNEAI
     LTLLSIINVF SSNSSNTRIN MVLNSNLVHI PDLATLNCLL GNLYMKLDHS KEGAFYHSEA
     LAINPYLWES YEAICKMRAT VDLKRVFFDI AGKKSNSHNN NAASSFPSTS LSHFEPRSQP
     SLYSKTNKNG NNNINNNVNT LFQSSNSPPS TSASSFSSIQ HFSRSQQQQA NTSIRTCQNK
     NTQTPKNPAI NSKTSSALPN NISMNLVSPS SKQPTISSLA KVYNRNKLLT TPPSKLLNND
     RNHQNNNNNN NNNNNNNNNN NNNNNNNNII NKTTFKTPRN LYSSTGRLTT SKKNPRSLII
     SNSILTSDYQ ITLPEIMYNF ALILRSSSQY NSFKAIRLFE SQIPSHIKDT MPWCLVQLGK
     LHFEIINYDM SLKYFNRLKD LQPARVKDME IFSTLLWHLH DKVKSSNLAN GLMDTMPNKP
     ETWCCIGNLL SLQKDHDAAI KAFEKATQLD PNFAYAYTLQ GHEHSSNDSS DSAKTCYRKA
     LACDPQHYNA YYGLGTSAMK LGQYEEALLY FEKARSINPV NVVLICCCGG SLEKLGYKEK
     ALQYYELACH LQPTSSLSKY KMGQLLYSMT RYNVALQTFE ELVKLVPDDA TAHYLLGQTY
     RIVGRKKDAI KELTVAMNLD PKGNQVIIDE LQKCHMQE
>P38071 nuc MITOCHONDRIAL RESPIRATORY FUNCTION PROTEIN 1.
     SSSAHQIPKH FKSLIYSTHE VEDCTKVLSV KNYTPKQDLS QSIVLKTLAF PINPSDINQL
     QGVYPSRPEK TYDYSTDEPA AIAGNEGVFE VVSLPSGSSK GDLKLGDRVI PLQANQGTWS
     NYRVFSSSSD LIKVNDLDLF SAATVSVNGC TGFQLVSDYI DWNSNGNEWI IQNAGTSSVS
     KIVTQVAKAK GIKTLSVIRD RDNFDEVAKV LEDKYGATKV ISESQNNDKT FAKEVLSKIL
     GENARVRLAL NSVGGKSSAS IARKLENNAL MLTYGGMSKQ PVTLPTSLHI FKGLTSKGYW
     VTEKNKKNPQ SKIDTISDFI KMYNYGHIIS PRDEIETLTW NTNTTTDEQL LELVKKGITG
     KGKKKMVVLE W
>P38129 nuc TRANSCRIPTION INITIATION FACTOR TFIID 90 KD SUBUNIT (TAFII-90).
     MSQKQSTNQN QNGTHQPQPV KNQRTNNAAG ANSGQQPQQQ SQGQSQQQGR SNGPFSASDL
     NRIVLEYLNK KGYHRTEAML RAESGRTLTP QNKQSPANTK TGKFPEQSSI PPNPGKTAKP
     ISNPTNLSSK RDAEGGIVSS GRLEGLNAPE NYIRAYSMLK NWVDSSLEIY KPELSYIMYP
     IFIYLFLNLV AKNPVYARRF FDRFSPDFKD FHGSEINRLF SVNSIDHIKE NEVASAFQSH
     KYRITMSKTT LNLLLYFLNE NESIGGSLII SVINQHLDPN IVESVTAREK LADGIKVLSD
     SENGNGKQNL EMNSVPVKLG PFPKDEEFVK EIETELKIKD DQEKQLNQQT AGDNYSGANN
     RTLLQEYKAM NNEKFKDNTG DDDKDKIKDK IAKDEEKKES ELKVDGEKKD SNLSSPARDI
     LPLPPKTALD LKLEIQKVKE SRDAIKLDNL QLALPSVCMY TFQNTNKDMS CLDFSDDCRI
     AAAGFQDSYI KIWSLDGSSL NNPNIALNNN DKDEDPTCKT LVGHSGTVYS TSFSPDNKYL
     LSGSEDKTVR LWSMDTHTAL VSYKGHNHPV WDVSFSPLGH YFATASHDQT ARLWSCDHIY
     PLRIFAGHLN DVDCVSFHPN GCYVFTGSSD KTCRMWDVST GDSVRLFLGH TAPVISIAVC
     PDGRWLSTGS EDGIINVWDI GTGKRLKQMR GHGKNAIYSL SYSKEGNVLI SGGADHTVRV
     WDLKKATTEP SAEPDEPFIG YLGDVTASIN QDIKEYGRRR TVIPTSDLVA SFYTKKTPVF
     KVKFSRSNLA LAGGAFRP
>P38157 nuc MALTOSE FERMENTATION REGULATORY PROTEIN MAL3R.
     MTLVKYACDY CRVRRVKCDG KKPCSRCIEH NFDCTYQQPL KKRGSKPIGT RSLKYIPKAK
     MFIDNKSCTA AAEILMKVPK KVIDQCLRLY HDNLYVIWPL LSYDDLHKLL DEEYNDHYVY
     WFLVALSAAN LSDLQSELES EGGFSFTGKQ LAVLCMSSRQ QFDDLSGRDI FRIMTYYCLL
     RCFSQSSDVR NSYRLCREAI GLVIVAGLHR EKAYESLSFR EQQLLRKVYY LLLLTERYYS
     VYVHCVTSLD TTIAPPQPEF VTDPRLSLDS FFEMIRVFTV PGKCFFDALA TESTSGSCTE
     DSLKKIWKEL HTASLEIEPW SYGYVDISFS RHWIRALAWK LVFQMNGTKF FSNANNAHIL
     VEIAKDMLDD IFLTPNNLYD VHGPGIPMKS LEVANALVDI VNKYDHNMKL EAWNILCDVS
     KFVFSLKHCN HKMFQRFSTK CQSALIDLPI SRPLRLNDDS KDEDDIIP
>P38333 nuc ENP1 PROTEIN.
     MARASSTKAR KQRHDPLLKD LDAAQGTLKK INKKKLAQND AANHDAANEE DGYIDSKASR
     KILQLAKEQQ DEIEGEELAE SERNKQFEAR FTTMSYDDED EDEDEDEEAF GEDISDFEPE
     GDYKEEEEIV EIDEEDAAMF EQYFKKSDDF NSLSGSYNLA DKIMASIREK ESQVEDMQDD
     EPLANEQNTS RGNISSGLKS GEGVALPEKV IKAYTTVGSI LKTWTHGKLP KLFKVIPSLR
     NWQDVIYVTN PEEWSPHVVY EATKLFVSNL TAKESQKFIN LILLERFRDN IETSEDHSLN
     YHIYRAVKKS LYKPSAFFKG FLFPLVETGC NVREATIAGS VLAKVSVPAL HSSAALSYLL
     RLPFSPPTTV FIKILLDKKY ALPYQTVDDC VYYFMRFRIL DDGSNGEDAT RVLPVIWHKA
     FLTFAQRYKN DITQDQRDFL LETVRQRGHK DIGPEIRREL LAGASREFVD PQEANDDLMI
     DVN
>P38826 nuc ORIGIN RECOGNITION COMPLEX PROTEIN, SUBUNIT 6 (ORIGIN RECOGNITION
     MSMQQVQHCV AEVLRLDPQE KPDWSSGYLK KLTNATSILY NTSLNKVMLK QDEEVARCHI
     CAYIASQKMN EKHMPDLCYY IDSIPLEPKK AKHLMNLFRQ SLSNSSPMKQ FAWTPSPKKN
     KRSPVKNGGR FTSSDPKELR NQLFGTPTKV RKSQNNDSFV IPELPPMQTN ESPSITRRKL
     AFEEDEDEDE EEPGNDGLSL KSHSNKSITG TRNVDSDEYE NHESDPTSEE EPLGVQESRS
     GRTKQNKAVG KPQSELKTAK ALRKRGRIPN SLLVKKYCKM TTEEIIRLCN DFELPREVAY
     KIVDEYNINA SRLVCPWQLV CGLVLNCTFI VFNERRRKDP RIDHFIVSKM CSLMLTSKVD
     DVIECVKLVK ELIIGEKWFR DLQIRYDDFD GIRYDEIIFR KLGSMLQTTN ILVTDDQYNI
     WKKRIEMDLA LTEPL
>P38902 nuc DNA-DIRECTED RNA POLYMERASE II 13.6 KD POLYPEPTIDE (EC 2.7.7.6)
     MNAPDRFELF LLGEGESKLK IDPDTKAPNA VVITFEKEDH TLGNLIRAEL LNDRKVLFAA
     YKVEHPFFAR FKLRIQTTEG YDPKDALKNA CNSIINKLGA LKTNFETEWN LQTLAADDAF
>P38989 nuc CHROMOSOME SEGREGATION PROTEIN SMC2 (DA-BOX PROTEIN SMC2).
     MKVEELIIDG FKSYATRTVI TDWDPQFNAI TGLNGSGKSN ILDAICFVLG IASMSTVRAS
     SLQDLIYKRG QAGVTKASVT IVFDNTDKSN SPIGFTNSPQ ISVTRQVVLG GTSKYLINGH
     RAPQQSVLQL FQSVQLNINN PNFLIMQGKI TKVLNMKPSE ILSLIEEAAG TKMFEDRREK
     AERTMSKKET KLQENRTLLT EEIEPKLEKL RNEKRMFLEF QSTQTDLEKT ERIVVSYEYY
     NIKHKHTSIR ETLENGETRM KMLNEFVKKT SEEIDSLNED VEEIKLQKEK ELHKEGTISK
     LENKENGLLN EISRLKTSLS IKVENLNDTT EKSKALESEI ASSSAKLIEK KSAYANTEKD
     YKMVQEQLSK QRDLYKRKEE LVSTLTTGIS STGAADGGYN AQLAKAKTEL NEVSLAIKKS
     SMKMELLKKE LLTIEPKLKE ATKDNELNVK HVKQCQETCD KLRARLVEYG FDPSRIKDLK
     QREDKLKSHY YQTCKNSEYL KRRVTNLEFN YTKPYPNFEA SFVHGVVGQL FQIDNDNIRY
     ATALQTCAGG RLFNVVVQDS QTATQLLERG RLRKRVTIIP LDKIYTRPIS SQVLDLAKKI
     APGKVELAIN LIRFDESITK AMEFIFGNSL ICEDPETAKK ITFHPKIRAR SITLQGDVYD
     PEGTLSGGSR NTSESLLVDI QKYNQIQKQI ETIQADLNHV TEELQTQYAT SQKTKTIQSD
     LNLSLHKLDL AKRNLDANPS SQIIARNEEI LRDIGECENE IKTKQMSLKK CQEEVSTIEK
     DMKEYDSDKG SKLNELKKEL KLLAKELEEQ ESESERKYDL FQNLELETEQ LSSELDSNKT
     LLHNHLKSIE SLKLENSDLE GKIRGVEDDL VTVQTELNEE KKRLMDIDDE LNELETLIKK
     KQDEKKSSEL ELQKLVHDLN KYKSNTNNME KIIEDLRQKH EFLEDFDLVR NIVKQNEGID
     LDTYRERSKQ LNEKFQELRK KVNPNIMNMI ENVEKKEAAL KTMIKTIEKD KMKIQETISK
     LNEYKRETLV KTWEKVTLDF GNIFADLLPN SFAKLVPCEG KDVTQGLEVK VKLGNIWKES
     LIELSGGQRS LIALSLIMAL LQFRPAPMYI LDEVDAALDL SHTQNIGHLI KTRFKGSQFI
     VVSLKEGMFA NANRVFRTRF QDGTSVVSIM
>P38996 nuc NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN NAB3.
     MSDENHNSDV QDIPSPELSV DSNSNENELM NNSSADDGIE FDAPEEEREA EREEENEEQH
     ELEDVNDEEE EDKEEKGEEN GEVINTEEEE EEEHQQKGGN DDDDDDNEEE EEEEEDDDDD
     DDDDDDDEEE EEEEEEEGND NSSVGSDSAA EDGEDEEDKK DKTKDKEVEL RRETLEKEQK
     DVDEAIKKIT REENDNTHFP TNMENVNYDL LQKQVKYIMD SNMLNLPQFQ HLPQEEKMSA
     ILAMLNSNSD TALSVPPHDS TISTTASASA TSGARSNDQR KPPLSDAQRR MRFPRADLSK
     PITEEEHDRY AAYLHGENKI TEMHNIPPKS RLFIGNLPLK NVSKEDLFRI FSPYGHIMQI
     NIKNAFGFIQ FDNPQSVRDA IECESQEMNF GKKLILEVSS SNARPQFDHG DHGTNSSSTF
     ISSAKRPFQT ESGDMYNDDN GAGYKKSRRH TVSCNIFVKR TADRTYAIEV FNRFRDGTGL
     ETDMIFLKPR MELGKLINDA AYNGVWGVVL VNKTHNVDVQ TFYKGSQGET KFDEYISISA
     DDAVAIFNNI KNNRNNSRPT DYRAMSHQQN IYGAPPLPVP NGPAVGPPPQ TNYYQGYSMP
     PPQQQQQQPY GNYGMPPPSH DQGYGSQPPI PMNQSYGRYQ TSIPPPPPQQ QIPQGYGRYQ
     AGPPPQPPSQ TPMDQQQLLS AIQNLPPNVV SNLLSMAQQQ QQQPHAQQQL VGLIQSMQGQ
     APQQQQQQLG GYSSMNSSSP PPMSTNYNGQ NISAKPSAPP MSHQPPPPQQ QQQQQQQQQQ
     QQQQPAGNNV QSLLDSLAKL QK
>P39001 nuc TRANSCRIPTIONAL REGULATOR UME6 (NEGATIVE TRANSCRIPTIONAL REGULATOR OF
     MLDKARSQSK HMDESNAAAS LLSMETTANN HHYLHNKTSR ATLMNSSQDG KKHAEDEVSD
     GANSRHPTIS SASIESLKTT YDENPLLSIM KSTCAPNNTP VHTPSGSPSL KVQSGGDIKD
     DPKENDTTTT TNTTLQDRRD SDNAVHAAAS PLAPSNTPSD PKSLCNGHVA QATDPQISGA
     IQPQYTATNE DVFPYSSTST NSNTATTTIV AGAKKKIHLP PPQAPAVSSP GTTAAGSGAG
     TGSGIRSRTG SDLPLIITSA NKNNGKTTNS PMSILSRNNS TNNNDNNSIQ SSDSRESSNN
     NEIGGYLRGG TKRGGSPSND SQVQHNVHDD QCAVGVAPRN FYFNKDREIT DPNVKLDENE
     SKINISFWLN SKYRDEAYSL NESSSNNASS NTDTPTNSRH ANTSSSITSR NNFQHFRFNQ
     IPSQPPTSAS SFTSTNNNNP QRNNINRGED PFATSSRPST GFFYGDLPNR NNRNSPFHTN
     EQYIPPPPPK YINSKLDGLR SRLLLGPNSA SSSTKLDDDL GTAAAVLSNM RSSPYRTHDK
     PISNVNDMNN TNALGVPASR PHSSSFPSKG VLRPILLRIH NSEQQPIFES NNSTAVFDED
     QDQNQDLSPY HLNLNSKKVL DPTFESRTRQ VTWNKNGKRI DRRLSAPEQQ QQLEVPPLKK
     SRRSVGNARV ASQTNSDYNS LGESSTSSAP SSPSLKASSG LAYTADYPNA TSPDFAKSKG
     KNVKPKAKSK AKQSSKKRPN NTTSKSKANN SQESNNATSS TSQGTRSRTG CWICRLRKKK
     CTEERPHCFN CERLKLDCHY DAFKPDFVSD PKKKQMKLEE IKKKTKEAKR RAMKKK
>P39009 nuc DNA DAMAGE RESPONSE PROTEIN KINASE DUN1 (EC 2.7.1.-).
     MSLSTKREHS GDVTDSSFKR QQRSNKPSSE YTCLGHLVNL IPGKEQKVEI TNRNVTTIGR
     SRSCDVILSE PDISTFHAEF HLLQMDVDNF QRNLINVIDK SRNGTFINGN RLVKKDYILK
     NGDRIVFGKS CSFLFKYASS SSTDIENDDE KVSSESRSYK NDDEVFKKPQ ISATSSQNAT
     TSAAIRKLNK TRPVSFFDKY LLGKELGAGH YALVKEAKNK KTGQQVAVKI FHAQQNDDQK
     KNKQFREETN ILMRVQHPNI VNLLDSFVEP ISKSQIQKYL VLEKIDDGEL FERIVRKTCL
     RQDESKALFK QLLTGLKYLH EQNIIHRDIK PENILLNITR RENPSQVQLG PWDEDEIDIQ
     VKIADFGLAK FTGEMQFTNT LCGTPSYVAP EVLTKKGYTS KVDLWSAGVI LYVCLCGFPP
     FSDQLGPPSL KEQILQAKYA FYSPYWDKID DSVLHLISNL LVLNPDERYN IDEALNHPWF
     NDIQQQSSVS LELQRLQITD NKIPKTYSEL SCL
>P39104 nuc PHOSPHATIDYLINOSITOL 4-KINASE PIK1 (EC 2.7.1.67) (PI4-KINASE)
     MHKASSSKKS FDDTIELKKN EQLLKLINSS EFTLHNCVEL LCKHSENIGI HYYLCQKLAT
     FPHSELQFYI PQLVQVLVTM ETESMALEDL LLRLRAENPH FALLTFWQLQ ALLTDLSTDP
     ASYGFQVARR VLNNLQTNLF NTSSGSDKNV KIHENVAPAL VLSSMIMSAI AFPQLSEVTK
     PLVESQGRRQ KAFVFKLARS AMKDFTKNMT LKNTLLNKKT SRSKRVSSNR SSTPTSPIDL
     IDPIKTKEDA SFRKSRHSEV KLDFDIVDDI GNQVFEERIS SSIKLPKRKP KYLDNSYVHR
     TYDGKNINRD GSISNTAKAL DGNKGDYISP KGRNDENNEI GNNEDETGGE TEEDADALNS
     DHFTSSMPDL HNIQPRTSSA SSASLEGTPK LNRTNSQPLS RQAFKNSKKA NSSLSQEIDL
     SQLSTTSKIK MLKANYFRCE TQFAIALETI SQRLARVPTE ARLSALRAEL FLLNRDLPAE
     VDIPTLLPPN KKGKLHKLVT ITANEAQVLN SAEKVPYLLL IEYLRDEFDF DPTSETNERL
     LKKISGNQGG LIFDLNYMNR KENNENRNES TLTSNNTRSS VYDSNSFNNG ASRNEGLSST
     SRSDSASTAH VRTEVNKEED LGDMSMVKVR NRTDDEAYRN ALVIQSAANV PILPDDSQDR
     SPELNFGSNL DEVLIENGIN SKNIHSQTDA LADQMRVSAV MLAQLDKSPQ QLSESTKQIR
     AQIISSMKEV QDKFGYHDLE ALHGMAGERK LENDLMTGGI DTSYLGEDWA TKKERIRKTS
     EYGHFENWDL CSVIAKTGDD LRQEAFAYQM IQAMANIWVK EKVDVWVKRM KILITSANTG
     LVETITNAMS VHSIKKALTK KMIEDAELDD KGGIASLNDH FLRAFGNPNG FKYRRAQDNF
     ASSLAAYSVI CYLLQVKDRH NGNIMIDNEG HVSHIDFGFM LSNSPGSVGF EAAPFKLTYE
     YIELLGGVEG EAFKKFVELT KSSFKALRKY ADQIVSMCEI MQKDNMQPCF DAGEQTSVQL
     RQRFQLDLSE KEVDDFVENF LIGKSLGSIY TRIYDQFQLI TQGIYS
>P39678 nuc TRANSCRIPTION FACTOR MBP1 (MBF SUBUNIT P120).
     MSNQIYSARY SGVDVYEFIH STGSIMKRKK DDWVNATHIL KAANFAKAKR TRILEKEVLK
     ETHEKVQGGF GKYQGTWVPL NIAKQLAEKF SVYDQLKPLF DFTQTDGSAS PPPAPKHHHA
     SKVDRKKAIR SASTSAIMET KRNNKKAEEN QFQSSKILGN PTAAPRKRGR PVGSTRGSRR
     KLGVNLQRSQ SDMGFPRPAI PNSSISTTQL PSIRSTMGPQ SPTLGILEEE RHDSRQQQPQ
     QNNSAQFKEI DLEDGLSSDV EPSQQLQQVF NQNTGFVPQQ QSSLIQTQQT ESMATSVSSS
     PSLPTSPGDF ADSNPFEERF PGGGTSPIIS MIPRYPVTSR PQTSDINDKV NKYLSKLVDY
     FISNEMKSNK SLPQVLLHPP PHSAPYIDAP IDPELHTAFH WACSMGNLPI AEALYEAGTS
     IRSTNSQGQT PLMRSSLFHN SYTRRTFPRI FQLLHETVFD IDSQSQTVIH HIVKRKSTTP
     SAVYYLDVVL SKIKDFSPQY RIELLLNTQD KNGDTALHIA SKNGDVVFFN TLVKMGALTT
     ISNKEGLTAN EIMNQQYEQM MIQNGTNQHV NSSNTDLNIH VNTNNIETKN DVNSMVIMSP
     VSPSDYITYP SQIATNISRN IPNVVNSMKQ MASIYNDLHE QHDNEIKSLQ KTLKSISKTK
     IQVSLKTLEV LKESSKDENG EAQTNDDFEI LSRLQEQNTK KLRKRLIRYK RLIKQKLEYR
     QTVLLNKLIE DETQATTNNT VEKDNNTLER LELAQELTML QLQRKNKLSS LVKKFEDNAK
     IHKYRRIIRE GTEMNIEEVD SSLDVILQTL IANNNKNKGA EQIITISNAN SHA
>P39682 nuc PRE-MRNA PROCESSING PROTEIN PRP39.
     MPDETNFTIE DIEPRPDALR GLDTQFLQDN TALVQAYRGL DWSDISSLTQ MVDVIEQTVV
     KYGNPNDSIK LALETILWQI LRKYPLLFGF WKRFATIEYQ LFGLKKSIAV LATSVKWFPT
     SLELWCDYLN VLCVNNPNET DFIRNNFEIA KDLIGKQFLS HPFWDKFIEF EVGQKNWHNV
     QRIYEYIIEV PLHQYARFFT SYKKFLNEKN LKTTRNIDIV LRKTQTTVNE IWQFESKIKQ
     PFFNLGQVLN DDLENWSRYL KFVTDPSKSL DKEFVMSVFD RCLIPCLYHE NTWMMYIKWL
     TKKNISDEVV VDIYQKANTF LPLDFKTLRY DFLRFLKRKY RSNNTLFNNI FNETVSRYLK
     IWPNDILLMT EYLCMLKRHS FKNSLDQSPK EILEKQTSFT KILETSITNY INNQIDAKVH
     LQTLINDKNL SIVVVELIKT TWLVLKNNMQ TRKYFNLYQK NILIKNSVPF WLTYYKFEKS
     NVNFTKLNKF IRELGVEIYL PTTVMNDILT DYKTFYLTHS NIVTYESSII DSNTFDPILY
     PELKMSNPKY DPVLNTTANV DWHKKTEWKE AGHIGITTER PQISNSIIEC NSGTLIQKPI
     SLPNFRNLEK INQVKINDLY TEEFLKEGK
>P39929 nuc NUCLEAR PROTEIN SNF7.
     MWSSLFGWTS SNAKNKESPT KAIVRLREHI NLLSKKQSHL RTQITNQENE ARIFLTKGNK
     VMAKNALKKK KTIEQLLSKV EGTMESMEQQ LFSIESANLN LETMRAMQEG AKAMKTIHSG
     LDIDKVDETM DEIREQVELG DEISDAISRP LITGANEVDE DELDEELDML AQENANQETS
     KIVNNNVNAA PISENKVSLP SVPSNKIKQS ENSVKDGEEE EDEEDEDEKA LRELQAEMGL
>P39933 nuc TRANSCRIPTION FACTOR IIIA (TFIIIA).
     MGGEVLNNEG MPLAELKQET IPISRSESSE SLNSLTSTRS SSSNRPKTYF CDYDGCDKAF
     TRPSILTEHQ LSVHQGLRAF QCDKCAKSFV KKSHLERHLY THSDTKPFQC SYCGKGVTTR
     QQLKRHEVTH TKSFICPEEG CNLRFYKHPQ LRAHILSVHL HKLTCPHCNK SFQRPYRLRN
     HISKHHDPEV ENPYQCTFAG CCKEFRIWSQ LQSHIKNDHP KLKCPICSKP CVGENGLQMH
     MIIHDDSLVT KNWKCHICPD MSFSRKHDLL THYGSIHTEE DIPLELKYKI SDIQQLVQDH
     GVQLGNSKHS NEQDEEKISN RLRKRRKLTE NNNVEFLQNE VDLEKRLESG ENGLNLLLNT
     VGRKYRCFYN NCSRTFKTKE KYEKHIDKHK VHELKLKILQ EKEENKTLVD QNHKEPFIIQ
     KETQSAGDK
>P40068 nuc TRANSCRIPTIONAL ACTIVATOR FLO8 (PDH5 PROTEIN).
     MSYKVNSSYP DSIPPTEQPY MASQYKQDLQ SNIAMATNSE QQRQQQQQQQ QQQQQWINQP
     TAENSDLKEK MNCKNTLNEY IFDFLTKSSL KNTAAAFAQD AHLDRDKGQN PVDGPKSKEN
     NGNQNTFSKV VDTPQGFLYE WWQIFWDIFN TSSSRGGSEF AQQYYQLVLQ EQRQEQIYRS
     LAVHAARLQH DAERRGEYSN EDIDPMHLAA MMLGNPMAPA VQMRNVNMNP IPIPMVGNPI
     VNNFSIPPYN NANPTTGATA VAPTAPPSGD FTNVGPTQNR SQNVTGWPVY NYPMQPTTEN
     PVGNPCNNNT TNNTTNNKSP VNQPKSLKTM HSTDKPNNVP TSKSTRSRSA TSKAKGKVKA
     GLVAKRRRKN NTATVSAGST NACSPNITTP GSTTSEPAMV GSRVNKTPRS DIATNFRNQA
     IIFGEEDIYS NSKSSPSLDG ASPSALASKQ PTKVRKNTKK ASTSAFPVES TNKLGGNSVV
     TGKKRSPPNT RVSRRKSTPS VILNADATKD ENNMLRTFSN TIAPNIHSAP PTKTANSLPF
     PGINLGSFNK PAVSSPLSSV TESCFDPESG KIAGKNGPKR AVNSKVSASS PLSIATPRSG
     DAQKQRSSKV PGNVVIKPPH GFSTTNLNIT LKNSKIITSQ NNTVSQELPN GGNILEAQVG
     NDSRSSKGNR NTLSTPEEKK PSSNNQGYDF DALKNSSSLL FPNQAYASNN RTPNENSNVA
     DETSASTNSG DNDNTLIQPS SNVGTTLGPQ QTSTNENQNV HSQNLKFGNI GMVEDQGPDY
     DLNLLDTNEN DFNFINWEG
>P40070 nuc U6 SNRNA-ASSOCIATED PROTEIN.
     MLPLYLLTNA KGQQMQIELK NGEIIQGILT NVDNWMNLTL SNVTEYSEES AINSEDNAES
     SKAVKLNEIY IRGTFIKFIK LQDNIIDKVK QQINSNNNSN SNGPGHKRYY NNRDSNNNRG
     NYNRRNNNNG NSNRRPYSQN RQYNNSNSSN INNSINSINS NNQNMNNGLG GSVQHHFNSS
     SPQKVEF
>P40317 nuc SOK1 PROTEIN.
     MDQPRTHSGP TTASNPAPSS TNSSSAPSAT NSKQERSSSS LSKPSSVVPS KDSPDGDAIA
     KTQAAALKND MKSGDTSTLD GSSQNIIPNR ASMQKYIDQS SDLLSRSSGV ITPSMSLNAS
     TNATNNDSSG NSANSSDLKI PIDRDNTIFK TFDTKTGQFL KNDDNEEEIR RNNKVDSIPP
     KNIYTNINNP SPSPPPSSKQ PPSASAPQLP PATEPHKEQA AQQQPPGNAS NFLRIFSNKK
     MRSHSVPTIL HSSLRKLSSH NQYYRNQNIL LNHPTPSGIS KKKFSRNHHQ PYLHSNNPLS
     SNPLSLKRAI FLNQQISGNA STNANNDNIN NSTATSMTNQ SFLSSSNFDL TLEDRINYIK
     ATPTPVPFPP INLQGLKEID LQEILKNPQL RHDIIFDPLL QFRPNLDGER GNKKRQLANI
     YWNDVQNEIY VYSKRPEIFQ YNRSRLVPLF DTLRDVLLTI VPQKESPMIN NVLDTELNIQ
     ELLKGSLIMS NLSGWLADLF KHHCAPMRDP WVDKMSNKFK EAERDSSLTR LIEGLRLVFQ
     ILETMKLDIA NHQIRILRPA LLSNAVEFEK QYFNTLIASK RVNLNTSLLW FDKKFNENVT
     AGLVRNPSSI TIPDVYNICI RSIINLLSCR KMVREYPTPL SFDHARLILL RADIRQIVCI
     LVCRLLFQQL VANDPSMDKA TKEYVIHTYS TKRLKNEIIS IITDEHGNCR WTKNTMSIAV
     HLCKVIDDLH REYDNNGSCE QARRPQLPSL DNSKITFAKS WLSKQTQPLS EVYGVLENRV
     FKSLEDAIFN RSECTIDGRV KQDFVYLYNT NNGNVGSTNT LSTTTDTASV KISPSLMSPS
     KTSTTTPTGN AIASRGLFAA TELEEFENVY RHLYALINLH WSVFGPHYIE MLGDKVNKKG
     I
>P40422 nuc DNA-DIRECTED RNA POLYMERASES I, II, AND III 7.7 KD POLYPEPTIDE
     MSREGFQIPT NLDAAAAGTS QARTATLKYI CAECSSKLSL SRTDAVRCKD CGHRILLKAR
     TKRLVQFEAR
>P40469 nuc DNA REPAIR/TRANSCRIPTION PROTEIN MET18/MMS19.
     MTPDELNSAV VTFMANLNID DSKANETAST VTDSIVHRSI KLLEVVVALK DYFLSENEVE
     RKKALTCLTT ILAKTPKDHL SKNECSVIFQ FYQSKLDDQA LAKEVLEGFA ALAPMKYVSI
     NEIAQLLRLL LDNYQQGQHL ASTRLWPFKI LRKIFDRFFV NGSSTEQVKR INDLFIETFL
     HVANGEKDPR NLLLSFALNK SITSSLQNVE NFKEDLFDVL FCYFPITFKP PKHDPYKISN
     QDLKTALRSA ITATPLFAED AYSNLLDKLT ASSPVVKNDT LLTLLECVRK FGGSSILENW
     TLLWNALKFE IMQNSEGNEN TLLNPYNKDQ QSDDVGQYTN YDACLKIINL MALQLYNFDK
     VSFEKFFTHV LDELKPNFKY EKDLKQTCQI LSAIGSGNVE IFNKVISSTF PLFLINTSEV
     AKLKLLIMNF SFFVDSYIDL FGRTSKESLG TPVPNNKMAE YKDEIIMILS MALTRSSKAE
     VTIRTLSVIQ FTKMIKMKGF LTPEEVSLII QYFTEEILTD NNKNIYYACL EGLKTISEIY
     EDLVFEISLK KLLDLLPDCF EEKIRVNDEE NIHIETILKI ILDFTTSRHI LVKESITFLA
     TKLNRVAKIS KSREYCFLLI STIYSLFNNN NQNENVLNEE DALALKNAIE PKLFEIITQE
     SAIVSDNYNL TLLSNVLFFT NLKIPQAAHQ EELDRYNELF ISEGKIRILD TPNVLAISYA
     KILSALNKNC QFPQKFTVLF GTVQLLKKHA PRMTETEKLG YLELLLVLSN KFVSEKDVIG
     LFDWKDLSVI NLEVMVWLTK GLIMQNSLES SEIAKKFIDL LSNEEIGSLV SKLFEVFVMD
     ISSLKKFKGI SWNNNVKILY KQKFFGDIFQ TLVSNYKNTV DMTIKCNYLT ALSLVLKHTP
     SQSVGPFIND LFPLLLQALD MPDPEVRVSA LETLKDTTDK HHTLITEHVS TIVPLLLSLS
     LPHKYNSVSV RLIALQLLEM ITTVVPLNYC LSYQDDVLSA LIPVLSDKKR IIRKQCVDTR
     QVYYELGQIP FE
>P40957 nuc SPINDLE ASSEMBLY CHECKPOINT COMPONENT MAD1 (MITOTIC MAD1 PROTEIN).
     MDVRAALQCF FSALSGRFTG KKLGLEIYSI QYKMSNSGGS SPFLESPGGS PDVGSTNGQS
     NRQIQALQFK LNTLQNEYEI EKLQLQKQTN ILEKKYKATI DELEKALNDT KYLYESNDKL
     EQELKSLKER SANSMNDKDK CIEELRTTLQ NKDLEMETLR QQYDSKLSKV TNQCDHFKLE
     AESSHSLLMK YEKEIKRQSV DIKDLQHQVM EKDDELSSVK ASKMINSHPN YSTEEFNELT
     EMNKMIQDQV QYTKELELAN MQQANELKKL KQSQDTSTFW KLENEKLQNK LSQLHVLESQ
     YENLQLENID LKSKLTKWEI YNDSDDDDDN NVNNNDNNNN NKNDNNNDNN NDTSNNNNIN
     NNNRTKNNIR NNPEEIIRDW KLTKKECLIL TDMNDKLRLD NNNLKLLNDE MALERNQILD
     LNKNYENNIV NLKRLNHELE QQKSLSFEEC RLLREQLDGL YSAQNNALLE VENSETHASN
     KNVNEDMNNL IDTYKNKTED LTNELKKLND QLLSNSNDVE TQRKKRKLTS DQIGLNYSQR
     LNELQLENVS VSRELSKAQT TIQLLQEKLE KLTKLKEKKI RILQLRDGPF IKDQFIKKNK
     LLLLEKENAD LLNELKKNNP AVETVPISVY DSLNFELKQF EQEVFKSNKR FSRLKQVFNN
     KSLEFIDVVN SLLGFKLEFQ QDSRVKIFSC FKPEKYLIAD LNENTLKSNL DADIEGWDDL
     MNLWVEDRGQ LPCFLATITL RLWEQRQAK
>P40971 nuc LYSINE BIOSYNTHESIS REGULATORY PROTEIN LYS14.
     MFESVNLDEN SPEDRELAKV LSPPGSYLSP ASLDSGSSFT NSGTSTSCFE PKNNLPSLSF
     LNARAGSLGG IFNHKQMTSP SNSNIGGENV ESTTSSNDGS NENAGHPTTS EQDQNADHPT
     ISQADDNGHS SLTPNPAVTS TVTDKKGNTV KRKYSRNGCS ECKRRRMKCD ETKPTCWQCA
     RLNRQCVYVL NPKNKKRRTS NAQRVKEFRK HSTSLDNDHN NARKRQHSSC KAEKKKKVRQ
     NLSEDTTDPK PITDNGKNVP LDEIESLEIP NLDLTTTMNG YDVNLLMQNL NDMVNMKLHD
     SYLLNEELKG LDLPDLDIPE LLPASNVNSS VPISFLVNNV ITFNTKLSSF KLGGIHDKYL
     KIFYYDCLDS IAPFFQNQGN PLRDILLSFA KNEAYLLSSI LATGASIAYR KSNNLEDERN
     YCAYLSHCLS LLGEQFKNES NVLNRIEPII LTVIMLAWDC IYSMNSQWRS HLKGVTDLFK
     KINAGNSSKV LNVAKCWFKV METFASISTV FGGSLIDNND LDAIFDPYDY QYVDSLKFLN
     IMTPLNEFNL LRGHKEDFDL VIKEVFKSLN TIRSTEKNYF SKEEGLFTKK LDYLLLSSQT
     SSEKSKDQIS YFNTQKILVE IDKQLDYEFI DKSGIIPSDN QSHPRISNIH DNAIDMVTLK
     NGEEVAISWY DISHQTQVLS FLLIVLLKLL GMPKESSTIQ QVVKKIMSFF KFLDSDSPPQ
     NSRTCYSNFA VLIAGLNAMD EETRAIVKRY YKINGGKFQK LTEHNLNRLE KVWYGKNQNY
     RLEEQDVLTW
>P41812 nuc POP1 PROTEIN.
     MSGSLSRGNG GKKVLNKNQL LKRNRIRNAR SIRAEAVAAS STKTGTPSDL SESGSKLNVD
     QFISSRQFEV KQLQLAMHNS KAASSTRIFQ ALPRKLRRRT ASHNVRRIPK RMRNRALREM
     RKSDQQDVLK GSSASSRKAH GLNAKQLYKA RMSIKLLRLA SKSTSMKLSM PPEVTSSNCH
     VRQKIKTLKR MIKESSTANP NIKLLNNRMG SYDCTGVNEL APIPKGRVKY TKRQKHFAWL
     PTHIWNAKRS HMMKRWGYQM VWAPTQKCFK LTHRLGGDTC SSDGALCMDS SYIGTIIVKD
     KSNDSEGDFL KSIIGKLTAE RANLRKYREG QVLFQGLIYS FNEENGEDST KPLGPCDVFW
     VQKDTAIIRL HPSIYTQVFN ILLQHKEKLT VQDCRYSLAS VTLKGAKALE SLASCLRSTE
     YSKSFEQFKM VSMITDHNAL PQRCTFAFEA IDPRHLAAPK KLNDSQRKTV NSDDILSLHE
     NYPQDEINAV FNELCDPESR TQSYNNQNTL KEISARRYKL LTATPNSINK TTVPFKESDD
     PSIPLVIIRR LKTRDWIVVL PWFWLLPLWH LLNRIPRMYH IGLRQFQQIQ YENKQLYFPD
     DYPFTQLGYI ENSFYKKEAS KTKWDRKPMG KRINFEKIKD IHNTKLPAYS GEIGDFFSSD
     WRFLQILRNG IDYLQRNDKT LELMDSKKTG QFNAQGVRDI NCVNDVLEFC KDYEAKTKAM
     SLSIEENIPV ALCKNRKCQF RTPDSISVNS SSFSLTFFPR CIIAVSCTLL ERGHPKDNAR
     IYQVPEKDLE HWLQLAKGVY RPNGRKDHDL KIPLPEVHDL IGFITSGTYH LNCGNGMGIG
     FIDHHAAIRQ PTRYVLIRNV GTNTYRLGEW SKISV
>P41895 nuc TRANSCRIPTION INITIATION FACTOR IIF, ALPHA SUBUNIT (TFIIF-ALPHA)
     MSRRNPPGSR NGGGPTNASP FIKRDRMRRN FLRMRMGQNG SNSSSPGVPN GDNSRGSLVK
     KDDPEYAEER EKMLLQIGVE ADAGRSNVKV KDEDPNEYNE FPLRAIPKED LENMRTHLLK
     FQSKKKINPV TDFHLPVRLH RKDTRNLQFQ LTRAEIVQRQ KEISEYKKKA EQERSTPNSG
     GMNKSGTVSL NNTVKDGSQT PTVDSVTKDN TANGVNSSIP TVTGSSVPPA SPTTVSAVES
     NGLSNGSTSA ANGLDGNAST ANLANGRPLV TKLEDAGPAE DPTKVGMVKY DGKEVTNEPE
     FEEGTMDPLA DVAPDGGGRA KRGNLRRKTR QLKVLDENAK KLRFEEFYPW VMEDFDGYNT
     WVGSYEAGNS DSYVLLSVED DGSFTMIPAD KVYKFTARNK YATLTIDEAE KRMDKKSGEV
     PRWLMKHLDN IGTTTTRYDR TRRKLKAVAD QQAMDEDDRD DNSEVELDYD EEFADDEEAP
     IIDGNEQENK ESEQRIKKEM LQANAMGLRD EEAPSENEED ELFGEKKIDE DGERIKKALQ
     KTELAALYSS DENEINPYLS ESDIENKENE SPVKKEEDSD TLSKSKRSSP KKQQKKATNA
     HVHKEPTLRV KSIKNCVIIL KGDKKILKSF PEGEWNPQTT KAVDSSNNAS NTVPSPIKQE
     EGLNSTVAER EETPAPTITE KDIIEAIGDG KVNIKEFGKF IRRKYPGAEN KKLMFAIVKK
     LCRKVGNDHM ELKKE
>P41896 nuc TRANSCRIPTION INITIATION FACTOR IIF, BETA SUBUNIT (TFIIF-BETA)
     MSSGSAGAPA LSNNSTNSVA KEKSGNISGD EYLSQEEEVF DGNDIENNET KVYEESLDLD
     LERSNRQVWL VRLPMFLAEK WRDRNNLHGQ ELGKIRINKD GSKITLLLNE NDNDSIPHEY
     DLELTKKVVE NEYVFTEQNL KKYQQRKKEL EADPEKQRQA YLKKQEREEE LKKKQQQQKR
     RNNRKKFNHR VMTDRDGRDR YIPYVKTIPK KTAIVGTVCH ECQVMPSMND PNYHKIVEQR
     RNIVKLNNKE RITTLDETVG VTMSHTGMSM RSDNSNFLKV GREKAKSNIK SIRMPKKEIL
     DYLFKLFDEY DYWSLKGLKE RTRQPEAHLK ECLDKVATLV KKGPYAFKYT LRPEYKKLKE
     EERKATLGEL ADEQTGSAGD NAQGDAEADL EDEIEMEDVV
>P43321 nuc SMALL NUCLEAR RIBONUCLEOPROTEIN D3 HOMOLOG.
     MTMNGIPVKL LNEAQGHIVS LELTTGATYR GKLVESEDSM NVQLRDVIAT EPQGAVTHMD
     QIFVRGSQIK FIVVPDLLKN APLFKKNSSR PMPPIRGPKR R
>P43634 nuc CHA4 ACTIVATORY PROTEIN.
     MMLEPSPPPL TTTVTPSLPS SLKKSVTDND QNNNNVPRKR KLACQNCRRR RRKCNMEKPC
     SNCIKFRTEC VFTQQDLRNK RYSTTYVEAL QSQIRSLKEQ LQILSSSSST IASNALSSLK
     NNSDHGDAPN EKILKYGETA QSALPSSESN DENESDAFTK KMPSESPPPV GTNSIYPSNS
     LSIIKKKTDG STRYQQQQVS LKNLSRSPLI LRSLSLFFKW LYPGHYLFIH RETFLSAFFG
     DTNTKSYYCS EELVFAIAAL GSLISYKSET ELFQQSEVFY QRAKTIVLKK IFQLEDSSLA
     ESSSSSKLAI IQTLLCLAFY DIGSGENPMA WYLSGLAFRI AHEIGLHLNP EAWSNVYEDE
     LSIMDFEVRS RIYWGCYIAD HLIAILFGRS TSLRLSNSTV PETDELPEIE TGIEEYIYDP
     KVILSTANPL KKLIVLSRIT EIFASKIFSP NETLLQRSEY LAKFNLEVYN WRRDLPPELQ
     WTKRSLMEMT DFNPTIAYVW FHYYIVLISY NKPFIYEIKQ SRELVEGYVD ELYYLLKVWK
     NKFKTFEKAT IYMIYSAILA IQCMKSNLIK KDRKQDFLNF LSAPTLNYEL ARKFIENSED
     ALHNSETMDL LGTLSHGNDF ALEYNFDFTL LNEIDMLIGG NTNDGLSK
>P45818 nuc ATP-DEPENDENT RNA HELICASE ROK1.
     MDIFRVLTRG ASVKKESGPK AKAADYSVIN GNDENHKEDN NESQIVKELD FFRNKRIISK
     VEDDREKTTE NDSPNKEEKS GNDDGLIKPV ITNTVEASAL RKSYKGNVSG IDIPLPIGSF
     EDLISRFSFD KRLLNNLIEN GFTEPTPIQC ECIPVALNNR DVLACGPTGS GKTLAFLIPL
     VQQIIDDKQT AGLKGLIISP TKELANQIFI ECFKLSYKIF LEKKRPLQVA LLSKSLGAKL
     KNKVVSDKKY DIIISTPLRL IDVVKNEALD LSKVKHLIFD EADKLFDKTF VEQSDDILSA
     CREPSLRKAM FSATIPSNVE EIAQSIMMDP VRVIIGHKEA ANTNIEQKLI FCGNEEGKLI
     AIRQLVQEGE FKPPIIIFLE SITRAKALYH ELMYDRINVD VIHAERTALQ RDRIIERFKT
     GELWCLICTD VLARGIDFKG VNLVINYDVP GSSQAYVHRI GRTGRGGRSG KAITFYTKQD
     SVAIKPIINV MKQSGCEVSE WMDKMAKMTR KEKESIKNGK AHKERKQITT VPKMDKAKRR
     RQQEMIAASK RRKNEELSKK HFSK
>P45976 nuc FIP1 PROTEIN.
     MSSSEDEDDK FLYGSDSELA LPSSKRSRDD EADAGASSNP DIVKRQKFDS PVEETPATAR
     DDRSDEDIYS DSSDDDSDSD LEVIISLGPD PTRLDAKLLD SYSTAATSSS KDVISVATDV
     SNTITKTSDE RLITEGEANQ GVTATTVKAT ESDGNVPKAM TGSIDLDKEG IFDSVGITTI
     DPEVLKEKPW RQPGANLSDY FNYGFNEFTW MEYLHRQEKL QQDYNPRRIL MGLLSLQQQG
     KLNSANDTDS NLGNIIDNNN NVNNANMSNL NSNMGNSMSG TPNPPAPPMH PSFPPLPMFG
     SFPPFPMPGM MPPMNQQPNQ NQNQNSK
>P46669 nuc DNA-DEPENDENT RNA POLYMERASE 36 KD POLYPEPTIDE (EC 2.7.7.6) (A43).
     MSQVKRANEN RETARFIKKH KKQVTNPIDE KNGTSNCIVR VPIALYVSLA PMYLENPLQG
     VMKQHLNPLV MKYNNKVGGV VLGYEGLKIL DADPLSKEDT SEKLIKITPD TPFGFTWCHV
     NLYVWQPQVG DVLEGYIFIQ SASHIGLLIH DAFNASIKKN NIPVDWTFVH NDVEEDADVI
     NTDENNGNNN NEDNKDSNGG SNSLGKFSFG NRSLGHWVDS NGEPIDGKLR FTVRNVHTTG
     RVVSVDGTLI SDADEEGNGY NSSRSQAESL PIVSNKKIVF DDEVSIENKE SHKELDLPEV
     KEDNGSEIVY EENTSESNDG ESSDSD
>P46678 nuc TRANSCRIPTION FACTOR TFIIIB B" COMPONENT (TFIIIB90).
     MSSIVNKSGT RFAPKVRQRR AATGGTPTPK PRTPQLFIPE SKEIEEDNSD NDKGVDENET
     AIVEKPSLVG ERSLEGFTLT GTNGHDNEIG DEGPIDASTQ NPKADVIEDN VTLKPAPLQT
     HRDQKVPRSS RLASLSKDNE SRPSFKPSFL DSSSNSNGTA RRLSTISNKL PKKIRLGSIT
     ENDMNLKTFK RHRVLGKPSS AKKPAGAHRI SIVSKISPPT AMTDSLDRNE FSSETSTSRE
     ADENENYVIS KVKDIPKKVR DGESAKYFID EENFTMAELC KPNFPIGQIS ENFEKSKMAK
     KAKLEKRRHL RELRMRARQE FKPLHSLTKE EQEEEEEKRK EERDKLLNAD IPESDRKAHT
     AIQLKLNPDG TMAIDEETMV VDRHKNASIE NEYKEKVDEN PFANLYNYGS YGRGSYTDPW
     TVEEMIKFYK ALSMWGTDFN LISQLYPYRS RKQVKAKFVN EEKKRPILIE LALRSKLPPN
     FDEYCCEIKK NIGTVADFNE KLIELQNEHK HHMKEIEEAK NTAKEEDQTA QRLNDANLNK
     KGSGGIMTND LKVYRKTEVV LGTIDDLKRK KLKERNNDDN EDNEGSEEEP EIDQ
>P46962 nuc CTD KINASE BETA SUBUNIT (EC 2.7.1.-) (CTD KINASE 38 KD SUBUNIT)
     MPSTFESQLF FSRPFLSKRQ IQRAQKNTIS DYRNYNQKKL AVFKFLSDLC VQLKFPRKTL
     ETAVYFYQRY HLFNRFETEV CYTVATSCLT LGCKEVETIK KTNDICTLSL RLRNVVKINT
     DILENFKKRV FQIELRILES CSFDYRVNNY VHIDEYVIKI GRELSFDYKL CNLAWVIAYD
     ALKLETILVI PQHSIALAIL KIAYELLDNK NWSSKRYSLF ETDEKSVNEA YFDIVNFYIN
     SFDMCDLQRH LPADLLPIGV ERFMELKKNA GPESGLPQIP DHLLNADPYI TITRDNNVQE
     RRYVLSLELI NGESSINSST RHA
>P46963 nuc CTD KINASE GAMMA SUBUNIT (EC 2.7.1.-) (CTD KINASE 32 KD SUBUNIT)
     MDSLEARLQF IQVLKNLQKT LHKTRDSITS SSTTTPPSSQ QKLNNDPIQF YLRNYRHHYE
     DFHQCLFDTT MKMDPLDRLD VVIYYVRIIR NLYPHSHSNT NVTKVLNEVL LMDIDLVFEL
     CLPCQDWKSL TNQATCKELF LDLSKLIHYD ATSVTHTPSD TTLIDATTWY SVKTERTTKD
     YKESLQRTES LLKDRDLKKL AFFQQFNSDT TAINPDLQTQ PTNANILLHR MEADRELHKR
     SKETSWYIER PSNDILDESE FKSLWTHFET TDSGFDKDDY KNIKALNDIA KASYIY
>P47047 nuc MRNA TRANSPORT REGULATOR MTR4.
     MDSTDLFDVF EETPVELPTD SNGEKNADTN VGDTPDHTQD KKHGLEEEKE EHEENNSENK
     KIKSNKSKTE DKNKKVVVPV LADSFEQEAS REVDASKGLT NSETLQVEQD GKVRLSHQVR
     HQVALPPNYD YTPIAEHKRV NEARTYPFTL DPFQDTAISC IDRGESVLVS AHTSAGKTVV
     AEYAIAQSLK NKQRVIYTSP IKALSNQKYR ELLAEFGDVG LMTGDITINP DAGCLVMTTE
     ILRSMLYRGS EVMREVAWVI FDEVHYMRDK ERGVVWEETI ILLPDKVRYV FLSATIPNAM
     EFAEWICKIH SQPCHIVYTN FRPTPLQHYL FPAHGDGIYL VVDEKSTFRE ENFQKAMASI
     SNQIGDDPNS TDSRGKKGQT YKGGSAKGDA KGDIYKIVKM IWKKKYNPVI VFSFSKRDCE
     ELALKMSKLD FNSDDEKEAL TKIFNNAIAL LPETDRELPQ IKHILPLLRR GIGIHHSGLL
     PILKEVIEIL FQEGFLKVLF ATETFSIGLN MPAKTVVFTS VRKWDGQQFR WVSGGEYIQM
     SGRAGRRGLD DRGIVIMMID EKMEPQVAKG MVKGQADRLD SAFHLGYNMI LNLMRVEGIS
     PEFMLEHSFF QFQNVISVPV MEKKLAELKK DFDGIEVEDE ENVKEYHEIE QAIKGYREDV
     RQVVTHPANA LSFLQPGRLV EISVNGKDNY GWGAVVDFAK RINKRNPSAV YTDHESYIVN
     VVVNTMYIDS PVNLLKPFNP TLPEGIRPAE EGEKSICAVI PITLDSIKSI GNLRLYMPKD
     IRASGQKETV GKSLREVNRR FPDGIPVLDP VKNMKIEDED FLKLMKKIDV LNTKLSSNPL
     TNSMRLEELY GKYSRKHDLH EDMKQLKRKI SESQAVIQLD DLRRRKRVLR RLGFCTPNDI
     IELKGRVACE ISSGDELLLT ELIFNGNFNE LKPEQAAALL SCFAFQERCK EAPRLKPELA
     EPLKAMREIA AKIAKIMKDS KIEVVEKDYV ESFRHELMEV VYEWCRGATF TQICKMTDVY
     EGSLIRMFKR LEELVKELVD VANTIGNSSL KEKMEAVLKL IHRDIVSAGS LYL
>P47988 nuc TY1 ENHANCER ACTIVATOR.
     MTAPLWPNKN EKNHTVKRAL STDMTSNILS STNASSNEEN SRSSSAANVR SGTGANTLTN
     GGSTRKRLAC TNCRNRRKKC DLGFPCGNCS RLELVCNVND EDLRKKRYTN KYVKSLESHI
     AQLETNLKNL VQKIYPDDEQ ILNRMMVGDV LSALPDSSQV SINYTDQTPS LPIPATRGTF
     IIENDKVSQP LSSFNQQTEP STLNSGIFNT QKQNFEESLD DQLLLRRSLT PQGEKKKKPL
     VKGSLYPEGP VSYKRKHPVK SDSLLPVSSL TAATDPSTFS DGITAGNSVL VNGELKKRIS
     DLKTTVIVRG LNDDNPNSIN NDPRILKSLS NFYKWLYPGY FIFVHRESFL YGFFNHSKNN
     YEDSSYCSVE LIYAMCAVGS RLTPDLQEYS EVYYQRSKKT LLQLVFDEQS TARITTVQAL
     FCLAFYELGK GNNQLGWYFS GLAIRVGYDM GFQLDPKVWY VDDNNLQLTQ SELEIRSRIY
     WGCYIADHFI CLMLGRTSTL SVSNSTMPES DELPEVNGTE EFRFIGRHVL QISLPLKNLI
     ILSRLVQIFT SKIFIESEDI ARKLKYLNTF NSQVYNWRQS LPEFLQWSKT LIENDDVSTD
     PTISYFWYCY YIVRLTFNKP FIEDSQESET VVIEIIDDLK TLLDNFGKKF GNYTKGNLYQ
     LYSCLLAINC LKKLKEIRSS EQDSWNAQLD FFNHIFYTQL YPAYDLPKKL QEDTELETEQ
     ENQMLNQVGN INYTHDFSLS HEIDDLIREL FGVGTPQKL
>P49960 nuc U4/U6 SNRNA-ASSOCIATED SPLICING FACTOR PRP24 (U4/U6SNRP PROTEIN).
     MEYGHHARPD SKRPLDEGSP AAAGLTSKKA NEALTRNREL TTVLVKNLPK SYNQNKVYKY
     FKHCGPIIHV DVADSLKKNF RFARIEFARY DGALAAITKT HKVVGQNEII VSHLTECTLW
     MTNFPPSYTQ RNIRDLLQDI NVVALSIRLP SLRFNTSRRF AYIDVTSKED ARYCVEKLNG
     LKIEGYTLVT KVSNPLEKSK RTDSATLEGR EIMIRNLSTE LLDENLLRES FEGFGSIEKI
     NIPAGQKEHS FNNCCAFMVF ENKDSAERAL QMNRSLLGNR EISVSLADKK PFLERNEVKR
     LLASRNSKEL ETLICLFPLS DKVSPSLICQ FLQEEIHINE KDIRKILLVS DFNGAIIIFR
     DSKFAAKMLM ILNGSQFQGK VIRSGTINDM KRYYNNQQNH SMKHVKPSCI NMMEKGPNLQ
     VKKKIPDKQE QMSNDDFRKM FLGE
>P50106 nuc DNA-DIRECTED RNA POLYMERASE I 14 KD POLYPEPTIDE (EC 2.7.7.6) (A14).
     MMKGSRRTGN NTATTLNTPV VIHATQLPQH VSTDEVLQFL ESFIDEKENI IDSTTMNTIS
     GNAADADAAA VANTSLNIDT NLSSSISQLK RIQRDFKGLP PAQDFSAAPI QVSTTEKKET
     SIGVSATGGK KTTFADE
>P50874 nuc ORIGIN RECOGNITION COMPLEX PROTEIN, SUBUNIT 5 (ORIGIN RECOGNITION
     MNVTTPEVAF REYQTNCLAS YISADPDITP SNLILQGYSG TGKTYTLKKY FNANPNLHAV
     WLEPVELVSW KPLLQAIART VQYKLKTLYP NIPTTDYDPL QVEEPFLLVK TLHNIFVQYE
     SLQEKTCLFL ILDGFDSLQD LDAALFNKYI KLNELLPKDS KINIKFIYTM LETSFLQRYS
     THCIPTVMFP RYNVDEVSTI LVMSRCGELM EDSCLRKRII EEQITDCTDD QFQNVAANFI
     HLIVQAFHSY TGNDIFALND LIDFKWPKYV SRITKENIFE PLALYKSAIK LFLSTDDNLS
     ENGQGESAIT TNRDDLENSQ TYDLSIISKY LLIASYICSY LEPRYDASIF SRKTRIIQGR
     AAYGRRKKKE VNPRYLQPSL FAIERLLAIF QAIFPIQGKA ESGSLSALRE ESLMKANIEV
     FQNLSELHTL KLIATTMNKN IDYLSPKVRW KVNVPWEIIK EISESVHFNI SDYFSDIHE
>P52488 nuc UBIQUITIN-ACTIVATING ENZYME E1-LIKE (POLYMERASE-INTERACTING PROTEIN
     MPRETSLVTI IGEDSYKKLR SSRCLLVGAG GIGSELLKDI ILMEFGEIHI VDLDTIDLSN
     LNRQFLFRQK DIKQPKSTTA VKAVQHFNNS KLVPYQGNVM DISTFPLHWF EQFDIIFNAL
     DNLAARRYVN KISQFLSLPL IESGTAGFDG YMQPIIPGKT ECFECTKKET PKTFPVCTIR
     STPSQPIHCI VWAKNFLFNQ LFASETSGNE DDNNQDWGTD DAEEIKRIKQ ETNELYELQK
     IIISRDASRI PEILNKLFIQ DINKLLAIEN LWKTRTKPVP LSDSQINTPT KTAQSASNSV
     GTIQEQISNF INITQKLMDR YPKEQNHIEF DKDDADTLEF VATAANIRSH IFNIPMKSVF
     DIKQIAGNII PAIATTNAIV AGASSLISLR VLNLLKYAPT TKYTDLNMAF TAKASNLSQN
     RYLSNPKLAP PNKNCPVCSK VCRGVIKLSS DCLNKMKLSD FVVLIREKYS YPQDISLLDA
     SNQRLLFDYD FEDLNDRTLS EINLGNGSII LFSDEEGDTM IRKAIELFLD VDDELPCNTC
     SLPDVEVPLI KANNSPSKNE EEEKNEKGAD VVATTNSHGK DGIVILDDDE GEITIDAEPI
     NGSKKRPVDT EISEAPSNKR TKLVNEPTNS DIVELD
>P52553 nuc PROTEIN YKE2.
     MSELGAKYQQ LQNELEEFIV ARQKLETQLQ ENKIVNEEFD QLEEDTPVYK LTGNVLLPVE
     QSEARTNVDK RLEFIETEIT RCEKNIRDKQ EELEKMRSEL IKLNNTAAST GPGR
>P52960 nuc PEROXISOME PROLIFERATION TRANSCRIPTIONAL REGULATOR.
     MYFTDESSPA MNRVGKKRNR LSFVCQACRK AKTKCDQEKP RCGRCTKQNL FCIYDVARQA
     APRNPNKDAT IARLKKEIRY WRNKTVDLTQ EKKDFYTALK RPTEELAARR TCKSLQENSF
     PISLYKTHPR LIMTKVMKRE INPLSEKYLI FQDTFLKTLI ASVLLSCSRN SMIPALNADI
     SRSRTQPCVK NNVVKMREVL LKNSKYESQR KSINEFTDRL LQRKNPEEQI AVNKVISLLY
     SNRESSYLED TCPTENDYSD LLKGYINEIE KTLPPKAIIE QYLSHFFEHI FHLIPFASKE
     MLEESIHTTV QYNELGEVRL SMGTTLIRNK MENLCILLLI LRIAYISLTF IEDKIEDYSP
     YITKEMLEQY PIQSEVIFLA QQILASENWC ACANENTISC LLYIWCAFVF SPTEGDFLLE
     QPSDVIINLV ILIGTSIGLH RDPSDFPALN HPEASDKRLL NLRRIQWLSI ISMATLESSL
     KGRLLVSPLS MIDLFIDVRD PNCVEIYKKR VKKDLTGSES DEQLLEIHEI FFHRAQLALF
     LSDLNNITIS YSGSVPMDTL ETLRVKANEL LKNKFQLRSV DINIYDEEKT FQKLTFNSIL
     NSISLSGQIL GKLMMLRASI ALMLYFETLA MERSECLSFF YKYFFQCCAD TISLIRFFFL
     YFNGSYEKVL SSLVCFITTK VIQLAVPTTM FTLLVIIMRV ELAKNMLLVK CNECNARGDI
     SDLPEIKEKI KSLDTIKENF ERLLLEVYLL ASQNLRFKYF YIFKMLTLFD VFIQRLRKGQ
     LFSGLFVKVD KDLTTKKIAT MLELTLGINL DKSDHLIDRL KGKNLTVNFT LDQLYQIIKE
     FDRIKNIGVA DPQNSLNPSK PNMKDNTPTI ELLLNSSVEN ESVPPYSSSN DPTNVGNAST
     YSLAHNISNQ NNEENMPPSI GSSESNRAAP NLNFMPINNN YNNSGSNINN NDNVKLPSNF
     KNYYDPPMSS LDISMDVPDI FGSLDFFDYD LLFQND
>P53040 nuc TRANSCRIPTION INITIATION FACTOR TFIID 60 KD SUBUNIT (TAFII-60).
     MSTQQQSYTI WSPQDTVKDV AESLGLENIN DDVLKALAMD VEYRILEIIE QAVKFKRHSK
     RDVLTTDDVS KALRVLNVEP LYGYYDGSEV NKAVSFSKVN TSGGQSVYYL DEEEVDFDRL
     INEPLPQVPR LPTFTTHWLA VEGVQPAIIQ NPNLNDIRVS QPPFIRGAIV TALNDNSLQT
     PVTSTTASAS VTDTGASQHL SNVKPGQNTE VKPLVKHVLS KELQIYFNKV ISTLTAKSQA
     DEAAQHMKQA ALTSLRTDSG LHQLVPYFIQ FIAEQITQNL SDLQLLTTIL EMIYSLLSNT
     SIFLDPYIHS LMPSILTLLL AKKLGGSPKD DSPQEIHEFL ERTNALRDFA ASLLDYVLKK
     FPQAYKSLKP RVTRTLLKTF LDINRVFGTY YGCLKGVSVL EGESIRFFLG NLNNWARLVF
     NESGITLDNI EEHLNDDSNP TRTKFTKEET QILVDTVISA LLVLKKDLPD LYEGKGEKVT
     DEDKEKLLER CGVTIGFHIL KRDDAKELIS AIFFGE
>P53043 nuc SERINE/THREONINE PROTEIN PHOSPHATASE T (EC 3.1.3.16) (PPT).
     MSTPTAADRA KALERKNEGN VFVKEKHFLK AIEKYTEAID LDSTQSIYFS NRAFAHFKVD
     NFQSALNDCD EAIKLDPKNI KAYHRRALSC MALLEFKKAR KDLNVLLKAK PNDPAATKAL
     LTCDRFIREE RFRKAIGGAE NEAKISLCQT LNLSSFDANA DLANYEGPKL EFEQLYDDKN
     AFKGAKIKNM SQEFISKMVN DLFLKGKYLP KKYVAAIISH ADTLFRQEPS MVELENNSTP
     DVKISVCGDT HGQFYDVLNL FRKFGKVGPK HTYLFNGDFV DRGSWSCEVA LLFYCLKILH
     PNNFFLNRGN HESDNMNKIY GFEDECKYKY SQRIFNMFAQ SFESLPLATL INNDYLVMHG
     GLPSDPSATL SDFKNIDRFA QPPRDGAFME LLWADPQEAN GMGPSQRGLG HAFGPDITDR
     FLRNNKLRKI FRSHELRMGG VQFEQKGKLM TVFSAPNYCD SQGNLGGVIH VVPGHGILQA
     GRNDDQNLII ETFEAVEHPD IKPMAYSNGG FGL
>P53114 nuc NUT1 PROTEIN.
     MEKESVYNLA LKCAERQLTS MEFSNLYKEF FNEKFPSLIQ EEEEDTTTTA NINEVKKASD
     LVDTPSNNTA ATADTTHLHE ALDIVCSDFV KILNLEKPLI LADYIVEVLL VNYNSDMIKC
     FLPKLNSVRN SLLLAHFFSK SCSFFAKLSD TLIIDQVRKD LGNVIVPNIL SLDMNSMNKE
     LIAIVSKLLQ TTLKLSPSPI LLTSAGCKNG SFTLLNQLSQ TNKLLFKRVS QTFEAKLHFK
     DTKPFLNKDS TNEFVGSPSL TSPQYIPSPL SSTKPPGSVN SAAKYKDMKL LRYYKNIWLN
     NKIINWEISN PDFLSKYSAI TSSIFQESFN SVQNLDQLLT DLIETSFTCF AQFVSNKQYH
     QANSNLTLLE RKWVIFITKH LPLLILENSS RSPRVVTNAL DNIDEKVVKA IRIYFTEKDD
     NKTNNEDLFD DYPSTSLDIR HDFIKGLIML NLQPASVINN YLREDQMIDT SILPTRDDLF
     VRNLQGIQEV VHNTNSFIIS SLDTLELESI TESITHDSSN GLFQVLHNFE SVAPTKQREI
     VKAFLSIFED AIKELNYNRI AKICALLFFN FSHSLTTILS FSSPAALMKT LIKFVDLSRN
     GRNGSNGNDE SSEYETINIS LSFSWAILLI INLTQTYGIS VVDVALKYPE LSIKNSFIIN
     FISNLPNVSD KYYLEESNVN DSDMLTKSHN TVQSWLCDLF VNGSITDQLI QNIETRQLAN
     LIPFIVKQVL LSVEIGVLTD ISSLIGGFEY FLQPLLLVGL IKTFYWLEQF LSCVKNDTIS
     EDILQGIFNL LNTLFNPVTL NEDSKAFHTA VLRLNAIPLL KVLRKFRVQS QSNYGIYSSD
     AQGDPNLEPL IAKLVAVLNV SPVYDVDPRI INSENDYSRK QLGYGKFLIL NENPINKIMT
     NQINSFWSLH SSTYYNLDYL FELIELVTPK SFLFDVLKTL EYKLATYGVP GSENKRGSLD
     SEHVFDYFFY FLVLYDVKTA EEASQLIEYM ENDAKKSKGD VDIKGEDLHE KNDSAEVRQE
     TQPKAEATQD DDFDMLFGEN DTSTQAYEEE EENEDNDGNN RTNNVPMIKA EETPSKTNKI
     SILKRHSFAV LLHERKLLND LALENGEITK TENEKFISYH DKYLCMLKTC VF
>P53338 nuc MALTOSE FERMENTATION REGULATORY PROTEIN MAL1R.
     MTLTKQTCAK QACDCCRIRR VKCDGKRPCS SCLQNSLDCT YLQPSRKRGP KSIRLRSLKR
     IAEVQRESGP NTIATAPVIY KRVPKKLIDQ CLRLYHDNLY VIWPLLSYDD LHKLLEEKYN
     DNYVYWFLTA LSAATLSDLQ TEIKSEEEVT FTGKQLSNLC ISSCQQFDDL DNSNIFNIMT
     YYCLHRSFAQ ISNARTSYRL CCEAVGLITV AGLHREETYG SLTFEEQQLR RKLYYLLLMT
     ERYYAIYLHC ATSLDATIAP PQLELVTDPQ LSMDSFLEMI RVFTVPGKCF FDALAADSTD
     ASCTEESLKK IWNELHTTSS EIEPWSNGYI DISFSRHWIR ILAWKLAYQM RGSNFSLNAN
     NGQIPIEIAR DMLIDTYLTP ENLYDVHGPG VPVKTLEIAT ALVDIVGQYD HNMKLEAWNV
     LHDVCKFAFS LNHYNNDMLK RFSTKCQNAL ITLPISKPLQ LDGYPKDNED IDP
>P53540 nuc SPINDLE POLE BODY COMPONENT SPC98.
     MELEPTLFGI IEALAPQLLS QSHLQTFVSD VVNLLRSSTK SATQLGPLID FYKLQSLDSP
     ETTIMWHKIE KFLDALFGIQ NTDDMVKYLS VFQSLLPSNY RAKIVQKSSG LNMENLANHE
     HLLSPVRAPS IYTEASFENM DRFSERRSMV SSPNRYVPSS TYSSVTLRQL SNPYYVNTIP
     EEDILKYVSY TLLATTSALF PFDHEQIQIP SKIPNFESGL LHLIFEAGLL YQSLGYKVEK
     FRMLNISPMK KALIIEISEE LQNYTAFVNN LVSSGTVVSL KSLYREIYEN IIRLRIYCRF
     TEHLEELSGD TFLIELNIFK SHGDLTIRKI ATNLFNSMIS LYYEYLMNWL TKGLLRATYG
     EFFIAENTDT NGTDDDFIYH IPIEFNQERV PAFIPKELAY KIFMIGKSYI FLEKYCKEVQ
     WTNEFSKKYH VLYQSNSYRG ISTNFFEIIN DQYSEIVNHT NQILNQKFHY RDVVFALKNI
     LLMGKSDFMD ALIEKANDIL ATPSDSLPNY KLTRVLQEAV QLSSLRHLMN SPRNSSVING
     LDARVLDLGH GSVGWDVFTL DYILYPPLSL VLNVNRPFGR KEYLRIFNFL WRFKKNNYFY
     QKEMLKSNDI IRSFKKIRGY NPLIRDIINK LSRISILRTQ FQQFNSKMES YYLNCIIEEN
     FKEMTRKLQR TENKSQNQFD LIRLNNGTIE LNGILTPKAE VLTKSSSSKP QKHAIEKTLN
     IDELESVHNT FLTNILSHKL FATNTSEISV GDYSGQPYPT SLVLLLNSVY EFVKVYCNLN
     DIGYEIFIKM NLNDHEASNG LLGKFNTNLK EIVSQYKNFK DRLYIFRADL KNDGDEELFL
     LSKSLR
>P53628 nuc TRANSCRIPTION REGULATORY PROTEIN SNF12 (SWI/SNF COMPLEX COMPONENT
     MSKVMKPSNG KGSRKSSKAA TPDTKNFFHA KKKDPVNQDK ANNASQITPT VPHSHPSDMV
     IPDHLAELIP ELYSFQQLVD SEKRLDHFIH LRNLHMKRMV AQWERSKLSQ EFLYPHLNFP
     NVKFLRIFIS NVSENQPWQM DTNNEADLMA LENATWTMRI EGRLLDNVQA NDPAREKFSS
     FIESIVVDFK NKENDNVPST KFNAAPEENA TEGPSDKKLN LNLPLQFSLP NGDNSTTTNT
     DQNNATMGEE TAKKDMSSTT PKLESVKWQY DPNNPVDFDG LDIKRVGSEN VECTISILRK
     SSPEEPFMSY SPQLTAIIGL KSGTSHDAIF SIYKYIHLNE LLTNDESAFE NLMGNRNNHN
     SNTSTSKMLD AASSQVSIVK LDTQLITLLP SSLKESSPDT MKLTDLLSLI NSTHLLPLQP
     IEIDYTVRVD KASTYGELVL DIEVPDVNAL KFNNTQRESQ IGAAELNENA RELEQIKPKI
     ALQDKEITSV LSNLHESNKR YRFFKKISED PVKALNECIA STSNALKVLS GDEGYNEDMV
     RRANFYKENE AMLRENIEVI LSNGRM
>P54784 nuc ORIGIN RECOGNITION COMPLEX PROTEIN, SUBUNIT 1 (ORIGIN RECOGNITION
     MAKTLKDLQG WEIITTDEQG NIIDGGQKRL RRRGAKTEHY LKRSSDGIKL GRGDSVVMHN
     EAAGTYSVYM IQELRLNTLN NVVELWALTY LRWFEVNPLA HYRQFNPDAN ILNRPLNYYN
     KLFSETANKN ELYLTAELAE LQLFNFIRVA NVMDGSKWEV LKGNVDPERD FTVRYICEPT
     GEKFVDINIE DVKAYIKKVE PREAQEYLKD LTLPSKKKEI KRGPQKKDKA TQTAQISDAE
     TRATDITDNE DGNEDESSDY ESPSDIDVSE DMDSGEISAD ELEEEEDEEE DEDEEEKEAR
     HTNSPRKRGR KIKLGKDDID ASVQPPPKKR GRKPKDPSKP RQMLLISSCR ANNTPVIRKF
     TKKNVARAKK KYTPFSKRFK SIAAIPDLTS LPEFYGNSSE LMASRFENKL KTTQKHQIVE
     TIFSKVKKQL NSSYVKEEIL KSANFQDYLP ARENEFASIY LSAYSAIESD SATTIYVAGT
     PGVGKTLTVR EVVKELLSSS AQREIPDFLY VEINGLKMVK PTDCYETLWN KVSGERLTWA
     ASMESLEFYF KRVPKNKKKT IVVLLDELDA MVTKSQDIMY NFFNWTTYEN AKLIVIAVAN
     TMDLPERQLG NKITSRIGFT RIMFTGYTHE ELKNIIDLRL KGLNDSFFYV DTKTGNAILI
     DAAGNDTTVK QTLPEDVRKV RLRMSADAIE IASRKVASVS GDARRALKVC KRAAEIAEKH
     YMAKHGYGYD GKTVIEDENE EQIYDDEDKD LIESNKAKDD NDDDDDNDGV QTVHITHVMK
     ALNETLNSHV ITFMTRLSFT AKLFIYALLN LMKKNGSQEQ ELGDIVDEIK LLIEVNGSNK
     FVMEIAKTLF QQGSDNISEQ LRIISWDFVL NQLLDAGILF KQTMKNDRIC CVKLNISVEE
     AKRAMNEDET LRNL
>P54790 nuc ORIGIN RECOGNITION COMPLEX PROTEIN, SUBUNIT 3 (ORIGIN RECOGNITION
     MSDLNQSKKM NVSEFADAQR SHYTVYPSLP QSNKNDKHIP FVKLLSGKES EVNVEKRWEL
     YHQLHSHFHD QVDHIIDNIE ADLKAEISDL LYSETTQKRR CFNTIFLLGS DSTTKIELKD
     ESSRYNVLIE LTPKESPNVR MMLRRSMYKL YSAADAEEHP TIKYEDINDE DGDFTEQNND
     VSYDLSLVEN FKRLFGKDLA MVFNFKDVDS INFNTLDNFI ILLKSAFKYD HVKISLIFNI
     NTNLSNIEKN LRQSTIRLLK RNYHKLDVSS NKGFKYGNQI FQSFLDTVDG KLNLSDRFVE
     FILSKMANNT NHNLQLLTKM LDYSLMSYFF QNAFSVFIDP VNVDFLNDDY LKILSRCPTF
     MFFVEGLIKQ HAPADEILSL LTNKNRGLEE FFVEFLVREN PINGHAKFVA RFLEEELNIT
     NFNLIELYHN LLIGKLDSYL DRWSACKEYK DRLHFEPIDT IFQELFTLDN RSGLLTQSIF
     PSYKSNIEDN LLSWEQVLPS LDKENYDTLS GDLDKIMAPV LGQLFKLYRE ANMTINIYDF
     YIAFRETLPK EEILNFIRKD PSNTKLLELA ETPDAFDKVA LILFMQAIFA FENMGLIKFQ
     STKSYDLVEK CVWRGI
>P54791 nuc ORIGIN RECOGNITION COMPLEX PROTEIN, SUBUNIT 4 (ORIGIN RECOGNITION
     MTISEARLSP QVNLLPIKRH SNEEVEETAA ILKKRTIDNE KCKDSDPGFG SLQRRLLQQL
     YGTLPTDEKI IFTYLQDCQQ EIDRIIKQSI IQKESHSVIL VGPRQSYKTY LLDYELSLLQ
     QSYKEQFITI RLNGFIHSEQ TAINGIATQL EQQLQKIHGS EEKIDDTSLE TISSGSLTEV
     FEKILLLLDS TTKTRNEDSG EVDRESITKI TVVFIFDEID TFAGPVRQTL LYNLFDMVEH
     SRVPVCIFGC TTKLNILEYL EKRVKSRFSQ RVIYMPQIQN LDDMVDAVRN LLTVRSEISP
     WVSQWNETLE KELSDPRSNL NRHIRMNFET FRSLPTLKNS IIPLVATSKN FGSLCTAIKS
     CSFLDIYNKN QLSNNLTGRL QSLSDLELAI LISAARVALR AKDGSFNFNL AYAEYEKMIK
     AINSRIPTVA PTTNVGTGQS TFSIDNTIKL WLKKDVKNVW ENLVQLDFFT EKSAVGLRDN
     ATAAFYASNY QFQGTMIPFD LRSYQMQIIL QELRRIIPKS NMYYSWTQL
>Q00416 nuc TRNA-SPLICING ENDONUCLEASE POSITIVE EFFECTOR.
     MHSKFCEREV QMLQHFAIQR HVPHEHVAKF NDIVCQWRVE AVFPILRNIS VNDNTGINIT
     NEIETAMYEC LCNPHMLRLN KQLKATFEAI FKFFYDTKHR LLDVTNPLSI KTFISGVIFC
     WCEGSKEENE WSRAFLKDLY SRNFHINLSN LTPDIIEEVY IHILFLQNPA NWTEIVVSQF
     WSRLLPVFNL FDKDVFIEYF QVPKNVESLK KTFKFPLEPI FKMWYNHLSK SYHDKPLDFL
     LRGLTMFLNK FGSEFWSKIE PFTFHSILDI IFNRDSFPIK LIKIQDNPIV EHQTEVYFQL
     TGSVTDLLSW TLPFYHALSP SKRIQMVRKV SMAFLRIIAN YPSLKSIPKA CLMNSATALL
     RAVLTIKENE RAMLYKNDEF ETVLLTKTDS RALLNNPLIQ DIIIRSASNP NDFYPGLGAA
     SASVATSTMM VLAECIDFDI LLLCHRTFKL YSGKPISEIP ISTNVLENVT NKIDLRSFHD
     GPLLAKQLLV SLKNINGLLI VPSNTAVAEA HNALNQKFLL LSTRLMEKFA DILPGQLSKI
     LADEDASQGF WSCIFSSDKH LYQAATNILY NTFDVEGRLE GILAILNSNL TVNLKNINVM
     LQRLINCEFY EPCPRAVRVL MDVVSAFVDP ISGVFANFQT LKSQNTEKEF LKFWESCWLF
     LDTIYKFTLK WASKYDYSEL ENFTKDTLDL SRSLVDSFRE FSDILHDQTK NLLLNVLETF
     KNMLYWLRLS DEVLLESCVR LIISTSDLAH EKHVKVDDSL VEMMAKYASK AKRFSNKLTE
     QQASEILQKA KIFNKALTEE VATEAENYRK EKELSRLGKV IDLTDSVPAS PSLSPSLSST
     IASSSAESRA DYLQRKALSS SITGRPRVAQ PKITSFGTFQ SSANAKLHRT KPVKPLSKME
     LARMQLLNNR VVHPPSAPAF HTKSRGLSNK NDDSSSEESD NDIESARELF AIAKAKGKGI
     QTVDINGKVV KRQTAAELAK QELEHMRKRL NVDMNPLYEI ILQWDYTRNS EYPDDEPIGN
     YSDVKDFFNS PADYQKVMKP LLLLESWQGL CSSRDREDYK PFSIIVGNRT AVSDFYDVYA
     SVAKQVIQDC GISESDLIVM AYLPDFRPDK RLSSDDFKKA QHTCLAKVRT LKNTKGGNVD
     VTLRIHRNHS FSKFLTLRSE IYCVKVMQMT TIEREYSTLE GLEYYDLVGQ ILQAKPSPPV
     NVDAAEIETV KKSYKLNTSQ AEAIVNSVSK EGFSLIQGPP GTGKTKTILG IIGYFLSTKN
     ASSSNVIKVP LEKNSSNTEQ LLKKQKILIC APSNAAVDEI CLRLKSGVYD KQGHQFKPQL
     VRVGRSDVVN VAIKDLTLEE LVDKRIGERN YEIRTDPELE RKFNNAVTKR RELRGKLDSE
     SGNPESPMST EDISKLQLKI RELSKIINEL GRDRDEMREK NSVNYRNRDL DRRNAQAHIL
     AVSDIICSTL SGSAHDVLAT MGIKFDTVII DEACQCTELS SIIPLRYGGK RCIMVGDPNQ
     LPPTVLSGAA SNFKYNQSLF VRMEKNSSPY LLDVQYRMHP SISKFPSSEF YQGRLKDGPG
     MDILNKRPWH QLEPLAPYKF FDIISGRQEQ NAKTMSYTNM EEIRVAIELV DYLFRKFDNK
     IDFTGKIGII SPYREQMQKM RKEFARYFGG MINKSIDFNT IDGFQGQEKE IILISCVRAD
     DTKSSVGFLK DFRRMNVALT RAKTSIWVLG HQRSLAKSKL WRDLIEDAKD RSCLAYACSG
     FLDPRNNRAQ SILRKFNVPV PSEQEDDYKL PMEYITQGPD EVKSNKDTKK RRVVDEGEEA
     DKAVKKKKKE KKKEKKKSKA DDKKKNNKKA ESPSTSSGTK KKSSIFGGMS VPSAVVPKTF
     PDVDSNKKAA AVVGKKKNNK HVCFSDDVSF IPRNDEPEIK VTRSLSSVLK EKQLGLKETR
     TISPPEISNN EDDDDEDDYT PSISDSSLMK SEANGRNNRV ASHNQNFSAS IYDDPQVSQA
     KQTQVPAAIT KHRSSNSVLS GGSSRILTAS DYGEPNQNGQ NGANRTLSQH VGNANQYSTA
     PVGTGELHET LPAHPQDSYP AEAEDPYDLN PHPQPQSSAF KGPGSGPTGT RNSSRRNASS
     SPFIPKKRKP RS
>Q00453 nuc PROBABLE TRANSCRIPTION REPRESSOR PROTEIN RGM1.
     MRGKQPKRNK DNASVKRNYR CVGYPDCNMS FNRTEHLARH IRKHTGEKPF QCNICLKFFS
     RIDNLRQHQS SVHSDVDLMS LRRLQQSANS TANDPNATRM FPQLRPYGIV VQPAPVPYNL
     PISTPASPQD TISLYAPPYF PHPMPSAPIP LPHQPPPLPI YSYMQPLFLN HTPIQNHNIV
     ELPPDSSDTP ASPSKVQSFD QAKDASPNAK K
>Q00539 nuc NAM8 PROTEIN.
     MSYKQTTYYP SRGNLVRNDS SPYTNTISSE TNNSSTSVLS LQGASNVSLG TTGNQLYMGD
     LDPTWDKNTV RQIWASLGEA NINVRMMWNN TLNNGSRSSM GPKNNQGYCF VDFPSSTHAA
     NALLKNGMLI PNFPNKKLKL NWATSSYSNS NNSLNNVKSG NNCSIFVGDL APNVTESQLF
     ELFINRYAST SHAKIVHDQV TGMSKGYGFV KFTNSDEQQL ALSEMQGVFL NGRAIKVGPT
     SGQQQHVSGN NDYNRSSSSL NNENVDSRFL SKGQSFLSNG NNNMGFKRNH MSQFIYPVQQ
     QPSLNHFTDP NNTTVFIGGL SSLVTEDELR AYFQPFGTIV YVKIPVGKCC GFVQYVDRLS
     AEAAIAGMQG FPIANSRVRL SWGRSAKQTA LLQQAMLSNS LQVQQQQPGL QQPNYGYIPS
     STCEAPVLPD NNVSSTMLPG CQILNYSNPY ANANGLGSNN FSFYSNNNAT NTQATSLLAD
     TSSMDLSGTG GQQVIMQGSE AVVNSTNAML NRLEQGSNGF MFA
>Q00578 nuc DNA REPAIR HELICASE RAD25.
     MTDVEGYQPK SKGKIFPDMG ESFFSSDEDS PATDAEIDEN YDDNRETSEG RGERDTGAMV
     TGLKKPRKKT KSSRHTAADS SMNQMDAKDK ALLQDTNSDI PADFVPDSVS GMFRSHDFSY
     LRLRPDHASR PLWISPSDGR IILESFSPLA EQAQDFLVTI AEPISRPSHI HEYKITAYSL
     YAAVSVGLET DDIISVLDRL SKVPVAESII NFIKGATISY GKVKLVIKHN RYFVETTQAD
     ILQMLLNDSV IGPLRIDSDH QVQPPEDVLQ QQLQQTAGKP ATNVNPNDVE AVFSAVIGGD
     NEREEEDDDI DAVHSFEIAN ESVEVVKKRC QEIDYPVLEE YDFRNDHRNP DLDIDLKPST
     QIRPYQEKSL SKMFGNGRAR SGIIVLPCGA GKTLVGITAA CTIKKSVIVL CTSSVSVMQW
     RQQFLQWCTL QPENCAVFTS DNKEMFQTES GLVVSTYSMV ANTRNRSHDS QKVMDFLTGR
     EWGFIILDEV HVVPAAMFRR VVSTIAAHAK LGLTATLVRE DDKIGDLNFL IGPKLYEANW
     MELSQKGHIA NVQCAEVWCP MTAEFYQEYL RETARKRMLL YIMNPTKFQA CQFLIQYHER
     RGDKIIVFSD NVYALQEYAL KMGKPFIYGS TPQQERMNIL QNFQYNDQIN TIFLSKVGDT
     SIDLPEATCL IQISSHYGSR RQEAQRLGRI LRAKRRNDEG FNAFFYSLVS KDTQEMYYST
     KRQAFLVDQG YAFKVITHLH GMENIPNLAY ASPRERRELL QEVLLKNEEA AGIEVGDDAD
     NSVGRGSNGH KRFKSKAVRG EGSLSGLAGG EDMAYMEYST NKNKELKEHH PLIRKMYYKN
     LKK
>Q00723 nuc PRE-MRNA SPLICING FACTOR PRP38.
     MAVNEFQVES NISPKQLNNQ SVSLVIPRLT RDKIHNSMYY KVNLSNESLR GNTMVELLKV
     MIGAFGTIKG QNGHLHMMVL GGIEFKCILM KLIEIRPNFQ QLNFLLNVKN ENGFDSKYII
     ALLLVYARLQ YYYLNGNNKN DDDENDLIKL FKVQLYKYSQ HYFKLKSFPL QVDCFAHSYN
     EELCIIHIDE LVDWLATQDH IWGIPLGKCQ WNKIYNSDEE SSSSESESNG DSEDDNDTSS
     ES
>Q00816 nuc HEX2 PROTEIN (SRN1 PROTEIN) (REG1 PROTEIN).
     MSTNLANYFA GKKDIENEHV NRNASHESNS KSDVKISGND NDNDEDMGPS VSMAVQAKND
     DDFHKSTFNL KRTRSMGLLD EYIDPTKKLL GRSDDLYDND NEYYDNSSNN SSSNSSDDDY
     DDGYQEHSTS VSPPPADNDS YLIPQDDNDV VVEPERHVDY LSHEWKESEI SNSWKYIILK
     KKKRDVDLVN AARLENASWR TWAKARNNLK TVSPEVVNWS KDSDVTWLYG PIVRDSEGNA
     QSEEEHDLER GYGSDDENSK RISMPTKNSK SIAAAPKPIL KKRTVTEIIE DNALWKLNEA
     RKHMTEMKHA SVIMDPNGNK NVHDDFDALA AQVNAQYYHY PKESNSSVSL KSQHSDKKDN
     STIPNPVGEN SNGGGDKGEE DLHLKSALHV QNNRSTAQSN KSILENSTND RKANLDQNLN
     SPDNNRFPSS TSSSNRDNEN NSMGLSSILT SNPSEKSNKP TKNRHIHFND RVEQCMALRY
     PASQSEDDES DDENKQYVDV NNNANVTTIN NNRTPLLAIQ HKSIPINSAT EHLNKNTSDD
     DTSSQSSSSS HSDDEEHGGL YINARFSRRS DSGVHSPITD NSSVASSTTS RAHVRPIIKL
     LPDTTLNYGS DEESDNGEFN GYGNAVSHNV NTSRGYDYIY DYNSVYTGDT SSFLPVDSCD
     IVDVPEGMDL QTAIADDNAS NYEFNNAVES KEKHVPQLHK ASANNTTRQH GSHMLLYDDD
     NYSSSSDSEQ QFIEDSQYNS SDDEEEEDDD DQEVDDNHDE GLSLRRTLSL GKSGSTNSLY
     DLAQPSLSSA TPQQKNPTNF TGGKTDVDKD AQLAVRPYPL KRNSSSGNFI FNSDSEEESS
     SEEEQRPLPA NSQLVNRSVL KGSVTPANIS SQKKKALPKQ PKASDSSQSF RIVNNTPSPA
     EVGASDVAIE GYFSPRNESI KSVVSGGNMM DHQDHSEMDT LAKGFENCHI NNASKLKDKK
     VDSVQTTRKE ASLTDSSNES LHKVVQNARG MASKYLHSWK KSDVKPQENG NDSS
>Q00947 nuc ZINC FINGER PROTEIN STP1.
     MNCITIDVFF TAFSHPCKRK KKQADSCINC KDSLIKSRFT LQTKGKGKLY RLYHIRSKMP
     STTLLFPQKH IRAIPGKIYA FFRELVSGVI ISKPDLSHHY SCENATKEEG KDAADEEKTT
     TSLFPESNNI DRSLNGGCSV IPCSMDVSDL NTPISITLSP ENRIKSEVNA KSLLGSRPEQ
     DTGAPIKMST GVTSSPLSPS GSTPEHSTKV LNNGEEEFIC HYCDATFRIR GYLTRHIKKH
     AIEKAYHCPF FNSATPPDLR CHNSGGFSRR DTYKTHLKAR HVLYPKGVKP QDRNKSSGHC
     AQCGEYFSTI ENFVENHIES GDCKALPQGY TKKNEKRSGK LRKIKTSNGH SRFISTSQSV
     VEPKVLFNKD AVEAMTIVAN NSSGNDIISK YGNNKLMLNS ENFKVDIPKR KRKYIKKKQQ
     QVSGSTVTTP EVATQNNQEV APDEISSATI FSPFDTHLLE PVPSSSSESS AEVMFHGKQM
     KNFLIDINSF TNQQQQAQDN PSFLPLDIEQ SSYDLSEDAM SYPIISTQSN RDCTQYDNTK
     ISQILQSQLN PEYLSENHMR ETQQYLNFYN DNFGSQF
>Q01080 nuc DNA-DIRECTED RNA POLYMERASE I 49 KD POLYPEPTIDE (EC 2.7.7.6) (A49).
     MSVKRSVSEI EIESVQDQPS VAVGSFFKGF RAPSDTTFDL YKKKKSEKDE FVLHGENERL
     EYEGYTDSSS QASNQYVVGL FNPEKKSIQL YKAPVLVSKV VSKSSKNLRG PKIKSKSDTR
     PSALRNALGE AFGTKKAKKA IADLERNRID SDKLTDSAID IVDSVRTASK DLPTRAQLDE
     ITSNDRPTPL ANIDATDVEQ IYPIESIIPK KELQFIRVSS ILKEADKEKK LELFPYQNNS
     KYVAKKLDSL TQPSQMTKLQ LLYYLSLLLG VYENRRVNNK TKLLERLNSP PEILVDGILS
     RFTVIKPGQF GRSKDRSYFI DPQNEDKILC YILAIIMHLD NFIVEITPLA HELNLKPSKV
     VSLFRVLGAI VKGATVAQAE AFGIPKSTAA SYKIATMKVP FKLPEMTRRG RGPRR
>Q01159 nuc MRNA CAPPING ENZYME (MRNA GUANYLYLTRANSFERASE) (EC 2.7.7.50)
     MVLAMESRVA PEIPGLIQPG NVTQDLKMMV CKLLNSPKPT KTFPGSQPVS FQHSDVEEKL
     LAHDYYVCEK TDGLRVLMFI VINPVTGEQG CFMIDRENNY YLVNGFRFPR LPQKKKEELL
     ETLQDGTLLD GELVIQTNPM TKLQELRYLM FDCLAINGRC LTQSPTSSRL AHLGKEFFKP
     YFDLRAAYPN RCTTFPFKIS MKHMDFSYQL VKVAKSLDKL PHLSDGLIFT PVKAPYTAGG
     KDSLLLKWKP EQENTVDFKL ILDIPMVEDP SLPKDDRNRW YYNYDVKPVF SLYVWQGGAD
     VNSRLKHFDQ PFDRKEFEIL ERTYRKFAEL SVSDEEWQNL KNLEQPLNGR IVECAKNQET
     GAWEMLRFRD DKLNGNHTSV VQKVLESIND SVSLEDLEEI VGDIKRCWDE RRANMAGGSG
     RPLPSQSQNA TLSTSKPVHS QPPSNDKEPK YVDEDDWSD
>Q02100 nuc CRE-BINDING BZIP PROTEIN SKO1.
     MSSEERSRQP STVSTFDLEP NPFEQSFASS KKALSLPGTI SHPSLPKELS RNNSTSTITQ
     HSQRSTHSLN SIPEENGNST VTDNSNHNDV KKDSPSFLPG QQRPTIISPP ILTPGGSKRL
     PPLLLSPSIL YQANSTTNPS QNSHSVSVSN SNPSAIGVSS TSGSLYPNSS SPSGTSLIRQ
     PRNSNVTTSN SGNGFPTNDS QMPGFLLNLS KSGLTPNESN IRTGLTPGIL TQSYNYPVLP
     SINKNTITGS KNVNKSVTVN GSIENHPHVN IMHPTVNGTP LTPGLSSLLN LPSTGVLANP
     VFKSTPTTNT TDGTVNNSIS NSNFSPNTST KAAVKMDNPA EFNAIEHSAH NHKENENLTT
     QIENNDQFNN KTRKRKRRMS STSSTSKASR KNSISRKNSA VTTAPAQKDD VENNKISNNV
     TLDENEEQER KRKEFLERNR VAASKFRKRK KEYIKKIEND LQFYESEYDD LTQVIGKLCG
     IIPSSSSNSQ FNVNVSTPSS SSPPSTSLIA LLESSISRSD YSSAMSVLSN MKQLICETNF
     YRRGGKNPRD DMDGQEDSFN KDTNVVKSEN AGYPSVNSRP IILDKKYSLN SGANISKSNT
     TTNNVGNSAQ NIINSCYSVT NPLVINANSD THDTNKHDVL STLPHNN
>Q02260 nuc SMALL NUCLEAR RIBONUCLEOPROTEIN D1 HOMOLOG.
     MKLVNFLKKL RNEQVTIELK NGTTVWGTLQ SVSPQMNAIL TDVKLTLPQP RLNKLNSNGI
     AMASLYLTGG QQPTASDNIA SLQYINIRGN TIRQIILPDS LNLDSLLVDQ KQLNSLRRSG
     QIANDPSKKR RRDFGAPANK RPRRGL
>Q02457 nuc TBF1 PROTEIN (TTAGGG REPEAT-BINDING FACTOR 1) (TBF ALPHA).
     MDSQVPNNNE SLNRFNDIIQ SLPARTRLTI CSLCLLDNIS TQLLRFLILN ANSPNIIAVL
     TDQTAFLSSG ETEIFQTLVK LFKQIRMIYH TRSPLLSVHD VAPGLWFPNS PPPLILRGHE
     AFIITAIRKA NLLTFLLTSL NCLNYGFELL QSIFLDIFCP NTNTVGNNSL EQSGKFLKSQ
     AILYLDLKTQ AYIAGLKEFQ DETNEISLEK KQELLDLIFP SNLADILVQR RTGDSGDITL
     LTPSEKDFVE RCDRRRENLK IVQDFNSLTQ SYEWAQFIRE LLDYCNKNMG LIIWGRKGRG
     KSPLYDFDVN EFDPQVLFST GTRTVEFMDD QNQPSSASAF LSTARPNHYS THTPTTDVSS
     KNPAITQSIV DAAVAASMSN SSSGPHSSHN NSSNSNNNGS IGLRKPKAKR TWSKEEEEAL
     VEGLKEVGPS WSKILDLYGP GGKITENLKN RTQVQLKDKA RNWKLQYLKS GKPLPDYLIK
     VTGNLEKIYK AKKKFSQSPN SSTIMEQNLS QHPSSAASAT EDTQTHQEDS HGQNSDNMPS
     NGLFGNSTSD NTGFDPHLED GM
>Q02516 nuc HAP5 TRANSCRIPTIONAL ACTIVATOR.
     MTDRNFSPQQ GQGPQESLPE GPQPSTMIQR EEMNMPRQYS EQQQLQENEG EGENTRLPVS
     EEEFRMVQEL QAIQAGHDQA NLPPSGRGSL EGEDNGNSDG ADGEMDEDDE EYDVFRNVGQ
     GLVGHYKEIM IRYWQELINE IESTNEPGSE HQDDFKSHSL PFARIRKVMK TDEDVKMISA
     EAPIIFAKAC EIFITELTMR AWCVAERNKR RTLQKADIAE ALQKSDMFDF LIDVVPRRPL
     PQ
>Q02642 nuc BTF3 HOMOLOG EGD1 (GAL4 DNA-BINDING ENHANCER PROTEIN).
     MPIDQEKLAK LQKLSANNKV GGTRRKLNKK AGSSAGANKD DTKLQSQLAK LHAVTIDNVA
     EANFFKDDGK VMHFNKVGVQ VAAQHNTSVF YGLPQEKNLQ DLFPGIISQL GPEAIQALSQ
     LAAQMEKHEA KAPADAEKKD EAIPELVEGQ TFDADVE
>Q02792 nuc RIBONUCLEIC ACID TRAFFICKING PROTEIN 1 (EC 3.1.11.-).
     MGVPSFFRWL SRKYPKIISP VLEEQPQIVD GVILPLDYSA SNPNGELDNL YLDMNGIVHP
     CSHPENKPPP ETEDEMLLAV FEYTNRVLNM ARPRKVLVMA VDGVAPRAKM NQQRARRFRS
     ARDAQIENEA REEIMRQREE VGEIIDDAVR NKKTWDSNAI TPGTPFMDKL AAALRYWTAF
     KLATDPGWKN LQVIISDATV PGEGEHKIMN FIRSQRADPE YNPNTTHCIY GLDADLIFLG
     LATHEPHFKI LREDVFAQDN RKRNNLKDTI NMTEEEKQFL QKQNSEQPFL WLHINVLREY
     LSAELWVPGL PFTFDLERAI DDWVFMCFFC GNDFLPHLPC LDVRENSIDI LLDIWKVVLP
     KLKTYMTCDG VLNLPSVETL LQHLGSREGD IFKTRHIQEA RKKEAFERRK AQKNMSKGQD
     RHPTVATEQL QMYDTQGNLA KGSWNLTTSD MVRLKKELML ANEGNEEAIA KVKQQSDKNN
     ELMKDISKEE IDDAVSKANK TNFNLAEVMK QKIINKKHRL EKDNEEEEIA KDSKKVKTEK
     AESECDLDAE IKDEIVADVN DRENSETTEV SRDSPVHSTV NVSEGPKNGV FDTDEFVKLF
     EPGYHERYYT AKFHVTPQDI EQLRKDMVKC YIEGVAWVLM YYYQGCASWN WFYPYHYAPL
     ATDFHGFSHL EIKFEEGTPF LPYEQLMSVL PAASGHALPK IFRSLMSEPD SEIIDFYPEE
     FPIDMNGKKM SWQGIALLPF IDQDRLLTAV RAQYPLLSDA ERARNIRGEP VLLISNKNAN
     YERFSKKLYS KENNNNNVVV KFQHFKSGLS GIVSKDVEGF ELNGKIVCPI QGGSLPNLST
     TLILKMSYRL IPLPSRNKSI ILNGFIPSEP VLTAYDLDSI MYKYNNQNYS RRWNFGNDLK
     QNIVPVGPKG ITQYKPRTGG YRAFFYFAEL SRNNVQPAHN YGRNSYNSQP GFNNSRYDGG
     NNNYRQNSNY RNNNYSGNRN SGQYSGNSYS RNNKQSRYDN SRANRR
>Q03018 nuc ESP1 PROTEIN.
     MMVKQEEPLN EISPNTPMTS KSYLLNDTLS KVHHSGQTRP LTSVLSGDAS SNSIGILAMH
     NNIIRDFTKI ASNNIDLAIE DITTVDHSLN SIYSLLKSHH MWGHINSTVK QHLMIIVKLI
     NNNALGLASS EIIFLFNETN LFQAHSLKNI LLADFSTWND YYLSNLKILA LQIILKRKLV
     DEYLPHILEL FSHDKRYLLK DPNLKAHALT KIVLSFFSVT TSCKVLFGLK FLQYIKQFKL
     PFKKFISNIT VECFSKNLLH KNYLEMGPNK IYLNSFYLSY SMLYDGLDKI MLLDILSYEE
     TTEVQRAIKS KKEFNEYCNM SENRLLWSCI SVDDLNVILE NATNFLQNKG KHISATLKCL
     VCLWSTIRLE GLPKNKDILR QFDCTVIYIN SNIKSINDES AAALLSELLG VLSEICIDYK
     EPKRLSNIIS VLFNASVLFK SHSFLLKTAN LEISNVLISN DSKTSHRTIL KFEKFISSAQ
     SAQKKIEIFS CLFNVYCMLR NDTLSFVFDF CQNAFIHCFT RLKITKFIEF SNSSEIMLSV
     LYGNSSIENI PSENWSQLSR MIFCSLRGIF DLDPLELNNT FDKLHLLNKY ELLIRIVYLL
     NLDMSKHLTT NLSKITKLYI NKWLQKSDEK AERISSFEMD FVKMLLCYLN FNNFDKLSIE
     LSLCIKSKEK YYSSIVPYAD NYLLEAYLSL YMIDDALMMK NQLQKTMNLS TAKIEQALLH
     ASSLINVHLW DSDLTAFQIY FGKTLPAMKP ELFDINNDHN LPMSLYIKVI LLNIKIFNES
     AKLNIKAGNV ISAVIDCRKA QNLALSLLKK KNKLSQGSRL ALLKSLSFSF FQLIKIHIRI
     GSARDCEFYS KELSRIISDL EEPIIVYRCL HFLHRYYMIT EQTCLQNITL GKANKAFDYL
     DAEADITSLT MFLYDNKEFV KLEQSLVLYF GDQLEKTFLP NLWKLHLGKD IDDSICLSEY
     MPKNVINRVH NMWQKVMSQL EEDPFFKGMF ESTLGIPSSL PVIPSTMPNN ILKTPSKHST
     GLKLCDSPRS SSMTPRGKNI RQKFDRIAAI SKLKQMKELL ESLKLDTLDN HELSKISSLS
     SLTLTILSNI TSIHNAESSL ITNFSLTDLP RHMPLLFDKV LNNIDNKNYR EFRVSSLIAP
     NNISTITESI RVSAAQKDLM ESNLNINVIT IDFCPITGNL LLSKLEPRRK RRTHLRLPLI
     RSNSRDLDEV HLSFPEATKK LLSIINESNQ TTSVEVTNKI KTREERKSWW TTRYDLDKRM
     QQLLNNIENS WFNGVQGFFS PEVVDNSLFE KFKDKFYEIL HQNLPSRKLY GNPAMFIKVE
     DWVIELFLKL NPQEIDFLSK MEDLIYFVLD ILLFHGEENA YDEIDFSMLH VQLEEQIKKY
     RATMTTNSIF HTFLVVSSSC HLFPWECLSF LKDLSITRVP SYVCLNKLLS RFHYQLPLQV
     TIEDNISMIL NPNGDLSRTE SKFKGMFQKI IDAKPSSQLV MNEKPEEETL LKMLQNSNLF
     VYIGHGGGEQ YVRSKEIKKC TKIAPSFLLG CSSAAMKYYG KLEPTGTIYT YLLGGCPMVL
     GNLWDVTDKD IDKFSEELFE KMGFRCNTDD LNGNSLSVSY AVSKSRGVCH LRYLNGAAPV
     IYGLPIKFVS
>Q03330 nuc TRANSCRIPTIONAL ACTIVATOR GCN5.
     MVTKHQIEED HLDGATTDPE VKRVKLENNV EEIQPEQAET NKQEGTDKEN KGKFEKETER
     IGGSEVVTDV EKGIVKFEFD GVEYTFKERP SVVEENEGKI EFRVVNNDNT KENMMVLTGL
     KNIFQKQLPK MPKEYIARLV YDRSHLSMAV IRKPLTVVGG ITYRPFDKRE FAEIVFCAIS
     STEQVRGYGA HLMNHLKDYV RNTSNIKYFL TYADNYAIGY FKKQGFTKEI TLDKSIWMGY
     IKDYEGGTLM QCSMLPRIRY LDAGKILLLQ EAALRRKIRT ISKSHIVRPG LEQFKDLNNI
     KPIDPMTIPG LKEAGWTPEM DALAQRPKRG PHDAAIQNIL TELQNHAAAW PFLQPVNKEE
     VPDYYDFIKE PMDLSTMEIK LESNKYQKME DFIYDARLVF NNCRMYNGEN TSYYKYANRL
     EKFFNNKVKE IPEYSHLID
>Q03465 nuc NUCLEAR PROTEIN SON1 (UB FUSION DEGRADATION PROTEIN 5).
     MASTELSLKR TLTDILEDEL YHTNPGHSQF TSHYQNYHPN ASITPYKLVN KNKENNTFTW
     NHSLQHQNES SAASIPPQQT YHFPIFNKYA DPTLTTTTSF TTSEATANDR QINNVHLIPN
     EIKGASETPL QKTVNLKNIM KVSDPYVPTR NTFNYDVKIS NDFFDNGDNL YGNDEEVLFY
     EDNYNPKMQW SLQDNSAAIN NEDARAIFNN EFDSDDDDIS DDEEDEIEEN CLQQEQHQEE
     PLLSLDVTPI SMFGSDQKTG RAKSSSHLFN EYSYVDSNMD SISSVVSEDL LDERGHEKIE
     DEDEDNDLDE DDIYDISLLK NRRKQSFVLN KNTIDFERFP SPSTSANVPS TATTGKRKPA
     KSSSNRSCVS NSNENGTLER IKKPTSAVVS SNASRRKLIN YTKKHLSSHS STNSNSKPST
     ASPSAHTSSS DGNNEIFTCQ IMNLITNEPC GAQFSRSYDL TRHQNTIHAK RKIVFRCSEC
     IKILGSEGYQ KTFSRLDALT RHIKSKHEDL SLEQRQEVTK FAKANIGYVM G
>Q03957 nuc CTD KINASE ALPHA SUBUNIT (EC 2.7.1.-) (CTD KINASE 58 KD SUBUNIT)
     MSYNNGNTYS KSYSRNNKRP LFGKRSPNPQ SLARPPPPKR IRTDSGYQSN MDNISSHRVN
     SNDQPGHTKS RGNNNLSRYN DTSFQTSSRY QGSRYNNNNT SYENRPKSIK RDETKAEFLS
     HLPKGPKSVE KSRYNNSSNT SNDIKNGYHA SKYYNHKGQE GRSVIAKKVP VSVLTQQRST
     SVYLRIMQVG EGTYGKVYKA KNTNTEKLVA LKKLRLQGER EGFPITSIRE IKLLQSFDHP
     NVSTIKEIMV ESQKTVYMIF EYADNDLSGL LLNKEVQISH SQCKHLFKQL LLGMEYLHDN
     KILHRDVKGS NILIDNQGNL KITDFGLARK MNSRADYTNR VITLWYRPPE LLLGTTNYGT
     EVDMWGCGCL LVELFNKTAI FQGSNELEQI ESIFKIMGTP TINSWPTLYD MPWFFMIMPQ
     QTTKYVNNFS EKFKSVLPSS KCLQLAINLL CYDQTKRFSA TEALQSDYFK EEPKPEPLVL
     DGLVSCHEYE VKLARKQKRP NILSTNTNNK GNGNSNNNNN NNNDDDDK
>Q04226 nuc TRANSCRIPTION INITIATION FACTOR TFIID 40 KD SUBUNIT (P40) (TAFII-40)
     MTEPQGPLDT IPKVNYPPIL TIANYFSTKQ MIDQVISEDQ DYVTWKLQNL RTGGTSINNQ
     LNKYPKYKYQ KTRINQQDPD SINKVPENLI FPQDILQQQT QNSNYEDTNT NEDENEKLAQ
     DEQFKLLVTN LDKDQTNRFE VFHRTSLNKT QVKKLASTVA NQTISENIRV FLQAVGKIYA
     GEIIELAMIV KNKWLTSQMC IEFDKRTKIG YKLKKYLKKL TFSIIENQQY KQDYQSDSVP
     EDEPDFYFDD EEVDKRETTL GNSLLQSKSL QQSDHNSQDL KLQLIEQYNK LVLQFNKLDV
     SIEKYNNSPL LPEHIREAWR LYRLQSDTLP NAYWRTQGEG QGSMFR
>Q04437 nuc HIGH AFFINITY DNA-BINDING FACTOR SUBUNIT 2 (KU80 HOMOLOG).
     MSSESTTFIV DVSPSMMKNN NVSKSMAYLE YTLLNKSKKS RKTDWISCYL ANCPVSENSQ
     EIPNVFQIQS FLAPVTTTAT IGFIKRLKQY CDQHSHDSSN EGLQSMIQCL LVVSLDIKQQ
     FQARKILKQI VVFTDNLDDL DITDEEIDLL TEELSTRIIL IDCGKDTQEE RKKSNWLKLV
     EAIPNSRIYN MNELLVEITS PATSVVKPVR VFSGELRLGA DILSTQTSNP SGSMQDENCL
     CIKVEAFPAT KAVSGLNRKT AVEVEDSQKK ERYVGVKSII EYEIHNEGNK KNVSEDDQSG
     SSYIPVTISK DSVTKAYRYG ADYVVLPSVL VDQTVYESFP GLDLRGFLNR EALPRYFLTS
     ESSFITADTR LGCQSDLMAF SALVDVMLEN RKIAVARYVS KKDSEVNMCA LCPVLIEHSN
     INSEKKFVKS LTLCRLPFAE DERVTDFPKL LDRTTTSGVP LKKETDGHQI DELMEQFVDS
     MDTDELPEIP LGNYYQPIGE VTTDTTLPLP SLNKDQEENK KDPLRIPTVF VYRQQQVLLE
     WIHQLMINDS REFEIPELPD SLKNKISPYT HKKFDSTKLV EVLGIKKVDK LKLDSELKTE
     LEREKIPDLE TLLKRGEQHS RGSPNNSNN
>Q06213 nuc NUT2 PROTEIN.
     MNGNSTNNEQ LQQELATTQD QVASIIESFV ELGVSIYDFP GTPEATKGMI TNLQRNVDRL
     YKLNVRSNDP QSSLSKVDIP LEVVQYIEDG RNPDIYTREF VEAIRRSNQY QRGKMHGLKQ
     LRDSLADKIV DEFPELKEPV EDIIKRTSPI DNVSNTH
>Q08162 nuc DIS3 PROTEIN.
     MSVPAIAPRR KRLADGLSVT QKVFVRSRNG GATKIVREHY LRSDIPCLSR SCTKCPQIVV
     PDAQNELPKF ILSDSPLELS APIGKHYVVL DTNVVLQAID LLENPNCFFD VIVPQIVLDE
     VRNKSYPVYT RLRTLCRDSD DHKRFIVFHN EFSEHTFVER LPNETINDRN DRAIRKTCQW
     YSEHLKPYDI NVVLVTNDRL NREAATKEVE SNIITKSLVQ YIELLPNADD IRDSIPQMDS
     FDKDLERDTF SDFTFPEYYS TARVMGGLKN GVLYQGNIQI SEYNFLEGSV SLPRFSKPVL
     IVGQKNLNRA FNGDQVIVEL LPQSEWKAPS SIVLDSEHFD VNDNPDIEAG DDDDNNESSS
     NTTVISDKQR RLLAKDAMIA QRSKKIQPTA KVVYIQRRSW RQYVGQLAPS SVDPQSSSTQ
     NVFVILMDKC LPKVRIRTRR AAELLDKRIV ISIDSWPTTH KYPLGHFVRD LGTIESAQAE
     TEALLLEHDV EYRPFSKKVL ECLPAEGHDW KAPTKLDDPE AVSKDPLLTK RKDLRDKLIC
     SIDPPGCVDI DDALHAKKLP NGNWEVGVHI ADVTHFVKPG TALDAEGAAR GTSVYLVDKR
     IDMLPMLLGT DLCSLKPYVD RFAFSVIWEL DDSANIVNVN FMKSVIRSRE AFSYEQAQLR
     IDDKTQNDEL TMGMRALLKL SVKLKQKRLE AGALNLASPE VKVHMDSETS DPNEVEIKKL
     LATNSLVEEF MLLANISVAR KIYDAFPQTA MLRRHAAPPS TNFEILNEML NTRKNMSISL
     ESSKALADSL DRCVDPEDPY FNTLVRIMST RCMMAAQYFY SGAYSYPDFR HYGLAVDIYT
     HFTSPIRRYC DVVAHRQLAG AIGYEPLSLT HRDKNKMDMI CRNINRKHRN AQFAGRASIE
     YYVGQVMRNN ESTETGYVIK VFNNGIVVLV PKFGVEGLIR LDNLTEDPNS AAFDEVEYKL
     TFVPTNSDKP RDVYVFDKVE VQVRSVMDPI TSKRKAELLL K
>Q12315 nuc RNA EXPORT FACTOR GLE1.
     MRFVFDEVFN SDTDSPEFEE TCSTTSSTSS QCPTPEPSPA IKLPSFTKVG TKKLVNESVV
     ILDPALENAL RDLNLQSKLI PINEPIVAAS SIIVPHSTNM PLPRASHSSL LDNAKNSNAT
     APLLEAIEES FQRKMQNLVL ANQKEIQSIR ENKRRVEEQR KRKEEEERKR KEAEEKAKRE
     QELLRQKKDE EERKRKEAEA KLAQQKQEEE RKKIEEQNEK ERQLKKEHEA KLLQQKDKLG
     KAVTNFDKIS KMFWHYKDKI AQIKQDIVLP IKKADVNVRN LLSRHKRKIN PKFGQLTNSN
     QQLFKIQNEL TQLINDTKGD SLAYHWILNF IAKAVVHQAE TEVRVKPESA LPLGKLTLYL
     LVQFPELQEL FMARLVKKCP FVIGFTCEID TEKGRQNMGW KRNNENKWED NTSYDERMGG
     ILSLFAIITR LQLPQEFITT TSHPFPIALS WHILARICNT PLNLITNTHF VILGSWWDAA
     AVQFLQAYGN QASKLLILIG EELTSRMAEK KYVGAARLRI LLEAWQNNNM ESFPEMSP
>P53378 nuc TUBULIN GAMMA CHAIN.
     MGGEIITLQA GQCGNHVGKF LWSQLAKEHA IGTDGLSQLP DSSTERDDDT KPFFRENSRN
     KFTPRAIMMD SEPSVIADVE NTFRGFFDPR NTWVASDGAS AGNSWANGYD IGTRNQDDIL
     NKIDKEIDST DNFEGFQLLH SVAGGTGSGL GSNLLEALCD RYPKKILTTY SVFPARSSEV
     VVQSYNTILA LRRLIEDSDA TVVFDNASLL NISGKVFRNP NIDLQHTNQL ISTIISSVTN
     SIRFPSYMYS SMSSIYSTLI PSPELHFLSP SFTPFTSDYI HDDIAHKGHS SYDVMLDLLD
     PSNSLVSTAM NNPTYFNVYN TIIGNVEPRQ ISRAMTKLQQ RIKFPSWSSS AMHVNIGRRS
     PYLPLQPNEN EVSGMMLSNM STVVNVFENA CNTFDKVFAK GAFLNNYNVG DLFQSMQNVQ
     DEFAESREVV QSLMEDYVAA EQDSYLDDVL VDDENMVGEL EEDLDADGDH KLV
>P01365 nuc MATING-TYPE PROTEIN ALPHA-1.
     MFTSKPAFKI KNKASKSYRN TAVSKKLKEK RLAEHVRPSC FNIIRPLKKD IQIPVPSSRF
     LNKIQIHRIA SGSQNTQFRQ FNKTSIKSSK KYLNSFMAFR AYYSQFGSGV KQNVLSSLLA
     EEWHADKMQH GIWDYFAQQY NFINPGFGFV EWLTNNYAEV RGDGYWEDVF VHLAL
>P06102 nuc GENERAL NEGATIVE REGULATOR OF TRANSCRIPTION SUBUNIT 3.
     MAHRKLQQEV DRVFKKINEG LEIFNSYYER HESCTNNPSQ KDKLESDLKR EVKKLQRLRE
     QIKSWQSSPD IKDKDSLLDY RRSVEIAMEK YKAVEKASKE KAYSNISLKK SETLDPQERE
     RRDISEYLSQ MIDELERQYD SLQVEIDKLL LLNKKKKTSS TTNDEKKEQY KRFQARYRWH
     QQQMELALRL LANEELDPQD VKNVQDDINY FVESNQDPDF VEDETIYDGL NLQSNEAIAH
     EVAQYFASQN AEDNNTSDAN ESLQDISKLS KKEQRKLERE AKKAAKLAAK NATGAAIPVA
     GPSSTPSPVI PVADASKETE RSPSSSPIHN ATKPEEAVKT SIKSPRSSAD NLLPSLQKSP
     SSATPETPTN VHTHIHQTPN GITGATTLKP ATLPAKPAGE LKWAVAASQA VEKDRKVTSA
     SSTISNTSTK TPTTAAATTT SSNANSRIGS ALNTPKLSTS SLSLQPDNTG ASSSAATAAA
     VLAAGAAAVH QNNQAFYRNM SSSHHPLVSL ATNPKSEHEV ATTVNQNGPE NTTKKVMEQK
     EEESPEERNK LQVPTFGVFD DDFESDRDSE TEPEEEEQPS TPKYLSLEQR EAKTNEIKKE
     FVSDFETLLL PSGVQEFIMS SELYNSQIES KITYKRSRDM CEISRLVEVP QGVNPPSPLD
     AFRSTQQWDV MRCSLRDIII GSERLKEDSS SIYAKILENF RTLEMFSLFY NYYFAITPLE
     REIAYKILNE RDWKVSKDGT MWFLRQGEVK FFNEICEVGD YKIFKLDDWT VIDKINFRLD
     YSFLQPPVDT ASEVRDVSVD NNNVNDQSNV TLEQQKQEIS HGKQLLKQLK QGKISV
>P06700 nuc REGULATORY PROTEIN SIR2 (SILENT INFORMATION REGULATOR 2).
     MTIPHMKYAV SKTSENKVSN TVSPTQDKDA IRKQPDDIIN NDEPSHKKIK VAQPDSLRET
     NTTDPLGHTK AALGEVASME LKPTNDMDPL AVSAASVVSM SNDVLKPETP KGPIIISKNP
     SNGIFYGPSF TKRESLNARM FLKYYGAHKF LDTYLPEDLN SLYIYYLIKL LGFEVKDQAL
     IGTINSIVHI NSQERVQDLG SAISVTNVED PLAKKQTVRL IKDLQRAINK VLCTRLRLSN
     FFTIDHFIQK LHTARKILVL TGAGVSTSLG IPDFRSSEGF YSKIKHLGLD DPQDVFNYNI
     FMHDPSVFYN IANMVLPPEK IYSPLHSFIK MLQMKGKLLR NYTQNIDNLE SYAGISTDKL
     VQCHGSFATA TCVTCHWNLP GERIFNKIRN LELPLCPYCY KKRREYFPEG YNNKVGVAAS
     QGSMSERPPY ILNSYGVLKP DITFFGEALP NKFHKSIRED ILECDLLICI GTSLKVAPVS
     EIVNMVPSHV PQVLINRDPV KHAEFDLSLL GYCDDIAAMV AQKCGWTIPH KKWNDLKNKN
     FKCQEKDKGV YVVTSDEHPK TL
>P07261 nuc GLYCOLYTIC GENES TRANSCRIPTIONAL ACTIVATOR GCR1.
     MNFLTQAMSE TFQGTNNRIK RNVRTQSVPS TSYNNGKESY GPNTNQLNAL LSQLEQQTSV
     DSTSTSSNFY SIAQYILQSY FKVNVDSLNS LKLVDLIVDQ TYPDSLTLRK LNEGATGQPY
     DYFNTVSRDA DISKCPIFAL TIFFVIRWSH PNPPISIENF TTVPLLDSNF ISLNSNPLLY
     IQNQNPNSNS SVKVSRSQTF EPSKELIDLV FPWLSYLKQD MLLIDRTNYK LYSLCELFEF
     MGRVAIQDLR YLSQHPLLLP NIVTFISKFI PELFQNEEFK GIGSIKNSNN NALNNVTGIE
     TQFLNPSTEE VSQKVDSYFM ELSKKLTTEN IRLSQEITQL KADMNSVGNV CNQILLLQRQ
     LLSGNQAIGS KSENIVSSTG GGILILDKNS INSNVLSNLV QSIDPNHSKP NGQAQTHQRG
     PKGQSHAQVQ STNSPALAPI NMFPSLSNSI QPMLGTLAPQ PQDIVQKRKL PLPGSIASAA
     TGSPFSPSPV GESPYSKRFK LDDKPTPSQT ALDSLLTKSI SSPRLPLSTL ANTAVTESFR
     SPQQFQHSPD FVVGGSSSST TENNSKKVNE DSPSSSSKLA ERPRLPNNDS TTSMPESPTE
     VAGDDVDREK PPESSKSEPN DNSPESKDPE KNGKNSNPLG TDADKPVPIS NIHNSTEAAN
     SSGTVTKTAP SFPQSSSKFE IINKKDTKAG PNEAIKYKLS RENKTIWDLY AEWYIGLNGK
     SSIKKLIENY GWRRWKVSED SHFFPTRRII MDYIETECDR GIKLGRFTNP QQPREDIRKI
     LVGDLEKFRI NNGLTLNSLS LYFRNLTKNN KEICIFENFK NWNVRSMTEE EKLKYCKRRH
     NTPS
>P13902 nuc INO4 PROTEIN.
     MTNDIKEIQT IQPGLSEIKE IKGELANVKK RKRRSKKINK LTDGQIRINH VSSEKKRREL
     ERAIFDELVA VVPDLQPQES RSELIIYLKS LSYLSWLYER NEKLRKQIIA KHEAKTGSSS
     SSDPVQEQNG NIRDLVPKEL IWELGDGQSG Q
>P19541 nuc PUTATIVE TRANSCRIPTIONAL REGULATORY PROTEIN IN MKK2-COX11 INTERGENIC
     MSANSGVKRA SKAFKTCLFC KRSHVVCDKQ RPCSRCVKRD IAHLCREDDI AVPNEMPSQH
     ESSPNDNNIQ GKYANKAHTG IPSDYQNEPV NKSGSTYGEE LSPKLDSSLV NDTTSLLLPQ
     QPVFVSENVG SEFSSLNEFL SMLENPLLTQ TSLSSSSASN VHLENGSQTT QSPLEYQNDN
     RRDEIGVARQ ENRSPTIMSG SSNSISKGDK QDQEKEESRI LANANENSAP TPKEQFFLTA
     ADPSTEMTPE HRLKLVINAK LEAGLLKPYN YAKGYARLQD YMDKYMNQSS KQRILKPLST
     IRPAFRTIAR SLKDVDLVLV EESFERMLLS YDRVFTSMSM PACLCRRTGE IYRANKEFAS
     LVDCTVDDLR DGKLAIYELM TEESAVNFWE KYGSIAFDKG QKAVLTSCSL RTKDGIRKRP
     CCFSFTIRRD RYNIPICIVG NFIPLS
>P20134 nuc FLOCCULATION SUPPRESSION PROTEIN (SFL1 PROTEIN).
     MSEEETVSAP APASTPAPAG TDVGSGGAAA GIANAGAEGG DGAEDVKKHG SKMLVGPRPP
     QNAIFIHKLY QILEDESLHD LIWWTPSGLS FMIKPVERFS KALATYFKHT NITSFVRQLN
     IYGFHKVSHD HSSNDANSGD DANTNDDSNT HDDNSGNKNS SGDENTGGGV QEKEKSNPTK
     IWEFKHSSGI FKKGDIEGLK HIKRRASSRN NSSINSRKNS SNQNYDIDSG ARVRPSSIQD
     PSTSSNSFGN FVPQIPGANN SIPEYFNNSH VTYENANHAP LESNNPEMQE QNRPPNFQDE
     TLKHLKEINF DMVKIIESMQ HFISLQHSFC SQSFTFKNVS KKKSENIVKD HQKQLQAFES
     DMLTFKQHVM SRAHRTIDSL CAVNAAATAA SVAPAPAPTS TSAYAPKSQY EMMVPPGNQY
     VPQKSSSTTN IPSRFNTASV PPSQLLYNTN RSRNQHVTYA SEPAHVPNFI NQPIPIQQLP
     PQYADTFSTP QMMHNPFASK NNNKPGNTKR TNSVLMDPLT PAASVGVQGP LNYPIMNINP
     SVRDYNKPVP QNMAPSPIYP INEPTTRLYS QPKMRSLGST SSLPNDRRNS PLKLTPRSSL
     NEDSLYPKPR NSLKSSISGT SLSSSFTLVA NNPAPIRYSQ QGLLRSLNKA ANCAPDSVTP
     LDSSVLTGPP PKNMDNLPAV SSNLINSPMN VEHSSSLSQA EPAPQIELPQ PSLPTTSTTK
     NTGEADNSKR KGSGVYSLLN QEDSSTSSAD PKTEDKAAPA LKKVKM
>P22149 nuc IRON-REGULATED TRANSCRIPTIONAL REPRESSOR AFT1.
     MEGFNPADIE HASPINSSDS HSSSFVYALP KSASEYVVNH NEGRASASGN PAAVPSPIMT
     LNLKSTHSLN IDQHVHTSTS PTETIGHIHH VEKLNQNNLI HLDPVPNFED KSDIKPWLQK
     IFYPQGIELV IERSDAFKVV FKCKAAKRGR NARRKRKDKP KGQDHEDEKS KINDDELEYA
     SPSNATVTNG PQTSPDQTSS IKPKKKRCVS RFNNCPFRVR ATYSLKRKRW SIVVMDNNHS
     HQLKFNPDSE EYKKFKEKLR KDNDVDAIKK FDELEYRTLA NLPIPTATIP CDCGLTNEIQ
     SFNVVLPTNS NVTSSASSST VSSISLDSSN ASKRPCLPSV NNTGSINTNN VRKPKSQCKN
     KDTLLKRTTM QNFLTTKSRL RKTGTPTSSQ HSSTAFSGYI DDPFNLNEIL PLPASDFKLN
     TVTNLNEIDF TNIFTKSPHP HSGSTHPRQV FDQLDDCSSI LFSPLTTNTN NEFEGESDDF
     VHSPYLNSEA DFSQILSSAP PVHHDPNETH QENQDIIDRF ANSSQEHNEY ILQYLTHSDA
     ANHNNIGVPN NNSHSLNTQH NVSDLGNSLL RQEALVGSSS TKIFDELKFV QNGPHGSQHP
     IDFQHVDHRH LSSNEPQVRS HQYGPQQQPP QQLQYHQNQP HDGHNHEQHQ TVQKDMQTHE
     SLEIMGNTLL EEFKDIKMVN GELKYVKPED
>P22216 nuc PROTEIN KINASE SPK1 (EC 2.7.1.-) (SERINE-PROTEIN KINASE 1).
     MENITQPTQQ STQATQRFLI EKFSQEQIGE NIVCRVICTT GQIPIRDLSA DISQVLKEKR
     SIKKVWTFGR NPACDYHLGN ISRLSNKHFQ ILLGEDGNLL LNDISTNGTW LNGQKVEKNS
     NQLLSQGDEI TVGVGVESDI LSLVIFINDK FKQCLEQNKV DRIRSNLKNT SKIASPGLTS
     STASSMVANK TGIFKDFSII DEVVGQGAFA TVKKAIERTT GKTFAVKIIS KRKVIGNMDG
     VTRELEVLQK LNHPRIVRLK GFYEDTESYY MVMEFVSGGD LMDFVAAHGA VGEDAGREIS
     RQILTAIKYI HSMGISHRDL KPDNILIEQD DPVLVKITDF GLAKVQGNGS FMKTFCGTLA
     YVAPEVIRGK DTSVSPDEYE ERNEYSSLVD MWSMGCLVYV ILTGHLPFSG STQDQLYKQI
     GRGSYHEGPL KDFRISEEAR DFIDSLLQVD PNNRSTAAKA LNHPWIKMSP LGSQSYGDFS
     QISLSQSLSQ QKLLENMDDA QYEFVKAQRK LQMEQQLQEQ DQEDQDGKIQ GFKIPAHAPI
     RYTQPKSIEA ETREQKLLHS NNTENVKSSK KKGNGRFLTL KPLPDSIIQE SLEIQQGVNP
     FFIGRSEDCN CKIEDNRLSR VHCFIFKKRH AVGKSMYESP AQGLDDIWYC HTGTNVSYLN
     NNRMIQGTKF LLQDGDEIKI IWDKNNKFVI GFKVEINDTT GLFNEGLGML QEQRVVLKQT
     AEEKDLVKKL TQMMAAQRAN QPSASSSSMS AKKPPVSDTN NNGNNSVLND LVESPINANT
     GNILKRIHSV SLSQSQIDPS KKVKRAKLDQ TSKGPENLQF S
>P24813 nuc TRANSCRIPTION FACTOR CAD1 (YAP-2 PROTEIN).
     MGNILRKGQQ IYLAGDMKKQ MLLNKDGTPK RKVGRPGRKR IDSEAKSRRT AQNRAAQRAF
     RDRKEAKMKS LQERVELLEQ KDAQNKTTTD FLLCSLKSLL SEITKYRAKN SDDERILAFL
     DDLQEQQKRE NEKGTSTAVS KAAKELPSPN SDENMTVNTS IEVQPHTQEN EKVMWNIGSW
     NAPSLTNSWD SPPGNRTGAV TIGDESINGS EMPDFSLDLV SNDRQTGLEA LDYDIHNYFP
     QHSERLTAEK IDTSACQCEI DQKYLPYETE DDTLFPSVLP LAVGSQCNNI CNRKCIGTKP
     CSNKEIKCDL ITSHLLNQKS LASVLPVAAS HTKTIRTQSE AIEHISSAIS NGKASCYHIL
     EEISSLPKYS SLDIDDLCSE LIIKAKCTDD CKIVVKARDL QSALVRQLL
>P25301 nuc DNA REPAIR PROTEIN RAD57.
     MPRALSIKFD NTYMDLYDEL PESKLLYDEE FSYLLDAVRQ NGVCVVDFLT LTPKELARLI
     QRSINEVFRF QQLLVHEYNE KYLEICEKNS ISPDNGPECF TTADVAMDEL LGGGIFTHGI
     TEIFGESSTG KSQLLMQLAL SVQLSEPAGG LGGKCVYITT EGDLPTQRLE SMLSSRPAYE
     KLGITQSNIF TVSCNDLINQ EHIINVQLPI LLERSKGSIK LVIIDSISHH LRVELQNKSF
     RESQENKNYL DRMAEKLQIL AHDYSLSVVV ANQVGDKPLA NSPVAHRTYV TDYDYQLGWL
     VGWKNSTILY RQMNSLLGAS SNNDEILSDD EDYMLIERVM STVNDRNYDF FSKKKPPIIE
     NKTVERNSSS PISRQSKKRK FDYRVPNLGL TWSNHVSTRI LLQKSFKAST IIQRGEAHLY
     KGGDSASFWQ VKRTMKVVYS TFAKPGQIAY QITKRGIETA
>P25337 nuc G10 PROTEIN HOMOLOG.
     MPRIKTRRSK PAPDGFEKIK PTLTDFEIQL RDAQKDKSSK LAAKSNEQLW EIMQLHHQRS
     RYIYTLYYKR KAISKDLYDW LIKEKYADKL LIAKWRKTGY EKLCCLRCIQ KNETNNGSTC
     ICRVPRAQLE EEARKKGTQV SFHQCVHCGC RGCASTD
>P25359 nuc RRP43 PROTEIN.
     MAESTTLETI EIHPITFPPE VLARISPELS LQRHLSLGIR PCLRKYEEFR DVAIENNTLS
     RYADAGNIDT KNNILGSNVL KSGKTIVITS ITGGIIEETS ASIKDLDDFG EEELFEVTKE
     EDIIANYASV YPVVEVERGR VGACTDEEMT ISQKLHDSIL HSRILPKKAL KVKAGVRSAN
     EDGTFSVLYP DELEDDTLNE TNLKMKRKWS YVLYAKIVVL SRTGPVFDLC WNSLMYALQS
     VKLPRAFIDE RASDLRMTIR TRGRSATIRE TYEIICDQTK SVPLMINAKN IAFASNYGIV
     ELDPECQLQN SDNSEEEEVD IDMDKLNTVL IADLDTEAEE TSIHSTISIL AAPSGNYKQL
     TLMGGGAKIT PEMIKRSLLL SRVRADDLST RFNI
>P25364 nuc HCM1 PROTEIN.
     MMNEDISIID GHNSFLTEKS TVLLTQAKRT LEDEKEMITP PSSTVRKTMK EVNKRPSHPL
     SPDHSSPIAP SKAKRQRSDT CARSNGNLTL EEILQSLERR RINGELAKKP PYSYATLICL
     AILQSQEGNV TLSQIYHWIH VHFPYYKQKD ASWQNSIRHN LSLNDAFIKT EKSCDGKGHF
     WEVRPGAETK FFKGENRGYE FVKDSLQDIG KYFEIDSTLD ELEQVESGEG NDDLPDEEER
     EEAGKFPSIE IQLNSSPILR VSQLHHIPQL KTDNSVLNPH ENLESMRNMI ENDVNNIDSL
     EPPYVMKKYH TSLGLPSLVN AKDHFQAGVK NNNITQANRF NTLPITSAKS PQNFRKYFTS
     FNSNFEDLSP LRSNVGAGSL LDPLPYSPLK LYDQKNLALM SKPQSQQSYS NSQLPPPPSS
     HGSDLLKTPK MRHSDGLEKT PSRLISTPKD GNSILRKWQT PSHLFEDLYC SPLFRAIETP
     IRYITTPGGT LETQISPRKS SAPDVLTSAT NSKFASSGLF GVDVYSVWKR ATEKISDGNN
     TTDSNQKHHP YHNHPSNDSG NEKN
>P25555 nuc SINGLE-STRAND TELOMERIC DNA-BINDING PROTEIN GBP2 (G-STRAND BINDING
     MERELGMYGN DRSRSRSPVR RRLSDDRDRY DDYNDSSSNN GNGSRRQRRD RGSRFNDRYD
     QSYGGSRYHD DRNWPPRRGG RGRGGSRSFR GGRGGGRGRT LGPIVERDLE RQFDATKRNF
     ENSIFVRNLT FDCTPEDLKE LFGTVGEVVE ADIITSKGHH RGMGTVEFTK NESVQDAISK
     FDGALFMDRK LMVRQDNPPP EAAKEFSKKA TREEIDNGFE VFIINLPYSM NWQSLKDMFK
     ECGHVLRADV ELDFNGFSRG FGSVIYPTED EMIRAIDTFN GMEVEGRVLE VREGRFNKRK
     NNDRYNQRRE DLEDTRGTEP GLAQDAAVHI DETAAKFTEG VNPGGDRNCF IYCSNLPFST
     ARSDLFDLFG PIGKINNAEL KPQENGQPTG VAVVEYENLV DADFCIQKLN NYNYGGCSLQ
     ISYARRD
>P25611 nuc PUTATIVE 95.7 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN PAU3
     MDSITVKKPR LRLVCLQCKK IKRKCDKLRP ACSRCQQNSL QCEYEERTDL SANVAANDSD
     GFNSSHKLNF EQQPVLERTG LRYSLQVPEG VVNATLSIWN AEDMLVIVGL VTFLDYPFAA
     HSLAQHDQYI RALCASLYGM ALVDFSNYAN GIPCEDTSRS ILGPLSFIEK AIFRRIEHSK
     QFRVQSAALG LLYNAFSMEE ENFSTLLPSL IAEVEDVLMQ KKDCEILLRC FYQNIYPFYP
     FMDISLFESD LTSLLLQDDN NRWKISTEVK NVRKKIETLS LLTIVMAMAL MHSKLDANLL
     SMVKENASES ARKLSLLCHK LLCLLDVFRY PNENTFTCLL YFYVSEHLDP ESPDCVLSPT
     NLLTLHHLLN LSMTLGLQYE PSKYKRFKDP EVIRQRRILW LGVQSLLFQI SLAEGDAGKS
     NSEYMEAYLT DFEEYIEASS EYEKSSASES NVQMNDIVWN KYKFHVILSK LMSDCTSVIQ
     HPQLFHILGN IKRSEDFMAE NFPTSSIYQP LHEKEPNAIK VGKSTVLDVM DIQKTEIFLT
     NIVGSMCFLN IFDVLSLHFE KKCVMHWEEY EKNYHFLTLK SFNAYLKLAG LISDYLENKF
     QGNILESRGY IIDKQICFML VRIWMFQCRI LLRFSYKQES QKKLASSSIS TNDNEKEDEM
     IVILERLIKH IRNQMAHLVD LAKGKLQDSY FGAYQTVPMF RYVVYLIDVG GLVSVTNGFW
     DKISSDGEIP PKVQQAVRLK WGLDCNNSRR IKQKLISSQS LQSFNQVLLC QMEDAVLSSS
     FAIKANTAMS QNTAEEFFNI SEEEALNQLL ENNNFDAFWD LLGENLSDMP SL
>P25648 nuc SUPPRESSOR OF RNA POLYMERASE B SRB8.
     MHLLKDWTDT FVYILEKLIF DMTNHYNDSQ QLRTWKRQIS YFLKLLGNCY SLRLINKEIF
     HHWLVEFINK MENFEFLPLS LHILMIFWND ICQIDTNAPV AATITSSQKE PFFLVTKITD
     MLLHKYYIVS SSKSMINDEN YIINDIKKNN KIKLNILKIL SSLILKIFQE QSLEVFIFPT
     SNWEIYKPLL FEIVSNADTN QNSDMKKKLE LISYRNESLK NNSSIRNVIM SASNANDFQL
     TIVTCKQFPK LSCIQLNCID TQFTKLLDDN PTEFDWPTYV DQNPLTMHKI IQLILWSIHP
     SRQFDHYESN QLVAKLLLLR INSTDEDLHE FQIEDAIWSL VFQLAKNFSA QKRVVSYMMP
     SLYRLLNILI TYGIIKVPTY IRKLISSGLL YLQDSNDKFV HVQLLINLKI SPLMKSQYNM
     VLRNVMEYDV KFYEIFNFDQ LVEITEQIKM RILSNDITNL QLSKTPLSIK IMVAEWYLSH
     LCSGILSSVN RTVLLKIFKI FCIDLEVFHH FFKWIEFIVY HQLLSDIESL EALMDILLCY
     QKLFSQFIND HILFTKTFIF IYKKVLKEKD VPAYNVTSFM PFWKFFMKNF PFVLKVDNDL
     RIELQSVYND EKLKTEKLKN DKSEVLKVYS MINNSNQAVG QTWNFPEVFQ VNIRFLLHNS
     EIIDTNTSKQ FQKARNNVML LIATNLKEYN KFMSIFLKRK DFTNKNLIQL ISLKLLTFEV
     TQNVLGLEYI IRLLPINLEN NDGSYGLFLK YHKEQFIKSN FEKILLTCYE LEKKYHGNEC
     EINYYEILLK ILITYGSSPK LLATSTKIIM LLLNDSVENS SNILEDILYY STCPSETDLN
     DIPLGSGQPD NDTVVTNDDK SDDDDHTVDE IDHVEYYVMM DFANLWVFQA FTCFCIKKIM
     ENNEPAMAME DLKNFIFQII EITNSNDLCS QIFDQLKDMQ TIEMITQIVE KDFCTSCLQN
     NNQKIDDNYI VVVIEIITSL SMRFQRETSG MIVISMENYH LLIKIIRQLS ELNEGNLSKR
     EIQIDAVLKI FSFHQDSIFQ RIIADLSADK PTSPFIDSIC KLFDKISFNL RLKLFLYEIL
     SSLKSFAIYS STIDAPAFHT SGKVELPKKL LNLPPFQVSS FVKETKLHSG DYGEEEDADQ
     EESFSLNLGI GIVEIAHENE QKWLIYDKKD HKYVCTFSME PYHFISNYNT KYTDDMATGS
     NDTTAFNDSC VNLSLFDARF ERKNPH
>P26449 nuc CELL CYCLE ARREST PROTEIN BUB3.
     MQIVQIEQAP KDYISDIKII PSKSLLLITS WDGSLTVYKF DIQAKNVDLL QSLRYKHPLL
     CCNFIDNTDL QIYVGTVQGE ILKVDLIGSP SFQALTNNEA NLGICRICKY GDDKLIAASW
     DGLIEVIDPR NYGDGVIAVK NLNSNNTKVK NKIFTMDTNS SRLIVGMNNS QVQWFRLPLC
     EDDNGTIEES GLKYQIRDVA LLPKEQEGYA CSSIDGRVAV EFFDDQGDDY NSSKRFAFRC
     HRLNLKDTNL AYPVNSIEFS PRHKFLYTAG SDGIISCWNL QTRKKIKNFA KFNEDSVVKI
     ACSDNILCLA TSDDTFKTNA AIDQTIELNA SSIYIIFDYE N
>P26793 nuc STRUCTURE SPECIFIC ENDONUCLEASE RAD27.
     MGIKGLNAII SEHVPSAIRK SDIKSFFGRK VAIDASMSLY QFLIAVRQQD GGQLTNEAGE
     TTSHLMGMFY RTLRMIDNGI KPCYVFDGKP PDLKSHELTK RSSRRVETEK KLAEATTELE
     KMKQERRLVK VSKEHNEEAQ KLLGLMGIPY IIAPTEAEAQ CAELAKKGKV YAAASEDMDT
     LCYRTPFLLR HLTFSEAKKE PIHEIDTELV LRGLDLTIEQ FVDLCIMLGC DYCESIRGVG
     PVTALKLIKT HGSIEKIVEF IESGESNNTK WKIPEDWPYK QARMLFLDPE VIDGNEINLK
     WSPPKEKELI EYLCDDKKFS EERVKSGISR LKKGLKSGIQ GRLDGFFQVV PKTKEQLAAA
     AKRAQENKKL NKNKNKVTKG RR
>P26798 nuc INO2 PROTEIN.
     MQQATGNELL GILDLDNDID FETAYQMLSS NFDDQMSAHI HENTFSATSP PLLTHELGII
     PNVATVQPSH VETIPADNQT HHAPLHTHAH YLNHNPHQPS MGFDQALGLK LSPSSSGLLS
     TNESNAIEQF LDNLISQDMM SSNASMNSES HLHIRSPKKQ HRYTELNQRY PETHPHSNTG
     ELPTNTADVP TEFTTREGPH QPIGNDHYNP PPFSVPEIRI PDSDIPANIE DDPVKVRKWK
     HVQMEKIRRI NTKEAFERLI KSVRTPPKEN GKRIPKHILL TCVMNDIKSI RSANEALQHI
     LDDS
>P28320 nuc 32.3 KD PROTEIN IN CWP1-MBR1 INTERGENIC REGION.
     MSERKAINKY YPPDYNPLEA EKLSRKMAKK LKTMNKSHAS IRLMTPFSMR CLECNEYIPK
     SRKFNGKKEL LKEKYLDSIK IYRLTISCPR CANSIAFRTD PGNSDYVMEV GGVRNYVPQK
     PNDDLNAKTA VESIDETLQR LVREKEMEQN EKMGIKEQAD DKMDLLEKRL AKIQQEQEDD
     EELENLRKKN LEMSQRAEMI NRSKHAQQEK AVTTDDLDNL VDQVFDNHRQ RTNKPGNNND
     EKRTPLFNPT STKGKIQKKS SVRTNPLGIV IKRGKSLK
>P30665 nuc CELL DIVISION CONTROL PROTEIN 54.
     MSQQSSSPTK EDNNSSSPVV PNPDSVPPQL SSPALFYSSS SSQGDIYGRN NSQNLSQGEG
     NIRAAIGSSP LNFPSSSQRQ NSDVFQSQGR QGRIRSSASA SGRSRYHSDL RSDRALPTSS
     SSLGRNGQNR VHMRRNDIHT SDLSSPRRIV DFDTRSGVNT LDTSSSSAPP SEASEPLRII
     WGTNVSIQEC TTNFRNFLMS FKYKFRKILD EREEFINNTT DEELYYIKQL NEMRELGTSN
     LNLDARNLLA YKQTEDLYHQ LLNYPQEVIS IMDQTIKDCM VSLIVDNNLD YDLDEIETKF
     YKVRPYNVGS CKGMRELNPN DIDKLINLKG LVLRSTPVIP DMKVAFFKCN VCDHTMAVEI
     DRGVIQEPAR CERIDCNEPN SMSLIHNRCS FADKQVIKLQ ETPDFVPDGQ TPHSISLCVY
     DELVDSCRAG DRIEVTGTFR SIPIRANSRQ RVLKSLYKTY VDVVHVKKVS DKRLDVDTST
     IEQELMQNKV DHNEVEEVRQ ITDQDLAKIR EVAAREDLYS LLARSIAPSI YELEDVKKGI
     LLQLFGGTNK TFTKGGRYRG DINILLCGDP STSKSQILQY VHKITPRGVY TSGKGSSAVG
     LTAYITRDVD TKQLVLESGA LVLSDGGVCC IDEFDKMSDS TRSVLHEVME QQTISIAKAG
     IITTLNARSS ILASANPIGS RYNPNLPVTE NIDLPPPLLS RFDLVYLVLD KVDEKNDREL
     AKHLTNLYLE DKPEHISQDD VLPVEFLTMY ISYAKEHIHP IITEAAKTEL VRAYVGMRKM
     GDDSRSDEKR ITATTRQLES MIRLAEAHAK MKLKNVVELE DVQEAVRLIR SAIKDYATDP
     KTGKIDMNLV QTGKSVIQRK LQEDLSREIM NVLKDQASDS MSFNELIKQI NEHSQDRVES
     SDIQEALSRL QQEDKVIVLG EGVRRSVRLN NRV
>P31380 nuc HYPOTHETICAL 128.5 KD HELICASE IN ATS1-TPD3 INTERGENIC REGION.
     MSGSHSNDED DVVQVPETSS PTKVASSSPL KPTSPTVPDA SVASLRSRFT FKPSDPSEGA
     HTSKPLPSGS PEVALVNLAR EFPDFSQTLV QAVFKSNSFN LQSARERLTR LRQQRQNWTW
     NKNASPKKSE TPPPVKKSLP LANTGRLSSI HGNINNKSSK ITVAKQKTSI FDRYSNVINQ
     KQYTFELPTN LNIDSEALSK LPVNYNKKRR LVRADQHPIG KSYESSATQL GSAREKLLAN
     RKYGRHANDN DEEEEESMMT DDDDASGDDY TESTPQINLD EQVLQFINDS DIVDLSDLSD
     TTMHKAQLIA SHRPYSSLNA FVNTNFNDKD TEENASNKRK RRAAASANES ERLLDKITQS
     IRGYNAIESV IKKCSSYGDL VTSQMKKWGV QVEGDNSELD LMNLGEDDDD DNDDGNNDNN
     NSNNNNTAGA DATSKEKEDT KAVVEGFDET SAEPTPAPAP APVERETKRI RNTTKPKVVE
     DEDDDVDLEA IDDELPQSEH EDDDYEEEDE DYNDEEEDVE YDDGDDDDDD DDEFVATRKN
     THVISTTSRN GRKPIVKFFK GKPRLLSPEI SLKDYQQTGI NWLNLLYQNK MSCILADDMG
     LGKTCQVISF FAYLKQINEP GPHLVVVPSS TLENWLREFQ KFAPALKIEP YYGSLQEREE
     LRDILERNAG KYDVIVTTYN LAAGNKYDVS FLKNRNFNVV VYDEGHMLKN STSERFAKLM
     KIRANFRLLL TGTPLQNNLK ELMSLLEFIM PNLFISKKES FDAIFKQRAK TTDDNKNHNP
     LLAQEAITRA KTMMKPFILR RRKDQVLKHL PPKHTHIQYC ELNAIQKKIY DKEIQIVLEH
     KRMIKDGELP KDAKEKSKLQ SSSSKNLIMA LRKASLHPLL FRNIYNDKII TKMSDAILDE
     PAYAENGNKE YIKEDMSYMT DFELHKLCCN FPNTLSKYQL HNDEWMQSGK IDALKKLLKT
     IIVDKQEKVL IFSLFTQVLD ILEMVLSTLD YKFLRLDGST QVNDRQLLID KFYEDKDIPI
     FILSTKAGGF GINLVCANNV IIFDQSFNPH DDRQAADRAH RVGQTKEVNI TTLITKDSIE
     EKIHQLAKNK LALDSYISED KKSQDVLESK VSDMLEDIIY DENSKPKGTK E
>P32494 nuc ADA3 PROTEIN (NGG1 PROTEIN).
     MPRHGRRGKL PKGEKLPKKE GGDNTPSKLL SSMLKTLDLT FERDIGMLNG KSVRSIPNKK
     TLLELQSQLD SLNEILGTIA RGDQETIEAL RKIRDSKNEK QANDEKQETS NADGQHESST
     ATEETNIIDK GVQSPPKPPP SNEISGTIEN DVESIKQAAD NMAKEEINED KDLQVHRDQP
     REKRPFDSET ENRATENENT QRPDNKKQKI DVDKMENDPT VKNPKSEFVV SQTLPRAAAA
     LGLFNEEGLE STGEDFLKKK YNVASYPTND LKDLLPGELP DMDFSHPKPT NQIQFNTFLA
     FVENFFKDLS DDNLKFLKMK YIIPDSLQFD KTYDPEVNPF IIPKLGPLYT DVWFKDENDK
     NSAYKKPSPY SNDASTILPK KSANELDDNA LESGSISCGP LLSRLLSAVL KDDNDKSELQ
     SSKIIRDGGL PRTGGEDDIQ SFRNNNNDTV DMTLSQENGP SVQTPDNDID EEASFQAKLA
     ENKGSNGGTT STLPQQIGWI TNGINLDYPT FEERLKRELK YVGIYMNLPK DENNPNSDDP
     DWVTGREDDE ISAELRELQG TLKQVTKKNQ KRKAQLIPLV ERQLAWQEYS SILEDLDKQI
     DQAYVKRIRV PKKRKKHHTA ASNNVNTGTT SQIAQQKAAN SSLKSLLDKR QRWINKIGPL
     FDKPEIMKRI PNESVFKDMD QEEDEDEADV FAQNTNKDVE LN
>P32569 nuc SUPPRESSOR OF RNA POLYMERASE B SRB4.
     MTTEDPDSNH LSSETGIKLA LDPNLITLAL SSNPNSSLHS PTSDEPVPES AGKADTSIRL
     EGDELENKTK KDNDKNLKFL KNKDSLVSNP HEIYGSMPLE QLIPIILRQR GPGFKFVDLN
     EKELQNEIKQ LGSDSSDGHN SEKKDTDGAD ENVQIGEDFM EVDYEDKDNP VDSRNETDHK
     TNENGETDDN IETVMTQEQF VKRRRDMLEH INLAMNESSL ALEFVSLLLS SVKESTGMSS
     MSPFLRKVVK PSSLNSDKIP YVAPTKKEYI ELDILNKGWK LQSLNESKDL LRASFNKLSS
     ILQNEHDYWN KIMQSISNKD VIFKIRDRTS GQKLLAIKYG YEDSGSTYKH DRGIANIRNN
     IESQNLDLIP HSSSVFKGTD FVHSVKKFLR VRIFTKIESE DDYILSGESV MDRDSESEEA
     ETKDIRKQIQ LLKKIIFEKE LMYQIKKECA LLISYGVSIE NENKVIIELP NEKFEIELLS
     LDDDSIVNHE QDLPKINDKR ANLMLVMLRL LLVVIFKKTL RSRISSPHGL INLNVDDDIL
     IIRPILGKVR FANYKLLLKK IIKDYVLDIV PGSSITETEV EREQPQENKN IDDENITKLN
     KEIRAFDKLL NIPRRELKIN LPLTEHKSPN LSLMLESPNY CNALIHIKFS AGTEANAVSF
     DTTFSDFKEV EDFLHFIVAE YIQQKKV
>P32570 nuc SUPPRESSOR OF RNA POLYMERASE B SRB6.
     MSNQALYEKL EQTRTILSVK LAELINMTTI ADRNDDDEGS FAQENSELAV ATTSVMMVNN
     QTMQLIKNVQ DLLILTRSIK EKWLLNQIPV TEHSKVTRFD EKQIEELLDN CIETFVAEKT
     T
>P32585 nuc SUPPRESSOR OF RNA POLYMERASE B SRB5.
     MVQQLSLFGS IGDDGYDLLI STLTTISGNP PLLYNSLCTV WKPNPSYDVE NVNSRNQLVE
     PNRIKLSKEV PFSYLIDETM MDKPLNFRIL KSFTNDKIPL NYAMTRNILH NTVPQVTNFN
     STNEDQNNSK HTEDTVNESR NSDDIIDVDM DASPAPSNES CSPWSLQISD IPAAGNNRSV
     SMQTIAETII LSSAGKNSSV SSLMNGLGYV FEFQYLTIGV KFFMKHGLIL ELQKIWQIEE
     AGNSQITSGG FLLKAYINVS RGTDIDRINY TETALMNLKK ELQGYIELSV PDRQSMDSRV
     AHGNILI
>P32607 nuc RETROGRADE REGULATION PROTEIN 1.
     MSSIPAGTDP GSCGANFKND RKRRDKINDR IQELLSIIPK DFFRDYYGNS GSNDTLSEST
     PGALGLSSKA KGTGTKDGKP NKGQILTQAV EYISHLQNQV DTQNREEVEL MVKATQLAKQ
     TGTIVNDINL ENTSAEVALS RIGVGPLAAT NDDSVRPPAK RLSSFEYGGY GEYGNGS
>P32628 nuc UV EXCISION REPAIR PROTEIN PROTEIN RAD23.
     MVSLTFKNFK KEKVPLDLEP SNTILETKTK LAQSISCEES QIKLIYSGKV LQDSKTVSEC
     GLKDGDQVVF MVSQKKSTKT KVTEPPIAPE SATTPGRENS TEASPSTDAS AAPAATAPEG
     SQPQEEQTAT TERTESASTP GFVVGTERNE TIERIMEMGY QREEVERALR AAFNNPDRAV
     EYLLMGIPEN LRQPEPQQQT AAAAEQPSTA ATTAEQPAED DLFAQAAQGG NASSGALGTT
     GGATDAAQGG PPGSIGLTVE DLLSLRQVVS GNPEALAPLL ENISARYPQL REHIMANPEV
     FVSMLLEAVG DNMQDVMEGA DDMVEGEDIE VTGEAAAAGL GQGEGEGSFQ VDYTPEDDQA
     ISRLCELGFE RDLVIQVYFA CDKNEEAAAN ILFSDHAD
>P32639 nuc PRE-MRNA SPLICING HELICASE BRR2 (EC 3.6.1.-).
     MTEHETKDKA KKIREIYRYD EMSNKVLKVD KRFMNTSQNP QRDAEISQPK SMSGRISAKD
     MGQGLCNNIN KGLKENDVAV EKTGKSASLK KIQQHNTILN SSSDFRLHYY PKDPSNVETY
     EQILQWVTEV LGNDIPHDLI IGTADIFIRQ LKENEENEDG NIEERKEKIQ HELGINIDSL
     KFNELVKLMK NITDYETHPD NSNKQAVAIL ADDEKSDEEE VTEMSNNANV LGGEINDNED
     DDEEYDYNDV EVNSKKKNKR ALPNIENDII KLSDSKTSNI ESVPIYSIDE FFLQRKLRSE
     LGYKDTSVIQ DLSEKILNDI ETLEHNPVAL EQKLVDLLKF ENISLAEFIL KNRSTIFWGI
     RLAKSTENEI PNLIEKMVAK GLNDLVEQYK FRETTHSKRE LDSGDDQPQS SEAKRTKFSN
     PAIPPVIDLE KIKFDESSKL MTVTKVSLPE GSFKRVKPQY DEIHIPAPSK PVIDYELKEI
     TSLPDWCQEA FPSSETTSLN PIQSKVFHAA FEGDSNMLIC APTGSGKTNI ALLTVLKALS
     HHYNPKTKKL NLSAFKIVYI APLKALVQEQ VREFQRRLAF LGIKVAELTG DSRLSRKQID
     ETQVLVSTPE KWDITTRNSN NLAIVELVRL LIIDEIHLLH DDRGPVLESI VARTFWASKY
     GQEYPRIIGL SATLPNYEDV GRFLRVPKEG LFYFDSSFRP CPLSQQFCGI KERNSLKKLK
     AMNDACYEKV LESINEGNQI IVFVHSRKET SRTATWLKNK FAEENITHKL TKNDAGSKQI
     LKTEAANVLD PSLRKLIESG IGTHHAGLTR SDRSLSEDLF ADGLLQVLVC TATLAWGVNL
     PAHTVIIKGT DVYSPEKGSW EQLSPQDVLQ MLGRAGRPRY DTFGEGIIIT DQSNVQYYLS
     VLNQQLPIES QFVSKLVDNL NAEVVAGNIK CRNDAVNWLA YTYLYVRMLA SPMLYKVPDI
     SSDGQLKKFR ESLVHSALCI LKEQELVLYD AENDVIEATD LGNIASSFYI NHASMDVYNR
     ELDEHTTQID LFRIFSMSEE FKYVSVRYEE KRELKQLLEK APIPIREDID DPLAKVNVLL
     QSYFSQLKFE GFALNSDIVF IHQNAGRLLR AMFEICLKRG WGHPTRMLLN LCKSATTKMW
     PTNCPLRQFK TCPVEVIKRL EASTVPWGDY LQLETPAEVG RAIRSEKYGK QVYDLLKRFP
     KMSVTCNAQP ITRSVMRFNI EIIADWIWDM NVHGSLEPFL LMLEDTDGDS ILYYDVLFIT
     PDIVGHEFTL SFTYELKQHN QNNLPPNFFL TLISENWWHS EFEIPVSFNG FKLPKKFPPP
     TPLLENISIS TSELGNDDFS EVFEFKTFNK IQSQVFESLY NSNDSVFVGS GKGTGKTAMA
     ELALLNHWRQ NKGRAVYINP SGEKIDFLLS DWNKRFSHLA GGKIINKLGN DPSLNLKLLA
     KSHVLLATPV QFELLSRRWR QRKNIQSLEL MIYDDAHEIS QGVYGAVYET LISRMIFIAT
     QLEKKIRFVC LSNCLANARD FGEWAGMTKS NIYNFSPSER IEPLEINIQS FKDVEHISFN
     FSMLQMAFEA SAAAAGNRNS SSVFLPSRKD CMEVASAFMK FSKAIEWDML NVEEEQIVPY
     IEKLTDGHLR APLKHGVGIL YKGMASNDER IVKRLYEYGA VSVLLISKDC SAFACKTDEV
     IILGTNLYDG AEHKYMPYTI NELLEMVGLA SGNDSMAGKV LILTSHNMKA YYKKFLIEPL
     PTESYLQYII HDTLNNEIAN SIIQSKQDCV DWFTYSYFYR RIHVNPSYYG VRDTSPHGIS
     VFLSNLVETC LNDLVESSFI EIDDTEAEVT AEVNGGDDEA TEIISTLSNG LIASHYGVSF
     FTIQSFVSSL SNTSTLKNML YVLSTAVEFE SVPLRKGDRA LLVKLSKRLP LRFPEHTSSG
     SVSFKVFLLL QAYFSRLELP VDFQNDLKDI LEKVVPLINV VVDILSANGY LNATTAMDLA
     QMLIQGVWDV DNPLRQIPHF NNKILEKCKE INVETVYDIM ALEDEERDEI LTLTDSQLAQ
     VAAFVNNYPN VELTYSLNNS DSLISGVKQK ITIQLTRDVE PENLQVTSEK YPFDKLESWW
     LVLGEVSKKE LYAIKKVTLN KETQQYELEF DTPTSGKHNL TIWCVCDSYL DADKELSFEI
     NVK
>P32641 nuc CHECKPOINT PROTEIN RAD24.
     MDSTNLNKRP LLQYSLSSLG SQITKWSSSR PTSPVRKARS TENDFLSKQD TSSILPSIND
     DGGEQWYEKF KPNCLEQVAI HKRKLKDVQE ALDAMFLPNA KHRILLLSGP SGCSKSTVIK
     ELSKILVPKY RQNSNGTSFR STPNEHKVTE FRGDCIVNDL PQMESFSEFL KGARYLVMSN
     LSLILIEDLP NVFHIDTRRR FQQLILQWLY SSEPLLPPLV ICITECEIPE NDNNYRKFGI
     DYTFSAETIM NKEILMHPRL KRIKFNPINS TLLKKHLKFI CVQNMKMLKE KNKWNKRQEV
     IDYIAQETGD IRSAITTLQF WATSSGSLPI STRESTISYF HAIGKVIHGS HSTNNDNEMI
     NNLFENSNNL LSKEDFKLGI LENYNTFNKG EFSISDASSI VDCLSECDNM NGLPESNEYG
     LREVRKTFRN ISKQGHNHGT VYFPREWKVR KLQNSFKVQA EDWLNVSLYK YNAVHSFRNI
     TLEFGYYAPL IRKCQSYKKK YILYYLKNLP SGSSGPKQTM DKFSDIMKVE NGIDVVDRIG
     GPIEALSVED GLAPLMDNDS NNCDHLEDQK KERDRRLRML IDQYERNVMM ANDDLEDEET
     SFNDDPIVDS DSDNSNNIGN ETFGRSDEDE SLCEILSQRQ PRKAPVISES LSDSDLEIL
>P32786 nuc RNA POLYMERASE I SPECIFIC TRANSCRIPTION INITIATION FACTOR RRN6.
     MSEGQIPSSD VLGSQLGVGV QGASLYCPQE NYTTKKQENP QWLRPVDDTL AEDALDLHIV
     VKSLLCDTAI RYISDDKVLQ ESDADDDLIT SDIDEDTDNQ GDTSIVVNPV IPVVPKDVHF
     FKKVDVGNDS MFGVNCDTPV SFQDYIPSDL LRNLDDTLQE STNSSRPMQD AFFWDPTVAN
     RLDSQYIQTA SDLRNYRDGT EIIAYASGKT GSVLNIAVLT RQNTLHLNRH NNVTSIELHS
     PIKSIKIPGA SESIGRRSNL VGIITENSFQ IFRIESVHSR SCDVMVSSSE PLYFVEIDDL
     QVVDFAFNPW DLQQFAIIDI KGNWSIGRIP KNFNNNNKRK LQLIDNLHGT IFDPEELSSW
     KRIEWFSHFQ KILVFDRSKM IEIDFMNNWQ TEVVQAKAWS NIRDYKRIDD KNGILLTSRE
     IIIVGASESN DPVRRISWKH DLDPDDTTLR ITVQKVKKPD HILLVAFVYS MRHKRIYMHV
     FSHRKANLFQ SLGCSTVLEI PGGTPTGIET ILTLDHIDDE SRREEDADEN FELVVDFLVK
     LRNSSEVYYY ALSNTQNSEP NKQETPIIVD HPEWASLFNN ADEREKESIG ALVSQIKLKE
     RERISRVQNL IEHENSHDED KYLQDLGYRL SIATNELLES WQKTKDESIL SGSLSHSKLK
     NLLENSDSFA SIPEFSSLLD QFFQYYQDQD VTFIGFEKLL HLFLHEDVPG LDIFYNKLLQ
     CWVLVSPQAE LLTKEIVKDI IWSLARLEKP SLFEPIQNEI SRSLSGPYQD IISSWDMDDI
     NEEDESNEFN FDSQFSAPFN GRPPFNLNSQ SQIPTIKSSQ SSGLARRKRI LKTQSQKATP
     LSQSTQNLSV LPDSMTPAFT LMQPPSSQIS FVNDSQPRNS QKAKKKKKRI RGFG
>P32788 nuc HYPOTHETICAL 32.6 KD PROTEIN IN SCT1-HIR1 INTERGENIC REGION.
     MSDRDQIEPV TNALDAESDS SDDFGNFSDA SVENDLYNQN STLTTSSESV VDNCLNKILP
     KGEFDLEEET IKNDCFKLSK LIEDERPHVI YEQLVQLDPV LQPFIWNKSH IRRNLLHILR
     LSDNNGSEGV GTKREEEPLN DELFKRICDA VEKNEQTATG LFLRDNFKID YTPPMTLKSL
     QKEEEREQEQ HIPQLLMADF TSMDEESLRQ YHDTLCQSID FLVSKSRSLK KQQRDLLKDK
     TTFENVVTNL TGHTQRLQRD EIALYNKKRN KKKRFSWVGY
>P32862 nuc PUTATIVE 128.2 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN PTM1-IXR1
     MNELNTVSTN SSDSTKNGGT SNSPDDMDSA AAASHAIKKR TKASRACDQC RKKKIKCDYK
     DEKGVCSNCQ RNGDRCSFDR VPLKRGPSKG YTRSTSHPRT NEIQDHNNSR SYNTFDNSNN
     TLNNNTGNSG DNGINSNTVP STPSRSNSVL LPPLTQYIPQ AGGIPPSFQN PAIQSTMPAG
     NIGQQQFWKV PYHEFQHQRK GSIDSLQSDI SVRTLNPNEQ LSYNTVQQSP ITNKHTNDSG
     NANGSVTGSG SASGSGGYWS FIRTSGLLAP TDDHNGEQTR RSSSIPSLLR NTSNSLLLGG
     QPQLPPPQQQ SQPQAHQQKL QQGQNLYSYS QFSQQQPYNP SISSFGQFAA NGFHSRQGSV
     ASEAMSPSAP AMFTSTSTNP VNVAQQTQRP QGQQVPQFSS ELDGNKRRQS APVSVTLSTD
     RLNGNENNNG EINNNNGSNN SGSSKDTSQH SQESVTTPAA LEASSPGSTP QRSTKKRRKS
     YVSKKTKPKR DSSISITSKD SAHPMTTSST IAYGQISDVD LIDTYYEFIH VGFPIIPLNK
     TTLTSDLLLV NTQPISNIHE VNSYVILWFR NSLELLVRVA LKQKPGGKFF DNIVGVALSP
     SNDNNKAGFT TATARDDAEK TRRDSHNEVQ DTLEVQSVFI AALNECFQKI VDIHPKFREN
     NDQISPKIKV IYLSTFILLN YILAFVGYDN SFVLGMSVTI FNEFKLYKLL LFPEPDINDV
     KPPVDEEVST GNGNTKTSEF EIGSESAGHM NPSNSPNSMD ENISHYSVLF KRLYVLLSVF
     DSLQSCAFGG PKLLNISIQG STERFFSNDL GSKWCLEQSQ LRLKSVLQSL KLGELMSELT
     RNRISMNGNR KPGFDITNSS SLLSEYVETQ PLSVAQLFCK LLIGKHNFIN CLLSLYDSEA
     GVYSDLTLDL SSKIADSLCS LISIILQVLT LILRLNPTNS IDFNYRPPNP PANNPTVQEG
     PSAMGSSPVA GNLSAAPPSE GNPDFYKKLL GLKQDTGTIL SDLCRGIISP FAIAILHEVY
     NITELVKQMP TSLISIMMTA TTTQNTQDTK KSQDLVMKLS NSMNEVVQIT SVLTMIKPFK
     IFEHELNKPI MSLTGGLSST TRNDVMWPKS GQGLRESSVM KTLLDERRTS GTQPTTAPVA
     AEEPRLENVA LENFVSIGWK LLDDSELGWY
>P33122 nuc SERINE-RICH PROTEIN TYE7 (BASIC-HELIX-LOOP-HELIX PROTEIN SGC1).
     MNSILDRNVR SSETTLIKPE SEFDNWLSDE NDGASHINVN KDSSSVLSAS SSTWFEPLEN
     IISSASSSSI GSPIEDQFIS SNNEESALFP TDQFFSNPSS YSHSPEVSSS IKREEDDNAL
     SLADFEPASL QLMPNMINTD NNDDSTPLKN EIELNDSFIK TNLDAKETKK RAPRKRLTPF
     QKQAHNKIEK RYRININTKI ARLQQIIPWV ASEQTAFEVG DSVKKQDEDG AETAATTPLP
     SAAATSTKLN KSMILEKAVD YILYLQNNER LYEMEVQRLK SEIDTLKQDQ K
>P33200 nuc PLEIOTROPIC DRUG RESISTANCE REGULATORY PROTEIN 3.
     MKVKKSTRSK VSTACVNCRK RKIKCTGKYP CTNCISYDCT CVFLKKHLPQ KEDSSQSLPT
     TAVAPPSSHA NVEASADVQH LDTAIKLDNQ YYFKLMNDLI QTPVSPSATH APDTSNNPTN
     DNNILFKDDS KYQNQLVTYQ NILTNLYALP PCDDTQLLID KTKSQLNNLI NSWNPEINYP
     KLSSFSPRPQ RSIETYLLTN KYRNKIHMTR FSFWTDQMVK SQSPDSFLAT TPLVDEVFGL
     FSPIQAFSLR GIGYLIKKNI ENTGSSMLID TKETIYLILR LFDLCYEHLI QGCISISNPL
     ENYLQKIKQT PTTTASASLP TSPAPLSNDL VISVIHQLPQ PFIQSITGFT TTQLIENLHD
     SFSMFRIVTQ MYAQHRKRFA EFLNQAFSLP HQEKSVLFSS FCSSEYLLST LCYAYYNVTL
     YHMLDINTLD YLEILVSLLE IQNEIDERFG FEKMLEVAVT CSTKMGLSRW EYYVGIDENT
     AERRRKIWWK IYSLEKRFLT DLGDLSLINE HQMNCLLPKD FRDMGFINHK EFLTKIGTSS
     LSPSSPKLKN LSLSRLIEYG ELAIAQIVGD FFSETLYNEK FTSLEVSVKP TIIRQKLLEK
     VFEDIESFRL KLAKIKLHTS RVFQVAHCKY PEYPKNDLIE AAKFVSYHKN TWFSILGAVN
     NLIARLSEDP EVITEQSMKY ANEMFQEWRE INQFLIQVDT DFIVWACLDF YELIFFVMAS
     KFYVEDPHIT LEDVINTLKV FKRITNIISF FNNNLDEKDY DCQTFREFSR SSSLVAISIR
     IIFLKYCYAE QIDRAEFIER LKEVEPGLSD LLREFFDTRS FIYRYMLKSV EKSGFHLIIR
     KMLESDYKFL YRDKLATGNI PDQGNSSQIS QLYDSTAPSY NNASASAANS PLKLSSLLNS
     GEESYTQDAS ENVPCNLRHQ DRSLQQTKRQ HSAPSQISAN ENNIYNLGTL EEFVSSGDLT
     DLYHTLWNDN TSYPFL
>P33309 nuc DOM34 PROTEIN.
     MKDEYLKYKG VTVTDESGAS NVDIPVGKYL SFTLDYVYPF TIIKQNFNKF MQKLLNEACN
     IEYKSDTAAV VLQEGIAHVC LVTSSSTILK QKIEYSMPKK KRTTDVLKFD EKTEKFYKAI
     YSAMKKDLNF DKLKTIILCS PGFYAKILMD KIFQYAEEEH NKKILDNKGM FFIAHCSTGY
     LQGINEVLKN PLYASKLQDT KYSKEIMVMD EFLLHLNKDD DKAWYGEKEV VKAAEYGAIS
     YLLLTDKVLH SDNIAQREEY LKLMDSVESN GGKALVLSTL HSLGEELDQL TGIACILKYP
     LPDLDEDDGE E
>P33399 nuc LA PROTEIN HOMOLOG.
     MSEKPQQEEQ EKPQSRRNSF AVIEFTPEVL DRCLKQVEFY FSEFNFPYDR FLRTTAEKND
     GWVPISTIAT FNRMKKYRPV DKVIEALRSS EILEVSADGE NVKRRVPLDL TAARNARIEQ
     NQRTLAVMNF PHEDVEASQI PELQENLEAF FKKLGEINQV RLRRDHRNKK FNGTVLVEFK
     TIPECEAFLK SYSNDDESNE ILSYEGKKLS VLTKKQFDLQ REASKSKNFS GRSRSFNGHK
     KKNLPKFPKN KKKNGKEESK EDSSAIADDD EEHKE
>P34160 nuc GCR3 PROTEIN (STO1 PROTEIN) (SUT1 PROTEIN).
     MFNRKRRGDF DEDENYRDFR PRMPKRQRIP PVVQLCKEMM PDIRTIGESV KAFEDDIKFL
     SEAIMNEYGH EDYFNNALLS TLNAVVVEQP QKQAAIALLT MVVNSKNNVA GKSIINYFFE
     ELQKWCKQTY NDEFKSTSNE TGPWNKIKLI LRFLSILSPM FLVDELINIY KSLFELSIEL
     NNLDPGNRVP LSEAIYTNTL LNIPYLFFFN RNNDGLRTKV EELLAYVEQN YLVKTTDINL
     LREYNGEPPY EMVELVRVVL PNVKKALINN LEQLNELFPD WNHLLTPQTG DEGFNDALTL
     PSVDDLKSFV RLNKNFGSVD SMWKTPRYAF HVYLPNSAGN FETVVPISTY AGQLFNDIII
     DLVESLEFNR KEVARQVITL DLFFKAGIFT EPGESIAQLI ATYEENPLAP TFKIEDLAIE
     TILGLIFKLP SVSQPFAYFY TLLVDICQNS PKAIAPVFGR AFRFFYSHLD SLDFELKLRY
     LDWFSIQMSN FNFSWKWNEW EDDSIKFGKY FYNPKVNFAK NLIQKELRLT SNFSEVEDSL
     PQEFTKYLDT SYIPRDQLIN YYQSLFTGYT VEEDSVRKND LYFRQEGVPM ENTVRKILDY
     THKANNSREV TELESILGEL KNEYGSIISD FNRFVIILLV QAVTDSGSRS LSHANKYIND
     LKEDLKTIFA KIELDIETKE YIIIEAVLTF WNANPQTGFL VADAFKYAGL LTSRTIFTFI
     FNETGLKNNG LIEATAIEAV FRNLSQQISE ENESGNNFEF VFERLCTIAN STIDLLDVNA
     DEDIEIPKVN GEMDIDDIED DKLDLKWKYF TVIGFIKSIL RRYSHEYREL ADKFIANIDN
     AIPHESTRRT ISNWIQETKE V
>P34162 nuc SUPPRESSOR OF RNA POLYMERASE B SRB2.
     MGKSAVIFVE RATPATLTEL KDALSNSILS VRDPWSIDFR TYRCSIKNLP ADVSKLMYSI
     TFHHHGRQTV LIKDNSAMVT TAAAADIPPA LVFNGSSTGV PESIDTILSS KLSNIWMQRQ
     LIKGDAGETL ILDGLTVRLV NLFSSTGFKG LLIELQADEA GEFETKIAGI EGHLAEIRAK
     EYKTSSDSLG PDTSNEICDL AYQYVRALEL
>P34217 nuc HYPOTHETICAL 73.8 KD PROTEIN IN SAS3-SEC17 INTERGENIC REGION.
     METSSFENAP PAAINDAQDN NINTETNDQE TNQQSIETRD AIDKENGVQT ETGENSAKNA
     EQNVSSTNLN NAPTNGALDD DVIPNAIVIK NIPFAIKKEQ LLDIIEEMDL PLPYAFNYHF
     DNGIFRGLAF ANFTTPEETT QVITSLNGKE ISGRKLKVEY KKMLPQAERE RIEREKREKR
     GQLEEQHRSS SNLSLDSLSK MSGSGNNNTS NNQLFSTLMN GINANSMMNS PMNNTINNNS
     SNNNNSGNII LNQPSLSAQH TSSSLYQTNV NNQAQMSTER FYAPLPSTST LPLPPQQLDF
     NDPDTLEIYS QLLLFKDREK YYYELAYPMG ISASHKRIIN VLCSYLGLVE VYDPRFIIIR
     RKILDHANLQ SHLQQQGQMT SAHPLQPNST GGSMNRSQSY TSLLQAHAAA AANSISNQAV
     NNSSNSNTIN SNNGNGNNVI INNNSASSTP KISSQGQFSM QPTLTSPKMN IHHSSQYNSA
     DQPQQPQPQT QQNVQSAAQQ QQSFLRQQAT LTPSSRIPSG YSANHYQINS VNPLLRNSQI
     SPPNSQIPIN SQTLSQAQPP AQSQTQQRVP VAYQNASLSS QQLYNLNGPS SANSQSQLLP
     QHTNGSVHSN FSYQSYHDES MLSAHNLNSA DLIYKSLSHS GLDDGLEQGL NRSLSGLDLQ
     NQNKKNLW
>P34228 nuc PUTATIVE 118.2 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN UBP13-KIP1
     MVKDNRDSDQ DQDFSSAHMK RQPEQQQLQQ HQFPSKKQRI SHHDDSHQIN HRPVTSCTHC
     RQHKIKCDAS QNFPHPCSRC EKIGLHCEIN PQFRPKKGSQ LQLLRQDVDE IKSKLDTLLA
     NDSVFVHLLQ QIPMGNSLLN KLNLHPTPTP GTIIPNPDSS PSSGSPTSSA AQRDSKVSVQ
     TYLSREPQLL QANQGSNTNK FKANNEASSH MTLRASSLAQ DSKGLVATEP NKLPPLLNDS
     ALPNNSKESL PPALQMAFYK NNSAGNTPNG PFSPIQKTYS PHTTSTTVTT TTNQPPFAAT
     SHVATNNNAD RTKTPVVATT TTMPLLPSPH ANVDEFVLGD ISISIEKANR LHHIFVTRYL
     PYFPIMYSNN ATELYSQSQL LFWTVMLTAC LSDPEPTMYC KLSSLIKQLA IETCWIRTPR
     STHISQALLI LCIWPLPNQK VLDDCSYRFV GLAKSLSYQL GLHRGEFISE FTRTQTSMPN
     AEKWRTRTWL GIFFAELCWA SILGLPPTSQ TDYLLEKALS CGDEESEEDN NDSIDNNNND
     KRNKKDEPHV ESKYKLPGSF RRLLSLANFQ AKLSHIIGSS TSSPDGLLEP KYRAETLSIL
     GKELDLLAKT LNFQSDDTVN IYFLYVKLTV CCFAFLPETP PTDQIPYVTE AYLTATKIVT
     LLNNLLETHQ LIELPIYIRQ AATFSALILF KLQLTPLLPD KYFDSARQSV VTIHRLYRNQ
     LTAWATSVEN DISRTASMLE KLNFVLIMHP EVFVEEDGII SRMRSHLTGS LFYDLVWCVH
     EARRREMDPE YNKQALEKAA KKRKFSSNGI YNGTSSTGGI TDRKLYPLPL YNHISRDDFE
     TVTKTTPSGT TVTTLVPTKN ALKQQEKLAK TNNGDSDGSI MEINGIPLSM LGETGSVKFQ
     SLFANTSNSN DYNNNRTLLD ASNDISIPSN SIYPVASVPA SNNNPQSTKV DYYSNGPSVI
     PDLSMKRSVS TPVNHFPASV PGLRNHPVGN LSNNVTLGID HPIPREHSNL QNVTMNYNNQ
     FSNANAIGRS QSSMSHSRTP LFRSIYDSWI PRPTPVL
>P34909 nuc GENERAL NEGATIVE REGULATOR OF TRANSCRIPTION SUBUNIT 4.
     MMNPHVQENL QAIHNALSNF DTSFLSEDEE DYCPLCIEPM DITDKNFFPC PCGYQICQFC
     YNNIRQNPEL NGRCPACRRK YDDENVRYVT LSPEELKMER AKLARKEKER KHREKERKEN
     EYTNRKHLSG TRVIQKNLVY VVGINPPVPY EEVAPTLKSE KYFGQYGKIN KIVVNRKTPH
     SNNTTSEHYH HHSPGYGVYI TFGSKDDAAR CIAQVDGTYM DGRLIKAAYG TTKYCSSYLR
     GLPCPNPNCM FLHEPGEEAD SFNKRELHNK QQAQQQSGGT AFTRSGIHNN ISTSTAGSNT
     NLLSENFTGT PSPAAMRAQL HHDSHTNAGT PVLTPAPVPA GSNPWGVTQS ATPVTSINLS
     KNSSSINLPT LNDSLGHHTT PTTENTITST TTTTNTNATS HSHGSKKKQS LAAEEYKDPY
     DALGNAVDFL DARLHSLSNY QKRPISIKSN IIDEETYKKY PSLFSWDKIE ASKKSDNTLA
     NKLVEILAIK PIDYTASVVQ FLQSVNVGVN DNITITDNTK TPTQPIRLQT VSQQIQPPLN
     VSTPPPGIFG PQHKVPIQQQ QMGDTSSRNS SDLLNQLING RKIIAGN
>P35178 nuc HYPOTHETICAL 33.2 KD PROTEIN IN SSS1-SLU7 INTERGENIC REGION.
     METSNFVKQL SSNNRKTRVN ALEALKKYLT AKQFKENKQI EFNKLWKGLY YAMWFSDRPR
     PQQRLANELG ELHGLYFDPK DNSTADELTT NDKAFIKFSR GFWKVMCFEW FNIDRYRLDK
     YLLLIRRVLF SQLKYLQSRN WDKKLVDEYI KKVLRWLPLS GSPKVYTGIP IHIVDILLDE
     WERLLKDGDE DDEDEENKEE EMRKIAESAK KTPLADVIAI FQDIVADYNN SKVLREKIKE
     DLFSDTRLVS WDILEGETQH NDSSNESEEE EEEEWKGF
>P35197 nuc ZINC FINGER PROTEIN GCS1.
     MSDWKVDPDT RRRLLQLQKI GANKKCMDCG APNPQWATPK FGAFICLECA GIHRGLGVHI
     SFVRSITMDQ FKPEELLRME KGGNEPLTEW FKSHNIDLSL PQKVKYDNPV AEDYKEKLTC
     LCEDRVFEER EHLDFDASKL SATSQTAASA TPGVAQSREG TPLENRRSAT PANSSNGANF
     QKEKNEAYFA ELGKKNQSRP DHLPPSQGGK YQGFGSTPAK PPQERSAGSS NTLSLENFQA
     DPLGTLSRGW GLFSSAVTKS FEDVNETVIK PHVQQWQSGE LSEETKRAAA QFGQKFQETS
     SYGFQAFSNF TKNFNGNAED SSTAGNTTHT EYQKIDNNDK KNEQDEDKWD DF
>P35207 nuc ANTIVIRAL PROTEIN SKI2.
     MSEGFSSSSI QELYQSLKEI TNNADVELFE DRITKLDFES TDEPKHANDI IKDRFLRPSN
     ALPWSLLDMV QDVPHTSSPE DCSGKLDYKE LLKVPDPINR TSYQFKRTGL EGKISGYKEE
     VDLKEVANAN ASNSLSITRS INHNQNSVRG STAQLPFTPG GIPMKSVKTD SEQNGSSTMA
     NATKLLHKDG QGLFDIPEGM NRGIKPMDSP AENEDQNGQF KELKQLNEID NELDIRIEAN
     EAKLKEEEKS AKSISEEIME EATEETTADN ADDAEIDELL PIGIDFGRTK PVSKSVPVKK
     EWAHVVDLNH KIENFDELIP NPARSCPFEL DTFQKEAVYH LEQGDSVFVA AHTSAGKTVV
     AEYAIAMAHR NMTKTIYTSP IKALSNQKFR DFKETFDDVN IGLITGDVQI NPDANCLIMT
     TEILRSMLYR GADLIRDVEF VIFDEVHYVN DQDRGVVWEE VIIMLPQHVK FILLSATVPN
     TYEFANWIGR TKQKNIYVIS TPKRPVPLEI NIWAKKELIP VINQNSEFLE ANFRKHKEIL
     NGESAKGAPS KTDNGRGGST ARGGRGGSNT RDGRGGRGNS TRGGANRGGS RGAGAIGSNK
     RKFFTQDGPS KKTWPEIVNY LRKRELLPMV VFVFSKKRCE EYADWLEGIN FCNNKEKSQI
     HMFIEKSITR LKKEDRDLPQ ILKTRSLLER GIAVHHGGLL PIVKELIEIL FSKGFIKVLF
     ATETFAMGLN LPTRTVIFSS IRKHDGNGLR ELTPGEFTLA GRAGRRGLDS TGTVIVMAYN
     SPLSIATFKE VTMGVPTRLQ SQFRLTYNMI LNLLRIEALR VEEMIKYSFS ENAKETLQPE
     HEKQIKVLQE ELQTIEYKSC EICDNDIEKF LELMLAYKEA TVNLMQEMVK SPSILHILKE
     GRLVAFRDPN DCLKLGFVFK VSLKDAVCVI MTFTKPYKLP NGEPNHLIYF PKADGYRRRN
     FPKFQKTDFY MEEVPVTAIE VITKRKFAAP LGKVIKKDVA ALNEFNAETN NILDGKTLKE
     AINIEKQGLK IHQILLDRTN IRDEIFKLKS IKCPNLSQHI VPKFKAHVIK KKIEELYHLM
     SDQNLSLLPD YEKRLAVLKD TEFIDQNHNV LLKGRVACEI NSGYELVLTE LILDNFLGSF
     EPEEIVALLS VFVYEGKTRE EEPPIVTPRL AKGKQRIEEI YKKMLCVFNT HQIPLTQDEA
     EFLDRKRFAM MNVVYEWARG LSFKEIMEMS PEAEGTVVRV ITWLDEICRE VKTASIIIGN
     STLHMKMSRA QELIKRDIVF AASLYL
>P35718 nuc DNA-DIRECTED RNA POLYMERASE III 25 KD POLYPEPTIDE (EC 2.7.7.6) (C25).
     MFILSKIADL VRIPPDQFHR DTISAITHQL NNKFANKIIP NVGLCITIYD LLTVEEGQLK
     PGDGSSYINV TFRAVVFKPF LGEIVTGWIS KCTAEGIKVS LLGIFDDIFI PQNMLFEGCY
     YTPEESAWIW PMDEETKLYF DVNEKIRFRI EREVFVDVKP KSPKERELEE RAQLENEIEG
     KNEETPQNEK PPAYALLGSC QTDGMGLVSW WE
>P35817 nuc BDF1 PROTEIN.
     MTDITPVLCN DVDVNGNNVN DDVSSNLKRP IDQGDPSNGL AEEENPANNQ LHLKKARLDG
     DALTSSPAGL AENGIEGATL AANGENGYNA TGSGPEDEQQ GLKKEEGGQG TKQEDLDENS
     KQELPMEVPK EPAPAPPPEP DMNNLPQNPI PKHQQKHALL AIKAVKRLKD ARPFLQPVDP
     VKLDIPFYFN YIKRPMDLST IERKLNVGAY EVPEQITEDF NLMVNNSIKF NGPNAGISQM
     ARNIQASFEK HMLNMPAKDA PPVIAKGRRS SAQEDAPIVI RRPQTHNGRP KRTIHPPKSK
     DIYPYESKKP KSKRLQQAMK FCQSVLKELM AKKHASYNYP FLEPVDPVSM NLPTYFDYVK
     EPMDLGTIAK KLNDWQYQTM EDFEREVRLV FKNCYTFNPD GTIVNMMGHR LEEVFNSKWA
     DRPNLDDYDS DEDSRTQGDY DDYESEYSES DIDETIITNP AIQYLEEQLA RMKVELQQLK
     KQELEKIRKE RRLARGSKKR GKRSKGRSGS KNASSKGRRD KKNKLKTVVT YDMKRIITER
     INDLPTSKLE RAIDIIKKSM PNISEDDEVE LDLDTLDNHT ILTLYNTFFR QYESSSGASN
     GLDGTSGVTR DASSLSPTSA GSRKRRSKAL SQEEQSRQIE KIKNKLAILD SASPLSQNGS
     PGQIQSAAHN GFSSSSDDDV SSESEEE
>P35995 nuc PUTATIVE 82.2 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN FRE2 5'REGION.
     MKNTELSQKK KLDRQSRRKP AKSCHFCRVR KLKCDRVRPF CGSCSSRNRK QCEYKENTSA
     MEDQLRKKYR RCSKLEMARR IEELESQLTK QSQPNIHEGQ NPLSNMRYLS SKHNRHILYG
     PTSYRAILAT QTDTFAKYRE EIWQVLKLSR NNWKREHHYS TLSEISSIET APPHSGSPSV
     IEYLCESLPN YEVLCEYLTD FFASDFYDSY QIVHKEKVLR DLQDCFVKGP RSHKTGQHTI
     ISLNLDSKKN YYKVGVMTAI MCLASHPKEV PEAIEVFHKV LTSFVSAKVF YTERVQFLFL
     RYLYINVAGL DGGDQSHCIF IHGLTIDTAI HMGLNEDLRR LYLSKNHPIE EIPYLERLWL
     WILFTDVKIS LSTGIPVRIN DDFVNKVRLE NYSSSGDILL YKTTLRLRNI MKQIHAREKP
     PDIPLIIEDL KKFTIKMFKP LDFYLNASNL NGNEFTELQL WHATLHMIGS LSNLYTLTHQ
     DFDARIFNFS VLAPLNSLHL CFNVLETYFE LDNSKLSSKS LCLSKKWPHL NNALFLIYVN
     AFRALIQIYT IFLQYMENKD IQLFIQRNSS ALTYSICPGD FEGPHNKCIS LKIAFKEMEN
     IFDHIHQEKL KPLTQIWQNS YYFSIIISME KIGRRAFNKG MKNIDEGPET ENDATENSLT
     TILNDLEGPL EDFSENFIDD ILGSPSAFFD TAISGWSNFE DFFSR
>P36023 nuc PUTATIVE 101.8 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN LAS1-CCP1
     MGYDSQVRTK KRHRITVVCT NCKKRKSKCD RTKPCGTCVR LGDVDSCVYL TDSSGQPESS
     PSLNDADPLR KQSTPAERIS PGFIKKRRSS QTRQDEDHWQ RVRELENQSS LYYLPIHEET
     PFFIDLIPNG FYLETKRSAD NLFGLFTDRA IENRDPYLQA MVTFRSIAIK KMMDKLGSNG
     NNVKNGSLPK SFEALSTFDA DDERHISDDV VGKGNNFRMH QTIHKSLFNK FAQYRENNAK
     KFSSETILAK DYLPPLKILE SEVLALFEEK IYNMIPIFDM KVLRHEITIF YQNIVEKGNP
     ISIKHYDHMV FCIILLIIKI CRLSVQFSKL TPYIYPVLQE IDTSKFLALV KHYLFETKVL
     RKCNLLQLQC LILLRFLHWC APEDGDGPET QYCQILMGTI ISSCKEMGIN WYCFSHPEKY
     SFKINRHTRP SYDIMKPSDY ISVFRKIWSY VLFWDRKMCF ISGEECQIGK TLQCHFKEEA
     DTPTWYIRML TLDNLMKKIN DTLNDDPGKV DLNLLHRLIN DLKRNFHILK SLSKNEKETM
     RHFDFEMEWI IDLFSLSLLH GEMIFYEYDC NITKFYKSFQ DLWDMVIHIS EKCYNYFFNS
     DALEVDSLTK FYTNRIVEIV ANKVLVIVPA FILRGDRFKT IQYADKKKMI EFLYGVSSVY
     FNEFGFEYYR CFRKMFTAKI AYKILNRSCE KDAWRIILKF LLNELKLEDN GDSYIDYNDM
     RLNDICPIIL EFQETVQKYD GYRPDILSIW NNEFYPIGKY NDDMTGFKFQ MRIKEMQEFL
     DMEKYSDRFN IFSSFYDHAS SQLAKHTEVD TNISITNEQV AEIPQKELLQ QPLAPALPVN
     DLIVSEFDVI EDIFDPVDFV SFF
>P36047 nuc PROTEIN PHOSPHATASES PP1 REGULATORY SUBUNIT SDS22.
     MDKNSVNKDS EEKDERHKIE VVDDTNPDFI TADSELTQDL PDDVEVIDLV HLKIKSLEDL
     NLYRFKNLKQ LCLRQNLIES ISEVEVLPHD KIVDLDFYDN KIKHISSNVN KLTKLTSLDL
     SFNKIKHIKN LENLTDLENL YFVQNSISKI ENLSTLKSLK NLELGGNKVH SIEPDSFEGL
     SNLEEIWLGK NSIPRLINLH PLKNLKILSI QSNKLKKIEN LEELTNLEEL YLSHNFITKI
     EGLEKNLKLT TLDVTSNKIT SLENLNHLSN LTDIWASFNK IDQSFESLGE NLSALSRLET
     IYLEGNPIQL ENKTSYRRKL TMNLPPSLQK IDATYIRG
>P36070 nuc RNA POLYMERASE I SPECIFIC TRANSCRIPTION INITIATION FACTOR RRN3.
     MMAFENTSKR PPQDFVAPID QKKRKVQFSD STGLVTLQPE EIKDEVFSAA MYSRFVKSAL
     DDLDKNDSTQ IGIIANQVAL PSKNPERIND KNLNILLDIL SSNINRIESS RGTFLIQSII
     NFEKWWELPP HTLSKYIYFI KILCSSIPKW WQDVSMILVS CFILPIKQTV CHHDMLKYFL
     RMIPSSMGFI DTYLAKFFPN KNDTRRKLVN YTSNLLKLRG YCSELGFQIW SLLIEKIISI
     DVELQNELDE LDDDVDDDDL EEVDLEDDDD LDDDSGDDDD ENCGNSNEEL RSGAADGSQS
     DSEDMDIIEG MDGTEEYNVE LTQGIKELST KLDSILTLVS THVEEQVTPE SLESGEGVGV
     FNTLTTLFKT HVLPTYYTRS IQYIMFHVSQ QQLELMDSFL VTLIDISFAV NEAAEKKIKS
     LQYLGSYIAR AKKLSRTQII FVASYLTSWL NRYVIEREEE VDQRGGMERF KHFYAAFQAL
     CYIFCFRHNI FRDTDGNWEC ELDKFFQRMV ISKFNPLKFC NENVMLMFAR IAQQESVAYC
     FSIIENNNNE RLRGIIGKAD SDKKENSAQA NTTSSSWSLA TRQQFIDLQS YFPYDPLFLK
     NYKILMKEYY IEWSEASGEY ESDGSDD
>P36100 nuc TRANSCRIPTION INITIATION FACTOR IIE, ALPHA SUBUNIT (TFIIE-ALPHA)
     MDRPIDDIVK NLLKFVVRGF YGGSFVLVLD AILFHSVLAE DDLKQLLSIN KTELGPLIAR
     LRSDRLISIH KQREYPPNSK SVERVYYYVK YPHAIDAIKW KVHQVVQRLK DDLDKNSEPN
     GYMCPICLTK YTQLEAVQLL NFDRTEFLCS LCDEPLVEDD SGKKNKEKQD KLNRLMDQIQ
     PIIDSLKKID DSRIEENTFE IALARLIPPQ NQSHAAYTYN PKKGSTMFRP GDSAPLPNLM
     GTALGNDSSR RAGANSQATL HINITTASDE VAQRELQERQ AEEKRKQNAV PEWHKQSTIG
     KTALGRLDNE EEFDPVVTAS AMDSINPDNE PAQETSYQNN RTLTEQEMEE RENEKTLNDY
     YAALAKKQAK LNKEEEEEEE EEEDEEEEEE EEMEDVMDDN DETARENALE DEFEDVTDTA
     GTAKTESNTS NDVKQESIND KTEDAVNATA TASGPSANAK PNDGDDDDDD DDDEMDIEFE
     DV
>P36145 nuc TRANSCRIPTION INITIATION FACTOR IIE, BETA SUBUNIT (TFIIE-BETA)
     MSKNRDPLLA NLNAFKSKVK SAPVIAPAKV GQKKTNDTVI TIDGNTRKRT ASERAQENTL
     NSAKNPVLVD IKKEAGSNSS NAISLDDDDD DEDFGSSPSK KVRPGSIAAA ALQANQTDIS
     KSHDSSKLLW ATEYIQKKGK PVLVNELLDY LSMKKDDKVI ELLKKLDRIE FDPKKGTFKY
     LSTYDVHSPS ELLKLLRSQV TFKGISCKDL KDGWPQCDET INQLEEDSKI LVLRTKKDKT
     PRYVWYNRGG NLKCIDEEFV KMWENVQLPQ FAELPRKLQD LGLKPASVDP ATIKRQTKRV
     EVKKKRQRKG KITNTHMTGI LKDYSHRV
>P38073 nuc PUTATIVE 103.4 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN RPL2-ODP1
     MSHHVPNLYG TPIRDPHERK RNSASMGEVN QSVSSRNCER GSEKGTKQRK KASHACDQCR
     RKRIKCRFDK HTGVCQGCLE VGEKCQFIRV PLKRGPAKKR GSVVSIEKFS SDNDPLQYRP
     RTHSYPMNSG NNYLPSLARN SSFPSISSLF VPSITAQSQQ FVKVPYDDIK RRSSLAILGS
     DSSISTEFGG NYRLDENLNV RQEGKDIVAK GMITPVEEMG ACSSNVRRQG SQSLPIQEQR
     ASPYINPFIS GRSRLSSLSY TSEATTSEGN TQGKNQCMLT PNSVRSIEKE RLNSLTAGFP
     NKKLGTDGRS DKWDKNSTWK PVYRSSNPSH PSTEKNVSLN QEASAKPLML GTYRQFDATS
     FYKVLGIYYN FFHINFPVIP INKSKFTDML DPEKPNVIDE IRQINNEIIQ CFKTALEVLV
     FCKIKQRRSS KSTKSWSRDS LCDFQKGLYY IQNFNKCIAD CFQSLITIKP VLKQNSSVIP
     SRIKFIYFST IIVLNFILIL AGEESSLLLG PSVGVFNEFQ AHKLFLPFQN TSPMLLLNSN
     EESGDEILDY AVLFKRLYIL LNILDTLQSF RLGQPKLINL NFGSAIETYF SDKTGHNQVV
     EKAPVALDNI LRNLKLGEFI TYFVLNRKSL QVNVPHHLLF TNQTDYGEFA VEKGEHDNIA
     GKFETLLKKK EILIRKLLNI EQKNDHILEN CCNSDAEMKN IGELVCSMIT LVSGILDSIT
     NMNAENSVDL DSKPLPNAYF AQDSEEELMS PTQSITSNLA SEENTRCTTK DLMGTVSIFM
     LPMVEECYNI ISLIGPIPTT LISLYIRNGN MAKGINDRIM TLSTALNELV QITALFNTLE
     PFRKNAHDRA KRYYVSATSS TGCYESVMKS MYSGKCAASN ASNVAPSEEE NKKILKKFAD
     IGWKLMDDSE LGCCCCFFN
>P38082 nuc PUTATIVE 25.0 KD ZINC FINGER PROTEIN IN ORC2-TIP1 INTERGENIC REGION.
     MSIGYKDNLM STILAKDRKC EFPINFECSP SQITLMPEMF SFNNERKYQT LIPLMKTSHL
     IDDDLKDKLN KCAFDFFSGK QANRTSDGTI SRLTASGKTS PILPLQNINI VKAENTGNGK
     SDPYSSIKIS KPTKTVIKLK STKTNTAGQR TRHFCKICST GFTTSGHLSR HNRIHTGEKN
     HICPHEGCGQ RFSRHDNCNQ HYRTHANKKK RNWKRREASS
>P38086 nuc HYPOTHETICAL 108.0 KD HELICASE IN HSP26-SEC18 INTERGENIC REGION.
     MAVISVKPRR REKILQEVKN SSVYQTVFDS GTTQMQIPKY ENKPFKPPRR VGSNKYTQLK
     PTATAVTTAP ISKAKVTVNL KRSISAGPTL NLAKKPNNLS SNENTRYFTI MYRKPTTKKH
     KTWSGDGYAT LKASSDKLCF YNEAGKFLGS SMLPSDSDSL FETLFKAGSN EVQLDYELKE
     NAEIRSAKEA LSQNMGNPSP PTTSTTETVP STKNDGGKYQ MPLSQLFSLN TVKRFKSVTK
     QTNEHMTTVP KTSQNSKAKK YYPVFDVNKI DNPIVMNKNA AAEVDVIVDP LLGKFLRPHQ
     REGVKFMYDC LMGLARPTIE NPDIDCTTKS LVLENDSDIS GCLLADDMGL GKTLMSITLI
     WTLIRQTPFA SKVSCSQSGI PLTGLCKKIL VVCPVTLIGN WKREFGKWLN LSRIGVLTLS
     SRNSPDMDKM AVRNFLKVQR TYQVLIIGYE KLLSVSEELE KNKHLIDMLV CDEGHRLKNG
     ASKILNTLKS LDIRRKLLLT GTPIQNDLNE FFTIIDFINP GILGSFASFK RRFIIPITRA
     RDTANRYNEE LLEKGEERSK EMIEITKRFI LRRTNAILEK YLPPKTDIIL FCKPYSQQIL
     AFKDILQGAR LDFGQLTFSS SLGLITLLKK VCNSPGLVGS DPYYKSHIKD TQSQDSYSRS
     LNSGKLKVLM TLLEGIRKGT KEKVVVVSNY TQTLDIIENL MNMAGMSHCR LDGSIPAKQR
     DSIVTSFNRN PAIFGFLLSA KSGGVGLNLV GRSRLILFDN DWNPSVDLQA MSRIHRDGQK
     KPCFIYRLVT TGCIDEKILQ RQLMKNSLSQ KFLGDSEMRN KESSNDDLFN KEDLKDLFSV
     HTDTKSNTHD LICSCDGLGE EIEYPETNQQ QNTVELRKRS TTTWTSALDL QKKMNEAATN
     DDAKKSQYIR QCLVHYKHID PARQDELFDE VITDSFTELK DSITFAFVKP GEICLREQ
>P38114 nuc PUTATIVE 126.9 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN YSW1-RIB7
     MNMDSGITSS HGSMDKTQKQ SSEWAANQKH NQRVENTRVL MGPAVPAMPP VPSNFPPVPT
     GTIMSPQLSP FPDHRLRHHP LAHMMPADKN FLAYNMESFK SRVTKACDYC RKRKIRCTEI
     EPISGKCRNC IKYNKDCTFH FHEELKRRRE EALNNKGNGK SVKKPRLDKE NKFKDENFDI
     AVRSRNTSST DSSPKLHTNL SQEYIGVSAG KSASDKEDTW PDFVPIDRTV LEKIELNHTK
     VAGKVFVLEE ICKNMKGTIE KLAEKSKIDV IDKEYMKRPK RKQYSKALLT KQKMFHFRQN
     VLSHLTDEEF LSPINEMFTT TFKYSILQTK LVLDFSFRSA SSPSSDNILY PLPRLAIAKR
     LLKNIKCPSL ASLLHIVDVD QCLQFADVHF DPAKGRLTSS QAFLLNICLC LGATVTNFEE
     KQELVDEDNH ETYYFEKFEL WRLRSFTFLN SVYYYHKLSV ARADMTALKA LLLLAKFAQQ
     KISASSAVKV LSVAIKVALD LRLNLHSTYE DLELDEIIKR RRLWCYCFST DKFFSVVLSR
     PPFLKEENTD VLTDESYVEL FRDKILPNLS IKYDDSKLEG VKDIVSVVNL LANHLEYVPY
     IQSYFLSRLS LIESQIYYSC FSIRTTLDDT LDEIIENVLE NQKALDRMRD DLPTILSLEN
     YKENMRILSL DSSKLDFEVS CCTTILLHLR WYHQKITLSL FVISIIGDNL DQRESSRHDI
     AEIIRRSRLD FKRNCIEVLN ILKDFEYYPT VQNEFLYFSL TTVFSMFLYL SEIMVNDEHA
     METGYIIGLL RDTHTRMLGS EERCLSVHNL KWQTSLFFYT FFLRSTMEKF NLTSKYAKFY
     AFDSNYYEGV LNRLVKHTRE SKDDMVELLK TSFINKEKMA AFGSFVTEDQ EKMEVSFNIF
     NEITIQDLNF LQFSSIPKLW ENKTLEPGEE YHHSNGTNTD NNETTGADDT DDNNNNNNNN
     NKNGNNSSST INNNNNNYSN SNNNDNDNNI NDDDDDDDDD DDDDDDDDDD DDNDDDYSNN
     GADDDEEDDD YDRSLFPTGL ASLLDASYPE RTANDYRDEN EQSNKLFEKI EGHLEHGVFF
     YDRDFFFKNV CVKM
>P38128 nuc HYPOTHETICAL 49.4 KD PROTEIN IN RPS101-MBA1 INTERGENIC REGION.
     MGRRKIEIEP IKDDRNRTVT FIKRKAGLFK KAHELSVLCQ VDIAVIILGS NNTFYEYSSV
     DMSNLLNVHQ NNTDLPHNII EPSDYGDYVK KPRVVLNERK RRRRRATVLQ PASHSGSCTV
     SSQDSSSVQN NGNLSAPLAS NDAGNAGVST PLVHCHGAIS RSGSNHSDCA RNSADYQMLQ
     GGLNSGGSFH ANDYKESVDQ QHVANEAIHR NFMNKRIRPD THLLLSESNH SNYHNFYPSP
     YENLPKPSLP ASLVGNIPSF QSQFVQVIPA NSNPMGKGFN GTGDSESFEA KQKIHPTVAI
     SNTLEGPAPV QAMVHHLHQL NSNRGKLSGK PYLKLNIPKA TNDACQRSPA MYSGTASPKT
     DVQATPNQML ASNMSSPLSR SKFLGFKNND MDDLYHNGRC GSTYVNNKTF FLKPPIGRPP
     KFPKSPSSSI VVFPSSVASS TLKSTSSTNS PD
>P38132 nuc CELL DIVISION CONTROL PROTEIN 47.
     MSAALPSIQL PVDYNNLFNE ITDFLVTFKQ DTLSSDATRN ENEDENLDAE NIEQHLLEKG
     PKYMAMLQKV ANRELNSVII DLDDILQYQN EKFLQGTQAD DLVSAIQQNA NHFTELFCRA
     IDNNMPLPTK EIDYKDDVLD VILNQRRLRN ERMLSDRTNE IRSENLMDTT MDPPSSMNDA
     LREVVEDETE LFPPNLTRRY FLYFKPLSQN CARRYRKKAI SSKPLSVRQI KGDFLGQLIT
     VRGIITRVSD VKPAVEVIAY TCDQCGYEVF QEVNSRTFTP LSECTSEECS QNQTKGQLFM
     STRASKFSAF QECKIQELSQ QVPVGHIPRS LNIHVNGTLV RSLSPGDIVD VTGIFLPAPY
     TGFKALKAGL LTETYLEAQF VRQHKKKFAS FSLTSDVEER VMELITSGDV YNRLAKSIAP
     EIYGNLDVKK ALLLLLVGGV DKRVGDGMKI RGDINVCLMG DPGVAKSQLL KAICKISPRG
     VYTTGKGSSG VGLTAAVMKD PVTDEMILEG GALVLADNGI CCIDEFDKMD ESDRTAIHEV
     MEQQTISISK AGINTTLNAR TSILAAANPL YGRYNPRLSP LDNINLPAAL LSRFDILFLM
     LDIPSRDDDE KLAEHVTYVH MHNKQPDLDF TPVEPSKMRE YIAYAKTKRP VMSEAVNDYV
     VQAYIRLRQD SKREMDSKFS FGQATPRTLL GIIRLSQALA KLRLADMVDI DDVEEALRLV
     RVSKESLYQE TNKSKEDESP TTKIFTIIKK MLQETGKNTL SYENIVKTVR LRGFTMLQLS
     NCIQEYSYLN VWHLINEGNT LKFVDDGTMD TDQEDSLVST PKLAPQTTAS ANVSAQDSDI
     DLQDA
>P38140 nuc PUTATIVE 60.3 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN PRP5-ALG7
     MCTPDENDYK TSTDPDTSAN TNHTLEKKKR KKRKNTNVAC VNCSRLHVSC EAKRPCLRCI
     SKGLTATCVD APRKKSKYLA GIPNRELPMN IQPDLPPRKI MIPIYNNSSN SSLNVNNMGE
     QQKFTSPQHI VHKAKFLSNA ADSEYSILSN IIYQDTLSNK IPIDILYSNT NSTSNSTIGN
     SSNNSPTGTN TSPEETEMEK IRQLYSEQRA NIPPHPYPSS NQNVYSILLG PNSAKIVASQ
     VNLFANHFPL VPVDSADNSL NFKRLLPRDP SEKSSQINWD SSINQYYLNS ETVTFPELAI
     PLKRRKNHLV SVSLESCSPD AANIKSNVEW EHSLRYSTPM EIYTSINAPF SHTPGFHHLL
     VYLKHRFNQQ DLVKMCRSIA EFRPIFIACS VTLTEEDMIF MEQCYQRTLL EYVKFIAQIG
     TPTCIWRRNG QISYVNEEFE ILCGWTREEL LNKMTFIVEI MDDESVRDYF KTLSKVAYRD
     FRGSEKMKVC RLLSPIKGKI IHCCCMWTLK RDVSGLPLMI LGNFMPILN
>P38141 nuc PUTATIVE 51.8 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN PRP5-ALG7
     MVNSKRQQRS KKVASSSKVP PTKGRTFTGC WACRFKKRRC DENRPICSLC AKHGDNCSYD
     IRLMWLEENI YKVRKHSLIS SLQARKSKSK PLCQKISKSR FKQMTHFRQL SPPTSDCEDS
     VHEASKETTL PNDNTFTISV RRLKIYNNAV ASVFGSMTNR DYTQKRIDKK LDELLNMVEN
     DISVVNLNCS KHGPYSVFRA NPAAVTSALT DQLPSPGHSM SSAEETTTAA LSSPPEDSTS
     LIDIIQGKIF GILWFNCYGN MILNRQEYTT WFINKMRNSL TTEFIRFLGK IIDDPDINMA
     SCLFKECIAR WSCVDWQSIA ITMLVIIHGY TCPNLTKLLR VWFLQQKLLR FSMYPLVNFI
     INNTQDLDVL YHCNGLLGNA DLFEDPYQDE LTSELHVLVT ERLVNSWKDT ILQQLCSCQD
     TTLSCSQLRY WQLQLKCNQQ FYKDVYAMQD
>P38144 nuc HYPOTHETICAL 131.1 KD HELICASE IN ALG7-ENP1 INTERGENIC REGION.
     MAYMLAIANF HFFKFYTRMR KKHENNSCNE KDKDENLFKI ILAIFLQEKK KYDCISSGSI
     MTASEEYLEN LKPFQVGLPP HDPESNKKRY LLKDANGKKF DLEGTTKRFE HLLSLSGLFK
     HFIESKAAKD PKFRQVLDVL EENKANGKGK GKHQDVRRRK TEHEEDAELL KEEDSDDDES
     IEFQFRESPA YVNGQLRPYQ IQGVNWLVSL HKNKIAGILA DEMGLGKTLQ TISFLGYLRY
     IEKIPGPFLV IAPKSTLNNW LREINRWTPD VNAFILQGDK EERAELIQKK LLGCDFDVVI
     ASYEIIIREK SPLKKINWEY IIIDEAHRIK NEESMLSQVL REFTSRNRLL ITGTPLQNNL
     HELWALLNFL LPDIFSDAQD FDDWFSSEST EEDQDKIVKQ LHTVLQPFLL RRIKSDVETS
     LLPKKELNLY VGMSSMQKKW YKKILEKDLD AVNGSNGSKE SKTRLLNIMM QLRKCCNHPY
     LFDGAEPGPP YTTDEHLVYN AAKLQVLDKL LKKLKEEGSR VLIFSQMSRL LDILEDYCYF
     RNYEYCRIDG STAHEDRIQA IDDYNAPDSK KFVFLLTTRA GGLGINLTSA DVVVLYDSDW
     NPQADLQAMD RAHRIGQKKQ VKVFRLVTDN SVEEKILERA TQKLRLDQLV IQQNRTSLKK
     KENKADSKDA LLSMIQHGAA DVFKSGTSTG SAGTPEPGSG EKGDDIDLDE LLLKSENKTK
     SLNAKYETLG LDDLQKFNQD SAYEWNGQDF KKKIQRDIIS PLLLNPTKRE RKENYSIDNY
     YKDVLNTGRS STPSHPRMPK PHVFHSHQLQ PPQLKVLYEK ERMWTAKKTG YVPTMDDVKA
     AYGDISDEEE KKQKLELLKL SVNNSQPLTE EEEKMKADWE SEGFTNWNKL EFRKFITVSG
     KYGRNSIQAI ARELAPGKTL EEVRAYAKAF WSNIERIEDY EKYLKIIENE EEKIKRVKMQ
     QEALRRKLSE YKNPFFDLKL KHPPSSNNKR TYSEEEDRFI LLMLFKYGLD RDDVYELVRD
     EIRDCPLFEL DFYFRSRTPV ELARRGNTLL QCLEKEFNAG IVLDDATKDR MKKEDENGKR
     IREEFADQTA NEKENVDGVE SKKAKIEDTS NVGTEQLVAE KIPENETTH
>P38151 nuc HYPOTHETICAL 45.8 KD PROTEIN IN PCS60-ABD1 INTERGENIC REGION.
     MSTETTKPSI TTTPTTVLVS PNTLKRKKGE DTSEEQLEAE IKRVALKDAD SHSDNDHDSP
     DNVPSDVHLR MLCLVKHASL IVGHKGATIS RIKSETSARI NISNNIRGVP ERIVYVRGTC
     DDVAKAYGMI VRALLEEHGN EDNGEDIEIS INLLIPHHLM GCIIGKRGSR LREIEDLSAA
     KLFASPNQLL LSNDRILTIN GVPDAIHIAT FYISQTLLNF QMESPQKNVK RSIYYQPTQF
     NSVLIDHSQP NTIFHQRNHQ YHPSDKLLSY KPNKNLPISS TLLSMATPQY TTASVANATA
     FQPNFVIPNV TVLDGPVISP APGNHLLMNF VQQEIFIDEK FVGNVIGKDG KHINSVKEST
     GCSIIIQDPV EGSSERRLTI RGTFMASQAA IMLISNKIEI DRSNAERKRR SPL
>P38165 nuc RETROGRADE REGULATION PROTEIN 3.
     MMNNNESEAE NQRLLDELMN QTKVLQETLD FSLVTPTPHH NDDYKIHGSA YPGGETPAQQ
     HEKLSYINTH NSNDNNNLMG SQARSNSQTP TASTIYEEAE SQSSYLDDMF RTSQGGRPVT
     QNSISSIGQG PLRSSYSMAY DSPVDRAMNT PLQQQEGLKA ELPHDFLFQH GTDDTMYNLT
     DDLSSSLSSS INSDMMTPNT YSSSFSYNPQ SLGPASVSST YSPKVRSPSS SFRAGSFLSS
     SFRHGSINTP RTRHTSISSN MTENIGPGSV PKILGGLTSD EKLRRKREFH NAVERRRREL
     IKQKIKELGQ LVPPSLLNYD DLGKQIKPNK GIILDRTVEY LQYLAEILEI QARKKKALLA
     KIKELEEKKS SVAALSPFTN NHHASSGQNN SENSEERIID IRSVPNALMN EQNSKAELHN
     WEPPLYDSVG NHNHAGTMES HPHTNIHEEL KEFLSGDLIE AEDNAKLMFG DDNSNPADYL
     LEFGSG
>P38204 nuc RNA POLYMERASE I SPECIFIC TRANSCRIPTION INITIATION FACTOR RRN10.
     MDRNVYEACS NIIKEFGTHV VSADEVLAEK IDNAVPIPFK TREEIDADVE KDRNEGVFEG
     NIIPDIDLRV VHYYATQLCL NKYPHLINAF DETSLITLGL LIEKWVKDYL TSIQTEQGRQ
     SKVIGKGPCE FISKHIDYRH APGNI
>P38251 nuc ACTIVATOR 1 SUBUNIT 5 (REPLICATION FACTOR C SUBUNIT 5).
     MSLWVDKYRP KSLNALSHNE ELTNFLKSLS DQPRDLPHLL LYGPNGTGKK TRCMALLESI
     FGPGVYRLKI DVRQFVTASN RKLELNVVSS PYHLEITPSD MGNNDRIVIQ ELLKEVAQME
     QVDFQDSKDG LAHRYKCVII NEANSLTKDA QAALRRTMEK YSKNIRLIMV CDSMSPIIAP
     IKSRCLLIRC PAPSDSEIST ILSDVVTNER IQLETKDILK RIAQASNGNL RVSLLMLESM
     ALNNELALKS SSPIIKPDWI IVIHKLTRKI VKERSVNSLI ECRAVLYDLL AHCIPANIIL
     KELTFSLLDV ETLNTTNKSS IIEYSSVFDE RLSLGNKAIF HLEGFIAKVM CCLD
>P38629 nuc ACTIVATOR 1 40 KD SUBUNIT (REPLICATION FACTOR C 40 KD SUBUNIT).
     MSTSTEKRSK ENLPWVEKYR PETLDEVYGQ NEVITTVRKF VDEGKLPHLL FYGPPGTGKT
     STIVALAREI YGKNYSNMVL ELNASDDRGI DVVRNQIKDF ASTRQIFSKG FKLIILDEAD
     AMTNAAQNAL RRVIERYTKN TRFCVLANYA HKLTPALLSR CTRFRFQPLP QEAIERRIAN
     VLVHEKLKLS PNAEKALIEL SNGDMRRVLN VLQSCKATLD NPDEDEISDD VIYECCGAPR
     PSDLKAVLKS ILEDDWGTAH YTLNKVRSAK GLALIDLIEG IVKILEDYEL QNEETRVHLL
     TKLADIEYSI SKGGNDQIQG SAVIGAIKAS FENETVKANV
>P38630 nuc ACTIVATOR 1 95 KD SUBUNIT (REPLICATION FACTOR C 95 KD SUBUNIT)
     MVNISDFFGK NKKSVRSSTS RPTRQVGSSK PEVIDLDTES DQESTNKTPK KMPVSNVIDV
     SETPEGEKKL PLPAKRKASS PTVKPASSKK TKPSSKSSDS ASNITAQDVL DKIPSLDLSN
     VHVKENAKFD FKSANSNADP DEIVSEIGSF PEGKPNCLLG LTIVFTGVLP TLERGASEAL
     AKRYGARVTK SISSKTSVVV LGDEAGPKKL EKIKQLKIKA IDEEGFKQLI AGMPAEGGDG
     EAAEKARRKL EEQHNIATKE AELLVKKEEE RSKKLAATRV SGGHLERDNV VREEDKLWTV
     KYAPTNLQQV CGNKGSVMKL KNWLANWENS KKNSFKHAGK DGSGVFRAAM LYGPPGIGKT
     TAAHLVAQEL GYDILEQNAS DVRSKTLLNA GVKNALDNMS VVGYFKHNEE AQNLNGKHFV
     IIMDEVDGMS GGDRGGVGQL AQFCRKTSTP LILICNERNL PKMRPFDRVC LDIQFRRPDA
     NSIKSRLMTI AIREKFKLDP NVIDRLIQTT RGDIRQVINL LSTISTTTKT INHENINEIS
     KAWEKNIALK PFDIAHKMLD GQIYSDIGSR NFTLNDKIAL YFDDFDFTPL MIQENYLSTR
     PSVLKPGQSH LEAVAEAANC ISLGDIVEKK IRSSEQLWSL LPLHAVLSSV YPASKVAGHM
     AGRINFTAWL GQNSKSAKYY RLLQEIHYHT RLGTSTDKIG LRLDYLPTFR KRLLDPFLKQ
     GADAISSVIE VMDDYYLTKE DWDSIMEFFV GPDVTTAIIK KIPATVKSGF TRKYNSMTHP
     VAIYRTGSTI GGGGVGTSTS TPDFEDVVDA DDNPVPADDE ETQDSSTDLK KDKLIKQKAK
     PTKRKTATSK PGGSKKRKTK A
>P38682 nuc ZINC FINGER PROTEIN GLO3.
     MSNDEGETFA TEQTTQQVFQ KLGSNMENRV CFDCGNKNPT WTSVPFGVML CIQCSAVHRN
     MGVHITFVKS STLDKWTINN LRRFKLGGNH KARDFFLKNN GKQLLNTANV DAKTKYTSPV
     AKKYKIHLDK KVQKDMELYP SELVLNGQDS SDSPLDTDSD ASRSTSKENS VDDFFSNWQK
     PSSNSSSKLN VNTGSLAPKN NTTGSTPKTT VTKTRSSILT ASRKKPVLNS QDKKKHSILS
     SSRKPTRLTA KKVDKSQAED LFDQFKKEAQ QEKEDEFTNS SSSTKIRQND YDSQFMNNSK
     GNNNNSIDDI NTQPDEFNDF LNDTSNSFDT TRKEQQDTLT PKFAKLGFGM TMNDANDLAK
     QQKESQKIAQ GPRYTGRIAE RYGTQKAISS DQLFGRGSFD EAANREAHDK LKTFDNATSI
     SSSSYFGEDK EVDEFGNPIN SSGSGAGNFD GRNSNNGFID FNASADDELQ MLRDVVEQGA
     EKLGSYLRDY LRK
>P38699 nuc STB5 PROTEIN.
     MDGPNFAHQG GRSQRTTELY SCARCRKLKK KCGKQIPTCA NCDKNGAHCS YPGRAPRRTK
     KELADAMLRG EYVPVKRNKK VGKSPLSTKS MPNSSSPLSA NGAITPGFSP YENDDAHKMK
     QLKPSDPINL VMGASPNSSE GVSSLISVLT SLNDNSNPSS HLSSNENSMI PSRSLPASVQ
     QSSTTSSFGG YNTPSPLISS HVPANAQAVP LQNNNRNTSN GDNGSNVNHD NNNGSTNTPQ
     LSLTPYANNS APNGKFDSVP VDASSIEFET MSCCFKGGRT TSWVREDGSF KSIDRSLLDR
     FIAAYFKHNH RLFPMIDKIA FLNDAATITD FERLYDNKNY PDSFVFKVYM IMAIGCTTLQ
     RAGMVSQDEE CLSEHLAFLA MKKFRSVIIL QDIETVRCLL LLGIYSFFEP KGSSSWTISG
     IIMRLTIGLG LNRELTAKKL KSMSALEAEA RYRVFWSAYC FERLVCTSLG RISGIDDEDI
     TVPLPRALYV DERDDLEMTK LMISLRKMGG RIYKQVHSVS AGRQKLTIEQ KQEIISGLRK
     ELDEIYSRES ERRKLKKSQM DQVERENNST TNVISFHSSE IWLAMRYSQL QILLYRPSAL
     MPKPPIDSLS TLGEFCLQAW KHTYTLYKKR LLPLNWITLF RTLTICNTIL YCLCQWSIDL
     IESKIEIQQC VEILRHFGER WIFAMRCADV FQNISNTILD ISLSHGKVPN MDQLTRELFG
     ASDSYQDILD ENNVDVSWVD KLV
>P38704 nuc PUTATIVE 60.8 KD ZINC FINGER PROTEIN IN GPA1-ERG11 INTERGENIC REGION.
     MPILSLSSTR NSVLTRIYDY LKALVQQVIV PNVEDDKSSK STPFEKLEPA KQNHPQKDCC
     ATEKDDLVDV SELFPKQNNK QLSLTSKSSV VPCALNLDNL ETPFSIKIDN NGAVTTQLNL
     DEPILRGPSR GEPAKLQNDL ISSPPLEESY INNDQYKALF PSNFLPITPV SSVITPASKK
     SIDESPLSDE VQGIADESSE TLPYICHYCD ARFRIRGYLT RHIKKHAKRK AYHCPFFDNS
     ISQELRCHTS GGFSRRDTYK THLKSRHFTY PEGVKPQDRN KSPGVCTQCG EHFSTSESWV
     ENHIEAGSCK GLPEGYSEGI REKKKTSKMK MIKTSDGQTR FISSDESVSE PALQNKNCIE
     ATVMQSKERP NDKIIPTKTE KNDFGIGTQW FERKQISRPT QTTQSRGPTE VQNLKEWSII
     SPPILSPQNA SSVPQEYQSS RYTLHMDSPA LSSASSALSP LSGDPITTTE TNKSYPLDSE
     QSLLEPDKTE EDAINQSKES NMISINEMLQ KQMDFELLGE NHLKETQDYL ALYKKAYGIE
     F
>P38749 nuc HYPOTHETICAL 38.0 KD PROTEIN IN PRPS4-STE20 INTERGENIC REGION.
     MTPSNMDDNT SGFMKFINPQ CQEEDCCIRN SLFQEDSKCI KQQPDLLSEQ TAPFPILEDQ
     CPALNLDRSN NDLLLQNNIS FPKGSDLQAI QLTPISGDYS TYVMADNNNN DNDSYSNTNY
     FSKNNGISPS SRSPSVAHNE NVPDDSKAKK KAQNRAAQKA FRERKEARMK ELQDKLLESE
     RNRQSLLKEI EELRKANTEI NAENRLLLRS GNENFSKDIE DDTNYKYSFP TKDEFFTSMV
     LESKLNHKGK YSLKDNEIMK RNTQYTDEAG RHVLTVPATW EYLYKLSEER DFDVTYVMSK
     LQGQECCHTH GPAYPRSLID FLVEEATLNE
>P38781 nuc PUTATIVE 101.3 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN CUP1-CPR2
     MMDMQVRKVR KPPACTQCRK RKIGCDRAKP ICGNCVKYNK PDCFYPDGPG KMVAVPSASG
     MSTHGNGQGS NHFSQGNGVN QKNVMIQTQY PIMQTSIEAF NFSFNPSVDT AMQWTKAASY
     QNNNTNNNTA PRQNSSTVSS NVHGNTIVRS DSPDVPSMDQ IREYNTRLQL VNAQSFDYTD
     NPYSFNVGIN QDSAVFDLMT SPFTQEEVLI KEIDFLKNKL LDLQSLQLKS LKEKSNLNAD
     NTTANKINKT GENSKKGKVD GKRAGFDHQT SRTSQSSQKY FTALTITDVQ SLVQVKPLKD
     TPNYLFTKNF IIFRDHYLFK FYNILHDICH INQFKVSPPN NKNHQQYMEV CKVNFPPKAI
     IIETLNSESL NNLNIEEFLP IFDKTLLLEF VHNSFPNGDT CPSFSTVDLP LSQLTKLGEL
     TVLLLLLNDS MTLFNKQAIN NHVSALMNNL RLIRSQITLI NLEYYDQETI KFIAITKFYE
     SLYMHDDHKS SLDEDLSCLL SFQIKDFKLF HFLKKMYYSR HSLLGQSSFM VPAAENLSPI
     PASIDTNDIP LIANDLKLLE TQAKLINILQ GVPFYLPVNL TKIESLLETL TMGVSNTVDL
     YFHDNEVRKE WKDTLNFINT IVYTNFFLFV QNESSLSMAV QHSSNNNKTS NSERCAKDLM
     KIISNMHIFY SITFNFIFPI KSIKSFSSGN NRFHSNGKEF LFANHFIEIL QNFIAITFAI
     FQRCEVILYD EFYKNLSNEE INVQLLLIHD KILEILKKIE IIVSFLRDEM NSNGSFKSIK
     GFNKVLNLIK YMLRFSKKKQ NFARNSDNNN VTDYSQSAKN KNVLLKFPVS ELNRIYLKFK
     EISDFLMERE VVQRSIIIDK DLESDNLGIT TANFNDFYDA FYN
>P38889 nuc PUTATIVE TRANSCRIPTION FACTOR SKN7 (POS9 PROTEIN).
     MSFSTINSNV NKTTGDSNNN TTENSSTADL LGMDLLQSGP RLMNTMQPNN SSDMLHINNK
     TNNVQQPAGN TNISSANAGA KAPANEFVRK LFRILENNEY PDIVTWTENG KSFVVLDTGK
     FTTHILPNHF KHSNFASFVR QLNKYDFHKV KRSPEERQRC KYGEQSWEFQ HPEFRVHYGK
     GLDNIKRKIP AQRKVLLDES QKALLHFNSE GTNPNNPSGS LLNESTTELL LSNTVSKDAF
     GNLRRRVDKL QKELDMSKME SYATKVELQK LNSKYNTVIE SLITFKTINE NLLNNFNTLC
     STLANNGIEV PIFGDNGNRN PTGNTNPATT TAIQSNNNTN NASPATSTVS LQLPNLPDQN
     SLTPNAQNNT VTLRKGFHVL LVEDDAVSIQ LCSKFLRKYG CTVQVVSDGL SAISTLEKYR
     YDLVLMDIVM PNLDGATATS IVRSFDNETP IIAMTGNIMN QDLITYLQHG MNDILAKPFT
     RDDLHSILIR YLKDRIPLCE QQLPPRNSSP QTHSNTNTAN SNPNTINEQS LAMLPQDNPS
     TTTPVTPGAS ISSAQHVQQG QQEQQHQIFH AQQQQQHHNA IANARSDVAI PNLEHEINTV
     PHSSMGSTPQ LPQSTLQENQ LS
>P38904 nuc SPP41 PROTEIN.
     MAYDEDDGEI NFNELVGNLL SSHNQEGQEE GEVQGGEQEG DDFEKIYPTS ENIEPKHPDD
     SQHMHNSPDQ NIEIPHFVDE EDELVSVVAN AVQNIDDEQA KPENHLENGS EHVTSDTADD
     NHEKEQQQEW AHILQQEILK SDGEPLRENT ERRVSTSQHH PSQRTDDALD QDDENLRMAI
     LESLQELNTN EEEEKEPEKH EHAAPNDKLS SKKSSKKKKK DKSKNRESSK DKSSKKSKSS
     SHSKKHAKDR NKEKQSKPTN NENTLDLSNI LENLIHENDN AAIDTAKQTV DIQDNSHTDN
     TNNEDVEAQA LVEATLKAFE NELLSSAPTE EPSQEQSIGP VSSRKAVEPP RKPTADDIPL
     AMLQAFKPKK RPPQEKKKTK SKTSKAASTA NKSPASESTS KKKKKKKTVK ESNKSQEAYE
     DDEFSRILAD MVNQVVNTSL KETSTHTATQ DNKLESESDF TSPVQSQYTT EDASTANDDS
     LDLNQIMQNA MAMVFQNQND DEFDENIVED FNRGLGDLSV SDLLPHDNLS RMEKKSVPKS
     SSKSEKKTAI SRRASKKASR DASSVELTEV PSKPKKPSKT EVSLEKKLRK KYVSIANEAA
     SVARKKRWAK NKELKEKEKL ERQTAREERR HKKKLEKQRL AEEQEELKKI VERGPPYPPD
     LRLTKSGKPK KPYRRWTPEE LLKRSQEAEK PRKVKKERKK KEKKMKVPSS ALKKIPLFNF
     VKGNVQPSAR HRLNDIEGSL STIGLHKSPD GVRRILSRPK SEDHEWPLSD SSASQNYDAH
     LKTVVHKEKI PFHPPWTIPS QPPFALPVAR RKKIPNIKKY RKRTNNSFRV SKEGTASTRN
     RILPAILLPI INTLKAAAKS QTAAGATPEE ARKRLATIIQ HAKSTVIRAA LQARKNSMQA
     AHSKGTTTEL ATTASRMKNP LKMIPIFNTS RVKQQLDKQL PARSAGTEIS SSESPDKATP
     DPHSNSTIAG HTLKGVTTPI KIEDSDANVP PVSIAVSTIE PSQDKLELTK RAESVEPVEN
     NVETAKETQS VQEIKENVGT KASEEVTLTE DKTNGDPKNE KRILIESPVE KTDKKKPGEK
     IATDLNEDAS LSDKKDGDEK STLHSDAAQL TGNEPDSVNT TTGKPKLIDV SLKPLNEAKP
     KIPIIFPLKR PQIKPEVSVI NLVQNLVNTK IPEIKNESVD LGSNITDILS STITNILPEI
     TATDVKNYQY EDENVKYLKK TPRQVLNLDG LVPPSGRCIT KAKRVRRIKK LSADATTAPE
     ADGKANSESI TYTFDIPSPE EVQSKRSVVL KFAKARLTEA ELSCLKKEIN NVRKRRWREM
     NSTKNWEYDV KSRLKKRANA FFGEGESETK SKWIEERFQE KVSQEKYKDR LETTETQANN
     TKIVIDDKEI LNILR
>P38922 nuc HRB1 PROTEIN (TOM34 PROTEIN).
     MSDDHGYERD NHLSRRSGNY NGRRKFADTY RGSRDRGEYR GGRERSDYRE RERFNNRDNP
     RSRDRYDDRR RGRDVTGRYG NRRDDYPRSF RSRHNTRDDS RRGGFGSSGA RGDYGPLLAR
     ELDSTYEEKV NRNYSNSIFV GNLTYDSTPE DLTEFFSQIG KVVRADIITS RGHHRGMGTV
     EFTNSDDVDR AIRQYDGAFF MDRKIFVRQD NPPPSNNIKE RKALDRGELR HNRKTHEVIV
     KNLPASVNWQ ALKDIFKECG NVAHADVELD GDGVSTGSGT VSFYDIKDLH RAIEKYNGYS
     IEGNVLDVKS KESVHNHSDG DDVDIPMDDS PVNEEARKFT ENVVGGGERN RLIYCSNLPF
     STAKSDLYDL FETIGKVNNA ELRYDSKGAP TGIAVVEYDN VDDADVCIER LNNYNYGGCD
     LDISYAKRL
>P38931 nuc SUPPRESSOR OF RNA POLYMERASE B SRB9 (SCA1 PROTEIN).
     MSSDASTYRL EDVLSSFYRV EKIKKINYHQ YISKAQNDQW SIQMEFMLRK QDPKTLVALL
     SRDLWCFSIN DDPVPTPPAI EHKPVSPDKI GTFTADYSKP NLPPHYALFL KALRRKIYIN
     LALGSHNKLI QFGNACISLS GVPNYLVQLE PHLFVNGDLT VSLCAKNMGL VPMKEENLEE
     SFLSKHALYL APSGIRMHLA PASKQGYLIT PPKHTELLLT TLSVSHGINL QNKKNLKWVA
     VVPDLGHLNG HTPTIASYLT PLLEAKKLVW PLHLIFAQPV ADIENSTSGD PSEFHCLQDA
     LDAIDDFIQL KQTAAYRTPG SSGVLSSNIA GTNPLSSDGA YTEQFQHYKN NSISSQPASY
     HSVQETNKIS PKDFSPNFTG IDKLMLSPSD QFAPAFLNTP NNNINENELF NDRKQTTVSN
     DLENSPLKTE LEANGRSLEK VNNSVSKTGS VDTLHNKEGT LEQREQNENL PSDKSDSMVD
     KELFGEDEDE DLFGDSNKSN STNESNKSIS DEITEDMFEM SDEEENNNNK SINKNNKEMH
     TDLGKDIPFF PSSEKPNIRT MSGTTKRLNG KRKYLDIPID EMTLPTSPLY MDPGAPLPVE
     TPRDRRKSVF APLNFNPIIE NNVDNKYKSG GKFSFSPLQK EEALNFDISM ADLSSSEEEE
     DEEENGSSDE DLKSLNVRDD MKPSDNISTN TNIHEPQYIN YSSIPSLQDS IIKQENFNSV
     NDANITSNKE GFNSIWKIPQ NDIPQTESPL KTVDSSIQPI ESNIKMTLED NNVTSNPSEF
     TPNMVNSEIS NLPKDKSGIP EFTPADPNLS FESSSSLPFL LRHMPLASIP DIFITPTPVV
     TISEKEQDIL DLIAEQVVTD YNILGNLGIP KIAYRGVKDC QEGLITTTML QLFSTFDRLN
     GNDTISKFYN MKQPYVFVKK HHELIKVKHD SQPFIKFLNF RPPNGIKNFK SLLLSSSFKE
     DCLSFAPTLS QTYINQELGF CELLKLTNED PPGLMYLKAF DKNKLLLLAA QIVSYCSNNK
     NSIKNVPPIL IILPLDNATL TELVDKANIF QVIKNEVCAK MPNIELYLKV IPMDFIRNVL
     VTVDQYVNVA ISIYNMLPPK SVKFTHIAHT LPEKVNFRTM QQQQMQQQQQ QQQQQQNNST
     GSSSIIYYDS YIHLAYSRSV DKEWVFAALS DSYGQGSMTK TWYVGNSRGK FDDACNQIWN
     IALNLASKKF GKICLILTRL NGILPDDELM NWRRLSGRNI HLAVVCVDDN SKISFIDEDK
     LYPSFKPIYK DTRFGGRMDM TRLYDYEIRD IDQDIHGIVF QHPFPLAHSQ HRCAIRSGAL
     IKFKKCDGDT VWDKFAVNLL NCPHSDSTQL LETILEEFRN LAALNVWYGL SDGEDGHIPW
     HILAVKKMMN TLVHTRVKIA NTSAATVHTA TSSSIILSDK
>P38953 nuc DNA REPAIR PROTEIN RAD55.
     MSLGIPLSQL IVESPKPLSS GITGLDEILN LGFQARSIYE IFGPPGIGKT NFGIQLVCNS
     LEGIQQSEIN DDKILWIETF QEMPINILRE RFQKFKIVEE NVKRVRITKF GQLLYFFQNL
     FKLSQSVRYK LVIIDGFSQL VCDHLCTLSK RGGGMIDKTI HELKCRHLIL IFTVMTKYTH
     STGSTIIVLN DCMNTAFQSN EFESLEEYYE ILDDGSNFFV NSNNERRKNN VHILKSALVA
     NIAMGSKDST WEVFLRDRIG LFRDWNEQVD ETVFVKSKRV KASSSQSNEG CTTIKEMRIN
     KRNFENLRIA IVFNLHGEDR KREGRNLKRS RSSDDRNYIV KFDFDKATGQ LRDIIDLKPD
     TANIASFPTL STSSSSCSQV FNNIDSNDNP LPNAEGKEEI IYDSEG
>P38956 nuc TRANSCRIPTION REGULATORY PROTEIN SNF11 (SWI/SNF COMPLEX COMPONENT
     MSSEIAYSNT NTNTENENRN TGAGVDVNTN ANANANATAN ATANATANAT AELNLPTVDE
     QRQYKVQLLL HINSILLARV IQMNNSLQNN LQNNINNSNN NNIIRIQQLI SQFLKRVHAN
     LQCISQINQG VPSAKPLILT PPQLANQQQP PQDILSKLYL LLARVFEIW
>P39073 nuc MEIOTIC MRNA STABILITY PROTEIN KINASE UME5 (EC 2.7.1.-).
     MYQRPMQVQG QQQAQSFVGK KNTIGSVHGK APMLMANNDV FTIGPYRARK DRMRVSVLEK
     YEVIGYIAAG TYGKVYKAKR QINSGTNSAN GSSLNGTNAK IPQFDSTQPK SSSSMDMQAN
     TNALRRNLLK DEGVTPGRIR TTREDVSPHY NSQKQTLIKK PLTVFYAIKK FKTEKDGVEQ
     LHYTGISQSA CREMALCREL HNKHLTTLVE IFLERKCVHM VYEYAEHDLL QIIHFHSHPE
     KRMIPPRMVR SIMWQLLDGV SYLHQNWVLH RDLKPANIMV TIDGCVKIGD LGLARKFHNM
     LQTLYTGDKV VVTIWYRAPE LLLGARHYTP AVDLWSVGCI FAELIGLQPI FKGEEAKLDS
     KKTVPFQVNQ LQRILEVLGT PDQKIWPYLE KYPEYDQITK FPKYRDNLAT WYHSAGGRDK
     HALSLLYHLL NYDPIKRIDA FNALEHKYFT ESDIPVSENV FEGLTYKYPA RRIHTNDNDI
     MNLGSRTKNN TQASGITAGA AANALGGLGV NRRILAAAAA AAAAVSGNNA SDEPSRKKNR
     R
>P39520 nuc IFH1 PROTEIN (RRP3 PROTEIN).
     MAGKKSPRKS TINHSTHSGK LPANIKRLIK KGESDTKSRQ SPPTLSTTRP RRFSLIYSSE
     SSLSDVSDSD KNKSTNPHKI KRKAKNISNN SQGKKSKLIQ RQIDNDDEGT ESSDYQAVTD
     GEESENEEEE SEEEEEDDDE DDDDDDDDGS DSDSDSETSS DDENIDFVKL TAQRKKRAMK
     ALSAMNTNSN TLYSSRENSN KNKSVKLSPK KENEEEQKEE KEKEKEEQQK QQESNKKEVN
     GSGTTTTQQA LSFKFKKEDD GISFGNGNEG YNEDIGEEVL DLKNKENNGN EEDKLDSKVM
     LGNNDELRFP NISESDESEY DIDQDAYFDV INNEDSHGEI GTDLETGEDD LPILEEEEQN
     IVSELQNDDE LSFDGSIHEE GSDPVEDAEN KFLQNEYNQE NGYDEEDDEE DEIMSDFDMP
     FYEDPKFANL YYYGDGSEPK LSLSTSLPLM LNDEKLSKLK KKEAKKREQE ERKQRRKLYK
     KTQKPSTRTT SNVDNDEYIF NVFFQSDDEN SGHKSKKGRH KSGKSHIEHK NKGSNLIKSN
     DDLEPSTHST VLNSGKYDSS DDEYDNILLD VAHMPSDDEC SESETSHDAD TDEELRALDS
     DSLDIGTELD DDYEDDDDDS SVTNVFIDID DLDPDSFYFH YDSDGSSSLI SSNSDKENSD
     GSKDCKHDLL ETVVYVDDES TDEDDNLPPP SSRSKNIGSK AKEIVSSNVV GLRPPKLGTW
     ETDNKPFSII DGLSTKSLYA LIQEHQQLRE QHQRAQTPDV KREGSSNGNN GDELTLNELL
     NMSELEDDSP SHTDDMENNY NDAINSKSTN GHAADWYEVP KVPLSAFRNK GINAYEEDEY
     MIPANSNRKV PIGYIGNERT RKKIDKMKEL QRKKTEKKRQ LKKKKKLLKI RKQRQKAIKE
     QETMNLQLGI NGHEIIGNNN SHSDINTGTD FTTNENTPMN ELPSHAPEDA SLIPHNSDLA
     VDSNTRKNST KSVGLDEIHE ILGKDENDLL SVGDINGYDA QEGHVIEDTD ADILASLTAP
     VQFDNTLSHE NSNSMWRRRQ SMVEAAAENL RFTKNGLFSE SALADIEGIM GNDVNHSFEF
     NDVLQ
>P39521 nuc PRE-RRNA PROCESSING PROTEIN FHL1.
     MDGEMAIIES SNHVGTSSPT TETQFTIDSS ALKDQETKES ITNSPTSEVP IETKLPKSSD
     IVTEEKHPQN TTTDIENEVE NPVTDDNGNL KLELPDNLDN ADFSKLLEFD AKNDEALFNS
     NELLSHTMDP VNNIDLTHDH SREVSSKEDI NIEPVNPDED EREKTQDNTA AVKTEGIRNS
     EDTSIQKDEP TADAIYTDVH KLSVNKDTET LPTLVDEKNN MLHMRNNSIT PIMFQQHELV
     GQPPQNTVTE NNSTDAETTQ RKLSEPIDAS LPLPNEQPTI FAYARLDFQS FTFYVQTLHA
     IIGRRSENDF SHKVDVNLGP SKSISRRHAQ IFYNFGTGRF ELSIIGKNGA FVDDIFVEKG
     NTVPLRNKTK IQIGQIPFQF ILPEQERNDD SKSPENADIA ESEINTRNLK KNEPKSKKKI
     TTGAKPKKAQ TKPAVKKEKK PPKIPKKVYT LEEIPVEYRT KPTVSYSAML TTCIRKYSTA
     KGMSLSEIYA GIRELFPYYK YCPDGWQSSV RHNLSLNKSF RKVSKEGKGW LWGLDEEYIA
     ERERQKKKQS EIAVAKAQAA QLKLEQQQHK LQQVPQRGKK DIVSQRSNVN ARKQNISQTL
     AANRAASNRK NTASDNQRTM KYLQEQLVIL TRDRKGLSKQ VIAAILTQAL AMTINQVTQA
     AKNKGITGNP LTALMDKNPQ HLNLILAAAV NAATAKVTKG EVKQLVNPET TAAAALAAKA
     QHSKPIRQPI VQTPHVPDRP PSQLSASASS HPNNYLHDKQ PGSFDPSSLS RFFQPRQNAR
     ATSSVAATSV PAAASQNVDA QPKPKPAQDN DLESESGTSS SSSSSSESGS ESDSGSDDGS
     ASGSGDNSST SSESESESDS GSEVDEKNNK NEKIDSESIK NNESKDDIPS KDENSSNDNR
     EISKTDEEGH DSKRRKVSED INEGITEVNV SLEEKL
>P39529 nuc PUTATIVE 86.7 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN NUC1-NCE1
     MTPKESGKPI SCAMKKLKGK RSKILVLSRD AGTNELKPTK GRAHRACIAC RKRKVRCSGN
     IPCRLCQTNS YECKYDRPPR NSSVFDREVS DDSSLYAQRA SHEREDSKGP ISSIDYKKVV
     ETIFPPETLR QILASSSFNS QNFLDTIKTC LLQGQLNVNQ VIRQSLPKDT PWHMQTSVPL
     PPREIALKFI QKTWDCACVL FRFYHRPTII SILDSIYEAE KHGKQYTPEQ VKTQPLIYSV
     LAVGALFSKE DLSKDSKATR EFYTDEGYRY FLEAKNSLDF SNITDIYSIQ AIFMMTIFLQ
     CSANLKACYS FIGIALRAAL KEGLHRRSSI VGPTPIQDET KKRLFWSVYK LDLYMNCILG
     FPSGIDESDI DQEFPLDVDD ENISTIGIKF QDWRTISSCG MNNKHTKLIL IMSRIYKLMY
     SLRRKPLEED SRTQIVSLND QLDNWYAQLP DILKVDTIRY RQTQPPLTVS ANDTSSPYTK
     PKKLLYLDFL LSKIVLYKPF YHYISIDPLD IPEFQFQIHM AENCIEVAKK VIQLSYEMIT
     QNLLSGSYWF SIHTIFFSVA CLKFYVYQTE KGLIRNGKVD SDIHNATQLG SEILSLLKGA
     SNASKRTFEV LNQLFKEFNE KTSVLSEQLL NIVKLQRQES SGALVPQLQT NNNFTKCQGE
     LHHGQQHHQT PATSLRSILN LPQGEADLKF QNTNNESHTT TAAQEEYLDK LLAEFEEFDY
     SINRVLPDVI DFSALIGQDS SANNQIFSSE FSSDPTVN
>P39684 nuc PES4 PROTEIN (DNA POLYMERASE EPSILON SUPPRESSOR 4).
     MYSISNKKPS ILSMVPLNIL KNQDLKVKKD QEKKISFNPV VTPIRPDDYH EKTSRSSSSS
     HSDSPEFLRI NNNKSGHKNG KLKSFESKKL VPLFIGDLHE TVTEETLKGI FKKYPSFVSA
     KVCLDSVTKK SLGHGYLNFE DKEEAEKAME ELNYTKVNGK EIRIMPSLRN TTFRKNFGTN
     VFFSNLPLNN PLLTTRVFYD TFSRYGKILS CKLDSRKDIG FVYFEDEKTA RNVIKMYNNT
     SFFGKKILCG IHFDKEVRSV PNFETQKSRL DAETIIEKEQ SLNEKHSKGN DKESKNIYSS
     SQNSIFIKNL PTITTRDDIL NFFSEVGPIK SIYLSNATKV KYLWAFVTYK NSSDSEKAIK
     RYNNFYFRGK KLLVTRAQDK EERAKFIESQ KISTLFLENL SAVCNKEFLK YLCHQENIRP
     FKIQIDGYDE NSSTYSGFIK FRNFEDATRI FNFLNNRLVG GSIVTTSWER QNNAPKYHDG
     YGMRNIHTSS HPQITPYYQY SHANSLNSPH MRDLSSMNSS TRSLIKNKNF NKKVLETFEK
     QVRRGIDFMR FPSATRDENV HGIAEYIFDT YWNRDVLILD KFLSLLNSSP YHEGVLQKQI
     EEAASSLGFK R
>P39720 nuc PUTATIVE 118.2 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN ACS1-GCV3
     MVENSTQKAP HAGNDDNSST KPYSEAFFLG FNNPTPGLEA EHSSTSPAPE NSETHNRKRN
     RILFVCQACW KSKTKCDREK PECGRCVKHG LKCVYDVSKQ PAPRIPSKDA IISRLEKDMF
     YWKDKAMKLL TEREVNESGK RSASPINTNN ASGDSPDTKK QHKMEPIYEQ SGNGDINNGT
     RNDIEINLYR SHPTMIMSKV MKREVKPLSE NYIIIQDCFL KILVTSVFLD TSKNTMIPAL
     TANANITRAQ PSVANNLLKL KEMLIRQCQT EDEKNRVNEF TDRILQNTNS NRNLKIGMLL
     SMLYNSVGYQ YLEDHCPQGG EYSDLLRNLI NECEAILPSY EIIERYKNHF YEYVYPSLPF
     IELEIFEESL SQTIFPDPNN PSKVQIRMGS THLRAKVENL SLLLVILKLS YMSIRFLDHS
     TADSSFYLSK EIIDKYPIPN DFILLSPRCL ASENWCACAN ENIISCLLYI WSFFAFSPEE
     GDFFLEHPTD VISSLIMMLS TSIGLHRDPS DFPQLISPST SDKRTLNHRR ILWLSIVTVC
     SFEASLKGRH SVSPISLMAL FLNIKDPDSL TVYMNRVRGD LSDINNHTLL RIHKFTFKRA
     QLALLLSDLD NLTMTYYGSF HLHSIEFIRE KIEIFVEENF PIVPLKSVAQ DKSDLDDMNV
     ISEMNILSSE NSSSFHNRIM NKLLMLRTSM AVFLHFETLI TKDKSIFPFY KKYFMVSCMD
     ALSLINYFNK FFNGEYRHAI SSLTSFNVTK FIQLALSSTI FSLLGIILRI GLAIHMLSSE
     VQKLSGTTDP RIKELNTKVE KFSTLQRDLE SALEGIYCSA SEHLRFTYFP VFKMLALFDV
     IVQRMRKGEL WHGIFTMIQM EQMHSRIIKT LSITLGVKLD KKDRLLEELM ACNHVANFSV
     EDIDELNRNI KKEIQISSGL KPPVNTIDLT NGEPFGNAVP TFTKTWSSSL DNLEKLSSAA
     AVGQSLDYNS GLRQGPLAGG GSKEQTPIAG MNNLNNSINA TPIVDNSSGS QLPNGFDRGQ
     ANNTPFPGYF GGLDLFDYDF LVWAMTLLKN FLSKLLPIHF IN
>P39875 nuc EXONUCLEASE I (EXO I) (DHS1 PROTEIN).
     MGIQGLLPQL KPIQNPVSLR RYEGEVLAID GYAWLHRAAC SCAYELAMGK PTDKYLQFFI
     KRFSLLKTFK VEPYLVFDGD AIPVKKSTES KRRDKRKENK AIAERLWACG EKKNAMDYFQ
     KCVDITPEMA KCIICYCKLN GIRYIVAPFE ADSQMVYLEQ KNIVQGIISE DSDLLVFGCR
     RLITKLNDYG ECLEICRDNF IKLPKKFPLG SLTNEEIITM VCLSGCDYTN GIPKVGLITA
     MKLVRRFNTI ERIILSIQRE GKLMIPDTYI NEYEAAVLAF QFQRVFCPIR KKIVSLNEIP
     LYLKDTESKR KRLYACIGFV IHRETQKKQI VHFDDDIDHH LHLKIAQGDL NPYDFHQPLA
     NREHKLQLAS KSNIEFGKTN TTNSEAKVKP IESFFQKMTK LDHNPKVANN IHSLRQAEDK
     LTMAIKRRKL SNANVVQETL KDTRSKFFNK PSMTVVENFK EKGDSIQDFK EDTNSQSLEE
     PVSESQLSTQ IPSSFITTNL EDDDNLSEEV SEVVSDIEED RKNSEGKTIG NEIYNTDDDG
     DGDTSEDYSE TAESRVPTSS TTSFPGSSQR SISGCTKVLQ KFRYSSSFSG VNANRQPLFP
     RHVNQKSRGM VYVNQNRDDD CDDNDGKNQI TQRPSLRKSL IGARSQRIVI DMKSVDERKS
     FNSSPILHEE SKKRDIETTK SSQARPAVRS ISLLSQFVYK GK
>P39943 nuc HYPOTHETICAL 43.1 KD PROTEIN IN GAL83-YPT8 INTERGENIC REGION.
     MNYLRDRFPP DNDQRPFRCE ICSRGFHRLE HKKRHGRTHT GEKPHKCTVQ GCPKSFSRSD
     ELKRHLRTHT KGVQRRRIKS KGSRKTVVNT ATAAPTTFNE NTGVSLTGIG QSKVPPILIS
     VAQNCDDVNI RNTGNNNGIV ETQAPAILVP VINIPNDPHP IPSSLSTTSI TSIASVYPST
     SPFQYLKSGF PEDPASTPYV HSSGSSLALG ELSSNSSIFS KSRRNLAAMS GPDSLSSSKN
     QSSASLLSQT SHPSKSFSRP PTDLSPLRRI MPSVNTGDME ISRTVSVSSS SSSLTSVTYD
     DTAAKDMGMG IFFDRPPVTQ KACRSNHKYK VNAVSRGRQH ERAQFHISGD DEDSNVHRQE
     SRASNTSPNV SLPPIKSILR QIDNFNSAPS YFSK
>P39956 nuc PUTATIVE 90.2 KD ZINC FINGER PROTEIN IN CCA1-ADK2 INTERGENIC REGION.
     MTKLIAPSEI VGGVPVFKPT YEQFEDFYAY CKAINKYGMK SGVVKVIPPK EWKDKLDLPY
     SAETLQKIKI KSPIQQHISG NKGLFMVQNV EKNKTYNIIQ WKDLSKDYVP PEDPKARRNS
     RKGSVSKSTK LKLKNFESSF NIDDFEQFRT EYTIDLSDFQ NTERLKFLEE YYWKTLNFTT
     PMYGADTPGS IFPEGLNVWN VAKLPNILDH METKVPGVND SYLYAGLWKA SFSWHLEDQD
     LYSINYIHFG APKQWYSIPQ EDRFKFYKFM QEQFPEEAKN CPEFLRHKMF LASPKLLQEN
     GIRCNEIVHH EGEFMITYPY GYHAGFNYGY NLAESVNFAL EEWLPIGKKA GKCHCISDSV
     EIDVKKLAKS WRDNNKESKG TPPLNQLPNP AMPLLHRPTL KEMESSSLRS TSPDVGHFSN
     FKSKSSGVSS PLLSRMKDYS NIVEPTLEDP TLKLKRISSF QEQPLNKLLK RETSQTAMLT
     DHEDNIVAMS LTSMANSAAS SPRLPLSRLN SSNELSNAQP LLDMTNNTLA FPRPNGPSGL
     NPLLYISNKN ISGISHSAPH SPVNPNISLI KRVKSPNIVT LNISRESSRS PIALNYEARQ
     QHSQQHSFST PSTVSNLSTS VLGPLSDTND IKTPHPERPN HKTANRILKK ESPVETSKSN
     LILSKVASTR QEDSFTSRND DLDKEQGSSP LNSKFAPEEI VLSGKNKIYI CKECQRKFSS
     GHHLTRHKKS VHSGEKPHSC PKCGKRFKRR DHVLQHLNKK IPCISNETTV DAPIMNPTVQ
     PQDGKAAINQ QSTPLN
>P39959 nuc PUTATIVE 50.3 KD ZINC FINGER PROTEIN IN PAK1-RPS26B INTERGENIC REGION.
     MSLYPLQRFE SNDTVFSYTL NSKTELFNES RNNDKQHFTL QLIPNANANA KEIDNNNVEI
     INDLTGNTIV DNCVTTATSS NQLERRLSIS DYRTENGNYY EYEFFGRREL NEPLFNNDIV
     ENDDDIDLNN ESDVLMVSDD ELEVNERFSF LKQQPLDGLN RISSTNNLKN LEIHEFIIDP
     TENIDDELED SFTTVPQSKK KVRDYFKLNI FGSSSSSNNN SNSLGCEPIQ TENSSSQKMF
     KNRFFRSRKS TLIKSLPLEQ ENEVLINSGF DVSSNEESDE SDHAIINPLK LVGNNKDIST
     QSIAKTTNPF KSGSDFKMIE PVSKFSNDSR KDLLAAISEP SSSPSPSAPS PSVQSSSSSH
     GLVVRKKTGS MQKTRGRKPS LIPDASKQFG CEFCDRRFKR QEHLKRHVRS LHMCEKPFTC
     HICNKNFSRS DNLNQHVKTH ASL
>P39961 nuc PUTATIVE 91.1 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN ISC10 3'REGION.
     MAAKRGLAKQ KSRVTKACDR CHRKKIKCNS KKPCFGCIGS QSKCTYRNQF REPIEAFFNY
     TGSLSNDLDN AKCSIAKLKA QLPPSAPASL QKGLANICTE LEKIQPQLYL NLDSKEISSY
     GGLKSIETEI IGKQSKSLNR FSNAFESNTA QNVSMYFGVY SPLLYFASTG ISWITKKLIS
     CSNDRETRET IYLFLKFLDA SSASHAGPKV TSISPLEYYS KLNGLSCGND VLIQHIMSNI
     SNEIKGNTNI NQTIKFNKPT DWFMYGVQLM EQHHKALDRK SSKKLLPLKY FLEQDELIFC
     LCLEYFERSL FSTMYDLTIL KGLVSLMKHR YWIDDPFVLG RIISTMSRRS LDAGLNRWEY
     YIGQDEDTAE EYRKLWWDCY WWDRWYSLVT GKQPLIPHEM TSCLFPKDVV GLGVDDSMDC
     FTLINLVELD PSKFDICISF GYILLTKIIT AVFSGLLYNR HFTDYRLFAT PNAKDLNGTA
     RQLMVEFSKI CKIFQCIQDK LIPFLKQYSE NSNVFELYTH FGFAKVCCFQ GMESLILRIQ
     NLLQERERIE LDSCVKDIRL QTFEASVDIL TDVLKHEDTF YIFRCSWFIY AILMNITLNF
     IETPRRNSIC YLSLMCRMIA SYNDLFVSSG NVNFKGNNAF SKKLENGTAV SFILTRICCQ
     MYTRSQKMAK ESLFCELKKY GQACSDAGQA ALDIECIWYR NIIGEHKESS FRKEILSILD
     REMGDLVNNR VIGVQGKNQE GACYEKLSPS STSVSVGMDF CSLENFVTAE SLPDLLNLFW
     EDTEFGITKE NLGE
>P39970 nuc HYPOTHETICAL 54.6 KD PROTEIN IN MEI4-SAP1 INTERGENIC REGION.
     MDYKHNFATS PDSFLDGRQN PLLYTDFLSS NKELIYKQPS GPGLVDSAYN FHHQNSLHDR
     SVQENLGPMF QPFGVDISHL PITNPPIFQS SLPAFDQPVY KRRISISNGQ ISQLGEDLET
     VENLYNCQPP ILSSKAQQNP NPQQVANPSA AIYPSFSSNE LQNVPQPHEQ ATVIPEAAPQ
     TGSKNIYAAM TPYDSNIKLN IPAVAATCDI PSATPSIPSG DSTMNQAYIN MQLRLQAQMQ
     TKAWKNAQLN VHPCTPASNS SVSSSSSCQN INDHNIENQS VHSSISHGVN HHTVNNSCQN
     AELNISSSLP YESKCPDVNL THANSKPQYK DATSALKNNI NSEKDVHTAP FSSMHTTATF
     QIKQEARPQK IENNTAGLKD GAKAWKRARL LERNRIAASK CRQRKKMSQL QLQREFDQIS
     KENTMMKKKI ENYEKLVQKM KKISRLHMQE CTINGGNNSY QSLQNKDSDV NGFLKMIEEM
     IRSSSLYDE
>P40314 nuc BTF3 HOMOLOG BTT1.
     MPVDQEKLAK LHKLSAANKV GGTRRKINKK GNLYNNNDKD NTKLQAELHK LHPMTIENVA
     EANFFKKNGK VLHFNSAVVQ IAPQCNLTMI HGQPKENTLN GLYPSVASQL GSQELEYLTG
     LAHNLENEQT VLDQLGDRCS ETKQQVMNS
>P40339 nuc ACTIVATOR 1 37 KD SUBUNIT (REPLICATION FACTOR C 37 KD SUBUNIT).
     MSKTLSLQLP WVEKYRPQVL SDIVGNKETI DRLQQIAKDG NMPHMIISGM PGIGKTTSVH
     CLAHELLGRS YADGVLELNA SDDRGIDVVR NQIKHFAQKK LHLPPGKHKI VILDEADSMT
     AGAQQALRRT MELYSNSTRF AFACNQSNKI IEPLQSRCAI LRYSKLSDED VLKRLLQIIK
     LEDVKYTNDG LEAIIFTAEG DMRQAINNLQ STVAGHGLVN ADNVFKIVDS PHPLIVKKML
     LASNLEDSIQ ILRTDLWKKG YSSIDIVTTS FRVTKNLAQV KESVRLEMIK EIGLTHMRIL
     EGVGTYLQLA SMLAKIHKLN NKA
>P40348 nuc ACTIVATOR 1 41 KD SUBUNIT (REPLICATION FACTOR C 41 KD SUBUNIT).
     MFEGFGPNKK RKISKLAAEQ SLAQQPWVEK YRPKNLDEVT AQDHAVTVLK KTLKSANLPH
     MLFYGPPGTG KTSTILALTK ELYGPDLMKS RILELNASDE RGISIVREKV KNFARLTVSK
     PSKHDLENYP CPPYKIIILD EADSMTADAQ SALRRTMETY SGVTRFCLIC NYVTRIIDPL
     ASRCSKFRFK ALDASNAIDR LRFISEQENV KCDDGVLERI LDISAGDLRR GITLLQSASK
     GAQYLGDGKN ITSTQVEELA GVVPHDILIE IVEKVKSGDF DEIKKYVNTF MKSGWSAASV
     VNQLHEYYIT NDNFDTNFKN QISWLLFTTD SRLNNGTNEH IQLLNLLVKI SQL
>P40352 nuc DNA REPAIR AND RECOMBINATION PROTEIN RAD26.
     MEDKEQQDNA KLENNESLKD LGVNVLSQSS LEEKIANDVT NFSNLQSLQQ EETRLERSKT
     ALQRYVNKKN HLTRKLNNTT RISVKQNLRD QIKNLQSDDI ERVLKDIDDI QSRIKELKEQ
     VDQGAENKGS KEGLQRPGET EKEFLIRTGK ITAFGHKAGF SLDTANREYA KNDEQKDEDF
     EMATEQMVEN LTDEDDNLSD QDYQMSGKES EDDEEEENDD KILKELEDLR FRGQPGEAKD
     DGDELYYQER LKKWVKQRSC GSQRSSDLPE WRRPHPNIPD AKLNSQFKIP GEIYSLLFNY
     QKTCVQWLYE LYQQNCGGII GDEMGLGKTI QVIAFIAALH HSGLLTGPVL IVCPATVMKQ
     WCNEFQHWWP PLRTVILHSM GSGMASDQKF KMDENDLENL IMNSKPSDFS YEDWKNSTRT
     KKALESSYHL DKLIDKVVTD GHILITTYVG LRIHSDKLLK VKWQYAVLDE GHKIRNPDSE
     ISLTCKKLKT HNRIILSGTP IQNNLTELWS LFDFIFPGKL GTLPVFQQQF VIPINIGGYA
     NATNIQVQTG YKCAVALRDL ISPYLLRRVK ADVAKDLPQK KEMVLFCKLT KYQRSKYLEF
     LHSSDLNQIQ NGKRNVLFGI DILRKICNHP DLLDRDTKRH NPDYGDPKRS GKMQVVKQLL
     LLWHKQGYKA LLFTQSRQML DILEEFISTK DPDLSHLNYL RMDGTTNIKG RQSLVDRFNN
     ESFDVFLLTT RVGGLGVNLT GANRIIIFDP DWNPSTDMQA RERAWRIGQK REVSIYRLMV
     GGSIEEKIYH RQIFKQFLTN RILTDPKQKR FFKIHELHDL FSLGGENGYS TEELNEEVQK
     HTENLKNSKS EESDDFEQLV NLSGVSKLES FYNGKEKKEN SKTEDDRLIE GLLGGESNLE
     TVMSHDSVVN SHAGSSSSNI ITKEASRVAI EAVNALRKSR KKITKQYEIG TPTWTGRFGK
     AGKIRKRDPL KNKLTGSAAI LGNITKSQKE ASKEARQENY DDGITFARSK EINSNTKTLE
     NIRAYLQKQN NFFSSSVSIL NSIGVSLSDK EDVIKVRALL KTIAQFDKER KGWVLDEEFR
     NNNAS
>P40356 nuc POLY-GLUTAMINE DOMAIN PROTEIN PGD1.
     MAPSEILKRT TETVTKTSSI RQRKTDTTAV KTTGMDSIIP AGVKLDDLQV ILAKNENETR
     DKVCKQINEA RDEILPLRLQ FNEFIQIMAN IDQEGSKQAD RMAKYLHIRD KILQLNDRFQ
     TLSSHLEALQ PLFSTVPEYL KTADNRDRSF QLLEPLSTYN KNGNAVCSTA TVVSTNHSAA
     ASTPTTTATP HANPITHAHS LSNPNSTATM QHNPLAGKRG PKSGSTMGTP TVHNSTAAAP
     IAAPKKPRKP RQTKKAKAQA QAQAQAQAQV YAQQSTVQTP ITASMAAALP NPTPSMINSV
     SPTNVMGTPL TNMMSPMGNA YSMGAQNQGG QVSMSQFNGS GNGSNPNTNT NSNNTPLQSQ
     LNLNNLTPAN ILNMSMNNDF QQQQQQQQQQ QQPQPQYNMN MGMNNMNNGG KELDSLDLNN
     LELGGLNMDF L
>P40466 nuc FORK HEAD PROTEIN HOMOLOG 1.
     MSVTSREQKF SGKYSSYTAQ DRQGLVNAVT CVLSSSSDPV AVSSDYSNSL SIAREVNAYA
     KIAGCDWTYY VQKLEVTIGR NTDSLNLNAV PGTVVKKNID IDLGPAKIVS RKHAAIRFNL
     ESGSWELQIF GRNGAKVNFR RIPTGPDSPP TVLQSGCIID IGGVQMIFIL PEQETIISDY
     CLNHLMPKLL STYGTNGNNN PLLRNIIEGS TYLREQRLQE EARLQQLDHL HTPLSSSSDV
     NPIGDPHGDT IMMEEDEEDE NYTRGGIRPN TYTSSSNNAV TNGNVPHIEN PSDLSLDENR
     YIKPPQSYAS MITQAILSTP EGSISLADIY KFISDNYAFY RFSQMAWQNS VRHNLSLNKA
     FEKVPKRAGQ QGKGMNWKIS DEVRRDFLNK WNAGKLSKIR RGASVTRQLQ LHMSKFGEIP
     APESSSIDPR GIKAQKVKKS LQATSSILGE SAPQLQRTQL TGQISTTTSM DVTTNANVNN
     SSLS
>P40467 nuc PUTATIVE 108.8 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN FKH1-STH1
     MPEQAQQGEQ SVKRRRVTRA CDECRKKKVK CDGQQPCIHC TVYSYECTYK KPTKRTQNSG
     NSGVLTLGNV TTGPSSSTVV AAAASNPNKL LSNIKTERAI LPGASTIPAS NNPSKPRKYK
     TKSTRLQSKI DRYKQIFDEV FPQLPDIDNL DIPVFLQIFH NFKRDSQSFL DDTVKEYTLI
     VNDSSSPIQP VLSSNSKNST PDEFLPNMKS DSNSASSNRE QDSVDTYSNI PVGREIKIIL
     PPKAIALQFV KSTWEHCCVL LRFYHRPSFI RQLDELYETD PNNYTSKQMQ FLPLCYAAIA
     VGALFSKSIV SNDSSREKFL QDEGYKYFIA ARKLIDITNA RDLNSIQAIL MLIIFLQCSA
     RLSTCYTYIG VAMRSALRAG FHRKLSPNSG FSPIEIEMRK RLFYTIYKLD VYINAMLGLP
     RSISPDDFDQ TLPLDLSDEN ITEVAYLPEN QHSVLSSTGI SNEHTKLFLI LNEIISELYP
     IKKTSNIISH ETVTSLELKL RNWLDSLPKE LIPNAENIDP EYERANRLLH LSFLHVQIIL
     YRPFIHYLSR NMNAENVDPL CYRRARNSIA VARTVIKLAK EMVSNNLLTG SYWYACYTIF
     YSVAGLLFYI HEAQLPDKDS AREYYDILKD AETGRSVLIQ LKDSSMAASR TYNLLNQIFE
     KLNSKTIQLT ALHSSPSNES AFLVTNNSSA LKPHLGDSLQ PPVFFSSQDT KNSFSLAKSE
     ESTNDYAMAN YLNNTPISEN PLNEAQQQDQ VSQGTTNMSN ERDPNNFLSI DIRLDNNGQS
     NILDATDDVF IRNDGDIPTN SAFDFSSSKS NASNNSNPDT INNNYNNVSG KNNNNNNITN
     NSNNNHNNNN NDNNNNNNNN NNNNNNNNNS GNSSNNNNNN NNNKNNNDFG IKIDNNSPSY
     EGFPQLQIPL SQDNLNIEDK EEMSPNIEIK NEQNMTDSND ILGVFDQLDA QLFGKYLPLN
     YPSE
>P40529 nuc HYPOTHETICAL 32.6 KD PROTEIN IN MET30-PIG2 INTERGENIC REGION.
     MSTSVPVKKA LSALLRDPGN SHCADCKAQL HPRWASWSLG VFICIKCAGI HRSLGTHISK
     VKSVDLDTWK EEHLVKLIQF KNNLRANSYY EATLADELKQ RKITDTSSLQ NFIKNKYEYK
     KWIGDLSSIE GLNDSTEPVL HKPSANHSLP ASNARLDQSS NSLQKTQTQP PSHLLSTSRS
     NTSLLNLQVS SLSKTTSNTS VTSSATSIGA ANTKTGNRVG EFGQRNDLKK SILSLYSKPS
     AQTQSQNSFF TSTTPQPCNT PSPFVNTGIT ATNNNSMNSN SSSNISLDDN ELFKNVWS
>P40561 nuc HYPOTHETICAL 29.0 KD PROTEIN IN BET1-PAN1 INTERGENIC REGION.
     MSQEEKVDAK ATLKTEISNN KKNDKQELEL DELVGKLSIE GTPQVSQKLS KEEKHAHQLE
     ADSRSIFVGN ITPDVTPEQI EDHFKDCGQI KRITLLYDRN TGTPKGYGYI EFESPAYREK
     ALQLNGGELK GKKIAVSRKR TNIPGFNRHY NSQNQYFQQW QWNYPLMAYP NPDTFPYYPP
     YPPNQSPNQN FGYNKNNYYR SPYNNKNRTF QKKHFNSAKD STKNIRSTSQ KPVVMPSDNV
     KSSTQEKDSK
>P40565 nuc HYPOTHETICAL 17.1 KD PROTEIN IN BET1-PAN1 INTERGENIC REGION.
     MNKIQQINDK ELQSGILSPH QSWHNEYKDN AYIYIGNLNR ELTEGDILTV FSEYGVPVDV
     ILSRDENTGE SQGFAYLKYE DQRSTILAVD NLNGFKIGGR ALKIDHTFYR PKRSLQKYYE
     AVKEELDRDI VSKNNAEKLI LAKKDQPN
>P40567 nuc HYPOTHETICAL 12.8 KD PROTEIN IN PRI1-DBF8 INTERGENIC REGION.
     MVEPARKKQR IDRDTHHTVA EPVTEAKNTL YVSQLNEKIN MQRLRVNLFL LFATFGEVLK
     VSMNFKKQRG QAFITMRTID QASLAQISLN GERFFGKPLK VEFSKSETKT L
>P40573 nuc TRANSCRIPTIONAL ACTIVATOR OF SULFUR METABOLISM MET28.
     MSAKQGWEKK STNIDIASRK GMNVNNLSEH LQNLISSDSE LGSRLLSLLL VSSGNAEELI
     SMINNGQDVS QFKKLREPRK GKVAATTAVV VKEEEAPVST SNELDKIKQE RRRKNTEASQ
     RFRIRKKQKN FENMNKLQNL NTQINKLRDR IEQLNKENEF WKAKLNDINE IKSLKLLNDI
     KRRNMGR
>P40574 nuc HYPOTHETICAL 28.4 KD PROTEIN IN MET28-STA1 INTERGENIC REGION.
     MALPLIKPKE SEESHLALLS KIHVSKNWKL PPRLPHRAAQ RRKRVHRLHE DYETEENDEE
     LQKKKRQNRD AQRAYRERKN NKLQVLEETI ESLSKVVKNY ETKLNRLQNE LQAKESENHA
     LKQKLETLTL KQASVPAQDP ILQNLIENFK PMKAIPIKYN TAIKRHQHST ELPSSVKCGF
     CNDNTTCVCK ELETDHRKSD DGVATEQKDM SMPHAECNNK DNPNGLCSNC TNIDKSCIDI
     RSIIH
>P40917 nuc TRANSCRIPTIONAL ACTIVATOR CIN5.
     MLMQIKMDNH PFNFQPILAS HSMTRDSTKP KKMTDTAFVP SPPVGFIKEE NKADLHTISV
     VASNVTLPQI QLPKIATLEE PGYESRTGSL TDLSGRRNSV NIGALCEDVP NTAGPHIARP
     VTINNLIPPS LPRLNTYQLR PQLSDTHLNC HFNSNPYTTA SHAPFESSYT TASTFTSQPA
     ASYFPSNSTP ATRKNSATTN LPSEERRRVS VSLSEQVFNE GERYNNDGQL IGKTGKPLRN
     TKRAAQNRSA QKAFRQRREK YIKNLEEKSK LFDGLMKENS ELKKMIESLK SKLKE
>P40956 nuc GTS1 PROTEIN (LSR1 PROTEIN).
     MRFRSSSHSL KHVDRELKEL INSSENANKC GECGNFYPTW CSVNLGVFLC GRCASVHRKV
     FGSRDDDAFS NVKSLSMDRW TREDIDELVS LGGNKGNARF WNPKNVPFPF DGDDDKAIVE
     HYIRDKYILG KFRYDEIKPE DFGSRMDDFD GESDRFDERN RSRSRSRSHS FYKGGHNRSD
     YGGSRDSFQS SGSRYSRQLA ELKDMGFGDT NKNLDALSSA HGNINRAIDY LEKSSSSRNS
     VSAAATTSTP PLPRRRATTS GPQPAIFDGT NVITPDFTSN SASFVQAKPA VFDGTLQQYY
     DPATGMIYVD QQQYAMAMQQ QQQQQQQLAV AQAQAQAQAQ AQAQVQAQAQ AQAQAQAQAQ
     QIQMQQLQMQ QQQQAPLSFQ QMSQGGNLPQ GYFYTQ
>P40962 nuc ZINC FINGER PROTEIN RTS2.
     MADYDSAKYW SKQGARRGLQ KTRYYCQICQ RQCKDANGFQ SHNKSPSHLR KISQVTAEDA
     RRYNIQFEKG FLQLLKQRHG EKWIDANKVY NEYVQDRDHV HMNATMHRSL TQFVRYLGRA
     GKVDVDMDID DTSENVEGPL LIRIHPSSLS SPSEDGMLRS QQEEQEVIAA ELLKRQLNRA
     KRQTEKVYQP EMKSEISGDS TLKRVQVTFH GNGRVNKKKK KVPPRKDGIK FR
>P40969 nuc CENTROMERE DNA-BINDING PROTEIN COMPLEX CBF3 SUBUNIT B (CENTROMERE
     MFNRTTQLKS KHPCSVCTRR KVKCDRMIPC GNCRKRGQDS ECMKSTKLIT ASSSKEYLPD
     LLLFWQNYEY WITNIGLYKT KQRDLTRTPA NLDTDTEECM FWMNYLQKDQ SFQLMNFAME
     NLGALYFGSI GDISELYLRV EQYWDRRADK NHSVDGKYWD ALIWSVFTMC IYYMPVEKLA
     EIFSVYPLHE YLGSNKRLNW EDGMQLVMCQ NFARCSLFQL KQCDFMAHPD IRLVQAYLIL
     ATTTFPYDEP LLANSLLTQC IHTFKNFHVD DFRPLLNDDP VESIAKVTLG RIFYRLCGCD
     YLQSGPRKPI ALHTEVSSLL QHAAYLQDLP NVDVYREENS TEVLYWKIIS LDRDLDQYLN
     KSSKPPLKTL DAIRRELDIF QYKVDSLEED FRSNNSRFQK FIALFQISTV SWKLFKMYLI
     YYDTADSLLK VIHYSKVIIS LIVNNFHAKS EFFNRHPMVM QTITRVVSFI SFYQIFVESA
     AVKQLLVDLT ELTANLPTIF GSKLDKLVYL TERLSKLKLL WDKVQLLDSG DSFYHPVFKI
     LQNDIKIIEL KNDEMFSLIK GLGSLVPLNK LRQESLLEEE DENNTEPSDF RTIVEEFQSE
     YNISDILS
>P40992 nuc RNA POLYMERASE I SPECIFIC TRANSCRIPTION INITIATION FACTOR RRN7.
     MSTFIRGPIC GTDNCPSRLW RIIDGRRTCQ YGHVMEGDVE FNDDEDDLNG LGAGVITRRL
     NLTTNATGSF QSSQLTNSQL LQQQQRQSHK KFKKLIGHEA KLLFLKSFQF ILKRQIRWLI
     TEMRFPKEFE HVAKIIWLKI LKTINDQPQE ELKLQLHMTS TISILYLAST HLSLPVYTCD
     YIKWICTAKM PYFQASEILP KSWRIQLPNY YVSILEGSIS PFNGQLYNKI ALTCGMIHFK
     EFFNSEISCQ GLLLKLVMQC ALPPEFYFYT KQVIEFEETD IRNLTLWERT DERHTGRVSN
     HAELRVLSYF MLTINWMLSF DRDRQYPLKW ILSLTESLTQ RTTTSESIGR NIVKVVYPDK
     PTSSDYFQWS EEETLEFLKW MEKQFLPTQT KSLHNENGSM EMTIDQKIAR RKLYKIFPLD
     REANHDGEFN DSTHQLTFIE DLQERYAKQT PFFESNKIRD SLNYQEANPP ARKEAIGRLL
     THIASQLLVD FAISKEQLKD CISRIKNACL HRMN
>P41546 nuc HAC1 PROTEIN.
     MEMTDFELTS NSQSNLAIPT NFKSTLPPRK RAKTKEEKEQ RRIERILRNR RAAHQSREKK
     RLHLQYLERK CSLLENLLNS VNLEKLADHE DALTCSHDAF VASLDEYRDF QSTRGASLDT
     RASSHSSSDT FTPSPLNCTM EPRLCRPRVC RFRVGPRDFM GAAECLRRKM YQSRRRYLPY
     TINNLFDAVA SPLADPLCDD IAGNSLPFDN SIDLDNWRNP AVITMTRKLQ
>P41696 nuc ASPARAGINE-RICH ZINC FINGER PROTEIN AZF1.
     MPPPTAQFMG PTQAGQNESQ NQSSGEAGEQ NQEHGQGPTP ILNQSQPASS QPQHQQQRNE
     SISYYTNFNQ PRYSTDASIN SFLNISDNVP VTSTGGPSSG GAYSNLPRLS TSSTHQPPDL
     SQIGRGFSIV NNLFPQQQQL QNQHRQQQQQ QQQQSHQQPP FKTPSFSTGL TGSSSQYQFL
     PRNDNTSQPP SKRNSVYLGP NDGPDFEFFS MQQSQQPQFQ PSSRRESNSM RPPLLIPAAT
     TKSQSNGTNN SGNMNTNADY ESFFNTGTNN SNSNQNPYFL SSRNNSLKFN PEDFDFQFKR
     RNSFVRGTLD HSSQNAFIPE SRLNSLSVNN KANGDPVADN VTNNMKGKSN EVDNDDGNDS
     SNNNNNNNNN NNNENNNDNN NDNNDNSINS ATSTNIPNQE DHSLASTDTT SNSRKDLKEI
     EQRLRKHLND EDNYSSAISR PLDKNDVIEG SEGLNKHIDE SGMQPNIIKK RKKDDSTVYV
     KNEMPRTDPP MSKDNSTSAE GAAMANFSGK EPPIPDISSV SDDATNLIGA TKVDQLMLII
     QARKKGFTEK VNTTQDGDLL FNQTMDILPP KSELVGGVEK PKGTQNTRAV KKHECPYCHR
     LFSQATHLEV HVRSHIGYKP FVCDYCGKRF TQGGNLRTHE RLHTGEKPYS CDICDKKFSR
     KGNLAAHLVT HQKLKPFVCK LENCNKTFTQ LGNMKAHQNR FHKETLNALT AKLAEMNPSE
     NIPLEERQLL EYFASIYKNS NRGIKGRGKG VGTKKSTISS PENHPASTIL NPNTNANNAI
     ANDSENNGNP EGNIDSSSNS NPGSHSMISP TQKDMGTLQS QFIQNNFNNS VNSSNPSNQP
     IINYNYTTLP HSRLGSSSSS NTNNNNSNFS VGAAPGVLMA PTTNNDFSFN LDQSNDNERS
     QQEQVRFKNI NYKS
>P41813 nuc FORK HEAD PROTEIN HOMOLOG 2.
     MSSSNFNEMN ELNMTQTNYG STKYTAQHHQ GVINAIISSL TAPDQPTTVS LQYSNDKNMA
     TEIQAYAKLS GPNWTYYVKD LEVSIGRNTD PLNSALQENS DGVKNSYRVN IDLGPAKVVS
     RKHAIIKYNM NIGGWELHIL GRNGAKVNFQ RTHNGPNNPP IRLSSGTLLD IGGTQMMFIL
     PDSDPVVAPI CIEHLMPNLI NMFGLEGNNN PLLRDIIKQS NYAKQRQLTS NQQIKGFKLY
     GSGGNAPFGS GANLGPSEQG IFNNNNNSKN KNGYFTSINP NYTASTTTSN TINPQAASPQ
     GPPNTIIAAN FVDSYKSSNA YPQALDFTSD LSHDENRNVK PPHSYATMIT QAILSSPEGV
     ISLADIYKYI SSNYAYYRFA KSGWQNSIRH NLSLNKAFEK VPRRPNEPGK GMKWRISESY
     QQEFLNKWNT GKVGKIRRGS SVARQLQLHM AKFNSLPMEM DYRLSLNMAQ PPKRQLQSHN
     VLEPSNNNII EGFVQHVPSK GNLPASQQSQ PPVSHQNQSQ QPPPQEQRQE IQFTFADTQN
     RNIALARPIK TPQLQAPNSN ANLNQNNMKE YKESLHPPAI SISQMNRQSP NNALVSFTNA
     CANSKIINNI SDSADKSTNN NGGTKMNLPA ISTSSLDENG NLEPTTTTSS GNSNSVPQTG
     TTTSSLAANS LRLSQPYDTL LRSPTKAFHI TAMEAYTPER GSANRARSPL HSNSNNTNNN
     GANNSNLQTS GMENKQTGLV LDSNVLKSME SNNDNRRLTP STSKSQNVKS SPGVWNLLQF
     SSTNNTPAAD SGGNKRGFSI NPDIKAKENE NATSEKDSDS NSNDLETKDI NSSPLKNQGG
     STANAKELIL DTDGAKISII NN
>P41817 nuc HOMEOBOX PROTEIN CUP9.
     MNYNCEIQNR NSKNVDNQVS LPPIQVLFNS IEKRSMPELA FSNIEYSHGN LRSSTEEQNY
     PAPVLLPQHH SIAYPAINSG GTSTTATPTA STVETSKTSS SAMDTQSQYG SSKKSKSASD
     DAKPCYKSAP IYEIINKEKD AGAQYNRPFS DFVESKSRRK QNSGRRSNLP KETVQILNTW
     LLNHLNNPYP TQQEKRELLI KTGLTKIQLS NWFINVRRRK IFSDYYTLVN SIPNDNANNT
     PVERVQNVSA YHNTLSATNN TMYDATSTCS TDYELSKRFA HAPVTRRKKL IDRLEELKKL
     SNPDMN
>P41833 nuc TRANSCRIPTIONAL REGULATOR SPO8.
     MINDKLVHFL IQNYDDILRA PLSGQLKDVY SLYISGGYDD EMQKLRNDKD EVLQFEQFWN
     DLQDIIFATP QSIQFDQNLL VADRPEKIVY LDVFSLKILY NKFHAFYYTL KSSSSSCEEK
     VSSLTTKPEA DSEKDQLLGR LLGVLNWDVN VSNQGLPREQ LSNRLQNLLR EKPSSFQLAK
     ERAKYTTEVI EYIPICSDYS HASLLSTSVY IVNNKIVSLQ WSKISACQEN HPGLIECIQS
     KIHFIPNIKP QTDISLGDCS YLDTCHKLNT CRYIHYLQYI PSCLQERADR ETASENKRIR
     SNVSIPFYTL GNCSAHCIKK ALPAQWIRCD VRKFDFRVLG KFSVVIADPA WNIHMNLPYG
     TCNDIELLGL PLHELQDEGI IFLWVTGRAI ELGKESLNNW GYNVINEVSW IKTNQLGRTI
     VTGRTGHWLN HSKEHLLVGL KGNPKWINKH IDVDLIVSMT RETSRKPDEL YGIAERLAGT
     HARKLEIFGR DHNTRPGWFT IGNQLTGNCI YEMDVERKYQ EFMKSKTGTS HTGTKKIDKK
     QPSKLQQQHQ QQYWNNMDMG SGKYYAEAKQ NPMNQKHTPF ESKQQQKQQF QTLNNLYFAQ
>P42073 nuc RNA END FORMATION PROTEIN 2.
     MSAPVPQLVN ISHALQASTI QQIRLDMVDF NKDCKLSSIQ LARIDKYIDS LQAALNQFTK
     DNLHIERKEK NVTEADIQLY SGLKSMYLDY LNQLIKLKHE KQHHSTPPIA NDVSLDFFVN
     QLPKFSPEER KNYIDNLILN KNSHNRLSKM DGLVDAVINL CVLDTSVAEN VRSYMKLLDT
     LGFQKGSNST GTKANLKKKL ASSKAKIKDS EKEKEKEKDK SKVKMKTKLK PSPLLNNDDK
     NSSPSPTAST SSMKKLKSGL FNKNEAKSTE SLPTSSKKKL SFSKYLNKDD ADMTKLGTKR
     SIDVDFKVNP EASTVASNII SSSTSGSSTT TVATPASSEE PLKKKTKISV QDSNVQSILR
     NGKPKKARIS SIKFLDDSQL IKVYGDDLPN QGLQVSPTQL KKILKPFKEG EPKEIILFED
     MSIKLKPLDL MFLKNTNSDD YMDISETKGG PIHCETRTPL IYRKNFNHFN PDLNKRPPRE
     PIEFDLNGNT NSTPTIAKAF GKNSLLLRKD RGGLPYKHVP IVKRNKYPPR PVH
>P42944 nuc GZF3 PROTEIN.
     MASQATTLRG YNIRKRDNVF EPKSSENLNS LNQSEEEGHI GRWPPLGYEA VSAEQKSAVQ
     LRESQAGASI SNNMNFKAND KSFSTSTAGR MSPDTNSLHH ILPKNQVKNN GQTMDANCNN
     NVSNDANVPV CKNCLTSTTP LWRRDEHGAM LCNACGLFLK LHGKPRPISL KTDVIKSRNR
     KSNTNHAHNL DNFRNQTLIA ELKGDCNIES SGRKANRVTS EDKKKKSSQL LMGTSSTAKI
     SKKPKTESKE RSDSHLSATK LEVLMSGDCS RPNLKPKLPK QDTAIYQEKL LTFPSYTDVK
     EYSNSAHQSA FIKERSQFNA ASFPLNASHS VTSKTGADSP QLPHLSMLLG SLSSTSISNN
     GSEIVSNCNN GIASTAATLA PTSSRTTDSN PSEVPNQIRS TMSSPDIISA KRNDPAPLSF
     HMASINDMLE TRDRAISNVK TETTPPHFIP FLQSSKAPCI SKANSQSISN SVSSSDVSGR
     KFENHPAKDL GDQLSTKLHK EEEIIKLKTR INELELVTDL YRRHINELDG KCRALEERLQ
     RTVKQEGNKG G
>P42950 nuc PUTATIVE 70.4 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN SME1-MEF2
     MTKKLPSELK QTRKSIQTAC EFCHTKHIQC DVGRPCQNCL KRNIGKFCRD KKRKSRKRIE
     KHGTQPYLNL GKRLVIHDVP SKTVSPSSVH LQRDFLSSDQ EKPGKTPAHN TNIQYTYNIN
     DNFQSAGSIP RITNFNTNNR QTVLENTSNN ISASQAVHLM NDPIIPTVRK STLNLKSHFL
     EQHKAMQQPL ATNCLVATSN VPVHSGMDDS NKSDDDVDDE TNIHFDSMWC NDEYMKLKDI
     VDISTPFLPN NSQIFSLQES EYPNPSASTR GNSSLHLTNL LNSTKSVNDQ KDSSIGHSTS
     TFNTYDEVVS RPFISLDMLH LNRGANANTH PSHNAKLESE CDSSSHSDAD LEKHDTDFIS
     PSKFRELVKT PQDLYDNKCL IKPHNYKLAY TKLLTTLRKK FLEGAEIDKS ASVKDEHSTQ
     KHNLRYDLEV IIRSILERYA PIFISLTSNM IEEDLLLQEV TLQRALLDLE NMAKLVSCTP
     MCIWRRSGEI CFVSNEFYSL TGFNKNLLLD RTSFIFEYLD HKSVSNYFQI FNELLAFGYN
     DINKRKKLLM LNACSSTSSK ITEGFSFTTD GKAIFTKCNL LLSNGLYLKC ACCWTVKRDS
     FNIPILVMGQ FLPIFEMD
>P43551 nuc PUTATIVE 62.1 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN AGP3-ALR2
     MARNRQACDC CCIRRVKCDR KKPCKCCLQH NLQCTYLRPL KKRGPKPVKV RNLKKVDDVQ
     VFSKSSSGGI MKVPKALIDQ CLRLYNDKLY VIWPLLCYDD LYELLEKRYD ETCVYWFLVS
     LSAATLSDLQ TEIESEGGVT FTGIQLSSFC MSSRQEFDDF NGSDIFKIMT YYCLNRCYAQ
     MSNSRTSYRL SCEAVGLIKL AGFHREETLK LLPFDEQQLG RKVYYLLLLT ERYFSVYTHC
     ATSLDTTIAP PQPENVTDPR LSLDSFLEMI RVFTVPGKCF FDALATDSAN VTCTEDSLKK
     IWRELHTVPL EIEPWSYGYV DISFSRHWIR TLAWKLVLQI SGMRISFLSN SKNTHIPVEI
     ARDMLEDTFL IPKNLYAVHG PGISVKALEI ADALVDVVNQ YDQNAESEAW NFLFDISKFV
     FSLKHCDSTL VDKFTTKCQC ALITLPLSNP LESTDGSKED VDALP
>P43574 nuc GAT1 PROTEIN.
     MHVFFPLLFR PSPVLFIACA YIYIDIYIHC TRCTVVNITM STNRVPNLDP DLNLNKEIWD
     LYSSAQKILP DSNRILNLSW RLHNRTSFHR INRIMQHSNS IMDFSASPFA SGVNAAGPGN
     NDLDDTDTDN QQFFLSDMNL NGSSVFENVF DDDDDDDDVE THSIVHSDLL NDMDSASQRA
     SHNASGFPNF LDTSCSSSFD DHFIFTNNLP FLNNNSINNN HSHNSSHNNN SPSIANNTNA
     NTNTNTSAST NTNSPLLRRN PSPSIVKPGS RRNSSVRKKK PALKKIKSST SVQSSATPPS
     NTSSNPDIKC SNCTTSTTPL WRKDPKGLPL CNACGLFLKL HGVTRPLSLK TDIIKKRQRS
     STKINNNITP PPSSSLNPGA AGKKKNYTAS VAASKRKNSL NIVAPLKSQD IPIPKIASPS
     IPQYLRSNTR HHLSSSVPIE AETFSSFRPD MNMTMNMNLH NASTSSFNNE AFWKPLDSAI
     DHHSGDTNPN SNMNTTPNGN LSLDWLNLNL
>P43610 nuc HYPOTHETICAL 88.7 KD HELICASE IN CDC26-SAP155 INTERGENIC REGION.
     MSRCSNAALM TVVEDAVGAR VAARTRNMSN GVNYREKEVN DLTADISDSD SDLDSEDNKH
     GKGDNDTAPI WLQDDVHSDE DIQLDSEDDS DTEAVQAQVV DKLAKDTKSE QKSLDDELSE
     MDTKTVSLKL KKLNEFVRQS QVYSSIIADT LLHRSNEVAN ANTKDNSNSD DEEHSSKKRK
     TKKKSITDFF KKQKKNEDTT TQNGAPDDAA IKQPRLLKNC ILKPYQLEGL NWLITLYENG
     LNGILADEMG LGKTVQSIAL LAFIYEMDTK GPFLVTAPLS TLDNWMNEFA KFAPDLPVLK
     YYGTNGYKER SAKLKNFFKQ HGGTGIVITS YEIILRDTDL IMSQNWKFLI VDEGHRLKNI
     NCRLIKELKK INTSNRLLLT GTPLQNNLAE LWSLLNFIMP DIFADFEIFN KWFDFDSLNL
     GSGSNSEALN KLINDELQKN LISNLHTILK PFLLRRLKKV VLANILPPKR EYIINCPMTS
     AQEKFYKAGL NGKLKKTMFK ELIKDFFTLN DEYIGHVSNR SIRDFINYKL SGNETSNTDN
     KINPTLLQMD KLYKKNLQME ISNKKLQNMM MQLRQIIDST FLFYFPYLHP EDLTLETLLK
     TSGKLQILQK LIPPLISEGH KVLIYSQFVN MLDLIEDWCD LNSFATFRID GSVNNETRKD
     QLEKFNSSKD KHNIFLLSTR AAGLGINLVG ADTVVLFDSD WNPQVDLQAM DRCHRIGQES
     PVIVYRLCCD NTIEHVILTR AANKRNLERM VIQMGKFNNL KKLALNEGFF FEGKQSGC
>P46674 nuc LEUCINE PERMEASE TRANSCRIPTIONAL REGULATOR.
     MNTSFGSVVP STNFNFFKGH GNNDNTSANS TVNNSNFFLN SNETKPSKNV FMVHSTSQKK
     SQQPLQNLSH SPSYTENKPD KKKKYMINDA KTIQLVGPLI SSPDNLGFQK RSHKARELPR
     FLINQEPQLE KRAFVQDPWD KANQEKMISL EESIDDLNEL YETLKKMRNT ERSIMEEKGL
     VDKADSAKDL YDAIVFQGTC LDMCPTFERS RRNVEYTVYS YEKNQPNDKK ASRTKALKVF
     ARPAAAAAPP LPSDVRPPHI LVKTLDYIVD NLLTTLPESE GFLWDRMRSI RQDFTYQNYS
     GPEAVDCNER IVRIHLLILH IMVKSNVEFS LQQELEQLHK SLITLSEIYD DVRSSGGTCP
     NEAEFRAYAL LSKIRDPQYD ENIQRLPKHI FQDKLVQMAL CFRRVISNSA YTERGFVKTE
     NCLNFYARFF QLMQSPSLPL LMGFFLQMHL TDIRFYALRA LSHTLNKKHK PIPFIYLENM
     LLFNNRQEII EFCNYYSIEI INGDAADLKT LQHYSHKLSE TQPLKKTYLT CLERRLQKTT
     YKGLINGGED NLASSVYVKD PKKDRIPSIA DQSFLMENFQ NNYNEKLNQN SSVKPQINTS
     PKRVATRPNH FPFSQESKQL PQISQSHTLS TNPLLTPQVH GDLSEQKQQQ IKTVTDGGSP
     FVFDQSAQNS TVEASKAHMI STTSNGAYDE KLSSEQEEMR KKEEQRIEEE KTQLKKKQEN
     ADKQVITEQI ANDLVKEVVN SSVISIVKRE FSEANYRKDF IDTMTRELYD AFLHERLYLI
     YMDSRAELKR NSTLKKKFFE KWQASYSQAK KNRILEEKKR EEIKLVSHQL GVPGFKKSTC
     LFRTPYKGNV NSSFMLSSSD KNLIFSPVND EFNKFATHLT KISKLWRPLE MQSIYYDNLT
     KKFPSNSLTP ANLFIYAKDW TSLSNRWILS KFNLQTAQDS KKFSNNIISS RIICIDDEYE
     PSDFSDLQLL IFNTGVTNPD IFDLEMKLKD DGEELIKLIT GISLNTNICF SLLIIYWESA
     ENTLSESTIK HLLKLNRISK NYSSVIERID LMNLTEESPH KCLEDKLSEI SHSYVYKLTE
     RGKYDKTLRQ KRSLAGIHSR STQLQTTKDI DQKMKKMLEK EKNKYQQQIG ERNTYAHLES
     HIDASPRSKK RKLPILLSTS HSSQFKTPLA SRLNTSGSST SPPLPSHLAM KFRKNSRVTS
     LHTVLPVSTP SHSNNIPAAS FSGNNTTDIQ SQQLIENQKS TSVYLNNVSE RILGNQEICQ
     TPINPVTPVL DGADQGKEDI PDSILELKIL IDSVKKKVNN D
>P46677 nuc TRANSCRIPTION INITIATION FACTOR TFIID 145 KD SUBUNIT (TBP-ASSOCIATED
     MVKQQGSGKT NLANEDEAYE AIFGGEFGSL EIGSYIGGDE GANSKDYTEH LPDAVDFEDE
     DELADDDDDL PEESDANLHP AMMTMGAYDD VNENGAVLGI DSNSLNMQLP EINGDLSQQF
     ILEDDGGTPA TSNALFMGMD ANEIHLATET GVLDGSGANE IGHSQLSIGG VNGNDMSING
     GFIMEPDMSD GKHKKATKLD LINHEKYLLK KYFPDFEKGK ILKWNKLIYR RSVPYHWHSE
     ISRVKKPFMP LNLKFKVQQD DKRLFNSRTI SYVAPIYQGK NNLLQSNSSA SRRGLIHVSI
     DELFPIKEQQ KKRKIIHDEK TISEDLLIAT DDWDQEKIIN QGTSSTATLA DSSMTPNLKF
     SGGYKLKSLI EDVAEDWQWD EDMIIDAKLK ESKHAELNMN DEKLLLMIEK TNNLAQQKQQ
     LDSSNLILPL NETILQQKFN LSNDDKYQIL KKTHQTKVRS TISNLNIQHS QPAINLQSPF
     YKVAVPRYQL RHFHRENFGS HIRPGTKIVF SKLKARKRKR DKGKDVKESF STSQDLTIGD
     TAPVYLMEYS EQTPVALSKF GMANKLINYY RKANEQDTLR PKLPVGETHV LGVQDKSPFW
     NFGFVEPGHI VPTLYNNMIR APVFKHDISG TDFLLTKSSG FGISNRFYLR NINHLFTVGQ
     TFPVEEIPGP NSRKVTSMKA TRLKMIIYRI LNHNHSKAIS IDPIAKHFPD QDYGQNRQKV
     KEFMKYQRDG PEKGLWRLKD DEKLLDNEAV KSLITPEQIS QVESMSQGLQ FQEDNEAYNF
     DSKLKSLEEN LLPWNITKNF INSTQMRAMI QIHGVGDPTG CGEGFSFLKT SMKGGFVKSG
     SPSSNNNSSN KKGTNTHSYN VAQQQKAYDE EIAKTWYTHT KSLSISNPFE EMTNPDEINQ
     TNKHVKTDRD DKKILKIVRK KRDENGIIQR QTIFIRDPRV IQGYIKIKEQ DKEDVNKLLE
     EDTSKINNLE ELEKQKKLLQ LELANLEKSQ QRRAARQNSK RNGGATRTEN SVDNGSDLAG
     VTDGKAARNK GKNTTRRCAT CGQIGHIRTN KSCPMYSSKD NPASPK
>P46948 nuc RRP41 PROTEIN.
     MSRLEIYSPE GLRLDGRRWN ELRRFESSIN THPHAADGSS YMEQGNNKII TLVKGPKEPR
     LKSQMDTSKA LLNVSVNITK FSKFERSKSS HKNERRVLEI QTSLVRMFEK NVMLNIYPRT
     VIDIEIHVLE QDGGIMGSLI NGITLALIDA GISMFDYISG ISVGLYDTTP LLDTNSLEEN
     AMSTVTLGVV GKSEKLSLLL VEDKIPLDRL ENVLAIGIAG AHRVRDLMDE ELRKHAQKRV
     SNASAR
>P46954 nuc SIP4 PROTEIN.
     MAKRKYGRSY SLDDTDSCSN KVLIVPTGQS SSNAITDFSV RKAHACDRCR LKKIKCDGLK
     PNCSNCAKID FPCKTSDKLS RRGLPKGYTE LLEKEVVRLT NMNASSSANA NSNLPFINDT
     FYCFDNYNTQ SENQRFLGHL TWNILTNTFP TQKAVVFTDD RNNIDLQLQL LTNFLNLNGD
     FNHLPNFLLL KYDYNLQFLK NLLSVIIKDF FKRQNSLLLL LYPTNLWKNL LLDKINSTAM
     TGEPITLLAL LYIIQFTWSC FDDFKLFKVT KLIVSLTTNS KLDLKVLQLV NLSIFYFMGA
     SVDSCKSKSS LTEHSNVNSV IWTNDLLNLN FTNILNMGLY INPKNLIPIS GNNNNNKSNE
     EDDRIVTFWC FQFLSSWWSL IQGLPKSNFL TEEFQPKSIS VLEIPRLKPF EILLNFIIYS
     LDGCNLLNIS SLNVSDPNFQ FFQNELESFK KNLLLWNLYH NLSDHDNFRF LTSSSNKKLT
     TNLLLKNLTG LNHKLNQPDF VEIQLTLFYL SLKLMTLKEG DQDLKKEDIS LEILSLYFLI
     LTDDSNNDDN QQLQPQQLNL YHFTPFNSID IIDLCLNNLN NWSLSLKYES GQNQPHSSKI
     KFEKFQNFLN HWCPIWYYDE FSTNPFLQIL KINFKLLPFE TIHYSQEEQR LLISLNKLRY
     LDAVSSFNSS SVKSNFASKV NTQLNLLQHS SSNSNFLDAS PYDFNKIFMN NFENYDYETD
     EGYAEDDDEE DSDSDNSLPL EIPFKKSKNK CKNRNKELSQ RLSLFENRDS NSVDFNTDTN
     LNLNPDSPSV TSSKKKYLDH IILDNRDIVS NHDSSKQKFK IQNILNSTF
>P46959 nuc GCD14 PROTEIN.
     MSTNCFSGYK DLIKEGDLTL IWVSRDNIKP VRMHSEEVFN TRYGSFPHKD IIGKPYGSQI
     AIRTKGSNKF AFVHVLQPTP ELWTLSLPHR TQIVYTPDSS YIMQRLNCSP HSRVIEAGTG
     SGSFSHAFAR SVGHLFSFEF HHIRYEQALE EFKEHGLIDD NVTITHRDVC QGGFLIKKGD
     TTSYEFGNNE TAASLNANVV FLDLPAPWDA IPHLDSVISV DEKVGLCCFS PCIEQVDKTL
     DVLEKYGWTD VEMVEIQGRQ YESRRQMVRS LNDALERLRD IKRHKLQGVE RRKRMFNNTI
     DSNDEKVGKR NEDGVPLTEK AKFNPFGKGS RIKEGDSNYK WKEVTKMEAE IKSHTSYLTF
     AFKVVNRSRD DEKVNEILRS TEK
>P46974 nuc ZINC FINGER PROTEIN ZMS1.
     MEPFAFGRGA PALCILTAAA RINLDNFVPC CWALFRLSFF FPLDPAYIRN ENKETRTSWI
     SIEFFFFVKH CLSQHTFFSK TLAPKRNFRA KKLKDIGDTR IDRADKDFLL VPEPSMFVNG
     NQSNFAKPAG QGILPIPKKS RIIKTDKPRP FLCPTCTRGF VRQEHLKRHQ HSHTREKPYL
     CIFCGRCFAR RDLVLRHQQK LHAALVGTGD PRRMTPAPNS TSSFASKRRH SVAADDPTDL
     HIIKIAGNKE TILPTPKNLA GKTSEELKEA VVALAKSNNV ELPVSAPVMN DKREKTPPSK
     AGSLGFREFK FSTKGVPVHS ASSDAVIDRA NTPSSMHKTK RHASFSASSA MTYMSSSNSP
     HHSITNFELV EDAPHQVGFS TPQMTAKQLM ESVSELDLPP LTLDEPPQAI KFNLNLFNND
     PSGQQQQQQQ QQQNSTSSTI VNSNNGSTVA TPGVYLLSSG PSLTDLLTMN SAHAGAGGYM
     SSHHSPFDLG CFSHDKPTVS EFNLPSSFPN TIPSNSTTAS NSYSNLANQT YRQMSNEQPL
     MSLSPKNPPT TVSDSSSTIN FNPGTNNLLE PSMEPNDKDS NIDPAAIDDK WLSEFINNSD
     PKSTFKINFN HFNDIGFIYS PPSSRSSIPN KSPPNHSATS LNHEKASLSP RLNLSLNGST
     DLPSTPQNQL KEPSYSDPIS HSSHKRRRDS VMMDYDLSNF FSSRQLDISK VLNGTEQNNS
     HVNDDVLTLS FPGETDSNAT QKQLPVLTPS DLLSPFSVPS VSQVLFTNEL RSMMLADNNI
     DSGAFPTTSQ LNDYVTYYKE EFHPFFSFIH LPSIIPNMDS YPLLLSISMV GALYGFHSTH
     AKVLANAAST QIRKSLKVSE KNPETTELWV IQTLVLLTFY CIFNKNTAVI KGMHGQLTTI
     IRLLKASRLN LPLESLCQPP IESDHIMEYE NSPHMFSKIR EQYNAPNQMN KNYQYFVLAQ
     SRIRTCHAVL LISNLFSSLV GADCCFHSVD LKCGVPCYKE ELYQCRNSDE WSDLLCQYKI
     TLDSKFSLIE LSNGNEAYEN CLRFLSTGDS FFYGNARVSL STCLSLLISI HEKILIERNN
     ARISNNNTNS NNIELDDIEW KMTSRQRIDT MLKYWENLYL KNGGILTPTE NSMSTINANP
     AMRLIIPVYL FAKMRRCLDL AHVIEKIWLK DWSNMNKALE EVCYDMGSLR EATEYALNMV
     DAWTSFFTYI KQGKRRIFNT PVFATTCMFT AVLVISEYMK CVEDWARGYN ANNPNSALLD
     FSDRVLWLKA ERILRRLQMN LIPKECDVLK SYTDFLRWQD KDALDLSALN EEQAQRAMDP
     NTDINETIQL IVAASLSSKC LYLGVQILGD APIWPIILSF AHGLQSRAIY SVTKKRNTRI
>P47043 nuc HYPOTHETICAL 98.9 KD ZINC FINGER PROTEIN IN BTN1-PEP8 INTERGENIC
     MDALTPRDSP KRDDSMATSA ATAASAKPDA LTIGKEGIVH GHIHNYNNLT YIHGHLHHSA
     PVNDSSASAT PAAAAVADAA TSAFASGASH DMGGDCHVNE KCKEYTDCQH FEFLNYHNNP
     SLTKYNDTAT YNSNNHSFAN NFHSVASDPT SPQQNSKSDL PRRKDSWFND DLILLPSSKK
     NKPNPPPGSD DCYCTPKILE ICCDETHPKS EANIKQGESD QPTKKDISEN GNDVAIFTDV
     KNDHLMPNFN LHDQYCNSTN HDSHNHNNTV PDSFSQLMSH LSEIDCDLTC DTPCTASTSA
     TSGHKFVQDH QSSNNDDVFH KYCKFCEEST DNQPCSKHMH LESKPPQLPP KCSSLRKPTN
     TLQGTNHAYH EHILNTDMDL KILEDLCNIS SLYEVPFGKH INHHDHNNAG NGCDGSSTGN
     NENGNQTMNL LLSSINRCNP KNNLNGSNNN TAGATSTDHQ HHHHRIQFHS HKPNRNNIVN
     NSGISAANTT ADLTNNDLND LISREYSYER FRNQSEPPSL PKVTHQNQKN RRSWPTKDLE
     STDFSSLEDS LPSSISPPIQ TTSTINFNWC FKEEKNNDLK CKWKECPESC SSLFDLQRHL
     LKDHVSQDFK HPMEPLACNW EDCDFLGDDT CSIVNHINCQ HGINFDIQFA NPDSFLPGSI
     SKEKHHLLHC PNPQTHEVSK ADGAPDMTSA NDVSNIPPIK QPEQVICQWD GCNKSFSSAQ
     ELNDHLEAVH LTRGKSEYQC LWHDCHRTFP QRQKLIRHLK VHSKYKPYKC KTCKRCFSSE
     ETLVQHTRTH SGEKPYKCHI CNKKFAISSS LKIHIRTHTG EKPLQCKICG KRFNESSNLS
     KHIKTHQKKY KCSDCSKSFD DLGKLNSQKV KCALERKPYL
>P47175 nuc HYPOTHETICAL 41.2 KD PROTEIN IN RPS7B-DAL5 INTERGENIC REGION.
     MDATSRMEQP DVFVSKLYHL LQGNAYSNII QWSTDGSKLV IWNPDQFTKV ILERFFGIHT
     FAAFVKQLSK YNFQKAGRPD CVEFSNIHFQ KDNINSLSLV KAHQSAATPN VAAVNNMNKQ
     CTFHWDPFKV NSILSKAIGK PSFEKLVKNV DRLQGNLDEL KSTNADSLRI IREINASLQT
     ISYHQFHAYQ TANFLQENFE AIKKVVCPDS CLQHQQRQPK RPKRYSLLLL IPNASELSET
     PLMRFAGVFE FMNCSLDTAT QWHPQLHPEA YDLLFVTVSP NMQQEHLIYF KRLRNLLPSF
     PVIAIINRPV SPQDTSIAPS NYSRYYFHHF LQLGFSDILV SPFTPTQLIT LLSKHLRT
>P47821 nuc RNA POLYMERASE II HOLOENZYME CYCLIN-LIKE SUBUNIT.
     MSGSFWTSTQ RHHWQYTKAS LAKERQKLWL LECQLFPQGL NIVMDSKQNG IEQSITKNIP
     ITHRDLHYDK DYNLRIYCYF LIMKLGRRLN IRQYALATAH IYLSRFLIKA SVREINLYML
     VTTCVYLACK VEECPQYIRT LVSEARTLWP EFIPPDPTKV TEFEFYLLEE LESYLIVHHP
     YQSLKQIVQV LKQPPFQITL SSDDLQNCWS LINDSYINDV HLLYPPHIIA VACLFITISI
     HGKPTKGSSL ASAASEAIRD PKNSSSPVQI AFNRFMAESL VDLEEVMDTI QEQITLYDHW
     DKYHEQWIKF LLHTLYLRPA SAI
>P47822 nuc SUPPRESSOR OF RNA POLYMERASE B SRB7.
     MTDRLTQLQI CLDQMTEQFC ATLNYIDKNH GFERLTVNEP QMSDKHATVV PPEEFSNTID
     ELSTDIILKT RQINKLIDSL PGVDVSAEEQ LRKIDMLQKK LVEVEDEKIE AIKKKEKLLR
     HVDSLIEDFV DGIANSKKST
>P47976 nuc ZINC FINGER PROTEIN CTH1.
     MMPNVAPNSY YLNIPNANST STTTSSIFSD LNKEYESKIK EIEEYYIKTL LNENTDNDDS
     SSSEGHNINE TDILSEYSPR PSPWLPSKPN CYHPLGDFKD LIISDSRPTN TLPINNPFAG
     NNNISTLATT EKKRKKRSLE VRVNPTYTTS AFSLPLTAEN LQKLSQVDSQ STGLPYTLPI
     QKTTKLEPCR RAPLQLPQLV NKTLYKTELC ESFTIKGYCK YGNKCQFAHG LNELKFKKKS
     NNYRTKPCIN WSKLGYCPYG KRCCFKHGDD KDVEIYQNAN DGRSKDTALT PLPTSLAPSN
     NDNITNLSKP RNLHTSVKAL QRMTW
>P47977 nuc ZINC FINGER PROTEIN CTH2 (YTIS11 PROTEIN).
     MWAQLSYTRP ESQKTDLTSL FSTDQEQNPL NDYQYQINIR ELEEYYNKTI LNEDNIQETS
     SEISSAVSFS PPKNTNAIQP GLLYDPQLMN PFLPSAHLNS TAPTTFKKKL EVQINPDYVP
     KSSQLPLTSQ NLQQLSQQKP KNDASFSSEK ESSAQPKVKS QVQETPKQLY KTELCESFTL
     KGSCPYGSKC QFAHGLGELK VKKSCKNFRT KPCVNWEKLG YCPYGRRCCF KHGDDNDIAV
     YVKAGTYCNV SSTSKQSDEK RSNGRGSAKK KNLNVKVKAL QRMTW
>P48510 nuc UBIQUITIN-LIKE PROTEIN DSK2.
     MSLNIHIKSG QDKWEVNVAP ESTVLQFKEA INKANGIPVA NQRLIYSGKI LKDDQTVESY
     HIQDGHSVHL VKSQPKPQTA SAAGANNATA TGAAAGTGAT PNMSSGQSRG FNPLADLTSA
     RYAGYLNMPS ADMFGPDGGA LNNDSNNQDE LLRMMENPIF QSQMNEMLSN PQMLDFMIQS
     NPQLQAMGPQ ARQMLQSPMF RQMLTNPDMI RQSMQFARMM DPNAGMGSAG GAASAFPAPG
     GDAPEEGSNT NTTSSSNTGN NAGTNAGTNA GANTAANPFA SLLNPALNPF ANAGNRASTG
     MPAFDPALLA SMFQPPVQAS QAEDTRPPEE RYEHQLRQLN DMGFFDFDRN VAALRRSGGS
     VQGALDSLLN GDV
>P48581 nuc DNA DAMAGE CHECKPOINT CONTROL PROTEIN RAD17.
     MRINSELANK FSASTVHLEH ITTALSCLTP FGSKDDVLIF IDADGLSFVR ENNHVIKIQL
     LLSRELFMSY SYRNETEDHM KLCVKINHIL DSVSVMNRNS DDIVECTLSY DGHGSPFVLI
     FEDSFISERV EYSTYLIKDF DTNGLELDRE RISFEAIIKG EALHSALKDL KEIGCKECYV
     YAKTEANDEN VFALISKSQL GFSKIKLPSN RSILEKLQVF DGDSTTVIDG FAVIGFFDFT
     SFDKIRKSTK IASKVLFRMD VHGVLSVNIL SQTDDVIITD TTRPSNNRPG SIRQLQLPKD
     YPGIVIEVCM LEKESIDEAA QTEIELLMET NELGNRNSFK KSTIRKRYGT DKGNETSNDN
     LLQLNGKKIK LPSEEENNKN RESEDEENHC KYPTKDIPIF F
>P49704 nuc PRE-MRNA SPLICING FACTOR PRP31.
     MSSEEDYFDE LEYDLADEVN EEKEDIQTKK LTTVNCQTEK FNPFEILPES IELFRTLALI
     SPDRLSLSET AQILPKIVDL KRILQQQEID FIKLLPFFNE IIPLIKSNIK LMHNFLISLY
     SRRFPELSSL IPSPLQYSKV ISILENENYS KNESDELFFH LENKAKLTRE QILVLTMSMK
     TSFKNKEPLD IKTRTQILEA NSILENLWKL QEDIGQYIAS KISIIAPNVC FLVGPEIAAQ
     LIAHAGGVLE FSRIPSCNIA SIGKNKHLSH ELHTLESGVR QEGYLFASDM IQKFPVSVHK
     QMLRMLCAKV SLAARVDAGQ KNGDRNTVLA HKWKAELSKK ARKLSEAPSI SETKALPIPE
     TNPKRKELGE NLGSTRKNSD YRMSDNYKIG WNLAKQEQTV LDSYGEEVGL GMSNTSLQQA
     VGATSGSRRS AGNQAKLTKV MKHRISEANQ QADEFLISLG HNTEQPNLSP EMVQMHKKQH
     TNPEEETNWF SGHG
>P50104 nuc PUTATIVE 109.8 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN SOK2-FMS1
     MSINHEIYYI LVFEHRSVAI KLIIVVIVLL QFFLARSRQI DRTWAHTNRK ERFREMTAIG
     NTDDALDTST AASKENGKGR LRVQKACELC KKRKVKCDGN NPCLNCSKHQ KECRYDFKAT
     NRKRRRRQVA SAVRDVSKTY AETSESFPRD LLSKSNIIIN APSDGVSSSA SNSPNPNSHY
     HHISSTLPFM SGRPNHTFHS GSNLNGENNN NSFPEDHMAK LLLQLSSKLG NTTKESSIRT
     TRTNASDVNA NPTVVNMKNS QEDCDTNHRS AICDSAEALH NNNINSKENK IINSQITNTV
     NDHFESPWQT FSLDKYRFHR RYQNILPYYL GVSILKDLSP QTIEYAKLKR PRVQNYGWNL
     SGGHYLKYKG DFRSQEKNIR HESKFFDFDD PVHLSLINKL LRYYFDEINP VFSIIHEATF
     WQQYNNKFLR QGKQNNSSAN LFTSMLYLIL STTLRFREGH LDGQKGQGTY SNTSLNITFE
     EKSILIKKPS IEENLFKYAY LIINTLTFEW ESFELIQSWL LITFYFRTCY RQTACWNALS
     QAVNMCNGMS LYLNKFPEIH STYDESKAWH CFWCCFIMDK LISFQMGRFY QLSLPASEMC
     EQMNLVKSKK FLQEEDDWFH EETFQMLDLS IIVTQFLKRD AQDLNLNETV QLRSQLGQWY
     DTFIVGSQTN AYDDNYRYFY QVQPFMTYLD IRLTFEVRQL FCLIAPSSTA NNKSLEYVVD
     TELLISHCQM AIENLAEITR SNLFFVPWWL NLSQLFTVNL ICIIYLHAGI AVTQNKAIMQ
     SCQEIWRTLE CSKPKNRPSM LPECLWCLKM LNHMFCIRLR DSALQLEATL GTDHGDDTPN
     RNKFEQFKKV GDNDADVEVD AGEREENADE RQENPHNNSK RVPLATRSHN TTNFDGSIAI
     SPESAVANLG TDTGLPSDVL DTVSKIGNSP NVFDDDLFSN LLWFDQNFA
>P51979 nuc HFM1 PROTEIN.
     MQSEAFPSIY ESNENCIISS PTGSGKTVLF ELAILRLIKE TNSDTNNTKI IYIAPTKSLC
     YEMYKNWFPS FVNLSVGMLT SDTSFLETEK AKKCNIIITT PEKWDLLTRR WSDYSRLFEL
     VKLVLVDEIH TIKEKRGASL EVILTRMNTM CQNIRFVALS ATVPNIEDLA LWLKTNNELP
     ANILSFDESY RQVQLTKFVY GYSFNCKNDF QKDAIYNSKL IEIIEKHADN RPVLIFCPTR
     ASTISTAKFL LNNHIFSKSK KRCNHNPSDK ILNECMQQGI AFHHAGISLE DRTAVEKEFL
     AGSINILCST STLAVGVNLP AYLVIIKGTK SWNSSEIQEY SDLDVLQMIG RAGRPQFETH
     GCAVIMTDSK MKQTYENLIH GTDVLESSLH LNLIEHLAAE TSLETVYSIE TAAAVNWLRN
     TFFYVRFGKN PAAYQEVNRY VSFHSVEDSQ INQFCQYLLD TLVKVKIIDI SNGEYKSTAY
     GNAMTRHYIS FESMKQFINA KKFLSLQGIL NLLATSEEFS VMRVRHNEKK LFKEINLSPL
     LKYPFLTEKK QSQIIDRVSQ KVSLLIQYEL GGLEFPSYEG ASKLHQTLVQ DKFLVFRHCF
     RLLKCMVDTF IEKSDGTSLK NTLFLLRSLN GHCWENTPMV LRQLKTIGLV SVRRLIRHGI
     TNLEEMGHLS DTQIEYYLNL KIGNGIKIKN DISLLPCLNI RTKLENCKIE NEELWLTFKV
     EISATFKSSI WHGQHLSLDI ETEKSSGELI DFRRLQVNKL QSPRGFRISA KISPKLEKIE
     FSIHCQEIAG LGKTIVYSTD HLASQFSAKT PNIRKDLNSL EKCLFYESSS DGEVGKTSRV
     SHKDGLEESL SSDDSILDYL NERKKSSKAV ESAAVIHPEA HSSSHFSNGR QVRSNGNYEC
     FHSCKDKTQC RHLCCKEGIP VKYIKEKGPS SIKPVSKPDQ IRQPLLAKNI NTTPHLEKRL
     NSKPKQWQEE NTDIATVHTL PSKIYNLSQQ MSSMEAGEQV LKSGPENCPE IIPIDLESSD
     SYSSNTAASS ISDPNGDLDF LGSDIEFE
>P53035 nuc REGULATORY PROTEIN MIG2.
     MPKKQTNFPV DNENRPFRCD TCHRGFHRLE HKKRHLRTHT GEKPHHCAFP GCGKSFSRSD
     ELKRHMRTHT GQSQRRLKKA SVQKQEFLTV SGIPTIASGV MIHQPIPQVL PANMAINVQA
     VNGGNIIHAP NAVHPMVIPI MAQPAPIHAS AASFQPATSP MPISTYTPVP SQSFTSFQSS
     IGSIQSNSDV SSIFSNMNVR VNTPRSVPNS PNDGYLHQQH IPQQYQHQTA SPSVAKQQKT
     FAHSLASALS TLQKRTPVSA PSTTIESPSS PSDSSHTSAS SSAISLPFSN APSQLAVAKE
     LESVYLDSNR YTTKTRRERA KFEIPEEQEE DTNNSSSGSN EEEHESLDHE SSKSRKKLSG
     VKLPPVRNLL KQIDVFNGPK RV
>P53050 nuc MGA1 PROTEIN.
     MQPKTFVHQL HAILLEPEVN KWIYWSPTDN TVFFLKPYDP NFSTHVLKRY FKHGNVNSFV
     RQLHMYGFHK LSHPSPDQSS ANNGNVKELV EWKFTHPSGF FFKEANAGIL NKIQRKSTGV
     GKDGKRKNIL SPISVSYVDA SRLNVLSQQS GPVSAREPSN MFMGSPVHYS TSQSPPHISI
     PQQQQSSGPY LISSLPPQQP TVNMMRRQSI SARMMNSYDY PNQFSTQDSI VQPQQPQQVL
     SPQALSGPPM KKSGTLSSTD DLKTTSLPIV NYPMPYHPGA FAQQQQQQQQ PLPTVPPYSS
     YSTPFPSMMN SLSNSASNSP ALGVCNNNVT LPKKSNISER QALDNHIQTL KNSLSTITDL
     IEKHINSASQ DENKTLTNDA MNKDLRTSLS LLQNSKEEII QLESKWMSMQ SVKTTALPLQ
     ETTNTSSTLT SLTSSIIPKS IPIITKGEVA TKPASY
>P53091 nuc MINICHROMOSOME MAINTENANCE PROTEIN 6.
     MSSPFPADTP SSNRPSNSSP PPSSIGAGFG SSSGLDSQIG SRLHFPSSSQ PHVSNSQTGP
     FVNDSTQFSS QRLQTDGSAT NDMEGNEPAR SFKSRALNHV KKVDDVTGEK VREAFEQFLE
     DFSVQSTDTG EVEKVYRAQI EFMKIYDLNT IYIDYQHLSM RENGALAMAI SEQYYRFLAF
     LQKGLRRVVR KYAPELLNTS DSLKRSEGDE GQADEDEQQD DDMNGSSLPR DSGSSAAPGN
     GTSAMATRSI TTSTSPEQTE RVFQISFFNL PTVHRIRDIR SEKIGSLLSI SGTVTRTSEV
     RPELYKASFT CDMCRAIVDN VEQSFKYTEP TFCPNPSCEN RAFWTLNVTR SRFLDWQKVR
     IQENANEIPT GSMPRTLDVI LRGDSVERAK PGDRCKFTGV EIVVPDVTQL GLPGVKPSST
     LDTRGISKTT EGLNSGVTGL RSLGVRDLTY KISFLACHVI SIGSNIGASS PDANSNNRET
     ELQMAANLQA NNVYQDNERD QEVFLNSLSS DEINELKEMV KDEHIYDKLV RSIAPAVFGH
     EAVKKGILLQ MLGGVHKSTV EGIKLRGDIN ICVVGDPSTS KSQFLKYVVG FAPRSVYTSG
     KASSAAGLTA AVVRDEEGGD YTIEAGALML ADNGICCIDE FDKMDISDQV AIHEAMEQQT
     ISIAKAGIHA TLNARTSILA AANPVGGRYN RKLSLRGNLN MTAPIMSRFD LFFVILDDCN
     EKIDTELASH IVDLHMKRDE AIEPPFSAEQ LRRYIKYART FKPILTKEAR SYLVEKYKEL
     RKDDAQGFSR SSYRITVRQL ESMIRLSEAI ARANCVDEIT PSFIAEAYDL LRQSIIRVDV
     DDVEMDEEFD NIESQSHAAS GNNDDNDDGT GSGVITSEPP ADIEEGQSEA TARPGTSEKK
     KTTVTYDKYV SMMNMIVRKI AEVDREGAEE LTAVDIVDWY LLQKENDLGS LAEYWEERRL
     AFKVIKRLVK DRILMEIHGT RHNLRDLENE ENENNKTVYV IHPNCEVLDQ LEPQDSS
>P53115 nuc HYPOTHETICAL 171.5 KD HELICASE IN NUT1-ARO2 INTERGENIC REGION.
     MSLAVLLNKE DKDISDFSKT TAGKSAKKNS RERVADVAPT RVLDKKQAYL SQLNSEFNRI
     KRRDSIEQLY QDWKFINLQE FELISEWNQQ SKDWQFDNTN DSQDLHFKKL YRDMSMINKE
     WAEYQSFKNA NLSDIINEKD ADEDEEDDED ELEDGEEDME EDEASTGRHT NGKSMRGNGI
     QKSRKKDAAA AAAIGKAIKD DQTHADTVVT VNGDENEDGN NGEDEDNDND NENNNDNDND
     NENENDNDSD NDDEEENGEE DEEEEEIEDL DEEDFAAFEE QDDNDDEDFN PDVEKRRKRS
     SSSSSSTKLS MNSLSLITSK KINKNITINS DRPKIVRELI KMCNKNKHQK IKKRRFTNCI
     VTDYNPIDSK LNIKITLKQY HVKRLKKLIN DAKREREREE ALKNNVGLDG NDLDNDEDGS
     ESHKRRKLNN NTANGADDAN KRKFNTRHGL PTYGMKMNAK EARAIQRHYD NTYTTIWKDM
     ARKDSTKMSR LVQQIQSIRS TNFRKTSSLC AREAKKWQSK NFKQIKDFQT RARRGIREMS
     NFWKKNEREE RDLKKKIEKE AMEQAKKEEE EKESKRQAKK LNFLLTQTEL YSHFIGRKIK
     TNELEGNNVS SNDSESQKNI DISALAPNKN DFHAIDFDNE NDEQLRLRAA ENASNALAET
     RAKAKQFDDH ANAHEEEEEE DELNFQNPTS LGEITIEQPK ILACTLKEYQ LKGLNWLANL
     YDQGINGILA DEMGLGKTVQ SISVLAHLAE NHNIWGPFLV VTPASTLHNW VNEISKFLPQ
     FKILPYWGNA NDRKVLRKFW DRKNLRYNKN APFHVMVTSY QMVVTDANYL QKMKWQYMIL
     DEAQAIKSSQ SSRWKNLLSF HCRNRLLLTG TPIQNSMQEL WALLHFIMPS LFDSHDEFNE
     WFSKDIESHA EANTKLNQQQ LRRLHMILKP FMLRRVKKNV QSELGDKIEI DVLCDLTQRQ
     AKLYQVLKSQ ISTNYDAIEN AATNDSTSNS ASNSGSDQNL INAVMQFRKV CNHPDLFERA
     DVDSPFSFTT FGKTTSMLTA SVANNNSSVI SNSNMNLSSM SSNNISNGKF TDLIYSSRNP
     IKYSLPRLIY EDLILPNYNN DVDIANKLKN VKFNIFNPST NYELCLFLSK LTGEPSLNEF
     FRVSTTPLLK RVIERTNGPK NTDSLSFKTI TQELLEVTRN APSEGVMASL LNVEKHAYER
     EYLNCIQRGY HPNVSAPPVT IEVLGSSHVT NSINNELFDP LISQALSDIP AITQYNMHVK
     KGIPVEDFPK TGLFPEPLNK NFSSNISMPS MDRFITESAK LRKLDELLVK LKSEGHRVLI
     YFQMTKMMDL MEEYLTYRQY NHIRLDGSSK LEDRRDLVHD WQTNPEIFVF LLSTRAGGLG
     INLTAADTVI FYDSDWNPTI DSQAMDRAHR LGQTRQVTVY RLLVRGTIEE RMRDRAKQKE
     QVQQVVMEGK TQEKNIKTIE VGENDSEVTR EGSKSISQDG IKEAASALA
>P53147 nuc HYPOTHETICAL 31.3 KD HOMEOBOX PROTEIN IN PRP20-VPS45 INTERGENIC
     MGTSIVNLNQ KIELPPIQVL FESLNRENET KPHFEERRLY QPNPSFVPRT NIAVGSPVNP
     VPVSSPVFFI GPSPQRSIQN HNAIMTQNIR QYPVIYNNNR EVISTGERNY IITVGGPPVT
     SSQPEYEHIS TPNFYQEQRL AQPHPVNESM MIGGYTNPQP ISISRGKMLS GNISTNSVRG
     SNNGYSAKEK KHKAHGKRSN LPKATVSILN KWLHEHVNNP YPTVQEKREL LAKTGLTKLQ
     ISNWFINARR RKIFSGQNDA NNFRRKFSSS TNLAKF
>P53243 nuc PUTATIVE 91.0 KD ZINC FINGER PROTEIN IN SPT4-ROM1 INTERGENIC REGION.
     MAAGQKKYIC SFCLKPFSRS EHKIRHERSH AGVKPFQCQV CKHSFVRRDL LQRHIRTVHR
     TFLLSSYASM TGDKADIPVS LGVGDVDSTS PRDIKMETLV NSMIKVNSGL INIHYHSSNV
     EKMDKQQRCV IGKESSSLKK GKSRFKQVKS RLESSISVKI LQEYSLDFIS SRDILTFFRM
     GVSHLVENKI FQNFFPDLFS SLQNDELVES FWINKPFGLI IACLGMSISL NQDSQKLWFI
     CCTNLYASSS KHDNDFDTED ILSQTEQHDV FALILFYSLL VMLENNIPVS NSIKKFDVFS
     MLQDILKPFT VASSSYHYLN SKENAWFIFD LWVNILRDSN NFNNDSLLIF GWFVNQEFIS
     SNPLKDFIYK GPSMSTTDLT LKHINILADS AYVYFIIKKT YPQELPSDFR VHDLLVYLNE
     CFVMQQPIKP ETSANPSLFA NVMNARITDC KSKSNWLLWE TIWFEFINNL TLRNGTTRNI
     WFIDNFPQVS TSCLLHHSSS FVDETLITTN LSIISMLLNL KSFTLASLNP RNIQLITDIV
     SFQLKLFSSE LIASSDVSPS QVSQLLVNPN VHLMLYFWFD TIYVQRQSYL SSTEKEEFEK
     VEVFVNDYII THQKNLVTDL HSILFDFWSD SFIAYHILLH AIVSSLRDNI LYPYLIYSPH
     LNDQTKALLT DISNWSCFAL QQPFRKTSRG SLSGASDMKS FSVASCLPLS PNFLKRDSNC
     NKILLPPLDI KAIEPISTSN YTYVNSAPKQ QEKEQPLLRA TGNNINLVQT IVVPPQVNME
     SQEFSASSTD NKQS
>P53316 nuc HYPOTHETICAL 89.5 KD PROTEIN IN MGA1-GCN4 INTERGENIC REGION.
     MNIAEEPSDE VISSGPEDTD ICSQQTSASA EAGDQSIKIE RKTSTGLQLE QLANTNLLTI
     RIKWQLQEEE DDHCNSRITD QIMDTIQHYK GISVNNSDTE TYEFLPDTRR LQVLEQNKDI
     YLYEHGSQEY EKSYKDNEEE DDWRYDTVLQ AQFKYPKSLE NACTDISELL KSEPIGQHID
     KWSIGVNKHA LTYPGNIFVG GIAKSLSIGE LSFLFSKYGP ILSMKLIYDK TKGEPNGYGF
     ISYPLGSQAS LCIKELNGRT VNGSTLFINY HVERKERERI HWDHVKENNN DDNFRCLFIG
     NLPYHNPEKV ETLITPKEVI EVIKKELSKK FPDFDIISYY FPKRSNTRSS SSVSFNEEGS
     VESNKSSNNT NGNAQDEDML KGYGFIKLIN HEQALAAIET FNGFMWHGNR LVVNKAVQHK
     VYNNHNSHDR HPSISNHNDM EVLEFANNPM YDYNNYTYDR YYFNNNKNGN SNDTSNVRYF
     DSVRSTPVAE KMDLFYPQRE SFSEGRGQRV PRFMGNKFDM YQYPSTSYSL PIPMSNQQES
     NLYVKHIPLS WTDEDLYDFY KSFGEIISVK VITVGGSKNK YRQQSNDSSS DNDLPVGSSR
     GYGFVSFESP LDAAKAILNT DGYQVSKDQV LSVSFAQKRG NLSSSDDDDQ SQTDNSSKFQ
     NFQPHNDYHK AYPTKYNKKF INALMTQNQS QQQVSRENYF IPLQYPNTNT KPVNSYNLIS
     ANQNNANWMM PMFPSFGFIP QVPPVPYIIP PQNPAANHIP IMANGSNEEE EFSSGDYSMD
     Y
>P53327 nuc PUTATIVE RNA HELICASE YGR271W.
     MSTEYSADSS KSFMIAMQSM IDTSQTFNLD RSKISLPDFD DELKKVQKDE PNQRTELTVL
     SQDRNDWDDI FEEFKDISFA QLQSIIDSYK TKNAVAVYKK IGKLINEAET TLSSNVLLET
     VLQMVYKHQK QELEKELLDF LGTGNIDLVS LLLQHRRMIV ATPIETTILL IKNAVNSTPE
     FLTQQDIRNQ VLESAEDAKN RKLNPATKII KYPHVFRKYE AGSTTAMAFA GQKFTLPVGT
     TRMSYNTHEE IIIPAADQAS NKNYLYTKLL KISDLDHFCK TVFPYETLNQ IQSLVYPVAY
     KTNENMLICA PTGAGKTDIA LLTIINTIKQ FSVVNGENEI DIQYDDFKVI YVAPLKALAA
     EIVDKFSKKL APFNIQVREL TGDMQLTKAE ILATQVIVTT PEKWDVVTRK ANGDNDLVSK
     VKLLIIDEVH LLHEDRGPVI ETLVARTLRQ VESSQSMIRI IGLSATLPNF MDVADFLGVN
     RQIGMFYFDQ SFRPKPLEQQ LLGCRGKAGS RQSKENIDKV AYDKLSEMIQ RGYQVMVFVH
     SRKETVKSAR NFIKLAESNH EVDLFAPDPI EKDKYSRSLV KNRDKDMKEI FQFGFGIHHA
     GMARSDRNLT EKMFKDGAIK VLCCTATLAW GVNLPADCVI IKGTQVYDSK KGGFIDLGIS
     DVIQIFGRGG RPGFGSANGT GILCTSNDRL DHYVSLITQQ HPIESRFGSK LVDNLNAEIS
     LGSVTNVDEA IEWLGYTYMF VRMRKNPFTY GIDWEEIAND PQLYERRRKM IVVAARRLHA
     LQMIVFDEVS MHFIAKDLGR VSSDFYLLNE SVEIFNQMCD PRATEADVLS MISMSSEFDG
     IKFREEESKE LKRLSDESVE CQIGSQLDTP QGKANVLLQA YISQTRIFDS ALSSDSNYVA
     QNSVRICRAL FLIGVNRRWG KFSNVMLNIC KSIEKRLWAF DHPLCQFDLP ENIIRRIRDT
     KPSMEHLLEL EADELGELVH NKKAGSRLYK ILSRFPKINI EAEIFPITTN VMRIHIALGP
     DFVWDSRIHG DAQFFWVFVE ESDKSQILHF EKFILNRRQL NNQHEMDFMI PLSDPLPPQV
     VVKVVSDTWI GCESTHAISF QHLIRPFNET LQTKLLKLRP LPTSALQNPL IESIYPFKYF
     NPMQTMTFYT LYNTNENAFV GSPTGSGKTI VAELAIWHAF KTFPGKKIVY IAPMKALVRE
     RVDDWRKKIT PVTGDKVVEL TGDSLPDPKD VHDATIVITT PEKFDGISRN WQTRKFVQDV
     SLIIMDEIHL LASDRGPILE MIVSRMNYIS SQTKQPVRLL GMSTAVSNAY DMAGWLGVKD
     HGLYNFPSSV RPVPLKMYID GFPDNLAFCP LMKTMNKPVF MAIKQHSPDK PALIFVASRR
     QTRLTALDLI HLCGMEDNPR RFLNIDDEEE LQYYLSQVTD DTLKLSLQFG IGLHHAGLVQ
     KDRSISHQLF QKNKIQILIA TSTLAWGVNL PAHLVIIKGT QFFDAKIEGY RDMDLTDILQ
     MMGRAGRPAY DTTGTAIVYT KESKKMFYKH FLNVGFPVES SLHKVLDDHL GAEITSGSIT
     NKQEALDFLS WTFLFRRAHH NPTYYGIEDD TSTAGVSEHL SSLIDSTLEN LRESQCVLLH
     GDDIVATPFL SISSYYYISH LTIRQLLKQI HDHATFQEVL RWLSLAVEYN ELPVRGGEII
     MNEEMSQQSR YSVESTFTDE FELPMWDPHV KTFLLLQAHL SRVDLPIADY IQDTVSVLDQ
     SLRILQAYID VASELGYFHT VLTMIKMMQC IKQGYWYEDD PVSVLPGLQL RRIKDYTFSE
     QGFIEMTPQQ KKKKLLTLEE IGRFGYKKLL NVFDQLTFGM TESEDTKKRF VSVCQRLPVL
     EGMKFEEQEN NEVLTFYSKH LSSKHNNGFE VYCDKFPKIQ KELWFLIGHK GDELLMIKRC
     QPKQMNKEVI IHCDLFIPEE IRGEELQFSL INDALGLRYD MVHKLIS
>P53397 nuc 8-OXOGUANINE DNA GLYCOSYLASE (EC 3.2.2.-).
     MSYKFGKLAI NKSELCLANV LQAGQSFRWI WDEKLNQYST TMKIGQQEKY SVVILRQDEE
     NEILEFVAVG DCGNQDALKT HLMKYFRLDV SLKHLFDNVW IPSDKAFAKL SPQGIRILAQ
     EPWETLISFI CSSNNNISRI TRMCNSLCSN FGNLITTIDG VAYHSFPTSE ELTSRATEAK
     LRELGFGYRA KYIIETARKL VNDKAEANIT SDTTYLQSIC KDAQYEDVRE HLMSYNGVGP
     KVADCVCLMG LHMDGIVPVD VHVSRIAKRD YQISANKNHL KELRTKYNAL PISRKKINLE
     LDHIRLMLFK KWGSYAGWAQ GVLFSKEIGG TSGSTTTGTI KKRKWDMIKE TEAIVTKQMK
     LKVELSDLHI KEAKID
>P53437 nuc RNA POLYMERASE I SPECIFIC TRANSCRIPTION INITIATION FACTOR RRN9.
     MSDLDEESQI ETQIDAPIED IIRGSELTTT TADKETLKSA NELLDSLEHS HRVDLSLHLY
     SAYLLKRLLY KANEKKHFYE VNQFVKTQIK DNWTSWPNPN TIIDPSVDKL YEDIPEGIAN
     VSVQPGEISN RALMHASDMM RVELDAQWQK FLSKSALDHD VTLDVDELNI PNEISRNILV
     KLDSLFEGLH DKIAKENEFD VRQDKHSNNI RANQIDDEPM QANRRIKYTY HDLVSRGCEM
     NEDMTDIYMK SLELYNDIPE KYKKRKFRLP KQILKKYHQP KKTSSYLKEL LSKTREDFIP
     VEKLLKDKRL TSKDKSKLQR LNREETEDAL NKRTFFQVKG YLEDENEISD YELDDCLIEL
     PNGNI
>P53438 nuc SOK2 PROTEIN.
     MPIGNPINTN DIKSNRMRQE SNMSAVSNSE STIGQSTQQQ QQQQQYLGQS VQPLMPVSYQ
     YVVPEQWPYP QYYQQPQSQS QQQLQSQPQM YQVQESFQSS GSDSNASNPP STSVGVPSNA
     TATALPNGSA ITTKKSNNST NISNNVPYYY YFPQMQAQQS MAYSYPQAYY YYPANGDGTT
     NGATPSVTSN QVQNPNLEKT YSTFEQQQQH QQQQQLQAQT YPAQPPKIGN AFSKFSKSGP
     PSDSSSGSMS PNSNRTSRNS NSISSLAQQP PMSNYPQPST YQYPGFHKTS SIPNSHSPIP
     PRSLTTPTQG PTSQNGPLSY NLPQVGLLPP QQQQQVSPLY DGNSITPPVK PSTDQETYLT
     ANRHGVSDQQ YDSMAKTMNS FQTTTIRHPM PLIATTNATG SNTSGTSASI IRPRVTTTMW
     EDEKTLCYQV EANGISVVRR ADNDMVNGTK LLNVTKMTRG RRDGILKAEK IRHVVKIGSM
     HLKGVWIPFE RALAIAQREK IADYLYPLFI RDIQSVLKQN NPSNDSSSSS SSTGIKSISP
     RTYYQPINNY QNPNGPSNIS AAQLTYSSMN LNNKIIPNNS IPAVSTIAAG EKPLKKCTMP
     NSNQLEGHTI TNLQTLSATM PMKQQLMGNI ASPLSYPRNA TMNSASTLGI TPADSKPLTP
     SPTTTNTNQS SESNVGSIHT GITLPRVESE SASHSKWSKE ADSGNTVPDN QTLKEPRSSQ
     LPISALTSTD TDKIKTSTSD EATQPNEPSE AEPVKESESS KSQVDGAGDV SNEEIAADDT
     KKQEK
>P53551 nuc HISTONE H1.
     MAPKKSTTKT TSKGKKPATS KGKEKSTSKA AIKKTTAKKE EASSKSYREL IIEGLTALKE
     RKGSSRPALK KFIKENYPIV GSASNFDLYF NNAIKKGVEA GDFEQPKGPA GAVKLAKKKS
     PEVKKEKEVS PKPKQAATSV SATASKAKAA STKLAPKKVV KKKSPTVTAK KASSPSSLTY
     KEMILKSMPQ LNDGKGSSRI VLKKYVKDTF SSKLKTSSNF DYLFNSAIKK CVENGELVQP
     KGPSGIIKLN KKKVKLST
>P53617 nuc NRD1 PROTEIN.
     MQQDDDFQNF VATLESFKDL KSGISGSRIK KLTTYALDHI DIESKIISLI IDYSRLCPDS
     HKLGSLYIID SIGRAYLDET RSNSNSSSNK PGTCAHAINT LGEVIQELLS DAIAKSNQDH
     KEKIRMLLDI WDRSGLFQKS YLNAIRSKCF AMDISNNTAN TASQQLSLDP KQRSKQILSN
     LKKSPPLNLN ISLPTDLTST DPAKQQAALF QVIAALQKHF KTLPSHTSVG TVAPPQAHTI
     TEYGSRRERE RERERYNSRR NRSRSPPAPF SQPSTGRKDR YPSVAQDQYS IGAPNTTFGT
     NNHHLYPDEL NVSNNPHYRP KPVSYDSTLP PDHIKVYSRT LFIGGVPLNM KEWDLANVLK
     PFAEVQSVIL NNSRKHAFVK VYSRHEAENV LQNFNKDGAL PLRTRWGVGF GPRDCCDYQH
     GYSIIPMHRL TDADKKWSVS AQWGGTSGQP LVTGIVFEEP DIIVGEGVSS KAISQKMPTD
     SGRNGPRSGK PNKSGSISSI SPVPYGNAPL ASPPPQQYVQ PMMQQPYGYA PNQPLPSQGP
     AAAAPPVPQQ QFDPTAQLNS LMNMLNQQQQ QQQQS
>P53685 nuc HST1 PROTEIN (HOMOLOGOUS TO SIR2 PROTEIN 1).
     MNILLMQRIV SFILVVSQGR YFHVGELTMT MLKRPQEEES DNNATKKLKT RLTYPCILGK
     DKVTGKFIFP AITKDDVMNA RLFLKDNDLK TFLEYFLPVE VNSIYIYFMI KLLGFDVKDK
     ELFMALNSNI TSNKERSSAE LSSIHAKAED EDELTDPLEK KHAVKLIKDL QKAINKVLST
     RLRLPNFNTI DHFTATLRNA KKILVLTGAG VSTSLGIPDF RSSEGFYSKI RHLGLEDPQD
     VFNLDIFLQD PSVFYNIAHM VLPPENMYSP LHSFIKMLQD KGKLLRNYTQ NIDNLESYAG
     IDPDKLVQCH GSFATASCVT CHWQIPGEKI FENIRNLELP LCPYCYQKRK QYFPMSNGNN
     TVQTNINFNS PILKSYGVLK PDMTFFGEAL PSRFHKTIRK DILECDLLIC IGTSLKVAPV
     SEIVNMVPSH VPQILINRDM VTHAEFDLNL LGFCDDVASL VAKKCHWDIP HKKWQDLKKI
     DYNCTEIDKG TYKIKKQPRK KQQ
>P53686 nuc HST2 PROTEIN (HOMOLOGOUS TO SIR2 PROTEIN 2).
     MSVSTASTEM SVRKIAAHMK SNPNAKVIFM VGAGISTSCG IPDFRSPGTG LYHNLARLKL
     PYPEAVFDVD FFQSDPLPFY TLAKELYPGN FRPSKFHYLL KLFQDKDVLK RVYTQNIDTL
     ERQAGVKDDL IIEAHGSFAH CHCIGCGKVY PPQVFKSKLA EHPIKDFVKC DVCGELVKPA
     IVFFGEDLPD SFSETWLNDS EWLREKITTS GKHPQQPLVI VVGTSLAVYP FASLPEEIPR
     KVKRVLCNLE TVGDFKANKR PTDLIVHQYS DEFAEQLVEE LGWQEDFEKI LTAQGGMGDN
     SKEQLLEIVH DLENLSLDQS EHESADKKDK KLQRLNGHDS DEDGASNSSS SQKAAKE
>P53687 nuc HST3 PROTEIN (HOMOLOGOUS TO SIR2 PROTEIN 3).
     MTSVSPSPPA SRSGSMCSDL PSSLQTEKLA HIIGLDADDE VLRRVTKQLS RSRRIACLTG
     AGISCNAGIP DFRSSDGLYD LVKKDCSQYW SIKSGREMFD ISLFRDDFKI SIFAKFMERL
     YSNVQLAKPT KTHKFIAHLK DRNKLLRCYT QNIDGLEESI GLTLSNRKLP LTSFSSHWKN
     LDVVQLHGDL KTLSCTKCFQ TFPWSRYWSR CLRRGELPLC PDCEALINKR LNEGKRTLGS
     NVGILRPNIV LYGENHPSCE IITQGLNLDI IKGNPDFLII MGTSLKVDGV KQLVKKLSKK
     IHDRGGLIIL VNKTPIGESS WHGIIDYQIH SDCDNWVTFL ESQIPDFFKT QDQIKKLRQL
     KREASDLRKQ MKAQKDSIGT PPTTPLRTAQ GIDIQGNNEL NTKIKSLNTV KRKILSPENS
     SEEDEEENLD TRKRAKIRPT FGDNQAS
>P53688 nuc HST4 PROTEIN (HOMOLOGOUS TO SIR2 PROTEIN 4).
     MKQKFVLPIT PPSTAEKKPQ TENRCNENLK PRRLLPQLKK SVRNRKPRLS YRPELNSVFD
     LDAYVDSTHL SKSQRHHMDR DAGFISYALN YSKRMVVVSG AGISVAAGIP DFRSSEGIFS
     TVNGGSGKDL FDYNRVYGDE SMSLKFNQLM VSLFRLSKNC QPTKFHEMLN EFARDGRLLR
     LYTQNIDGLD TQLPHLSTNV PLAKPIPSTV QLHGSIKHME CNKCLNIKPF DPELFKCDDK
     FDSRTEIIPS CPQCEEYETV RKMAGLRSTG VGKLRPRVIL YNEVHPEGDF IGEIANNDLK
     KRIDCLIIVG TSLKIPGVKN ICRQFAAKVH ANRGIVLYLN TSMPPKNVLD SLKFVDLVVL
     GDCQHVTSLL
>P53749 nuc PUTATIVE TRANSCRIPTIONAL REGULATORY PROTEIN IN BIO3-HXT17 INTERGENIC
     MDRSKDARKR SISLACTVCR KRKLKCDGNK PCGRCIRLNT PKECIYNIDK RKDKRKIKNG
     SKVFLFKNNT IDNGNNSILE NKGLNEDLSS HIYEKEAPKF DSDIDISRFG TNDAVIFNND
     GWDTSLPIDF DFDEFNTETT DFDDFLKLLG DNSPSKEQKS LSYSPTATGL SGVVKETESE
     DNAPTRSRLI DVLFENKLHS VPGISKWHLY ELESQYPNLE CTEGNSDEKF LLSTVLCLGS
     LTIRKRELLN HSNIDNRPLL PENSISKLTT DAFKYYNAAK TLVPDLLSHP TIDGFCGLVL
     MANFMTMMIS LEHQLYLSIN ALQLAVALNL NNNTKCKELL ESNSDGIGVI LLFWNIWCSS
     CMLATIHGKN PFITLEQITT PLPCEISPRN KTNKLLIDFM QIRIKLATLQ SKIFQRLYTS
     STANEVPFVN LEREFEEVSL QITRLKGFPI FEEHLFYRSR VLMLELSCLR AQASFLLYRP
     YLITGESLQA VTMAKSIIHE IWSQYTKQFP DNEKERHERL DWNFCYPLRT ASLTLCISCI
     ILLRYKQVVQ FLKGTELFEY ILALEILQDL VQVLPIEQNL IDIIKYPISP VQLSGDSFVE
     FWGRILY
>P53769 nuc HYPOTHETICAL 29.7 KD PROTEIN IN REC102-SFH1 INTERGENIC REGION.
     MFRKRLVNKS SSDEKNQKKR QKINFSEEKL VASDEEKGSS DLMSLAKSGN SRTLQLSHEN
     EGKLQKKGED LDKYTLTVND DSTKEDLLNF ERKELAEKAK KRRPSDDNEL VLNMSGKNKR
     LTKQINQPTN IRTTVLMDFQ PDVCKDYKQT GYCGYGDSCK FLHSRDDFKT GWKLNQEWNA
     DKEDSKAVTL DLEKIPFKCT LCKEDYKSPV VTNCGHYFCG SCFAKDMKKG TKCFICHKET
     HGSAKVASDL QKMLNKRKS
>P53863 nuc HYPOTHETICAL 68.8 KD PROTEIN IN URE2-SSU72 INTERGENIC REGION.
     MKTCYYELLG VETHASDLEL KKAYRKKALQ YHPDKNPDNV EEATQKFAVI RAAYEVLSDP
     QERAWYDSHK EQILNDTPPS TDDYYDYEVD ATVTGVTTDE LLLFFNSALY TKIDNSAAGI
     YQIAGKIFAK LAKDEILSGK RLGKFSEYQD DVFEQDINSI GYLKACDNFI NKTDKLLYPL
     FGYSPTDYEY LKHFYKTWSA FNTLKSFSWK DEYMYSKNYD RRTKREVNRR NEKARQQARN
     EYNKTVKRFV VFIKKLDKRM KEGAKIAEEQ RKLKEQQRKN ELNNRRKFGN DNNDEEKFHL
     QSWQTVKEEN WDELEKVYDN FGEFENSKND KEGEVLIYEC FICNKTFKSE KQLKNHINTK
     LHKKNMEEIR KEMEEENITL GLDNLSDLEK FDSADESVKE KEDIDLQALQ AELAEIERKL
     AESSSEDESE DDNLNIEMDI EVEDVSSDEN VHVNTKNKKK RKKKKKAKVD TETEESESFD
     DTKDKRSNEL DDLLASLGDK GLQTDDDEDW STKAKKKKGK QPKKNSKSTK STPSLSTLPS
     SMSPTSAIEV CTTCGESFDS RNKLFNHVKI AGHAAVKNVV KRKKVKTKRI
>P53883 nuc HYPOTHETICAL 45.7 KD PROTEIN IN RPS3-PSD1 INTERGENIC REGION.
     MSETELSKED AVTKKDNEEQ VKKALLDPTK KRKAEDEIEI DLKSSIPLSK KQKRLLRRGK
     VTLEELNAKY NIDPKSIEEY KEDAEKKKSG ASEKDAQGEE STINTPTGDE SGEVVKKKKK
     DENKYGVWIG NLSFDTTKDD LVRFFIAKTK DNEDEKSRVT EQDITRLSMP RVAAKNSNAM
     KNKGFCYMFF KNVEQMKAVL ELSESHLNGR NMLIKDSENY SGRPDKDDLV AMSKNPPSRI
     LFVGNLSFDV TDDLLRKHFQ HCGDIVKIRM ATFEDSGKCK GFAFIDFKNE EGSTNELKDK
     SCRKIAGRPL RMEYGEDRSK RQVRKKVENV SRNNSSSFDI SNNKGYDRAG QDNGSKPEYK
     RSNANRRPPV DSNNRTKSSV ALATAQRGSA AIVPSQGKKV KFD
>P53927 nuc HYPOTHETICAL 25.4 KD PROTEIN IN CYB5-LEU4 INTERGENIC REGION.
     MVKSTSKTST KETVTKQPTE EKPIQEKEEL ALETSSSSSD EEDEKDEDEI EGLAASDDEQ
     SGTHKIKRLN PKKQANEKKS KDKKTLEEYS GIIYVSRLPH GFHEKELSKY FAQFGDLKEV
     RLARNKKTGN SRHYGFLEFV NKEDAMIAQE SMNNYLLMGH LLQVRVLPKG AKIEKLYKYK
     KRVLVEKGIT KPVKQLKDNM KQKHEERIKK LAKSGIEFKW
>P53968 nuc HYPOTHETICAL 76.3 KD ZINC FINGER PROTEIN IN KTR5-UME3 INTERGENIC
     MSFSNGNMAS YMTSSNGEEQ SINNKNDIDD NSAYRRNNFR NSSNSGSHTF QLSDLDLDVD
     MRMDSANSSE KISKNLSSGI PDSFDSNVNS LLSPSSGSYS ADLNYQSLYK PDLPQQQLQQ
     QQLQQQQQQQ QQQQQQQQKQ TPTLKVEQSD TFQWDDILTP ADNQHRPSLT NQFLSPRSNY
     DGTTRSSGID SNYSDTESNY HTPYLYPQDL VSSPAMSHLT ANNDDFDDLL SVASMNSNYL
     LPVNSHGYKH ISNLDELDDL LSLTYSDNNL LSASNNSDFN NSNNGIINTA DTQNSTIAIN
     KSKVGTNQKM LLTIPTSSTP SPSTHAAPVT PIISIQEFNE GHFPVKNEDD GTLQLKVRDN
     ESYSATNNNN LLRPDDNDYN NEALSDIDRS FEDIINGRKL KLKKSRRRSS QTSNNSFTSR
     RSSRSRSISP DEKAKSISAN REKLLEMADL LPSSENDNNR ERYDNDSKTS YNTINSSNFN
     EDNNNNNLLT SKPKIESGIV NIKNELDDTS KDLGILLDID SLGQFEQKVG FKNDDNHENN
     DNGTFSVKKN DNLEKLDSVT NNRKNPANFA CDVCGKKFTR PYNLKSHLRT HTNERPFICS
     ICGKAFARQH DRKRHEDLHT GKKRYVCGGK LKDGKPWGCG KKFARSDALG RHFKTESGRR
     CITPLYEEAR QEKSGQES
>P54000 nuc SUB1 PROTEIN.
     MSYYNRYRNK RRSDNGGGNL SNSNNNNGGM PSGLSASDAI FDLGKNKRVT VRQFRNINLI
     DIREYYLDSS TGEMKPGKKG ISLTEDLYDE LLKHRLNIDE ALRRLGSKRP KTKMVRLLSD
     DEYEDDNNND STNNDKDKNG KDKNSPKKRR EDKSKASNES HDLEPRSKKK KPAPPTLLPH
     EENIQNAERE ANATLIIPGQ AGRKQQEERK QKEKEEAEEA KAKAVAEQEK EAKAKEKIAE
     PEPEPVPTLQ AKKEDIVSNI NESKDANSSD EEFAQSLEAE MNKAEDDISE EE
>P54785 nuc ZINC FINGER PROTEIN HMS1.
     MNADHHLQQQ QQQRQQHQQQ QHQQQQHQHQ HQQQQHTILQ NVSNTNNIGS DSLASQPFNT
     TTVSSNKDDV MVNSGARELP MPLHQQQYIY PYYQYTSNNS NNNNVTAGNN MSASPIVHNN
     SNNSNNSNIS ASDYTVANNS TSNNNNNNNN NNNNNNNIHP NQFTAAANMN SNAAAAAYYS
     FPTANMPIPQ QDQQYMFNPA SYISHYYSAV NSNNNGNNAA NNGSNNSSHS APAPAPGPPH
     HHHHHSNTHN NLNNGGAVNT NNAPQHHPTI ITDQFQFQLQ QNPSPNLNLN INPAQPLHLP
     PGWKINTMPQ PRPTTAPNHP PAPVPSSNPV ASNLVPAPSS DHKYIHQCQF CEKSFKRKSW
     LKRHLLSHSQ QRHFLCPWCL SRQKRKDNLL QHMKLKHTNY LLDELKKNNI IFNYNNSSSS
     NNNNDNNNNN NSNSASGSGG AGAAAAAATA PENEDGNGYD TNIKTLINDG VLNKDDVKRV
     LNNLIVSHNK
>Q01722 nuc GLYCOLYTIC GENES TRANSCRIPTIONAL ACTIVATOR GCR2.
     MHHQTKLDVF IIRAYNLLSN ESVISGASLQ SVTNSPQTTT NTPSGMVNGA VGTGIANPTG
     LMGSDSTPNI DEIITSTGSN ALTKTNSDSA NGTPNGNSSS TSAISNASNP ATTGNNASSS
     ATSNGIYTQA QYSQLFAKIS KLYNATLSSG SIDDRSTSPK SAIELYQRFQ QMIKELELSF
     DASPYAKYFR RLDGRLWQIK TDSELENDEL WRLVSMSIFT VFDPQTGQIL TQGRRKGNSL
     NTSTKGSPSD LQGINNGNNN GNNGNIGNGS NIKNYGNKNM PNNRTKKRGT RVAKNAKNGK
     NNKNSNKERN GITDTSAFSN TTISNPGTNM LFDPSLSQQL QKRLQTLSQD VNSRSLTGYY
     TQPTSPGSGG FEFGLSHADL NPNASSNTMG YNTMSNNGSH SWKRRSLGSL DVNTLDDEAV
     EELLQLTNTS KRQRPMTTAA EGALINDGPD TNLNANNTQM KVDLNPSNSM GPIDTEAVIR
     PLKEAYDAII SEKGQRIVQL ERELELQRQE TQWLRKMLIE DMGCVRSMLR DLQR
>Q02554 nuc CUS1 PROTEIN.
     MARTKSRKRS GNNQNKNASV VNNKAEIAAM IDARRLEQKK KGGVTNSKGK TNKVVDAKLE
     KEFKDVLQRF QVQENDTPKE ITKDEKNNHV VIVEKNPVMN RKHTAEDELE DTPSDGIEEH
     LSARKRRKTE KPSLSQLKSQ VPYPQIIEWY DCDARYPGLL ASIKCTKNVI PVPSHWQSKK
     EYLSGRSLLG KRPFELPDII KKTNIEQMRS TLPQSGLDGQ DEKSLKEASR ARVQPKMGAL
     DLDYKKLHDV FFKIGANWKP DHLLCFGDVY YENRNLFEET NWKRMVDHKR PGRISQELRA
     IMNLPEGQLP PWCMKMKDIG LPTGYPDLKI AGLNWDITNL KGDVYGKIIP NHHSRSKKQG
     RNYFGALISF ETPEFENSKE DTQANAENGR QDDKIDDEVE HKLDHFQEDI SEVTSAEEKL
     ERNEEESEKQ LYTVLK
>Q02574 nuc CHECKPOINT PROTEIN MEC3.
     MKLKLIVNGC EAPDDYKLLR TTINTVASLR KTAILRFNSE RLTIISTPKS SLNSSNNGTI
     LRGDTGQLWC TIPHDVFRLY TVISARELNT ITMECNCDSL LSVFKRYDRV MNQGSSSNMI
     IKLQSMPEWN TNNGTLSGGT AGGVDTTSKP NPICALGITF EEIVHTSGPN DAIVMDGGVD
     EHNGLPTTVG TGNLLASNKV IMHSFKVPVK LLFRAQDTRI QEPMINYIQL MMYKLPPISG
     EFGSAFHGFI RRVERYSNVN HIHLMGVKKK EHGNEGDDVE LKIIVNELDW HLEICWNGPL
     DSVIQRQEGL TDNPSQNQHI DTDGRQEEGS LPIIEADKPM SSLYTNTRDR EMEENIRYDE
     DLLRIEDSSI ADTRGNIYTA DTSGDTEFND ISVMVEKAEQ ESSSTHEVII RCKDWKVCSK
     LYAAFEEVVL AISHDESCVF HCSLDRGSLE DSEEVEKPRE RGQIIYYIAR SKGL
>Q02983 nuc RNA POLYMERASE I SPECIFIC TRANSCRIPTION INITIATION FACTOR RRN5.
     MEHQQLRKYV ELYNKEVEEF YNGAASGRPA EFHPSKVHVK SIHEKAGTAN AGVEISSVGV
     DWDSEEKNTF FWCLSRYSIH RVDEWRSLLP RKSAMEILGY YRLLRRASAS ARSRKAGDDG
     APIAYEMSAE WVALETKLSE TVMAITEGAA EVADEEGHCE GLIDYESWKR RWVAIYSHSR
     IAEIRPLPRH ALPLSRSATQ TLERCVSRYT RTLLWCTALA GMASRSVSAR AAESRGHKSL
     PTVVTRRQVE RALCTEARSR DLHVLPRRIV LTLRKWELDY PREGKLFRTK EMAHLFLQSQ
     LSRRDAPPVH QDENQENQEN QENQEQDNTA SEGESEAERD EIDEADLFRS ALHENQLLKW
     LSK
>Q03081 nuc TRANSCRIPTIONAL REGULATOR MET31.
     MKLAQDMNVD EIFLKQAAEA IAVISSSPTH TDPIIRELLH RIRQSSPLSA VIPAPENVLK
     AGEPENMARG LIRIPETQTK RTGGNNHSKE GAQLYSCAKC QLKFSRSSDL RRHEKVHSLV
     LPHICSNCGK GFARKDALKR HSNTLTCQRN RKKLSEGSDV DVDELIKDAI KNGTGLL
>Q03435 nuc NHP10 PROTEIN.
     MSVEEKKRRL EELKDQNVVL GLAIQRSRLS VKRLKLEYGV LLERLESRIE LDPELNCEDP
     LPTLASFKQE LLTKPFRKSK TKRHKVKERD PNMPKRPTNA YLLYCEMNKE RIRQNGSLDV
     TRDLAEGWKN LNEQDRKPYY KLYSEDRERY QMEMEIYNKK ISNIDADDDK EENEQKIKNN
     EEGSSTKVAD SKGGEDGSLV SSN
>Q03631 nuc PUTATIVE 107.6 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN CPR3-HMG1
     MDTQIAITGV AVGKEINNDN SKTDQKVSLP KADVPCIDKA TQTIIEGCSK DDPRLSYPTK
     LETTEKGKTK RNSFACVCCH SLKQKCEPSD VNDIYRKPCR RCLKHKKLCK FDLSKRTRKR
     KPRSRSPTPF ESPMVNVSTK SKGPTDSEES SLKDGTSYLA SFPSDPNAKQ FPNSRTVLPG
     LQQSLSDLWS TLSQPPSYGA REAETTSTGE ITTNNHTKSN GSVPTNPAVL ASNDEHTNIS
     DAPVIYSTYN SPVPISSAPT SINSEALFKH RPKIVGDEET QNVKVKRQKK SYSRHMTRSF
     RKQLQSLIIS QKGKIRDISM KLDTWSKQWN DLVEKSMFLP TIADPVSVGI ISHEEATLRL
     HLYKTEISYL SKLPFIKVEE NVSVDELRKK KPILFSVIMS CVSIVLTPKQ TTRGTIMKLD
     SFVLNLITNQ IFKANNKSIE IIESLSTLCL WYNFFEWSSK TRYHIFNYIC CCLTRDLGPT
     YVNRSFGMFS DEDPKRFKSP LELYSNGASL TLLVYISALN ISIFLRQSIQ ARWSHVTEKA
     CEDLVKETKK SRHYDNDKLL LDSADDPILV QFAKMNHVLE NIHTHLHERD LNDDEFDDPI
     FTKKYLNKLM EKYHKQLQEI FTKLDRNRPR VIAFYYSVEA YLYQYKLAVF IGEMSHTINE
     KVELPREIMD DFVKCYHCCK SALEEFSKLE PILITSLPLF HTSRIIYTVG MLLLKLRYSV
     VAIPSFHDLM PLTDDAIALV IGVNNLLEKT SELYPFNNSL YKFRYVIALF CQTYANKVID
     VADRYNAERE KLKEKQVIDE VSNGHDGTKP INAYVTESQK MPTEEDPIID NNTNQNITAV
     PDEMLPVYSR VRDDTAAMNL NINSTSYMNE SPHEHRESMT GTTLLPPPFI SNDVTNSADS
     TNIKPSPSSS VDNLNDYLTD INSLAWGVNS LNDEFWTDLF MNDI
>Q03654 nuc HYPOTHETICAL 67.7 KD PROTEIN IN RAR1-SCJ1 INTERGENIC REGION.
     MPPVPIYVKG GVWTNVEDQI LKAAVQKYGT HQWSKVASLL QKKTARQSEL RWNEYLNPKL
     NFTEFSKEED AQLLDLAREL PNQWRTIADM MARPAQVCVE RYNRLLESED SGGAALSTGV
     TDLKAGDINP NAETQMARPD NGDLEDEEKE MLAEARARLL NTQGKKATRK IRERMLEESK
     RIAELQKRRE LKQAGINVAI KKPKKKYGTD IDYNEDIVYE QAPMPGIYDT STEDRQIKKK
     FEQFERKVNR KGLDGNKDKP SKKNKDKKRK HDENEHVEKA ALGESTTLTD EYKKPKLILS
     APGTKQGKVT YKKKLESKRQ KLIEAQATGT VLTPKELLPH DSGQEDNERS NIKSGKQLKS
     RIRKFLVQMF ASLPSPKNDF EIVLSEDEKE EDAEIAEYEK EFENERAMNE EDNFIEPPSQ
     NDAPRVSLVA VPLAYSTLPI PEFKNNPQSA IDNKYNLLVA NAINKEPHMV PEDTVDFLKE
     VESRMQHITQ GRTSMKIQFK TAMPPTEVLL ESIQSKVESI EQLQRKLQHV QPLEQQNNEM
     CSTLCHHSLP ALIEGQRKYY ADYYAYRQEI RSLEGRRKRL QAMLNSSSSI
>Q04545 nuc HYPOTHETICAL 141.5 KD ZINC FINGER PROTEIN IN TUB1-CPR3 INTERGENIC
     MSSEEFKGLP IKRDISSTIY ADRPPALSAP PCVGATGNDK IQVLPIPKKS RTIKTDKPRP
     FLCHICTRGF VRQEHLKRHQ RAHTNEKPFL CVFCGRCFAR RDLVLRHQHK LHSALVSKES
     INSKDKTEID AINDKNIIQI QGNKQTILPT PSNPLAKTAV QLKKAAKEKK NGKQGKLDLS
     PSYGANNHST DVSPSVGNSS TPAVIEETDS SSHFPLPDTN IPTKSKRHAS FSASSAFTYS
     SDNFQKLHQQ AKSDFDELQE SIPHQVGFST PQLTAQQLIE NAIESGVVDL ETLDLPPFLS
     LDGLPPASSS AAVAASEQID ICPSSATDTI SGANSTPNQA ATAPPFQLPI ARESSSLFLA
     NTPYLSDFLT MGSSYGGSGG FAKSITADPS LDYFNYKNHS HPDSRHNNSS SGINYSNNKN
     NNESIEKSQN NSNVINETID HTDIHAHHAD AHDDSFIESE EWLSKFIMDS QIDNDLKLNI
     NHFNDIGFNN LHPQNPTTHS EPRNMHNENR DMHRSASKFQ SVSENISPRE QMSLFKTKQN
     KAISKFLSDE KIPSTASPSS SASPVQFDKK NVDINEFLLD ESVSNLFTTR QIDLFKKNVN
     LYSPLFQNQK DAVSSTSLTP SLTTQTATTQ SGPGWTDSSQ KLTFFTEQLR NLIIKENNLK
     SNLFPTVDEL NHYVDLYQVE FHKYFPFIHL YSIIPSSENY PLVISISMIG ALYGFHSTHA
     LLLSKIARTR VRMFLENTRS NHDKTPIWLM QSLVLLTFTS IFSNDMNAFR TVNTQIMILV
     QLIKISKLNY PLENFIKPPI ESDHVLEYQD NPAVLNQFKA QYNTREQINR NFKYFILAQS
     RIRICHIVLL ISNLFKSLVD FDCCFHSIDL KCGVPCYNEV LFFCENSRTW NENLTRFNIV
     LDSKFSLIEV SNGESNYEKC LMYLSNGNPY LYKNAKISFK TLLSLLISIH EKINIERDAL
     KDSYESDFHA KNVQWRMHSR PLVATMLKHW ELLYIKNGGI LALSDENLPI INTNPSFRLI
     IPLYFFAKLR KCLDIAPTLR CIWNQDWNSM NSSLEKVCYE RESLREATEY AVSVITFWID
     TVSVMKGKST QTPIFTITCI FVSILVIAGY MRRLEDFAQN KNSDCMIGSL KSTDRILWLK
     AFKTLKRIES HLSEREYKLQ TFAEFLRVPD NGSLDIESLD SSLIENTLNS HDVTNQALDI
     ITRTRLSSRT LYCGARILGD TPVWPVSLLF AHALQSRAIY NINHRKSVNS V
>Q05854 nuc PUTATIVE 151.3 KD TRANSCRIPTIONAL REGULATORY PROTEIN.
     MGRPRKNVSQ EKIQQLKREL ELAGNRTDVL LQDKKGRSRS CLLCRRRKQR CDHKLPSCTA
     CLKAGIKCVQ PSKYSSSTSN SNTNNNTPTA GTVPPTPHPV IKRELQDSSI GAGAGAATSL
     NDMTIIKPIS TSNSNVDAGD ANEFRKTIKS VTTNSNPNLM RQDKDQYTIF LEKKLKSLET
     LLDLSPGCNQ YNYELSQYKK VSHLFSNNTS DYSRPNSSNM VILPLPSPSN KPLENTNNNG
     SNVNAATNDT SASTNNINNN NAICQSASLL NDPLETLDFT KCIFAKYNLK KEFLMYDPIF
     ELNEKLSRSF LDTFFTRLQF KYPILDEQEI YTFYDHYLHN KILIPPSSPA TSSAAPPSNS
     HSYSEIEFHF LSGRMWLVFS ISAYLLMTTG KYKGFPPHRY FSTAIRHITK CGLHLNYVQQ
     IELLTLLVLY IIRTDRDSLI LYDIIKDVMG ISKKKLHLNQ WYPNDPFANK KLRLFWCVYL
     LERMICVAVG KPYTIKESEI NLPLFNNDSF YTKGVHAAAP STNDHGVQFI NQSLKLRRIE
     SQFVETLQLL KNDSRSVKQS IDQLPLVRKF FEDLEVWRKS YSTLDVKNFE NETLKLYYYR
     SVRLLIQPYL EFFAPEDRLF RECQAAAGQI CQLYKIFHQK TLNGHSTPAV HTVFVAGVTL
     IYCMWLARNF DDQRRKKLGD ASKHTRPLIS ASLFSTMDDL RACSVCLYVM TERSNFARTF
     RDTFDQLMNA TVGNLIERCG PDSSELIFMA SSVAKRTEPK NINDEANKAI SSGDTLHDSN
     SANAANLSNS NDKNISHNGG MPPAVARIFG KGQAEEHAGF VENSQVDLAE QEKFKKKQGV
     LEKTSVPKSL AHLLTKMDDR SRISNSSMSY TTSSSSSSSS SSSSSTLSFP SSQEKNLKIN
     VNNDNNGMTI SSVNREHNNN HNNNNDNNNN NNNNNNNSNN NNNVNNNDNE SNSRSTTNNS
     CNNGNNSQYV RNNNVTMEND VERPIQDQYI VKKPTNQTEF DWQVFQQQAF LQQQLAQHNL
     QAYLSSLNTD TMTNRSPSKS SSISTASSHS DPIPIAMTQS PTPYPQTSNM LPQQHVSRPL
     PQQQREQPQQ HITSPQRFSE SNFTNQLNNG MINSNPLQSA IFSNHTSENK QLRDVEESNF
     STSPLRADYG NNIISSIPAS FTSNSIPVSV KQARNGSSSG DILFSNGAHD MINNISTWTN
     NSVLDALNSK SILQTIFPQS QEPSSLSMDK QQQQHQQQNM CSENNVTANN FQQTQNDPSY
     NRNLFMMSNQ EGVQYNLDET EKNGPKTQVE ANTSANLHFD NVIPTVTNAD IRKKRSNWDN
     MMTSGPVEDF WTINDDYGFL T
>Q06217 nuc SMALL NUCLEAR RIBONUCLEOPROTEIN D2 HOMOLOG.
     MKIILLKRAE LEELEEFEFK HGPMSLINDA MVTRTPVIIS LRNNHKIIAR VKAFDRHCNM
     VLENVKELWT EKKGKNVINR ERFISKLFLR GDSVIVVLKT PVE
>Q06639 nuc PUTATIVE 101.7 KD TRANSCRIPTIONAL REGULATORY PROTEIN IN PRO1-CPR5
     MDIRGRKMKK PPACVQCRKR KIGCDRVKPI CGNCMKHNKM DCFYPDVPGQ YVPSSSSSSN
     TRQVANGPYL NSYYASRRVS KETAALLQKN PELASLEQIR EYNTRLQLLN AQNQLNNRSS
     AANATLNQQH TQYIPKSVPS LESKPVTSAN ESSTPLNWVQ GPAIFHMLTS PYTQDEIINH
     EMNFLKGRLL ELQEITGKKI TGVNLDLKQD SSAQMQSSHS NRNQEEFLTI KKRKLSEDGV
     TDGDGKPIPE SERRPHLNEF KDLDPQFLDT NKVFNVFNSA ISEEGRNRLW LLPKNINKSS
     IFQIQYLIER DPFLFKFFND LNILIETQFN GPLHDLVASR NSIERNSGIS QILKFPSQSI
     TQTLINKYLS TITETNSILP ILKPKRLLPI VEQLFPSNTI NKPNSKDFET IFQVFSVTND
     QLLNLGFITL CLLILFESLN STVLIPLRDD EHLQLFNVLF NYLPLLKSNL TTLRFEIEKR
     SMCNIETLRF ISLWKYYQFV MDTSSSSSFV IDYDEDMHMA CLLSLNHETQ NQSHILTWNF
     IFKNYCWRHL FLGQLPLLMS EPFTNSTPII DPLLNNDFEL IDFEVNLMKY LQSKDQQLSI
     DKIIQLIKLL KNKNIEVSQG CLTTPSIINN IMDSLIYRNS MLYLNFYLLL QFETLKNYAK
     FNEILEDFLE LSRETLFFVF SNLANIKFAG HEFTFINKSI VVLQTLVLML LALYQRSFDS
     SKRTNDANEI SEQTDIHSNN DNSKRIKNKN VIHLIINKIA MLLSDYTKNC KKQNKLIENL
     IIKIKTISKY IKNLEENKVT TSADSNYSIN NGFSGISAEQ LIKLNHELSK ISESLIKTDF
     YEQRKNSTVS NGVLGAAAPV DSDANSDTFG LTKENFNEVF EAIRS
>Q07350 nuc PRE-MRNA SPLICING FACTOR PRP11.
     MNYLEGVGSK KGGGGIASES QFNLQRRKEV ESLLSKGENV PYTFQDEKDD QVRSNPYIYK
     NHSGKLVCKL CNTMHMSWSS VERHLGGKKH GLNVLRRGIS IEKSSLGREG QTTHDFRQQQ
     KIIEAKQSLK NNGTIPVCKI ATVKNPKNGS VGLAIQVNYS SEVKENSVDS DDKAKVPPLI
     RIVSGLELSD TKQKGKKFLV IAYEPFENIA IELPPNEILF SENNDMDNNN DGVDELNKKC
     TFWDAISKLY YVQFFFKQAE QEQADV
>Q07478 nuc PROBABLE ATP-DEPENDENT RNA HELICASE P47 HOMOLOG.
     MSHEGEEDLL EYSDNEQEIQ IDASKAAEAG ETGAATSATE GDNNNNTAAG DKKGSYVGIH
     STGFKDFLLK PELSRAIIDC GFEHPSEVQQ HTIPQSIHGT DVLCQAKSGL GKTAVFVLST
     LQQLDPVPGE VAVVVICNAR ELAYQIRNEY LRFSKYMPDV KTAVFYGGTP ISKDAELLKN
     KDTAPHIVVA TPGRLKALVR EKYIDLSHVK NFVIDECDKV LEELDMRRDV QEIFRATPRD
     KQVMMFSATL SQEIRPICRR FLQNPLEIFV DDEAKLTLHG LQQYYIKLEE REKNRKLAQL
     LDDLEFNQVI IFVKSTTRAN ELTKLLNASN FPAITVHGHM KQEERIARYK AFKDFEKRIC
     VSTDVFGRGI DIERINLAIN YDLTNEADQY LHRVGRAGRF GTKGLAISFV SSKEDEEVLA
     KIQERFDVKI AEFPEEGIDP STYLNN
>Q08032 nuc CELL DIVISION CONTROL PROTEIN 45.
     MYYGISQFSE AYNKILRNSS SHSSCQLVIF VSCLNIDALC ATKMLSLLFK KQLVQSQIVP
     IFGYSELRRH YSQLDDNINS LLLVGFGGVI DLEAFLEIDP QEYVIDTDEK SGEQSFRRDI
     YVLDAHRPWN LDNIFGSQII QCFDDGTVDD TLGEQKEAYY KLLELDEESG DDELSGDEND
     NNGGDDEATD ADEVTDEDEE DEDETISNKR GNSSIGPNDL SKRKQRKKQI HEYEGVLEEY
     YSQGTTVVNS ISAQIYSLLS AIGETNLSNL WLNILGTTSL DIAYAQVYNR LYPLLQDEVK
     RLTPSSRNSV KTPDTLTLNI QPDYYLFLLR HSSLYDSFYY SNYVNAKLSL WNENGKKRLH
     KMFARMGIPL STAQETWLYM DHSIKRELGI IFDKNLDRYG LQDIIRDGFV RTLGYRGSIS
     ASEFVEALTA LLEVGNSTDK DSVKINNDNN DDTDGEEEED NSAQKLTNLR KRWVSNFWLS
     WDALDDRKVE LLNRGIQLAQ DLQRAIFNTG VAILEKKLIK HLRIYRLCVL QDGPDLDLYR
     NPLTLLRLGN WLIECCAESE DKQLLPMVLA SIDENTDTYL VAGLTPRYPR GLDTIHTKKP
     ILNNFSMAFQ QITAETDAKV RIDNFESSII EIRREDLSPF LEKLTLSGLL
>Q08096 nuc RNA 3'-TERMINAL PHOSPHATE CYCLASE (EC 6.5.1.4) (RNA-3'-PHOSPHATE
     MSSSAPKYTT FQGSQNFRLR IVLATLSGKP IKIEKIRSGD LNPGLKDYEV SFLRLIESVT
     NGSVIEISYT GTTVIYRPGI IVGGASTHIC PSSKPVGYFV EPMLYLAPFS KKKFSILFKG
     ITASHNDAGI EAIKWGLMPV MEKFGVRECA LHTLKRGSPP LGGGEVHLVV DSLIAQPITM
     HEIDRPIISS ITGVAYSTRV SPSLVNRMID GAKKVLKNLQ CEVNITADVW RGENSGKSPG
     WGITLVAQSK QKGWSYFAED IGDAGSIPEE LGEKVACQLL EEISKSAAVG RNQLPLAIVY
     MVIGKEDIGR LRINKEQIDE RFIILLRDIK KIFNTEVFLK PVDEADNEDM IATIKGIGFT
     NTSKKIA
>Q08387 nuc DNA LIGASE II (EC 6.5.1.1) (POLYDEOXYRIBONUCLEOTIDE SYNTHASE (ATP))
     MISALDSIPE PQNFAPSPDF KWLCEELFVK IHEVQINGTA GTGKSRSFKY YEIISNFVEM
     WRKTVGNNIY PALVLALPYR DRRIYNIKDY VLIRTICSYL KLPKNSATEQ RLKDWKQRVG
     KGGNLSSLLV EEIAKRRAEP SSKAITIDNV NHYLDSLSGD RFASGRGFKS LVKSKPFLHC
     VENMSFVELK YFFDIVLKNR VIGGQEHKLL NCWHPDAQDY LSVISDLKVV TSKLYDPKVR
     LKDDDLSIKV GFAFAPQLAK KVNLSYEKIC RTLHDDFLVE EKMDGERIQV HYMNYGESIK
     FFSRRGIDYT YLYGASLSSG TISQHLRFTD SVKECVLDGE MVTFDAKRRV ILPFGLVKGS
     AKEALSFNSI NNVDFHPLYM VFDLLYLNGT SLTPLPLHQR KQYLNSILSP LKNIVEIVRS
     SRCYGVESIK KSLEVAISLG SEGVVLKYYN SSYNVASRNN NWIKVKPEYL EEFGENLDLI
     VIGRDSGKKD SFMLGLLVLD EEEYKKHQGD SSEIVDHSSQ EKHIQNSRRR VKKILSFCSI
     ANGISQEEFK EIDRKTRGHW KRTSEVAPPA SILEFGSKIP AEWIDPSESI VLEIKSRSLD
     NTETNMQKYA TNCTLYGGYC KRIRYDKEWT DCYTLNDLYE SRTVKSNPSY QAERSQLGLI
     RKKRKRVLIS DSFHQNRKQL PISNIFAGLL FYVLSDYVTE DTGIRITRAE LEKTIVEHGG
     KLIYNVILKR HSIGDVRLIS CKTTTECKAL IDRGYDILHP NWVLDCIAYK RLILIEPNYC
     FNVSQKMRAV AEKRVDCLGD SFENDISETK LSSLYKSQLS LPPMGELEID SEVRRFPLFL
     FSNRIAYVPR RKISTEDDII EMKIKLFGGK ITDQQSLCNL IIIPYTDPIL RKDCMNEVHE
     KIKEQIKASD TIPKIARVVA PEWVDHSINE NCQVPEEDFP VVNY
>Q12041 nuc TRANSCRIPTIONAL REGULATOR MET32.
     MEDQDAAFIK QATEAIVDVS LNIDNIDPII KELLERVRNR QNRLQNKKPA LIPAENGVDI
     NSQGGNIKVK KENALPKPPK SSKSKPQDRR NSTGEKRFKC AKCSLEFSRS SDLRRHEKTH
     FAILPNICPQ CGKGFARKDA LKRHYDTLTC RRNRTKLLTA GGEGINELLK KVKQSNIVHR
     QDNNHNGSSN G
>Q12060 nuc TRANSCRIPTIONAL COACTIVATOR HFI1/ADA1.
     MSAIQSPAPK PLQPTYPAAS PASTNAYMKP GLIGSPAVSN HTEPNNGNNE TAEPQGPNQR
     IDLGAMIEEL TSLLGKESWT KYAQIISLFI LGKLSRKELS NELELVFSPS AASLEKSNTN
     HHHSLVRLHN QLLLGIFANS LRENPLGRNG NESSWGFGNG SNNPNNKLKR INKHNSQIEV
     YKKIVMSLPL NDRNRLKMIT KEAGKRGFIF CSVFQARLNN IPKIPIVTNP ESLKRVKSNN
     LKTPLEWSQD IMNGFNVPLA SESHSLPDTD SFYLRMVGIA REHGLVGTVD ARCVELISLA
     LDQYLKNIIE FTIDTVRYRR KKYSDYYDLN ESGLYKSVSE MAADKRDAKI KQLDDDKNED
     ECADEAKSIN NGNNSSKDDI GDISMSSITK AGEAVNEELH ENRTISLTNE DIYDSLSIFP
     NLVEPSGSYY ALTNLGLVND DELVDMKSNI DDLPDFLNEK PTFTPLDERN VGTRHELNWL
     IKGILTED
>Q12086 nuc DNA-DAMAGE INDUCIBLE PROTEIN DIN7.
     MGIPGLLPQL KRIQKQVSLK KYMYQTLAID GYAWLHRASC ACAFELVMNK PTNKYLQFFI
     KRLQLLKRLK IKPYIVFDGD SLFVKNHTET RRRKKRLENE MIAKKLWSAG NRYNAMEYFQ
     KSVDITPEMA KCIIDYCKLH SIPYIVAPFE ADPQMVYLEK MGLIQGIISE DSDLLVFGCK
     TLITKLNDQG KALEISKDDF SALPENFPLG ELSEQQFRNL VCLAGCDYTS GIWKVGVVTA
     MKIVKRYSEM KDILIQIERT EKLCFSKAFK QQVEFANYAF QYQRVFCPLS NQITTLNNIP
     KAVTNSHAEI IKIMKCIGSV VERGSGVRKD VINTKNIDHK VHEMIAKGEL HPVDMASKLI
     NRERKLKARK LFKVGLLGGE SNSFNKKVEQ PLVDTQDVLS ERENSLDNKN ASSIYMTSPA
     AISGTVPSIF
>Q12277 nuc RRP42 PROTEIN.
     MSLSVAEKSY LYDSLASTPS IRPDGRLPHQ FRPIEIFTDF LPSSNGSSRI IASDGSECIV
     SIKSKVVDHH VENELLQVDV DIAGQRDDAL VVETITSLLN KVLKSGSGVD SSKLQLTKKY
     SFKIFVDVLV ISSHSHPVSL ISFAIYSALN STYLPKLISA FDDLEVEELP TFHDYDMVKL
     DINPPLVFIL AVVGNNMLLD PAANESEVAN NGLIISWSNG KITSPIRSVA LNDSNVKSFK
     PHLLKQGLAM VEKYAPDVVR SLENL
>Q12341 nuc HISTONE ACETYLTRANSFERASE (EC 2.3.1.48).
     MSANDFKPET WTSSANEALR VSIVGENAVQ FSPLFTYPIY GDSEKIYGYK DLIIHLAFDS
     VTFKPYVNVK YSAKLGDDNI VDVEKKLLSF LPKDDVIVRD EAKWVDCFAE ERKTHNLSDV
     FEKVSEYSLN GEEFVVYKSS LVDDFARRMH RRVQIFSLLF IEAANYIDET DPSWQIYWLL
     NKKTKELIGF VTTYKYWHYL GAKSFDEDID KKFRAKISQF LIFPPYQNKG HGSCLYEAII
     QSWLEDKSIT EITVEDPNEA FDDLRDRNDI QRLRKLGYDA VFQKHSDLSD EFLESSRKSL
     KLEERQFNRL VEMLLLLNNS PSFELKVKNR LYIKNYDALD QTDPEKAREA LQNSFILVKD
     DYRRIIESIN KSQG
>Q12514 nuc HYPOTHETICAL 65.9 KD PROTEIN YPR065W.
     MSQRKLQQDI DKLLKKVKEG IEDFDDIYEK FQSTDPSNSS HREKLESDLK REIKKLQKHR
     DQIKTWLSKE DVKDKQSVLM TNRRLIENGM ERFKSVEKLM KTKQFSKEAL TNPDIIKDPK
     ELKKRDQVLF IHDCLDELQK QLEQYEAQEN EEQTERHEFH IANLENILKK LQNNEMDPEP
     VEEFQDDIKY YVENNDDPDF IEYDTIYEDM GCEIQPSSSN NEAPKEGNNQ TSLSSIRSSK
     KQERSPKKKA PQRDVSISDR ATTPIAPGVE SASQSISSTP TPVSTDTPLH TVKDDSIKFD
     NSTLGTPTTH VSMKKKESEN DSEQQLNFPP DRTDEIRKTI QHDVETNAAF QNPLFNDELK
     YWLDSKRYLM QPLQEMSPKM VSQLESSLLN CPDSLDADSP CLYTKPLSLP HPTSIFFPNE
     PIRFVYPYDV PLNLTNNEND TDNKFGKDSK AKSKKDDDIY SRTSLARIFM KFDLDTLFFI
     FYHYQGSYEQ FLAARELFKN RNWLFNKVDR CWYYKEIEKL PPGMGKSEEE SWRYFDYKKS
     WLARRCGNDF VYNEEDFEKL
>Q12692 nuc PROBABLE HISTONE H2A VARIANT.
     MSGKAHGGKG KSGAKDSGSL RSQSSSARAG LQFPVGRIKR YLKRHATGRT RVGSKAAIYL
     TAVLEYLTAE VLELAGNAAK DLKVKRITPR HLQLAIRGDD ELDSLIRATI ASGGVLPHIN
     KALLLKVEKK GSKK
>Q12749 nuc DNA REPAIR PROTEIN RHC18 (RAD18 HOMOLOG).
     MISTTISGKR PIEQVDDELL SLTAQQENEE QQQQRKRRRH QFAPMTQFNS NTLDEDSGFR
     SSSDVATADQ DNFLEESPSG YIKKVILRNF MCHEHFELEL GSRLNFIVGN NGSGKSAILT
     AITIGLGAKA SETNRGSSLK DLIREGCYSA KIILHLDNSK YGAYQQGIFG NEIIVERIIK
     RDGPASFSLR SENGKEISNK KKDIQTVVDY FSVPVSNPMC FLSQDAARSF LTASTSQDKY
     SHFMKGTLLQ EITENLLYAS AIHDSAQENM ALHLENLKSL KAEYEDAKKL LRELNQTSDL
     NERKMLLQAK SLWIDVAHNT DACKNLENEI SGIQQKVDEV TEKIRNRQEK IERYTSDGTT
     IEAQIDAKVI YVNEKDSEHQ NARELLRDVK SRFEKEKSNQ AEAQSNIDQG RKKVDALNKT
     IAHLEEELTK EMGGDKDQMR QELEQLEKAN EKLREVNNSL VVSLQDVKNE ERDIQHERES
     ELRTISRSIQ NKKVELQNIA KGNDTFLMNF DRNMDRLLRT IEQRKNEFET PAIGPLGSLV
     TIRKGFEKWT RSIQRAISSS LNAFVVSNPK DNRLFRDIMR SCGIRSNIPI VTYCLSQFDY
     SKGRAHGNYP TIVDALEFSK PEIECLFVDL SRIERIVLIE DKNEARNFLQ RNPVNVNMAL
     SLRDRRSGFQ LSGGYRLDTV TYQDKIRLKV NSSSDNGTQY LKDLIEQETK ELQNIRDRYE
     EKLSEVRSRL KEIDGRLKST KNEMRKTNFR MTELKMNVGK VVDTGILNSK INERKNQEQA
     IASYEAAKEE LGLKIEQIAQ EAQPIKEQYD STKLALVEAQ DELQQLKEDI NSRQSKIQKY
     KDDTIYYEDK KKVYLENIKK IEVNVAALKE GIQRQIQNAC AFCSKERIEN VDLPDTQEEI
     KRELDKVSRM IQKAEKSLGL SQEEVIALFE KCRNKYKEGQ KKYMEIDEAL NRLHNSLKAR
     DQNYKNAEKG TCFDADMDFR ASLKVRKFSG NLSFIKDTKS LEIYILTTND EKARNVDTLS
     GGEKSFSQMA LLLATWKPMR SRIIALDEFD VFMDQVNRKI GTTLIVKKLK DIARTQTIII
     TPQDIGKIAD IDSSGVSIHR MRDPERQNNS NFYN
>Q99181 nuc HSH49 PROTEIN.
     MNYSADSGNT VYVGNIDPRI TKEQLYELFI QINPVLRIKY PKDKVLQAYQ GYAFIEFYNQ
     GDAQYAIKIM NNTVRLYDRL IKVRQVTNST GTTNLPSNIS KDMILPIAKL FIKNLADSID
     SDQLVKIFNK FGKLIREPEI FYLSNGKLKC AYVYFEDFEK ADLAIKSLNN QLVANNRITV
     DYAFKENGKG NAKYGDDVDR LLNKEALKHN MLK
>Q99189 nuc MRNA TRANSPORT REGULATOR MTR10.
     MDNLQVSDIE TALQCISSTA SQDDKNKALQ FLEQFQRSTV AWSICNEILS KEDPTNALLE
     LNIFAAQTLR NKVTYDLSQL ENNLPQFKDS LLTLLLSHNQ KLIITQLNVA LARLAIQFLE
     WQNPIFEIIS LLNSSPSILL NFLRILPEET LDIASTSLTE VEFNSRIHEL IDPIAEDVLK
     FLVSCIDLLQ NTDGNSSSSI SLEQILRCLN SWSYEFPVEQ LLTVQPLINL VFETISNGNE
     SDMEAFDSAI DCLCVILRES RDTTNEQLIS ALFHQLMLLQ EKLLPTLFTD HPLNDEYDDD
     LLEGMTRLFV EAGEAWSVVI SKNPDFFKPM VLVLLMLTCK NEDLDVVSYT FPFWFNFKQS
     LVLPRYQESR KAYSDIFVKL INGIITHLQY PSGQFSSKEE EDKFKDFRYH MGDVLKDCTA
     VVGTSEALSQ PLIRIKSAIE NNNSWQIMEA PLFSLRTMAK EISLTENTIL PEIIKIICNL
     PEQAKIRYAS TLVLGRYTEW TAKHPELLEV QLQYIFNGFQ LHEGSSDMQS IITASSHALM
     FFCSDCSKLL VGYIDQLINF FLNVQSSIDI ESQFELCQGL SAVINNQPEA KVSVIFQKLV
     DDNLRQIEAL IPQWKANPTL LAPQIADKID LLYALFEELK PRYNYPQQGS EPLLPRIEFI
     WKALRTLLVD AGAMTDSIIV ERVAKLLRRI FERFHVFCEP ILPSVAEFLI QGYLTTGFGS
     YLWCSGSLIV IFGDDESFPI SPSLKDAVWK FALSQCETFI LNFNKFDKLQ LNDYHEAIID
     FFSLISDLIM FYPGAFLNST ELLGPVLNVA LECVNKLDNY DAYICILRCL DDIISWGFKT
     PPISTVSIEI VPDEWRKQVI NEVVIAHGNQ LILVLFIGLV TTFENTAHSD AISCIVKCLR
     ILTEANNNDA TICIDWIYKV VEQLGQVTLN ERDNLAKAVV EGLNSKDYRK VREGIRAFVG
     WYSRKNINSR FE
>Q99383 nuc NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN NAB4.
     MSSDEEDFND IYGDDKPTTT EEVKKEEEQN KAGSGTSQLD QLAALQALSS SLNKLNNPNS
     NNSSSNNSNQ DTSSSKQDGT ANDKEGSNED TKNEKKQESA TSANANANAS SAGPSGLPWE
     QLQQTMSQFQ QPSSQSPPQQ QVTQTKEERS KADLSKESCK MFIGGLNWDT TEDNLREYFG
     KYGTVTDLKI MKDPATGRSR GFGFLSFEKP SSVDEVVKTQ HILDGKVIDP KRAIPRDEQD
     KTGKIFVGGI GPDVRPKEFE EFFSQWGTII DAQLMLDKDT GQSRGFGFVT YDSADAVDRV
     CQNKFIDFKD RKIEIKRAEP RHMQQKSSNN GGNNGGNNMN RRGGNFGNQG DFNQMYQNPM
     MGGYNPMMNP QAMTDYYQKM QEYYQQMQKQ TGMDYTQMYQ QQMQQMAMMM PGFAMPPNAM
     TLNQPQQDSN ATQGSPAPSD SDNNKSNDVQ TIGNTSNTDS GSPPLNLPNG PKGPSQYNDD
     HNSGYGYNRD RGDRDRNDRD RDYNHRSGGN HRRNGRGGRG GYNRRNNGYH PYNR
>P30822 nuc CHROMOSOME REGION MAINTENANCE PROTEIN 1.
     MEGILDFSND LDIALLDQVV STFYQGSGVQ QKQAQEILTK FQDNPDAWQK ADQILQFSTN
     PQSKFIALSI LDKLITRKWK LLPNDHRIGI RNFVVGMIIS MCQDDEVFKT QKNLINKSDL
     TLVQILKQEW PQNWPEFIPE LIGSSSSSVN VCENNMIVLK LLSEEVFDFS AEQMTQAKAL
     HLKNSMSKEF EQIFKLCFQV LEQGSSSSLI VATLESLLRY LHWIPYRYIY ETNILELLST
     KFMTSPDTRA ITLKCLTEVS NLKIPQDNDL IKRQTVLFFQ NTLQQIATSV MPVTADLKAT
     YANANGNDQS FLQDLAMFLT TYLARNRALL ESDESLRELL LNAHQYLIQL SKIEERELFK
     TTLDYWHNLV ADLFYEVQRL PATEMSPLIQ LSVGSQAIST GSGALNPEYM KRFPLKKHIY
     EEICSQLRLV IIENMVRPEE VLVVENDEGE IVREFVKESD TIQLYKSERE VLVYLTHLNV
     IDTEEIMISK LARQIDGSEW SWHNINTLSW AIGSISGTMS EDTEKRFVVT VIKDLLDLTV
     KKRGKDNKAV VASDIMYVVG QYPRFLKAHW NFLRTVILKL FEFMHETHEG VQDMACDTFI
     KIVQKCKYHF VIQQPRESEP FIQTIIRDIQ KTTADLQPQQ VHTFYKACGI IISEERSVAE
     RNRLLSDLMQ LPNMAWDTIV EQSTANPTLL LDSETVKIIA NIIKTNVAVC TSMGADFYPQ
     LGHIYYNMLQ LYRAVSSMIS AQVAAEGLIA TKTPKVRGLR TIKKEILKLV ETYISKARNL
     DDVVKVLVEP LLNAVLEDYM NNVPDARDAE VLNCMTTVVE KVGHMIPQGV ILILQSVFEC
     TLDMINKDFT EYPEHRVEFY KLLKVINEKS FAAFLELPPA AFKLFVDAIC WAFKHNNRDV
     EVNGLQIALD LVKNIERMGN VPFANEFHKN YFFIFVSETF FVLTDSDHKS GFSKQALLLM
     KLISLVYDNK ISVPLYQEAE VPQGTSNQVY LSQYLANMLS NAFPHLTSEQ IASFLSALTK
     QYKDLVVFKG TLRDFLVQIK EVGGDPTDYL FAEDKENALM EQNRLEREKA AKIGGLLKPS
     ELDD
>P06782 nuc CARBON CATABOLITE DEREPRESSING PROTEIN KINASE (EC 2.7.1.-).
     MSSNNNTNTA PANANSSHHH HHHHHHHHHH GHGGSNSTLN NPKSSLADGA HIGNYQIVKT
     LGEGSFGKVK LAYHTTTGQK VALKIINKKV LAKSDMQGRI EREISYLRLL RHPHIIKLYD
     VIKSKDEIIM VIEYAGNELF DYIVQRDKMS EQEARRFFQQ IISAVEYCHR HKIVHRDLKP
     ENLLLDEHLN VKIADFGLSN IMTDGNFLKT SCGSPNYAAP EVISGKLYAG PEVDVWSCGV
     ILYVMLCRRL PFDDESIPVL FKNISNGVYT LPKFLSPGAA GLIKRMLIVN PLNRISIHEI
     MQDDWFKVDL PEYLLPPDLK PHPEEENENN DSKKDGSSPD NDEIDDNLVN ILSSTMGYEK
     DEIYESLESS EDTPAFNEIR DAYMLIKENK SLIKDMKANK SVSDELDTFL SQSPPTFQQQ
     SKSHQKSQVD HETAKQHARR MASAITQQRT YHQSPFMDQY KEEDSTVSIL PTSLPQIHRA
     NMLAQGSPAA SKISPLVTKK SKTRWHFGIR SRSYPLDVMG EIYIALKNLG AEWAKPSEED
     LWTIKLRWKY DIGNKTNTNE KIPDLMKMVI QLFQIETNNY LVDFKFDGWE SSYGDDTTVS
     NISEDEMSTF SAYPFLHLTT KLIMELAVNS QSN
>P15938 nuc PRE-MRNA SPLICING FACTOR RNA HELICASE PRP16.
     MGHSGREERI KDIFKELTSK ELTPGLLLTL QKLAQKPNTN LEQFIASCKA LTKLSSNNPI
     IFNELLELLK NKSEEDSTGP KKIAPSINKR KKFKIQLDLD DNEDELDSPV QKKPAPTRTL
     FKRIDKLKAK QLRQYSPTVK DPSPNSEQQT QNGHAETKDY EPTRSEVVEE DREWYDNDDD
     YGNLVPEPLS ELPEEAKLLP VIRNIDNDDA LRNTVQLYPI PLKQRMEWIP PFLSKFALEN
     KVPTSIIIGS ISETSSQVSA LSMVNPFRNP DSEFSANAKR GSKLVALRRI NMEHIQQSRD
     NTTVLNTAMG EVLGLENNNK AKDKSNQKIC DDTALFTPSK DDIKHTKEQL PVFRCRSQLL
     SLIRENQVVV IIGETGSGKT TQLAQYLYEE GYANDRGKSI VVTQPRRVAA ISVAKRVAME
     MQVPLGKEVG YSIRFEDVTD SECTKLKFVT DGILLRETLL DDTLDKYSCV IIDEAHERSL
     NTDILLGFFK ILLARRRDLK LIITSATMNA KKFSAFFGNA PQFTIPGRTF PVQTIYTSNP
     VQDYVEAAVS QAVKIHLAND CSSGDILIFM TGQEDIETTF DTLQEKFLQV YSKKFGTANF
     EEINDIEILP IYSALPADLQ FKIFQDLHGT KRKIIIATNI AETSLTIKGI RYVIDCGYSK
     LKVYNPKIGL DSLVITPISK ANADQRSGRA GRTAPGTAYR LYTEDTFKED MYLQTIPEIQ
     RTNLSNTLLL LKSLDVTDEL SKFPFIDKPP LQTFLSSLYE LWFIGAIDTS GQLTPLGLQM
     AKFPLQPSLS KILLIAVRNG CSDEMLTIVS MLSVPQVFYR PKERQKEADI ARNKFFIAKS
     DHLTLLNVFE QWRANNFSSH WCNKHFVQYK SLVRARDIRD QLLTILKSQK IPVISSGKDW
     DIIKKCICSG FAHQAAKITG LRNYVHLKTG VSVQLHPTSA LHGLGDLPPY VVYHELLMTS
     KEYICCVTSV DPFWLMEYGG LLYDIKRIKN DQEATTTGLF GEHYEHTLDK VEDDIDINIR
     RCKDMRDSVI QELKMTDNSN KEDKKQKTKK QNILNGKENS MKPFKRRKPF F
>P35201 nuc MIF2 PROTEIN.
     MDYMKLGLKS RKTGIDVKQD IPKDEYSMEN IDDFFKDDET SLISMRRKSR RKSSLFLPST
     LNGDTKNVLP PFLQSYKSQD DEVVQSPSGK GDGSRRSSLL SHQSNFLSPA NDFEPIEEEP
     EQEENDIRGN DFATPITQKL SKPTYKRKYS TRYSLDTSES PSVRLTPDRI TNKNVYSDVP
     DLVADEDDDD RVNTSLNTSD NALLEDELED DGFIPESEED GDYIESDSSL DSGSDSASDS
     DGDNTYQEVE EEAEVNTNDN EDDYIRRQAS DVVRTDSIID RNGLRKSTRV KVAPLQYWRN
     EKIVYKRKSN KPVLDIDKIV TYDESEDEEE ILAAQRRKKQ KKKPTPTRPY NYVPTGRPRG
     RPKKDPNAKE NLIPEDPNED IIERIESGGI ENGEWLKHGI LEANVKISDT KEETKDEIIA
     FAPNLSQTEQ VKDTKDENFA LEIMFDKHKE YFASGILKLP AISGQKKLSN SFRTYITFHV
     IQGIVEVTVC KNKFLSVKGS TFQIPAFNEY AIANRGNDEA KMFFVQVTVS EDANDDNDKE
     LDSTFDTFG
>P15646 nuc FIBRILLARIN (NUCLEOLAR PROTEIN 1).
     MSFRPGSRGG SRGGSRGGFG GRGGSRGGAR GGSRGGFGGR GGSRGGARGG SRGGFGGRGG
     SRGGARGGSR GGRGGAAGGA RGGAKVVIEP HRHAGVYIAR GKEDLLVTKN MAPGESVYGE
     KRISVEEPSK EDGVPPTKVE YRVWNPFRSK LAAGIMGGLD ELFIAPGKKV LYLGAASGTS
     VSHVSDVVGP EGVVYAVEFS HRPGRELISM AKKRPNIIPI IEDARHPQKY RMLIGMVDCV
     FADVAQPDQA RIIALNSHMF LKDQGGVVIS IKANCIDSTV DAETVFAREV QKLREERIKP
     LEQLTLEPYE RDHCIVVGRY MRSGLKK
>P21372 nuc PRE-MRNA PROCESSING RNA HELICASE PRP5.
     METIDSKQNI NRESLLEERR KKLAKWKQKK AQFDAQKEHQ TSRNDIVTNS LEGKQTTEKF
     TERQERVKEE LRKRKNEFRK SDEPVSVKPS KKKSKRSKVK KKISFDFSDD DDSEIGVSFR
     SKEHIQKAPE HDNEKDPLDE FMTSLKEEKM SNSKGMYDRG DILDVEDQLF ELGGTDDEDV
     EDNTDNSNIA KIAKLKAKKR VKQIYYSPEE LEPFQKNFYI ESETVSSMSE MEVEELRLSL
     DNIKIKGTGC PKPVTKWSQL GLSTDTMVLI TEKLHFGSLT PIQSQALPAI MSGRDVIGIS
     KTGSGKTISY LLPLLRQVKA QRPLSKHETG PMGLILAPTR ELALQIHEEV TKFTEADTSI
     RSVCCTGGSE MKKQITDLKR GTEIVVATPG RFIDILTLND GKLLSTKRIT FVVMDEADRL
     FDLGFEPQIT QIMKTVRPDK QCVLFSATFP NKLRSFAVRV LHSPISITIN SKGMVNENVK
     QKFRICHSED EKFDNLVQLI HERSEFFDEV QSENDGQSSD VEEVDAKAII FVSSQNICDF
     ISKKLLNAGI VTCAIHAGKP YQERLMNLEK FKREKNSILL CTEVLSRGLN VPEVSLVIIY
     NAVKTFAQYV HTTGRTARGS RSGTAITLLL HDELSGAYIL SKAMRDEEIK ALDPLQAKEL
     QEMSAKFESG MKKGKFRLSK GFGGKGLENI KSKREEAQNK DLELKKNDKR SDDLEKKISN
     PREGHDSVSE SSALIPRLNY ELFKESTDGS IIFYAKVYIN DLPQIVRWEA TKNTTLLFIK
     HETGCSITNK GKFYPEGKEP KNENDEPKLY LLIEGQDEKD IQLSIELLEQ KVKEGVVKAA
     SLSLKSTKY
>P25294 nuc SIS1 PROTEIN.
     MVKETKLYDL LGVSPSANEQ ELKKGYRKAA LKYHPDKPTG DTEKFKEISE AFEILNDPQK
     REIYDQYGLE AARSGGPSFG PGGPGGAGGA GGFPGGAGGF SGGHAFSNED AFNIFSQFFG
     GSSPFGGADD SGFSFSSYPS GGGAGMGGMP GGMGGMHGGM GGMPGGFRSA SSSPTYPEEE
     TVQVNLPVSL EDLFVGKKKS FKIGRKGPHG ASEKTQIDIQ LKPGWKAGTK ITYKNQGDYN
     PQTGRRKTLQ FVIQEKSHPN FKRDGDDLIY TLPLSFKESL LGFSKTIQTI DGRTLPLSRV
     QPVQPSQTST YPGQGMPTPK NPSQRGNLIV KYKVDYPISL NDAQKRAIDE NF
>Q02821 nuc IMPORTIN ALPHA SUBUNIT (KARYOPHERIN ALPHA SUBUNIT) (SERINE-RICH RNA
     MDNGTDSSTS KFVPEYRRTN FKNKGRFSAD ELRRRRDTQQ VELRKAKRDE ALAKRRNFIP
     PTDGADSDEE DESSVSADQQ FYSQLQQELP QMTQQLNSDD MQEQLSATVK FRQILSREHR
     PPIDVVIQAG VVPRLVEFMR ENQPEMLQLE AAWALTNIAS GTSAQTKVVV DADAVPLFIQ
     LLYTGSVEVK EQAIWALGNV AGDSTDYRDY VLQCNAMEPI LGLFNSNKPS LIRTATWTLS
     NLCRGKKPQP DWSVVSQALP TLAKLIYSMD TETLVDACWA ISYLSDGPQE AIQAVIDVRI
     PKRLVELLSH ESTLVQTPAL RAVGNIVTGN DLQTQVVINA GVLPALRLLL SSPKENIKKE
     ACWTISNITA GNTEQIQAVI DANLIPPLVK LLEVAEYKTK KEACWAISNA SSGGLQRPDI
     IRYLVSQGCI KPLCDLLEIA DNRIIEVTLD ALENILKMGE ADKEARGLNI NENADFIEKA
     GGMEKIFNCQ QNENDKIYEK AYKIIETYFG EEEDAVDETM APQNAGNTFG FGSNVNQQFN
     FN
>P29496 nuc MINICHROMOSOME MAINTENANCE PROTEIN 5 (CELL DIVISION CONTROL PROTEIN
     MSFDRPEIYS APVLQGESPN DDDNTEIIKS FKNFILEFRL DSQFIYRDQL RNNILVKNYS
     LTVNMEHLIG YNEDIYKKLS DEPSDIIPLF ETAITQVAKR ISILSRAQSA NNNDKDPENT
     SMDTDSLLLN SLPTFQLILN SNANQIPLRD LDSEHVSKIV RLSGIIISTS VLSSRATYLS
     IMCRNCRHTT SITINNFNSI TGNTVSLPRS CLSTIESESS MANESNIGDE STKKNCGPDP
     YIIIHESSKF IDQQFLKLQE IPELVPVGEM PRNLTMTCDR YLTNKVIPGT RVTIVGIYSI
     YNSKNGAGSG RSGGGNGGSG VAIRTPYIKI LGIQSDVETS SIWNSVTMFT EEEEEEFLQL
     SRNPKLYEIL TNSIAPSIFG NEDIKKAIVC LLMGGSKKIL PDGMRLRGDI NVLLLGDPGT
     AKSQLLKFVE KVSPIAVYTS GKGSSAAGLT ASVQRDPMTR EFYLEGGAMV LADGGVVCID
     EFDKMRDEDR VAIHEAMEQQ TISIAKAGIT TVLNSRTSVL AAANPIYGRY DDLKSPGDNI
     DFQTTILSRF DMIFIVKDDH NEERDISIAN HVINIHTGNA NAMQNQQEEN GSEISIEKMK
     RYITYCRLKC APRLSPQAAE KLSSNFVTIR KQLLINELES TERSSIPITI RQLEAIIRIT
     ESLAKLELSP IAQERHVDEA IRLFQASTMD AASQDPIGGL NQASGTSLSE IRRFEQELKR
     RLPIGWSTSY QTLRREFVDT HRFSQLALDK ALYALEKHET IQLRHQGQNI YRSGV
>P32500 nuc NUCLEAR ENVELOPE PROTEIN NDC1.
     MIQTPRELLN PRYTYHTIFS DVCKTRFNHL VTRLFFICSI IQTVVISLLA LPHSPLWELA
     LAFIPNILAL NLVSLLIIVT RKNYMHVKNF GFANSLTFIL GQLLSVKFLV YQGVYSMGSI
     LLSFVLGVVF GRGGSGWKPY YKLFIWLVVP TIYNLQHHVT DADKLSFNCE NFFQAPQDYV
     LERVKRIMEK SVILSVISMF VLPIFTTVFF SRQKSGLFDS FTNGVLAVTN LLIISCIIFI
     TFEFINIAFD AHMSIGCLHK GKLISNLSST PMETLLSGLS ADKPFTRLTA YQELAYRATS
     LDPSLRAPIY HSKFRSSSGN TWSLILNECL KTIQINNEKV VQYLRSVQDL GGSATARHKK
     KVENLDYMYE NGKLTSANER LFGNRPSMMA PLRDNGLLDE SPNRLRVRTD DSVLLNRGNK
     KRHRSSYYDN DLDETTQTFN GSIFTHETTF MTAMRLMLKK LKNSIMSFIF PSYAERQSSD
     ESDNYRLLPN GSNKAQISII DIWSISKKRQ AEKLVPLPIC HANSVVALTG LLIRSKTEDP
     KGGIIASVGD ILKTLERSIC ALGEFADWDP ESMAYTAFQT QRTAQDRVQQ DSEDEDSMKD
     TTDMISVLYQ LSTSAFMEIV LEYNVALNDV YLDADVAKLA NWFLEVYASG NPNAT
>P20676 nuc NUCLEOPORIN NUP1 (NUCLEAR PORE PROTEIN NUP1).
     MSSNTSSVMS SPRVEKRSFS STLKSFFTNP NKKRPSSKKV FSSNLSYANH LEESDVEDTL
     HVNKRKRVSG TSQHSDSLTQ NNNNAPIIIY GTENTERPPL LPILPIQRLR LLREKQRVRN
     MRELGLIQST EFPSITSSVI LGSQSKSDEG GSYLCTSSTP SPIKNGSCTR QLAGKSGEDT
     NVGLPILKSL KNRSNRKRFH SQSKGTVWSA NFEYDLSEYD AIQKKDNKDK EGNAGGDQKT
     SENRNNIKSS ISNGNLATGP NLTSEIEDLR ADINSNRLSN PQKNLLLKGP ASTVAKTAPI
     QESFVPNSER SGTPTLKKNI EPKKDKESIV LPTVGFDFIK DNETPSKKTS PKATSSAGAV
     FKSSVEMGKT DKSTKTAEAP TLSFNFSQKA NKTKAVDNTV PSTTLFNFGG KSDTVTSASQ
     PFKFGKTSEK SENHTESDAP PKSTAPIFSF GKQEENGDEG DDENEPKRKR RLPVSEDTNT
     KPLFDFGKTG DQKETKKGES EKDASGKPSF VFGASDKQAE GTPLFTFGKK ADVTSNIDSS
     AQFTFGKAAT AKETHTKPSE TPATIVKKPT FTFGQSTSEN KISEGSAKPT FSFSKSEEER
     KSSPISNEAA KPSFSFPGKP VDVQAPTDDK TLKPTFSFTE PAQKDSSVVS EPKKPSFTFA
     SSKTSQPKPL FSFGKSDAAK EPPGSNTSFS FTKPPANETD KRPTPPSFTF GGSTTNNTTT
     TSTKPSFSFG APESMKSTAS TAAANTEKLS NGFSFTKFNH NKEKSNSPTS FFDGSASSTP
     IPVLGKPTDA TGNTTSKSAF SFGTANTNGT NASANSTSFS FNAPATGNGT TTTSNTSGTN
     IAGTFNVGKP DQSIASGNTN GAGSAFGFSS SGTAATGAAS NQSSFNFGNN GAGGLNPFTS
     ATSSTNANAG LFNKPPSTNA QNVNVPSAFN FTGNNSTPGG GSVFNMNGNT NANTVFAGSN
     NQPHQSQTPS FNTNSSFTPS TVPNINFSGL NGGITNTATN ALRPSDIFGA NAASGSNSNV
     TNPSSIFGGA GGVPTTSFGQ PQSAPNQMGM GTNNGMSMGG GVMANRKIAR MRHSKR
>P32499 nuc NUCLEOPORIN NUP2 (NUCLEAR PORE PROTEIN NUP2) (P95).
     MAKRVADAQI QRETYDSNES DDDVTPSTKV ASSAVMNRRK IAMPKRRMAF KPFGSAKSDE
     TKQASSFSFL NRADGTGEAQ VDNSPTTESN SRLKALNLQF KAKVDDLVLG KPLADLRPLF
     TRYELYIKNI LEAPVKFIEN PTQTKGNDAK PAKVEDVQKS SDSSSEDEVK VEGPKFTIDA
     KPPISDSVFS FGPKKENRKK DESDSENDIE IKGPEFKFSG TVSSDVFKLN PSTDKNEKKT
     ETNAKPFSFS SATSTTEQTK SKNPLSLTEA TKTNVDNNSK AEASFTFGTK HAADSQNNKP
     SFVFGQAAAK PSLEKSSFTF GSTTIEKKND ENSTSNSKPE KSSDSNDSNP SFSFSIPSKN
     TPDASKPSFN FGVPNSSKNE TSKPVFSFGA ATPSAKEASQ EDDNNNVEKP SSKPAFNFIS
     NAGTEKEKES KKDSKPAFSF GISNGSESKD SDKPSLPSAV DGENDKKEAT KPAFSFGINT
     NTTKTADTKA PTFTFGSSAL ADNKEDVKKP FSFGTSQPNN TPSFSFGKTT ANLPANSSTS
     PAPSIPSTGF KFSLPFEQKG SQTTTNDSKE ESTTEATGNE SQDATKVDAT PEESKPINLQ
     NGEEDEVALF SQKAKLMTFN AETKSYDSRG VGEMKLLKKK DDPSKVRLLC RSDGMGNVLL
     NATVVDSFKY EPLAPGNDNL IKAPTVAADG KLVTYIVKFK QKEEGRSFTK AIEDAKKEMK
>P34077 nuc 96 KD NUCLEOPORIN-INTERACTING COMPONENT.
     MLETLRGNKL HSGTSKGANK KLNELLESSD NLPSASSELG SIQVSINELR RRVFQLRSKN
     KASKDYTKAH YLLANSGLSF EDVDAFIKDL QTNQFLEPNP PKIIESEELE FYIRTKKEEN
     ILMSIEQLLN GATKDFDNFI NHNLNLDWAQ HKNEVMKNFG ILIQDKKTVD HKKSISSLDP
     KLPSWGNKGN NILNSNESRL NVNENNILRE KFENYARIVF QFNNSRQANG NFDIANEFIS
     ILSSANGTRN AQLLESWKIL ESMKSKDINI VEVGKQYLEQ QFLQYTDNLY KKNMNEGLAT
     NVNKIKSFID TKLKKADKSW KISNLTVING VPIWALIFYL LRAGLIKEAL QVLVENKANI
     KKVEQSFLTY FKAYASSKDH GLPVEYSTKL HTEYNQHIKS SLDGDPYRLA VYKLIGRCDL
     SRKNIPAVTL SIEDWLWMHL MLIKEKDAEN DPVYERYSLE DFQNIIISYG PSRFSNYYLQ
     TLLLSGLYGL AIDYTYTFSE MDAVHLAIGL ASLKLFKIDS STRLTKKPKR DIRFANILAN
     YTKSFRYSDP RVAVEYLVLI TLNEGPTDVE LCHEALRELV LETKEFTVLL GKIGRDGARI
     PGVIEERQPL LHVRDEKEFL HTITEQAARR ADEDGRIYDS ILLYQLAEEY DIVITLVNSL
     LSDTLSASDL DQPLVGPDDN SETNPVLLAR RMASIYFDNA GISRQIHVKN KEICMLLLNI
     SSIRELYFNK QWQETLSQME LLDLLPFSDE LSARKKAQDF SNLDDNIVKN IPNLLIITLS
     CISNMIHILN ESKYQSSTKG QQIDSLKNVA RQCMIYAGMI QYRMPRETYS TLINIDVSL
>P35729 nuc NUCLEOPORIN NUP120 (NUCLEAR PORE PROTEIN NUP120).
     MACLSRIDAN LLQYYEKPEP NNTVDLYVSN NSNNNGLKEG DKSISTPVPQ PYGSEYSNCL
     LLSNSEYICY HFSSRSTLLT FYPLSDAYHG KTINIHLPNA SMNQRYTLTI QEVEQQLLVN
     VILKDGSFLT LQLPLSFLFS SANTLNGEWF HLQNPYDFTV RVPHFLFYVS PQFSVVFLED
     GGLLGLKKVD GVHYEPLLFN DNSYLKSLTR FFSRSSKSDY DSVISCKLFH ERYLIVLTQN
     CHLKIWDLTS FTLIQDYDMV SQSDSDPSHF RKVEAVGEYL SLYNNTLVTL LPLENGLFQM
     GTLLVDSSGI LTYTFQNNIP TNLSASAIWS IVDLVLTRPL ELNVEASYLN LIVLWKSGTA
     SKLQILNVND ESFKNYEWIE SVNKSLVDLQ SEHDLDIVTK TGDVERGFCN LKSRYGTQIF
     ERAQQILSEN KIIMAHNEDE EYLANLETIL RDVKTAFNEA SSITLYGDEI ILVNCFQPYN
     HSLYKLNTTV ENWFYNMHSE TDGSELFKYL RTLNGFASTL SNDVLRSISK KFLDIITGEL
     PDSMTTVEKF TDIFKNCLEN QFEITNLKIL FDELNSFDIP VVLNDLINNQ MKPGIFWKKD
     FISAIKFDGF TSIISLESLH QLLSIHYRIT LQVLLTFVLF DLDTEIFGQH ISTLLDLHYK
     QFLLLNLYRQ DKCLLAEVLL KDSSEFSFGV KFFNYGQLIA YIDSLNSNVY NASITENSFF
     MTFFRSYIIE NTSHKNIRFF LENVECPFYL RHNEVQEFMF AMTLFSCGNF DQSYEIFQLH
     DYPEAINDKL PTFLEDLKSE NYHGDSIWKD LLCTFTVPYR HSAFYYQLSL LFDRNNSQEF
     ALKCISKSAE YSLKEIQIEE LQDFKEKQHI HYLNLLIHFR MFEEVLDVLR LGHECLSDTV
     RTNFLQLLLQ EDIYSRDFFS TLLRLCNAHS DNGELYLRTV DIKIVDSILS QNLRSGDWEC
     FKKLYCFRML NKSERAAAEV LYQYILMQAD LDVIRKRKCY LMVINVLSSF DSAYDQWILN
     GSKVVTLTDL RDELRGL
>P36161 nuc NUCLEOPORIN NUP133 (NUCLEAR PORE PROTEIN NUP133).
     MSEKKVHLRL RKELSVPIAV VENESLAQLS YEEESQASLM DISMEQQQLR LHSHFDNSKV
     FTENNRYIVK TLQTDYSSGF SNDDELNGYI DMQIGYGLVN DHKKVYIWNI HSTQKDTPYI
     TVPFRSDDND EIAVAPRCIL TFPATMDESP LALNPNDQDE TGGLIIIKGS KAIYYEDINS
     INNLNFKLSE KFSHELELPI NSSGGEKCDL MLNCEPAGIV LSTNMGRIFF ITIRNSMGKP
     QLKLGKLLNK PFKLGIWSKI FNTNSSVVSL RNGPILGKGT RLVYITTNKG IFQTWQLSAT
     NSHPTKLIDV NIYEAILESL QDLYPFAHGT LKIWDSHPLQ DESSQLFLSS IYDSSCNETY
     YILSTIIFDS SSNSFTIFST YRLNTFMESI TDTKFKPKIF IPQMENANDT NEVTSILVMF
     PNAVVITQVN SKLDSSYSMR RKWEDIVSLR NDIDIIGSGY DSKSLYVLTK QMGVLQFFVK
     ENEETNSKPE VGFVKSHVDQ AVYFSKINAN PIDFNLPPEI SLDQESIEHD LKLTSEEIFH
     SNGKYIPPML NTLGQHLSVR KEFFQNFLTF VAKNFNYKIS PELKLDLIEK FEILNCCIKF
     NSIIRQSDVL NDIWEKTLSN YNLTQNEHLT TKTVVINSPD VFPVIFKQFL NHVVFVLFPS
     QNQNFKLNVT NLINLCFYDG ILEEGEKTIR YELLELDPME VDTSKLPWFI NFDYLNCINQ
     CFFDFTFACE EEGSLDSYKE GLLKIVKILY YQFNQFKIWI NTQPVKSVNA NDNFININNL
     YDDNHLDWNH VLCKVNLKEQ CIQIAEFYKD LSGLVQTLQT LDQNDSTTVS LYETFFNEFP
     KEFSFTLFEY LIKHKKLNDL IFRFPQQHDV LIQFFQESAP KYGHVAWIQQ ILDGSYADAM
     NTLKNITVDD SKKGESLSEC ELHLNVAKLS SLLVEKDNLD INTLRKIQYN LDTIDAEKNI
     SNKLKKGEVQ ICKRFKNGSI REVFNILVEE LKSTTVVNLS DLVELYSMLD DEESLFIPLR
     LLSVDGNLLN FEVKKFLNAL VWRRIVLLNA SNEGDKLLQH IVKRVFDEEL PKNNDFPLPS
     VDLLCDKSLL TPEYISETYG RFPIDQNAIR EEIYEEISQV ETLNSDNSLE IKLHSTIGSV
     AKEKNYTINY ETNTVEY
>P38181 nuc NUCLEOPORIN NUP170 (NUCLEAR PORE PROTEIN NUP170).
     MFQSFFHNNG PAAAGETFSD SRSYPLTNHQ EVPRNGLNEL ASSATKAQQQ PTHILNSYPI
     TGSNPLMRAS AMGATSGSIN PNMSNMNEHI RVSGMGTSKP LDLAGKYIDH LQHKDSNTPV
     LDERSYYNSG VDYNFSREKN GLGAFTPFEK QDVFNIPDEI LHEFSTSQTK TDMGIFPELN
     RCWITIDNKL ILWNINNDNE YQVVDDMKHT IQKVALVRPK PNTFVPAVKH LLLISTTMEL
     FMFAISLDKA TNELSVFNTH LSVPVQGIDV IDIVSHERSG RIFFAGQASG LNIWELHYSG
     SDDWFNSKCS KVCLTKSALL SLLPTNMLSQ IPGVDFIQAL FEDNSNGNGG FSQETITQLT
     IDQQRGIIYS LSSKSTIRAY VITEKSLEGP MSIEPAYISR IIGTTTARAA PILGPKYLKI
     VKISSVAPEE NNNLFLVALT VGGVRLYFNG SMGRFNIEAL RLESIKFPPS SVTPEVIQQE
     LLHQQQEQAK RSFPFFSNLM SSEPVLLKFQ KKSSVLLETT KASTIISPGI FFSAVIKSSQ
     QTHQQEKKEN SSVTGTTATA GSKTVKQQPV TLQHKLFVSV PDYGILKTHG KYVENATFLE
     TAGPVQQIIP LSGLFNATTK PQGFANEFAT QYTSETLRVA VLTSTSIEIY KYRTPDEIFE
     DLIDNPLPFV LNYGAAEACS TALFVTCKSN KSEKLRSNAL TFLTMGIPGV VDIKPVYNRY
     SVSTVSSLLS KPTLSTATTN LQQSITGFSK PSPANKEDFD LDDVILSPRF YGIALLITRL
     LRDIWGRHVF MTFTDNRVTS HAFISSSDPI TPSINNLKSD EISQNRNIIS KVSISKDCIE
     YYLSSINILN EFFITYGDSI SQISAPYVLA NNSNGRVIDK TEEVANQAES IAINAMIKMV
     QSIKEGLSFL NVLYEESEVE GFDNQYLGFK DIISFVSLDV QKDLVKLDFK DLFAPNDKTK
     SLIREILLSI INRNITKGAS IEYTATALQE RCGSFCSASD ILGFRAIEHL RRAKEIGLRN
     YDSLNYHLKN ATALLEQIVD DLSIEKLKEA VSMMLSVNYY PKSIEFLLNI ANSMDKGKLA
     CQYVANGFLE NDDRKQYYDK RILVYDLVFD TLIKVDELAE KKQSSKTQNQ ISISNDDEVK
     LRQKSYEAAL KYNDRLFHYH MYDWLVSQNR EEKLLDIETP FILPYLMEKA GSSLKISNIL
     WVYYSRRSKF FESAEILYRL ATSNFDITLF ERIEFLSRAN GFCNSVSPLS QKQRIVQLAS
     RIQDACEVAG IQGDILSLVY TDARIDSAIK DELIKTLDGK ILSTSELFND FAVPLSYHEI
     ALFIFKIADF RDHEVIMAKW DELFQSLRME FNNTGKKEDS MNFINLLSNV LIKIGKNVQD
     SEFIFPIFEL FPIVCNFFYE TLPKEHIVSG SIVSIFITAG VSFNKMYYIL KELIETSDSD
     NSVFNKEMTW LIHEWYKSDR KFRDIISYND IIHLKEYKID NDPIEKYVKN SGNNLGICFY
     KE
>P40064 nuc NUCLEOPORIN NUP157 (NUCLEAR PORE PROTEIN NUP157).
     MYSTPLKKRI DYDRETFTAS ASLGGNRLRN RPRDDQNNGK PNLSSRSFLS ERKTRKDVLN
     KYGEAGNTIE SELRDVTTHV KISGLTSSEP LQLASEFVQD LSFRDRNTPI LDNPDYYSKG
     LDYNFSDEVG GLGAFTPFQR QQVTNIPDEV LSQVSNTEIK SDMGIFLELN YCWITSDNKL
     ILWNINNSSE YHCIDEIEHT ILKVKLVKPS PNTFVSSVEN LLIVATLFDI YILTISFNDR
     THELNIFNTG LKVNVTGFNV SNIISYERTG QIFFTGATDG VNVWELQYNC SENLFNSKSN
     KICLTKSNLA NLLPTKLIPS IPGGKLIQKV LEGDAGTEEE TISQLEVDQS RGVLHTLSTK
     SIVRSYLITS NGLVGPVLID AAHIRRGMNA LGVKNSPLLS NRAFKIAKIV SISMCENNDL
     FLAVITTTGV RLYFKGSISR RSIGSLKLDS VKFPPTSISS SLEQNKSFII GHHPLNTHDT
     GPLSTQKASS TYINTTCAST IISPGIYFTC VRKRANSGEL SKGITNKALL ENKEEHKLYV
     SAPDYGILKN YGKYVENTAL LDTTDEIKEI VPLTRSFNYT STPQGYANVF ASQYSAEPLK
     VAVLTSNALE IYCYRTPDEV FESLIENPLP FIHSYGLSEA CSTALYLACK FNKSEHIKSS
     ALAFFSAGIP GVVEIKPKSS RESGSVPPIS QNLFDKSGEC DGIVLSPRFY GSALLITRLF
     SQIWEERVFV FKRASKTEKM DAFGISITRP QVEYYLSSIS VLADFFNIHR PSFVSFVPPK
     GSNAITASDA ESIAMNALIL LINSIKDALS LINVFYEDID AFKSLLNTLM GAGGVYDSKT
     REYFFDLKFH DLFTPNAKTK QLIKEILIEV VNANIASGTS ADYIVNVLKE RFGSFCHSAD
     ILCYRAGEHL EAAQKFEMID SKISRNHLDT AIDLYERCAE NIELCELRRV VDIMVKLNYQ
     PKTVGFLLRF ADKIDKGNQA QEYVSRGCNT ADPRKVFYDK RINVYTLIFE IVKSVDDYTS
     IEQSPSIANI SIFSPASSLK KRVYSVIMNS NNRFFHYCFY DWLVANKRQD YLLRLDSQFV
     LPYLKERAEK SLEISNLLWF YLFKEEHFLE AADVLYALAS SDFDLKLSER IECLARANGL
     CDSSTSFDQK PALVQLSENI HELFDIASIQ DDLLNLVRNE TRIDEDYRKQ LTLKLNGRVL
     PLSDLFNDCA DPLDYYEIKL RIFKVSQFKD EKVIQGEWNR LLDSMKNAPS PDVGSVGQES
     FLSSISNTLI RIGKTTRDTD VVFPVHFLMN KILESFIDKS SAADGSVCSM FLLAGVSHLK
     LYYILSRIIE NSEGNVELAK KEMVWLIKDW YQSDSDLRGS IAPEQIKKLE KYDPNTDPVQ
     DYVKDRHHGL K
>P40368 nuc NUCLEOPORIN NUP82 (NUCLEAR PORE PROTEIN NUP82).
     MSQSSRLSAL PIFQASLSAS QSPRYIFSSQ NGTRIVFIQD NIIRWYNVLT DSLYHSLNFS
     RHLVLDDTFH VISSTSGDLL CLFNDNEIFV MEVPWGYSNV EDVSIQDAFQ IFHYSIDEEE
     VGPKSSIKKV LFHPKSYRDS CIVVLKEDDT ITMFDILNSQ EKPIVLNKPN NSFGLDARVN
     DITDLEFSKD GLTLYCLNTT EGGDIFAFYP FLPSVLLLNE KDLNLILNKS LVMYESLDST
     TDVIVKRNVI KQLQFVSKLH ENWNSRFGKV DIQKEYRLAK VQGPFTINPF PGELYDYTAT
     NIATILIDNG QNEIVCVSFD DGSLILLFKD LEMSMSWDVD NYVYNNSLVL IERVKLQREI
     KSLITLPEQL GKLYVISDNI IQQVNFMSWA STLSKCINES DLNPLAGLKF ESKLEDIATI
     ERIPNLAYIN WNDQSNLALM SNKTLTFQNI SSDMKPQSTA AETSISTEKS DTVGDGFKMS
     FTQPINEILI LNDNFQKACI SPCERIIPSA DRQIPLKNEA SENQLEIFTD ISKEFLQRIV
     KAQTLGVSIH NRIHEQQFEL TRQLQSTCKI ISKDDDLRRK FEAQNKKWDA QLSRQSELME
     RFSKLSKKLS QIAESNKFKE KKISHGEMKW FKEIRNQILQ FNSFVHSQKS LQQDLSYLKS
     ELTRIEAETI KVDKKSQNEW DELRKMLEID SKIIKECNEE LLQVSQEFTT KTQ
>P40477 nuc NUCLEOPORIN NUP159 (NUCLEAR PORE PROTEIN NUP159).
     MSSLKDEVPT ETSEDFGFKF LGQKQILPSF NEKLPFASLQ NLDISNSKSL FVAASGSKAV
     VGELQLLRDH ITSDSTPLTF KWEKEIPDVI FVCFHGDQVL VSTRNALYSL DLEELSEFRT
     VTSFEKPVFQ LKNVNNTLVI LNSVNDLSAL DLRTKSTKQL AQNVTSFDVT NSQLAVLLKD
     RSFQSFAWRN GEMEKQFEFS LPSELEELPV EEYSPLSVTI LSPQDFLAVF GNVISETDDE
     VSYDQKMYII KHIDGSASFQ ETFDITPPFG QIVRFPYMYK VTLSGLIEPD ANVNVLASSC
     SSEVSIWDSK QVIEPSQDSE RAVLPISEET DKDTNPIGVA VDVVTSGTIL EPCSGVDTIE
     RLPLVYILNN EGSLQIVGLF HVAAIKSGHY SINLESLEHE KSLSPTSEKI PIAGQEQEEK
     KKNNESSKAL SENPFTSANT SGFTFLKTQP AAANSLQSQS SSTFGAPSFG SSAFKIDLPS
     VSSTSTGVAS SEQDATDPAS AKPVFGKPAF GAIAKEPSTS EYAFGKPSFG APSFGSGKSS
     VESPASGSAF GKPSFGTPSF GSGNSSVEPP ASGSAFGKPS FGTPSFGSGN SSAEPPASGS
     AFGKPSFGTS AFGTASSNET NSGSIFGKAA FGSSSFAPAN NELFGSNFTI SKPTVDSPKE
     VDSTSPFPSS GDQSEDESKS DVDSSSTPFG TKPNTSTKPK TNAFDFGSSS FGSGFSKALE
     SVGSDTTFKF GTQASPFSSQ LGNKSPFSSF TKDDTENGSL SKGSTSEIND DNEEHESNGP
     NVSGNDLTDS TVEQTSSTRL PETPSDEDGE VVEEEAQKSP IGKLTETIKK SANIDMAGLK
     NPVFGNHVKA KSESPFSAFA TNITKPSSTT PAFSFGNSTM NKSNTSTVSP MEEADTKETS
     EKGPITLKSV ENPFLPAKEE RTGESSKKDH NDDPKDGYVS GSEISVRTSE SAFDTTANEE
     IPKSQDVNNH EKSETDPKYS QHAVVDHDNK SKEMNETSKN NERSGQPNHG VQGDGIALKK
     DNEKENFDSN MAIKQFEDHQ SSEEDASEKD SRQSSEVKES DDNMSLNSDR DESISESYDK
     LEDINTDELP HGGEAFKARE VSASADFDVQ TSLEDNYAES GIQTDLSESS KENEVQTDAI
     PVKHNSTQTV KKEAVDNGLQ TEPVETCNFS VQTFEGDENY LAEQCKPKQL KEYYTSAKVS
     NIPFVSQNST LRLIESTFQT VEAEFTVLME NIRNMDTFFT DQSSIPLVKR TVRSINNLYT
     WRIPEAEILL NIQNNIKCEQ MQITNANIQD LKEKVTDYVR KDIAQITEDV ANAKEEYLFL
     MHFDDASSGY VKDLSTHQFR MQKTLRQKLF DVSAKINHTE ELLNILKLFT VKNKRLDDNP
     LVAKLAKESL ARDGLLKEIK LLREQVSRLQ LEEKGKKASS FDASSSITKD MKGFKVVEVG
     LAMNTKKQIG DFFKNLNMAK
>P46673 nuc NUCLEOPORIN NUP85 (NUCLEAR PORE PROTEIN NUP85).
     MTIDDSNRLL MDVDQFDFLD DGTAQLSNNK TDEEEQLYKR DPVSGAILVP MTVNDQPIEK
     NGDKMPLKFK LGPLSYQNMA FITAKDKYKL YPVRIPRLDT SKEFSAYVSG LFEIYRDLGD
     DRVFNVPTIG VVNSNFAKEH NATVNLAMEA ILNELEVFIG RVKDQDGRVN RFYELEESLT
     VLNCLRTMYF ILDGQDVEEN RSEFIESLLN WINRSDGEPD EEYIEQVFSV KDSTAGKKVF
     ETQYFWKLLN QLVLRGLLSQ AIGCIERSDL LPYLSDTCAV SFDAVSDSIE LLKQYPKDSS
     STFREWKNLV LKLSQAFGSS ATDISGELRD YIEDFLLVIG GNQRKILQYS RTWYESFCGF
     LLYYIPSLEL SAEYLQMSLE ANVVDITNDW EQPCVDIISG KIHSILPVME SLDSCTAAFT
     AMICEAKGLI ENIFEGEKNS DDYSNEDNEM LEDLFSYRNG MASYMLNSFA FELCSLGDKE
     LWPVAIGLIA LSATGTRSAK KMVIAELLPH YPFVTNDDIE WMLSICVEWR LPEIAKEIYT
     TLGNQMLSAH NIIESIANFS RAGKYELVKS YSWLLFEASC MEGQKLDDPV LNAIVSKNSP
     AEDDVIIPQD ILDCVVTNSM RQTLAPYAVL SQFYELRDRE DWGQALRLLL LLIEFPYLPK
     HYLVLLVAKF LYPIFLLDDK KLMDEDSVAT VIEVIETKWD DADEKSSNLY ETIIEADKSL
     PSSMATLLKN LRKKLNFKLC QAFM
>P48837 nuc NUCLEOPORIN NUP57 (NUCLEAR PORE PROTEIN NUP57).
     MFGFSGSNNG FGNKPAGSTG FSFGQNNNNT NTQPSASGFG FGGSQPNSGT ATTGGFGANQ
     ATNTFGSNQQ SSTGGGLFGN KPALGSLGSS STTASGTTAT GTGLFGQQTA QPQQSTIGGG
     LFGNKPTTTT GGLFGNSAQN NSTTSGGLFG NKVGSTGSLM GGNSTQNTSN MNAGGLFGAK
     PQNTTATTGG LFGSKPQGST TNGGLFGSGT QNNNTLGGGG LFGQSQQPQT NTAPGLGNTV
     STQPSFAWSK PSTGSNLQQQ QQQQIQVPLQ QTQAIAQQQQ LSNYPQQIQE QVLKCKESWD
     PNTTKTKLRA FVYNKVNETE AILYTKPGHV LQEEWDQAME KKPSPQTIPI QIYGFEGLNQ
     RNQVQTENVA QARIILNHIL EKSTQLQQKH ELDTASRILK AQSRNVEIEK RILKLGTQLA
     TLKNRGLPLG IAEEKMWSQF QTLLQRSEDP AGLGKTNELW ARLAILKERA KNISSQLDSK
     LMVFNDDTKN QDSMSKGTGE ESNDRINKIV EILTNQQRGI TYLNEVLEKD AAIVKKYKNK
     T
>P49686 nuc NUCLEOPORIN NUP42 (NUCLEAR PORE PROTEIN NUP42).
     MSAFGNPFTS GAKPNLSNTS GINPFTNNAA STNNMGGSAF GRPSFGTANT MTGGTTTSAF
     GMPQFGTNTG NTGNTSISAF GNTSNAAKPS AFGAPAFGSS APINVNPPST TSAFGAPSFG
     STGFGAMAAT SNPFGKSPGS MGSAFGQPAF GANKTAIPSS SVSNSNNSAF GAASNTPLTT
     TSPFGSLQQN ASQNASSTSS AFGKPTFGAA TNTQSPFGTI QNTSTSSGTG VSPFGTFGTN
     SNNKSPFSNL QSGAGAGSSP FGTTTSKANN NNNVGSSAFG TTNNQSPFSG GSGGTFGSAS
     NLNKNTNGNF QSSFGNKGFS FGITPQNDAN KVSQSNPSFG QTMPNTDPNI SLKSNGNATS
     FGFGQQQMNA TNVNANTATG KIRFVQGLSS EKDGILELAD LAEETLKIFR ANKFELGLVP
     DIPPPPALVA
>P49687 nuc NUCLEOPORIN NUP145 (NUCLEAR PORE PROTEIN NUP145).
     MFNKSVNSGF TFGNQNTSTP TSTPAQPSSS LQFPQKSTGL FGNVNVNANT STPSPSGGLF
     NANSNANSIS QQPANNSLFG NKPAQPSGGL FGATNNTTSK SAGSLFGNNN ATANSTGSTG
     LFSGSNNIAS STQNGGLFGN SNNNNITSTT QNGGLFGKPT TTPAGAGGLF GNSSSTNSTT
     GLFGSNNTQS STGIFGQKPG ASTTGGLFGN NGASFPRSGE TTGTMSTNPY GINISNVPMA
     VADMPRSITS SLSDVNGKSD AEPKPIENRR TYSFSSSVSG NAPLPLASQS SLVSRLSTRL
     KATQKSTSPN EIFSPSYSKP WLNGAGSAPL VDDFFSSKMT SLAPNENSIF PQNGFNFLSS
     QRADLTELRK LKIDSNRSAA KKLKLLSGTP AITKKHMQDE QDSSENEPIA NADSVTNIDR
     KENRDNNLDN TYLNGKEQSN NLNKQDGENT LQHEKSSSFG YWCSPSPEQL ERLSLKQLAA
     VSNFVIGRRG YGCITFQHDV DLTAFTKSFR EELFGKIVIF RSSKTVEVYP DEATKPMIGH
     GLNVPAIITL ENVYPVDKKT KKPMKDTTKF AEFQVFDRKL RSMREMNYIS YNPFGGTWTF
     KVNHFSIWGL VNEEDAEIDE DDLSKQEDGG EQPLRKVRTL AQSKPSDKEV ILKTDGTFGT
     LSGKDDSIVE EKAYEPDLSD ADFEGIEASP KLDVSKDWVE QLILAGSSLR SVFATSKEFD
     GPCQNEIDLL FSECNDEIDN AKLIMKERRF TASYTFAKFS TGSMLLTKDI VGKSGVSIKR
     LPTELQRKFL FDDVYLDKEI EKVTIEARKS NPYPQISESS LLFKDALDYM EKTSSDYNLW
     KLSSILFDPV SYPYKTDNDQ VKMALLKKER HCRLTSWIVS QIGPEIEEKI RNSSNEIEQI
     FLYLLLNDVV RASKLAIESK NGHLSVLISY LGSNDPRIRD LAELQLQKWS TGGCSIDKNI
     SKIYKLLSGS PFEGLFSLKE LESEFSWLCL LNLTLCYGQI DEYSLESLVQ SHLDKFSLPY
     DDPIGVIFQL YAANENTEKL YKEVRQRTNA LDVQFCWYLI QTLRFNGTRV FSKETSDEAT
     FAFAAQLEFA QLHGHSLFVS CFLNDDKAAE DTIKRLVMRE ITLLRASTND HILNRLKIPS
     QLIFNAQALK DRYEGNYLSE VQNLLLGSSY DLAEMAIVTS LGPRLLLSNN PVQNNELKTL
     REILNEFPDS ERDKWSVSIN VFEVYLKLVL DNVETQETID SLISGMKIFY DQYKHCREVA
     ACCNVMSQEI VSKILEKNNP SIGDSKAKLL ELPLGQPEKA YLRGEFAQDL MKCTYKI
>P52593 nuc NUCLEOPORIN NUP188 (NUCLEAR PORE PROTEIN NUP188).
     MATPSFGNSS PQLTFTHVAN FMNDAAADVS AVDAKQLAQI RQFLKANKTN LIESLNTIRQ
     NVTSSGDHNK LRSTIANLLQ INVDNDPFFA QSEDLSHAVE FFMSERSSRL HIVYSLLVNP
     DIDLETYSFI DNDRFNVVGK LISIISSVIQ NYDIITASSL AHDYNNDQDM FTIVSLVQLK
     KFSDLKFILQ ILQILNLMIL NTKVPVDIVN QWFLQYQNQF VEFCRNINST DKSIDTSSLQ
     LYKFQNFQDL SYLSETLISR ISSLFTITTI LILGLNTSIA QFDIQSPLYM DTETFDTVNS
     ALENDVATNI VNEDPIFHPM IHYSWSFILY YRRALQSSES FDDSDITKFA LFAESHDVLQ
     KLNTLSEILS FDPVYTTVIT VFLEFSLNFI PITASTSRVF AKIISKAPEQ FIENFLTNDT
     FEKKLSIIKA KLPLLNESLI PLINLALIDT EFANFELKDI CSFAVTKSSL NDLDYDLIAD
     TITNSSSSSD IIVPDLIELK SDLLVAPPLE NENSNCLLSI PKSTKGKILT IKQQQQQQQQ
     QNGQQPPTTS NLIIFLYKFN GWSLVGRILQ NLLHSYMEKG TQLDDLQHEL MISIIKLVTN
     VVDPKTSIEK SSEILSYLSN SLDTSASTIN GASIIQVIFE IFEISLQRKD YTSIVQCCEF
     MTMLTPNYLH LVSSYLNKSD LLDKYGKTGL SNMILGSVEL STGDYTFTIQ LLKLTKVFIR
     ESLSLKNIHI SKRSKIDIIN KLILHAIHIF ESYYNWKYNN FLQKFEIAFH LTLIFYDVLH
     DVFTINPHQK DQLIISSSAN KLLQLFLTPM DSIDLAPNTL TNILISPLNT TTKILGDKIL
     GNLYSKVMNN SFKLCTLLIA IRGSNRDLKP SNLEKLLFIN SSKLVDVYTL PSYVHFKVQI
     IELLSYLVEA PWNDDYPFLL SFLGEAKSMA FLKEVLSDLS SPVQDWNLLR SLYIFFTTLL
     ESKQDGLSIL FLTGQFASNK KINDESSIDK KSSILTVLQK NSLLLDSTPE EVSCKLLETI
     TYVLNTWTNS KIFIKDPKFV NSLLAKLKDS KKLFQKKENL TRDETVSLIK KYKLISRIVE
     IFALCIYNST DSNSEILNFL NQEDLFELVH HFFQIDGFNK TFHDELNLKF KEKWPSLELQ
     SFQKIPLSRI NENENFGYDI PLLDIVLKAD RSWNEPSKSQ TNFKEEITDA SLNLQYVNYE
     ISTAKAWGAL ITTFVKRSTV PLNDGFVDLV EHFLKLNIDF GSDKQMFTQI YLERIELSFY
     ILYSFKLSGK LLKEEKIIEL MNKIFTIFKS GEIDFIKNIG KSLKNNFYRP LLRSVLVLLE
     LVSSGDRFIE LISDQLLEFF ELVFSKGVYL ILSEILCQIN KCSTRGLSTD HTTQIVNLED
     NTQDLLLLLS LFKKITNVNP SKNFNVILAS SLNEVGTLKV ILNLYSSAHL IRINDEPILG
     QITLTFISEL CSIEPIAAKL INSGLYSVLL ESPLSVAIQQ GDIKPEFSPR LHNIWSNGLL
     SIVLLLLSQF GIKVLPETCL FVSYFGKQIK STIYNWGDNK LAVSSSLIKE TNQLVLLQKM
     LNLLNYQELF IQPKNSDDQQ EAVELVIGLD SEHDKKRLSA ALSKFLTHPK YLNSRIIPTT
     LEEQQQLEDE SSRLEFVKGI SRDIKALQDS LFKDV
>P52891 nuc NUCLEOPORIN NUP84 (NUCLEAR PORE PROTEIN NUP84).
     MELSPTYQTE RFTKFSDTLK EFKIEQNNEQ NPIDPFNIIR EFRSAAGQLA LDLANSGDES
     NVISSKDWEL EARFWHLVEL LLVFRNADLD LDEMELHPYN SRGLFEKKLM QDNKQLYQIW
     IVMVWLKENT YVMERPKNVP TSKWLNSITS GGLKSCDLDF PLRENTNVLD VKDKEEDHIF
     FKYIYELILA GAIDEALEEA KLSDNISICM ILCGIQEYLN PVIDTQIANE FNTQQGIKKH
     SLWRRTVYSL SQQAGLDPYE RAIYSYLSGA IPNQEVLQYS DWESDLHIHL NQILQTEIEN
     YLLENNQVGT DELILPLPSH ALTVQEVLNR VASRHPSESE HPIRVLMASV ILDSLPSVIH
     SSVEMLLDVV KGTEASNDII DKPYLLRIVT HLAICLDIIN PGSVEEVDKS KLITTYISLL
     KLQGLYENIP IYATFLNESD CLEACSFILS SLEDPQVRKK QIETINFLRL PASNILRRTT
     QRVFDETEQE YSPSNEISIS FDVNNIDMHL IYGVEWLIEG KLYVDAVHSI IALSRRFLLN
     GRVKALEQFM ERNNIGEICK NYELEKIADN ISKDENEDQF LEEITQYEHL IKGIREYEEW
     QKSVSLLSSE SNIPTLIEKL QGFSKDTFEL IKTFLVDLTS SNFADSADYE ILYEIRALYT
     PFLLMELHKK LVEAAKLLKI PKFISEALAF TSLVANENDK IYLLFQSSGK LKEYLDLVAR
     TATLSN
>P53011 nuc NUCLEAR PORE PROTEIN SEH1.
     MQPFDSGHDD LVHDVVYDFY GRHVATCSSD QHIKVFKLDK DTSNWELSDS WRAHDSSIVA
     IDWASPEYGR IIASASYDKT VKLWEEDPDQ EECSGRRWNK LCTLNDSKGS LYSVKFAPAH
     LGLKLACLGN DGILRLYDAL EPSDLRSWTL TSEMKVLSIP PANHLQSDFC LSWCPSRFSP
     EKLAVSALEQ AIIYQRGKDG KLHVAAKLPG HKSLIRSISW APSIGRWYQL IATGCKDGRI
     RIFKITEKLS PLASEESLTN SNMFDNSADV DMDAQGRSDS NTEEKAELQS NLQVELLSEH
     DDHNGEVWSV SWNLTGTILS SAGDDGKVRL WKATYSNEFK CMSVITAQQ
>Q02199 nuc NUCLEOPORIN NUP49/NSP49 (NUCLEAR PORE PROTEIN NUP49/NSP49).
     MFGLNKASST PAGGLFGQAS GASTGNANTG FSFGGTQTGQ NTGPSTGGLF GAKPAGSTGG
     LGASFGQQQQ QSQTNAFGGS ATTGGGLFGN KPNNTANTGG GLFGANSNSN SGSLFGSNNA
     QTSRGLFGNN NTNNINNSSS GMNNASAGLF GSKPAGGTSL FGNTSTSSAP AQNQGMFGAK
     PAGTSLFGNN AGNTTTGGGL FGSKPTGATS LFGSSNNNNN NNNSNNIMSA SGGLFGNQQQ
     QLQQQPQMQC ALQNLSQLPI TPMTRISELP PQIRQEIEQL DQYIQKQVQI SHHLKADTID
     HDELIDSIPR DVAYLLKSES ATSQYLKQDL KKISSFKSLI DEDLLDTQTF SVLLQQLLTP
     GSKISSNDLD KFFQKKIHLY EKKLEDYCRI LSDIETAVNG IDTDLFGAPN NPNSTAITAD
     LGSSEAENLL QLKTGLAAIV STVIEEFTLF MDIAERIAVL HQKTKTLASL SI
>Q02629 nuc NUCLEOPORIN NUP100/NSP100 (NUCLEAR PORE PROTEIN NUP100/NSP100).
     MFGNNRPMFG GSNLSFGSNT SSFGGQQSQQ PNSLFGNSNN NNNSTSNNAQ SGFGGFTSAA
     GSNSNSLFGN NNTQNNGAFG QSMGATQNSP FGSLNSSNAS NGNTFGGSSS MGSFGGNTNN
     AFNNNSNSTN SPFGFNKPNT GGTLFGSQNN NSAGTSSLFG GQSTSTTGTF GNTGSSFGTG
     LNGNGSNIFG AGNNSQSNTT GSLFGNQQSS AFGTNNQQGS LFGQQSQNTN NAFGNQNQLG
     GSSFGSKPVG SGSLFGQSNN TLGNTTNNRN GLFGQMNSSN QGSSNSGLFG QNSMNSSTQG
     VFGQNNNQMQ INGNNNNSLF GKANTFSNSA SGGLFGQNNQ QQGSGLFGQN SQTSGSSGLF
     GQNNQKQPNT FTQSNTGIGL FGQNNNQQQQ STGLFGAKPA GTTGSLFGGN SSTQPNSLFG
     TTNVPTSNTQ SQQGNSLFGA TKLTNMPFGG NPTANQSGSG NSLFGTKPAS TTGSLFGNNT
     ASTTVPSTNG LFGNNANNST STTNTGLFGA KPDSQSKPAL GGGLFGNSNS NSSTIGQNKP
     VFGGTTQNTG LFGATGTNSS AVGSTGKLFG QNNNTLNVGT QNVPPVNNTT QNALLGTTAV
     PSLQQAPVTN EQLFSKISIP NSITNPVKAT TSKVNADMKR NSSLTSAYRL APKPLFAPSS
     NGDAKFQKWG KTLERSDRGS STSNSITDPE SSYLNSNDLL FDPDRRYLKH LVIKNNKNLN
     VINHNDDEAS KVKLVTFTTE SASKDDQASS SIAASKLTEK AHSPQTDLKD DHDESTPDPQ
     SKSPNGSTSI PMIENEKISS KVPGLLSNDV TFFKNNYYIS PSIETLGNKS LIELRKINNL
     VIGHRNYGKV EFLEPVDLLN TPLDTLCGDL VTFGPKSCSI YENCSIKPEK GEGINVRCRV
     TLYSCFPIDK ETRKPIKNIT HPLLKRSIAK LKENPVYKFE SYDPVTGTYS YTIDHPVLT
>Q02630 nuc NUCLEOPORIN NUP116/NSP116 (NUCLEAR PORE PROTEIN NUP116/NSP116).
     MFGVSRGAFP SATTQPFGST GSTFGGQQQQ QQPVANTSAF GLSQQTNTTQ APAFGNFGNQ
     TSNSPFGMSG STTANGTPFG QSQLTNNNAS GSIFGGMGNN TALSAGSASV VPNSTAGTSI
     KPFTTFEEKD PTTGVINVFQ SITCMPEYRN FSFEELRFQD YQAGRKFGTS QNGTGTTFNN
     PQGTTNTGFG IMGNNNSTTS ATTGGLFGQK PATGMFGTGT GSGGGFGSGA TNSTGLFGSS
     TNLSGNSAFG ANKPATSGGL FGNTTNNPTN GTNNTGLFGQ QNSNTNGGLF GQQQNSFGAN
     NVSNGGAFGQ VNRGAFPQQQ TQQGSGGIFG QSNANANGGA FGQQQGTGAL FGAKPASGGL
     FGQSAGSKAF GMNTNPTGTT GGLFGQTNQQ QSGGGLFGQQ QNSNAGGLFG QNNQSQNQSG
     LFGQQNSSNA FGQPQQQGGL FGSKPAGGLF GQQQGASTFA SGNAQNNSIF GQNNQQQQST
     GGLFGQQNNQ SQSQPGGLFG QTNQNNNQPF GQNGLQQPQQ NNSLFGAKPT GFGNTSLFSN
     STTNQSNGIS GNNLQQQSGG LFQNKQQPAS GGLFGSKPSN TVGGGLFGNN QVANQNNPAS
     TSGGLFGSKP ATGSLFGGTN STAPNASSGG IFGSNNASNT AATTNSTGLF GNKPVGAGAS
     TSAGGLFGNN NNSSLNNSNG STGLFGSNNT SQSTNAGGLF QNNTSTNTSG GGLFSQPSQS
     MAQSQNALQQ QQQQQRLQIQ NNNPYGTNEL FSKATVTNTV SYPIQPSATK IKADERKKAS
     LTNAYKMIPK TLFTAKLKTN NSVMDKAQIK VDPKLSISID KKNNQIAISN QQEENLDESI
     LKASELLFNP DKRSFKNLIN NRKMLIASEE KNNGSQNNDM NFKSKSEEQE TILGKPKMDE
     KETANGGERM VLSSKNDGED SATKHHSRNM DEENKENVAD LQKQEYSEDD KKAVFADVAE
     KDASFINENY YISPSLDTLS SYSLLQLRKV PHLVVGHKSY GKIEFLEPVD LAGIPLTSLG
     GVIITFEPKT CIIYANLPNR PKRGEGINVR ARITCFNCYP VDKSTRKPIK DPNHQLVKRH
     IERLKKNPNS KFESYDADSG TYVFIVNHAA EQT
>P39685 nuc NUCLEAR ENVELOPE PORE MEMBRANE PROTEIN POM152 (P150).
     MEHRYNVFND TPRGNHWMGS SVSGSPRPSY SSRPNVNTTR RFQYSDDEPA EKIRPLRSRS
     FKSTESNISD EKSRISERDS KDRYINGDKK VDIYSLPLIS TDVLEISKQR TFAVILFLII
     QCYKIYDLVI LKSGLPLSGL LFKNYRFNFI SKYFIIDSFF LYVLPSFNIP RLTFKPWVVY
     LQILAMLLLN IFISSDHEFV LISLIMTTWR KLYTKELSVT GSAINHHRIF DSSAHFKGAL
     TIKILPENTA MFNPLHESYC LPMDTNLFKI NSIDVPIRIN STEEIEYIEL EYRDLYTNSV
     ELRSLSKKDF KIIDNPKSFL KKDQSVLKSH SNDFEEGSTI RYLAVTLQDI GFYQIKKIVD
     SKKLNLKIHQ SHLVVPYCPI ASITGTGSND RCIGDSDNVS FEIQGVPPMK LAYSKIVNGQ
     TFSYVDSSLQ PEYFESPLQS SKSKQSFTQG ELNDLKWGRN QPVNINLDSS ITQDGKFAYK
     IDKITDGLGN VVDFTSLPEE LKKRYDLSYN FNVHEVPRAA LEERFDPKSP TKRSIAIVFE
     EIKNWISDIP YVISLSYTDA QDKSKKIMNV TTDSLTKVLQ ADLPGSYNLE YIESKFCPGE
     IVGKSNVLVT MPVAPTMEVK SFPILDQCVG QVGLNFELSF TGAPPYYYNT KIYKLENGER
     KLYDAKRYTS EGTRNRFSYS PPKEGNYEIV FDTVSNKLFT EPIKLEPVKE YTFKTSMRVK
     PSASLKLHHD LKLCLGDHSS VPVALKGQGP FTLTYDIIET FSSKRKTFEI KEIKTNEYVI
     KTPVFTTGGD YILSLVSIKD STGCVVGLSQ PDAKIQVRRD IPSAAFNFFE PIKEAKIKHG
     SVTEIPLKLS GEGPFTVKFK HMDYDGNIVK EFENKFQNSY KPALKVSKEG LYQLVDIRDS
     SCQGNVIYRN SLYKVSFLEK PKFAIQDNHH ITKVTENLFS KEEVCQGMEG TVDLALFGSP
     PFILEYDLMA PNGHISTKKI QVATKYASLK LPNQIPGEYI TTIKAIFDGN YGESDIHFRE
     HQSELIIKQT VHPIPDVAFA DGGKTLRACA ANVDQISFLE PINLKFLQGE SPFSITFSVY
     HESTSRTDQY TIDNIDSENF SFEKLYEGMK LGNHAITIDS VVDANGCVNS LISGPRNQIL
     VSITDAPKIH ILDPSTEYCV GDYVAYQLNG VAPFMIKYEF NGIPLKSKER SSQFVRLASE
     PGIISITSLQ DSSSQCIVDF TNPKLKSEFD DLSLNIHPIP SVTVSQGNYV TEDIREGDQA
     EVIFSFEGTP PFSLTYVRTE ETDGKHGKRR SQVVETHKVT DIYSHEYKVI TSLQGTYEAI
     EITDAYCFAK NDLFFNN
>P40991 nuc NUCLEOLAR PROTEIN NOP2.
     MGSRRHKNKQ AAPPTLEEFQ ARKEKKANRK LEKGKRPSTT QGDEVSDRKK KKSKPFKKSR
     KEEEEVVEED KDLPEVDLEE LSKARKSLFD DEEDDDEAGL VDEELKDEFD LEQEYDYDED
     EDNDAHPIFS DDDDEADLEE LNAQNMEALS KKLDEEEAEE AEEAEMELVE AENMQPRADI
     LPTEEQEEMM AQETPNLTST RTRMIEIVKV LENFKTLGAE GRSRGEYVDR LLKDICEYFG
     YTPFLAEKLF NLFSPAEAME FFEANEIARP ITIRTNTLKT RRRDLAQTLV NRGVNLQPIG
     SWTKVGLQIF DSQVPIGATP EYLAGHYILQ AASSFLPVIA LDPHENERIL DMAAAPGGKT
     TYISAMMKNT GCVFANDANK SRTKSLIANI HRLGCTNTIV CNYDAREFPK VIGGFDRILL
     DAPCSGTGVI GKDQSVKVSR TEKDFIQIPH LQKQLLLSAI DSVDCNSKHG GVIVYSTCSV
     AVEEDEAVID YALRKRPNVK LVDTGLAIGK EAFTSYRGKK FHPSVKLARR YYPHTYNVDG
     FFVAKFQKIG PSSFDDNQAS AKEKETAARK EALEEGIIHS DFATFEDEED DKYIEKSVKN
     NLLKKGVNPK AKRPSNEK
>P48240 nuc MRNA TRANSPORT REGULATOR MTR3.
     MNVQDRRRLL GPAAAKPMAF SNTTTHVPEK KSTDLTPKGN ESEQELSLHT GFIENCNGSA
     LVEARSLGHQ TSLITAVYGP RSIRGSFTSQ GTISIQLKNG LLEKYNTNEL KEVSSFLMGI
     FNSVVNLSRY PKSGIDIFVY LTYDKDLTNN PQDDDSQSKM MSSQISSLIP HCITSITLAL
     ADAGIELVDM AGAGEANGTV VSFIKNGEEI VGFWKDDGDD EDLLECLDRC KEQYNRYRDL
     MISCLMNQET
>Q05022 nuc RRNA BIOGENESIS PROTEIN RRP5.
     MVASTKRKRD EDFPLSREDS TKQPSTSSLV RNTEEVSFPR GGASALTPLE LKQVANEAAS
     DVLFGNESVK ASEPASRPLK KKKTTKKSTS KDSEASSANS DEARAGLIEH VNFKTLKNGS
     SLLGQISAIT KQDLCITFTD GISGYVNLTH ISEEFTSILE DLDEDMDSDT DAADEKKSKV
     EDAEYESSDD EDEKLDKSNE LPNLRRYFHI GQWLRCSVIK NTSLEPSTKK SKKKRIELTI
     EPSSVNIYAD EDLVKSTSIQ CAVKSIEDHG ATLDVGLPGF TGFIAKKDFG NFEKLLPGAV
     FLGNITKKSD RSIVVNTDFS DKKNKITQIS SIDAIIPGQI VDLLCESITK NGIAGKVFGL
     VSGVVNVSHL RTFSEEDLKH KFVIGSSIRC RIIACLENKS GDKVLILSNL PHILKLEDAL
     RSTEGLDAFP IGYTFESCSI KGRDSEYLYL ALDDDRLGKV HSSRVGEIEN SENLSSRVLG
     YSPVDDIYQL STDPKYLKLK YLRTNDIPIG ELLPSCEITS VSSSGIELKI FNGQFKASVP
     PLHISDTRLV YPERKFKIGS KVKGRVISVN SRGNVHVTLK KSLVNIEDNE LPLVSTYENA
     KNIKEKNEKT LATIQVFKPN GCIISFFGGL SGFLPNSEIS EVFVKRPEEH LRLGQTVIVK
     LLDVDADRRR IIATCKVSNE QAAQQKDTIE NIVPGRTIIT VHVIEKTKDS VIVEIPDVGL
     RGVIYVGHLS DSRIEQNRAQ LKKLRIGTEL TGLVIDKDTR TRVFNMSLKS SLIKDAKKET
     LPLTYDDVKD LNKDVPMHAY IKSISDKGLF VAFNGKFIGL VLPSYAVDSR DIDISKAFYI
     NQSVTVYLLR TDDKNQKFLL SLKAPKVKEE KKKVESNIED PVDSSIKSWD DLSIGSIVKA
     KIKSVKKNQL NVILAANLHG RVDIAEVFDT YEEITDKKQP LSNYKKDDVI KVKIIGNHDV
     KSHKFLPITH KISKASVLEL SMKPSELKSK EVHTKSLEEI NIGQELTGFV NNSSGNHLWL
     TISPVLKARI SLLDLADNDS NFSENIESVF PLGSALQVKV ASIDREHGFV NAIGKSHVDI
     NMSTIKVGDE LPGRVLKIAE KYVLLDLGNK VTGISFITDA LNDFSLTLKE AFEDKINNVI
     PTTVLSVDEQ NKKIELSLRP ATAKTRSIKS HEDLKQGEIV DGIVKNVNDK GIFVYLSRKV
     EAFVPVSKLS DSYLKEWKKF YKPMQYVLGK VVTCDEDSRI SLTLRESEIN GDLKVLKTYS
     DIKAGDVFEG TIKSVTDFGV FVKLDNTVNV TGLAHITEIA DKKPEDLSAL FGVGDRVKAI
     VLKTNPEKKQ ISLSLKASHF SKEAELASTT TTTTTVDQLE KEDEDEVMAD AGFNDSDSES
     DIGDQNTEVA DRKPETSSDG LSLSAGFDWT ASILDQAQEE EESDQDQEDF TENKKHKHKR
     RKENVVQDKT IDINTRAPES VADFERLLIG NPNSSVVWMN YMAFQLQLSE IEKARELAER
     ALKTINFREE AEKLNIWIAM LNLENTFGTE ETLEEVFSRA CQYMDSYTIH TKLLGIYEIS
     EKFDKAAELF KATAKKFGGE KVSIWVSWGD FLISHNEEQE ARTILGNALK ALPKRNHIEV
     VRKFAQLEFA KGDPERGRSL FEGLVADAPK RIDLWNVYVD QEVKAKDKKK VEDLFERIIT
     KKITRKQAKF FFNKWLQFEE SEGDEKTIEY VKAKATEYVA SHESQKADE
>P10080 nuc SINGLE-STRANDED NUCLEIC ACID-BINDING PROTEIN.
     MSAEIEEATN AVNNLSINDS EQQPRAPTHK TVIDPEDTIF IGNVAHECTE DDLKQLFVEE
     FGDEVSVEIP IKEHTDGHIP ASKHALVKFP TKIDFDNIKE NYDTKVVKDR EIHIKRARTP
     GQMQRGGFRG RGGFRGRGGF RGGFRGGYRG GFRGRGNFRG RGGARGGFNG QKREKIPLDQ
     MERSKDTLYI NNVPFKATKE EVAEFFGTDA DSISLPMRKM RDQHTGRIFT SDSANRGMAF
     VTFSGENVDI EAKAEEFKGK VFGDRELTVD VAVIRPENDE EEIEQETGSE EKQE
>P28007 nuc GAR1 PROTEIN.
     MSFRGGNRGG RGGFRGGFRG GRTGSARSFQ QGPPDTVLEM GAFLHPCEGD IVCRSINTKI
     PYFNAPIYLE NKTQVGKVDE ILGPLNEVFF TIKCGDGVQA TSFKEGDKFY IAADKLLPIE
     RFLPKPKVVG PPKPKNKKKR SGAPGGRGGA SMGRGGSRGG FRGGRGGSSF RGGRGGSSFR
     GGSRGGSFRG GSRGGSRGGF RGGRR
>P33750 nuc SOF1 PROTEIN.
     MKIKTIKRSA DDYVPVKSTQ ESQMPRNLNP ELHPFERARE YTKALNATKL ERMFAKPFVG
     QLGYGHRDGV YAIAKNYGSL NKLATGSADG VIKYWNMSTR EEFVSFKAHY GLVTGLCVTQ
     PRFHDKKPDL KSQNFMLSCS DDKTVKLWSI NVDDYSNKNS SDNDSVTNEE GLIRTFDGES
     AFQGIDSHRE NSTFATGGAK IHLWDVNRLK PVSDLSWGAD NITSLKFNQN ETDILASTGS
     DNSIVLYDLR TNSPTQKIVQ TMRTNAICWN PMEAFNFVTA NEDHNAYYYD MRNLSRSLNV
     FKDHVSAVMD VDFSPTGDEI VTGSYDKSIR IYKTNHGHSR EIYHTKRMQH VFQVKYSMDS
     KYIISGSDDG NVRLWRSKAW ERSNVKTTRE KNKLEYDEKL KERFRHMPEI KRISRHRHVP
     QVIKKAQEIK NIELSSIKRR EANERRTRKD MPYISERKKQ IVGTVHKYED SGRDRKRRKE
     DDKRDTQEK
>P37838 nuc NUCLEOLAR PROTEIN NOP4 (NUCLEOLAR PROTEIN NOP77).
     MEETIENVEV PSSNVSKQND DGLDMKTLFV RSIPQDVTDE QLADFFSNFA PIKHAVVVKD
     TNKRSRGFGF VSFAVEDDTK EALAKARKTK FNGHILRVDI AKRRDRSKKT SEVVEKSTPE
     SSEKITGQNN EDEDDADGED SMLKGKPKLI IRNMPWSCRD PVKLKKIFGR YGTVVEATIP
     RKRDGKLCGF AFVTMKKISN CRIALENTKD LKIDGRKVAV DFAVQKNRWE DYKKAQPEMN
     DKDDNESGNE DAEENHDDEE DENEEEDRQV DQASKNKESK RKAQNKREDF SVFVRNVPYD
     ATEESLAPHF SKFGSVKYAL PVIDKSTGLA KGTAFVAFKD QYTYNECIKN APAAGSTSLL
     IGDDVMPEYV YEGRVLSITP TLVREDAGRM AEKNAAKRKE ALGKAPGEKD RRNLYLLNEG
     RVVEGSKMAD LLTNTDMEIR EKSYKLRVEQ LKKNPSLHLS MTRLAIRNLP RAMNDKALKA
     LARKAVVEFA TEVKNKERHP LSKEEIIRST KEKYKFMGPD EIEAQKKKDK KSGVVKQAKV
     IMEVKGSTAG RSRGYGFVEF RDHKNALMGL RWLNCHAVTS DEILEGLNDD EKKQVDNDLG
     KGRRLCVEFA IENSNVVKRR REQLKQARTK RTRPDNEDTG DVGESENKKP KKEEATTPTN
     PDDKKMGDDI KRIIGFKRKR KHAKK
>P38911 nuc FK506-BINDING NUCLEAR PROTEIN (PEPTIDYL-PROLYL CIS-TRANS ISOMERASE)
     MSDLLPLATY SLNVEPYTPV PAIDVTMPIT VRITMAALNP EAIDEENKPS TLRIIKRNPD
     FEDDDFLGGD FDEDEIDEES SEEEEEEKTQ KKKKSKGKKA ESESEDDEED DDEDDEFQES
     VLLTLSPEAQ YQQSLDLTIT PEEEVQFIVT GSYAISLSGN YVKHPFDTPM GVEGEDEDED
     ADIYDSEDYD LTPDEDEIIG DDMDDLDDEE EEEVRIEEVQ EEDEEDNDGE EEQEEEEEEE
     QKEEVKPEPK KSKKEKKRKH EEKEEEKKAK KVKKVEFKKD LEEGPTKPKS KKEQDKHKPK
     SKVLEGGIVI EDRTIGDGPQ AKRGARVGMR YIGKLKNGKV FDKNTSGKPF AFKLGRGEVI
     KGWDIGVAGM SVGGERRIII PAPYAYGKQA LPGIPANSEL TFDVKLVSMK N
>Q01560 nuc NUCLEOLAR PROTEIN 3 (MITOCHONDRIAL TARGETING SUPRESSOR 1 PROTEIN).
     MSEAQETHVE QLPESVVDAP VEEQHQEPPQ APDAPQEPQV PQESAPQESA PQEPPAPQEQ
     NDVPPPSNAP IYEGEESHSV QDYQEAHQHH QPPEPQPYYP PPPPGEHMHG RPPMHHRQEG
     ELSNTRLFVR PFPLDVQESE LNEIFGPFGP MKEVKILNGF AFVEFEEAES AAKAIEEVHG
     KSFANQPLEV VYSKLPAKRY RITMKNLPEG CSWQDLKDLA RENSLETTFS SVNTRDFDGT
     GALEFPSEEI LVEALERLNN IEFRGSVITV ERDDNPPPIR RSNRGGFRGR GGFRGGFRGG
     FRGGFSRGGF GGPRGGFGGP RGGYGGYSRG GYGGYSRGGY GGSRGGYDSP RGGYDSPRGG
     YSRGGYGGPR NDYGPPRGSY GGSRGGYDGP RGDYGPPRDA YRTRDAPRER SPTR
>Q12499 nuc NUCLEOLAR PROTEIN NOP5.
     MAYVLTETSA GYALLKASDK KIYKSSSLIQ DLDSSDKVLK EFKIAAFSKF NSAANALEEA
     NSIIEGKVSS QLEKLLEEIK KDKKSTLIVS ETKLANAINK LGLNFNVVSD AVTLDIYRAI
     KEYLPELLPG MSDNDLSKMS LGLAHSIGRH KLKFSADKVD VMIIQAIALL DDLDKELNTY
     AMRCKEWYGW HFPELAKIVT DSVAYARIIL TMGIRSKASE TDLSEILPEE IEERVKTAAE
     VSMGTEITQT DLDNINALAE QIVEFAAYRE QLSNYLSARM KAIAPNLTQL VGELVGARLI
     AHSGSLISLA KSPASTIQIL GAEKALFRAL KTKHDTPKYG LLYHASLVGQ ATGKNKGKIA
     RVLAAKAAVS LRYDALAEDR DDSGDIGLES RAKVENRLSQ LEGRDLRTTP KVVREAKKVE
     MTEARAYNAD ADTAKAASDS ESDSDDEEEE KKEKKEKKRK RDDDEDSKDS KKAKKEKKDK
     KEKKEKKEKK EKKEKKEKKE KKSKKEKKEK K
>P27476 nuc NUCLEAR LOCALIZATION SEQUENCE BINDING PROTEIN (P67).
     MAKTTKVKGN KKEVKASKQA KEEKAKAVSS SSSESSSSSS SSSESESESE SESESSSSSS
     SSDSESSSSS SSDSESEAET KKEESKDSSS SSSDSSSDEE EEEEKEETKK EESKESSSSD
     SSSSSSSDSE SEKEESNDKK RKSEDAEEEE DEESSNKKQK NEETEEPATI FVGRLSWSID
     DEWLKKEFEH IGGVIGARVI YERGTDRSRG YGYVDFENKS YAEKAIQEMQ GKEIDGRPIN
     CDMSTSKPAG NNDRAKKFGD TPSEPSDTLF LGNLSFNADR DAIFELFAKH GEVVSVRIPT
     HPETEQPKGF GYVQFSNMED AKKALDALQG EYIDNRPVRL DFSSPRPNND GGRGGSRGFG
     GRGGGRGGNR GFGGRGGARG GRGGFRPSGS GANTAPLGRS RNTASFAGSK KTFD
>P22579 nuc PAIRED AMPHIPATHIC HELIX PROTEIN.
     MSQVWHNSNS QSNDVATSND ATGSNERNEK EPSLQGNKPG FVQQQQRITL PSLSALSTKE
     EDRRDSNGQQ ALTSHAAHIL GYPPPHSNAM PSIATDSALK QPHEYHPRPK SSSSSPSINA
     SLMNAGPAPL PTVGAASFSL SRFDNPLPIK APVHTEEPKS YNGLQEEEKA TQRPQDCKEV
     PAGVQPADAP DPSSNHADAN DDNNNNENSH DEDADYRPLN VKDALSYLEQ VKFQFSSRPD
     IYNLFLDIMK DFKSQAIDTP GVIERVSTLF RGYPILIQGF NTFLPQGYRI ECSSNPDDPI
     RVTTPMGTTT VNNNISPSGR GTTDAQELGS FPESDGNGVQ QPSNVPMVPS SVYQSEQNQD
     QQQSLPLLAT SSGLPSIQQP EMPAHRQIPQ SQSLVPQEDA KKNVDVEFSQ AISYVNKIKT
     RFADQPDIYK HFLEILQTYQ REQKPINEVY AQVTHLFQNA PDLLEDFKKF LPDSSASANQ
     QVQHAQQHAQ QQHEAQMHAQ AQAQAQAQAQ VEQQKQQQQF LYPASGYYGH PSNRGIPQQN
     LPPIGSFSPP TNGSTVHEAY QDQQHMQPPH FMPLPSIVQH GPNMVHQGIA NENPPLSDLR
     TSLTEQYAPS SIQHQQQHPQ SISPIANTQY GDIPVRPEID LDPSIVPVVP EPTEPIENNI
     SLNEEVTFFE KAKRYIGNKH LYTEFLKILN LYSQDILDLD DLVEKVDFYL GSNKELFTWF
     KNFVGYQEKT KCIENIVHEK HRLDLDLCEA FGPSYKRLPK SDTFMPCSGR DDMCWEVLND
     EWVGHPVWAS EDSGFIAHRK NQYEETLFKI EEERHEYDFY IESNLRTIQC LETIVNKIEN
     MTENEKANFK LPPGLGHTSM TIYKKVIRKV YDKERGFEII DALHEHPAVT APVVLKRLKQ
     KDEEWRRAQR EWNKVWRELE QKVFFKSLDH LGLTFKQADK KLLTTKQLIS EISSIKVDQT
     NKKIHWLTPK PKSQLDFDFP DKNIFYDILC LADTFITHTT AYSNPDKERL KDLLKYFISL
     FFSISFEKIE ESLYSHKQNV SESSGSDDGS SIASRKRPYQ QEMSLLDILH RSRYQKLKRS
     NDEDGKVPQL SEPPEEEPNT IEEEELIDEE AKNPWLTGNL VEEANSQGII QNRSIFNLFA
     NTNIYIFFRH WTTIYERLLE IKQMNERVTK EINTRSTVTF AKDLDLLSSQ LSEMGLDFVG
     EDAYKQVLRL SRRLINGDLE HQWFEESLRQ AYNNKAFKLY TIDKVTQSLV KHAHTLMTDA
     KTAEIMALFV KDRNASTTSA KDQIIYRLQV RSHMSNTENM FRIEFDKRTL HVSIQYIALD
     DLTLKEPKAD EDKWKYYVTS YALPHPTEGI PHEKLKIPFL ERLIEFGQDI DGTEVDEEFS
     PEGISVSTLK IKIQPITYQL HIENGSYDVF TRKATNKYPT IANDNTQKGM VSQKKELISK
     FLDCAVGLRN NLDEAQKLSM QKKWENLKDS IAKTSAGNQG IESETEKGKI TKQEQSDNLD
     SSTASVLPAS ITTVPQDDNI ETTGNTESSD KGAKIQ
>P32380 nuc NUF1 PROTEIN (SPINDLE POLY BODY SPACER PROTEIN SPC110).
     MDEASHLPNG SLKNMEFTPV GFIKSKRNTT QTQVVSPTKV PNANNGDENE GPVKKRQRRS
     IDDTIDSTRL FSEASQFDDS FPEIKANIPP SPRSGNVDKS RKRNLIDDLK KDVPMSQPLK
     EQEVREHQMK KERFDRALES KLLGKRHITY ANSDISNKEL YINEIKSLKH EIKELRKEKN
     DTLNNYDTLE EETDDLKNRL QALEKELDAK NKIVNSRKVD DHSGCIEERE QMERKLAELE
     RKLKTVKDQV LELENNSDVQ SLKLRSKEDE LKNLMNELNE LKSNAEEKDT QLEFKKNELR
     KRTNELNELK IKSDEMDLQL KQKQNESKRL KDELNELETK FSENGSQSSA KENELKMLKN
     KIAELEEEIS TKNSQLIAKE GKLASLMAQL TQLESKLNQR DSQLGSREEE LKKTNDKLQK
     DIRIAREETV SKDERIIDLQ KKVKQLENDL FVIKKTHSES KTITDNELES KDKLIKILEN
     DLKVAQEKYS KMEKELKERE FNYKISESKL EDEKTTLNEK ISNLAAENSQ LKNKIEDNST
     ATHHMKENYE KQLESLRKDI EEYKESAKDS EDKIEELKIR IAENSAKVSE KRSKDIKQKD
     EQISDLTQNL KLQEDEISSL KSIIDRYKKD FNQLKSEQSN IQHDLNLQIL NLENKLIESE
     DELKSLRDSQ KIEIENWKRK YNNLSLENDR LLTEKESASD KEREISILNR KLDEMDKEKW
     NLQESKEKYK RELQKVITAN DRLRREKEEL NENSNNIRIM EDKMTRIKKN YLSEITSLQE
     ENRRLEERLI LNERRKDNDS TMQLNDIISY YKLKYHSEVR HNNDLKVIND YLNKVLALGT
     RRLRLDTRKG EHSLNISLPD DDELDRDYYN SHVYTRYHDY EYPLRFNLNR RGPYFERRLS
     FKTVALLVLA CVRMKRIAFY RRSDDNRLRI LRDRIESSSG RISW
>P09119 pla CELL DIVISION CONTROL PROTEIN 6.
     MSAIPITPTK RIRRNLFDDA PATPPRPLKR KKLQFTDVTP ESSPEKLQFG SQSIFLRTKA
     LLQKSSELVN LNSSDGALPA RTAEYEQVMN FLAKAISEHR SDSLYITGPP GTGKTAQLDM
     IIRQKFQSLP LSLSTPRSKD VLRHTNPNLQ NLSWFELPDG RLESVAVTSI NCISLGEPSS
     IFQKIFDSFQ DLNGPTLQIK NMQHLQKFLE PYHKKTTFVV VLDEMDRLLH ANTSETQSVR
     TILELFLLAK LPTVSFVLIG MANSLDMKDR FLSRLNLDRG LLPQTIVFQP YTAEQMYEIV
     IQKMSSLPTI IFQPMAIKFA AKKCAGNTGD LRKLFDVLRG SIEIYELEKR FLLSPTRGSL
     NSAQVPLTPT TSPVKKSYPE PQGKIGLNYI AKVFSKFVNN NSTRTRIAKL NIQQKLILCT
     IIQSLKLNSD ATIDESFDHY IKAITKTDTL APLQRNEFLE ICTILETCGL VSIKKTKCKG
     KTKRFVDKID VDLDMREFYD EMTKISILKP FLH
>P32903 pla PLASMA MEMBRANE ATPASE PROTEOLIPID 1 PRECURSOR.
     MTLPGGVILV FILVGLACIA IIATIIYRKW QARQRGLQRF
>P35183 pla AST1 PROTEIN.
     MAKDILKNQD PKLQAMIVEH SAPAPKEIPM DAPVLKRVAR PLRHVKFIPI KSLIFHTKTG
     PMDFSYEKKI KTPIPKNKIV VRVSNVGLNP VDMKIRNGYT SSIYGEIGLG REYSGVITEV
     GENLNYAWHV GDEVYGIYYH PHLAVGCLQS SILVDPKVDP ILLRPESVSA EEAAGSLFCL
     ATGYNILNKL SKNKYLKQDS NVLINGGTSS VGMFVIQLLK RHYKLQKKLV IVTSANGPQV
     LQEKFPDLAD EMIFIDYLTC RGKSSKPLRK MLEEKKISQY DPVEDKETIL NYNEGKFDVV
     LDFVGGYDIL SHSSSLIHGG GAYVTTVGDY VANYKEDIFD SWDNPSANAR KMFGSIIWSY
     NYTHYYFDPN AKTASANNDW IEQCGDFLKN GTVKCVVDKV YDWKDHKEAF SYMATQRAQG
     KLIMNVEKF
>P40975 pla PLASMA MEMBRANE ATPASE PROTEOLIPID 2 PRECURSOR.
     MLMSTLPGGV ILVFILVGLA CIAIISTIIY RKWQARQRGL QRF
>P38993 pla IRON TRANSPORT MULTICOPPER OXIDASE PRECURSOR (EC 1.-.-.-).
     MTNALLSIAV LLFSMLSLAQ AETHTFNWTT GWDYRNVDGL KSRPVITCNG QFPWPDITVN
     KGDRVQIYLT NGMNNTNTSM HFHGLFQNGT ASMDGVPFLT QCPIAPGSTM LYNFTVDYNV
     GTYWYHSHTD GQYEDGMKGL FIIKDDSFPY DYDEELSLSL SEWYHDLVTD LTKSFMSVYN
     PTGAEPIPQN LIVNNTMNLT WEVQPDTTYL LRIVNVGGFV SQYFWIEDHE MTVVEIDGIT
     TEKNVTDMLY ITVAQRYTVL VHTKNDTDKN FAIMQKFDDT MLDVIPSDLQ LNATSYMVYN
     KTAALPTQNY VDSIDNFLDD FYLQPYEKEA IYGEPDHVIT VDVVMDNLKN GVNYAFFNNI
     TYTAPKVPTL MTVLSSGDQA NNSEIYGSNT HTFILEKDEI VEIVLNNQDT GTHPFHLHGH
     AFQTIQRDRT YDDALGEVPH SFDPDNHPAF PEYPMRRDTL YVRPQSNFVI RFKADNPGVW
     FFHCHIEWHL LQGLGLVLVE DPFGIQDAHS QQLSENHLEV CQSCSVATEG NAAANTLDLT
     DLTGENVQHA FIPTGFTKKG IIAMTFSCFA GILGIITIAI YGMMDMEDAT EKVIRDLHVD
     PEVLLNEVDE NEERQVNEDR HSTEKHQFLT KAKRFF
>P31377 pla HYPOTHETICAL 23.7 KD PROTEIN IN TPD3-DEP1 INTERGENIC REGION.
     MDVLKLGYEL DQLSDLVEER TRLVSVLKLA PTSNDNVTLK RQLGSILELL QKCAPNDELI
     SRYNTILDKI PDTAVDKELY RFQQQVARNT DEVSKESLKK VRFKNDDELT VMYKDDDEQD
     EESPLPSTHT PYKDEPLQSQ LQSQSQPQPP QPMVSNQELF INQQQQLLEQ DSHLGALSQS
     IGRTHDISLD LNMRSFLRTT RCWLI
>P08004 pla CHITIN SYNTHASE 1 (EC 2.4.1.16) (CHITIN-UDP ACETYL-GLUCOSAMINYL
     MSDQNNRSRN EYHSNRKNEP SYELQNAHSG LFHSSNEELT NRNQRYTNQN ASMGSFTPVQ
     SLQFPEQSQQ TNMLYNGDDG NNNTINDNER DIYGGFVNHH RQRPPPATAE YNDVFNTNSQ
     QLPSEHQYNN VPSYPLPSIN VIQTTPELIH NGSQTMATPI ERPFFNENDY YYNNRNSRTS
     PSIASSSDGY ADQEARPILE QPNNNMNSGN IPQYHDQPFG YNNGYHGLQA KDYYDDPEGG
     YIDQRGDDYQ INSYLGRNGE MVDPYDYENS LRHMTPMERR EYLHDDSRPV NDGKEELDSV
     KSGYSHRDLG EYDKDDFSRD DEYDDLNTID KLQFQANGVP ASSSVSSIGS KESDIIVSND
     NLTANRALKR SGTEIRKFKL WNGNFVFDSP ISKTLLDQYA TTTENANTLP NEFKFMRYQA
     VTCEPNQLAE KNFTVRQLKY LTPRETELML VVTMYNEDHI LLGRTLKGIM DNVKYMVKKK
     NSSTWGPDAW KKIVVCIISD GRSKINERSL ALLSSLGCYQ DGFAKDEINE KKVAMHVYEH
     TTMINITNIS ESEVSLECNQ GTVPIQLLFC LKEQNQKKIN SHRWAFEGFA ELLRPNIVTL
     LDAGTMPGKD SIYQLWREFR NPNVGGACGE IRTDLGKRFV KLLNPLVASQ NFEYKMSNIL
     DKTTESNFGF ITVLPGAFSA YRFEAVRGQP LQKYFYGEIM ENEGFHFFSS NMYLAEDRIL
     CFEVVTKKNC NWILKYCRSS YASTDVPERV PEFILQRRRW LNGSFFASVY SFCHFYRVWS
     SGHNIGRKLL LTVEFFYLFF NTLISWFSLS SFFLFFRILT VSIALAYHSA FNVLSVIFLW
     LYGICTLSTF ILSLGNKPKS TEKFYVLTCV IFAVMMIYMI FCSIFMSVKS FQNILKNDTI
     SFEGLITTEA FRDIVISLGS TYCLYLISSI IYLQPWHMLT SFIQYILLSP SYINVLNIYA
     FCNVHDLSWG TKGAMANPLG KINTTEDGTF KMEVLVSSSE IQANYDKYLK VLNDFDPKSE
     SRPTEPSYDE KKTGYYANVR SLVIIFWVIT NFIIVAVVLE TGGIADYIAM KSISTDDTLE
     TAKKAEIPLM TSKASIYFNV ILWLVALSAL IRFIGCSIYM IVRFFKKVTF R
>P39962 pla CASEIN KINASE I HOMOLOG 3 (EC 2.7.1.-).
     MSQRSSQHIV GIHYAVGPKI GEGSFGVIFE GENILHSCQA QTGSKRDSSI IMANEPVAIK
     FEPRHSDAPQ LRDEFRAYRI LNGCVGIPHA YYFGQEGMHN ILIIDLLGPS LEDLFEWCGR
     KFSVKTTCMV AKQMIDRVRA IHDHDLIYRD IKPDNFLISQ YQRISPEGKV IKSCASSSNN
     DPNLIYMVDF GMAKQYRDPR TKQHIPYRER KSLSGTARYM SINTHFGREQ SRRDDLESLG
     HVFFYFLRGS LPWQGLKAPN NKLKYEKIGM TKQKLNPDDL LLNNAIPYQF ATYLKYARSL
     KFDEDPDYDY LISLMDDALR LNDLKDDGHY DWMDLNGGKG WNIKINRRAN LHGYGNPNPR
     VNGNTARNNV NTNSKTRNTT PVATPKQQAQ NSYNKDNSKS RISSNPQSFT KQQHVLKKIE
     PNSKYIPETH SNLQRPIKSQ SQTYDSISHT QNSPFVPYSS SKANPKRSNN EHNLPNHYTN
     LANKNINYQS QRNYEQENDA YSDDENDTFC SKIYKYCCCC FCCC
>Q02805 pla ROD1 PROTEIN.
     MFSSSSRPSK EPLLFDIRLR NLDNDVLLIK GPPDEASSVL LSGTIVLSIT EPIQIKSLAL
     RLFGRLRLNI PTVLQTVHGP HKRYSKFERN IYSHFWDDFN IKSYFQNLYD NHNNGKITIS
     SKSSTNLAAL PKRKRALSTA SLISSNGQTS ASKNYHTLVK GNYEFPFSAI IPGSLVESVE
     GLPNAAVTYA LEATIERPKQ PDLICKKHLR VIRTLAIDAV ELSETVSVDN SWPEKVDYTI
     SIPTKAIAIG SSTMINILIV PILKGLKLGP VRISLVENSQ YCGSYGGVIN QERMVAKLKL
     KDPLKHVAQI KKKRSLNEAA DEGVDTDTGE FQDKWEVRAL LNIPASLTKC SQDCRILSNI
     KVRHKIKFTI SLLNPDGHIS ELRAALPVQL FISPFVPVNV KTSDVIERTL KTFGPSYQVT
     SQHDNSFSSK NFVDDSEEDV IFQRSASALQ LSSMPTIVSG STLNINSTDA EATAVADTTM
     VTSLMVPPNY GNHVYDRVYG EVTNEDETSA SASSSAVESQ AIHNIQNLYI SDSNNSNNPI
     LAPNPQIKIE DDSLNNCDSR GDSVNNSNLN LVNSNLTISE NWNNNSPSAN RYNNIINAGL
     NSPSLTPSFA HLSRRNSYSR QTSSTSLKND LELTDLSRVP SYDKAMKSDM IGEDLPPAYP
     EEELGVQENK KIELERPQIL HHKSTSSLLP LPGSSKSSNN LKRSSSRTHL SHSPLPRNNS
     GSSVSLQQLA RNNTDSSFNL NLSFTSAKSS TGSRHFPFNM TTSFTSNSSS KNNSHFDKTD
     STSDANKPRE EENYTSATHN RRSRSSSVRS NNSNSPLRQG TGSFANLMEM FTKRDRS
>P08679 pox CITRATE SYNTHASE, PEROXISOMAL (EC 4.1.3.7).
     MTVPYLNSNR NVASYLQSNS SQEKTLKERF SEIYPIHAQD VRQFVKEHGK TKISDVLLEQ
     VYGGMRGIPG SVWEGSVLDP EDGIRFRGRT IADIQKDLPK AKGSSQPLPE ALFWLLLTGE
     VPTQAQVENL SADLMSRSEL PSHVVQLLDN LPKDLHPMAQ FSIAVTALES ESKFAKAYAQ
     GISKQDYWSY TFEDSLDLLG KLPVIAAKIY RNVFKDGKMG EVDPNADYAK NLVNLIGSKD
     EDFVDLMRLY LTIHSDHEGG NVSAHTSHLV GSALSSPYLS LASGLNGLAG PLHGRANQEV
     LEWLFALKEE VNDDYSKDTI EKYLWDTLNS GRVIPGYGHA VLRKTDPRYM AQRKFAMDHF
     PDYELFKLVS SIYEVAPGVL TEHGKTKNPW PNVDAHSGVL LQYYGLKESS FYTVLFGVSR
     AFGILAQLIT DRAIGASIER PKSYSTEKYK ELVKNIESKL
>P13711 pox ACYL-COENZYME A OXIDASE (EC 1.3.3.6) (ACYL-COA OXIDASE).
     MTRRTTINPD SVVLNPQKFI QKERADSKIK VDQVNTFLES SPERRTLTHA LIDQIVNDPI
     LKTDTDYYDA KKMQEREITA KKIARLASYM EHDIKTVRKH FRDTDLMKEL QANDPDKASP
     LTNKDLFIFD KRLSLVANID PQLGTRVGVH LGLFGNCIKG NGTDEQIRYW LQERGATLMK
     GIYGCFAMTE LGHGSNVAQL QTRAVYDKQN DTFVIDTPDL TATKWWIGGA AHSATHAAVY
     ARLIVEGKDY GVKTFVVPLR DPSTFQLLAG VSIGDIGAKM GRDGIDNGWI QFRNVVIPRE
     FMLSRFTKVV RSPDGSVTVK TEPQLDQISG YSALLSGRVN MVMDSFRFGS KFATIAVRYA
     VGRQQFAPRK GLSETQLIDY PLHQYRVLPQ LCVPYLVSPV AFKLMDNYYS TLDELYNASS
     SAYKAALVTV SKKLKNLFID SASLKATNTW LIATLIDELR QTCGGHGYSQ YNGFGKGYDD
     WVVQCTWEGD NNVLSLTSAK SILKKFIDSA TKGRFDNTLD VDSFSYLKPQ YIGSVVSGEI
     KSGLKELGDY TEIWSITLIK LLAHIGTLVE KSRSIDSVSK LLVLVSKFHA LRCMLKTYYD
     KLNSRDSHIS DEITKESMWN VYKLFSLYFI DKHSGEFQQF KIFTPDQISK VVQPQLLALL
     PIVRKDCIGL TDSFELPDAM LNSPIGYFDG DIYHNYFNEV CRNNPVEADG AGKPSYHALL
     SSMLGRGFEF DQKLGGAANA EILSKINK
>P15202 pox CATALASE A (EC 1.11.1.6).
     MSKLGQEKNE VNYSDVREDR VVTNSTGNPI NEPFVTQRIG EHGPLLLQDY NLIDSLAHFN
     RENIPQRNPH AHGSGAFGYF EVTDDITDIC GSAMFSKIGK RTKCLTRFST VGGDKGSADT
     VRDPRGFATK FYTEEGNLDW VYNNTPVFFI RDPSKFPHFI HTQKRNPQTN LRDADMFWDF
     LTTPENQVAI HQVMILFSDR GTPANYRSMH GYSGHTYKWS NKNGDWHYVQ VHIKTDQGIK
     NLTIEEATKI AGSNPDYCQQ DLFEAIQNGN YPSWTVYIQT MTERDAKKLP FSVFDLTKVW
     PQGQFPLRRV GKIVLNENPL NFFAQVEQAA FAPSTTVPYQ EASADPVLQA RLFSYADAHR
     YRLGPNFHQI PVNCPYASKF FNPAIRDGPM NVNGNFGSEP TYLANDKSYT YIQQDRPIQQ
     HQEVWNGPAI PYHWATSPGD VDFVQARNLY RVLGKQPGQQ KNLAYNIGIH VEGACPQIQQ
     RVYDMFARVD KGLSEAIKKV AEAKHASELS SNSKF
>P27796 pox 3-KETOACYL-COA THIOLASE PEROXISOMAL PRECURSOR (EC 2.3.1.16) (BETA-
     MSQRLQSIKD HLVESAMGKG ESKRKNSLLE KRPEDVVIVA ANRSAIGKGF KGAFKDVNTD
     YLLYNFLNEF IGRFPEPLRA DLNLIEEVAC GNVLNVGAGA TEHRAACLAS GIPYSTPFVA
     LNRQCSSGLT AVNDIANKIK VGQIDIGLAL GVESMTNNYK NVNPLGMISS EELQKNREAK
     KCLIPMGITN ENVAANFKIS RKDQDEFAAN SYQKAYKAKN EGLFEDEILP IKLPDGSICQ
     SDEGPRPNVT AESLSSIRPA FIKDRGTTTA GNASQVSDGV AGVLLARRSV ANQLNLPVLG
     RYIDFQTVGV PPEIMGVGPA YAIPKVLEAT GLQVQDIDIF EINEAFAAQA LYCIHKLGID
     LNKVNPRGGA IALGHPLGCT GARQVATILR ELKKDQIGVV SMCIGTGMGA AAIFIKE
>P28240 pox ISOCITRATE LYASE (EC 4.1.3.1) (ISOCITRASE) (ISOCITRATASE) (ICL).
     MPIPVGNTKN DFAALQAKLD ADAAEIEKWW SDSRWSKTKR NYSARDIAVR RGTFPPIEYP
     SSVMARKLFK VLEKHHNEGT VSKTFGALDP VQISQMAKYL DTIYISGWQC SSTASTSNEP
     GPDLADYPMD TVPNKVEHLF KAQLFHDRKQ LEARSKAKSQ EELDEMGAPI DYLTPIVADA
     DAGHGGLTAV FKLTKMFIER GAAGIHMEDQ TSTNKKCGHM AGRCVIPVQE HVNRLVTIRM
     CADIMHSDLI VVARTDSEAA TLISSTIDTR DHYFIVGATN PNIEPFAEVL NDAIMSGASG
     QELADIEQKW CRDAGLKLFH EAVIDEIERS ALSNKQELIK KFTSKVGPLT ETSHREAKKL
     AKEILGHEIF FDWELPRVRE GLYRYRGGTQ CSIMRARAFA PYADLVWMES NYPDFQQAKE
     FAEGVKEKFP DQWLAYNLSP SFNWPKAMSV DEQHTFIQRL GDLGYIWQFI TLAGLHTNAL
     AVHNFSRDFA KDGMKAYAQN VQQREMDDGV DVLKHQKWSG AEYIDGLLKL AQGGVSATAA
     MGTGVTEDQF KENGVKK
>P29340 pox UBIQUITIN-CONJUGATING ENZYME E2-21 KD (EC 6.3.2.19) (UBIQUITIN-PROTEIN
     MPNFWILENR RSYTSDTCMS RIVKEYKVIL KTLASDDPIA NPYRGIIESL NPIDETDLSK
     WEAIISGPSD TPYENHQFRI LIEVPSSYPM NPPKISFMQN NILHCNVKSA TGEICLNILK
     PEEWTPVWDL LHCVHAVWRL LREPVCDSPL DVDIGNIIRC GDMSAYQGIV KYFLAERERI
     NNH
>P32419 pox MALATE DEHYDROGENASE, PEROXISOMAL (EC 1.1.1.37).
     VKVAILGASG GVGQPLSLLL KLSPYVSELA LYDIRAAEGI GKDLSHINTN SSCVGYDKDS
     IENTLSNAQV VLIPAGVPRK PGLTRDDLFK MNAGIVKSLV TAVGKFAPNA RILVISNPVN
     SLVPIAVETL KKMGKFKPGN VMGVTNLDLV RAETFLVDYL MLKNPKIGQE QDKTTMHRKV
     TVIGGHSGET IIPIITDKSL VFQLDKQYEH FIHRVQFGGD EIVKAKQGAG SATLSMAFAG
     AKFAEEVLRS FHNEKPETES LSAFVYLPGL KNGKKAQQLV GDNSIEYFSL PIVLRNGSVV
     SIDTSVLEKL SPREEQLVNT AVKELRKNIE KGKSFILDSS KL
>P80667 pox PEROXISOMAL MEMBRANE PROTEIN PAS20 (PEROXIN-13).
     MSSTAVPRPK PWETSASLEE PQRNAQSLSA MMTSNQQDSR PTEESNNSNS ASESAPEVLP
     RPAALNSSGT YGESNTIPGI YGNSNYGIPY DNNPYSMNSI YGNSIGRYGY GGSYYGNNYG
     SFYGGGYGAG AGYGMNNGSG LGESTKATFQ LIESLIGAVT GFAQMLESTY MATHNSFFTM
     ISVAEQFGNL KEMLGSFFGI FAIMKFLKKI LYRATKGRLG IPPKNFAESE GSKNKLIEDF
     QKFNDSGTIN SNEKATRRKI SWKPLLFFLM AVFGFPYLLN KFITKLQTSG TIRASQGNGS
     EPIDPSKLEF ARALYDFVPE NPEMEVALKK GDLMAILSKK DPLGRDSDWW KVRTKNGNIG
     YIPYNYIEII KRRKKIEHVD DETRTH
>Q02207 pox PEROXISOMAL HYDRATASE-DEHYDROGENASE-EPIMERASE (HDE) (CONTAINS:
     MPGNLSFKDR VVVITGAGGG LGKVYALAYA SRGAKVVVND LGGTLGGSGH NSKAADLVVD
     EIKKAGGIAV ANYDSVNENG EKIIETAIKE FGRVDVLINN AGILRDVSFA KMTEREFASV
     VDVHLTGGYK LSRAAWPYMR SQKFGRIINT ASPAGLFGNF GQANYSAAKM GLVGLAETLA
     KEGAKYNINV NSIAPLARSR MTENVLPPHI LKQLGPEKIV PLVLYLTHES TKVSNSIFEL
     AAGFFGQLRW ERSSGQIFNP DPKTYTPEAI LNKWKEITDY RDKPFNKTQH PYQLSDYNDL
     ITKAKKLPPN EQGSVKIKSL CNKVVVVTGA GGGLGKSHAI WFARYGAKVV VNDIKDPFSV
     VEEINKLYGE GTAIPDSHDV VTEAPLIIQT AISKFQRVDI LVNNAGILRD KSFLKMKDEE
     WFAVLKVHLF STFSLSKAVW PIFTKQKSGF IINTTSTSGI YGNFGQANYA AAKAAILGFS
     KTIALEGAKR GIIVNVIAPH AETAMTKTIF SEKELSNHFD ASQVSPLVVL LASEELQKYS
     GRRVIGQLFE VGGGWCGQTR WQRSSGYVSI KETIEPEEIK ENWNHITDFS RNTINPSSTE
     ESSMATLQAV QKAHSSKELD DGLFKYTTKD CILYNLGLGC TSKELKYTYE NDPDFQVLPT
     FAVIPFMQAT ATLAMDNLVD NFNYAMLLHG EQYFKLCTPT MPSNGTLKTL AKPLQVLDKN
     GKAALVVGGF ETYDIKTKKL IAYNEGSFFI RGAHVPPEKE VRDGKRAKFA VQNFEVPHGK
     VPDFEAEIST NKDQAALYRL SGDFNPLHID PTLAKAVKFP TPILHGLCTL GISAKALFEH
     YGPYEELKVR FTNVVFPGDT LKVKAWKQGS VVVFQTIDTT RNVIVLDNAA VKLSQAKSKL
>P32573 pox SPORULATION PROTEIN SPS19 (SPORULATION-SPECIFIC PROTEIN SPX19).
     MDTMNTANTL DGKFVTEGSW RPDLFKGKVA FVTGGAGTIC RVQTEALVLL GCKAAIVGRD
     QERTEQAAKG ISQLAKDKDA VLAIANVDVR NFEQVENAVK KTVEKFGKID FVIAGAAGNF
     VCDFANLSPN AFKSVVDIDL LGSFNTAKAC LKELKKSKGS ILFVSATFHY YGVPFQGHVG
     AAKAGIDALA KNLAVELGPL GIRSNCIAPG AIDNTEGLKR LAGKKYKEKA LAKIPLQRLG
     STRDIAESTV YIFSPAASYV TGTVLVVDGG MWHLGTYFGH ELYPEALIKS MTSKL
>P38013 pox PUTATIVE PEROXISOMAL MEMBRANE PROTEIN.
     MSDLVNKKFP AGDYKFQYIA ISQSDADSES CKMPQTVEWS KLISENKKVI ITGAPAAFSP
     TCTVSHIPGY INYLDELVKE KEVDQVIVVT VDNPFANQAW AKSLGVKDTT HIKFASDPGC
     AFTKSIGFEL AVGDGVYWSG RWAMVVENGI VTYAAKETNP GTDVTVSSVE SVLAHL
>P38139 pox PUTATIVE PEROXISOMAL LIPASE IN CDC47-KTR3 INTERGENIC REGION
     MNMAERAEAT KSWSCEPLSG KTLEEIVQNA ENAADLVAYI RKPEVDLDFR LKFIAEHEEF
     FNEQLSDRNS RIRTCHNLSD KGIRGDTVFV FVPGLAGNLE QFEPLLELVD SDQKAFLTLD
     LPGFGHSSEW SDYPMLKVVE LIFVLVCDVL RKWSTAVPNN DNVNPFNGHK IVLVGHSMGC
     FLACHLYEQH MADTKAVQTL VLLTPPKAHI EQLSKDKHII QWALYGVFKL PWLFDVYRNK
     FDQVKGLQSS GIKQYFYQQG DDVKLKYRKF WQFKNNISNK SRTIIGYLLG WETVDWVKFN
     GVLTQTDMKQ KIIIFGAEKD PIAPIENLEF YKQTINKECL RKVIILPDCS HNLCFDRPEL
     VCENFQREVI DNSKL
>Q04364 pox HYPOTHETICAL 59.1 KD PROTEIN IN SOK2-FMS1 INTERGENIC REGION.
     MNEVTCSITG DNPIHKINNG LGLKWNNLGK FSDFQTNDSA ARDARTIDYI FTNCQTGSSI
     GKIDFRAALP ADKSQHSGVS EKEFSRLENQ WSKEFSCFPK NKNADVTKPS RNKHEKRSAN
     LHNRYFAQYY STAYQQNRIY PCRISYNEHS SVSNGWEFQF KSIENQLLNE LKIENNVEEK
     TVGYEYVAEY EETIDFMHML SSVPQTYQFL KSNIYITERD PYKIGCVLMD NGSNLNEVVM
     AFEAAISQDP SHINAWLKLG IVNFENESES NGELALRNCL NLDPNNTIAL ENLAIHHINQ
     QNESESLKLF HKWILSKFSK VFQPSAGENK DSINKIPKKA HLAHILESLL NMGIEKKDQY
     DIYSVLSILY YSDQKIKQSQ KCLEFLLLEK PNNGTIWNRY GAILANTKSY HSAINAYNKC
     KQLRPNFTRV RYNLAIAYMN KGDYVKASKM LIEVILLRSK GYEHNKAKMQ NKFMQNLKNA
     LIASKNFDSL DLINGSHNTE SLISTLKAIY NKMD
>Q04370 pox PEROXISOME ASSEMBLY PROTEIN PEX12 (PEROXIN-12).
     MSFYSNLPSA GQSSRGSSTS GRNGVGLEPL YPTIFEIMSS QEIDSLLPAS IRYLLANHLV
     ANFPNRYTLR LNKYFFEWFQ AIKGFVEWYH LKTYNSTFID RFYGLQLFSS RDRNLALTQC
     LNPKGQSEWP QGLQLNQQQK SVIFLEKIIL PYITAKLDEI LEKISMNNIF SSDETENKWP
     KRAFLRIYPF IKKLLALSNL LVKLLFLTKR TGSVSLLQYL FKIEYTTVRP LSSELSGLKE
     TKGMDNRLRK TNISSIFALM QGQLSIIPRF LTFMGSQFFP TFIFVLRVYQ WWTTQDMTTK
     LQKRVNDLDE DIPRPPFSSH SDKTEDKEGV SEACPVCEKT VQNPCVLETG YVACYPCAIS
     YLVNNEGHCP VTNKKLLGCT YNKHTNKWEV VTGIRKLLI
>Q05568 pox PEROXISOME ASSEMBLY PROTEIN PEX10 (PEROXIN-10).
     MKNDNKLQKE ALMRLSQLRF PFADAPSIVQ AHQKDEQIQG LLIMKVTELC KLIKSQLFVN
     SYPKELSIFA KLLYLLFTTG RRGRTLGEEY VDLTYTNRKG TRLAGRLKMI VFAFAYPLCP
     YFITKLYKKI MKNNKESKIE DTESVAAFCK GLLDFILDVH MTLFYFKGAF YSISKRIFGM
     RYVFKHILSK NEANFREEGS QKYKVLGYIL LAQNVMKWYP VLTSTLGSWI YGRKRTNDSI
     TRSSVGLQER SEHESIEGIP KESQLTHINL SDKNQLPFIP EASRKCILCL MNMSDPSCAP
     CGHLFCWSCL MSWCKERPEC PLCRQHCQPQ EILVLRQ
>P21826 pox MALATE SYNTHASE 2, GLYOXYSOMAL (EC 4.1.3.2).
     MVKISLDNTA LYADIDTTPQ FEPSKTTVAD ILTKDALEFI VLLHRTFNST RKQLLANRSN
     LQSKLDSGEY RFDFLPETEQ IRNDPTWQGA IPAPGLINRS SEITGPPLRN MLVNDLNAEV
     TTYMTDFEDS SSPTWENMIY GQVNLYDAIR NQIDFKTPRK EYRLKGDISR LPTLIVRPRG
     WHMVEKHLYI DDEPISASIF DFGLYFYHNA KELVKIGKGP YFYLPKMEHH MEVKLWNDIF
     CVAQDFIGMP RGTIRATVLI ETLPAAFQME EIIYQIREHS SGLNCGRWDY IFSTIKKLRN
     LNEHVLPNRD LVTMTSPFMD AYVKRLINTC HRRGVHAMGG MAAQIPIKDD PKANEAAMNK
     VRNDKIREMK NGHDGSWVAH PALAPICNEV FSNMGTANQI YFVPDVHVTS SDLLNTKIQD
     AQVTTEGIRV NLDIGLQYME AWLRGSGCVP INHLMEDAAT AEVSRCQLYQ WVKHGVVLSD
     TGDKVTPELT AKILNEETAK LASASPLGEK NKFALAAKYF LPEVTGKIFS DFLTTLLYDE
     IIKPSAKPVD LSKL
>P30952 pox MALATE SYNTHASE 1, GLYOXYSOMAL (EC 4.1.3.2).
     MVKVSLDNVK LLVDVDKEPF FKPSSTTVGD ILTKDALEFI VLLHRTFNNK RKQLLENRQV
     VQKKLDSGSY HLDFLPETAN IRNDPTWQGP ILAPGLINRS TEITGPPLRN MLINALNAPV
     NTYMTDFEDS ASPTWNNMVY GQVNLYDAIR NQIDFDTPRK SYKLNGNVAN LPTIIVRPRG
     WHMVEKHLYV DDEPISASIF DFGLYFYHNA KELIKLGKGP YFYLPKMEHH LEAKLWNDVF
     CVAQDYIGIP RGTIRATVLI ETLPAAFQME EIIYQLRQHS SGLNCGRWDY IFSTIKRLRN
     DPNHILPNRN QVTMTSPFMD AYVKRLINTC HRRGVHAMGG MAAQIPIKDD PAANEKAMTK
     VRNDKIRELT NGHDGSWVAH PALAPICNEV FINMGTPNQI YFIPENVVTA ANLLETKIPN
     GEITTEGIVQ NLDIGLQYME AWLRGSGCVP INNLMEDAAT AEVSRCQLYQ WVKHGVTLKD
     TGEKVTPELT EKILKEQVER LSKASPLGDK NKFALAAKYF LPEIRGEKFS EFLTTLLYDE
     IVSTKATPTD LSKL
>P53248 pox PEROXISOMAL PROTEIN PAS6 (PEROXIN-8).
     MFDHDVEYLI TALSSETRIQ YDQRLLDEIA ANVVYYVPRV KSPDTLYRLV GALFRSQFIV
     QLPPLRLLHI VKDVFLWKLE VSEPTLPISK FYLVWNAVFE SHRATWNLSQ LMVLDGVLVT
     YPSFKQLNNA YFIDESSNKT ALYYRNWKLQ LFSPIWAQLW NTAIVRANLS IQHCLLIALA
     LLFNQSNRSA LLHGVDVSWN LVTEKLLDLL EEYVHGIVQP MEIFSTDSVL STNLNHLASC
     LTSSITRSNE ATLVNSVRKL ERICRYLSDT VASLKEQQLD FKFQNVFILI ILALKELSAM
     NMTILPNHKD TFYSMICLSL FHVHVLTQKI GTVGFPSYDY VYDNLVTYFI VMDDLSKITT
     VLELMKRNNT KQDPNKLVFY INFLNKITNY YGCRIRLPFI TEFIEPLLHF DVFFSGKTGN
     TLDIEIKESI HTLTITVLSI DSSYSSQVAQ WQVSRILVYL KMSMDQFIAG KLSANQILLI
     FGHLSTQLPS LHNYNKHLLR DSLHETYIRI VNVKNPEKKN VLIECLIVQI AFINNPHHLI
     GWLNICLQLI NTHNKKLLQQ LWEMVSSLES SLAIDWWYTT VLSSQSSKL
>P38137 pox PEROXISOMAL-COENZYME A SYNTHETASE (EC 6.-.-.-).
     MTSAATVTAS FNDTFSVSDN VAVIVPETDT QVTYRDLSHM VGHFQTMFTN PNSPLYGAVF
     RQDTVAISMR NGLEFIVAFL GATMDAKIGA PLNPNYKEKE FNFYLNDLKS KAICVPKGTT
     KLQSSEILKS ASTFGCFIVE LAFDATRFRV EYDIYSPEDN YKRVIYRSLN NAKFVNTNPV
     KFPGFARSSD VALILHTSGT TSTPKTVPLL HLNIVRSTLN IANTYKLTPL DRSYVVMPLF
     HVHGLIGVLL STFRTQGSVV VPDGFHPKLF WDQFVKYNCN WFSCVPTISM IMLNMPKPNP
     FPHIRFIRSC SSALAPATFH KLEKEFNAPV LEAYAMTEAS HQMTSNNLPP GKRKPGTVGQ
     PQGVTVVILD DNDNVLPPGK VGEVSIRGEN VTLGYANNPK ANKENFTKRE NYFRTGDQGY
     FDPEGFLVLT GRIKELINRG GEKISPIELD GIMLSHPKID EAVAFGVPDD MYGQVVQAAI
     VLKKGEKMTY EELVNFLKKH LASFKIPTKV YFVDKLPKTA TGKIQRRVIA ETFAKSSRNK
     SKL
>P35056 pox PEROXISOMAL TARGETING SIGNAL RECEPTOR (PEROXISOMAL PROTEIN PAS10)
     MDVGSCSVGN NPLAQLHKHT QQNKSLQFNQ KNNGRLNESP LQGTNKPGIS EAFISNVNAI
     SQENMANMQR FINGEPLIDD KRRMEIGPSS GRLPPFSNVH SLQTSANPTQ IKGVNDISHW
     SQEFQGSNSI QNRNADTGNS EKAWQRGSTT ASSRFQYPNT MMNNYAYASM NSLSGSRLQS
     PAFMNQQQSG RSKEGVNEQE QQPWTDQFEK LEKEVSENLD INDEIEKEEN VSEVEQNKPE
     TVEKEEGVYG DQYQSDFQEV WDSIHKDAEE VLPSELVNDD LNLGEDYLKY LGGRVNGNIE
     YAFQSNNEYF NNPNAYKIGC LLMENGAKLS EAALAFEAAV KEKPDHVDAW LRLGLVQTQN
     EKELNGISAL EECLKLDPKN LEAMKTLAIS YINEGYDMSA FTMLDKWAET KYPEIWSRIK
     QQDDKFQKEK GFTHIDMNAH ITKQFLQLAN NLSTIDPEIQ LCLGLLFYTK DDFDKTIDCF
     ESALRVNPND ELMWNRLGAS LANSNRSEEA IQAYHRALQL KPSFVRARYN LAVSSMNIGC
     FKEAAGYLLS VLSMHEVNTN NKKGDVGSLL NTYNDTVIET LKRVFIAMNR DDLLQEVKPG
     MDLKRFKGEF SF
>Q12462 pox PEROXISOMAL MEMBRANE PROTEIN PMP27 (PEROXIN-11).
     VCDTLVYHPS VTRFVKFLDG SAGREKVLRL LQYLARFLAV QNSSLLARQL QAQFTTVRKF
     LRFLKPLNHL QAAAKFYDNK LASDNVVRVC NVLKNIFFAA YLSLDQVNLL RILKVIPVTV
     LTGKKIPRWS NWCWLFGLLS GLAMDLRKIQ TSHAQIAAFV KAKSQSQGDE HEDHKKVLGK
     AYQDRYTALR RLFWDAADSF IVLNNLGYLS SNEEYVALSG VVTSILGMQD MWKAT
>P53112 pox PEROXISOMAL MEMBRANE PROTEIN PEX14 (PEROXIN-14).
     MSDVVSKDRK ALFDSAVSFL KDESIKDAPL LKKIEFLKSK GLTEKEIEIA MKEPKKDGIV
     GDEVSKKIGS TENRASQDMY LYEAMPPTLP HRDWKDYFVM ATATAGLLYG AYEVTRRYVI
     PNILPEAKSK LEGDKKEIDD QFSKIDTVLN AIEAEQAEFR KKESETLKEL SDTIAELKQA
     LVQTTRSREK IEDEFRIVKL EVVNMQNTID KFVSDNDGMQ ELNNIQKEME SLKSLMNNRM
     ESGNAQDNRL FSISPNGIPG IDTIPSASEI LAKMGMQEES DKEKENGSDA NKDDNAVPAW
     KKAREQTIDS NASIPEWQKN TAANEISVPD WQNGQVEDSI P
>P28795 pox PEROXISOMAL MEMBRANE PROTEIN PAS3 (PEROXIN-3).
     MAPNQRSRSL LQRHRGKVLI SLTGIAALFT TGSVVVFFVK RWLYKQQLRI TEQHFIKEQI
     KRRFEQTQED SLYTIYELLP VWRMVLNEND LNLDSIVTQL KDQKNQLTRA KSSESRESSP
     LKSKAELWNE LELKSLIKLV TVTYTVSSLI LLTRLQLNIL TRNEYLDSAI KLTMQQENCN
     KLQNRFYNWV TSWWSDPEDK ADDAMVMAAK KSKKEGQEVY INEQAFLSLS WWILNKGWLS
     YNEIITNQIE IEFDGIHPRD TLTLEEFSSR LTNIFRNTNS QIFQQNNNNL TSILLPKDSS
     GQEFLLSQTL DADALTSFHS NTLVFNQLVN ELTQCIESTA TSIVLESLIN ESFHFIMNKV
     GIKTIAKKKP GQEDQQQYQM AVFAMSMKDC CQEMLQTTAG SSHSGSVNEY LATLDSVQPL
     DDLSASVYSN FGVSSSFSFK P
>P34230 pox PEROXISOMAL LONG-CHAIN FATTY ACID IMPORT PROTEIN 1 (PEROXISOMAL ABC
     MISTASAFYQ KHRVNLLRSS YIILLLATLY NSNSSSSNNK TDKKDSESTV LENKKIEEGK
     ETAVDREEDE SSKEELTIVS KHSTDSEDGA IIIDKESKTN HKGGERKGKV DFLFKLLLHD
     KKCLILFITQ AILLNIRTLL SLRVATLDGQ LVSTLVRAQY ANFTKILLGK WMILGIPASF
     INSLISYTTK LCAVTINRKV SDFLLSKYLS NHHTFYSVAS AESVSEIQDN LTKDIYTFSM
     NSSLLLNQLL KPMLDLILCS FKLLTSNTSV MGEGTLALGL IVYASNSLLK LIQPNFTRLT
     MASASLESWF RSLHSNLHSS NEEIALLRGQ KRELENVDYS FYRLVLFLNR EIKARAIYDV
     ATAFVIKYTW GAAGLVLCSI PIFFKNKPSE DTLQLKEPGN DMTADFITNR RLLVTASSSI
     GRFVELKRNI QQLRGIRLRL NKFNDLLDAN KGDDEKEPRD ERCIVEYDDS RIKFENIPLI
     TPANQVLVPE LSFDLKHGNH LLIIGPNGCG KSSLFRILGG LWPIRATPNK NHQSKLIMPR
     RTVDRDCAIF YLPQRPYMGN RSTFREQIIY PDSIEQFKER YHNDYDLGDA DLIKILQLLD
     LEDLVTENMS LLLAQRTSKN DSQQLSTEDN QSPCAIKVRD AFSIVRNWSE ELTIGVQQRL
     AMARMYYHKP KFAVLDECTS AVAPEMEQRM YENAQNFGIS LISVCHRTSL WHFHNYLLKF
     DGKGGYQFGP FNPKERLCNE EKLLELNAIL DQQVPLWERK LKDLTIAKES NIIRKSETNL
     NLFEKIEDPK TSKSNALFNA NKGQRITSPT GQETSKRLPL FSQPSSSASS NLLRNNKSLN
     KKVKTKKEEG KER
>P41909 pox PEROXISOMAL LONG-CHAIN FATTY ACID IMPORT PROTEIN 2 (PEROXISOMAL ABC
     MQLDSGARIM YIPEVELVDR QSPDDNKFMN ATDKKKRKRI FIPPKDNDVY EHDKFLFKNV
     ELERAKNSQL FYSKFLNQMN VLSKILIPTV FDKNFLLLTA QIFFLVMRTW LSLFVAKLDG
     QIVKNIIAGR GRSFLWDLGC WFLIAVPASY TNSAIKLLQR KLSLNFRVNL TRYIHDMYLD
     KRLTFYKLIF DAKASNSVIK NIDNSITNDV AKFCDATCSV FANIAKPVID LIFFSVYLRD
     NLGTVGVAGI FVNYFITGFI LRKYTPPLGK LAGERSASDG DYYNYHLNMI NNSEEIAFYQ
     GTAVERTKVK ELYDVLMEKM LLVDKVKFGY NMLEDYVLKY TWSGLGYVFA SIPIVMSTLA
     TGINSEEKNM KEFIVNKRLM LSLADAGSRL MHSIKDISQL TGYTNRIFTL LSVLHRVHSL
     NFNYGAVPSI LSIRTEDASR NSNLLPTTDN SQDAIRGTIQ RNFNGIRLEN IDVIIPSVRA
     SEGIKLINKL TFQIPLHIDP ITSKSNSIQD LSKANDIKLP FLQGSGSSLL ILGPNGCGKS
     SIQRIIAEIW PVYNKNGLLS IPSENNIFFI PQKPYFSRGG TLRDQIIYPM SSDEFFDRGF
     RDKELVQILV EVKLDYLLKR GVGLTYLDAI ADWKDLLSGG EKQRVNFARI MFHKPLYVVL
     DEATNAISVD MEDYLFNLLK RYRFNFISIS QRPTLIKYHE MLLEIGENRD GKWQLQAVGT
     DEAITSIDNE IEELERKLER VKGWEDERTK LREKLEII
>P00729 vac CARBOXYPEPTIDASE Y PRECURSOR (EC 3.4.16.5) (CARBOXYPEPTIDASE YSCY).
     MKAFTSLLCG LGLSTTLAKA ISLQRPLGLD KDVLLQAAEK FGLDLDLDHL LKELDSNVLD
     AWAQIEHLYP NQVMSLETST KPKFPEAIKT KKDWDFVVKN DAIENYQLRV NKIKDPKILG
     IDPNVTQYTG YLDVEDEDKH FFFWTFESRN DPAKDPVILW LNGGPGCSSL TGLFFELGPS
     SIGPDLKPIG NPYSWNSNAT VIFLDQPVNV GFSYSGSSGV SNTVAAGKDV YNFLELFFDQ
     FPEYVNKGQD FHIAGESYAG HYIPVFASEI LSHKDRNFNL TSVLIGNGLT DPLTQYNYYE
     PMACGEGGEP SVLPSEECSA MEDSLERCLG LIESCYDSQS VWSCVPATIY CNNAQLAPYQ
     RTGRNVYDIR KDCEGGNLCY PTLQDIDDYL NQDYVKEAVG AEVDHYESCN FDINRNFLFA
     GDWMKPYHTA VTDLLNQDLP ILVYAGDKDF ICNWLGNKAW TDVLPWKYDE EFASQKVRNW
     TASITDEVAG EVKSYKHFTY LRVFNGGHMV PFDVPENALS MVNEWIHGGF SL
>P07267 vac SACCHAROPEPSIN PRECURSOR (EC 3.4.23.25) (ASPARTATE PROTEASE)
     MFSLKALLPL ALLLVSANQV AAKVHKAKIY KHELSDEMKE VTFEQHLAHL GQKYLTQFEK
     ANPEVVFSRE HPFFTEGGHD VPLTNYLNAQ YYTDITLGTP PQNFKVILDT GSSNLWVPSN
     ECGSLACFLH SKYDHEASSS YKANGTEFAI QYGTGSLEGY ISQDTLSIGD LTIPKQDFAE
     ATSEPGLTFA FGKFDGILGL GYDTISVDKV VPPFYNAIQQ DLLDEKRFAF YLGDTSKDTE
     NGGEATFGGI DESKFKGDIT WLPVRRKAYW EVKFEGIGLG DEYAELESHG AAIDTGTSLI
     TLPSGLAEMI NAEIGAKKGW TGQYTLDCNT RDNLPDLIFN FNGYNFTIGP YDYTLEVSGS
     CISAITPMDF PEPVGPLAIV GDAFLRKYYS IYDLGNNAVG LAKAI
>P09232 vac CEREVISIN PRECURSOR (EC 3.4.21.48) (VACUOLAR PROTEASE B) (PROTEINASE
     MKLENTLFTL GALGSISAAL VIPNLENAAD HHELINKEDH HERPRKVEFT KDDDEEPSDS
     EDKEHGKFHK KGRKGQDKES PEFNGKRASG SHGSAHEGGK GMKPKHESSN DDDNDDKKKK
     PHHKGGCHEN KVEEKKMKGK KVKGKKHHEK TLEKGRHHNR LAPLVSTAQF NPDAISKIIP
     NRYIIVFKRG APQEEIDFHK ENVQQAQLQS VENLSAEDAF FISTKDTSLS TSEAGGIQDS
     FNIDNLFSGY IGYFTQEIVD LIRQNPLVDF VERDSIVEAT EFDTQNSAPW GLARISHRER
     LNLGSFNKYL YDDDAGRGVT SYVIDTGVNI NHKDFEKRAI WGKTIPLNDE DLDGNGHGTH
     CAGTIASKHY GVAKNANVVA VKVLRSNGSG TMSDVVKGVE YAAKAHQKEA QEKKKGFKGS
     TANMSLGGGK SPALDLAVNA AVEVGIHFAV AAGNENQDAC NTSPASADKA ITVGASTLSD
     DRAYFSNWGK CVDVFAPGLN ILSTYIGSDD ATATLSGTSM ASPHVAGLLT YFLSLQPGSD
     SEFFELGQDS LTPQQLKKKL IHYSTKDILF DIPEDTPNVL IYNGGGQDLS AFWNDTKKSH
     SSGFKQELNM DEFIGSKTDL IFDQVRDILD KLNII
>P11491 vac REPRESSIBLE ALKALINE PHOSPHATASE PRECURSOR (EC 3.1.3.1).
     MMTHRLPSEQ TRLVPGSDSS SRPKKRRISK RSKIIVSTVV CIGLLLVLVQ LAFPTSFAIR
     SASHKKKNVI FFVTDGMGPA SLSMARSFNQ HVNDLPIDDI LTLDEHFIGS SRTRSSDSLV
     TDSAAGATAF ASALKSYNGA IGVDPHHRPC GTVLEAAKLA GYLTGLVVTT RITDATPASF
     SSHVDYRWQE DLIATHQLGE YPLGRVVDLL MGGGRSHFYP QGEKASPYGH HGARKDGRDL
     IDEAQSNGWQ YVGDRKNFDS LLKSHGENVT FPFLGLFADN DIPFEIDRDE KEYPSLKEQV
     KVALGALEKA SNEDKDSNGF FLMVEGSRID HAGHQNDPAS QVREVLAFDE AFQYVLEFAE
     NSDTETVLVS TSDHETGGLV TSRQVTASYP QYVWYPQVLA NATHSGEFLK RKLVDFVHEH
     KGASSKIENF IKHEILEKDL GIYDYTESDL ETLIHLDDNA NAIQDKLNDM VSFRAQIGWT
     THGHSAVDVN IYAYANKKAT WSYVLNNLQG NHENTEVGQF LENFLELNLN EVTDLIRDTK
     HTSDFDATEI ASEVQHYDEY YHELTN
>P12868 vac VACUOLAR BIOGENESIS PROTEIN END1 (PEP5 PROTEIN).
     MSLSSWRQFQ LFENIPIRDP NFGGDSLLYS DPTLCAATIV DPQTLIIAVN SNIIKVVKLN
     QSQVIHEFQS FPHDFQITFL KVINGEFLVA LAESIGKPSL IRVYKLEKLP NREQLYHSQV
     ELKNGNNTYP ISVVSISNDL SCIVVGFING KIILIRGDIS RDRGSQQRII YEDPSKEPIT
     ALFLNNDATA CFAATTSRIL LFNTTGRNRG RPSLVLNSKN GLDLNCGSFN PATNEFICCL
     SNFIEFFSSS GKKHQFAFDL SLRKRIFCVD KDHILIVTEE TGVPTTSISV NELSPTIINR
     IFIIDAKNKI ISLNFVVSSA IIDIFSTSQS GKNITYLLTS EGVMHRITPK SLENQINIII
     QKELYPFALQ LAKQHSLSPL DVQEIHKKYG DYLFKKGLRK EATDQYIQCL DVVETSEIIS
     KFGVKEVPDP ESMRNLADYL WSLIKNSISQ RDHVTLLLIV LIKLKDVEGI DTFIQHFDRK
     GIWNEGVVMD DMDDVTFFYS DNDFFDLDLI LELMKESDFK RLSYRLAKKY SKDSLIIVDI
     LLNLLHNPVK AIKYIKSLPI DETLRCLVTY SKKLLEESPN ETNALLIEVF TGKFKPSTFE
     VDLDRRDTTG DFSENIRTVF YSYKTFFNYM NSNGTSDAMS ESSEASHEHE EPTYHPPKPS
     IVFSSFVTKP FEFVVFLEAC LACYQQYEGF DEDRQVILTT LYDLYLNLAQ NDVPERIDDW
     RSRATGVLRE SNKLVYSAAS NNTSKRVDNS IMLLISHMDQ SSASAKDKTK IDIASFANDN
     PEMDLLSTFR AMTLNEEPST CLKFLEKYGT EEPKLLQVAL SYFVSNKLIF KEMGGNEVLK
     EKVLRPIIEG ERMPLLDIIK ALSRTNVAHF GLIQDIIIDH VKTEDTEIKR NEKLIESYDK
     ELKEKNKKLK NTINSDQPLH VPLKNQTCFM CRLTLDIPVV FFKCGHIYHQ HCLNEEEDTL
     ESERKLFKCP KCLVDLETSN KLFEAQHEVV EKNDLLNFAL NSEEGSRDRF KVITEFLGRG
     AISYSDITI
>P14904 vac VACUOLAR AMINOPEPTIDASE I PRECURSOR (EC 3.4.11.22) (POLYPEPTIDASE)
     MEEQREILEQ LKKTLQMLTV EPSKNNQIAN EEKEKKENEN SWCILEHNYE DIAQEFIDFI
     YKNPTTYHVV SFFAELLDKH NFKYLSEKSN WQDSIGEDGG KFYTIRNGTN LSAFILGKNW
     RAEKGVGVIG SHVDALTVKL KPVSFKDTAE GYGRIAVAPY GGTLNELWLD RDLGIGGRLL
     YKKKGTNEIK SALVDSTPLP VCRIPSLAPH FGKPAEGPFD KEDQTIPVIG FPTPDEEGNE
     PPTDDEKKSP LFGKHCIHLL RYVAKLAGVE VSELIQMDLD LFDVQKGTIG GIGKHFLFAP
     RLDDRLCSFA AMIALICYAK DVNTEESDLF STVTLYDNEE IGSLTRQGAK GGLLESVVER
     SSSAFTKKPV DLHTVWANSI ILSADVNHLY NPNFPEVYLK NHFPVPNVGI TLSLDPNGHM
     ATDVVGTALV EELARRNGDK VQYFQIKNNS RSGGTIGPSL ASQTGARTID LGIAQLSMHS
     IRAATGSKDV GLGVKFFNGF FKHWRSVYDE FGEL
>P18962 vac DIPEPTIDYL AMINOPEPTIDASE B (EC 3.4.14.-) (DPAP B) (YSCV).
     MEGGEEEVER IPDELFDTKK KHLLDKLIRV GIILVLLIWG TVLLLKSIPH HSNTPDYQEP
     NSNYTNDGKL KVSFSVVRNN TFQPKYHELQ WISDNKIESN DLGLYVTFMN DSYVVKSVYD
     DSYNSVLLEG KTFIHNGQNL TVESITASPD LKRLLIRTNS VQNWRHSTFG SYFVYDKSSS
     SFEEIGNEVA LAIWSPNSND IAYVQDNNIY IYSAISKKTI RAVTNDGSSF LFNGKPDWVY
     EEEVFEDDKA AWWSPTGDYL AFLKIDESEV GEFIIPYYVQ DEKDIYPEMR SIKYPKSGTP
     NPHAELWVYS MKDGTSFHPR ISGNKKDGSL LITEVTWVGN GNVLVKTTDR SSDILTVFLI
     DTIAKTSNVV RNESSNGGWW EITHNTLFIP ANETFDRPHN GYVDILPIGG YNHLAYFENS
     NSSHYKTLTE GKWEVVNGPL AFDSMENRLY FISTRKSSTE RHVYYIDLRS PNEIIEVTDT
     SEDGVYDVSF SSGRRFGLLT YKGPKVPYQK IVDFHSRKAE KCDKGNVLGK SLYHLEKNEV
     LTKILEDYAV PRKSFRELNL GKDEFGKDIL VNSYEILPND FDETLSDHYP VFFFAYGGPN
     SQQVVKTFSV GFNEVVASQL NAIVVVVDGR GTGFKGQDFR SLVRDRLGDY EARDQISAAS
     LYGSLTFVDP QKISLFGWSY GGYLTLKTLE KDGGRHFKYG MSVAPVTDWR FYDSVYTERY
     MHTPQENFDG YVESSVHNVT ALAQANRFLL MHGTGDDNVH FQNSLKFLDL LDLNGVENYD
     VHVFPDSDHS IRYHNANVIV FDKLLDWAKR AFDGQFVK
>P22855 vac ALPHA-MANNOSIDASE (EC 3.2.1.24) (ALPHA-D-MANNOSIDE MANNOHYDROLASE).
     MSSEDIIYDP QFKPVQGIYE NRLRQFIDTG GDYHDLNLPK FYDKKRISLD HDHVKVWWYQ
     VSFERGSSPV SPDKRPSWKS IIERDKKGEL EFREANINQP FGPSWSTTWF KVKISLPEDW
     VKSNEQLLFQ WDCSNEGIVI DPKTLIPVTA FSGGERTEYV LPKTSDGKHF FYIEAGNNGM
     FGCGAGSTIN PPDDNRFFHL RKADIVWPDL DARALYIDFW MLGDAARELP GDSWQKHQAR
     QLGNAVMNLF DPNDRSSVRK CRELLQREYF DSFLESSKVY EQGESQVLTN VYGIGNCHID
     TAWLWPFAET RRKIVRSWSS QCTLMDRFPE YKFVASQAQQ FKWLLEDHPE FFNKVLIPKI
     QQSQFFAVGG TWVENDTNIP SGESLARQFF FGQRFFLKHF GLKSKIFWLP DTFGYSSQMP
     QLCRLSGIDK FLTQKLSWNN INSFPHSTFN WAGIDGSQLL THMPPGNTYT ADSHFGDVLR
     TAKQNKTPEY YGSGLMLYGK GDGGGGPTEE MLQKMRRIRS MNNRNGNVIP KLQVGITVDE
     FYDDILKRTN QGHDLPTWSG ELYFEFHRGT YTSQAQTKKL MRLSEIKLHD LEWIAAKTSV
     LYPDSYKYPS KQINELWENV LLCQFHDVLP GSCIEMVYKY EAVPMLHNVV KECTSLIDKT
     VQFLQSQSKA DLVEMRTLTW SKPEKVSEEC SLNGSYTSSV TGYDDYIVLA NGKLKVIICK
     KTGVITSITD ETLGVEYLDT EHGRNKLGAN QFVIYDDKPL GWQAWDTELY SVNQYKYVTK
     PKKVQVSCNT KEKCAVEVIF QISEKCKIKS VISLNATAVT DAKLSKVDIS TTVENWDARN
     KFLKVEFPVN IRNDFASYET QFGITKRPTH YNTSWDVAKF EVCHHKFADY SEYSKGVSIL
     NDCKYGFSTH GNLMRLSLLR SPKAPDAHAD MGTHEIKYAI YPHRGALSSD TVKLAHEFNY
     CFKYKLPKDI GMNFDDIISI SGDENVILSN IKRGEDDSAV KSNYSLNPRD EQSIVVRVYE
     SLGGESFASL NTTLNLKRIE KVDNLEMKVY KSLTATRDES NHAINRIPIK LRPFEIASFR
     LYF
>P27614 vac CARBOXYPEPTIDASE S PRECURSOR (EC 3.4.17.4) (YSCS) (GLY-X
     MIALPVEKAP RKSLWQRHRA FISGIVALII IGTFFLTSGL HPAPPHEAKR PHHGKGPMHS
     PKCEKIEPLS PSFKHSVDTI LHDPAFRNSS IEKLSNAVRI PTVVQDKNPN PADDPDFYKH
     FYELHDYFEK TFPNIHKHLK LEKVNELGLL YTWEGSDPDL KPLLLMAHQD VVPVNNETLS
     SWKFPPFSGH YDPETDFVWG RGSNDCKNLL IAEFEAIEQL LIDGFKPNRT IVMSLGFDEE
     ASGTLGAASL ASFLHERYGD DGIYSIIDEG EGIMEVDKDV FVATPINAEK GYVDFEVSIL
     GHGGHSSVPP DHTTIGIASE LITEFEANPF DYEFEFDNPI YGLLTCAAEH SKSLSKDVKK
     TILGAPFCPR RKDKLVEYIS NQSHLRSLIR TTQAVDIING GVKANALPET TRFLINHRIN
     LHSSVAEVFE RNIEYAKKIA EKYGYGLSKN GDDYIIPETE LGHIDITLLR ELEPAPLSPS
     SGPVWDILAG TIQDVFENGV LQNNEEFYVT TGLFSGNTDT KYYWNLSKNI YRFVGSIIDI
     DLLKTLHSVN EHVDVPGHLS AIAFVYEYIV NVNEYA
>P32912 vac VACUOLAR MORPHOGENESIS PROTEIN VAM7.
     MAANSVGKMS EKLRIKVDDV KINPKYVLYG VSTPNKRLYK RYSEFWKLKT RLERDVGSTI
     PYDFPEKPGV LDRRWQRRYD DPEMIDERRI GLERFLNELY NDRFDSRWRD TKIAQDFLQL
     SKPNVSQEKS QQHLETADEV GWDEMIRDIK LDLDKESDGT PSVRGALRAR TKLHKLRERL
     EQDVQKKSLP STEVTRRAAL LRSLLKECDD IGTANIAQDR GRLLGVATSD NSSTTEVQGR
     TNNDLQQGQM QMVRDQEQEL VALHRIIQAQ RGLALEMNEE LQTQNELLTA LEDDVDNTGR
     RLQIANKKAR HFNNSA
>P32939 vac GTP-BINDING PROTEIN YPT7.
     MSSRKKNILK VIILGDSGVG KTSLMHRYVN DKYSQQYKAT IGADFLTKEV TVDGDKVATM
     QVWDTAGQER FQSLGVAFYR GADCCVLVYD VTNASSFENI KSWRDEFLVH ANVNSPETFP
     FVILGNKIDA EESKKIVSEK SAQELAKSLG DIPLFLTSAK NAINVDTAFE EIARSALQQN
     QADTEAFEDD YNDAINIRLD GENNSCSC
>P33894 vac DIPEPTIDYL AMINOPEPTIDASE A (EC 3.4.14.-) (DPAP A) (YSCIV).
     MSASTHSHKR KNSHLFPQRK SSNSSMDKPF FPNNDSVANT DPQSNENGHT INEIRPTEAT
     IDVTDVPQTP FLQEQYSMRP RRESFQFNDI ENQHHTHSFF SVNKFNRRWG EWSLPEKRSY
     VLVFTLIALS VLVLLVILIP SKLLPTKITR PKTSAGDSSL GKRSFSIENV LNGDFAIPED
     TFHFIDPPQR LLGQDSDPGL YFTTKEIDGH TNFIAKQLFD ETFEVNLGGN RFLYEGVEFT
     VSTVQINYKL DKLIFGTNLE SEFRHSSKGF YWIKDLNTGN IEPILPPEKS DDNYELGLSK
     LSYAHFSPAY NYIYFVYENN LFLQQVNSGV AKKVTEDGSK DIFNAKPDWI YEEEVLASDQ
     AIWWAPDDSK AVFARFNDTS VDDIRLNRYT NMNEAYLSDT KIKYPKPGFQ NPQFDLFLVN
     LQNGIIYSIN TGGQKDSILY NGKWISPDTF RFEITDRNSK ILDVKVYDIP SSQMLTVRNT
     NSNLFNGWIE KTKDILSIPP KPELKRMDYG YIDIHADSRG FSHLFYYPTV FAKEPIQLTK
     GNWEVTGNGI VGYEYETDTI FFTANEIGVM SQHLYSISLT DSTTQNTFQS LQNPSDKYDF
     YDFELSSSAR YAISKKLGPD TPIKVAGPLT RVLNVAEIHD DSILQLTKDE KFKEKIKNYD
     LPITSYKTMV LDDGVEINYI EIKPANLNPK KKYPILVNIY GGPGSQTFTT KSSLAFEQAV
     VSGLDVIVLQ IEPRGTGGKG WSFRSWAREK LGYWEPRDIT EVTKKFIQRN SQHIDESKIA
     IWGWSYGGFT SLKTVELDNG DTFKYAMAVA PVTNWTLYDS VYTERYMNQP SENHEGYFEV
     STIQNFKSFE SLKRLFIVHG TFDDNVHIQN TFRLVDQLNL LGLTNYDMHI FPDSDHSIRY
     HNAQRIVFQK LYYWLRDAFA ERFDNTEVLH L
>P37302 vac AMINOPEPTIDASE Y PRECURSOR (EC 3.4.11.-).
     MHFSLKQLAV AAFYATNLGS AYVIPQFFQE AFQQEEPIEN YLPQLNDDDS SAVAANIPKP
     HIPYFMKPHV ESEKLQDKIK VDDLNATAWD LYRLANYSTP DYGHPTRVIG SKGHNKTMEY
     ILNVFDDMQD YYDVSLQEFE ALSGKIISFN LSDAETGKSF ANTTAFALSP PVDGFVGKLV
     EIPNLGCEEK DYASVVPPRH NEKQIALIER GKCPFGDKSN LAGKFGFTAV VIYDNEPKSK
     EGLHGTLGEP TKHTVATVGV PYKVGKKLIA NIALNIDYSL YFAMDSYVEF IKTQNIIADT
     KHGDPDNIVA LGAHSDSVEE GPGINDDGSG TISLLNVAKQ LTHFKINNKV RFAWWAAEEE
     GLLGSNFYAY NLTKEENSKI RVFMDYDMMA SPNYEYEIYD ANNKENPKGS EELKNLYVDY
     YKAHHLNYTL VPFDGRSDYV GFINNGIPAG GIATGAEKNN VNNGKVLDRC YHQLCDDVSN
     LSWDAFITNT KLIAHSVATY ADSFEGFPKR ETQKHKEVDI LNAQQPQFKY RADFLII
>P38929 vac CALCIUM-TRANSPORTING ATPASE 2 (EC 3.6.1.38) (VACUOLAR CA2+-ATPASE).
     MSRQDENSAL LANNENNKPS YTGNENGVYD NFKLSKSQLS DLHNPKSIRS FVRLFGYESN
     SLFKYLKTDK NAGISLPEIS NYRKTNRYKN YGDNSLPERI PKSFLQLVWA AFNDKTMQLL
     TVAAVVSFVL GLYELWMQPP QYDPEGNKIK QVDWIEGVAI MIAVFVVVLV SAANDYQKEL
     QFAKLNKKKE NRKIIVIRND QEILISIHHV LVGDVISLQT GDVVPADCVM ISGKCEADES
     SITGESNTIQ KFPVDNSLRD FKKFNSIDSH NHSKPLDIGD VNEDGNKIAD CMLISGSRIL
     SGLGRGVITS VGINSVYGQT MTSLNAEPES TPLQLHLSQL ADNISVYGCV SAIILFLVLF
     TRYLFYIIPE DGRFHDLDPA QKGSKFMNIF ITSITVIVVA VPEGLPLAVT LALAFATTRM
     TKDGNLVRVL RSCETMGSAT AVCSDKTGTL TENVMTVVRG FPGNSKFDDS KSLPVSEQRK
     LNSKKVFEEN CSSSLRNDLL ANIVLNSTAF ENRDYKKNDK NTNGSKNMSK NLSFLDKCKS
     RLSFFKKGNR EDDEDQLFKN VNKGRQEPFI GSKTETALLS LARLSLGLQP GELQYLRDQP
     MEKFNIEKVV QTIPFESSRK WAGLVVKYKE GKNKKPFYRF FIKGAAEIVS KNCSYKRNSD
     DTLEEINEDN KKETDDEIKN LASDALRAIS VAHKDFCECD SWPPEQLRDK DSPNIAALDL
     LFNSQKGLIL DGLLGIQDPL RAGVRESVQQ CQRAGVTVRM VTGDNILTAK AIARNCAILS
     TDISSEAYSA MEGTEFRKLT KNERIRILPN LRVLARSSPE DKRLLVETLK GMGDVVAVTG
     DGTNDAPALK LADVGFSMGI SGTEVAREAS DIILMTDDFS AIVNAIKWGR CVSVSIKKFI
     QFQLIVNITA VILTFVSSVA SSDETSVLTA VQLLWINLIM DTLAALALAT DKPDPNIMDR
     KPRGRSTSLI SVSTWKMILS QATLQLIVTF ILHFYGPELF FKKHEDEITS HQQQQLNAMT
     FNTFVWLQFF TMLVSRKLDE GDGISNWRGR ISAANLNFFQ DLGRNYYFLT IMAIIGSCQV
     LIMFFGGAPF SIARQTKSMW ITAVLCGMLS LIMGVLVRIC PDEVAVKVFP AAFVQRFKYV
     FGLEFLRKNH TGKHDDEEAL LEESDSPEST AFY
>P34756 vac PROBABLE PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE FAB1 (EC 2.7.1.68)
     MSSEEPHASI SFPDGSHVRS SSTGTSSVNT IDATLSRPNY IKKPSLHIMS TSTTSTTTDL
     VTNPILSNIS VPKISPPTSS SIATATSTSH VTGTASHSNI KANANTSTSV NKKNLPPTTS
     GRIPSSTIKR YPSRYKPSHS LQLPIKNDSN FKRSSIYASK STVTAIPIRN NRPISMQNSY
     ARTPDSDHDD VGDEVSSIKS ASSSLTASLS KSFLFAFYNN RKKDKTSNNG VLSKEYWMKD
     ESSKECFSCG KTFNTFRRKH HCRICGQIFC SSCTLLIDGD RFGCHAKMRV CYNCYEHADT
     YEDSSDEEND STMQLNEPRS RSRSRSSNTN PYSHSHSHLH LISQDNHNGT DLHDPVAATD
     NPQQQNEVYL LNDDDVQSIM TSGEDSKLFI STPPPPPKMA IPATKQGGSL EISFDSENDR
     ALHYQDDNPG RHHHLDSVPT RYTIRDMDNI SHYDTNSNST LRPHYNTNNS TITINNLNNT
     TSNNSNYNNT NSNSNINNPA HSLRRSIFHY VSSNSVNKDS NNSSATPASS AQSSSILDPA
     NRIIGNYAHR NYKFKFNYNS KGPSQQNDTA NGNNDNNNNN NNNNNNNNNN SASGIADNNN
     IPSNDNGTTF TLDKKKRNPL TKSKSTSAYL EYPLNEEDSS EDEGSMSIYS VLNDDHKTDN
     PIRSMRNSTK SFQRAQASLQ RMRFRRKSKS KHFPNNSKSS IYRDLNFLTN STPNLLSVVS
     DDNLYDDSSP LQDKASSSAA SRLTDRKFSN SSGSNNNSNS NSNINTDPWK RIASISGFKL
     KKEKKRELNE VSLLHMHALL KQLLNDQEIS NLQEWITLLD GALRKVLRTI LNARDLNTLD
     FRQTYVKIKR ISGGSPQNSE YIDGVVFSKA LPSKTMPRHL KNPRILLIMF PLEYQKNNNH
     FLSIESVFRQ EREYLDKLVS RLKSLHPDII YVGANVSGYA LELLNDSGIV VQFNMKPQVI
     ERIAKLTEAD IAISVDKLAT NIKMGECETF EVKSYIYGNI SKTYTFLRGC NPELGGTILL
     RGDSLENLRK IKQVSEFMVY AIFSLKLESS FFNDNFIQLS TDVYLKRAES KKLQVFEGYF
     ADFLIKFNNR ILTVSPTVDF PIPFLLEKAR GLEKKLIERI NQYESESDLD RQTQLNMLQG
     LESTITKKHL GNLIKFLHEM EIENLELEFQ KRSRQWEVSY SSSQNLLGTG SHQSITVLYS
     MVSTKTATPC VGPQIVTIDY FWDSDISIGQ FIENVVGTAR YPCQQGCNGL YLDHYRSYVH
     GSGKVDVLIE KFQTRLPKLK DIILTWSYCK KCGTSTPILQ ISEKTWNHSF GKYLEVMFWS
     YKDSVTGIGK CPHDFTKDHV KYFGYNDLVV RLEYSDLEVH ELITPPRKIK WKPHIDIKLK
     VELYYKILEK INNFYGSVLS RLERIKLDSM TKDKVLSGQA KIIELKSNAT EEQKLMLQDL
     DTFYADSPCD QHLPLNLVIK SLYDKAVNWN STFAIFAKSY LPSETDISRI TAKQLKKLFY
     DSSRKDSEDK KSLHDEKAKT RKPEKNELPL EGLKDVEKPK IDSKNTTENR DRTNEPQNAV
     TITTFKDDTP IIPTSGTSHL TVTPSASSVS SSLTPQTEER PPISRSGTGI SMTHDKSTRP
     NIRKMSSDSS LCGLASLANE YSKNNKVSKL ATFFDQMHFD ALSKEFELER ERERLQLNKD
     KYQAIRLQTS TPIVEIYKNV KDAVDEPLHS RSSGNNLSSA NVKTLEAPVG EHSRANNCNP
     PNLDQNLETE LENSISQWGE NILNPSGKTT ASTHLNSKPV VKETSENPKS IVRESDNSKS
     EPLPPVITTT TVNKVESTPQ PEKSLLMKTL SNFWADRSAY LWKPLVYPTC PSEHIFTDSD
     VIIREDEPSS LIAFCLSTSD YRNKMMNLNV QQQQQQQTAE AAPAKTGGNS GGTTQTGDPS
     VNISPSVSTT SHNKGRDSEI SSLVTTKEGL LNTPPIEGAR DRTPQESQTH SQANLDTLQE
     LEKIMTKKTA THLRYQFEEG LTVMSCKIFF TEHFDVFRKI CDCQENFIQS LSRCVKWDSN
     GGKSGSGFLK TLDDRFIIKE LSHAELEAFI KFAPSYFEYM AQAMFHDLPT TLAKVFGFYQ
     IQVKSSISSS KSYKMDVIIM ENLFYEKKTT RIFDLKGSMR NRHVEQTGKA NEVLLDENMV
     EYIYESPIHV REYDKKLLRA SVWNDTLFLA KMNVMDYSLV IGIDNEGYTL TVGIIDFIRT
     FTWDKKLESW VKEKGLVGGA SVIKQPTVVT PRQYKKRFRE AMERYILMVP DPWYREGN
>P41807 vac VACUOLAR ATP SYNTHASE 54 KD SUBUNIT (EC 3.6.1.34) (V-ATPASE 54 KD
     MGATKILMDS THFNEIRSII RSRSVAWDAL ARSEELSEID ASTAKALESI LVKKNIGDGL
     SSSNNAHSGF KVNGKTLIPL IHLLSTSDNE DCKKSVQNLI AELLSSDKYG DDTVKFFQED
     PKQLEQLFDV SLKGDFQTVL ISGFNVVSLL VQNGLHNVKL VEKLLKNNNL INILQNIEQM
     DTCYVCIRLL QELAVIPEYR DVIWLHEKKF MPTLFKILQR ATDSQLATRI VATNSNHLGI
     QLQYHSLLLI WLLTFNPVFA NELVQKYLSD FLDLLKLVKI TIKEKVSRLC ISIILQCCST
     RVKQHKKVIK QLLLLGNALP TVQSLSERKY SDEELRQDIS NLKEILENEY QELTSFDEYV
     AELDSKLLCW SPPHVDNGFW SDNIDEFKKD NYKIFRQLIE LLQAKVRNGD VNAKQEKIII
     QVALNDITHV VELLPESIDV LDKTGGKADI MELLNHSDSR VKYEALKATQ AIIGYTFK
>P27801 vac VACUOLAR MEMBRANE PROTEIN PEP3.
     MIKTRIEEVQ LQFLTGNTEL THLKVSNDQL IVTTQRTIYR INLQDPAIVN HFDCPLSKEL
     ETIMNVHVSP MGSVILIRTN FGRYMLLKDG EFTQLNKIKN LDLSSLHWIN ETTFLMGIKK
     TPKLYRVELT GKDITTKLWY ENKKLSGGID GIAYWEGSLL LTIKDNILYW RDVTNMKFPL
     VLPDESEQFE RLKHHAIKKF DSYNGLFAWV TSNGIVFGDL KEKQMEKDPA SNNFGKFLSS
     SKVLLNFELP DYQNDKDHLI KDIVLTAFHI LLLRKNTVTM VSQLNNDVVF HETIPRHQLT
     GSNTDSNEKF LGLVRDSVKE TFWCFSNINV FEIIIENEPN SVWNLLVRDN KFDKALSLKG
     LTVREIESVK LSKAMYLFHT AKDFHSAAQT LGSMKDLSHF GEIALNFLQI KDYNDLNVIL
     IKQLDNVPWK STQVVLSSWI IWNFMKQLND IELKINTTKP ASTDEDNLLN WNLNLKEKSN
     ELTKFLESHL EKLDNETVYQ IMSKQNRQNE LLIFASLIND MKFLLSFWID QGNWYESLKI
     LLTINNHDLV YKYSLILLLN SPEATVSTWM KIKDLDPNKL IPTILKFFTN WQNNSKLITN
     ISEYPENYSL TYLKWCVREV PKMCNPIVYN SILYMMITDP RNDMILENDI IKFMKSNENK
     YDLNFQLRLS LKFKKTKTSI FLLTRLNLFE DAIDLALKNN LIDDCKVIVN DEILIEDYKL
     RKRLWLKIAK HLLLSMKDID IKQLIRTILN DSNEILTIKD LLPFFNEYTT IANLKEELIK
     FLENHNMKMN EISEDIINSK NLKVEINTEI SKFNEIYRIL EPGKSCDECG KFLQIKKFIV
     FPCGHCFHWN CIIRVILNSN DYNLRQKTEN FLKAKSKHNL NDLENIIVEK CGLCSDININ
     KIDQPISIDE TELAKWNE
>P25515 vac VACUOLAR ATP SYNTHASE 16 KD PROTEOLIPID SUBUNIT (EC 3.6.1.34).
     MTELCPVYAP FFGAIGCASA IIFTSLGAAY GTAKSGVGIC ATCVLRPDLL FKNIVPVIMA
     GIIAIYGLVV SVLVCYSLGQ KQALYTGFIQ LGAGLSVGLS GLAAGFAIGI VGDAGVRGSS
     QQPRLFVGMI LILIFAEVLG LYGLIVALLL NSRATQDVVC
>P32563 vac VACUOLAR ATP SYNTHASE 95.5 KD SUBUNIT (EC 3.6.1.34).
     MAEKEEAIFR SAEMALVQFY IPQEISRDSA YTLGQLGLVQ FRDLNSKVRA FQRTFVNEIR
     RLDNVERQYR YFYSLLKKHD IKLYEGDTDK YLDGSGELYV PPSGSVIDDY VRNASYLEER
     LIQMEDATDQ IEVQKNDLEQ YRFILQSGDE FFLKGDNTDS TSYMDEDMID ANGENIAAAI
     GASVNYVTGV IARDKVATLE QILWRVLRGN LFFKTVEIEQ PVYDVKTREY KHKNAFIVFS
     HGDLIIKRIR KIAESLDANL YDVDSSNEGR SQQLAKVNKN LSDLYTVLKT TSTTLESELY
     AIAKELDSWF QDVTREKAIF EILNKSNYDT NRKILIAEGW IPRDELATLQ ARLGEMIARL
     GIDVPSIIQV LDTNHTPPTF HRTNKFTAGF QSICDCYGIA QYREINAGLP TIVTFPFMFA
     IMFGDMGHGF LMTLAALSLV LNEKKINKMK RGEIFDMAFT GRYIILLMGV FSMYTGFLYN
     DIFSKTMTIF KSGWKWPDHW KKGESITATS VGTYPIGLDW AWHGTENALL FSNSYKMKLS
     ILMGFIHMTY SYFFSLANHL YFNSMIDIIG NFIPGLLFMQ GIFGYLSVCI VYKWAVDWVK
     DGKPAPGLLN MLINMFLSPG TIDDELYPHQ AKVQVFLLLM ALVCIPWLLL VKPLHFKFTH
     KKKSHEPLPS TEADASSEDL EAQQLISAMD ADDAEEEEVG SGSHGEDFGD IMIHQVIHTI
     EFCLNCVSHT ASYLRLWALS LAHAQLSSVL WTMTIQIAFG FRGFVGVFMT VALFAMWFAL
     TCAVLVLMEG TSAMLHSLRL HWVESMSKFF VGEGLPYEPF AFEYKDMEVA VASASSSASS
>P17891 ves CLATHRIN LIGHT CHAIN (CLC).
     MSEKFPPLED QNIDFTPNDK KDDDTDFLKR EAEILGDEFK TEQDDILETE ASPAKDDDEI
     RDFEEQFPDI NSANGAVSSD QNGSATVSSG NDNGEADDDF STFEGANQST ESVKEDRSEV
     VDQWKQRRAV EIHEKDLKDE ELKKELQDEA IKHIDDFYDS YNKKKEQQLE DAAKEAEAFL
     KKRDEFFGQD NTTWDRALQL INQDDADIIG GRDRSKLKEI LLRLKGNAKA PGA
>P22137 ves CLATHRIN HEAVY CHAIN.
     MSDLPIEFTE LVDLMSLGIS PQFLDFRSTT FESDHFVTVR ETKDGTNSVA IVDLAKGNEV
     TRKNMGGDSA IMHPSQMVIS VRANGTIVQI FNLETKSKLK SFTLDEPVIF WRWLSETTLG
     FVTARSILTS NVFDGNVNAK PQLLTLRHAN LNNTQIINFV ANKNLDWFAV VGILQENGRI
     AGRIQLFSKQ RNISQAIDGH VAIFTNILLE GNGSTPVQVF VTGNRNATTG AGELRIIEID
     HDASLPSQYQ KETTDIFFPP DATNDFPIAV QVSEKYGIIY LLTKYGFIHL YELETGTNLF
     VNRITAESVF TAAPYNHENG IACINKKGQV LAVEISTSQI VPYILNKLSN VALALIVATR
     GGLPGADDLF QKQFESLLLQ NDYQNAAKVA ASSTSLRNQN TINRLKNIQA PPGAISPILL
     YFSTLLDKGK LNKEETIELA RPVLQQDRKQ LFEKWLKEDK LECSEELGDI VKPFDTTLAL
     ACYLRAGAHA KVISCLAELQ QFEKIIPYCQ KVGYQPNFLV LISSLIRSSP DRASEFAVSL
     LQNPETASQI DIEKIADLFF SQNHIQQGTS LLLDALKGDT PDQGHLQTRV LEVNLLHAPQ
     VADAILGNNI FSHYDKPTIA SLSEKAGLYQ RALENYTDIK DIKRCVVHTN ALPIDWLVGY
     FGKLNVEQSL ACLKALMDNN IQANIQTVVQ VATKFSDLIG PSTLIKLFED YNATEGLYYY
     LASLVNLTED KDVVYKYIEA AAKMKQYREI ERIVKDNNVY DPERVKNFLK DANLEDQLPL
     VIVCDRFDFV HEMILYLYKS QNLKFIETYV QQVNPSKTAQ VVGALLDMDC DEAFIQSLLQ
     SVLGQVPINE LTTEVEKRNR LKILLPFLEQ SLSQGIQDQA VYNALAKIYI DSNNSPEKFL
     KENDQYDTLD VGHYCEKRDP YLAYIAYEKG QNDDDLIRIT NENSMYKYQA RYLLERSDLD
     LWNKVLNQEN IHRRQLIDSV ISVGIPELTD PEPVSLTVQA FMTNGLKLEL IELLEKIILE
     PSPFNENVAL QGLLLLSAIK YEPTKVSSYI EKLDNYDADE IAPLCIEHDL KEEAFEIYDK
     HEMYGKALKV LIEDIMSLDR AASYADKINT PELWSQIGTA QLDGLRIPDA IESYIKAEDP
     SNYENVIDIA EQAGKYEELI PFLLMARKTL KEPKIDGALI LAYAELNKIH EIENLLAGSN
     VANLDHVGDK LFENKEYKAA RLCYSAVSNY SKLASTLVYL GDYQAAVDTA RKASNIKVWK
     LVNDACIEKK EFKLAQICGL NLIVHAEELD ELVERYESNG YFEELISLFE AGLGLERAHM
     GMFTELAILY SKYEPDKTFE HLKLFWSRIN IPKVIRAVEQ AHLWSELVFL YAHYDEWDNA
     ALTLIEKSTK DLDHAYFKEV VVKVSNLEIY YKAINFYVKF HPSLLVDLLT SLTPRLDIPR
     TVKIFSKSDN LPLIKPFLIN VLPKNNSVVN QAYHDLMIEE EDYKALQDAV DSYDKFDQLG
     LASRLESHKL IFFKKIGALL YRRNKKWAKS LSILKEEKLW KDAIETAAIS QDPKVVEALL
     TYFVETGNRE GFVALLYAAY NLVRIEFVLE ISWMNSLEDY IKPFEISIKK EQNDSIKKIT
     EELAKKSGSN EEHKDGQPLM LMNSAMNVQP TGF
>P32802 ves ENDOSOMAL P24A PROTEIN PRECURSOR (70 KD ENDOMEMBRANE PROTEIN)
     MIYKMAHVQL LLLYFFVSTV KAFYLPGVAP TTYRENDNIP LLVNHLTPSM NYQHKDEDGN
     NVSGDKENFL YSYDYYYNRF HFCQPEKVEK QPESLGSVIF GDRIYNSPFQ LNMLQEKECE
     SLCKTVIPGD DAKFINKLIK NGFFQNWLID GLPAAREVYD GRTKTSFYGA GFNLGFVQVT
     QGTDIEATPK GAETTDKDVE LETRNDCNMV KTYELPYFAN HFDIMIEYHD RGEGNYRVVG
     VIVEPVSIKR SSPGTCETTG SPLMLDEEND NEVYFTYSVK FNESATSWAT RWDKYLHVYD
     PSIQWFSLIN FSLVVVLLSS VVIHSLLRAL KSDFARYNEL NLDDDFQEDS GWKLNHGDVF
     RSPSQSLTLS ILVGSGVQLF LMVTCSIFFA ALGFLSPSSR GSLATVMFIL YALFGFVGSY
     TSMGIYKFFN GPYWKANLIL TPLLVPGAIL LIIIALNFFL MFVHSSGVIP ASTLFFMVFL
     WFLFSIPSSF AGSLIARKRC HWDEHPTKTN QIARQIPFQP WYLKTIPATL IAGIFPFGSI
     AVELYFIYTS LWFNKIFYMF GFLFFSFLLL TLTSSLVTIL ITYHSLCLEN WKWQWRGFII
     GGAGCALYVF IHSILFTKFK LGGFTTIVLY VGYSSVISLL CCLVTGSIGF ISSMLFVRKI
     YSSIKVD
>P43555 ves 47 KD ENDOMEMBRANE PROTEIN PRECURSOR (ENDOSOMAL P44 PROTEIN).
     MMMLITMKST VLLSVFTVLA TWAGLLEAHP LGDTSDASKL SSDYSLPDLI NARKVPNNWQ
     TGEQASLEEG RIVLTSKQNS KGSLWLKQGF DLKDSFTMEW TFRSVGYSGQ TDGGISFWFV
     QDSNVPRDKQ LYNGPVNYDG LQLLVDNNGP LGPTLRGQLN DGQKPVDKTK IYDQSFASCL
     MGYQDSSVPS TIRVTYDLED DNLLKVQVDN KVCFQTRKVR FPSGSYRIGV TAQNGAVNNN
     AESFEIFKMQ FFNGVIEDSL IPNVNAMGQP KLITKYIDQQ TGKEKLIEKT AFDADKDKIT
     NYELYKKLDR VEGKILANDI NALETKLNDV IKVQQELLSF MTTITKQLSS KPPANNEKGT
     STDDAIAEDK ENFKDFLSIN QKLEKVLVEQ EKYREATKRH GQDGPQVDEI ARKLMIWLLP
     LIFIMLVMAY YTFRIRQEII KTKLL
>Q00776 ves CLATHRIN COAT ASSEMBLY PROTEIN AP54 (CLATHRIN COAT ASSOCIATED PROTEIN
     MASAVYFCDH NGKPLLSRRY RDDIPLSAID KFPILLSDLE EQSNLIPPCL NHNGLEYLFI
     QHNDLYVVAI VTSLSANAAA IFTFLHKLVE VLSDYLKTVE EESIRDNFVI IYELLDEVMD
     YGIPQITETK MLKQYITQKS FKLVKSAKKK RNATRPPVAL TNSVSWRPEG ITHKKNEAFL
     DIVESINMLM TQKGQVLRSE IIGDVKVNSK LSGMPDLKLG INDKGIFSKY LDDDTNIPSA
     SATTSDNNTE TDKKPSITSS SATNKKKVNI ELEDLKFHQC VRLSKFENEK IITFIPPDGK
     FDLMNYRLST TIKPLIWCDV NVQVHSNSRI EIHCKAKAQI KRKSTATNVE ILIPVPDDAD
     TPTFKYSHGS LKYVPEKSAI LWKIRSFPGG KEYSMSAELG LPSISNNEDG NRTMPKSNAE
     ILKGPVQIKF QIPYFTTSGI QVRYLKINEP KLQYKSYPWV RYITQSGDDY TIRLT
>P25386 ves INTRACELLULAR PROTEIN TRANSPORT PROTEIN USO1.
     MDIIQGLIQQ PKIQSVDETI PTLCDRVENS TLISDRRSAV LGLKAFSRQY RESVIASGLK
     PLLNTLKRDY MDEDSVKAIL ETILILFIRG DGHDDLTRGW ISQQSRLQNG KYPSPLVMKQ
     EKEQVDQFSL WIADALTQSE DLIHLLVEFW EIDNFHIRLY TIQLLEAVMA TRPLKARSAL
     ISLPTSISTM VSLLDDMHEP IRDEAILLLM AVVNDSPHVQ KLVAFENIFE RLFSIIEEEG
     GLRGSLVVND CLSLINNILK YNTSNQTLFL ETGNLPKLAH LLSEPISQDE VFFWNDQRIV
     NINTALDIVS LTVEPGNTVT TKHQNALLDS SVLMVVLRLA FFHNIPKKVR PVALLTAANM
     VRSNEHAQLE FSKIDVPYFD PSLPVNSTAT AGPIKLIPVV SILINWMLYA NSVHTFDTRV
     ACSRLLKAYF MDNFDLQRDF LLKQVQLCNN STNNVGDNAK ENGGSNKSDK ESDSDKDTDG
     KDGTEYEGSF KANLFEVLLN YDAELNLNPF KLFFTTDIFM FFFQQDHKYS EELREITRNV
     TTGNDLEDEE PLKAIQTISE LLTTSLTAAD IRIPISYLTF LIYWLFGDFK ATNDFLSDKS
     VIKSLLSFSY QIQDEDVTIK CLVTMLLGVA YEFSSKESPF PRKEYFEFIT KTLGKDNYAS
     RIKQFKKDSY FSKVDMNEDS ILTPELDETG LPKVYFSTYF IQLFNENIYR IRTALSHDPD
     EEPISKISFE EVEKLQRQCT KLKGEITSLQ TETESTHENL TEKLIALTNE HKELDEKYQI
     LNSSHSSLKE NFSILETELK NVRDSLDEMT QLRDVLETKD KENQTALLEY KSTIHKQEDS
     IKTLEKGLET ILSQKKKAED GINKMGKDLF ALSREMQAVE ENCKNLQKEK DKSNVNHQKE
     TKSLKEDIAA KITEIKAINE NLEEMKIQCN NLSKEKEHIS KELVEYKSRF QSHDNLVAKL
     TEKLKSLANN YKDMQAENES LIKAVEESKN ESSIQLSNLQ NKIDSMSQEK ENFQIERGSI
     EKNIEQLKKT ISDLEQTKEE IISKSDSSKD EYESQISLLK EKLETATTAN DENVNKISEL
     TKTREELEAE LAAYKNLKNE LETKLETSEK ALKEVKENEE HLKEEKIQLE KEATETKQQL
     NSLRANLESL EKEHEDLAAQ LKKYEEQIAN KERQYNEEIS QLNDEITSTQ QENESIKKKN
     DELEGEVKAM KSTSEEQSNL KKSEIDALNL QIKELKKKNE TNEASLLESI KSVESETVKI
     KELQDECNFK EKEVSELEDK LKASEDKNSK YLELQKESEK IKEELDAKTT ELKIQLEKIT
     NLSKAKEKSE SELSRLKKTS SEERKNAEEQ LEKLKNEIQI KNQAFEKERK LLNEGSSTIT
     QEYSEKINTL EDELIRLQNE NELKAKEIDN TRSELEKVSL SNDELLEEKQ NTIKSLQDEI
     LSYKDKITRN DEKLLSIERD NKRDLESLKE QLRAAQESKA KVEEGLKKLE EESSKEKAEL
     EKSKEMMKKL ESTIESNETE LKSSMETIRK SDEKLEQSKK SAEEDIKNLQ HEKSDLISRI
     NESEKDIEEL KSKLRIEAKS GSELETVKQE LNNAQEKIRI NAEENTVLKS KLEDIERELK
     DKQAEIKSNQ EEKELLTSRL KELEQELDST QQKAQKSEEE RRAEVRKFQV EKSQLDEKAM
     LLETKYNDLV NKEQAWKRDE DTVKKTTDSQ RQEIEKLAKE LDNLKAENSK LKEANEDRSE
     IDDLMLLVTD LDEKNAKYRS KLKDLGVEIS SDEEDDEEDD EEDEEEGQVA
>P11655 ves MEMBRANE GLYCOPROTEIN SEC12.
     MKFVTASYNV GYPAYGAKFL NNDTLLVAGG GGEGNNGIPN KLTVLRVDPT KDTEKEQFHI
     LSEFALEDND DSPTAIDASK GIILVGCNEN STKITQGKGN KHLRKFKYDK VNDQLEFLTS
     VDFDASTNAD DYTKLVYISR EGTVAAIASS KVPAIMRIID PSDLTEKFEI ETRGEVKDLH
     FSTDGKVVAY ITGSSLEVIS TVTGSCIARK TDFDKNWSLS KINFIADDTV LIAASLKKGK
     GIVLTKISIK SGNTSVLRSK QVTNRFKGIT SMDVDMKGEL AVLASNDNSI ALVKLKDLSM
     SKIFKQAHSF AITEVTISPD STYVASVSAA NTIHIIKLPL NYANYTSMKQ KISKFFTNFI
     LIVLLSYILQ FSYKHNLHSM LFNYAKDNFL TKRDTISSPY VVDEDLHQTT LFGNHGTKTS
     VPSVDSIKVH GVHETSSVNG TEVLCTESNI INTGGAEFEI TNATFREIDD A
>P25385 ves VESICULAR TRANSPORT PROTEIN BOS1.
     MNALYNHAVK QKNQLQQELA RFEKNSVTAP ISLQGSISAT LVSLEKTVKQ YAEHLNRYKE
     DTNAEEIDPK FANRLATLTQ DLHDFTAKFK DLKQSYNENN SRTQLFGSGA SHVMDSDNPF
     STSETIMNKR NVGGASANGK EGSSNGGGLP LYQGLQKEQS VFERGNAQLD YILEMGQQSF
     ENIVEQNKIL SKVQDRMSNG LRTLGVSEQT ITSINKRVFK DKLVFWIALI LLIIGIYYVL
     KWLR
>P17898 ves DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE (EC 2.7.8.2) (SN-1,2-
     MRIARIVKHL YQSDDRSFLS NHVLRPFWRK FATIFPLWMA PNLVTLLGFC FIIFNVLTTL
     YYDPYFDQES PRWTYFSYAI GLFLYQTFDA CDGMHARRTG QQGPLGELFD HCIDSINTTL
     SMIPVCSMTG MGYTYMTIFS QFAILCSFYL STWEEYHTHK LYLAEFCGPV EGIIVLCISF
     IAVGIYGPQT IWHTKVAQFS WQDFVFDVET VHLMYAFCTG ALIFNIVTAH TNVVRYYESQ
     STKSATPSKT AENISKAVNG LLPFFAYFSS IFTLVLIQPS FISLALILSI GFSVAFVVGR
     MIIAHLTMQP FPMVNFPFLI PTIQLVLYAF MVYVLDYQKG SIVSALVWMG LGLTLAIHGM
     FINDIIYDIT TFLDIYALSI KHPKEI
>P22140 ves ETHANOLAMINEPHOSPHOTRANSFERASE (EC 2.7.8.1) (ETHPT).
     MGYFVPDSHI ENLKSYKYQS EDRSLVSKYF LKPFWQRFCH IFPTWMAPNI ITLSGFAFIV
     INVLTVFYYD PNLNTDTPRW TYFSYALGVF LYQTFDGCDG VHARRINQSG PLGELFDHSI
     DAINSTLSIF IFASETGMGF SYNLMLSQFA MLTNFYLSTW EEYHTHTLYL SEFSGPVEGI
     LIVCVSLILT GIYGKQVIWH TYLFTITVGD KVIDVDTLDI VFSLAVFGLV MNALSAKRNV
     DKYYRNSTSS ANNITQIEQD SAIKGLLPFF AYYASIALLV WMQPSFITLS FILSVGFTGA
     FTVGRIIVCH LTKQSFPMFN APMLIPLCQI VLYKICLSLW GIESNKIVFA LSWLGFGLSL
     GVHIMFMNDI IHEFTEYLDV YALSIKRSKL T
>P37296 ves VACUOLAR ATP SYNTHASE 101 KD SUBUNIT (EC 3.6.1.34) (V-ATPASE SUBUNIT
     MNQEEAIFRS ADMTYVQLYI PLEVIREVTF LLGKMSVFMV MDLNKDLTAF QRGYVNQLRR
     FDEVERMVGF LNEVVEKHAA ETWKYILHID DEGNDIAQPD MADLINTMEP LSLENVNDMV
     KEITDCESRA RQLDESLDSL RSKLNDLLEQ RQVIFECSKF IEVNPGIAGR ATNPEIEQEE
     RDVDEFRMTP DDISETLSDA FSFDDETPQD RGALGNDLTR NQSVEDLSFL EQGYQHRYMI
     TGSIRRTKVD ILNRILWRLL RGNLIFQNFP IEEPLLEGKE KVEKDCFIIF THGETLLKKV
     KRVIDSLNGK IVSLNTRSSE LVDTLNRQID DLQRILDTTE QTLHTELLVI HDQLPVWSAM
     TKREKYVYTT LNKFQQESQG LIAEGWVPST ELIHLQDSLK DYIETLGSEY STVFNVILTN
     KLPPTYHRTN KFTQAFQSIV DAYGIATYKE INAGLATVVT FPFMFAIMFG DMGHGFILFL
     MALFLVLNER KFGAMHRDEI FDMAFTGRYV LLLMGAFSVY TGLLYNDIFS KSMTIFKSGW
     QWPSTFRKGE SIEAKKTGVY PFGLDFAWHG TDNGLLFSNS YKMKLSILMG YAHMTYSFMF
     SYINYRAKNS KVDIIGNFIP GLVFMQSIFG YLSWAIVYKW SKDWIKDDKP APGLLNMLIN
     MFLAPGTIDD QLYSGQAKLQ VVLLLAALVC VPWLLLYKPL TLRRLNKNGG GGRPHGYQSV
     GNIEHEEQIA QQRHSAEGFQ GMIISDVASV ADSINESVGG GEQGPFNFGD VMIHQVIHTI
     EFCLNCISHT ASYLRLWALS LAHAQLSSVL WDMTISNAFS SKNSGSPLAV MKVVFLFAMW
     FVLTVCILVF MEGTSAMLHA LRLHWVEAMS KFFEGEGYAY EPFSFRAIIE
>P27351 ves PROBABLE BETA-ADAPTIN (CLATHRIN ASSEMBLY PROTEIN LARGE BETA CHAIN)
     MSDQKVFARY KANEIVTDLQ HFGVKKFKSN ITRRKNALRK IIANLVLGNY GEMSVLFSEL
     LKFWQIEDDL EVKRICHEYI RVIGALKPQQ AREALPFIMD DFKSRDEKLQ IMALRTLVLV
     PVKELSDQAF DCIISLVNHK SPPEQVTRTA IYALLDLDEI DHERVLGLSS ILHDIVKAQS
     SSPEVIVAAL HTLYSIHEKN ANMEPFRIPL ELAFDMLELL PELNEWNKAT VLEVLTTSVV
     PQHYLDTHEM IELALPYLQQ VNTYVVLNSL KFIMYLLNYV DVIKETLAEK LSNSVIALLD
     KPPELQFLVL RNVILLLLSR ESSLLRLDIS YFFIEYNDPI YIKDTKLECL YLLANKETLP
     RILEELEQYA TDIDIQMSRK SVRAIGNLAV KLDEDSVHDC VAVLLDLLEF GVDYVVQEII
     SVFRNILRKY PNNFKANVTE LVKHTEVVQE PESKNAMIWI ITQYSDVIPN YLELFRVFSS
     NMFSETLEVQ FSILNSAIKF FIRSPTKETE ELCMDLLKGC IDHENNPDLR DKTLMYWRLL
     SLTKTSRISN AITFESLKSV LDGELPLIEM NTKLDPTVLE ELELNIGTIV SIYLKPVSHI
     FRLNKTKLLP QSPILNPNKD LLPVVGNSFP PTGANRDRQN SESQSSTKSR KTAMMDDYDK
     PAEKINQLKG KRKSSSNNPS KLSRKPSTLL RKLSMKRPFS
>P35181 ves CLATHRIN COAT ASSEMBLY PROTEIN AP19 (CLATHRIN COAT ASSOCIATED PROTEIN
     MTQLKYLLLV SRQGKIRLKK WYTAMSAGEK AKIVKDLTPT ILARKPKMCN IIEYNDHKVV
     YKRYASLYFI VGMTPDVDNE LLTLEIIHRF VETMDTYFGN VCELDIIFNF SKVYDILNEM
     IMCDGSIAES SRKEVLHHVT VMDTMESNDN LERVLS
>P36000 ves PROBABLE BETA-ADAPTIN (CLATHRIN ASSEMBLY PROTEIN LARGE BETA CHAIN)
     MPPLDKRIKK FLKDSIRIAP KISGKGELSE LRTGLVSQYP QTRKDAIKKT IQQMTLGKDV
     SSLFPDVLKN IATIDVEQKK LVYLYVMNYA ETHPELCILA VNTFITDAQD PNPLIRCMAI
     RTMSMIRVDK ILEYIETPLR RTLHDDNAYV RKTAVICVAK LFQLNKDLCV ELGVVEDLVN
     ALDDSNPLVI ANATAALIEI HNMDMDAVDL SSLIQSHVSQ FLLALNECTE WARIIILGTL
     SEYSAKDSLE AQDIIDRVTA HLQHVNPAVV LATIKVIVRN LPQIEYSSNS LIMKRLSSAF
     VSLMSTPPEM QYVALKNIRI ILEKYPELLT KELRIFYVKF NDPLYVKLEK IDILVRLVDP
     SNLKQCTLLL TELKEYAMEY EPEFVSRAIQ ALSQLGIKYA QESFVSKVLD ILLELLERQD
     TIKDDCCISL CDLLRHCPGN DKMAKQVCAV FNTWSNPEVL LQSDIAKCNY VWLLGQHPNN
     FSDLESKINI FIENFVQEEA LTQMSLLMTI VRLHATLTGS MLQSVLELAT QQTHELDVRD
     MAMMYWRCLS MPNNESLVND LCQNKLPMIS NTLEKFSPEV LEKLLMELGT ISSIYFKPDS
     NRRKGKKYVQ NIVKGKHIEE LESMAKNEIS SKANDDVLLD FDERDDVTNT NAGMLNTLTT
     LGDLDDLFDF GPSEDATQIN TNDTKAVQGL KELKLGGDSN GISSGGKNNP DVSGGNIVSQ
     DLLDLF
>Q00381 ves CLATHRIN COAT ASSEMBLY PROTEIN AP17 (CLATHRIN COAT ASSOCIATED PROTEIN
     MAVQFILCFN KQGVVRLVRW FDVHSSDPQR SQDAIAQIYR LISSRDHKHQ SNFVEFSDST
     KLIYRRYAGL YFVMGVDLLD DEPIYLCHIH LFVEVLDAFF GNVCELDIVF NFYKVYMIMD
     EMFIGGEIQE ISKDMLLERL SILDRLD
